Citrus Sinensis ID: 005693
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 682 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LVM0 | 654 | Probable inactive recepto | yes | no | 0.904 | 0.943 | 0.709 | 0.0 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.913 | 0.973 | 0.619 | 0.0 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.892 | 0.951 | 0.576 | 0.0 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.878 | 0.910 | 0.551 | 1e-178 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.873 | 0.934 | 0.503 | 1e-166 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.844 | 0.879 | 0.468 | 1e-146 | |
| Q9SH71 | 587 | Putative inactive recepto | no | no | 0.835 | 0.971 | 0.443 | 1e-141 | |
| Q9FK10 | 601 | Probable inactive recepto | no | no | 0.819 | 0.930 | 0.461 | 1e-140 | |
| Q9FL63 | 614 | Inactive leucine-rich rep | no | no | 0.831 | 0.923 | 0.444 | 1e-138 | |
| Q9FMD7 | 625 | Probable inactive recepto | no | no | 0.872 | 0.952 | 0.432 | 1e-136 |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/627 (70%), Positives = 519/627 (82%), Gaps = 10/627 (1%)
Query: 60 LCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF 119
L V + A ADLNSDRQALL FA +VPHLR+LNW+STN IC+SWVG+ CT D T V
Sbjct: 31 LFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSDGTSVH 90
Query: 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 179
LRLPGIGL+GPIP NTLGKL++L +LSLRSN+L+G LP +I SLPSL Y+YLQHNNFSG
Sbjct: 91 ALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSG 150
Query: 180 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 239
++PS S QL +LDLSFNSFTG IP + QNL QLTGLSLQ+N LSG +PN D LR LN
Sbjct: 151 EVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLN 210
Query: 240 LSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPS--PTYSPPPF--IPRK 295
LS N L GSIPS+L FP+SSF GN+LLCG PL+ C +P PS P S PP P K
Sbjct: 211 LSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHK 270
Query: 296 QSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPK 355
+ SK+KL + II IA GG+A+LLL+ ++ILC C+KKKD + + K K +EK K
Sbjct: 271 EGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT----LTEKAK 326
Query: 356 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 415
+EFGSGVQEPEKNKLVFF GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK
Sbjct: 327 QEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 386
Query: 416 RLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGN 475
RLKEV GKR+FEQQMEI+ RVG HP+VVPLRAYYYSKDEKL+V DY+ +G+LS+LLHGN
Sbjct: 387 RLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGN 446
Query: 476 RGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535
RG+ +TPLDW++RVKI L A+G+AH+H+ GGPKF+HGNIK+SNV++ Q+ D CISDFGL
Sbjct: 447 RGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGL 506
Query: 536 TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
TPLM VP P R AGYRAPEV+ETRKH+HKSDVYSFGVL+LEMLTGK+P+QSP+RDDMVD
Sbjct: 507 TPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVD 566
Query: 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655
LPRWVQSVVREEWT+EVFD+ELMRFQNIEEEMVQMLQI MACVA+VP++RP MD+VVRMI
Sbjct: 567 LPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMI 626
Query: 656 EEVRQSDSE-NRPSSEEN-KSKDSNVQ 680
EE+R SDSE RPSS++N K KDSNVQ
Sbjct: 627 EEIRVSDSETTRPSSDDNSKPKDSNVQ 653
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 758 bits (1957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/639 (61%), Positives = 469/639 (73%), Gaps = 16/639 (2%)
Query: 53 AAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCT 112
AA LF + VS AD+ SD+QALL+FA VPH RKLNW+ST PIC SW GI C+
Sbjct: 6 AAFLFLLVTTFVSRC--LSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGITCS 63
Query: 113 QDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYL 172
++ RV LRLPG GL GP+P T KLDAL ++SLRSN L G +PS I SLP +R LY
Sbjct: 64 KNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYF 123
Query: 173 QHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI 232
NNFSG IP S +LV LDLS NS +GNIP S+QNLTQLT LSLQ+N+LSG IPN
Sbjct: 124 HENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLP- 182
Query: 233 PKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFI 292
P+L++LNLS+N L GS+PSS++ FP SSF GNSLLCG PL C +PSP+ + P
Sbjct: 183 PRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPTEG 242
Query: 293 PR-----KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASS 347
P + ++K+ L GAI+ IAVGGS +L ++ +I C KK+D G + + KA
Sbjct: 243 PGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKP 302
Query: 348 GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 407
G RS+ EEFGSGVQE EKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGT YKA+LE
Sbjct: 303 G-RSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILE 361
Query: 408 ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467
E TTVVVKRLKEV GKR+FEQQME VGR+ H NV PLRAYY+SKDEKLLVYDY+ G+
Sbjct: 362 EGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGN 421
Query: 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 527
S LLHGN GR LDWETR++I L ARG++HIHS G K HGNIK+ NVL+ Q+L
Sbjct: 422 FSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELH 481
Query: 528 GCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
C+SDFG+ PLM+ PSRS GYRAPE IETRKH+ KSDVYSFGVLLLEMLTGKA +
Sbjct: 482 VCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGK 541
Query: 587 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-NIEEEMVQMLQIGMACVAKVPDMR 645
+ +++VDLP+WVQSVVREEWT EVFDVEL++ Q N+EEEMVQMLQI MACV+K PD R
Sbjct: 542 TTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSR 601
Query: 646 PNMDEVVRMIEEVRQS----DSENRPSSEEN-KSKDSNV 679
P+M+EVV M+EE+R S S NR SS E +S DS V
Sbjct: 602 PSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSDSPV 640
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 708 bits (1827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/633 (57%), Positives = 457/633 (72%), Gaps = 24/633 (3%)
Query: 53 AAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCT 112
AA FF L ++L ADL SD QALL+FA +VPH KLNW+ +C SW+GI C
Sbjct: 10 AASFFFLLLAATAVL--VSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCD 67
Query: 113 QDR--TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYL 170
+ +RV +RLPG+GL G IP TLGKLDAL+VLSLRSN L G LPS+I SLPSL YL
Sbjct: 68 ESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYL 127
Query: 171 YLQHNNFSGKIPS----SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS 226
YLQHNNFSG++ + S S QLVVLDLS+NS +GNIP ++NL+Q+T L LQ+N+ G
Sbjct: 128 YLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGP 187
Query: 227 IPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTY 286
I + D+P ++ +NLSYN L G IP L+K P SF+GNSLLCGPPL AC A SPS
Sbjct: 188 IDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNL 247
Query: 287 SPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKG-KA 345
P P +++ IIAI VG S +L + +V L CL KK G +G +
Sbjct: 248 -PRPLTENLHPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLV-CLVKKTKKEEGGGEGVRT 305
Query: 346 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 405
GG + K ++FGSGVQ+PEKNKL FFE C++NFDLEDLL+ASAEVLGKGS+GTAYKAV
Sbjct: 306 QMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAV 365
Query: 406 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465
LE++T VVVKRL+EVV K++FEQQMEIVG++ QH N VPL AYYYSKDEKLLVY Y
Sbjct: 366 LEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTK 425
Query: 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525
GSL ++HGNRG +DWETR+KI GT++ ++++HS+ KF HG+IK+SN+L+ +D
Sbjct: 426 GSLFGIMHGNRG--DRGVDWETRMKIATGTSKAISYLHSL---KFVHGDIKSSNILLTED 480
Query: 526 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
L+ C+SD L L N+P R+ GY APEVIETR+ S +SDVYSFGV++LEMLTGK PL
Sbjct: 481 LEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPL 540
Query: 586 QSPTRDD---MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 642
P +D ++DLPRWV+SVVREEWTAEVFDVEL++FQNIEEEMVQMLQ+ +ACVA+ P
Sbjct: 541 TQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNP 600
Query: 643 DMRPNMDEVVRMIEEVRQSD-----SENRPSSE 670
+ RP M+EV RMIE+VR+ D +NR SSE
Sbjct: 601 ESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSE 633
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1615), Expect = e-178, Method: Compositional matrix adjust.
Identities = 346/627 (55%), Positives = 448/627 (71%), Gaps = 28/627 (4%)
Query: 76 SDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNN 135
+++QALL F +PH +L W+ ++ C +WVG+ C +++ + LRLPG GLVG IP+
Sbjct: 27 AEKQALLTFLQQIPHENRLQWNESDSAC-NWVGVECNSNQSSIHSLRLPGTGLVGQIPSG 85
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLD 193
+LG+L L VLSLRSN L+G +PS+ ++L LR LYLQHN FSG+ P+SF+ L+ LD
Sbjct: 86 SLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLD 145
Query: 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253
+S N+FTG+IP S+ NLT LTGL L +N SG++P+ + L N+S N L GSIPSSL
Sbjct: 146 ISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL-GLVDFNVSNNNLNGSIPSSL 204
Query: 254 QKFPNSSFVGNSLLCGPPLKAC--FPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIA 311
+F SF GN LCG PLK C F V+PSPSP+ P R S K KL AI+AI
Sbjct: 205 SRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPS--NRLSSKKSKLSKAAIVAII 262
Query: 312 VGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSG----------GRSEKPKEEFG-- 359
V + V LL+ ++L CL+K+ + +K +G G S +E G
Sbjct: 263 VASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTS 322
Query: 360 SGVQ-EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 418
SG+ E E+NKLVF EG Y+FDLEDLLRASAEVLGKGS GT+YKAVLEE TTVVVKRLK
Sbjct: 323 SGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK 382
Query: 419 EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA 478
+V+ K++FE QME+VG++ +HPNV+PLRAYYYSKDEKLLV+D+ +GSLS LLHG+RG+
Sbjct: 383 DVMASKKEFETQMEVVGKI-KHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGS 441
Query: 479 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538
GRTPLDW+ R++I + ARG+AH+H K HGNIKASN+L++ + D C+SD+GL L
Sbjct: 442 GRTPLDWDNRMRIAITAARGLAHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLNQL 499
Query: 539 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 598
+ + P+R AGY APEV+ETRK + KSDVYSFGVLLLE+LTGK+P Q+ ++ +DLPR
Sbjct: 500 FSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPR 559
Query: 599 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
WV SVVREEWTAEVFDVELMR+ NIEEEMVQ+LQI MACV+ VPD RP M EV+RMIE+V
Sbjct: 560 WVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619
Query: 659 RQSDSEN---RPSSEENKSKDSNVQTP 682
+S++ + R SS++ SK S QTP
Sbjct: 620 NRSETTDDGLRQSSDD-PSKGSEGQTP 645
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 584 bits (1506), Expect = e-166, Method: Compositional matrix adjust.
Identities = 314/624 (50%), Positives = 416/624 (66%), Gaps = 28/624 (4%)
Query: 70 AFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLV 129
A +D D++ALL+F + R LNW+ T+ +C W G+ C QD +R+ +RLPG+GL
Sbjct: 22 ANSDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLN 81
Query: 130 GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--P 187
G IP NT+ +L AL VLSLRSN+++G P + L L +LYLQ NN SG +P FS
Sbjct: 82 GQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWK 141
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-PKLRHLNLSYN-GL 245
L ++LS N F G IP S+ L ++ L+L +N LSG IP+ + L+H++LS N L
Sbjct: 142 NLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDL 201
Query: 246 KGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLG 305
G IP L++FP SS+ G ++ PP V P P P +K S + LGL
Sbjct: 202 AGPIPDWLRRFPFSSYTGIDII--PPGGNYTLVTPPP-----PSEQTHQKPSKARFLGLS 254
Query: 306 AIIAI----AVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGK-ASSGGRSEKPKEEFGS 360
+ + AV + L ++ +CY +K G +S K GG S E+F S
Sbjct: 255 ETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKGGMS---PEKFVS 311
Query: 361 GVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEV 420
+++ N+L FFEGC+Y+FDLEDLLRASAEVLGKG++GT YKAVLE++T+V VKRLK+V
Sbjct: 312 RMEDV-NNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDV 370
Query: 421 VVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR 480
GKRDFEQQMEI+G + +H NVV L+AYYYSKDEKL+VYDYF+ GS+++LLHGNRG R
Sbjct: 371 AAGKRDFEQQMEIIGGI-KHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENR 429
Query: 481 TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540
PLDWETR+KI +G A+G+A IH K HGNIK+SN+ +N + +GC+SD GLT +M+
Sbjct: 430 IPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMS 489
Query: 541 VPATP-SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 599
A P SR AGYRAPEV +TRK S SDVYSFGV+LLE+LTGK+P+ + D+++ L RW
Sbjct: 490 PLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRW 549
Query: 600 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV- 658
V SVVREEWTAEVFD+EL+R+ NIEEEMV+MLQI M+CV K D RP M ++VR+IE V
Sbjct: 550 VHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVG 609
Query: 659 --RQS---DSENRPSSEENKSKDS 677
R S + E +P SE S+ S
Sbjct: 610 NRRTSIEPEPELKPKSENGASETS 633
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1338), Expect = e-146, Method: Compositional matrix adjust.
Identities = 292/623 (46%), Positives = 388/623 (62%), Gaps = 47/623 (7%)
Query: 73 DLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI 132
DLN+DR ALL AV R W+ +W G+ C + RV LRLPG+ L G I
Sbjct: 32 DLNADRTALLSLRSAVGG-RTFRWNIKQTSPCNWAGVKC--ESNRVTALRLPGVALSGDI 88
Query: 133 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS-PQLV 190
P G L L LSLR N L+G LP ++++ +LR+LYLQ N FSG+IP FS LV
Sbjct: 89 PEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLV 148
Query: 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 250
L+L+ NSFTG I NLT+L L L++N LSGSIP+ D+P L N+S N L GSIP
Sbjct: 149 RLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLP-LVQFNVSNNSLNGSIP 207
Query: 251 SSLQKFPNSSFVGNSLLCGPPLKAC-----FPVAPSPSPTYSPPPFI-PRKQSSKQKLGL 304
+LQ+F + SF+ SL CG PLK C P P+ +PP ++ K KL
Sbjct: 208 KNLQRFESDSFLQTSL-CGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSG 266
Query: 305 GAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKP-----KEEFG 359
GAI I +G L+ L+++ C KK SN S+ S + ++P KE
Sbjct: 267 GAIAGIVIGCVVGFALIVLILMVLCRKK----SNKRSRAVDISTIKQQEPEIPGDKEAVD 322
Query: 360 SGV---------------------QEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSY 398
+G P KLVFF + FDLEDLLRASAEVLGKG++
Sbjct: 323 NGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTF 382
Query: 399 GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 458
GTAYKAVL+ T V VKRLK+V++ ++F++++E+VG + H N+VPLRAYY+S+DEKLL
Sbjct: 383 GTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAM-DHENLVPLRAYYFSRDEKLL 441
Query: 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 518
VYD+ GSLS LLHGNRGAGR+PL+W+ R +I +G ARG+ ++HS G +HGNIK+S
Sbjct: 442 VYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQG-TSTSHGNIKSS 500
Query: 519 NVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 577
N+L+ + D +SDFGL L+ AT P+R+ GYRAPEV + ++ S K DVYSFGV+LLE
Sbjct: 501 NILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLE 560
Query: 578 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV-QMLQIGMA 636
++TGKAP S ++ VDLPRWV+SV R+EW EVFD EL+ EEEM+ +M+Q+G+
Sbjct: 561 LITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLE 620
Query: 637 CVAKVPDMRPNMDEVVRMIEEVR 659
C ++ PD RP M EVVR +E +R
Sbjct: 621 CTSQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1293), Expect = e-141, Method: Compositional matrix adjust.
Identities = 276/622 (44%), Positives = 389/622 (62%), Gaps = 52/622 (8%)
Query: 56 LFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDR 115
LFF +I+ + ++ L D++ALL F + R L+W+ ++ +C SW G+ C ++
Sbjct: 5 LFF-FSLILCFVLISSQTLEDDKKALLHFLSSFNSSR-LHWNQSSDVCHSWTGVTCNENG 62
Query: 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 175
R+ +RLP +G G IP T+ +L +L+ LSLR N TG PS+ T+L SL +LYLQHN
Sbjct: 63 DRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQHN 122
Query: 176 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP 233
+ SG + + FS L VLDLS N F G+IP S+ LT L L+L +N+ SG IPN +P
Sbjct: 123 HLSGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPNLHLP 182
Query: 234 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIP 293
KL +NLS N L G+IP SLQ+F +S+F GN+L
Sbjct: 183 KLSQINLSNNKLIGTIPKSLQRFQSSAFSGNNL-------------------------TE 217
Query: 294 RKQSSKQKLGLGAIIAIAVGGSAVLLLVA----LVILCYCLKKKDNGSNGVSKGKASSGG 349
RK+ K GL + + + +A +L V+ ++I C+ G +S GK
Sbjct: 218 RKKQRKTPFGLSQLAFLLILSAACVLCVSGLSFIMITCF-------GKTRIS-GKLRKRD 269
Query: 350 RSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEES 409
S P E K++FF G ++ FDL+DLL +SAEVLGKG++GT YK +E+
Sbjct: 270 SSSPPGNWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDM 329
Query: 410 TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469
+TVVVKRLKEVVVG+R+FEQQMEI+G + +H NV L+AYYYSKD+KL VY Y+ GSL
Sbjct: 330 STVVVKRLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDDKLAVYSYYNHGSLF 388
Query: 470 TLLHGNRGA-GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528
+LHGNRG R PLDW+ R++I G ARG+A IH KF HGNIK+SN+ ++ G
Sbjct: 389 EILHGNRGRYHRVPLDWDARLRIATGAARGLAKIHE---GKFIHGNIKSSNIFLDSQCYG 445
Query: 529 CISDFGLTPLM-NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
CI D GLT +M ++P T ++GY APE+ +TR+ + SDVYSFGV+LLE+LTGK+P+
Sbjct: 446 CIGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQ 505
Query: 588 ----PTRDDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVP 642
PT + +DL W++SVV +EWT EVFD+E++ + EEEMV+MLQIG+ACVA
Sbjct: 506 AELVPTGGENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQ 565
Query: 643 DMRPNMDEVVRMIEEVRQSDSE 664
RP++ +V+++IE++R D+E
Sbjct: 566 QERPHIAQVLKLIEDIRSVDAE 587
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1285), Expect = e-140, Method: Compositional matrix adjust.
Identities = 278/603 (46%), Positives = 368/603 (61%), Gaps = 44/603 (7%)
Query: 60 LCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF 119
L V++ + + + D+ LL F + + H LNWS + IC W G+ C D + V
Sbjct: 9 LIVVIFNVCIEAETIKEDKHTLLQFVNNINHSHSLNWSPSLSICTKWTGVTCNSDHSSVD 68
Query: 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 179
L L GL G I + + +L L L L SN ++G P+ + +L +L L L N FSG
Sbjct: 69 ALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELKLDFNEFSG 128
Query: 180 KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH 237
+PS S +L VLDLS N F G+IP SI LT L L+L N SG IP+ IP L+
Sbjct: 129 PLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPDLHIPGLKL 188
Query: 238 LNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQS 297
LNL++N L G++P SLQ+FP S+FVGN +L PV S RK +
Sbjct: 189 LNLAHNNLTGTVPQSLQRFPLSAFVGNKVLA--------PVHSSL-----------RKHT 229
Query: 298 SKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPKEE 357
++ IA L V IL + + + SS + K +++
Sbjct: 230 KHHN---HVVLGIA-------LSVCFAILALLAILLVIIIHNREEQRRSSKDKPSKRRKD 279
Query: 358 FGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRL 417
V E + NK+VFFEG + FDLEDLLRASAEVLGKG +GT YK LE+S T+VVKR+
Sbjct: 280 SDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLEDSATIVVKRI 338
Query: 418 KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG 477
KEV V +R+FEQQ+E +G + +H NV LR Y+YSKDEKL+VYDY+ GSLSTLLHG +G
Sbjct: 339 KEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYYEHGSLSTLLHGQKG 397
Query: 478 -AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536
R L+WETR+ ++ GTARGVAHIHS G K HGNIK+SN+ +N GCIS G+
Sbjct: 398 LRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFLNGKGYGCISGTGMA 457
Query: 537 PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
LM+ + P + GYRAPE+ +TRK + SDVYSFG+L+ E+LTGK+ ++ +L
Sbjct: 458 TLMH--SLPRHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS--------EVANL 507
Query: 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
RWV SVVREEWT EVFD EL+R +EEEMV+MLQ+GM C A++P+ RPNM EVVRM+E
Sbjct: 508 VRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNMIEVVRMVE 567
Query: 657 EVR 659
E+R
Sbjct: 568 EIR 570
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FL63|Y5410_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At5g24100 OS=Arabidopsis thaliana GN=At5g24100 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 492 bits (1267), Expect = e-138, Method: Compositional matrix adjust.
Identities = 270/608 (44%), Positives = 378/608 (62%), Gaps = 41/608 (6%)
Query: 72 ADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP 131
DL DRQALLDF + + H R L W++++P+C +W G+ C D TRV L LPG L+G
Sbjct: 28 GDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCTTWPGVTCDIDGTRVTALHLPGASLLGV 87
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
IP T+ +L L++LSLRSN L G P + L L+ + L +N FSG +PS ++ L
Sbjct: 88 IPPGTISRLSELQILSLRSNGLRGPFPIDFLQLKKLKAISLGNNRFSGPLPSDYATWTNL 147
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
VLDL N F G+IP NLT L L+L N+ SG IP+ ++P LR LN S N L GSI
Sbjct: 148 TVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNSFSGEIPDLNLPGLRRLNFSNNNLTGSI 207
Query: 250 PSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLG--AI 307
P+SL++F NS+F GN+L+ F AP PP + K+ K + + AI
Sbjct: 208 PNSLKRFGNSAFSGNNLV--------FENAP-------PPAVVSFKEQKKNGIYISEPAI 252
Query: 308 IAIAVGGSAVLLLVALVILCYCLKKKDNGSNGV---SKGKASSGGRSEKPKEEFGSGVQ- 363
+ IA+ V+ V V++ C K+ S K K + SEK + G
Sbjct: 253 LGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLAKKMPSEKEVSKLGKEKNI 312
Query: 364 -----EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 418
+ E NK++FFEG + F+LEDLL ASAE LGKG +G YKAVLE+S + VKRLK
Sbjct: 313 EDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVLEDSKVIAVKRLK 372
Query: 419 EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG-NRG 477
++VV ++DF+ QMEIVG + +H NV PLRAY SK+EKL+VYDY ++GSLS LHG N
Sbjct: 373 DIVVSRKDFKHQMEIVGNI-KHENVAPLRAYVCSKEEKLMVYDYDSNGSLSLRLHGKNAD 431
Query: 478 AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537
G PL+WETR++ ++G A+G+ HIH+ HGNIK+SNV +N + GCIS+ GL P
Sbjct: 432 EGHVPLNWETRLRFMIGVAKGLGHIHTQ---NLAHGNIKSSNVFMNSEGYGCISEAGL-P 487
Query: 538 LMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592
L+ P + S+ YRAPEV +TR+ + +SD+YSFG+L+LE LTG++ + R +
Sbjct: 488 LLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTGRSIMDD--RKE 545
Query: 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652
+DL WV V+ ++WT EVFD+EL++ N+E +++QMLQ+G +C A VP RP+M +VV
Sbjct: 546 GIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMVPAKRPDMVKVV 605
Query: 653 RMIEEVRQ 660
+EE+ +
Sbjct: 606 ETLEEIER 613
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1246), Expect = e-136, Method: Compositional matrix adjust.
Identities = 274/634 (43%), Positives = 394/634 (62%), Gaps = 39/634 (6%)
Query: 56 LFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDR 115
FF +C++ +DL +DR+AL+ D V H R L W+ T P C +W G+ C +
Sbjct: 12 FFFFICLVS-----VTSDLEADRRALIALRDGV-HGRPLLWNLTAPPC-TWGGVQC--ES 62
Query: 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 175
RV LRLPG+GL GP+P +G L LE LS R N L G LP + +L LRYLYLQ N
Sbjct: 63 GRVTALRLPGVGLSGPLPI-AIGNLTKLETLSFRFNALNGPLPPDFANLTLLRYLYLQGN 121
Query: 176 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP 233
FSG+IPS P ++ ++L+ N+F G IP ++ + T+L L LQ N L+G IP I
Sbjct: 122 AFSGEIPSFLFTLPNIIRINLAQNNFLGRIPDNVNSATRLATLYLQDNQLTGPIPEIKI- 180
Query: 234 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIP 293
KL+ N+S N L GSIP L P ++F+GN LLCG PL AC PV + + T +P
Sbjct: 181 KLQQFNVSSNQLNGSIPDPLSGMPKTAFLGN-LLCGKPLDAC-PVNGTGNGTVTP----- 233
Query: 294 RKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNG--------SNGVSKGKA 345
+ KL GAI+ I +G +LL++ L++ C C KKK + V A
Sbjct: 234 GGKGKSDKLSAGAIVGIVIGCFVLLLVLFLIVFCLCRKKKKEQVVQSRSIEAAPVPTSSA 293
Query: 346 SSGGRSEKPKEEFGSGVQEPEKNK--------LVFFEGCSYNFDLEDLLRASAEVLGKGS 397
+ S P +G E +K L FF FDL+ LL+ASAEVLGKG+
Sbjct: 294 AVAKESNGPPAVVANGASENGVSKNPAAVSKDLTFFVKSFGEFDLDGLLKASAEVLGKGT 353
Query: 398 YGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL 457
+G++YKA + V VKRL++VVV +++F ++++++G + H N+V L AYY+S+DEKL
Sbjct: 354 FGSSYKASFDHGLVVAVKRLRDVVVPEKEFREKLQVLGSI-SHANLVTLIAYYFSRDEKL 412
Query: 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKA 517
+V++Y + GSLS LLHGN+G+GR+PL+WETR I LG AR ++++HS +HGNIK+
Sbjct: 413 VVFEYMSRGSLSALLHGNKGSGRSPLNWETRANIALGAARAISYLHSRDATT-SHGNIKS 471
Query: 518 SNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 577
SN+L+++ + +SD+ L P+++ +TP+R GYRAPEV + RK S K+DVYSFGVL+LE
Sbjct: 472 SNILLSESFEAKVSDYCLAPMISPTSTPNRIDGYRAPEVTDARKISQKADVYSFGVLILE 531
Query: 578 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-NIEEEMVQMLQIGMA 636
+LTGK+P ++ VDLPRWV S+ ++ ++VFD EL R+Q + E M+++L IG++
Sbjct: 532 LLTGKSPTHQQLHEEGVDLPRWVSSITEQQSPSDVFDPELTRYQSDSNENMIRLLNIGIS 591
Query: 637 CVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSE 670
C + PD RP M EV R+IEEV +S + P S+
Sbjct: 592 CTTQYPDSRPTMPEVTRLIEEVSRSPASPGPLSD 625
|
Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica. Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 682 | ||||||
| 224145409 | 636 | predicted protein [Populus trichocarpa] | 0.929 | 0.996 | 0.803 | 0.0 | |
| 297745748 | 656 | unnamed protein product [Vitis vinifera] | 0.957 | 0.995 | 0.792 | 0.0 | |
| 359478866 | 637 | PREDICTED: probable inactive receptor ki | 0.931 | 0.996 | 0.802 | 0.0 | |
| 255586379 | 635 | Nodulation receptor kinase precursor, pu | 0.928 | 0.996 | 0.802 | 0.0 | |
| 224126989 | 635 | predicted protein [Populus trichocarpa] | 0.926 | 0.995 | 0.788 | 0.0 | |
| 356537708 | 664 | PREDICTED: probable inactive receptor ki | 0.950 | 0.975 | 0.759 | 0.0 | |
| 449444334 | 630 | PREDICTED: probable inactive receptor ki | 0.920 | 0.996 | 0.773 | 0.0 | |
| 356500954 | 654 | PREDICTED: probable inactive receptor ki | 0.945 | 0.986 | 0.753 | 0.0 | |
| 356570023 | 631 | PREDICTED: probable inactive receptor ki | 0.925 | 1.0 | 0.770 | 0.0 | |
| 356553186 | 656 | PREDICTED: probable inactive receptor ki | 0.947 | 0.984 | 0.749 | 0.0 |
| >gi|224145409|ref|XP_002325632.1| predicted protein [Populus trichocarpa] gi|222862507|gb|EEF00014.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1049 bits (2712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/637 (80%), Positives = 560/637 (87%), Gaps = 3/637 (0%)
Query: 48 MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 107
MK + ++F ++ + P AFADL SD+QALLDFA AVPHLRKLNW+ + +C SWV
Sbjct: 1 MKIFLGSVIYF-FIILTIIFPFAFADLKSDKQALLDFATAVPHLRKLNWNPASSVCNSWV 59
Query: 108 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 167
G+ C +RTRV LRLPG+GLVG IP NTLGKLDAL VLSLRSNVL G LPS+ITSLPSL
Sbjct: 60 GVTCNSNRTRVSQLRLPGVGLVGHIPPNTLGKLDALRVLSLRSNVLEGDLPSDITSLPSL 119
Query: 168 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 227
L+LQHNNFSG IP+SFS QL VLDLSFNSFTGNIPQ++ NLTQL GLSLQ+N LSG I
Sbjct: 120 TNLFLQHNNFSGGIPTSFSLQLNVLDLSFNSFTGNIPQTLANLTQLIGLSLQNNTLSGPI 179
Query: 228 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVA--PSPSPT 285
P+ + +++ LNLSYN L GSIP SLQ FPNSSF+GNSLLCGPPL C PV PSPSP
Sbjct: 180 PDLNHTRIKRLNLSYNHLNGSIPVSLQNFPNSSFIGNSLLCGPPLNPCSPVIRPPSPSPA 239
Query: 286 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 345
Y PPP +PRK+SSK KL +GAIIAIAVGGSAVL LV L ILC CLKKKDNG + V KGKA
Sbjct: 240 YIPPPTVPRKRSSKVKLTMGAIIAIAVGGSAVLFLVVLTILCCCLKKKDNGGSSVLKGKA 299
Query: 346 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 405
S GR EKPKEEFGSGVQE EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 300 VSSGRGEKPKEEFGSGVQEHEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 359
Query: 406 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465
LEESTTVVVKRL+EVV+GKRDFEQQME VGRVGQHPN+VPLRAYYYSKDEKLLVYDY
Sbjct: 360 LEESTTVVVKRLREVVMGKRDFEQQMENVGRVGQHPNIVPLRAYYYSKDEKLLVYDYIPG 419
Query: 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525
GSLSTLLH NRGAGRTPLDW++RVKI LGTARG++H+HS+GGPKFTHGNIK++NVL++QD
Sbjct: 420 GSLSTLLHANRGAGRTPLDWDSRVKIALGTARGISHLHSVGGPKFTHGNIKSTNVLLSQD 479
Query: 526 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
DGCISDFGLTPLMNVPAT SRSAGYRAPEVIETRKH+HKSDVYSFGV+LLEMLTGKAP+
Sbjct: 480 HDGCISDFGLTPLMNVPATSSRSAGYRAPEVIETRKHTHKSDVYSFGVVLLEMLTGKAPI 539
Query: 586 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 645
QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGM CVAKVPDMR
Sbjct: 540 QSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDMR 599
Query: 646 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 682
PNM+EVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 600 PNMEEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 636
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745748|emb|CBI15804.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1046 bits (2704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/655 (79%), Positives = 575/655 (87%), Gaps = 2/655 (0%)
Query: 30 LHFCYSSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVP 89
+ F Y H IPC +QL MK S + + L VI LLPLA ADL++D+QALLDFADAVP
Sbjct: 2 VQFYYYGHSHIPCARQLPMKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVP 61
Query: 90 HLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLR 149
H RKLNW+S+ P+C SWVGINCT D +RV LRLPGIGL G IP TLGKLDALE+LSLR
Sbjct: 62 HRRKLNWNSSTPVCTSWVGINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLR 121
Query: 150 SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQN 209
SN+LTG LPS+I SLPSL+YL+LQHNNFSG IP+SFSPQL VLDLSFNSFTGNIP +I N
Sbjct: 122 SNLLTGKLPSDIPSLPSLQYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWN 181
Query: 210 LTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG 269
LTQLTGL+LQ+N+LSG+IP+ + KL+HLNLSYN L GSIPSSLQ+FPNSSFVGNSLLCG
Sbjct: 182 LTQLTGLNLQNNSLSGAIPDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCG 241
Query: 270 PPLKAC--FPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILC 327
PPL C P++PSP+P++ PP KQ SK+KL +G IIAIAVGG+ VL LV L+I
Sbjct: 242 PPLNNCSLTPLSPSPAPSFPSPPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFL 301
Query: 328 YCLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLR 387
CL+KKD+ +GV+KGKAS GGRSEKPKEEFGSGVQEP+KNKLVFFEGCSYNFDLEDLLR
Sbjct: 302 CCLRKKDSEGSGVAKGKASGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLR 361
Query: 388 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM+IVGRVGQHPNVVPLR
Sbjct: 362 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLR 421
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
AYYYSKDEKLLVYDY + GSLS LLHGNR GR+PLDW RVKI LG ARG+ HIHS+GG
Sbjct: 422 AYYYSKDEKLLVYDYVSGGSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGG 481
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSD 567
KFTHGNIK+SNVL+NQD +GCISDFGLTPLMN PAT SR+AGYRAPEVIE+RKH+HKSD
Sbjct: 482 GKFTHGNIKSSNVLLNQDFEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSD 541
Query: 568 VYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 627
VYSFGVLLLEMLTGKAPLQSP RDDMVDLPRWVQSVVREEWTAEVFD+ELMR+QNIEEEM
Sbjct: 542 VYSFGVLLLEMLTGKAPLQSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEM 601
Query: 628 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 682
VQMLQ+ MACVAKVPDMRP+MDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 602 VQMLQLAMACVAKVPDMRPSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 656
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478866|ref|XP_002276162.2| PREDICTED: probable inactive receptor kinase At5g58300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/637 (80%), Positives = 565/637 (88%), Gaps = 2/637 (0%)
Query: 48 MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 107
MK S + + L VI LLPLA ADL++D+QALLDFADAVPH RKLNW+S+ P+C SWV
Sbjct: 1 MKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVPHRRKLNWNSSTPVCTSWV 60
Query: 108 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 167
GINCT D +RV LRLPGIGL G IP TLGKLDALE+LSLRSN+LTG LPS+I SLPSL
Sbjct: 61 GINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLRSNLLTGKLPSDIPSLPSL 120
Query: 168 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 227
+YL+LQHNNFSG IP+SFSPQL VLDLSFNSFTGNIP +I NLTQLTGL+LQ+N+LSG+I
Sbjct: 121 QYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWNLTQLTGLNLQNNSLSGAI 180
Query: 228 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKAC--FPVAPSPSPT 285
P+ + KL+HLNLSYN L GSIPSSLQ+FPNSSFVGNSLLCGPPL C P++PSP+P+
Sbjct: 181 PDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCGPPLNNCSLTPLSPSPAPS 240
Query: 286 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 345
+ PP KQ SK+KL +G IIAIAVGG+ VL LV L+I CL+KKD+ +GV+KGKA
Sbjct: 241 FPSPPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFLCCLRKKDSEGSGVAKGKA 300
Query: 346 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 405
S GGRSEKPKEEFGSGVQEP+KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 301 SGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 360
Query: 406 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465
LEESTTVVVKRLKEVVVGKRDFEQQM+IVGRVGQHPNVVPLRAYYYSKDEKLLVYDY +
Sbjct: 361 LEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYVSG 420
Query: 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525
GSLS LLHGNR GR+PLDW RVKI LG ARG+ HIHS+GG KFTHGNIK+SNVL+NQD
Sbjct: 421 GSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGGGKFTHGNIKSSNVLLNQD 480
Query: 526 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
+GCISDFGLTPLMN PAT SR+AGYRAPEVIE+RKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 481 FEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSDVYSFGVLLLEMLTGKAPL 540
Query: 586 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 645
QSP RDDMVDLPRWVQSVVREEWTAEVFD+ELMR+QNIEEEMVQMLQ+ MACVAKVPDMR
Sbjct: 541 QSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEMVQMLQLAMACVAKVPDMR 600
Query: 646 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 682
P+MDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 601 PSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586379|ref|XP_002533837.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223526229|gb|EEF28551.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1023 bits (2646), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/637 (80%), Positives = 556/637 (87%), Gaps = 4/637 (0%)
Query: 48 MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 107
MKF A+ F L V+ +L LA ADLNSD+QALL+F+ A+PH R LNW+ + IC+SWV
Sbjct: 1 MKFFPASS--FRLIVLFTLFSLAIADLNSDKQALLNFSAAIPHYRLLNWNPASSICKSWV 58
Query: 108 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 167
G+ C +TRV LRLPG+G +G IP NTLGKLDAL VLSLRSN+L G LPS++TSLPSL
Sbjct: 59 GVTCNPSQTRVLELRLPGVGFIGQIPANTLGKLDALRVLSLRSNLLYGNLPSDVTSLPSL 118
Query: 168 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 227
R LYLQHNNFS IP+SFS QL VLDLSFNSF+G+IPQ+I NLTQLTGLSLQ+N LSG+I
Sbjct: 119 RNLYLQHNNFSSTIPTSFSSQLNVLDLSFNSFSGSIPQTIANLTQLTGLSLQNNTLSGAI 178
Query: 228 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 287
P+ + +LRHLNLSYN L GS+P SLQKFPNSSF GNSLLCG PL C P+ PSP+ +
Sbjct: 179 PDLNQSRLRHLNLSYNHLNGSVPFSLQKFPNSSFTGNSLLCGLPLNPCSPILSPPSPSPA 238
Query: 288 PPPFIP--RKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 345
P K+ SK KL LGAIIAIAVGG AVL L+ ++ILC CLKKKDNG + V KGKA
Sbjct: 239 SSPPPEMPHKKGSKAKLTLGAIIAIAVGGFAVLFLIVVIILCCCLKKKDNGGSSVLKGKA 298
Query: 346 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 405
S GR EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 299 VSSGRGEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
Query: 406 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465
LEESTTVVVKRLKEVVVGKR+FEQQMEIVGRVGQH NVVPLRAYYYSKDEKLLVYDY
Sbjct: 359 LEESTTVVVKRLKEVVVGKREFEQQMEIVGRVGQHQNVVPLRAYYYSKDEKLLVYDYIQG 418
Query: 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525
GSLSTLLHGNR AGRTPLDW+ RVKI LGTARG+AH+HS GGPKFTHGNIK+SNVL+NQD
Sbjct: 419 GSLSTLLHGNRQAGRTPLDWDNRVKIALGTARGIAHLHSAGGPKFTHGNIKSSNVLLNQD 478
Query: 526 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
DGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 479 HDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHTHKSDVYSFGVLLLEMLTGKAPL 538
Query: 586 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 645
QSP+RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGMACVAKVPDMR
Sbjct: 539 QSPSRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMACVAKVPDMR 598
Query: 646 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 682
PNMDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 599 PNMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 635
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126989|ref|XP_002319979.1| predicted protein [Populus trichocarpa] gi|222858355|gb|EEE95902.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2590), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/638 (78%), Positives = 552/638 (86%), Gaps = 6/638 (0%)
Query: 48 MKF--SSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQS 105
MKF +S LF L +I P A +DL SD+QALLDFA VPH RKLNW+ + +C+S
Sbjct: 1 MKFFRASVIHLFIILTII---FPFAISDLKSDKQALLDFAAVVPHSRKLNWNPASLVCKS 57
Query: 106 WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP 165
WVG+ C + TRV LRLPG+GL+G +P NTLGKLDAL LSLRSNVL G LPS++TSLP
Sbjct: 58 WVGVTCNSNDTRVVELRLPGVGLLGHVPPNTLGKLDALNTLSLRSNVLEGDLPSDVTSLP 117
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
SL+ L+LQHNNFSG +P+SFS +L VLDLSFNSFTGNIPQ+I NLTQLTGLSLQ+N LSG
Sbjct: 118 SLQNLFLQHNNFSGGVPTSFSLKLNVLDLSFNSFTGNIPQTIANLTQLTGLSLQNNALSG 177
Query: 226 SIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPV-APSPSP 284
IP+ + +++HLNLSYN L GSIP SLQKFPNSSF+GNSLLCGPPL C V P PSP
Sbjct: 178 PIPDLNHTRIKHLNLSYNHLNGSIPVSLQKFPNSSFIGNSLLCGPPLNPCSIVLPPPPSP 237
Query: 285 TYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGK 344
Y+PPP K+SSK KL +GAIIAIAVGGSAVL LV L++ C CLKKKDN GV KGK
Sbjct: 238 AYTPPPATSHKRSSKLKLTMGAIIAIAVGGSAVLFLVVLIVFCCCLKKKDNEGPGVLKGK 297
Query: 345 ASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 404
A S GR EKPKE+FGSGVQE EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA
Sbjct: 298 AVSSGRGEKPKEDFGSGVQESEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 357
Query: 405 VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464
VLEESTTVVVKRLKEVVVGKRDFEQQMEI GRVGQHPNVVPLRAYYYSKDE+LLVYDY
Sbjct: 358 VLEESTTVVVKRLKEVVVGKRDFEQQMEIAGRVGQHPNVVPLRAYYYSKDERLLVYDYIP 417
Query: 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 524
GSLSTLLH NRGAGRTPLDW++RVKI LGTARG++H+HS GGPKFTHGNIK+SNVL++Q
Sbjct: 418 GGSLSTLLHANRGAGRTPLDWDSRVKIALGTARGISHLHSAGGPKFTHGNIKSSNVLLSQ 477
Query: 525 DLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
D DGCISDFGLTPLMNVPA+ SRSAGYRAPEVIET KHSHKSDVYSFGV+LLEMLTGKAP
Sbjct: 478 DHDGCISDFGLTPLMNVPASSSRSAGYRAPEVIETSKHSHKSDVYSFGVILLEMLTGKAP 537
Query: 585 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDM 644
+QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGM CVAKVPDM
Sbjct: 538 IQSPRRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDM 597
Query: 645 RPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 682
RPNM+EVVRMIEE+RQSDSENRPSSE NKSKDSNV TP
Sbjct: 598 RPNMEEVVRMIEEIRQSDSENRPSSEGNKSKDSNVHTP 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537708|ref|XP_003537367.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 993 bits (2567), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/649 (75%), Positives = 557/649 (85%), Gaps = 1/649 (0%)
Query: 34 YSSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRK 93
++ LIP KQL MKF S + F L VIV PLA ADL+SD+QALL+FA+AVPH R
Sbjct: 17 FNCRYLIPFSKQLSMKFCSTSVASF-LFVIVIFFPLAIADLSSDKQALLNFANAVPHRRN 75
Query: 94 LNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVL 153
L W+ + +C SWVGI C ++RTRV +RLPG+GLVG IP+NTLGKLDA++++SLRSN+L
Sbjct: 76 LMWNPSTSVCSSWVGITCNENRTRVVKVRLPGVGLVGTIPSNTLGKLDAVKIISLRSNLL 135
Query: 154 TGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQL 213
+G LP++I SLPSL+YLYLQHNN SG IP+S SPQL+VLDLS+NSFTG IP++ QN++ L
Sbjct: 136 SGNLPADIGSLPSLQYLYLQHNNLSGDIPASLSPQLIVLDLSYNSFTGVIPKTFQNMSVL 195
Query: 214 TGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 273
T L+LQ+N+LSG IPN ++ L+ LNLSYN L GSIP +L+ FPNSSF GNSLLCGPPLK
Sbjct: 196 TSLNLQNNSLSGQIPNLNVTLLKLLNLSYNHLNGSIPKALEIFPNSSFEGNSLLCGPPLK 255
Query: 274 ACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKK 333
C V P+PSP +PPP +QSSK KL AII IAVGG+ VL +ALV + CLKK+
Sbjct: 256 PCSAVPPTPSPASTPPPSTTGRQSSKNKLSKIAIIVIAVGGAVVLFFIALVFVICCLKKE 315
Query: 334 DNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVL 393
DN + V KGK SGGR EKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVL
Sbjct: 316 DNRGSNVIKGKGPSGGRGEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVL 375
Query: 394 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 453
GKGSYGTAYKA+LEES TVVVKRLKEVVVGK+DFEQQMEI+GRVGQH NVVPLRAYYYSK
Sbjct: 376 GKGSYGTAYKAILEESMTVVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSK 435
Query: 454 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 513
DEKLLVYDY G+L TLLHG R GRTPLDW++R+KI LGTA+G+AHIHS+GGPKFTHG
Sbjct: 436 DEKLLVYDYVPGGNLHTLLHGGRTGGRTPLDWDSRIKISLGTAKGLAHIHSVGGPKFTHG 495
Query: 514 NIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 573
NIK+SNVL+NQD DGCISDFGL PLMNVPATPSR+AGYRAPEVIETRKHSHKSDVYSFGV
Sbjct: 496 NIKSSNVLLNQDNDGCISDFGLAPLMNVPATPSRAAGYRAPEVIETRKHSHKSDVYSFGV 555
Query: 574 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI 633
LLLEMLTGKAPLQSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI
Sbjct: 556 LLLEMLTGKAPLQSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQI 615
Query: 634 GMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 682
MACVAK+PDMRP+MDE VRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 616 AMACVAKMPDMRPSMDEAVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 664
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444334|ref|XP_004139930.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Cucumis sativus] gi|449475802|ref|XP_004154555.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2516), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/637 (77%), Positives = 551/637 (86%), Gaps = 9/637 (1%)
Query: 48 MKFSSAA--PLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQS 105
MKF SA+ PLFF VI++LL LA ADL SD+QALLDFA +VPH R LNW+ T PIC S
Sbjct: 1 MKFCSASVLPLFF---VIINLLHLAIADLESDKQALLDFASSVPHRRSLNWNDTTPICTS 57
Query: 106 WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP 165
WVG+ C+ D T V LRLPGIGLVG IP++TLGKLD L++LSLRSN+L+G +PS+ITSLP
Sbjct: 58 WVGVTCSADGTHVLTLRLPGIGLVGSIPSDTLGKLDGLKILSLRSNLLSGIIPSDITSLP 117
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
SL+YLYLQHNN SG +PSS SP LVVL+LSFN G IP+++QNLTQLTGL+LQ+NNLSG
Sbjct: 118 SLQYLYLQHNNLSGDVPSSLSPTLVVLNLSFNLLEGKIPKTVQNLTQLTGLNLQNNNLSG 177
Query: 226 SIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPT 285
SIP+ ++PKL+HLN+SYN L GSIP+ FPNSSF+GN LCG PLKAC + SP+P
Sbjct: 178 SIPDINLPKLKHLNISYNHLNGSIPTFFNTFPNSSFIGNPSLCGSPLKAC-SIVLSPAPH 236
Query: 286 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 345
P P I +KQSSK KL +G IIAIAVGG VL LV L ++ CLKKK+ G G KGK
Sbjct: 237 APPSPAISQKQSSK-KLKMGVIIAIAVGGFFVLFLVVLFVVLCCLKKKEGGDAGTRKGKV 295
Query: 346 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 405
S GGRSEKPKEEFGSGVQEPEKNKLVFFEGCS+NFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 296 SGGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSFNFDLEDLLRASAEVLGKGSYGTAYKAV 355
Query: 406 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465
LEE TTVVVKRLKEVVVGKR+FEQQM+IVGRVGQHPNV+PLRAYYYSKDEKLLVYDY
Sbjct: 356 LEEPTTVVVKRLKEVVVGKREFEQQMDIVGRVGQHPNVMPLRAYYYSKDEKLLVYDYVPG 415
Query: 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525
GSLS+LLHGNRG RTPLDW++RVKI L TA+G+AHIH+MGGPKFTHGNIKASNVL+ QD
Sbjct: 416 GSLSSLLHGNRGGERTPLDWDSRVKIALATAKGIAHIHAMGGPKFTHGNIKASNVLLIQD 475
Query: 526 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
++ C+SDFGLTPLMNVP SR+AGYRAPEVIE RKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 476 VNACVSDFGLTPLMNVPT--SRTAGYRAPEVIEARKHTHKSDVYSFGVLLLEMLTGKAPL 533
Query: 586 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 645
QSP RD+MVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI M CVAK+PDMR
Sbjct: 534 QSPGRDEMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMTCVAKLPDMR 593
Query: 646 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 682
PNMDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 594 PNMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 630
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500954|ref|XP_003519295.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2498), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/649 (75%), Positives = 553/649 (85%), Gaps = 4/649 (0%)
Query: 35 SSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKL 94
S ++L K++ MKF S+ F L +IV L PLA ADL+SD+QALLDFA AVPH R L
Sbjct: 9 SVNILYHTTKKISMKFYSSQVHRF-LFIIVILFPLAIADLSSDKQALLDFAAAVPHRRNL 67
Query: 95 NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 154
W+ PIC SWVGI C + TRV +RLPGIGLVG IP NTLGK+D+L +SLR+N+L+
Sbjct: 68 KWNPATPICSSWVGITCNPNGTRVVSVRLPGIGLVGTIPANTLGKIDSLRNISLRANLLS 127
Query: 155 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 214
G LP +ITSLPSL+YLYLQHNN SG +P+S S +L VLDLS+NSF+G IP+++QN+TQL
Sbjct: 128 GSLPPDITSLPSLQYLYLQHNNLSGSVPTSLSTRLNVLDLSYNSFSGAIPKTLQNITQLI 187
Query: 215 GLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKA 274
L+LQ+N+LSG IPN ++ KLRHLNLSYN L GSIP +LQ FPNSSF GNSL CG PLK+
Sbjct: 188 KLNLQNNSLSGQIPNLNVTKLRHLNLSYNHLNGSIPDALQIFPNSSFEGNSL-CGLPLKS 246
Query: 275 CFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKD 334
C V+ +P P+ P P + SSK KL AIIAIAVGG +LLLVAL+I+ CLKKKD
Sbjct: 247 CSVVSSTP-PSTPVSPSTPARHSSKSKLSKAAIIAIAVGGGVLLLLVALIIVLCCLKKKD 305
Query: 335 NGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLG 394
+ S V+KGK SGGRSEKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVLG
Sbjct: 306 DRSPSVTKGKGPSGGRSEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLG 365
Query: 395 KGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 454
KGSYGTAYKA+LEESTTVVVKRLKEVVVGKR+FEQQMEIVGRVG HPNVVPLRAYYYSKD
Sbjct: 366 KGSYGTAYKAILEESTTVVVKRLKEVVVGKREFEQQMEIVGRVGHHPNVVPLRAYYYSKD 425
Query: 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 514
EKLLVYDY SG+LSTLLHGNR +GRTPLDW +R+KI +G ARG+AHIHS+GGPKFTHGN
Sbjct: 426 EKLLVYDYIPSGNLSTLLHGNRASGRTPLDWNSRIKISVGIARGIAHIHSVGGPKFTHGN 485
Query: 515 IKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVL 574
+K+SNVL+N D DGCISDFGLTPLMNVPATPSR+AGYRAPEVIETRKH+HKSDVYSFG+L
Sbjct: 486 VKSSNVLLNHDNDGCISDFGLTPLMNVPATPSRAAGYRAPEVIETRKHTHKSDVYSFGIL 545
Query: 575 LLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIG 634
LLEMLTGKAP QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI
Sbjct: 546 LLEMLTGKAPQQSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIA 605
Query: 635 MACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSK-DSNVQTP 682
MACVAKVPDMRP+MDEVVRMIEE+R SDSENRPSSEEN+SK +S QTP
Sbjct: 606 MACVAKVPDMRPSMDEVVRMIEEIRLSDSENRPSSEENRSKEESAAQTP 654
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570023|ref|XP_003553192.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2483), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/632 (77%), Positives = 546/632 (86%), Gaps = 1/632 (0%)
Query: 48 MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 107
MKF S + F L VIV L PLA ADL+SD+QALLDFA+AVPH R L W+ + +C SWV
Sbjct: 1 MKFHSTSVASF-LFVIVILFPLAIADLSSDKQALLDFANAVPHRRNLMWNPSTSVCTSWV 59
Query: 108 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 167
GI C ++RTRV +RLPG+GLVG IP+NTLGKL A++++SLRSN+L+G LP++I SLPSL
Sbjct: 60 GITCNENRTRVVKVRLPGVGLVGTIPSNTLGKLGAVKIISLRSNLLSGNLPADIGSLPSL 119
Query: 168 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 227
+YLYLQHNN SG IP+S S QLVVLDLS+NSFTG IP + QNL++LT L+LQ+N+LSG I
Sbjct: 120 QYLYLQHNNLSGDIPASLSLQLVVLDLSYNSFTGVIPTTFQNLSELTSLNLQNNSLSGQI 179
Query: 228 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 287
PN ++ L+ LNLSYN L GSIP +LQ FPNSSF GNSLLCGPPLK C V P+PSP+ +
Sbjct: 180 PNLNVNLLKLLNLSYNQLNGSIPKALQIFPNSSFEGNSLLCGPPLKPCSVVPPTPSPSST 239
Query: 288 PPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASS 347
PP P +QSSK KL AIIAIAVGG+ VL VALV CLKK+D+ + V KGK S
Sbjct: 240 PPQSTPGRQSSKNKLSKIAIIAIAVGGAVVLFFVALVFFICCLKKEDDRGSNVIKGKGPS 299
Query: 348 GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 407
GGR EKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGTAYKA+LE
Sbjct: 300 GGRGEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILE 359
Query: 408 ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467
ES TVVVKRLKEVVVGK+DFEQQMEI+GRVGQH NVVPLRAYYYSKDEKLLVYDY G+
Sbjct: 360 ESMTVVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSKDEKLLVYDYVPGGN 419
Query: 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 527
L TLLHG R GRTPLDW++R+KI LGTA+G+AH+HS+GGPKFTHGNIK+SNVL+NQD D
Sbjct: 420 LHTLLHGGRTGGRTPLDWDSRIKISLGTAKGLAHVHSVGGPKFTHGNIKSSNVLLNQDND 479
Query: 528 GCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
GCISDFGL PLMNVPATPSR+AGYRAPEVIE RKHSHKSDVYSFGVLLLEMLTGKAPLQS
Sbjct: 480 GCISDFGLAPLMNVPATPSRTAGYRAPEVIEARKHSHKSDVYSFGVLLLEMLTGKAPLQS 539
Query: 588 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN 647
P RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI MACVAK+PDMRP+
Sbjct: 540 PGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKMPDMRPS 599
Query: 648 MDEVVRMIEEVRQSDSENRPSSEENKSKDSNV 679
MDEVVRMIEE+RQSDSENRPSSEENKSKDSNV
Sbjct: 600 MDEVVRMIEEIRQSDSENRPSSEENKSKDSNV 631
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553186|ref|XP_003544939.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2441), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/650 (74%), Positives = 550/650 (84%), Gaps = 4/650 (0%)
Query: 35 SSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKL 94
S ++L K++ MKF S F L +IV L PL ADL+SD+QALLDFA AVPH R L
Sbjct: 9 SVNILYHTAKKISMKFYSLQAHRF-LFIIVILCPLVIADLSSDKQALLDFAAAVPHRRNL 67
Query: 95 NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 154
W+ PIC SWVGI C + TRV +RLPGIGLVG IP NTLGK+D+L +SLR+N+L+
Sbjct: 68 KWNPATPICSSWVGITCNLNDTRVVSVRLPGIGLVGTIPANTLGKIDSLRNISLRANLLS 127
Query: 155 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 214
G LP++ITSLPSL+YLYLQHNN SG IP+S S +L VLDLS+NSFTG IP+++QNLTQL
Sbjct: 128 GSLPADITSLPSLQYLYLQHNNLSGNIPTSLSTRLNVLDLSYNSFTGAIPKTLQNLTQLI 187
Query: 215 GLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKA 274
L+LQ+N+LSG IPN ++ KLR LNLSYN L GSIP++LQ FPNSSF GNSL CG PLK+
Sbjct: 188 KLNLQNNSLSGLIPNLNVTKLRRLNLSYNHLNGSIPAALQIFPNSSFEGNSL-CGLPLKS 246
Query: 275 CFPVAPSPSPTYSPPPFIPR-KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKK 333
C V +P P+ +P P + SSK KL AIIAIAVGG +LLLVAL+I+ C KKK
Sbjct: 247 CPVVPSTPPPSSTPAPPSTPARHSSKSKLSKAAIIAIAVGGGVLLLLVALIIVLCCFKKK 306
Query: 334 DNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVL 393
D+GS +KGK SGGRSEKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVL
Sbjct: 307 DDGSPRATKGKGPSGGRSEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVL 366
Query: 394 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 453
GKGSYGTAYKA+LEESTTVVVKRLKE VVGKR+FEQQMEIVGRVG HPNVVPLRAYYYSK
Sbjct: 367 GKGSYGTAYKAILEESTTVVVKRLKEAVVGKREFEQQMEIVGRVGHHPNVVPLRAYYYSK 426
Query: 454 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 513
DEKLLVYDY SG+LSTLLHGNR +GRTPLDW +R+KI +G ARG+AHIHS+GGPKF HG
Sbjct: 427 DEKLLVYDYIPSGNLSTLLHGNRASGRTPLDWNSRIKISVGIARGIAHIHSVGGPKFAHG 486
Query: 514 NIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 573
N+K+SNVL+NQD DGCISDFGLTPLMNVP+TPSR+AGYRAPEVIETRKH+HKSDVYSFGV
Sbjct: 487 NVKSSNVLLNQDNDGCISDFGLTPLMNVPSTPSRAAGYRAPEVIETRKHTHKSDVYSFGV 546
Query: 574 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI 633
LLLEMLTGKAP QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI
Sbjct: 547 LLLEMLTGKAPQQSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQI 606
Query: 634 GMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSK-DSNVQTP 682
MACVAKVPDMRP+M+EVVRMIEE+R SDSENRPSSEEN+SK +S QTP
Sbjct: 607 AMACVAKVPDMRPSMEEVVRMIEEIRLSDSENRPSSEENRSKEESTAQTP 656
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 682 | ||||||
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.917 | 0.957 | 0.634 | 8e-211 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.513 | 0.546 | 0.648 | 2.7e-178 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.494 | 0.526 | 0.589 | 3e-168 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.887 | 0.919 | 0.494 | 2.3e-151 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.507 | 0.542 | 0.568 | 7.8e-144 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.469 | 0.488 | 0.518 | 5e-125 | |
| TAIR|locus:2154227 | 601 | AT5G53320 [Arabidopsis thalian | 0.445 | 0.505 | 0.542 | 4.5e-122 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.457 | 0.465 | 0.563 | 7.4e-122 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.431 | 0.454 | 0.556 | 5.9e-120 | |
| TAIR|locus:2024517 | 587 | AT1G64210 [Arabidopsis thalian | 0.475 | 0.551 | 0.476 | 5.9e-120 |
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2038 (722.5 bits), Expect = 8.0e-211, P = 8.0e-211
Identities = 404/637 (63%), Positives = 471/637 (73%)
Query: 50 FSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGI 109
F S + F L V + A ADLNSDRQALL FA +VPHLR+LNW+STN IC+SWVG+
Sbjct: 22 FLSTCLVSF-LFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGV 80
Query: 110 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY 169
CT D T V LRLPGIGL+GPIP NTLGKL++L +LSLRSN+L+G LP +I SLPSL Y
Sbjct: 81 TCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDY 140
Query: 170 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTXXXXXXXXXXXXXXXIPN 229
+YLQHNNFSG++PS S QL +LDLSFNSFTG IP + QNL +PN
Sbjct: 141 IYLQHNNFSGEVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPN 200
Query: 230 FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFXXXXXXXXXXXXX 289
D LR LNLS N L GSIPS+L FP+SSF GN+LLCG PL+ C
Sbjct: 201 LDTVSLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHIS 260
Query: 290 XXXX----RKQSSKQKXXXXXXXXXXXXXXXXXXXXXXXXXCYCLKKKDNGSNGVSKGKA 345
K+ SK+K C C+KKKD + + K K
Sbjct: 261 TPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT 320
Query: 346 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 405
+ EK K+EFGSGVQEPEKNKLVFF GCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 321 LT----EKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 376
Query: 406 LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465
LEESTT R+FEQQMEI+ RVG HP+VVPLRAYYYSKDEKL+V DY+ +
Sbjct: 377 LEESTTVVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPA 436
Query: 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525
G+LS+LLHGNRG+ +TPLDW++RVKI L A+G+AH+H+ GGPKF+HGNIK+SNV++ Q+
Sbjct: 437 GNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQE 496
Query: 526 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
D CISDFGLTPLM VP P R AGYRAPEV+ETRKH+HKSDVYSFGVL+LEMLTGK+P+
Sbjct: 497 SDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPV 556
Query: 586 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 645
QSP+RDDMVDLPRWVQSVVREEWT+EVFD+ELMRFQNIEEEMVQMLQI MACVA+VP++R
Sbjct: 557 QSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVR 616
Query: 646 PNMDEVVRMIEEVRQSDSEN-RPSSEEN-KSKDSNVQ 680
P MD+VVRMIEE+R SDSE RPSS++N K KDSNVQ
Sbjct: 617 PTMDDVVRMIEEIRVSDSETTRPSSDDNSKPKDSNVQ 653
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 2.7e-178, Sum P(2) = 2.7e-178
Identities = 232/358 (64%), Positives = 268/358 (74%)
Query: 329 CLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRA 388
C KK+D G + + KA G RS+ EEFGSGVQE EKNKLVFFEG SYNFDLEDLLRA
Sbjct: 284 CAKKRDGGQDSTAVPKAKPG-RSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRA 342
Query: 389 SAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRA 448
SAEVLGKGSYGT YKA+LEE TT R+FEQQME VGR+ H NV PLRA
Sbjct: 343 SAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRA 402
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 508
YY+SKDEKLLVYDY+ G+ S LLHGN GR LDWETR++I L ARG++HIHS G
Sbjct: 403 YYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGA 462
Query: 509 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSD 567
K HGNIK+ NVL+ Q+L C+SDFG+ PLM+ PSRS GYRAPE IETRKH+ KSD
Sbjct: 463 KLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSD 522
Query: 568 VYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-NIEEE 626
VYSFGVLLLEMLTGKA ++ +++VDLP+WVQSVVREEWT EVFDVEL++ Q N+EEE
Sbjct: 523 VYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEE 582
Query: 627 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE----NRPSSEEN-KSKDSNV 679
MVQMLQI MACV+K PD RP+M+EVV M+EE+R S S NR SS E +S DS V
Sbjct: 583 MVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSDSPV 640
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 3.0e-168, Sum P(2) = 3.0e-168
Identities = 207/351 (58%), Positives = 261/351 (74%)
Query: 329 CLKKKDNGSNGVSKG-KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLR 387
CL KK G +G + GG + K ++FGSGVQ+PEKNKL FFE C++NFDLEDLL+
Sbjct: 288 CLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLK 347
Query: 388 ASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 447
ASAEVLGKGS+GTAYKAVLE++T ++FEQQMEIVG++ QH N VPL
Sbjct: 348 ASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLL 407
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
AYYYSKDEKLLVY Y GSL ++HGNRG +DWETR+KI GT++ ++++HS+
Sbjct: 408 AYYYSKDEKLLVYKYMTKGSLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLHSL-- 463
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSD 567
KF HG+IK+SN+L+ +DL+ C+SD L L N+P R+ GY APEVIETR+ S +SD
Sbjct: 464 -KFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSD 522
Query: 568 VYSFGVLLLEMLTGKAPLQSPTRDD---MVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
VYSFGV++LEMLTGK PL P +D ++DLPRWV+SVVREEWTAEVFDVEL++FQNIE
Sbjct: 523 VYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIE 582
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS-----ENRPSSE 670
EEMVQMLQ+ +ACVA+ P+ RP M+EV RMIE+VR+ D +NR SSE
Sbjct: 583 EEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSE 633
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1477 (525.0 bits), Expect = 2.3e-151, P = 2.3e-151
Identities = 311/629 (49%), Positives = 404/629 (64%)
Query: 72 ADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP 131
++ +++QALL F +PH +L W+ ++ C +WVG+ C +++ + LRLPG GLVG
Sbjct: 23 SESTAEKQALLTFLQQIPHENRLQWNESDSAC-NWVGVECNSNQSSIHSLRLPGTGLVGQ 81
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QL 189
IP+ +LG+L L VLSLRSN L+G +PS+ ++L LR LYLQHN FSG+ P+SF+ L
Sbjct: 82 IPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNL 141
Query: 190 VVLDLSFNSFTGNIPQSIQNLTXXXXXXXXXXXXXXXIPNFDIPKLRHLNLSYNGLKGSI 249
+ LD+S N+FTG+IP S+ NLT +P+ + L N+S N L GSI
Sbjct: 142 IRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLG-LVDFNVSNNNLNGSI 200
Query: 250 PSSLQKFPNSSFVGNSLLCGPPLKACFXXXXXXXXXXXXXXXXXRKQSSKQKXXXXXXXX 309
PSSL +F SF GN LCG PLK C R S K K
Sbjct: 201 PSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVA 260
Query: 310 XXXXXXXXXXXXXXXXXCYCLKKKDNGSNGVSKGKASSG----------GRSEKPKEEFG 359
CL+K+ + +K +G G S +E G
Sbjct: 261 IIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTG 320
Query: 360 --SGVQ-EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXX 416
SG+ E E+NKLVF EG Y+FDLEDLLRASAEVLGKGS GT+YKAVLEE TT
Sbjct: 321 TSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKR 380
Query: 417 XXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR 476
++FE QME+VG++ +HPNV+PLRAYYYSKDEKLLV+D+ +GSLS LLHG+R
Sbjct: 381 LKDVMASKKEFETQMEVVGKI-KHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSR 439
Query: 477 GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536
G+GRTPLDW+ R++I + ARG+AH+H K HGNIKASN+L++ + D C+SD+GL
Sbjct: 440 GSGRTPLDWDNRMRIAITAARGLAHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLN 497
Query: 537 PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
L + + P+R AGY APEV+ETRK + KSDVYSFGVLLLE+LTGK+P Q+ ++ +DL
Sbjct: 498 QLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDL 557
Query: 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
PRWV SVVREEWTAEVFDVELMR+ NIEEEMVQ+LQI MACV+ VPD RP M EV+RMIE
Sbjct: 558 PRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIE 617
Query: 657 EVRQSDSEN---RPSSEENKSKDSNVQTP 682
+V +S++ + R SS++ SK S QTP
Sbjct: 618 DVNRSETTDDGLRQSSDD-PSKGSEGQTP 645
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 7.8e-144, Sum P(2) = 7.8e-144
Identities = 204/359 (56%), Positives = 259/359 (72%)
Query: 327 CYCLKKKDNGSNGVSKGKASS-GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDL 385
CY +K G +S K GG S P E+F S +++ N+L FFEGC+Y+FDLEDL
Sbjct: 280 CYVRRKLRRGDGVISDNKLQKKGGMS--P-EKFVSRMEDVN-NRLSFFEGCNYSFDLEDL 335
Query: 386 LRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVP 445
LRASAEVLGKG++GT YKAVLE++T+ RDFEQQMEI+G + +H NVV
Sbjct: 336 LRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQQMEIIGGI-KHENVVE 394
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L+AYYYSKDEKL+VYDYF+ GS+++LLHGNRG R PLDWETR+KI +G A+G+A IH
Sbjct: 395 LKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKGIARIHKE 454
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-SRSAGYRAPEVIETRKHSH 564
K HGNIK+SN+ +N + +GC+SD GLT +M+ A P SR AGYRAPEV +TRK S
Sbjct: 455 NNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQ 514
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
SDVYSFGV+LLE+LTGK+P+ + D+++ L RWV SVVREEWTAEVFD+EL+R+ NIE
Sbjct: 515 LSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIE 574
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV---RQS---DSENRPSSEENKSKDS 677
EEMV+MLQI M+CV K D RP M ++VR+IE V R S + E +P SE S+ S
Sbjct: 575 EEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEPELKPKSENGASETS 633
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 5.0e-125, Sum P(2) = 5.0e-125
Identities = 170/328 (51%), Positives = 227/328 (69%)
Query: 334 DNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVL 393
DNG N S A++ + K G+G P KLVFF + FDLEDLLRASAEVL
Sbjct: 322 DNG-NVYSVSAAAAAAMTGNGKASEGNG---PATKKLVFFGNATKVFDLEDLLRASAEVL 377
Query: 394 GKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 453
GKG++GTAYKAVL+ T ++F++++E+VG + H N+VPLRAYY+S+
Sbjct: 378 GKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAM-DHENLVPLRAYYFSR 436
Query: 454 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 513
DEKLLVYD+ GSLS LLHGNRGAGR+PL+W+ R +I +G ARG+ ++HS G +HG
Sbjct: 437 DEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQG-TSTSHG 495
Query: 514 NIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSDVYSFG 572
NIK+SN+L+ + D +SDFGL L+ AT P+R+ GYRAPEV + ++ S K DVYSFG
Sbjct: 496 NIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFG 555
Query: 573 VLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV-QML 631
V+LLE++TGKAP S ++ VDLPRWV+SV R+EW EVFD EL+ EEEM+ +M+
Sbjct: 556 VVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMV 615
Query: 632 QIGMACVAKVPDMRPNMDEVVRMIEEVR 659
Q+G+ C ++ PD RP M EVVR +E +R
Sbjct: 616 QLGLECTSQHPDQRPEMSEVVRKMENLR 643
|
|
| TAIR|locus:2154227 AT5G53320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
Identities = 172/317 (54%), Positives = 221/317 (69%)
Query: 344 KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYK 403
+ SS + K +++ V E + NK+VFFEG + FDLEDLLRASAEVLGKG +GT YK
Sbjct: 266 RRSSKDKPSKRRKDSDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYK 324
Query: 404 AVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463
LE+S T R+FEQQ+E +G + +H NV LR Y+YSKDEKL+VYDY+
Sbjct: 325 VDLEDSATIVVKRIKEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYY 383
Query: 464 ASGSLSTLLHGNRGA-GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 522
GSLSTLLHG +G R L+WETR+ ++ GTARGVAHIHS G K HGNIK+SN+ +
Sbjct: 384 EHGSLSTLLHGQKGLRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFL 443
Query: 523 NQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 582
N GCIS G+ LM+ + P + GYRAPE+ +TRK + SDVYSFG+L+ E+LTGK
Sbjct: 444 NGKGYGCISGTGMATLMH--SLPRHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGK 501
Query: 583 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 642
+ ++ +L RWV SVVREEWT EVFD EL+R +EEEMV+MLQ+GM C A++P
Sbjct: 502 S--------EVANLVRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLP 553
Query: 643 DMRPNMDEVVRMIEEVR 659
+ RPNM EVVRM+EE+R
Sbjct: 554 EKRPNMIEVVRMVEEIR 570
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 875 (313.1 bits), Expect = 7.4e-122, Sum P(2) = 7.4e-122
Identities = 181/321 (56%), Positives = 234/321 (72%)
Query: 363 QEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXX 422
Q +K K+VFFEG + F+LEDLLRASAE+LGKG +GTAYKAVLE+
Sbjct: 339 QVGDKGKMVFFEG-TRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVT 397
Query: 423 XX--RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR 480
++FEQQME++GR+ +H N+V L+AYY++++EKLLVYDY +GSL LLHGNRG GR
Sbjct: 398 VAGKKEFEQQMEVLGRL-RHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGR 456
Query: 481 TPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539
TPLDW TR+KI G ARG+A IH S K THG+IK++NVL+++ + +SDFGL+ +
Sbjct: 457 TPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLS-IF 515
Query: 540 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP--LQSPTRDDMVDLP 597
T ++S GYRAPE+I+ RKH+ KSDVYSFGVLLLE+LTGK P +++ VDLP
Sbjct: 516 APSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLP 575
Query: 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
RWVQSVVREEWTAEVFD+ELMR+++IEEEMV +LQI MAC A D RP M VV++IE+
Sbjct: 576 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIED 635
Query: 658 VRQSDSENRPSSEE-NKSKDS 677
+R SE P ++ N + DS
Sbjct: 636 IRGGGSEASPCNDGINSAVDS 656
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 5.9e-120, Sum P(2) = 5.9e-120
Identities = 167/300 (55%), Positives = 215/300 (71%)
Query: 369 KLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE 428
KLVFF + FDLEDLLRASAEVLGKG++GTAYKAVL+ T R+F+
Sbjct: 347 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADREFK 406
Query: 429 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR 488
+++E+VG + H N+VPLRAYYYS DEKLLVYD+ GSLS LLHGN+GAGR PL+WE R
Sbjct: 407 EKIEVVGAM-DHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVR 465
Query: 489 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSR 547
I LG ARG+ ++HS P +HGN+K+SN+L+ D +SDFGL L++ +T P+R
Sbjct: 466 SGIALGAARGLDYLHSQD-PLSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNR 524
Query: 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607
+ GYRAPEV + R+ S K+DVYSFGV+LLE+LTGKAP S ++ +DL RWV SV REE
Sbjct: 525 ATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREE 584
Query: 608 WTAEVFDVELMRFQ---NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
W EVFD ELM + ++EEEM +MLQ+G+ C + PD RP M EVVR I+E+RQS ++
Sbjct: 585 WRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQSGAD 644
|
|
| TAIR|locus:2024517 AT1G64210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 781 (280.0 bits), Expect = 5.9e-120, Sum P(2) = 5.9e-120
Identities = 160/336 (47%), Positives = 221/336 (65%)
Query: 336 GSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGK 395
G +S GK S P E K++FF G ++ FDL+DLL +SAEVLGK
Sbjct: 257 GKTRIS-GKLRKRDSSSPPGNWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGK 315
Query: 396 GSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE 455
G++GT YK +E+ +T R+FEQQMEI+G + +H NV L+AYYYSKD+
Sbjct: 316 GAFGTTYKVTMEDMSTVVVKRLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDD 374
Query: 456 KLLVYDYFASGSLSTLLHGNRGA-GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 514
KL VY Y+ GSL +LHGNRG R PLDW+ R++I G ARG+A IH G KF HGN
Sbjct: 375 KLAVYSYYNHGSLFEILHGNRGRYHRVPLDWDARLRIATGAARGLAKIHE-G--KFIHGN 431
Query: 515 IKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 573
IK+SN+ ++ GCI D GLT +M ++P T ++GY APE+ +TR+ + SDVYSFGV
Sbjct: 432 IKSSNIFLDSQCYGCIGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGV 491
Query: 574 LLLEMLTGKAPLQS----PTRDDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMV 628
+LLE+LTGK+P+ PT + +DL W++SVV +EWT EVFD+E++ + EEEMV
Sbjct: 492 VLLELLTGKSPVSQAELVPTGGENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMV 551
Query: 629 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
+MLQIG+ACVA RP++ +V+++IE++R D+E
Sbjct: 552 EMLQIGLACVALKQQERPHIAQVLKLIEDIRSVDAE 587
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LVM0 | Y5830_ARATH | No assigned EC number | 0.7097 | 0.9046 | 0.9434 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_XIX2581 | hypothetical protein (636 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 682 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 5e-43
Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ-MEI-VGRVGQHPNVVPLR 447
LG GS+GT YKA V VK LK+ + + EI + R HPN+V L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ KD LV +Y G L L PL + KI L RG+ ++HS G
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVI-ETRKH 562
H ++K N+L++++ I+DFGL + ++ + Y APEV+ +
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 563 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
K DV+S GV+L E+LTGK P D
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQ 207
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 4e-42
Identities = 161/608 (26%), Positives = 251/608 (41%), Gaps = 125/608 (20%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
+RL G +P+ KL + L + +N L G + S +PSL+ L L N F G
Sbjct: 409 VRLQDNSFSGELPSE-FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467
Query: 181 IPSSF-SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRH 237
+P SF S +L LDLS N F+G +P+ + +L++L L L N LSG IP+ KL
Sbjct: 468 LPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527
Query: 238 LNLSYNGLKGSIPSSLQKFP---------------------------------------- 257
L+LS+N L G IP+S + P
Sbjct: 528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587
Query: 258 ---------NSSFV-GNSLLCG----PPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLG 303
N+S V GN LCG L C V +PS +
Sbjct: 588 PSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWF----------------- 630
Query: 304 LGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQ 363
I +G VL LVA + ++ ++N E + E G
Sbjct: 631 ---YITCTLGAFLVLALVAFGFV--FIRGRNN---------------LELKRVENEDGTW 670
Query: 364 EPEKNKLVFFEG-CSYNFDLEDLLRASAE--VLGKGSYGTAYKA-VLEESTTVVVKRLKE 419
E L FF+ S + + D+L + E V+ +G G +YK ++ VVK + +
Sbjct: 671 E-----LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725
Query: 420 VVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 479
V M QHPN+V L S+ L+++Y +LS +L
Sbjct: 726 VNSIPSSEIADM----GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----- 776
Query: 480 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPL 538
L WE R KI +G A+ + +H P GN+ ++I+ +D L L
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR--LSLPGL 831
Query: 539 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP--LQSPTRDDMVDL 596
+ S+ Y APE ET+ + KSD+Y FG++L+E+LTGK+P + +V+
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
Query: 597 PRWVQSVVR-EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655
R+ S + W ++ QN E+V+++ + + C A P RP ++V++ +
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQN---EIVEVMNLALHCTATDPTARPCANDVLKTL 948
Query: 656 EEVRQSDS 663
E +S S
Sbjct: 949 ESASRSSS 956
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 8e-39
Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 17/195 (8%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG+G +GT Y A + V +K +K + + +++EI+ ++ HPN+V L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ ++ LV +Y GSL LL N G L + ++ILL G+ ++HS G
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSNG--- 112
Query: 510 FTHGNIKASNVLINQDLDGC-ISDFGL----TPLMNVPATPSRSAGYRAPEVIETR-KHS 563
H ++K N+L++ D ++DFGL T ++ T + Y APEV+ + +S
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 564 HKSDVYSFGVLLLEM 578
KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 8e-39
Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 46/287 (16%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 444
+ LG+G++G YK L ++T V VK LKE ++DF ++ ++ ++G HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA----GRTPLDWETRVKILLGTARGVA 500
L ++ LV +Y G L L +R ++ L + + + A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 554
++ S KF H ++ A N L+ +DL ISDFGL+ + + G + AP
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 609
E ++ + KSDV+SFGVLL E+ T G P P + ++ +++ R E
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSN-EEVLEYLRKGYRLPKPEYCP 233
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
E++++ ML C P+ RP E+V +E
Sbjct: 234 DELYEL--------------MLS----CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 29/270 (10%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E LG+GS+G Y A + V +K +K ++ + ++++I+ ++ +HPN+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNIVRLY 63
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ +D+ LV +Y G L LL L + L + ++HS G
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHSKG- 117
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 564
H ++K N+L+++D ++DFGL ++ + G Y APEV+ + +
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
D++S GV+L E+LTGK P L + + + + +I
Sbjct: 176 AVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKPP------FPPPEWDIS 224
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
E +++ + K P+ R +E ++
Sbjct: 225 PEAKDLIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 53/286 (18%)
Query: 391 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 443
+ LG+G++G YK L T V VK LKE + +F ++ I+ ++ HPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
V L + +V +Y G L L + L + +++ L A+G+ ++
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYR-----APEVI 557
S F H ++ A N L+ ++L ISDFGL+ + R G APE +
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 558 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-------LPRWVQSVVREEWT 609
+ K + KSDV+SFGVLL E+ T G+ P + +++++ LPR E
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR------PENCP 230
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655
E++++ MLQ C A P+ RP E+V +
Sbjct: 231 DELYEL--------------MLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 55/287 (19%)
Query: 391 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNV 443
+ LG+G++G YK L + V VK LKE +F ++ I+ ++ HPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
V L ++ ++V +Y G L L NR L + L ARG+ ++
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE 120
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-----------PLMNVPATPSRSAGYR 552
S F H ++ A N L+ ++L ISDFGL+ +P R
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP--------IR 169
Query: 553 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609
APE ++ K + KSDV+SFGVLL E+ T G+ P ++ +++ R
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYR---- 222
Query: 610 AEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 655
L + N E+ + MLQ C A+ P+ RP E+V ++
Sbjct: 223 -------LPKPPNCPPELYKLMLQ----CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 56/287 (19%)
Query: 391 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 443
+ LG+G++G YK L+ + V VK LKE + +F ++ I+ ++ HPNV
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
V L ++ +V +Y G L + L NR L + L ARG+ ++
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLE 119
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-----------PLMNVPATPSRSAGYR 552
S F H ++ A N L+ ++L ISDFGL+ +P R
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP--------IR 168
Query: 553 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609
APE ++ K + KSDV+SFGVLL E+ T G+ P ++ ++++ R
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYR---- 221
Query: 610 AEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 655
L + N E+ MLQ C A+ P+ RP E+V ++
Sbjct: 222 -------LPQPPNCPPELYDLMLQ----CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-27
Identities = 72/201 (35%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 66 LLPLAFADLNSDR-QALLDFA----DAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFG 120
L L F+ L+++ + LL F D + +L NW+S+ +C W GI C + +RV
Sbjct: 18 FLFLNFSMLHAEELELLLSFKSSINDPLKYLS--NWNSSADVCL-WQGITCN-NSSRVVS 73
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG 179
+ L G + G I + L ++ ++L +N L+G +P +I T+ SLRYL L +NNF+G
Sbjct: 74 IDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132
Query: 180 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRH 237
IP P L LDLS N +G IP I + + L L L N L G IPN ++ L
Sbjct: 133 SIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192
Query: 238 LNLSYNGLKGSIPSSLQKFPN 258
L L+ N L G IP L + +
Sbjct: 193 LTLASNQLVGQIPRELGQMKS 213
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 43/217 (19%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 445
E+LG+GS+G+ Y A+ +++ ++ +K V + E+ + + QHPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMA--VKSVELSGDSEEELEALEREIRILSSLQHPNIV- 62
Query: 446 LRAYYYSKDEK----LLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGT 495
YY S+ ++ L ++ +Y + GSLS+LL G+ P E ++ IL
Sbjct: 63 --RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLP---EPVIRKYTRQIL--- 111
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGL------TPLMNVPATPSR 547
G+A++HS G H +IK +N+L+ D DG ++DFG +
Sbjct: 112 -EGLAYLHSNG---IVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ + APEVI ++ +D++S G ++EM TGK P
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 391 EVLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
E +GKG +G YKA V +K +K K++ + + +HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
Y KDE +V ++ + GSL LL L + +G+ ++HS G
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHSNG--- 118
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSH 564
H +IKA+N+L+ D + + DFGL+ ++ T +R + + APEVI + + +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 565 KSDVYSFGVLLLEMLTGKAPL 585
K+D++S G+ +E+ GK P
Sbjct: 177 KADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 68/280 (24%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVPL 446
LG+GS+G Y A + V +K L + + K F ++++I+ + PN+V L
Sbjct: 6 RKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
++ + LV +Y GSL LL G + IL + ++HS G
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALEYLHSKG 121
Query: 507 GPKFTHGNIKASNVLINQDLDGC-ISDFGL----------TPLMNVPATPSRSAGYRAPE 555
H +IK N+L+++D + DFGL + + +P+T + GY APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 556 VIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612
V+ S SD++S G+ L E+LTG P + ++ E T +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ---TLKIILELPTPSL 235
Query: 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652
+ N E + +AK P R + +
Sbjct: 236 A--SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 64/142 (45%), Positives = 82/142 (57%), Gaps = 5/142 (3%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
L L G LVG IPN +L L +LE L+L SN L G +P E+ + SL+++YL +NN SG+
Sbjct: 169 LDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227
Query: 181 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR 236
IP L LDL +N+ TG IP S+ NL L L L N LSG IP F + KL
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287
Query: 237 HLNLSYNGLKGSIPSSLQKFPN 258
L+LS N L G IP + + N
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQN 309
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 22/204 (10%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAY 449
E LG+GSYG+ YKA+ +E+ VV +K V V + E EI + + P +V
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVA--IKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
Y+ + +V +Y +GS+S ++ + +T L E IL T +G+ ++HS K
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIM---KITNKT-LTEEEIAAILYQTLKGLEYLHSN---K 119
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRAPEVIETRK 561
H +IKA N+L+N++ ++DFG++ + V TP + APEVI+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF----WMAPEVIQEIG 175
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPL 585
+++K+D++S G+ +EM GK P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 445
+++G+G++G YK + E+ V +K++ + K E I+ + +HPN+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVA--IKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 504
+ D ++ +Y +GSL ++ G P E+ V + + +G+A++H
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKF---GPFP---ESLVAVYVYQVLQGLAYLHE 117
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAG---YRAPEVIETR 560
G H +IKA+N+L +D ++DFG+ T L +V + G + APEVIE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAP 584
S SD++S G ++E+LTG P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 38/279 (13%)
Query: 383 EDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEV-VVGKRDFEQQ----MEIVGRV 437
DL R VLG+GS G YK + + + LK++ V G +F +Q ++ + R
Sbjct: 1 SDLERVK--VLGQGSSGVVYKVRHKPTGKIYA--LKKIHVDGDEEFRKQLLRELKTL-RS 55
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 497
+ P VV +Y + E +V +Y GSL+ LL L + R +IL G
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILKG--- 111
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFG----LTPLMNVPATPSRSAGY 551
+ ++H+ H +IK SN+LIN G I+DFG L ++ T + Y
Sbjct: 112 -LDYLHTK--RHIIHRDIKPSNLLINSK--GEVKIADFGISKVLENTLDQCNTFVGTVTY 166
Query: 552 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611
+PE I+ +S+ +D++S G+ LLE GK P P + +L + + AE
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 650
F E F + AC+ K P RP+ E
Sbjct: 227 EFSPEFRDFIS-------------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 3e-23
Identities = 59/284 (20%), Positives = 127/284 (44%), Gaps = 52/284 (18%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRL-------KEVVVGKRDFEQQMEIVGRVGQHPN 442
+ +GKGS+G Y + V+K + KE + D +++I+ ++ HPN
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKL-NHPN 60
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
++ + K + +V +Y G LS + + P E + + + ++
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRAP 554
HS K H +IK N+ + + + DFG++ +++ V TP Y +P
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY----YLSP 172
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--EV 612
E+ + + +++KSD++S G +L E+ T K P + +++++L +++ ++
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG---ENLLEL---ALKILKGQYPPIPSQ 226
Query: 613 FDVELMRFQNIEEEMV-QMLQIGMACVAKVPDMRPNMDEVVRMI 655
+ EL +V +LQ K P+ RP++ ++++
Sbjct: 227 YSSEL-------RNLVSSLLQ-------KDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 444
+V+G G +G + L ++ V +K LK K DF + I+G+ HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNII 68
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L +++ +Y +GSL L N G V +L G A G+ ++
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSE 124
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG-----YRAPEVIE 558
M + H ++ A N+L+N +L +SDFGL+ L + AT + G + APE I
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 559 TRKHSHKSDVYSFGVLLLEMLT-GKAP 584
RK + SDV+SFG+++ E+++ G+ P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 393 LGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLR 447
LGKGS+G +++ + +K L K+ ++ +++ E + I+ R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKL- 58
Query: 448 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAH 501
Y + +EKL LV +Y G L + L GR E R + I+L + +
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS---EERARFYAAEIVLA----LEY 108
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA---TPSRSAGYRAPEVI 557
+HS+G + ++K N+L++ D ++DFGL L + + T + Y APEV+
Sbjct: 109 LHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
+ + D +S GVLL EMLTGK P + R ++ +
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 51/297 (17%)
Query: 393 LGKGSYGTAYKAVLE---ESTT--VVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 445
LG+G +G + ++T V VK L + DFE+++EI+ + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVK 70
Query: 446 LRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ + L+ +Y SGSL L +R ++ + + +G+ ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG 126
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEV 556
S ++ H ++ A N+L+ + ISDFGL ++ APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616
+ T K S SDV+SFGV L E+ T P QSP + + +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-------------------MIG 224
Query: 617 LMRFQNIEEEMVQMLQIG--MACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 671
+ + Q I ++++L+ G + P DEV +++ +++ ++RPS +
Sbjct: 225 IAQGQMIVTRLLELLKEGERLPRPPSCP------DEVYDLMKLCWEAEPQDRPSFAD 275
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLR 447
LGKGSYG+ YK LKEV +G +++ + V + HPN++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYA--LKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ ++ +V +Y G LS + R R + + +I + RG+ +H
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-- 122
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIETRKHSHK 565
K H ++K++N+L+ + I D G++ ++ N+ T + Y APEV + R +S+K
Sbjct: 123 -KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYK 181
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 625
SD++S G LL EM T P ++ M DL VQ ++ I
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEA---RSMQDLRYKVQR---------------GKYPPIPP 223
Query: 626 EMVQ-MLQIGMACVAKVPDMRPNMDEV 651
Q + + + P +RPN D++
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 57/290 (19%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
EV+G+G+YG YKA +++ +V +K + + + + +++ I+ + HPN+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 450 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ K D+ LV + GS++ L+ G R G+ L E IL T RG+A++H
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLH 130
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 553
K H +IK N+L+ ++ + + DFG V A + G R A
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFG------VSAQLDSTLGRRNTFIGTPYWMA 181
Query: 554 PEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTRDDMVDLPRWVQSVVR- 605
PEVI + +SDV+S G+ +E+ GK PL P R + +PR ++
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNPPPTLKS 240
Query: 606 -EEWTAEVFDVELMRFQN-IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
E W+ + F + I E C+ K + RP M+E++
Sbjct: 241 PENWSKK--------FNDFISE-----------CLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 6e-20
Identities = 59/151 (39%), Positives = 77/151 (50%), Gaps = 5/151 (3%)
Query: 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 175
++ L L L G IP + +L LE+L L SN TG +P +TSLP L+ L L N
Sbjct: 284 QKLISLDLSDNSLSGEIPE-LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 176 NFSGKIPSSFSPQ--LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--D 231
FSG+IP + L VLDLS N+ TG IP+ + + L L L SN+L G IP
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 232 IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262
LR + L N G +PS K P F+
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+GKG +G V VK LK+ + F + ++ + +HPN+V L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVV 69
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+ +V +Y A GSL L R GR + ++ L G+ ++ F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-SAGYRAPEVIETRKHSHKSDVY 569
H ++ A NVL+++DL +SDFGL + + + APE + +K S KSDV+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 570 SFGVLLLEMLT-GKAP 584
SFG+LL E+ + G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
+G G +G + E V +K ++E + + DF ++ +++ ++ HP +V L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE 70
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
+ LV+++ G LS L RG ET + + L G+A++ S H
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLES---SNVIH 123
Query: 513 GNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAGY----RAPEVIETRKHSHKSD 567
++ A N L+ ++ +SDFG+T ++ T S + +PEV K+S KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 568 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 595
V+SFGVL+ E+ + GK P ++ + ++V+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 392 VLGKGSYGTA--YKAVLEESTTVVVK-----RLKEVVVGKRDFEQQMEIVGRVGQHPNVV 444
VLGKG++G A Y+ E+ + VV K RL E +RD ++ I+ + QHPN++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLL-QHPNII 62
Query: 445 PLRAYY--YSKDEKLLV-YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
AYY + D LL+ +Y G+L + +G + E + L V++
Sbjct: 63 ---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSY 116
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRA 553
IH G H +IK N+ + + + DFG++ ++ V TP Y +
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY----YMS 169
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613
PE+ + K++ KSD+++ G +L E+LT K D + V +V+ +T V
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTF------DATNPLNLVVKIVQGNYTPVV- 222
Query: 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
E++ ++ + + + P+ RP DEV+
Sbjct: 223 -------SVYSSELISLVH---SLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG G +G + +T V VK LK + F Q+ +I+ ++ +H +V L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE 72
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
++ +V +Y + GSL L G G+ L V + A G+A++ S + H
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS--GEGKK-LRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 513 GNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAGY----RAPEVIETRKHSHKSD 567
++ A N+L+ ++L I+DFGL L + T A + APE + + KSD
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 568 VYSFGVLLLEMLT-GKAP 584
V+SFG+LL E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 445
+GKGS+G +K V + V +K++ + K + ++ E + ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDSSYII- 62
Query: 446 LRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLD--WETRVKILLGTARGVA 500
YY S KL +V +Y +G L LL RG P D W ++ILLG +A
Sbjct: 63 --RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLG----LA 115
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEV 556
H+HS K H +IK+ N+ ++ + I D G L+ N T + Y +PE+
Sbjct: 116 HLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAP 584
E + ++ KSDV++ GV+L E TGK P
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 70/245 (28%), Positives = 117/245 (47%), Gaps = 22/245 (8%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG G +G + ST V VK LK + + F ++ ++ + QH +V L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLM-KTLQHDKLVRLYAVVTK 72
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPL----DWETRVKILLGTARGVAHIHSMGGP 508
++ ++ +Y A GSL L + G G+ L D+ ++ A G+A+I
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQI------AEGMAYIER---K 122
Query: 509 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 563
+ H +++A+NVL+++ L I+DFGL ++ +R + APE I +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 564 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDD-MVDLPRWVQSVVREEWTAEVFDVELMRFQ 621
KSDV+SFG+LL E++T GK P + D M L R + E E++D+ ++
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWK 242
Query: 622 NIEEE 626
EE
Sbjct: 243 EKAEE 247
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG G +G ++ + +T V VK LK + +DF + +I+ ++ +HP ++ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL 72
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
++ +V + GSL L G GAGR L + + A G+A++ + + H
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG--GAGRA-LKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 513 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 567
++ A NVL+ ++ ++DFGL ++ +R + APE + S KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 568 VYSFGVLLLEMLT-GKAP 584
V+SFG+LL E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 395 KGSYGTAYKA------------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN 442
KG++G+ Y A VL++S + ++ V + Q G+ P
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ-------GESPY 58
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
V L + SKD LV +Y G ++L+ + G P DW + + GV +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKH 562
H G H +IK N+LI+Q ++DFGL+ + Y APE I
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGD 170
Query: 563 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--LPRWVQSVVREEWTAEVFD 614
SD +S G ++ E L G P + T D + D L R + W EV +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN------WPEEVKE 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 447
+ +G G+YG YKA + V +K +K + DFE Q EI + + +HPN+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHPNIV--- 63
Query: 448 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
AY+ Y + +KL +V +Y GSL + RG PL + T +G+A++H
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHE 119
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 554
G H +IK +N+L+ +D D ++DFG V A + + R AP
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFG------VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 555 EVIETRKHS---HKSDVYSFGVLLLEMLTGKAPL 585
EV + K D+++ G+ +E+ + P+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 57/208 (27%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 391 EVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 444
+V+G G +G ++ +L+ + V +K LK K+ DF + I+G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NII 69
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L +++ +Y +G+L L + G + V +L G A G+ ++
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQL---VGMLRGIAAGMKYLSD 125
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG-----YRAPEVI 557
M + H ++ A N+L+N +L+ +SDFGL+ ++ + T + S G + APE I
Sbjct: 126 M---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 558 ETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
RK + SDV+SFG+++ E+++ G+ P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 60/221 (27%), Positives = 111/221 (50%), Gaps = 24/221 (10%)
Query: 391 EVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 444
EV+G G +G + L+ V +K LK K RDF + I+G+ HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNII 68
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L +++ ++ +G+L + L N G T + V +L G A G+ ++
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQL---VGMLRGIAAGMKYLSE 124
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG--------YRAPE 555
M + H ++ A N+L+N +L +SDFGL+ L + + P+ ++ + APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 595
I RK + SDV+S+G+++ E+++ G+ P + D+++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-17
Identities = 52/144 (36%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 114 DRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQ 173
+F L L L G IP +LG +L + L+ N +G LPSE T LP + +L +
Sbjct: 378 SSGNLFKLILFSNSLEGEIPK-SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 174 HNNFSGKIPSSF--SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 229
+NN G+I S P L +L L+ N F G +P S + +L L L N SG++P
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495
Query: 230 FDIPKLRHLNLSYNGLKGSIPSSL 253
+ +L L LS N L G IP L
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDEL 519
|
Length = 968 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 391 EVLGKGSYGTAY---KAVLEESTTV-VVKRLKEVVVGKRD-FEQQME--IVGRVGQHPNV 443
+VLG+GS+G + K ++ + +K LK+ + RD +ME I+ V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFI 60
Query: 444 VPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAH 501
V L Y + + KL L+ D+ G L T L + + E VK L A + H
Sbjct: 61 VKLH-YAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDH 113
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS--RSAGYRAPEVI 557
+HS+G + ++K N+L++++ ++DFGL+ + + S + Y APEV+
Sbjct: 114 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
R H+ +D +SFGVL+ EMLTG P Q R + + +
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 442
LG+G++G + + V VK LKE ++DFE++ E++ QH N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHEN 69
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HG-------NRGAGRTPLDWETRVKILL 493
+V D ++V++Y G L+ L HG + + L ++I +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-RSAGYR 552
A G+ + + F H ++ N L+ DL I DFG++ +V T R G+
Sbjct: 130 QIASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMS--RDVYTTDYYRVGGHT 184
Query: 553 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
PE I RK + +SDV+SFGV+L E+ T GK P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-17
Identities = 70/235 (29%), Positives = 98/235 (41%), Gaps = 70/235 (29%)
Query: 106 WVGINCTQDRTR----VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI 161
W G +C D T+ + GL L GL G IPN + KL L+ ++L N + G +P +
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 162 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 221
S+ SL VLDLS+NSF G+IP+S+ LT L L+L N
Sbjct: 463 GSITSL----------------------EVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 222 NLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG-PPLKACFPVAP 280
+LSG +P G F +F N+ LCG P L+AC P
Sbjct: 501 SLSGRVP---------------AALGGRLLHRASF---NFTDNAGLCGIPGLRACGP--- 539
Query: 281 SPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDN 335
L +GA I IA G S L + + +C+ K++ N
Sbjct: 540 --------------------HLSVGAKIGIAFGVSVAFLFLVICAMCWW-KRRQN 573
|
Length = 623 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 46/288 (15%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 442
+ LG+G++G KA E++TV VK LK+ K D +ME++ +G+H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTPLDWETRVKIL-- 492
++ L + +V +Y A G+L L R G R P + T+ ++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 493 -LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 550
ARG+ + S K H ++ A NVL+ +D I+DFGL + ++ + G
Sbjct: 138 AYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 551 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 604
+ APE + R ++H+SDV+SFGVLL E+ T G +P +++ L +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-------L 247
Query: 605 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652
+E + E + QN +E+ ++ C +VP RP ++V
Sbjct: 248 KEGYRME-------KPQNCTQELYHLM---RDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 392 VLGKGSYGTAYKAV---LEESTT--VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 444
VLG G++GT YK V E V +K L+E ++ + ++ V HP+VV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVV 72
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHI 502
L S + L+ G L + ++ + L+W ++ A+G++++
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEV 556
H ++ A NVL+ I+DFGL L++V + G + A E
Sbjct: 126 EEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 557 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 591
I R ++HKSDV+S+GV + E++T G P + P +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 392 VLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 445
V+G G +G L+ V +K LK K RDF + I+G+ HPN++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIH 69
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L ++V +Y +GSL L + G V +L G A G+ ++ M
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ----FTVIQLVGMLRGIASGMKYLSDM 125
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVIE 558
G + H ++ A N+L+N +L +SDFGL+ ++ + P + G + APE I
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 559 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 594
RK + SDV+S+G+++ E+++ G+ P + D++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 54/130 (41%), Positives = 71/130 (54%), Gaps = 5/130 (3%)
Query: 128 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 186
L GPIP + L L L L N L+G +P + L +L L+L NNF+GKIP + +
Sbjct: 272 LSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 187 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 243
P+L VL L N F+G IP+++ LT L L +NNL+G IP L L L N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 244 GLKGSIPSSL 253
L+G IP SL
Sbjct: 391 SLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 40/218 (18%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRVGQ------H 440
EV+G G+ Y A+ L + V +KR+ D E+ ++ + + Q H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQAMSQCNH 58
Query: 441 PNVVPLRAYYYS---KDEKLLVYDYFASGSLSTLL-HGNRGAGRTPLDWETRVKILLGTA 496
PNVV YY S DE LV Y + GSL ++ G LD +L
Sbjct: 59 PNVV---KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVL 112
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 550
+G+ ++HS G H +IKA N+L+ +D I+DFG++ + +R
Sbjct: 113 KGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 551 --YRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 585
+ APEV+E + K+D++SFG+ +E+ TG AP
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQ------- 439
E++GKG+YG Y A+ TT + +K+V + R +Q ++V +
Sbjct: 7 ELIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 440 --HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 496
H N+V + +++ + +Y GS+ + L R GR E V+
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFE---EQLVRFFTEQVL 118
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDG-C-ISDFGLTP-----LMNVPATPSR-S 548
G+A++HS G H ++KA N+L+ D DG C ISDFG++ N + S
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLV--DADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 549 AGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAP 584
+ APEVI + + +S K D++S G ++LEM G+ P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 54/280 (19%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRA 448
E +GKG++G YK VL+ +T V VK + + KR F Q+ EI+ + HPN+V L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 508
K +V + GSL T L + + +++ L A G+ ++ S
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV----KKLLQMSLDAAAGMEYLESK--- 112
Query: 509 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---------SAGYR------- 552
H ++ A N L+ ++ ISDFG+ SR S G +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGM----------SREEEGGIYTVSDGLKQIPIKWT 162
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612
APE + +++ +SDV+S+G+LL E + P RE
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGD----------TPYPGMSNQQTRER----- 207
Query: 613 FDVEL-MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 651
+E R + ++ ++ + C A P+ RP+ E+
Sbjct: 208 --IESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 52/230 (22%), Positives = 103/230 (44%), Gaps = 41/230 (17%)
Query: 391 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVP 445
+++G+GS+ T A E + +K L + + K + + E++ R+ HP ++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 446 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
L YY +DE+ L V +Y +G L + G+ LD + + ++H
Sbjct: 67 L--YYTFQDEENLYFVLEYAPNGELLQYIR-KYGS----LDEKCTRFYAAEILLALEYLH 119
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS--------------- 548
S G H ++K N+L+++D+ I+DFG +++ ++P +
Sbjct: 120 SKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 549 ---------AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589
A Y +PE++ + SD+++ G ++ +MLTGK P +
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG+G +G + +T V +K LK + F Q+ +++ ++ +H +V L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 71
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
++ +V +Y + GSL L G G L V + A G+A++ M + H
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM---NYVH 125
Query: 513 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 567
+++A+N+L+ ++L ++DFGL L+ +R + APE + + KSD
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 568 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 595
V+SFG+LL E+ T G+ P +++D
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLD 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG G +G + V +K ++E + + DF ++ +++ ++ HPN+V L
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK 70
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
+ +V +Y A+G L L +G T E + + + ++ S G F H
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 513 GNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKSD 567
++ A N L+ +D +SDFGL +++ T S+ + PEV + + S KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 568 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 595
V+SFGVL+ E+ + GK P + + ++V+
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ LG G +G + T V +K LK+ + F + ++ ++ QHP +V L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVV 70
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+++ ++ +Y +GSL L G L + + A G+A I +
Sbjct: 71 -TQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 565
H +++A+N+L+++ L I+DFGL L+ +R + APE I + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 566 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
SDV+SFG+LL E++T G+ P T P +Q++ R + R N
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNLER--------GYRMPRPDNCP 229
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
EE+ +++ C + P+ RP + + ++E+
Sbjct: 230 EELYELM---RLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 53/262 (20%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 442
E LG+G++G YK L +T+V +K LKE K ++F Q+ E++ + QHPN
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPN 69
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG------RTPLDWETRVKI 491
+V L + ++++Y A G L L H + GA ++ LD + I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRS 548
+ A G+ ++ S F H ++ A N L+ + L ISDFGL+ + + S+S
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 549 ---AGYRAPEVIETRKHSHKSDVYSFGVLL-------------------LEMLTGKAPLQ 586
+ PE I K + +SD++SFGV+L +EM+ + L
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 587 SPTRDDMVDLPRWVQSVVREEW 608
P D P V +++ E W
Sbjct: 247 CP-----EDCPARVYALMIECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 34/274 (12%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRV 437
DLE L LG G+ G K + + ++ + + + + +Q +++I+ +
Sbjct: 2 DLEYL-----GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC 56
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 497
P +V +Y+ + + +Y GSL +L GR P KI + +
Sbjct: 57 -NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPER--ILGKIAVAVLK 111
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA-TPSRSAGYRAPE 555
G+ ++H K H ++K SN+L+N + DFG+ L+N A T ++ Y APE
Sbjct: 112 GLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE 169
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---WTAEV 612
I+ +S KSD++S G+ L+E+ TG+ P +Q +V E +
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPPPRLPSGK 228
Query: 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 646
F + F N C+ K P RP
Sbjct: 229 FSPDFQDFVN-------------LCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG G +G + +T V VK LK + F ++ +I+ ++ +H +V L A S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVV-S 71
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
++ +V +Y + GSL L G GR L V + A G+A+I M + H
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL--KDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIH 125
Query: 513 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 567
+++++N+L+ L I+DFGL L+ +R + APE + + KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 568 VYSFGVLLLEMLT-GKAP 584
V+SFG+LL E++T G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG+G +G + +T V +K LK + F Q+ +I+ ++ +H +VPL A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVV-S 71
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
++ +V ++ GSL L G G+ L V + A G+A+I M + H
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYIERM---NYIH 125
Query: 513 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 567
+++A+N+L+ +L I+DFGL L+ +R + APE + + KSD
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 568 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 626
V+SFG+LL E++T G+ P P V V E+ + Q E
Sbjct: 186 VWSFGILLTELVTKGRVP-----------YPGMVNREVLEQVER---GYRMPCPQGCPES 231
Query: 627 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
+ +++++ C K PD RP + + +E+
Sbjct: 232 LHELMKL---CWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 34/242 (14%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLK-EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 451
LG G +G ++ + + V +K LK + ++ ++DF+++++ + R+ +H +++ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCS 72
Query: 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG----TARGVAHIHSMGG 507
+ ++ + GSL L R+P V L+ A G+A++
Sbjct: 73 VGEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--ATPSRSAGYR--APEVIETRKHS 563
H ++ A N+L+ +DL ++DFGL L+ + + Y+ APE S
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 564 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL-------------PRWVQSVVREEWT 609
KSDV+SFG+LL EM T G+ P ++ D P+ + ++ E W
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWA 242
Query: 610 AE 611
AE
Sbjct: 243 AE 244
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 6e-16
Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 31/210 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG--RVGQHPNVVPLR 447
+ LG G++G+ Y A +E+ +V +K++K+ + E+ ++ +HPN+V L+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHSMG 506
+ DE V++Y G+L L+ +G P E+ ++ I+ +G+AHIH G
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKG---KPFS-ESVIRSIIYQILQGLAHIHKHG 119
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----------YRAPEV 556
F H ++K N+L++ I+DFGL A RS YRAPE+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGL-------AREIRSRPPYTDYVSTRWYRAPEI 169
Query: 557 I-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ + +S D+++ G ++ E+ T + PL
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR-PL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ------MEI-VGRVGQHPNV 443
E +G+G+ G YKA KEV + K +Q EI + + +HPN+
Sbjct: 25 EKIGEGASGEVYKAT-------DRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 502
V Y DE +V +Y GSL+ ++ N ++ E ++ + +G+ ++
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF----VRMN-EPQIAYVCREVLQGLEYL 132
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA--G---YRAPEVI 557
HS H +IK+ N+L+++D ++DFG + R++ G + APEVI
Sbjct: 133 HSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVVGTPYWMAPEVI 188
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ + + K D++S G++ +EM G+ P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 35/210 (16%)
Query: 393 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHPNV 443
+G+G+YG YKA + + +V +K++K FE + EI + HPN+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKELNHPNI 60
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 502
+ L + K + LV+++ + L + + L E+ +K L +G+A
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDR-QRGLP-ESLIKSYLYQLLQGLAFC 114
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSAGYRAPEV 556
HS G H ++K N+LIN + ++DFGL P P +R YRAPE+
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--WYRAPEL 169
Query: 557 IET-RKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ + +S D++S G + E+L+ + PL
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR-PL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 393 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 451
LG G YG Y+ V ++ S TV VK LKE + +F ++ ++ + +HPN+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 72
Query: 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 511
+ ++ ++ G+L L R R ++ + + + + ++ F
Sbjct: 73 REPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 512 HGNIKASNVLINQDLDGCISDFGLTPLM-----NVPATPSRSAGYRAPEVIETRKHSHKS 566
H ++ A N L+ ++ ++DFGL+ LM A + APE + K S KS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 567 DVYSFGVLLLEMLT-GKAP 584
DV++FGVLL E+ T G +P
Sbjct: 187 DVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 393 LGKGSYGTAYKAV---LEEST--TVVVKRLKEVVVGK-RDFEQQMEIVGRVGQHPNVVPL 446
LGKG++G+ L+++T V VK+L+ RDFE+++EI+ + QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEIL-KSLQHDNIVKY 70
Query: 447 RAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
+ YS + LV +Y GSL L +R K+LL ++ +
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-------KLLLYASQICKGMEY 123
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM------NVPATPSRSAGY-RAPEVI 557
+G ++ H ++ N+L+ + I DFGLT ++ P S + APE +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
K S SDV+SFGV+L E+ T SP + M
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 393 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR-DFEQQMEIVGRVGQHPNVVP 445
LG+G++G + A ++ V VK LKE R DF+++ E++ V QH ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL-TVLQHQHIVR 71
Query: 446 LRAYYYSKDEKLLVYDYFASGSL----------STLLHGNRGAGRTPLDWETRVKILLGT 495
L+V++Y G L + +L G L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRA-- 553
A G+ ++ S+ F H ++ N L+ Q L I DFG++ ++ +T G R
Sbjct: 132 ASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMS--RDIYSTDYYRVGGRTML 186
Query: 554 ------PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
PE I RK + +SD++SFGV+L E+ T GK P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 392 VLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVPL 446
VLGKGS+G A L+ + +K LK +VV+ D E M ++ +HP + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIHS 504
+ +K+ V +Y G L + + +GR +I+ G + +H
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICG----LQFLHK 114
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETR 560
G + ++K NVL+++D I+DFG+ MN S G Y APE+++ +
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWV 600
K++ D +SFGVLL EML G++P D++ D PRW+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 34/271 (12%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGK--RDFEQQMEIVGRVGQHPNVVPLR 447
+GKG + YKA+ L + V +K+++ E++ K +D ++++++ ++ HPNV+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYL 68
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
A + +E +V + +G LS ++ + R + T K + + H+HS
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCSALEHMHSK-- 125
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIETRKHS 563
+ H +IK +NV I + D GL + T + S G Y +PE I ++
Sbjct: 126 -RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---AEVFDVELMRF 620
KSD++S G LL EM A LQSP D ++L + + + ++ A+ + EL
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL--- 237
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 651
++V C+ P+ RP++ V
Sbjct: 238 ----RDLVSR------CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 8e-15
Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 62/236 (26%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-------------QQMEIVGRV 437
E LG+G+YG YKA +++ +V LK++ + + E +++
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVA--LKKIRLDNEE-EGIPSTALREISLLKEL------ 55
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTA 496
+HPN+V L +++ + LV++Y L L G PL +K I+
Sbjct: 56 -KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG----PLS-PNLIKSIMYQLL 108
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---- 550
RG+A+ HS + H ++K N+LIN DG ++DFGL +R+ G
Sbjct: 109 RGLAYCHSH---RILHRDLKPQNILIN--RDGVLKLADFGL----------ARAFGIPLR 153
Query: 551 ----------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
YRAPE++ ++ +S D++S G + EM+TGK + D +
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 31/211 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---QMEIVG----RVGQHPNV 443
E++G+G+YG Y+ + VV LK + + D + Q E+ R Q PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVA--LKIINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 444 VPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
YY Y K +L ++ +Y GS+ TL+ AG P+ + I+ +
Sbjct: 65 T---KYYGSYLKGPRLWIIMEYAEGGSVRTLMK----AG--PIAEKYISVIIREVLVALK 115
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS--AG---YRAPE 555
+IH +G H +IKA+N+L+ + + DFG+ L+N + RS G + APE
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-NSSKRSTFVGTPYWMAPE 171
Query: 556 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
VI E + + K+D++S G+ + EM TG P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 393 LGKGSYGTAYKAVL--------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 442
LG+G +G A +E+ TV VK LK+ K D +ME++ +G+H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 491
++ L ++ +Y + G+L L R G + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 550
ARG+ ++ S K H ++ A NVL+ ++ I+DFGL + N+ + G
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 551 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
+ APE + R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 27/203 (13%)
Query: 393 LGKGSYGTAYKAVLEE----STTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPL 446
LG G++G+ K V V VK LK+ + GK++F ++ ++ ++ HP +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV-- 59
Query: 447 RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHS 504
R K E L LV + G L L R + +V A G+A++ S
Sbjct: 60 RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG-----YRAPEVI 557
F H ++ A NVL+ ISDFG++ + + + +AG + APE I
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 558 ETRKHSHKSDVYSFGVLLLEMLT 580
K S KSDV+S+GV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 46/241 (19%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRD-FEQQM--EI-VGRVGQHPNVVPLR 447
+G+G+YG YKA + V +K+++ + +++ F EI + + +HPN+V L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 448 AYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHS 504
SK + +V++Y L+ LL + T E+++K + G+ ++HS
Sbjct: 65 EIVTSKGKGSIYMVFEYM-DHDLTGLLD-SPEVKFT----ESQIKCYMKQLLEGLQYLHS 118
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVI-- 557
G H +IK SN+LIN D ++DFGL + + YR PE++
Sbjct: 119 NG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ----------------SPTRDD---MVDLPR 598
TR + + D++S G +L E+ GK Q SPT ++ + LP
Sbjct: 176 ATR-YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234
Query: 599 W 599
+
Sbjct: 235 F 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 65/245 (26%), Positives = 119/245 (48%), Gaps = 23/245 (9%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG G +G + A + T V VK +K + F + ++ + QH +V L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV-T 71
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPL----DWETRVKILLGTARGVAHIHSMGGP 508
K+ ++ ++ A GSL L + G + PL D+ ++ A G+A I
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQI------AEGMAFIEQR--- 121
Query: 509 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 563
+ H +++A+N+L++ L I+DFGL ++ +R + APE I +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 564 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEVFDVELMRFQ 621
KSDV+SFG+LL+E++T G+ P + +++ L R + E E++++ + ++
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWK 241
Query: 622 NIEEE 626
N EE
Sbjct: 242 NRPEE 246
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 55/301 (18%)
Query: 392 VLGKGSYGTAYKAVLEE------STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNV 443
LG+G +G KA TTV VK LKE RD + ++ +V HP+V
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHV 65
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT---------------PLDWETR 488
+ L LL+ +Y GSL + L +R G + P +
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 489 VKILLGTA----RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPA 543
+ L+ A RG+ ++ M K H ++ A NVL+ + ISDFGL+ + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 544 TPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP 597
RS G + A E + ++ +SDV+SFGVLL E++T G P + + +L
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL- 241
Query: 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
+++ R E R +N EEM ++ + C + PD RP ++ + +E+
Sbjct: 242 --LKTGYRME-----------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEK 285
Query: 658 V 658
+
Sbjct: 286 M 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 391 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 445
+V+G+G++G +A++++ +K LKE RDF ++E++ ++G HPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 446 L------RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETR 488
L R Y Y + +Y G+L L +R P L +
Sbjct: 68 LLGACENRGYLY------IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 489 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS 546
++ A G + + +F H ++ A NVL+ ++L I+DFGL+ + V T
Sbjct: 122 LQFASDVATG---MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178
Query: 547 R-SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
R + A E + ++ KSDV+SFGVLL E+++ G P
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ +GKG +G V VK +K + F + ++ ++ +H N+V L
Sbjct: 12 QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA-FLAEASVMTQL-RHSNLVQLLGVI 68
Query: 451 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ L +V +Y A GSL L R GR+ L + +K L + ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANN 122
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYRAPEVIETRKHSHKSDV 568
F H ++ A NVL+++D +SDFGLT + T + APE + +K S KSDV
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 569 YSFGVLLLEMLT-GKAP 584
+SFG+LL E+ + G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 50/223 (22%), Positives = 97/223 (43%), Gaps = 52/223 (23%)
Query: 392 VLGKGSYGTAYKAVLEESTTVV-VKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVPL 446
+G G+YG AV + + V +K++ +++ KR ++++++ + +H N++ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHL-RHENIIGL 64
Query: 447 RAYYYSKD----EKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVA 500
+ +V + + L ++ + PL + ++ L RG+
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ-----PLT-DDHIQYFLYQILRGLK 117
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 550
++HS H ++K SN+L+N + D I DFGL +R
Sbjct: 118 YLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL----------ARGVDPDEDEKGFLT 164
Query: 551 -------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 585
YRAPE++ + K+ D++S G + E+LT K PL
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 82/319 (25%), Positives = 138/319 (43%), Gaps = 48/319 (15%)
Query: 354 PKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV 413
P +++PE +L F E D E L E+ G GS+G Y A + T V
Sbjct: 1 PSTSRAGSLKDPEIAELFFKE------DPEKLFTDLREI-GHGSFGAVYFA-RDVRTNEV 52
Query: 414 VKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468
V K GK+ E+ +I+ V +HPN + + Y + LV +Y GS
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSA 111
Query: 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528
S LL + PL I G +G+A++HS H +IKA N+L+ +
Sbjct: 112 SDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV 164
Query: 529 CISDFGLTPLMNVPATPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
++DFG + + + + + APEVI + ++ K DV+S G+ +E+ K PL
Sbjct: 165 KLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
Query: 586 QSPTRDDMVDLPRWVQ----SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKV 641
+ + M L Q ++ EW+ F+N + +C+ K+
Sbjct: 225 FN--MNAMSALYHIAQNESPTLQSNEWSD--------YFRNFVD----------SCLQKI 264
Query: 642 PDMRPNMDEVVRMIEEVRQ 660
P RP +E+++ + +R+
Sbjct: 265 PQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--------QMEI-VGRVGQHP 441
E +GKGS+G YKA+ + + VV +K + D E+ Q EI + P
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVA--IKVI-----DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 442 NVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
+ YY + K KL ++ +Y GS LL LD IL G
Sbjct: 60 YIT---KYYGSFLKGSKLWIIMEYCGGGSCLDLLK------PGKLDETYIAFILREVLLG 110
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS---AG---YR 552
+ ++H G H +IKA+N+L++++ D ++DFG++ + +T S+ G +
Sbjct: 111 LEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWM 165
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
APEVI+ + K+D++S G+ +E+ G+ PL
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 30/210 (14%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK------RDFEQQMEIVGRVGQHPNV 443
E+LG GS+G+ Y+ + L++ VK + G+ + EQ++ ++ ++ QHPN+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNI 64
Query: 444 VPLRAYYYSK--DEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
V Y ++ ++ L ++ + GSL+ LL G+ P+ +ILLG +
Sbjct: 65 V---QYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILLG----LE 116
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR---SAGYRAPE 555
++H H +IK +N+L+ D +G + +DFG+ + + S + APE
Sbjct: 117 YLHDRN---TVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
Query: 556 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAP 584
VI + + +D++S G +LEM TGK P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 393 LGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPL 446
+G+GS+G KA+L E+ V+K + + ++ E+ + V + HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIH 503
+ + +V DY G L ++ RG LDW V+I L + H+H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICLA----LKHVH 118
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIET 559
K H +IK+ N+ + +D + DFG+ ++N +R+ Y +PE+ E
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 594
R +++KSD+++ G +L EM T K ++ ++V
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVG-----QHPNVV 444
E +GKGS+GT K + ++V KE+ G E+Q +V V +HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILV--WKEIDYGNMTEKEKQQ-LVSEVNILRELKHPNIV 62
Query: 445 PLRAYYYSKD---EKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
YY + +Y +Y G L+ L+ + R ++ E +IL
Sbjct: 63 R----YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLA 117
Query: 499 VAHIH--SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YR 552
+ H S G H ++K +N+ ++ + + + DFGL ++ ++ +++ G Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
+PE + + KSD++S G L+ E+ P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 38/277 (13%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLR 447
LG G+ G+ K + TV+ K K V +G + + +I+ + + P +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAK--KVVHIGAKS-SVRKQILRELQIMHECRSPYIVSFY 69
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ +++ + ++ GSL + + G P+ E KI + G+ +++++
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY---KKGG--PIPVEILGKIAVAVVEGLTYLYNV-- 122
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-VPATPSRSAGYRAPEVIETRKHSHK 565
+ H +IK SN+L+N + DFG++ L+N + T ++ Y +PE I+ K++ K
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDD--------MVDLPRWVQSVVREEWTAEVFDVEL 617
SDV+S G+ ++E+ GK P DD ++DL +Q +V+E
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---LQQIVQEPPPRLPSS--- 236
Query: 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
F + V AC+ K P RP ++ M
Sbjct: 237 -DFPEDLRDFVD------ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 73/298 (24%), Positives = 135/298 (45%), Gaps = 58/298 (19%)
Query: 391 EVLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 445
+V+G+G++G KA +++ +KR+KE RDF ++E++ ++G HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 446 L------RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETR 488
L R Y Y L +Y G+L L +R P L +
Sbjct: 73 LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 489 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS 546
+ ARG+ ++ +F H ++ A N+L+ ++ I+DFGL+ + V T
Sbjct: 127 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 547 R-SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSV 603
R + A E + ++ SDV+S+GVLL E+++ G P T ++ + LP+
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----- 238
Query: 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV----RMIEE 657
L + N ++E+ +++ C + P RP+ +++ RM+EE
Sbjct: 239 ----------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 391 EVLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E++G+G +G AVL+ T V VK +K V + F ++ ++ ++ H N+V L
Sbjct: 12 EIIGEGEFG----AVLQGEYTGQKVAVKNIKCDVTAQA-FLEETAVMTKL-HHKNLVRLL 65
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+V + + G+L L R GR + ++ L A G+ ++ S
Sbjct: 66 GVILHNG-LYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES--- 118
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-SAGYRAPEVIETRKHSHKS 566
K H ++ A N+L+++D +SDFGL + ++ S+ + APE ++ +K S KS
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKS 178
Query: 567 DVYSFGVLLLEMLT-GKAP 584
DV+S+GVLL E+ + G+AP
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 74/303 (24%), Positives = 122/303 (40%), Gaps = 77/303 (25%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRVGQHPNVVPLRA 448
+G G++G Y AV L+ + VK ++ + ++ +M+++ + +HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVK--- 63
Query: 449 YYYS---KDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWE-TRV--KILLGTARGVAH 501
YY EK+ ++ +Y + G+L LL R LD RV LL G+A+
Sbjct: 64 -YYGVEVHREKVYIFMEYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLL---EGLAY 114
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG--------Y 551
+HS G H +IK +N+ + D +G I DFG + T Y
Sbjct: 115 LHSHG---IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 552 RAPEVIETRKHSHK---SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608
APEVI K +D++S G ++LEM TGK P
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP------------------------ 205
Query: 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 668
+ ++ E M +G +PD E ++ +SD + RP+
Sbjct: 206 -----------WSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT 254
Query: 669 SEE 671
+ E
Sbjct: 255 ASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 75/300 (25%), Positives = 134/300 (44%), Gaps = 48/300 (16%)
Query: 393 LGKGSYGTAYKAVL--------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 442
LG+G +G +A +++ TV VK LK+ K D +ME++ +G+H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 491
++ L + ++ +Y A G+L L R G L ++ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 550
ARG+ ++ S + H ++ A NVL+ +D I+DFGL + ++ S G
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 551 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 604
+ APE + R ++H+SDV+SFG+L+ E+ T G +P +++ L +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL-------L 249
Query: 605 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
RE + + N E+ +++ C VP RP ++V +++V + SE
Sbjct: 250 REGHRMD-------KPSNCTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 393 LGKGSYGTAY--------KAVLEESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 442
LG+G +G K + TV VK LK+ K D +ME++ +G+H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTP---LDWETRVKI 491
++ L ++ +Y + G+L L R G + P L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 550
ARG+ ++ S K H ++ A NVL+ +D I+DFGL + N+ + G
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 551 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
+ APE + R ++H+SDV+SFGVLL E+ T G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRV 437
D E+L E +GKGS+G +K + + VV + L+E D +Q++ ++ +
Sbjct: 1 DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 438 GQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 494
P V YY Y KD KL ++ +Y GS LL PLD IL
Sbjct: 60 -DSPYVT---KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILRE 109
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG--- 550
+G+ ++HS K H +IKA+NVL+++ + ++DFG+ L + + G
Sbjct: 110 ILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ APEVI+ + K+D++S G+ +E+ G+ P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 64/288 (22%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 392 VLGKGSYGTAYKAVLEES------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 443
LG+G +G + A + T V+VK L++ +F +++++ ++ H NV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNV 70
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT----PLDWETRVKILLGTARGV 499
V L + ++ +Y G L L + PL + +V + A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT---------PLMNVPATPSRSAG 550
H+ + +F H ++ A N L++ + +S L+ L N P R
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLR--- 183
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609
+ APE ++ S KSDV+SFGVL+ E+ T G+ P + +++++
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN-------------R 230
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
+ +EL + + +++ C A P RP+ E+V + E
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMT---RCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 391 EVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 444
+ LG GS+G + S V VK LK + DF ++ I+ + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLI 59
Query: 445 PLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLD--WETRVKILLGTARGVAH 501
R Y L +V + GSL L G + + V+I A G+ +
Sbjct: 60 --RLYGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQI----ANGMRY 112
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------AP 554
+ S +F H ++ A N+L+ D I DFGL + + AP
Sbjct: 113 LES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
E + TR SH SDV+ FGV L EM T G+ P
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
E +G+G+ GT Y A+ + V +K++ K++ +V R ++PN+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
Y DE +V +Y A GSL+ ++ T +D + + + +HS +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHS---NQ 135
Query: 510 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 565
H +IK+ N+L+ D ++DFG +TP + +T + + APEV+ + + K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 566 SDVYSFGVLLLEMLTGKAPL--QSPTR 590
D++S G++ +EM+ G+ P ++P R
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLR 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 64/250 (25%), Positives = 117/250 (46%), Gaps = 26/250 (10%)
Query: 391 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 445
+V+G+G++G KA +++ +KR+KE RDF ++E++ ++G HPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETRVKILLG 494
L + L +Y G+L L +R P L + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPSR-SAGY 551
ARG+ ++ +F H ++ A N+L+ ++ I+DFGL+ + V T R +
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 552 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSVVREEWT 609
A E + ++ SDV+S+GVLL E+++ G P T ++ + LP+ +
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237
Query: 610 AEVFDVELMR 619
EV+ +LMR
Sbjct: 238 DEVY--DLMR 245
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 61/212 (28%), Positives = 87/212 (41%), Gaps = 24/212 (11%)
Query: 392 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPLRA 448
VLGKG+YG Y A L + +K + E R + E + H N+V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA--RGVAHIHSMG 506
+ + GSLS LL G PL + I G+ ++H
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 507 GPKFTHGNIKASNVLINQDLDGC-ISDFG----LTPLMNVPATPSRSAGYRAPEVIE--T 559
+ H +IK NVL+N ISDFG L + T + + Y APEVI+
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAP---LQSP 588
R + +D++S G ++EM TGK P L P
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPN 442
E +G+G+ GT Y A+ + +T +EV + + + +QQ + +V R +HPN
Sbjct: 25 EKIGQGASGTVYTAI-DVATG------QEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
+V Y DE +V +Y A GSL+ ++ T +D + + + +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFL 131
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 558
HS H +IK+ N+L+ D ++DFG +TP + +T + + APEV+
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ + K D++S G++ +EM+ G+ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQME-------IVGRVGQHPN 442
+ LG G++ + Y+A ++ T + VK++ V + E+ +E ++ R+ HP+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPH 64
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
++ + L ++ A GS+S LL G + RG++++
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYG----AFKEAVIINYTEQLLRGLSYL 119
Query: 503 HSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVPATPSR--------SAGY 551
H + H ++K +N+LI+ Q L I+DFG + T + + +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 552 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
APEV+ ++ DV+S G +++EM T K P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 392 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 446
VLGKGS+G A L+ + + VK L K+V++ D E M ++ G+HP + L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSM 505
+ + +KD V +Y G L + H R +GR E R + G+ +H
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDL--MFHIQR-SGRFD---EPRARFYAAEIVLGLQFLHER 115
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRK 561
G + ++K NVL++ + I+DFG+ + T S G Y APE++ +
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRW 599
+ D ++ GVLL EML G++P + D++ V PRW
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 445
+VLGKGS+G A L+ + VK LK +VV+ D E M ++ ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 503
L + +K+ V ++ G L + H + GR L T +I+ G + +H
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL--MFH-IQDKGRFDLYRATFYAAEIVCG----LQFLH 113
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAPEVIET 559
S G + ++K NV++++D I+DFG+ N +T + Y APE+++
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWV 600
K++ D +SFGVLL EML G++P D++ + PRW+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 9e-13
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVGQHPNVVPLRAY 449
E++G G+YG YK ++ + ++ +V + + +Q++ ++ + H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 450 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ K D+ LV ++ +GS++ L+ +G L E I RG++H+H
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH 128
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 553
K H +IK NVL+ ++ + + DFG V A R+ G R A
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMA 179
Query: 554 PEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 585
PEVI + + KSD++S G+ +EM G PL
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 38/219 (17%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVGQHPNVVPLRAY 449
EV+G G+YG YK ++ + ++ +V + + + ++ ++ + H N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 450 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV--KILLGTARGVAH 501
+ K D+ LV ++ +GS++ L+ +G DW + +IL RG+AH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAYICREIL----RGLAH 136
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 552
+H+ K H +IK NVL+ ++ + + DFG V A R+ G R
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYW 187
Query: 553 -APEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 585
APEVI + + ++SD++S G+ +EM G PL
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 393 LGKGSYGTAYKAVL------EESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVP 445
LG+G++G + A ++ V VK LK+ ++DF ++ E++ + QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVK 71
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLL--HG------NRGAGRTPLDWETRVKILLGTAR 497
D ++V++Y G L+ L HG G L + I A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------- 550
G+ ++ S F H ++ N L+ ++L I DFG++ +V +T G
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS--RDVYSTDYYRVGGHTMLPI 186
Query: 551 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 608
+ PE I RK + +SDV+S GV+L E+ T GK P + +++++ Q V
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC--ITQGRV---- 240
Query: 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
L R + +E+ ++ + C + P MR N+ E+ +++ + ++
Sbjct: 241 --------LQRPRTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-------VGRVGQHPNV 443
E+LGKG++G +K L++ T V VK KE D Q+++I + + HPN+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKE------DLPQELKIKFLSEARILKQYDHPNI 54
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
V L + +V + G + L + +T + VK L A G+A++
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT----KQLVKFALDAAAGMAYLE 110
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-----------LMNVPATPSRSAGYR 552
S H ++ A N L+ ++ ISDFG++ L +P +
Sbjct: 111 S---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WT 161
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLT 580
APE + ++S +SDV+S+G+LL E +
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 393 LGKGSYG---TAYKAVLEESTTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVP 445
+G G++G +A + V +K++ V+ KR + ++++++ + +H N++
Sbjct: 18 VGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHL-RHENIIS 73
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L + S E + YF + L T LH R PL+ + L RG+ ++HS
Sbjct: 74 LSDIFISPLEDI----YFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPEVIET-RKHS 563
G H ++K SN+LIN++ D I DFGL + + T S YRAPE++ T +K+
Sbjct: 128 G---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 591
+ D++S G + EML GK PL P +D
Sbjct: 185 VEVDIWSAGCIFAEMLEGK-PL-FPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG G +G + V +K + E + + DF ++ +++ ++ HP +V L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ 70
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKFT 511
+ +V ++ +G L L +G + +LL + V + + F
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 512 HGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKS 566
H ++ A N L++ +SDFG+T +++ T S A + PEV K+S KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 567 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 596
DV+SFGVL+ E+ T GK P + + ++V++
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLR 447
+G+G + Y+A L + V +K+++ + + D ++++++ ++ HPNV+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYY 68
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
A + +E +V + +G LS ++ + R + +T K + + H+HS
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHMHSR-- 125
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRKHS 563
+ H +IK +NV I + D GL + T + S Y +PE I ++
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623
KSD++S G LL EM A LQSP D ++L + + E D + +
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQCDYPPLPSDHY 233
Query: 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
EE+ Q++ + C+ P+ RP++ V +
Sbjct: 234 SEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 62/270 (22%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
LG G +G V +K +KE + + +F ++ +++ ++ H +V L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK 70
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
+ +V +Y ++G L L R G+ + +++ G+A++ S +F H
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQL-LEMCKDVCEGMAYLES---KQFIH 123
Query: 513 GNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKSD 567
++ A N L++ +SDFGL+ +++ T S + + PEV+ K S KSD
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 568 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 626
V++FGVL+ E+ + GK P + + V+ V +R L R E+
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEK---VSQGLR-----------LYRPHLASEK 229
Query: 627 MVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
+ ++ +C + + RP +++ IE
Sbjct: 230 VYAIM---YSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 30/214 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPN 442
E +G+G+ GT Y T + V +EV + + + +QQ + +V R ++PN
Sbjct: 26 EKIGQGASGTVY-------TAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
+V Y DE +V +Y A GSL+ ++ T +D + + + +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFL 132
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 558
HS + H +IK+ N+L+ D ++DFG +TP + +T + + APEV+
Sbjct: 133 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTR 590
+ + K D++S G++ +EM+ G+ P ++P R
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E +GKGS+G YK + + VV + L+E D +Q++ ++ + P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYY 68
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
Y + ++ +Y GS LL PL+ IL +G+ ++HS
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHS--- 119
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHS 563
+ H +IKA+NVL+++ D ++DFG LT T + + APEVI+ +
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 564 HKSDVYSFGVLLLEMLTGKAP 584
K+D++S G+ +E+ G+ P
Sbjct: 180 FKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRV 437
D E+L E +GKGS+G +K + + VV + L+E D +Q++ ++ +
Sbjct: 1 DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 497
P V Y + ++ +Y GS LL P D +L +
Sbjct: 60 -DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILK 112
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRA 553
G+ ++HS K H +IKA+NVL+++ D ++DFG LT T + + A
Sbjct: 113 GLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVREEWTAE 611
PEVI+ + K+D++S G+ +E+ G+ P P R + +P+ + E++
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VLFLIPKNNPPTLTGEFSKP 228
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
F+ + AC+ K P RP E+++
Sbjct: 229 --------FKEFID----------ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 52/246 (21%)
Query: 393 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKR-------DFEQQMEI-VGRVGQHPNV 443
LG+G+Y YKA +E+ +V +K++K +G+R +F EI + + +HPN+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 502
+ L + K LV++ F L ++ ++ TP D +K +L T RG+ ++
Sbjct: 65 IGLLDVFGHKSNINLVFE-FMETDLEKVIK-DKSIVLTPAD----IKSYMLMTLRGLEYL 118
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRAPE 555
HS H ++K +N+LI D ++DFGL +P+R YRAPE
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF---GSPNRKMTHQVVTRWYRAPE 172
Query: 556 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ----------------SPTRD---DMVD 595
++ R + D++S G + E+L L +PT + +
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 596 LPRWVQ 601
LP +V+
Sbjct: 233 LPDYVE 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 53/291 (18%)
Query: 393 LGKGSYGTAYKAVL------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 444
LG+GS+G Y+ + E T V +K + E + + +F + ++ H +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 499
L + L+V + A G L + L R G P + +++ A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------- 552
A++ + KF H ++ A N ++ +DL I DFG+T + + YR
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY------ETDYYRKGGKGLL 183
Query: 553 -----APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVRE 606
APE ++ + KSDV+SFGV+L EM T + P Q + ++++
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF---------- 233
Query: 607 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
V D + E ++L++ C P MRP E+V +++
Sbjct: 234 -----VIDGGHLDLP--ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 392 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK-------RDFEQQMEIVGRVGQHPNVV 444
V+GKG++G ++++ T + +K + K R+ + I+ + HP +V
Sbjct: 7 VIGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLV 63
Query: 445 PLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHI 502
L Y + +E + LV D G L H ++ + E +VK + + ++
Sbjct: 64 NLW-YSFQDEENMYLVVDLLLGGDLR--YHLSQKVKFS----EEQVKFWICEIVLALEYL 116
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 558
HS G H +IK N+L+++ I+DF +TP +T S + GY APEV+
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST-SGTPGYMAPEVLC 172
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ +S D +S GV E L GK P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
E +GKG+YG YK ++ + VK L + + E + I+ + HPNVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 450 YYSKDEKL-----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
+Y D+ + LV + GS++ L+ G G+ LD IL G G+ H+H+
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG---YRAPEVIETR 560
+ H ++K +N+L+ + + DFG++ L + + S G + APEVI
Sbjct: 147 ---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 561 K-----HSHKSDVYSFGVLLLEMLTGKAPL 585
+ + + DV+S G+ +E+ G PL
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
QH N+V D + +Y GS++ LL+ N GA L +IL +G
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQIL----KG 118
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------ 552
+ ++H+ G H +IK +N+L++ ISDFG++ + + +++ G R
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 553 ----APEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
APEV++ ++ K+D++S G L++EMLTGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 392 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK-----RDFEQQMEIVGRVGQHPNVVPL 446
V+G+GS+G A S +KE+ + K D ++ ++ ++ +HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYA--MKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAF 63
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIH 503
+ + + +V +Y G L + RG T L W ++ + GV HIH
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----TPSRSAGYRAPEVIET 559
+ H +IK+ N+ + Q+ + DFG L+ P T + Y PE+ E
Sbjct: 118 E---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
+++KSD++S G +L E+ T K P Q+
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--------QMEIVGRVGQHPN 442
E LG+G+Y T YK TT + LKE+ D E+ ++ ++ + +H N
Sbjct: 6 EKLGEGTYATVYKG--RNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKEL-KHEN 59
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVA 500
+V L +++++ +LV++Y L + HG RGA LD T +G+A
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA----LDPNTVKSFTYQLLKGIA 114
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEV 556
H + H ++K N+LIN+ + ++DFGL +P + YRAP+V
Sbjct: 115 FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV 171
Query: 557 I-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592
+ +R +S D++S G ++ EM+TG+ +D
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 54/297 (18%)
Query: 393 LGKGSYGTAYKAVLEES-----------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQ 439
LG+G +G + V+ E+ T V VK LK K D +ME++ +G+
Sbjct: 26 LGEGCFG---QVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTP---LDWETR 488
H N++ L ++ +Y + G+L L R G + P L ++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 489 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSR 547
V ARG+ ++ S K H ++ A NVL+ +D I+DFGL + ++
Sbjct: 143 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 548 SAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 601
+ G + APE + R ++H+SDV+SFGVLL E+ T G +P +++ L +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259
Query: 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
+ + N E+ M++ C VP RP ++V ++ +
Sbjct: 260 RMDKP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 67/276 (24%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGK--RDFEQQMEIVGRVGQHPNVVPLR 447
+G+G + Y+A L + V +K+++ E++ K +D ++++++ ++ HPNV+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYL 68
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ +E +V + +G LS ++ + R + T K + V H+HS
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEHMHSR-- 125
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRKHS 563
+ H +IK +NV I + D GL + T + S Y +PE I ++
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623
KSD++S G LL EM A LQSP D ++L Q + E D + ++
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKI-------EQCDYPPLPTEHY 233
Query: 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659
E++ +++ + C+ PD RP++ V ++ +++
Sbjct: 234 SEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 71/279 (25%), Positives = 118/279 (42%), Gaps = 51/279 (18%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 442
E LG+ +G YK L E++ V +K LK+ G + +F+ + + R+ QHPN
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPN 69
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG------RTPLDWETRVKI 491
+V L + +++ Y + L L H + G+ ++ L+ V I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL---------TPLMNVP 542
+ A G+ + S H ++ NVL+ L+ ISD GL LM
Sbjct: 130 VTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV------- 594
P R + +PE I K S SD++S+GV+L E+ + G P + D++
Sbjct: 187 LLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243
Query: 595 ------DLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 627
D P WV +++ E W F RF++I +
Sbjct: 244 VLPCPDDCPAWVYTLMLECWNE--FPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 24/243 (9%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
E +GKG+YG +K + +++ + VK L + + E + I+ + HPNVV
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 450 YYSKDEK-----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
YY KD K LV + GS++ L+ G G ++ IL G+ H+H
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEALMGLQHLHV 142
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG---YRAPEVIETR 560
K H ++K +N+L+ + + DFG++ L + + S G + APEVI
Sbjct: 143 ---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 561 K-----HSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVR--EEWTAE 611
+ + + DV+S G+ +E+ G PL P R + +PR + E W+ E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIPRNPPPTLHQPELWSNE 258
Query: 612 VFD 614
D
Sbjct: 259 FND 261
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 445
++LGKGS+G + A L+ + +K LK +VV+ D E M ++ +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 503
L + +K+ V +Y G L + + + L T +I+ G + +H
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----LQFLH 113
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIET 559
S G + ++K N+L++ D I+DFG+ M A G Y APE++
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAP--------LQSPTRDDMVDLPRWVQSVVRE 606
+K++ D +SFGVLL EML G++P L R D PRW+ ++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 391 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNV 443
E LG+ ++G YK L + + V +K LK++ ++ +F+Q+ ++ + HPN+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNI 69
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG-------RTPLDWETRVKI 491
V L + ++++Y G L L H + G ++ LD + I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT------PLMNVPATP 545
+ A G+ ++ S F H ++ A N+LI + L ISD GL+ V
Sbjct: 130 AIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 598
+ PE I K S SD++SFGV+L E+ + G P + +++++ R
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 54/294 (18%)
Query: 378 YNFDLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 436
D E L E+ G GS+G Y A + + V +K++ GK+ E+ +I+
Sbjct: 9 SKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKE 65
Query: 437 VG-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKI 491
V +HPN + + Y + LV +Y GS S +L + PL I
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILE----VHKKPLQEVEIAAI 120
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPS 546
G +G+A++HS + H +IKA N+L+ + ++DFG L++ PA TP
Sbjct: 121 CHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS-PANSFVGTPY 176
Query: 547 RSAGYRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ-- 601
+ APEVI K DV+S G+ +E+ K PL + + M L Q
Sbjct: 177 ----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQND 230
Query: 602 --SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
++ +W+ + + +C+ K+P RP+ +E+++
Sbjct: 231 SPTLSSNDWS---------------DYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD--FEQQM--EI-VGRVGQHPNVVPLR 447
+G+G++G +KA E+ V LK+V + + + Q EI + QHP VV L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVA--LKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ +LV +Y S LS +L R + + + + +GVA++H+ G
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEE---RPLPEAQVK-SYMRMLLKGVAYMHANG- 119
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVI-ETRK 561
H ++K +N+LI+ D I+DFGL L + S YRAPE++ RK
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 598
+ D+++ G + E+L G +PL P +D+ L
Sbjct: 178 YDPGVDLWAVGCIFAELLNG-SPL-FPGENDIEQLAI 212
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 52/208 (25%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 391 EVLGKGSYGTAYKAVLE-ESTTVVVKR--LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
+ +G+GS+G Y A + +S V+K L ++ V +++ ++ I+ +HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP---LDWETRVKILLGTARGVAHIHS 504
A + +V +Y G L ++ RG + L W ++ + G+ HIH
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119
Query: 505 MGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIET 559
K H +IK+ N+ ++++ + + DFG+ +N + + G Y +PE+ +
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
R +++K+D++S G +L E+ T K P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 79/292 (27%), Positives = 122/292 (41%), Gaps = 50/292 (17%)
Query: 378 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV 437
Y D E++ E+ G GS+G Y A T VV K GK+ E+ +I+ V
Sbjct: 15 YKDDPEEIFVGLHEI-GHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEV 72
Query: 438 G-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 492
+HPN + + Y + LV +Y GS S LL + PL I
Sbjct: 73 KFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLE----VHKKPLQEVEIAAIT 127
Query: 493 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRS 548
G +G+A++HS H +IKA N+L+ + ++DFG +P + TP
Sbjct: 128 HGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY-- 182
Query: 549 AGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ---- 601
+ APEVI + ++ K DV+S G+ +E+ K PL + + M L Q
Sbjct: 183 --WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQNDSP 238
Query: 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
++ EWT F + C+ K+P RP E++R
Sbjct: 239 TLQSNEWTD-----SFRGFVDY-------------CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 55/291 (18%)
Query: 391 EVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVGKRDFEQQME-----IVGRVGQHP 441
V+GKG +G Y L +S VK L + D E+ + I+ + HP
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHP 56
Query: 442 NVVPLRAYYYSKD-EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG----TA 496
NV+ L + L+V Y G L + R P VK L+G A
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNP-----TVKDLIGFGLQVA 108
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--TPSRSAGYRAP 554
+G+ ++ S KF H ++ A N ++++ ++DFGL + + G + P
Sbjct: 109 KGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 555 ------EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREE 607
E ++T+K + KSDV+SFGVLL E++T AP P D D D+ ++ R
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVDSFDITVYLLQGRR-- 220
Query: 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
L++ + + + +++ +C P+MRP E+V IE++
Sbjct: 221 ---------LLQPEYCPDPLYEVML---SCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 71/288 (24%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 393 LGKGSYGTAYKAVLEE------STTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVV 444
+G G +G K +L E VVVK L+ F Q+++ R HPNV+
Sbjct: 3 IGNGWFG---KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPY-RELNHPNVL 58
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
LLV ++ G L L NRG + ++ A G+ +H
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----------ATPSRSAGYRAP 554
F H ++ N + DL I D+GL L P A P R + AP
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLR---WLAP 171
Query: 555 EVIETR-------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607
E++E R + KS+++S GV + E+ T D+ V ++ VVRE+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQ 226
Query: 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655
D++L + Q + + ++ C P+ RP +EV ++
Sbjct: 227 ------DIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 44/223 (19%)
Query: 393 LGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQM---------EIVGRVGQHP 441
+ KG+YG + A ++ST +K V+ K D ++ +I+ + Q P
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIK-----VIKKADMIRKNQVDQVLTERDILSQA-QSP 53
Query: 442 NVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
VV L YYS + L LV +Y G L++LL N G+ LD + +
Sbjct: 54 YVVKL---YYSFQGKKNLYLVMEYLPGGDLASLLE-NVGS----LDEDVARIYIAEIVLA 105
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL---------TPLMNVPATPSRSA 549
+ ++HS G H ++K N+LI+ + ++DFGL L + R
Sbjct: 106 LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 550 G---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589
G Y APEVI + HS D +S G +L E L G P T
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 38/223 (17%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRL----KEVVVGKRDFEQQMEIVG--RVGQHPNVV 444
EVLGKG+YGT Y + + + VK++ V+ ++++E+ E V + +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIH 503
+ + ++ GS+S++L NR G P+ + +IL GVA++H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQIL----DGVAYLH 119
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTP--------------LMNVPATPSR 547
+ H +IK +NV++ + G I DFG L ++ TP
Sbjct: 120 N---NCVVHRDIKGNNVMLMPN--GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY- 173
Query: 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 590
+ APEVI + KSD++S G + EM TGK PL S R
Sbjct: 174 ---WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 47/225 (20%)
Query: 393 LGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQ-------MEIVGRVGQHPNVV 444
LG G +G V ++ T +K +K+ + + ++ +E HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC----NHPFIV 56
Query: 445 PLRAYYYSKDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARG 498
L + KD+K +Y +Y G L T+L R G ++ R ++L
Sbjct: 57 KLYRTF--KDKKY-IYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIACVVLAFE-- 107
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPA-------TPSRSA 549
++H+ G + ++K N+L+ D +G + DFG + TP
Sbjct: 108 --YLHNRG---IIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP---- 156
Query: 550 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 594
Y APE+I + + D +S G+LL E+LTG+ P D M
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 391 EVLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEI------VGRVGQHPNV 443
V+G+G+YG K V +K+ KE D E + V R +H N+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTALREVKVLRQLRHENI 62
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
V L+ + K LV++Y +L LL + G L + + + +A+ H
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG----LPPDAVRSYIWQLLQAIAYCH 117
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEV-I 557
S H +IK N+L+++ + DFG + + YRAPE+ +
Sbjct: 118 SH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ DV++ G ++ E+L G+ PL
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE-PL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-- 438
D + L + +G GS+G Y A ++ VV + K GK+ E+ +I+ V
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIK-KMSYSGKQSNEKWQDIIKEVRFL 69
Query: 439 ---QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495
+HPN + R Y + LV +Y GS S LL + PL + G
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLE----VHKKPLQEVEIAAVTHGA 124
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPE 555
+G+A++HS H ++KA N+L+++ + DFG +M + + APE
Sbjct: 125 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPE 181
Query: 556 VI---ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
VI + ++ K DV+S G+ +E+ K PL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 388 ASAEVLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQME--IVGRVGQHPN 442
A + LG+G +G+ + L + + V VK +K + + + E + + + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 443 VVPLRAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLG 494
V+ L E +++ + G L + L +R G P L + VK +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMTD 120
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATP 545
A G+ ++ S F H ++ A N ++N++++ C++DFGL+ + + P
Sbjct: 121 IASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
+ + A E + R ++ KSDV+SFGV + E+ T G+ P
Sbjct: 178 VK---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 45/240 (18%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 445
+ LG GS+G + S +K L K +V + E + I+ + +HP +V
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLV- 64
Query: 446 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRV---KILLGTARGVA 500
Y +D+ L V +Y G L + L R +GR P R +++L +
Sbjct: 65 -NLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPV-ARFYAAQVVLA----LE 115
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPL-----MNVPATPSRSAGYRA 553
++HS+ + ++K N+L+ D DG I +DFG + TP Y A
Sbjct: 116 YLHSLD---IVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGRTYTLCGTPE----YLA 166
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 605
PE+I ++ + D ++ G+L+ EML G P + V P + +
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAK 226
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 397 SYGTAYKAVLEESTTVVV-----KRLKEVVVGKRDFEQQME--------IVGRVGQHPNV 443
SY + + E ST +V ++V V K D +Q ++ R QHPN+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
V + + Y DE +V ++ G+L+ ++ R ++ E + L + ++ +H
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLH 132
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIET 559
+ G H +IK+ ++L+ D +SDFG ++ +S G + APEVI
Sbjct: 133 AQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ + D++S G++++EM+ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 50/217 (23%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTT----VVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVV 444
++LG+G +G+ + L + V VK +K + + E+ + + HPNV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 445 PLRAYYYSKDEK------LLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTAR 497
L + +++ + G L + L +R G L +T +K ++ A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRS 548
G+ ++ + F H ++ A N ++ +D+ C++DFGL+ + + P +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 180
Query: 549 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
+ A E + R ++ KSDV++FGV + E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 393 LGKGSYGTAYKA------VLEESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVVP 445
LG+G++G + A ++ V VK LK+ + ++DF+++ E++ + QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVK 71
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKILLG 494
D ++V++Y G L+ L + +D + R + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---- 550
A G+ ++ S F H ++ N L+ +L I DFG++ +V +T G
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS--RDVYSTDYYRVGGHTM 186
Query: 551 ----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
+ PE I RK + +SDV+SFGV+L E+ T GK P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPNVV 444
+G+GS G A + + K+V V K D +Q ++ R H NVV
Sbjct: 30 IGEGSTGIVCIATEKHTG-------KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVV 82
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
+ Y DE +V ++ G+L+ ++ R ++ E + L R ++++H+
Sbjct: 83 DMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHN 136
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIET 559
G H +IK+ ++L+ D +SDFG ++ P R + + APEVI
Sbjct: 137 QG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISR 192
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAP 584
+ + D++S G++++EM+ G+ P
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 47/292 (16%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGK--RDFEQQMEIVGRV 437
DL+DL +G+G++GT K + + S T++ VKR++ V K + +++V R
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS 59
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 497
P +V + + + + + SL ++ + E KI + T +
Sbjct: 60 SDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLT-PLMNVPATPSRSAG---Y 551
+ ++ K H ++K SN+L+ D +G I DFG++ L++ A +R AG Y
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPY 173
Query: 552 RAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE- 607
APE I+ + +SDV+S G+ L E+ TGK P P + + D + VV+ +
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFD---QLTQVVKGDP 228
Query: 608 -----WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
F + F N+ C+ K RP E++
Sbjct: 229 PILSNSEEREFSPSFVNFINL-------------CLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 3e-11
Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
E +G+G+ GT + A+ + V +K++ K++ +V + ++PN+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ DE +V +Y A GSL+ ++ T +D + + + +H+ +
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHA---NQ 135
Query: 510 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 565
H +IK+ NVL+ D ++DFG +TP + +T + + APEV+ + + K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 566 SDVYSFGVLLLEMLTGKAPL--QSPTR 590
D++S G++ +EM+ G+ P ++P R
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLR 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 393 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 451
+G+GS G A ++ S +V VK++ +R+ ++ R QH NVV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 511
DE +V ++ G+L+ ++ R ++ E + L + ++ +H+ G
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 512 HGNIKASNVLINQDLDGCISDFGLTPLMN--VPATPSR--SAGYRAPEVIETRKHSHKSD 567
H +IK+ ++L+ D +SDFG ++ VP S + + APE+I + + D
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 568 VYSFGVLLLEMLTGKAP 584
++S G++++EM+ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 46/254 (18%)
Query: 373 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFE-- 428
F GCS D E L LG+G++G YKA ++ VV LK++++ K F
Sbjct: 1 FYGCSKLRDYEIL-----GKLGEGTFGEVYKARQIKTGRVVA--LKKILMHNEKDGFPIT 53
Query: 429 --QQMEIVGRVGQHPNVVPL--RAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGA 478
++++I+ ++ +HPNVVPL A K +V Y LS LL
Sbjct: 54 ALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS-V 110
Query: 479 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538
T + + LL G+ ++H H +IKA+N+LI+ I+DFGL
Sbjct: 111 KLTESQIKCYMLQLL---EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 539 MNVPATPSRSAG---------------YRAPE-VIETRKHSHKSDVYSFGVLLLEMLTGK 582
+ P + G YR PE ++ R+++ D++ G + EM T +
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
Query: 583 APLQSPTRDDMVDL 596
LQ + D + L
Sbjct: 225 PILQGKSDIDQLHL 238
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 47/227 (20%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG------------- 438
LG+G+YG KA V +K++K ++ D + ++VG G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 439 --QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGT 495
+H N++ L Y D LV D AS L ++ + L E++VK ILL
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDR-----KIRLT-ESQVKCILLQI 128
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT------PLMNVPATPSRSA 549
G+ +H F H ++ +N+ IN I+DFGL P + +
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 550 G------------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKA 583
YRAPE++ K+ D++S G + E+LTGK
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 31/204 (15%)
Query: 393 LGKGSYGTAY-----KAVLEESTTVVVKRLKEVVVGKRD------FEQQMEIVGRVGQHP 441
LGKGS+GT Y KAV EE +K LKE+ VG+ + Q+ +++ ++ HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEER----LKVLKEIPVGELNPNETVQANQEAQLLSKL-DHP 62
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT---PLDWETRVKILLGTARG 498
+V A + +D ++ +Y L L + G+T E +++LLG
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG---- 118
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAP 554
+H M + H ++KA N+ + +L I DFG++ L+ ++ T + + Y +P
Sbjct: 119 ---VHYMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 555 EVIETRKHSHKSDVYSFGVLLLEM 578
E ++ + + KSD++S G +L EM
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 392 VLGKGSYGTA----YKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVP 445
++GK K +T V VK++ K D + QQ I R QHPN++P
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ E +V A GS LL H G + + IL + +IH
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH 118
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCIS-----------DFGLTPLMNVPATPSRSAGYR 552
S G F H ++KAS++L++ D +S + + P + ++ +
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 553 APEVIETRKHSH--KSDVYSFGVLLLEMLTGKAPLQ 586
+PEV++ + KSD+YS G+ E+ G P +
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 392 VLGKGSYGTAYKA---------------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 436
VLG G+YG + VL+++T V + E +R +++
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER------QVLEA 60
Query: 437 VGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG- 494
V + P +V L Y + D KL L+ DY G L T L+ R E+ V++ +
Sbjct: 61 VRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY-QREHFT-----ESEVRVYIAE 113
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---- 550
+ H+H +G + +IK N+L++ + ++DFGL+ + R+
Sbjct: 114 IVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGT 169
Query: 551 --YRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAP 584
Y APEVI H D +S GVL E+LTG +P
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 445
VLGKGS+G A L+ES + VK LK +V++ D E M I+ HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 504
L + + D V ++ G L + +R D E R + + +H
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-----RFD-EARARFYAAEITSALMFLHD 114
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP--LMN--VPATPSRSAGYRAPEVIETR 560
G + ++K NVL++ + ++DFG+ + N +T + Y APE+++
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQ 601
+ D ++ GVLL EML G AP ++ DD+ V P W+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 55/206 (26%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYY 450
LG G++G YKA +E+ + ++ E + D+ ++EI+ HP +V L +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAF 78
Query: 451 YSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIHSMGGP 508
Y + ++ ++ G++ + +L +RG E +++++ + ++HSM
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLT------EPQIQVICRQMLEALQYLHSM--- 129
Query: 509 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVI--ETRK 561
K H ++KA NVL+ D D ++DFG++ NV R + + APEV+ ET K
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 562 ---HSHKSDVYSFGVLLLEMLTGKAP 584
+ +K+D++S G+ L+EM + P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 42/226 (18%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR-DFEQQMEIVGRVG----------QHP 441
+G+G+YG Y+A ++T+ E+V K+ + + + + +HP
Sbjct: 15 IGEGTYGIVYRA--RDTTS------GEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 442 NVVPLRAYYYSK--DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARG 498
N+V L+ K D LV +Y L++LL TP E++VK ++L RG
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEY-CEQDLASLLDNMP----TPFS-ESQVKCLMLQLLRG 120
Query: 499 VAHIHSMGGPKFT-HGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR----SAGY 551
+ ++H F H ++K SN+L+ GC I+DFGL +PA P + Y
Sbjct: 121 LQYLHE----NFIIHRDLKVSNLLLTDK--GCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 552 RAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
RAPE++ ++ D+++ G +L E+L K L + + +DL
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 19/166 (11%)
Query: 434 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 493
V ++ HPN+VP RA + + +E +V + A GS L+ + G + L IL
Sbjct: 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---AIAYILQ 108
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTP-------LMNVP 542
G + + +IH MG + H ++KAS++LI+ D L G S+ + + + P
Sbjct: 109 GVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165
Query: 543 ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
+ + +PEV++ + + KSD+YS G+ E+ G P +
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTV----VVKRLKEVVVGKRDFEQQME-IVGRVGQHPNVV 444
+VLG G++GT YK + + E TV +K L E K + E E ++ HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHI 502
L S +L V G L +H ++ + L+W ++ A+G+ ++
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EV 556
+ H ++ A NVL+ I+DFGL L+ + G + P E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 557 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 591
I RK +H+SDV+S+GV + E++T G P PTR+
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 388 ASAEVLGKGSYGTAYKAVLEES-TTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPN 442
S + +G G+YG+ A+ + + V +K+L + + KR + +++ ++ + QH N
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHM-QHEN 75
Query: 443 VVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVA 500
V+ L + S D Y + T L G PL E +V+ L+ G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLS-EDKVQYLVYQMLCGLK 131
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-SRSAGYRAPEVIET 559
+IHS G H ++K N+ +N+D + I DFGL + T + YRAPEVI
Sbjct: 132 YIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILN 188
Query: 560 RKHSHKS-DVYSFGVLLLEMLTGK 582
H +++ D++S G ++ EMLTGK
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 393 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVV 444
+G+G++G ++A E T V VK LKE + DF+++ ++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIV 71
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----------------GAGRTPLDWET 487
L L+++Y A G L+ L G PL
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 488 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----- 542
++ I A G+A++ KF H ++ N L+ +++ I+DFGL+ +
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 543 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 580
A P R + PE I +++ +SDV+++GV+L E+ +
Sbjct: 189 SENDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 392 VLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVV 444
VLG G++GT YK + V +K L+E K + E + ++ VG P V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVC 72
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHI 502
L + +L V G L + N+ + L+W ++ A+G++++
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EV 556
+ + H ++ A NVL+ I+DFGL L+++ T + G + P E
Sbjct: 126 EEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 557 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 591
I R+ +H+SDV+S+GV + E++T G P P R+
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-------QQMEIVGRVGQHPNV 443
E +G+G+YG YKA + T + LK+ + + D E +++ ++ + + +
Sbjct: 7 EKIGEGTYGKVYKA--RDKNTGKLVALKKTRL-EMDEEGIPPTALREISLLQMLSESIYI 63
Query: 444 VPLRAYYYSKDEK-----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
V L + +++ LV++Y S L + N PL +T + +G
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR----SAGYRA 553
VAH H G H ++K N+L+++ I+D GL ++P + YRA
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 554 PEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
PEV + + +S D++S G + EM K PL
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 392 VLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVP 445
+LGKG +G+ +A L+ V VK LK + D E+ + + + HPNV+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 446 LRAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLGTAR 497
L K +++ + G L T L +R G P L +T V+ ++ A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP--- 554
G+ ++ S F H ++ A N ++N+++ C++DFGL+ + + + P
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 555 ---EVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
E + ++ SDV++FGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 41/213 (19%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKE----VVVGKRDFE-----QQMEIVGRVGQH 440
+G G+YG A ++ V +K+L + KR + + M H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-------DH 73
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG---NRGAGRTPLDWETRVKILL-GTA 496
NV+ L + + L + F L T L G N L + ++ L+
Sbjct: 74 ENVIGLLDVF-TPASSL---EDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFLVYQIL 128
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 550
RG+ +IHS G H ++K SN+ +N+D + I DFGL + T G
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----GYVATRW 180
Query: 551 YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 582
YRAPE++ H +++ D++S G ++ E+LTGK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 41/239 (17%)
Query: 391 EVLGKGSYGTAYKAVLEESTT-VVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVV 444
E LG GS+G A + + +K LK+ + K +Q + HP +V
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPFIV 81
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHI 502
+ + ++ + ++ G L T L R AGR P D +++L ++
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLA----FEYL 134
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-------ATPSRSAGYRAPE 555
HS + ++K N+L++ ++DFG VP TP Y APE
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTLCGTPE----YLAPE 185
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTR------DDMVDLPRWVQSVVRE 606
VI+++ H D ++ GVLL E + G P +P R + P W R+
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244
|
Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 45/287 (15%)
Query: 393 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 444
LG+GS+G Y+ E T V VK + E + +F + ++ H +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 499
L L+V + A G L + L R GR P + +++ A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 551
A++++ KF H ++ A N ++ D I DFG+T ++ T G +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 187
Query: 552 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611
APE ++ + SD++SFGV+L E+ + + + P Q + E+
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS------------LAEQP--YQGLSNEQVLKF 233
Query: 612 VFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
V D L + N E + ++++ C P MRP E+V ++++
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 393 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVPLR 447
+G+G YG + A +++ +V +KR+K+ ++ K + + +I+ + +V L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEWLVKL- 66
Query: 448 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
Y + DE L L +Y G TLL+ N G + R + V +H +G
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLS---EDHARFYMAEMFE-AVDALHELG 121
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHK 565
+ H ++K N LI+ ++DFGL ++ + S Y APEV+ + +
Sbjct: 122 ---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDD-MVDLPRWVQSVVREEWTAEVFDV 615
D +S G +L E L G P T ++ +L W +++ R + F++
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 35/211 (16%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYY 450
LG G++G YKA +E+ + ++ + + D+ +++I+ HPN+V L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAF 71
Query: 451 YSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSMGGP 508
Y ++ ++ ++ A G++ + +L R PL E +++++ T + ++H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELER-----PLT-EPQIRVVCKQTLEALNYLHE---N 122
Query: 509 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------APEVI- 557
K H ++KA N+L D D ++DFG V A +R+ R APEV+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFG------VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 558 -ET---RKHSHKSDVYSFGVLLLEMLTGKAP 584
ET R + +K+DV+S G+ L+EM + P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRA 448
LG G++G YKA T + K + + DF +++I+ +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQ--HKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYE 69
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 508
Y+ +++ ++ ++ G+L +++ L + + +HS
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIML----ELERGLTEPQIRYVCRQMLEALNFLHSH--- 122
Query: 509 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVI--ETRK 561
K H ++KA N+L+ D D ++DFG++ N R + APEV+ ET K
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 562 ---HSHKSDVYSFGVLLLEMLTGKAPLQ--SPTR 590
+ +K+D++S G+ L+E+ + P +P R
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPN 442
E +G+G+YG YKA + + VV LK++ + D E + EI + + HPN
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVA--LKKI---RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVK-ILLGTARGVA 500
+V L +++++ LV+++ L + + +G PL +K L +G+A
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPL-----IKSYLFQLLQGLA 114
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRA 553
HS + H ++K N+LIN + ++DFGL VP R+ YRA
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRA 168
Query: 554 PEV-IETRKHSHKSDVYSFGVLLLEMLTGKA 583
PE+ + + +S D++S G + EM+T +A
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 394 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM--------EI-VGRVGQHPNVV 444
G+G+YG YKA + +K+ K D EQ EI + R +H NVV
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKF---KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 445 PLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
L + +K L++DY A L ++ +R A R + +L GV ++
Sbjct: 66 SLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVPATPSRSAG-------Y 551
HS H ++K +N+L+ + I D GL L N P P Y
Sbjct: 125 HSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 552 RAPEVIETRKHSHKS-DVYSFGVLLLEMLT 580
RAPE++ +H K+ D+++ G + E+LT
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 7e-10
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 54/221 (24%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--------QQM--EIV--GRVGQH 440
LGKG+YG +KA+ +R KEVV K+ F+ Q+ EI+ +G H
Sbjct: 15 LGKGAYGIVWKAI--------DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 441 PNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTAR 497
PN+V L ++++K LV++Y + T LH A + + + I+ +
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRAN---ILEDVHKRYIMYQLLK 118
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL----TPLMNVPATP----- 545
+ +IHS H ++K SN+L+N D C ++DFGL + L P P
Sbjct: 119 ALKYIHSGN---VIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 546 --SRSAGYRAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKA 583
+R YRAPE+ + + +++ D++S G +L EML GK
Sbjct: 173 VATR--WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 392 VLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 445
+LG G +G + L+ V + L+ K R F + +G+ H N+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVR 70
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L + ++V +Y ++G+L + L + G L + +L G A G+ ++ M
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM 126
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETR 560
G + H + A VL+N DL IS F A + +G + APE I+
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 561 KHSHKSDVYSFGVLLLEMLT-GKAP 584
S SDV+SFG+++ E+++ G+ P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 61/285 (21%), Positives = 120/285 (42%), Gaps = 43/285 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GK---------RDFEQQMEIVGR 436
E LG G++G YK V +++ + LKE+ V GK D ++ I+
Sbjct: 6 EHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 437 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD---WETRVKILL 493
+HPN+V + D +V D L + + + + W V+++L
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 550
+ ++H + H ++ +N+++ +D I+DFGL + + G
Sbjct: 125 A----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610
Y PE+++ + K+DV++FG +L +M T + P S +M+ L + V E
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS---TNMLSLATKIVEAVYEPLPE 235
Query: 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655
++ E + ++ +C+ + RP++ +V MI
Sbjct: 236 GMYS-EDVTD------VIT------SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 44/280 (15%)
Query: 393 LGKGSYGTAYKAVL-------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 443
LG G++G Y+ V VK L++ K++F ++ ++ HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLGTARGVAH 501
V L + + ++ + G L + L R P L + + I L A+G +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGC-----ISDFGLT-PLMNVPATPSRSAG----- 550
+ M F H ++ A N L+++ I DFGL + G
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609
+ APE + K + +SDV+SFGVL+ E+LT G+ P P ++ ++ + V + R
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALNNQ-EVLQHVTAGGR---- 231
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD 649
L + +N +++ Q++ C A+ P RP D
Sbjct: 232 -------LQKPENCPDKIYQLMTN---CWAQDPSERPTFD 261
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPL 446
+G G+ GT YK + + + LK V+ G +R +++EI+ R HPNVV
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYA--LK-VIYGNHEDTVRRQICREIEIL-RDVNHPNVVKC 137
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+ E ++ ++ GSL G A L R +IL G+A++H
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVAR-QIL----SGIAYLHRR- 187
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIET--- 559
H +IK SN+LIN + I+DFG++ ++ P S+ Y +PE I T
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245
Query: 560 --RKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ D++S GV +LE G+ P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 391 EVLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 445
+VLGKGS+G A L+ + V +K L K+V++ D + M I+ +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 504
L + +KD V +Y G L + +R D E R + + +H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-----KFD-EPRSRFYAAEVTLALMFLHR 114
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETR 560
G + ++K N+L++ + ++DFG+ + T + G Y APE+++
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
++ D ++ GVL+ EM+ G+ P ++ DD+ +
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 52/224 (23%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQ--HPNVV 444
++LG G +GT +K + + E ++ + + + G++ F++ + + +G H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHI 502
L +L V GSL + +R + + L+W ++ A+G+ ++
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRSAGYRA 553
H N+ A N+L+ D I+DFG+ L+ + TP + + A
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK---WMA 179
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 596
E I +++H+SDV+S+GV + EM++ G P ++ DL
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 380 FDLEDLLRASAEVLGKGSYGTAYKAVLEESTT---VVVKRL----KEVVVGKRDFEQQME 432
FD+ + E +G G+YG A+ ++ + V +K++ + KR E
Sbjct: 1 FDVGSRYKPI-ENIGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLR---E 54
Query: 433 I-VGRVGQHPNVVPLRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWET 487
+ + R +H N++ +R +V D S L ++H ++ PL E
Sbjct: 55 LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ-----PLTEEH 108
Query: 488 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPS 546
L RG+ +IHS H ++K SN+L+N+D + I DFG+ L + P
Sbjct: 109 IRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 547 R-------SAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ YRAPE++ + +++ D++S G + EML G+ L
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 392 VLGKGSYG-----TAYKAVLEEST-TVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNV 443
LG G++G TAY ++ V VK LK + +++I+ +G H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
V L L++ +Y G L L R + L E + A+G+A +
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-----VPATPSRSAGYRAPEVI 557
S H ++ A NVL+ I DFGL +MN V + APE I
Sbjct: 159 S---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 558 ETRKHSHKSDVYSFGVLLLEMLT 580
++ +SDV+S+G+LL E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 13/153 (8%)
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
P +V +YS E + ++ GSL +L + AGR P + ++ I RG+
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISI--AVLRGLT 113
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEV 556
++ K H ++K SN+L+N + + DFG++ L++ A +RS Y +PE
Sbjct: 114 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPER 169
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589
++ ++ +SD++S G+ L+EM G+ P+ P
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 392 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNV 443
VLGKGS+G K +L E +K LK +VV+ D E M ++ G+ P +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
L + + + D V +Y G L + G + P +I A G+ +H
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEI----AIGLFFLH 118
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIET 559
S G + ++K NV+++ + I+DFG+ ++ + Y APE+I
Sbjct: 119 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
+ + D ++FGVLL EML G+AP + D++
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 46/201 (22%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 392 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLRA 448
V+G+G++G + + +V+ + V +D Q E V ++ HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63
Query: 449 YYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
YY + +D+ L +V +Y G+L+ + + LD +T + + + H+H+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT- 119
Query: 506 GGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 561
H ++K N+L+++ I DFG++ +++ + G Y +PE+ E +
Sbjct: 120 --KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 562 HSHKSDVYSFGVLLLEMLTGK 582
++ KSD+++ G +L E+ + K
Sbjct: 178 YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 392 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNV 443
VLGKGS+G K +L E +K LK +V++ D E M ++ G+ P +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHI 502
L + + + D V +Y G L + H + G + P +I A G+ +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEI----AIGLFFL 117
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIE 558
HS G + ++K NV+++ + I+DFG+ +R + Y APE+I
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
+ + D ++FGVLL EML G+ P D++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVPLRAYY 450
+G G+YG YKA + + ++ ++ G DF QQ + + +H N+V Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
S+++ + +Y GSL + H PL + T +G+A++HS G
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK---HS 563
H +IK +N+L+ + D ++DFG+ + +S + APEV K ++
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 591
D+++ G+ +E+ A LQ P D
Sbjct: 188 QLCDIWAVGITAIEL----AELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 40/221 (18%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 410 TTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL----LVYD 461
V+++ K+ G E +++ + R+ N++ + + + L L+ +
Sbjct: 44 KEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNV 520
Y G L +L + L ++T++ + + +G+ +++ P + N+ + +
Sbjct: 103 YCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSF 154
Query: 521 LINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPEVIET--RKHSHKSDVYSFGVLLLE 577
L+ ++ I GL +++ P + + Y + +++ +++ K D+YS GV+L E
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214
Query: 578 MLTGKAPLQSPTRDDMVDL--------------PRWVQSVV 604
+ TGK P ++ T ++ DL P ++ +V
Sbjct: 215 IFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255
|
Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 393 LGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVPL 446
LGKG +G A ++T K+L + + KR EQ + +I+ +V +V L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSL 58
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTAR---GVAH 501
+ +KD+ LV G L + G G E R + A+ G+ H
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP------EARA--IFYAAQIICGLEH 110
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIE 558
+H + ++K NVL++ + ISD GL + AG Y APEV++
Sbjct: 111 LHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
+ D ++ G L EM+ G++P +
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 66/245 (26%), Positives = 99/245 (40%), Gaps = 63/245 (25%)
Query: 392 VLGKGSYGTAYKAVLEESTTVVV--KRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVP 445
V+G+G++G + V ++ T V K L++ + KR+ + +I+ P +V
Sbjct: 8 VIGRGAFGEVW-LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADSPWIVK 65
Query: 446 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVA 500
L YY +DE+ L V +Y G L LL R P + R +++L +
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLL--IR-KDVFPEET-ARFYIAELVLA----LD 115
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGL------------------TPLMN 540
+H +G F H +IK N+LI D DG I +DFGL L
Sbjct: 116 SVHKLG---FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 541 VPATPSRSA---------------GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
R Y APEV+ + + D +S GV+L EML G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 586 QSPTR 590
S T
Sbjct: 231 YSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 58/291 (19%), Positives = 106/291 (36%), Gaps = 73/291 (25%)
Query: 408 ESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465
V VK L+ + DF ++++I+ R+ PN+ L ++ +Y +
Sbjct: 45 APVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 466 GSLSTLLH------GNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN 519
G L+ L L + T + + A G+ ++ S+ F H ++ N
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160
Query: 520 VLINQDLDGCISDFGLTPLMNVPATPSRSAGY---------RAP--------EVIETRKH 562
L+ ++ I+DFG+ SR+ Y RAP E + K
Sbjct: 161 CLVGKNYTIKIADFGM----------SRNL-YSSDYYRVQGRAPLPIRWMAWESVLLGKF 209
Query: 563 SHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620
+ KSDV++FGV L E+LT + P + T ++
Sbjct: 210 TTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI-------------------------- 243
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 671
+N + + P P ++ ++ E + D E+RP+ E
Sbjct: 244 ENAGH--FFRDDGRQIYLPR-PPNCP--KDIYELMLECWRRDEEDRPTFRE 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLR 447
E +G+G++G + L ++T V VK +E + K F Q+ I+ + HPN+V L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 59
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
K +V + G T L G L + ++++ A G+ ++ S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLR-TEGP---RLKVKELIQMVENAAAGMEYLES--- 112
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEVIETR 560
H ++ A N L+ + ISDFG++ + + G + APE +
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 561 KHSHKSDVYSFGVLLLEMLT-GKAP 584
++S +SDV+SFG+LL E + G P
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVPLRAYY 450
+G G+YG YKA + + ++ ++ G+ DF QQ I+ + +H N+V Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+D+ + ++ GSL + H PL + T +G+ ++HS G
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKGK--- 127
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK---HS 563
H +IK +N+L+ + ++DFG++ + +S + APEV + ++
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 591
D+++ G+ +E+ A LQ P D
Sbjct: 188 QLCDIWAVGITAIEL----AELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 392 VLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 445
++G+G +G + V E++T + +K +K+ V+ ++ FE++ +I+ P +
Sbjct: 8 LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI-SNSPWIPQ 65
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L+ + KD LV +Y G L +LL NR D E + L A V IHS+
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYED--QFD-EDMAQFYL--AELVLAIHSV 118
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRSAGYRAPEVIETR 560
+ H +IK NVLI++ ++DFG + P + Y APEV+ T
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 561 KHSHKS------DVYSFGVLLLEMLTGKAPLQSPT 589
K D +S GV+ EM+ G++P T
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPLR 447
++G+GSYG K +E+ +V +K+ E K + M + + Q H N+V L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ K LV+++ L L G LD K L RG+ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH-- 119
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--------ATPSRSAGYRAPE-VIE 558
H +IK N+L++Q + DFG + P AT YRAPE ++
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVAT----RWYRAPELLVG 174
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPL 585
K+ D+++ G L+ EMLTG+ PL
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE-PL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 64/298 (21%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVV 444
+G+G +G Y+ V E V VK K + F Q+ I+ R HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM-RQFDHPHIV 70
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L +++ +V + G L + L N+ LD + + + +A++ S
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES 125
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 559
+F H +I A NVL++ + DFGL+ + + S G + APE I
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 560 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV-------------DLPRWVQSVVR 605
R+ + SDV+ FGV + E+L G P Q +D++ + P + S++
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 242
Query: 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
+ W + P RP E+ + ++ Q +
Sbjct: 243 KCWAYD------------------------------PSKRPRFTELKAQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 37/257 (14%)
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTAR 497
+HPN++ + + ++ + A GS ++LL G + E + IL G R
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS----EALIGNILFGALR 112
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-------------MNVPAT 544
G+ ++H G + H NIKAS++LI+ D G +S GL+ L + P
Sbjct: 113 GLNYLHQNG---YIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167
Query: 545 PSRSAGYRAPEVIETRKHSH--KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 602
+ + +PE++ + + KSD+YS G+ E+ TG+ P Q R M L + ++
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKG 225
Query: 603 VVREEWTAEVFDVELMRFQN--------IEEEMV--QMLQIGMACVAKVPDMRPNMDEVV 652
F E R +N I E +V M Q + + P +
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285
Query: 653 RMIEEVRQSDSENRPSS 669
++E Q D E RPS+
Sbjct: 286 NLVELCLQQDPEKRPSA 302
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 393 LGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 451
+G+GS G A + S V VK + +R+ ++ R QH NVV + Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 511
+E ++ ++ G+L+ ++ R L+ E + + + ++HS G
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 512 HGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSR--SAGYRAPEVIETRKHSHKSD 567
H +IK+ ++L+ D +SDFG + +VP S + + APEVI + + D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 568 VYSFGVLLLEMLTGKAPLQSPT 589
++S G++++EM+ G+ P S +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDS 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 64/287 (22%), Positives = 123/287 (42%), Gaps = 45/287 (15%)
Query: 393 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 444
LG+GS+G Y+ + E T V +K + E + +F + ++ H +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 499
L L++ + G L + L R + P + +++ A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 551
A++++ KF H ++ A N ++ +D I DFG+T ++ T G +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 187
Query: 552 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610
+PE ++ + SDV+SFGV+L E+ T + P Q + + V+R
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----------EQVLRFVMEG 237
Query: 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
+ D + N + + +++++ C P MRP+ E++ I+E
Sbjct: 238 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----FEQQMEI-VGRVGQHPNVVP 445
E +G+G+YGT +KA E+ +V LK V + D EI + + +H N+V
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVA--LKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L +S + LV++Y L G +D E + +G+A HS
Sbjct: 64 LYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSH 118
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETR 560
H ++K N+LIN++ + ++DFGL +P SA YR P+V+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGA 174
Query: 561 K-HSHKSDVYSFGVLLLEMLTGKAPL 585
K +S D++S G + E+ PL
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 393 LGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG G++G K V + + V +K LK K ++ M + Q N +R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLK-NENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 450 YYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-- 506
+ E L LV + + G L+ L G + +I + + H SMG
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKD------------EITVSNVVELMHQVSMGMK 109
Query: 507 ---GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG-----YRAPEV 556
G F H ++ A NVL+ ISDFGL+ + + +RSAG + APE
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 557 IETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
I RK S +SDV+S+G+ + E + G+ P
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 30/177 (16%)
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 552
G+A++HS + H ++ A NVL++ D I DFGL A P YR
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYYRVREDG 170
Query: 553 -------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--DDMVDLPRWVQSV 603
A E ++ K S+ SDV+SFGV L E+LT QSP + ++M+ + +V
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 604 VREEWTAEVFD--VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
VR E+ + + L +N +E+ +++ C RP ++ +++E+
Sbjct: 231 VR---LIELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 393 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 451
L GS G + A + VV+K +G++ ++ + HP+V+ ++
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLK------IGQKGTTLIEAMLLQNVNHPSVIRMKDTLV 127
Query: 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 511
S +V +++S L T L PL + + I G+ ++H+ +
Sbjct: 128 SGAITCMVLPHYSS-DLYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQ---RII 179
Query: 512 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY---RAPEVIETRKHSHKSDV 568
H ++K N+ IN CI D G V AG APEV+ K++ K+D+
Sbjct: 180 HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADI 239
Query: 569 YSFGVLLLEML 579
+S G++L EML
Sbjct: 240 WSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 51/203 (25%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG G+ G +K + S ++ ++L + + + ++++++ P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+YS E + ++ GSL +L + AGR P +V I +G+ ++ K
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLTYLREKH--K 124
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEVIETRKHSHK 565
H ++K SN+L+N + + DFG++ L++ A +RS Y +PE ++ +S +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPERLQGTHYSVQ 182
Query: 566 SDVYSFGVLLLEMLTGKAPLQSP 588
SD++S G+ L+EM G+ P+ P
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPP 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 21/231 (9%)
Query: 392 VLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 446
VLGKG +G V K+L++ + KR E + +I+ +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSL 65
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
Y +KD LV G L ++ AG + V G+ +H
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG---FEEGRAVFYAAEICCGLEDLHQ-- 120
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIETRK 561
+ + ++K N+L++ ISD GL ++VP + + GY APEV++ +
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNER 177
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREEWTAE 611
++ D ++ G LL EM+ G++P Q + ++ R V+ V+EE++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-09
Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 41/204 (20%)
Query: 427 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDW 485
F ++ + R+ HPN+V L + L V++Y +L +L A L
Sbjct: 25 FRRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-----AADGALPA 78
Query: 486 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGC--ISDFGLTPLM--- 539
+++L +A H+ G H ++K N++++Q + + DFG+ L+
Sbjct: 79 GETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGV 135
Query: 540 ------------NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
V TP+ Y APE + + SD+Y++G++ LE LTG+ +Q
Sbjct: 136 RDADVATLTRTTEVLGTPT----YCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQG 191
Query: 588 PTRDDM---------VDLPRWVQS 602
+ ++ V LP W+
Sbjct: 192 ASVAEILYQQLSPVDVSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 50/208 (24%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG G+ G K + S ++ ++L + + + ++++++ P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+YS E + ++ GSL +L + A R P E K+ + RG+A++ +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL---KEAKRIP--EEILGKVSIAVLRGLAYLREKH--Q 124
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEVIETRKHSHK 565
H ++K SN+L+N + + DFG++ L++ A +RS Y +PE ++ +S +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPERLQGTHYSVQ 182
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
SD++S G+ L+E+ G+ P+ P ++
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 76/311 (24%), Positives = 127/311 (40%), Gaps = 65/311 (20%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQ-----MEIVGRVGQHPNVV 444
E LG+G+YG K + T++ VKR++ V EQ+ ++I R P V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
+ + + + + + SL G T + + KI + + + ++HS
Sbjct: 64 TFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLT-IPEDILGKIAVSIVKALEYLHS 121
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVI---- 557
H ++K SNVLIN++ + DFG++ + + AG Y APE I
Sbjct: 122 K--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW------VQSVVRE---EW 608
+ + KSDV+S G+ ++E+ TG+ P S W ++ VV E +
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPFQQLKQVVEEPSPQL 228
Query: 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 668
AE F E F N C+ K RPN E+++ P
Sbjct: 229 PAEKFSPEFQDFVN-------------KCLKKNYKERPNYPELLQH------------PF 263
Query: 669 SEENKSKDSNV 679
E + SK+++V
Sbjct: 264 FELHLSKNTDV 274
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 37/209 (17%)
Query: 393 LGKGSYGTAYKAVLEES-TTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
+G G+YGT A+ + V +K+L + + KR + +++ ++ + +H NV+ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHM-KHENVIGL- 79
Query: 448 AYYYSKDEKLLVY-DY-----FASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVA 500
++ D L + D+ F L L+ + + E R++ L+ +G+
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-------EDRIQFLVYQMLKGLK 132
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAP 554
+IH+ G H ++K N+ +N+D + I DFGL T S G YRAP
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA-----RQTDSEMTGYVVTRWYRAP 184
Query: 555 EVIETRKH-SHKSDVYSFGVLLLEMLTGK 582
EVI H + D++S G ++ EMLTGK
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDFEQQM--EIVGRVGQHPNVVPL 446
++LGKG++G + S ++ KEV++ K + + V + +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+ + +KD V +Y G L H R + E R + A V+ + +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL--FFH----LSRERVFSEDRTRFY--GAEIVSALDYLH 112
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEVIE 558
K + ++K N+++++D I+DFGL + TP Y APEV+E
Sbjct: 113 SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE----YLAPEVLE 168
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
+ D + GV++ EM+ G+ P + + + +L
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 10/109 (9%)
Query: 483 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 537
LD E +L G+ H+HS G H ++K SN+++ D I DFGL T
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176
Query: 538 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
M P +R YRAPEVI + D++S G ++ E++ G Q
Sbjct: 177 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)
Query: 391 EVLGKGSYGTAY---------------KAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG 435
+VLG G+YG + VL+++T V + E +R +++
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER------QVLE 59
Query: 436 RVGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 494
+ Q P +V L Y + D KL L+ DY G L T L + R E V+I G
Sbjct: 60 HIRQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHL-----SQRERFK-EQEVQIYSG 112
Query: 495 -TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----S 548
+ H+H +G + +IK N+L++ + ++DFGL+ + +
Sbjct: 113 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 549 AGYRAPEVIETRKHSHKS--DVYSFGVLLLEMLTGKAPL 585
Y AP+++ H D +S GVL+ E+LTG +P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 392 VLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 446
VLGKG +G + + + K+L++ + KR E + +I+ +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSL 65
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV-----KILLGTARGVAH 501
Y +KD LV G L ++ N G E R +I G +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFD---EERAVFYAAEITCG----LED 117
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-ATPSR----SAGYRAPEV 556
+H + + ++K N+L++ ISD GL + +P R + GY APEV
Sbjct: 118 LHR---ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEV 172
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
++ +++ D + G L+ EM+ GK+P +
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 393 LGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVVPLR 447
+G G++G + + E + V + EV+ K++ + ++ V HP ++ R
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFII--R 65
Query: 448 AYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
++ D++ L + +Y G L + L R +GR + L + V + +
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRF-----SNSTGLFYASEIVCALEYL 117
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYRAPEVIETRKHSH 564
+ + ++K N+L++++ ++DFG L + T + Y APEVI+++ H+
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNK 177
Query: 565 KSDVYSFGVLLLEMLTGKAP 584
D ++ G+L+ EML G P
Sbjct: 178 AVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 63/223 (28%), Positives = 93/223 (41%), Gaps = 58/223 (26%)
Query: 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVAHIHSMGGPKFTHGN 514
LV DY +G L + RT + E +++LL V H+HS H +
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA----VHHVHSK---HMIHRD 168
Query: 515 IKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------YRAPEVIETRKHSHKS 566
IK++N+L+ + + DFG + + AT S G Y APE+ + +S K+
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA 226
Query: 567 DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 626
D++S GVLL E+LT K P FD E N+EE
Sbjct: 227 DMFSLGVLLYELLTLKRP----------------------------FDGE-----NMEEV 253
Query: 627 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 669
M + L + P + P M E+V + SD + RPSS
Sbjct: 254 MHKTLAGRYDPLP--PSISPEMQEIVTAL---LSSDPKRRPSS 291
|
Length = 496 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------Q 439
E +G+G+YG YKA V +K+++ E + E V
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIR--------LETEDEGVPSTAIREISLLKELN 56
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
HPN+V L +S+++ LV+++ L + T LD L +G+
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDL----DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YR 552
A+ HS + H ++K N+LI+++ ++DFGL VP R+ YR
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTHEVVTLWYR 166
Query: 553 APEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
APE+ + +R++S D++S G + EM+ + PL
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV---VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E+LG G+ GT YKA + ++ V L V ++ ++EI+ + P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFY 65
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
++ ++ + ++ GSL + P R I + +G+ ++ S+
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGR--IAVAVVKGLTYLWSL-- 114
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGL-TPLMN-VPATPSRSAGYRAPEVIETRKHSHK 565
K H ++K SN+L+N + DFG+ T L+N + T + Y APE I ++
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 566 SDVYSFGVLLLEMLTGKAP 584
SDV+S G+ +E+ G+ P
Sbjct: 174 SDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 392 VLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 446
VLGKG +G + + + KRL++ + KR E + +I+ +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNL 65
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
Y +KD LV G L ++ GN G + E + G+ +H
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FEEERALFYAAEILCGLEDLHR 120
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIET 559
+ ++K N+L++ ISD GL + +P S + GY APEV+
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
++++ D + G L+ EM+ G++P +
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 391 EVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNV 443
+VLG G++GT YK + V +K L+E K + E + ++ V +P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 71
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAH 501
L + +L + G L + H + + L+W ++ A+G+ +
Sbjct: 72 CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 124
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------E 555
+ + H ++ A NVL+ I+DFGL L+ + G + P E
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
I R ++H+SDV+S+GV + E++T G P
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 389 SAEVLGKGSYGTAYKAVLEESTT-----VVVKRLK----EVVVGKRDFEQQMEIVGRVGQ 439
+++L +G++G + +L + V VK +K E+ V ++ + G
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV-TLLLQESCLLYGL--S 66
Query: 440 HPNVVP-LRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGT-- 495
H N++P L + ++Y Y G+L L R G P T+ + +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-------TPSRS 548
A G++++H G H +I A N +I+++L I+D L+ + P +R
Sbjct: 127 ACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL-FPMDYHCLGDNENRP 182
Query: 549 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
+ A E + +++S SDV+SFGVLL E++T G+ P
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 393 LGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDF-----EQQMEIVGRVGQHPNVVP 445
+GKG++G Y+ +++ + +K L K+ +V K++ E+ + + + + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHS 504
L+ + + + LV DY + G L L GR E R K + + H+H
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE---GRFS---EDRAKFYIAELVLALEHLHK 114
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG---YRAPEVI-ET 559
+ ++K N+L++ + DFGL+ + T + G Y APEV+ +
Sbjct: 115 Y---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
+ ++ D +S GVL+ EM G +P + M
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 393 LGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVPLR 447
LGKG +G ++ + + K+L + + K+ E+ + EI+ +V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
+ SK LV G L ++ G RG L+ E + G+ H+HSM
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-----LEMERVIHYSAQITCGILHLHSM 114
Query: 506 GGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 561
+ ++K NVL++ D C +SD GL + T ++ AG Y APE+++
Sbjct: 115 D---IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQ 586
+S+ D ++ G + EM+ G+ P +
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 392 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 446
VLGKGS+G A + + + ++ K+VV+ D E M ++ + P + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIHSM 505
+ + + D V +Y G L + H + G + P +I + G+ +H
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEI----SVGLFFLHRR 120
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK 561
G + ++K NV+++ + I+DFG+ V +R+ Y APE+I +
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
+ D +++GVLL EML G+ P D++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 393 LGKGSYG---TAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHP 441
+G G+ G AY A+LE + V +K+L R F+ Q ++ + H
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVA 500
N++ L + + D + + L+ N + LD E +L G+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYI---VMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYRAPE 555
H+HS G H ++K SN+++ D I DFGL T M P +R YRAPE
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 195
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 591
VI + D++S G ++ EM+ G P D
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD--FEQ---QMEIVGRVGQHPNVVPLR 447
LGKG+YG+ YK + T V +KE+ + + F Q +++I+ + P +V
Sbjct: 9 LGKGNYGSVYKVL--HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFY 65
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
++ + + +Y +GSL L G P D +L V G
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPED------VLRRITYAVVK-----G 114
Query: 508 PKF-------THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEV 556
KF H ++K +NVL+N + + DFG++ N+ A+ +++ Y APE
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPER 172
Query: 557 IETR------KHSHKSDVYSFGVLLLEMLTGKAP 584
I++ ++ +SDV+S G+ +LEM G+ P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 445
+V+GKGS+G A + + VK L K++V+ +++ + M ++ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 504
L + + ++ V D+ G L L R E R + A + ++HS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP------EPRARFYAAEIASALGYLHS 114
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSRSAGYRAPEVIETR 560
+ + ++K N+L++ ++DFGL + T + Y APEVI +
Sbjct: 115 I---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+ + D + G +L EML G P +M D
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 391 EVLGKGSYGTAY---KAVLEESTTV-VVKRLKEVVVGKRDFEQQ-----MEIVGRVGQHP 441
+VLG G+YG + K ++ + +K L++ + ++ + ++ V Q P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 442 NVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGV 499
+V L Y + + KL L+ DY + G + T L+ E V+ G +
Sbjct: 66 FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS------EDEVRFYSGEIILAL 118
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRA 553
H+H +G + +IK N+L++ + ++DFGL+ + R+ Y A
Sbjct: 119 EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMA 174
Query: 554 PEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 585
PE+I + H D +S G+L+ E+LTG +P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 23/151 (15%)
Query: 449 YYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+Y +DE LV DY+ G L TLL ++ R P E + + V IHS+
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYIAEM--VLAIHSIH 119
Query: 507 GPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG-----YRAPEVIET 559
+ H +IK NVL+ D++G I +DFG MN T S Y +PE+++
Sbjct: 120 QLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 560 R-----KHSHKSDVYSFGVLLLEMLTGKAPL 585
K+ + D +S GV + EML G+ P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 20/101 (19%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 550
RG+ +IHS H ++K SN+L+N + D I DFGL + A P
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI----ADPEHDHTGFLTEY 169
Query: 551 -----YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 585
YRAPE++ K K+ D++S G +L EML+ + PL
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 392 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 446
V+GKGS+G A + VK L K+ ++ K++ + M ++ + +HP +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSM 505
+ + D+ V DY G L L R P E R + A + ++HS+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLHSL 115
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRK 561
+ ++K N+L++ ++DFGL + T S G Y APEV+ +
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+ D + G +L EML G P S +M D
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYR 552
G+ H+HS G H ++K SN+++ D I DFGL T M P +R YR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 184
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLTGK 582
APEVI + D++S G ++ EM+ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 8/110 (7%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPE 555
RG+ +IHS G H ++K SNV +N+D + I DFGL + T + YRAPE
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPE 185
Query: 556 VIETRKHSHKS-DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 604
++ H +++ D++S G ++ E+L GKA +D +D + + VV
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG---NDYIDQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 60/244 (24%)
Query: 392 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM------EIVGRVGQH 440
VLG+G +G K +L E +K LK ++ + + E M E +H
Sbjct: 6 VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RH 61
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGT 495
P +V L A + ++D V +Y A G L +H + + E R ++LG
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-------EPRAVFYAACVVLGL 114
Query: 496 ARGVAHIHSMGGPKFTHGN------IKASNVLINQDLDGC--ISDFGLTPL-MNVPATPS 546
++ H N +K N+L+ D +G I+DFGL M S
Sbjct: 115 -------------QYLHENKIVYRDLKLDNLLL--DTEGFVKIADFGLCKEGMGFGDRTS 159
Query: 547 RSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 603
G + APEV+ ++ D + GVL+ EML G++P +++ D S+
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SI 213
Query: 604 VREE 607
V +E
Sbjct: 214 VNDE 217
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVP 445
+V+GKGS+G A + E VK L++ + K+ E+ + ++ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 504
L + + D+ V DY G L L R E R + A + ++HS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCF------LEPRARFYAAEIASALGYLHS 114
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-ATPSRSAG---YRAPEVIETR 560
+ + ++K N+L++ ++DFGL T S G Y APEV+ +
Sbjct: 115 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+ D + G +L EML G P S +M D
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 393 LGKGSYG---TAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHP 441
+G G+ G AY AVL+ + V +K+L R F+ Q ++ + H
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVA 500
N++ L + + D + + L+ N + LD E +L G+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYL---VMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYRAPE 555
H+HS G H ++K SN+++ D I DFGL T M P +R YRAPE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 188
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 591
VI + D++S G ++ EM+ K + P RD
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 36/223 (16%)
Query: 386 LRASAE------VLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEI 433
LR AE V+G+G++G + V +ST V +K L + + KR F ++ +I
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 434 VGRVGQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKI 491
+ P VV L +Y +D++ L V +Y G L L+ + + V +
Sbjct: 97 MA-FANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPS 546
L IHSMG F H ++K N+L+++ ++DFG MN T
Sbjct: 154 ALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 547 RSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPL 585
+ Y +PEV++++ + + D +S GV L EML G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 47/214 (21%)
Query: 396 GSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVG---------------Q 439
G+YG Y+A +++ +V +K+LK E++ E G Q
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK--------MEKEKE-----GFPITSLREINILLKLQ 62
Query: 440 HPNVVPLRAYYYSK--DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTA 496
HPN+V ++ D+ +V +Y L +L+ + VK ++L
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS-----EVKCLMLQLL 116
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYR 552
GVAH+H H ++K SN+L+N I DFGL P P YR
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173
Query: 553 APEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
APE++ +++S D++S G + E+LT K PL
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK-PL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVV 444
+V+G+G++G + V +S+ V +K L + + KR F ++ +I+ +V
Sbjct: 49 KVIGRGAFG-EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIV 106
Query: 445 PLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVA 500
L +Y +D+K L V +Y G L L+ P W +++L +
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLA----LD 156
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRSAGYRAPE 555
IHSMG F H ++K N+L+++ ++DFG M+ T + Y +PE
Sbjct: 157 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 556 VIETRKHS----HKSDVYSFGVLLLEMLTGKAP 584
V++++ + D +S GV L EML G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 51/227 (22%)
Query: 392 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPNV 443
+G+G+YG YKA +++ +V LK+V + D E++ EI + R H N+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVA--LKKV---RLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 444 VPLRAYYYSKDEKL----------LVYDYFAS---GSL-STLLHGNRGAGRTPLDWETRV 489
V L+ K + L LV++Y G L S L+H + ++ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM------ 122
Query: 490 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-- 547
K LL G+ + H F H +IK SN+L+N ++DFGL L N + SR
Sbjct: 123 KQLL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPY 174
Query: 548 -----SAGYRAPEVI--ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
+ YR PE++ E R + DV+S G +L E+ T K Q+
Sbjct: 175 TNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 49/219 (22%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRL----------KEVVVGKRDFEQQMEIVGRVGQHP 441
LG+G++G Y ++ + VK++ KEV E +++++ + QH
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV----NALECEIQLLKNL-QHE 64
Query: 442 NVVPLRAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
+V YY DE L ++ +Y GS+ L T TR +IL G
Sbjct: 65 RIV---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QIL----EG 116
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFG-----------LTPLMNVPATP 545
V ++HS H +IK +N+L +D G + DFG T + +V TP
Sbjct: 117 VEYLHS---NMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ +PEVI + K+DV+S G ++EMLT K P
Sbjct: 172 Y----WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 39/215 (18%)
Query: 391 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------- 438
E +G+G+YG YKA V E T+ +K+++ EQ+ E V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNE--TIALKKIR--------LEQEDEGVPSTAIREISLLKE 57
Query: 439 -QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTA 496
QH N+V L+ +S+ LV++Y L + + + P +K L
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP----RLIKTYLYQIL 112
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR----SAGY 551
RG+A+ HS + H ++K N+LI++ + ++DFGL +P + Y
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWY 169
Query: 552 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 585
RAPE++ +H S D++S G + EM+ K PL
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK-PL 203
|
Length = 294 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 445
+V+GKGS+G A + + + VK L K+ ++ K++ M ++ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 446 LRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIH 503
L Y + EKL V DY G L H R R L E R + A + ++H
Sbjct: 61 LH-YSFQTAEKLYFVLDYVNGGEL--FFHLQRE--RCFL--EPRARFYAAEVASAIGYLH 113
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIET 559
S+ + ++K N+L++ ++DFGL + T S G Y APEV+
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+ D + G +L EML G P S M D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 392 VLGKGSYGTAYKAVLEEST----TVVVKRLKE--VVVGKRDF---EQQMEIVGRVGQHPN 442
VLGKG YG ++ +K LK+ +V ++D + + I+ V +HP
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPF 61
Query: 443 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVA 500
+V L Y + KL L+ +Y + G L L R + E L + +
Sbjct: 62 IVDL-IYAFQTGGKLYLILEYLSGGELFMHLE------REGIFMEDTACFYLSEISLALE 114
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP----LMNVPATPSRSAGYRAPEV 556
H+H G + ++K N+L++ ++DFGL V T + Y APE+
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+ H D +S G L+ +MLTG P + R +D
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 29/82 (35%), Positives = 47/82 (57%), Gaps = 11/82 (13%)
Query: 512 HGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATPSRSAG---YRAPEVIE----TRKH 562
H ++K SN+L+ D G + DFG++ + +RSAG Y APE I+ K+
Sbjct: 138 HRDVKPSNILL--DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY 195
Query: 563 SHKSDVYSFGVLLLEMLTGKAP 584
++DV+S G+ L+E+ TG+ P
Sbjct: 196 DIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAYYY 451
+G+G+YG YKA ++ LK++ EI + R +HPNV+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 452 SKDEK--LLVYDYFASGSLSTLLHGNRG--AGRTPLDW-ETRVKILLGTARGVAHIHSMG 506
S ++ L++DY A L ++ +R A + P+ + VK LL + + IH +
Sbjct: 69 SHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL--YQILDGIHYLH 125
Query: 507 GPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG-------YRAPE 555
H ++K +N+L+ + I+D G L N P P YRAPE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 556 VIETRKHSHKS-DVYSFGVLLLEMLTGK 582
++ +H K+ D+++ G + E+LT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 17/135 (12%)
Query: 132 IPNNTLGKLDALEVLSLR--------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 183
+ + + LD E L + SE+ L +L L L +NN + IP
Sbjct: 75 LSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPP 133
Query: 184 S---FSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHL 238
L LDLS N ++P ++NL L L L N+LS +P ++ L +L
Sbjct: 134 LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191
Query: 239 NLSYNGLKGSIPSSL 253
+LS N + +P +
Sbjct: 192 DLSGNKIS-DLPPEI 205
|
Length = 394 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-----VGRVGQHPNVVPLR 447
LG+G+ G+ K L+ + + + + + + Q +I + + + P +V
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALK---TITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 448 AYYYSKDEKLL--VYDYFASGSLSTLL-----HGNRGAGRTPLDWETRVKILLGTARGVA 500
+ + + +Y GSL ++ G R G L KI +G++
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLG-----KIAESVLKGLS 119
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-VPATPSRSAGYRAPEVIE 558
++HS K H +IK SN+L+ + + DFG++ L+N + T + ++ Y APE I+
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ +S SDV+S G+ LLE+ + P
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTV--VVKRL-KEVVVGKRDFEQQMEIVGRVGQ---HPNVV 444
++LGKG++G V E++T +K L KEV++ K + + RV Q HP +
Sbjct: 1 KLLGKGTFGKVI-LVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFLT 58
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L+ + + D V +Y G L H +R T E R + A V+ +
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEIVSALEY 110
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEV 556
+ + +IK N+++++D I+DFGL + TP Y APEV
Sbjct: 111 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE----YLAPEV 166
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
+E + D + GV++ EM+ G+ P + + + +L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 64/237 (27%), Positives = 98/237 (41%), Gaps = 38/237 (16%)
Query: 385 LLRASAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGR 436
LLRA LG G++G Y+ + V VK L E + DF + I+ +
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 437 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 496
H N+V L + + + ++ + A G L + L NR P +K LL A
Sbjct: 66 F-NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS--SLTMKDLLFCA 122
Query: 497 RGVAH-IHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSRSAGYR 552
R VA + F H +I A N L+ G I+DFG+ + R++ YR
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI------YRASYYR 176
Query: 553 ------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 596
PE + K+DV+SFGVLL E+ + G P T ++++
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 393 LGKGSYGT---AYKAVLEESTTVVVKRLKEV----VVGKRDFEQQMEIVGRVGQHPNVVP 445
LG+G+YG A A E TV +K++ V ++ KR ++++++ H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNITC 66
Query: 446 L---RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
L + +L +Y+ L ++ + PL + G+ +I
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYI 121
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----------YR 552
HS H ++K N+L+N D + I DFGL + P +AG YR
Sbjct: 122 HS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS--ENPGENAGFMTEYVATRWYR 176
Query: 553 APEVIETRKHSHKS-DVYSFGVLLLEMLTGK 582
APE++ + + K+ DV+S G +L E+L K
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPE 555
RG+ +IHS H ++K SN+ +N+D + I DFGL + T + YRAPE
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 187
Query: 556 VIETRKHSHKS-DVYSFGVLLLEMLTGK 582
++ H +++ D++S G ++ E+LTG+
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 51/232 (21%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKR--------------LKEVVVGKRDFEQQMEIVGRV 437
+G+G+YGT YKA L V +K+ L+E+ + K+ E
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ-LESF------- 58
Query: 438 GQHPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVK 490
+HPN+V L ++ KL LV+++ L+T L G + R +
Sbjct: 59 -EHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMR-Q 115
Query: 491 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-------PLMNVPA 543
+L RGV +HS + H ++K N+L+ D I+DFGL L +V
Sbjct: 116 LL----RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV 168
Query: 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
T YRAPEV+ ++ D++S G + E+ + + + D +D
Sbjct: 169 T----LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 393 LGKGSYGTAYKAVLEESTTVV-VKRLKEV----VVGKRDF-EQQMEIVGRVGQHPNVVPL 446
+G+GSYG +K E+ +V +K+ E V+ K E +M + +HPN+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML---KQLKHPNLVNL 65
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+ K + LV++Y L+ L RG + KI+ T + V H
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--------ATPSRSAGYRAPEVI- 557
H ++K N+LI + + DFG ++ P AT YRAPE++
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT----RWYRAPELLV 173
Query: 558 -ETRKHSHKSDVYSFGVLLLEMLTGKA 583
+T ++ DV++ G + E+LTG+
Sbjct: 174 GDT-QYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 392 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDF---EQQMEIVGRVGQHPNVVPL 446
V+G+GSY L+++ + ++ KE+V D + + + + HP +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+ + ++ V +Y G L + H R + L E + + ++H G
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLALNYLHERG 116
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIETRKH 562
+ ++K NVL++ + ++D+G+ P T S G Y APE++ +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 563 SHKSDVYSFGVLLLEMLTGKAPL 585
D ++ GVL+ EM+ G++P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 391 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDF-EQQMEIVGRVGQ-- 439
E LG+G++ +K + E T V++K L + R++ E E + Q
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS 57
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
H ++V DE ++V +Y GSL T L N+ + W+ V L A
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--INISWKLEVAKQLAWA--- 112
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGLTPLMNVPATPSRSAGY 551
+H + THGN+ A NVL+ ++ D +SD G++ + +
Sbjct: 113 --LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPW 170
Query: 552 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTG 581
PE IE ++ S +D +SFG L E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 50/225 (22%), Positives = 99/225 (44%), Gaps = 17/225 (7%)
Query: 392 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDF---EQQMEIVGRVGQHPNVVPL 446
V+G+GSY L+++ + ++ KE+V D + + + + +P +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+ + + LV +Y G L + H R + L E + +H G
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL--MFHMQR---QRKLPEEHARFYAAEICIALNFLHERG 116
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIETRKH 562
+ ++K NVL++ D ++D+G+ P T S G Y APE++ ++
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 563 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607
D ++ GVL+ EM+ G++P T + ++ ++ V+ E+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 166 SLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 223
+L+ L L +N + +F P L VLDLS N+ T P++ L L L L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 2e-06
Identities = 24/60 (40%), Positives = 32/60 (53%), Gaps = 4/60 (6%)
Query: 143 LEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSF 199
L+ L L +N LT +P LP+L+ L L NN + P +FS P L LDLS N+
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 70/303 (23%), Positives = 134/303 (44%), Gaps = 54/303 (17%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVP 445
E LG+G+Y T +K + + +V LKE+ + + +++ ++ + +H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVT 68
Query: 446 LRAYYYSKDEKLLVYDYFAS---------GSLSTLLHGNRGAGRTPLDWETRVKILL-GT 495
L ++ LV++Y G++ ++ VKI L
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM---------------HNVKIFLYQI 113
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATPSRSAGY 551
RG+A+ H K H ++K N+LIN+ + ++DFGL +VP + + Y
Sbjct: 114 LRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWY 170
Query: 552 RAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RWVQSVVREEWT 609
R P+V + + ++S + D++ G + EM +G+ T +D + L R + + E W
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVRMIEEVRQSDSENRPS 668
+ + + N + Q L I A P +D E + ++ + Q +S+ R S
Sbjct: 231 G-ISSNDEFKNYNFPKYKPQPL-INHA---------PRLDTEGIELLTKFLQYESKKRIS 279
Query: 669 SEE 671
+EE
Sbjct: 280 AEE 282
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-06
Identities = 14/42 (33%), Positives = 21/42 (50%), Gaps = 3/42 (7%)
Query: 74 LNSDRQALLDFADAV---PHLRKLNWSSTNPICQSWVGINCT 112
LN DR ALL F ++ P +W+ ++ SW G+ C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVG--RVGQHPNVVPLR 447
EV+GKGSYG A+ V +K++ +V D + + + R+ +HP++V ++
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR--TPLDWETRVKILLGTARGVAHIHSM 505
+ Y + + LH A TP + + LL R + +IH+
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL---RALKYIHTA 122
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-------RSAGYRAPEVIE 558
H ++K N+L N D I DFGL + + + YRAPE+
Sbjct: 123 N---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 559 T--RKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ K++ D++S G + E+LTGK PL
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK-PL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAYYY 451
+G+G+YG YKA ++ LK++ EI + R +HPNV+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 452 SK-DEKL-LVYDYFASGSLSTLLHGNRG--AGRTPLDW-ETRVKILLGTARGVAHIHSMG 506
S D K+ L++DY A L ++ +R A + P+ VK LL + + IH +
Sbjct: 69 SHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL--YQILDGIHYLH 125
Query: 507 GPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG-------YRAPE 555
H ++K +N+L+ + I+D G L N P P YRAPE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 556 VIETRKHSHKS-DVYSFGVLLLEMLTGK 582
++ +H K+ D+++ G + E+LT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 48/193 (24%), Positives = 68/193 (35%), Gaps = 64/193 (33%)
Query: 450 YYS---KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHSM 505
YYS KD V DY G + +LL R + E + + + +H M
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI------RLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 506 GGPKFTHGNIKASNVLINQDLDGCI--SDFGL---------------------------- 535
G F H +IK N+LI D DG I +DFGL
Sbjct: 121 G---FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 536 --TPLMNVPATPSR-----------------SAGYRAPEVIETRKHSHKSDVYSFGVLLL 576
+ + P + Y APEV+ ++ D +S GV+L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 577 EMLTGKAPLQSPT 589
EML G+ P + T
Sbjct: 236 EMLVGQPPFLADT 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV---VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E LG+GSY T YK + + +V V RL+E ++ ++ + +H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLH 69
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVAHIHSMG 506
++K+ LV++Y + L + + G G P VK+ L RG+++IH
Sbjct: 70 DIIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHP----ENVKLFLFQLLRGLSYIHQR- 122
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEV-IETRK 561
H ++K N+LI+ + ++DFGL +VP+ T S + YR P+V + + +
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+S D++ G + +EM+ G A P D+ D
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAF--PGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 412 VVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK--LLVYDYFASGS 467
V VK LK G D ++++EI+ R H N+V + L+ ++ SGS
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEIL-RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 527
L L N+ ++ + ++K + +G+ + +G ++ H ++ A NVL+ +
Sbjct: 95 LKEYLPRNKNK----INLKQQLKYAVQICKGMDY---LGSRQYVHRDLAARNVLVESEHQ 147
Query: 528 GCISDFGLTPLM-------NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 580
I DFGLT + V + APE + K SDV+SFGV L E+LT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTT--VVVKRLKEVVVGKRDFEQQMEIVGRVGQ---HPNVVP 445
++LGKG++G V E++T +K LK+ V+ +D RV Q HP +
Sbjct: 1 KLLGKGTFGKVI-LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 504
L+ + + D V +Y G L L R + E R + + ++HS
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHS 113
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEV 556
+ ++K N+++++D I+DFGL + TP Y APEV
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE----YLAPEV 167
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
+E + D + GV++ EM+ G+ P + + + +L
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 41/245 (16%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------QHPNV 443
+G+G+YG +KA L+ V LK V V + + + V +HPNV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 444 VPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
V L ++ KL LV+++ L+T L G ET ++ RG
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRG 122
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---SAGYRAPE 555
+ +HS + H ++K N+L+ ++DFGL + + + + YRAPE
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD--------DMVDLPRWVQSVVREE 607
V+ ++ D++S G + EM K PL + D D++ LP E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPG------EED 232
Query: 608 WTAEV 612
W +V
Sbjct: 233 WPRDV 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 33/212 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QH 440
E +G+G+YG YK +++ +V + K E + E V QH
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMK-------KIRLESEEEGVPSTAIREISLLKELQH 58
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
PN+V L+ + L+++ F S L L +D E L +G+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFE-FLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGIL 115
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAP 554
HS + H ++K N+LI+ G I +DFGL +P + YRAP
Sbjct: 116 FCHSR---RVLHRDLKPQNLLIDN--KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170
Query: 555 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
EV+ + ++S D++S G + EM T K PL
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 391 EVLGKGSYGTAYKAVL-EESTT---VVVKRLKEVVVGKRDFEQQMEIVGRVGQ---HPNV 443
++LGKG++G K +L E T +K LK+ V+ +D RV Q HP +
Sbjct: 1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVA 500
L+ + + D V +Y G L H +R R + R +I+ +
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIVSA----LG 109
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEV 556
++HS + ++K N+++++D I+DFGL ++ AT G Y APEV
Sbjct: 110 YLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
+E + D + GV++ EM+ G+ P + + + +L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 48/215 (22%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 392 VLGKGSYG-TAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPLR 447
V+GKGSYG + + V+K+L +R+ EQ+ +++ ++ +HPN+V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYR 65
Query: 448 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGA---GRTPLDWETRVKILLGTARGVAHIH 503
+ +D L +V + G L L +G ++W ++ A + ++H
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLH 119
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAPEVIET 559
H ++K NV + + + D G+ ++ ++ +T + Y +PE+
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 594
+ +++KSDV++ G + EM T K + + +V
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 12/201 (5%)
Query: 386 LRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP 445
LRAS E + + ++ KR+K E ++ +GR+ H N++
Sbjct: 169 LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILK 227
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
+ S+ ++ + S + PL +TR I+ V +IH
Sbjct: 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHD- 285
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY------RAPEVIET 559
K H +IK N+ +N D + DFG G+ +PE++
Sbjct: 286 --KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAG 342
Query: 560 RKHSHKSDVYSFGVLLLEMLT 580
+ +D++S G++LL+ML+
Sbjct: 343 DGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVPLR 447
LG+G+Y T +K + + +V LKE+ + + +++ ++ + +H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLH 69
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLH-GNRGAGRTPLDWETRVKILL-GTARGVAHIHSM 505
+++ LV++Y S L + GN L VKI + RG+++ H
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGN-------LMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEV-IETR 560
K H ++K N+LIN+ + ++DFGL +VP T S + YR P+V + +
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 561 KHSHKSDVYSFGVLLLEMLTGK 582
++S D++ G +L EM TG+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 4e-06
Identities = 23/60 (38%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 245
L LDLS N T + + L L L L NNL+ P +P LR L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 393 LGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVV 444
LG+G++ YK VL +S +V +EV V RD E + Q +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 445 PLRAYYYS-KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
++ Y +DE ++V +Y G L LH + L W ++ + A + ++
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNN--VSLHW--KLDVAKQLASALHYLE 118
Query: 504 SMGGPKFTHGNIKASNVLINQD-------LDGCISDFGL-TPLMNVPATPSRSAGYRAPE 555
K HGN+ N+L+ + +SD G+ +++ R + APE
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-WIAPE 174
Query: 556 VIE--TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDM 593
I + +D +SFG LLE+ + G+ PL + + +
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLR 447
AE LG+G+ + VL V VK L+ V + DF ++++I+ R+ ++PN++ L
Sbjct: 30 AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLL 83
Query: 448 AYYYSKDEKLLVYDYFASGSL----------STLLHGNRGAGRTPLDWETRVKILLGTAR 497
S D ++ +Y +G L ST H N + + +L +
Sbjct: 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN------IPSVSIANLLYMAVQ 137
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP---------LMNVPATPSRS 548
+ + + F H ++ N L+ I+DFG++ + P R
Sbjct: 138 IASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR- 196
Query: 549 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 580
+ A E I K + SDV++FGV L EM T
Sbjct: 197 --WMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 392 VLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN---VVPLR 447
VLGKG +G V K+L++ + KR E R+ + N VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
Y +KD LV G L ++ GN G D + + G+ +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FDEQRAIFYAAELCCGLEDLQR- 120
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIETR 560
+ + ++K N+L++ ISD GL + +P + + GY APEVI
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNE 176
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQ 586
K++ D + G L+ EM+ G++P +
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 6e-06
Identities = 20/46 (43%), Positives = 23/46 (50%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 177
IP+ L L+VL L N LT P + LPSLR L L NN
Sbjct: 15 IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVAHIHSMGGPKF 510
S D+ LL+ +Y + G L+ + R P E V +L + +HS K
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQIK-QRLKEHLPFQ-EYEVGLLFYQIVLALDEVHSR---KM 190
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPL------MNVPATPSRSAGYRAPEVIETRKHSH 564
H ++K++N+ + + DFG + ++V ++ + Y APE+ E +++S
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 594
K+D++S GV+L E+LT P + P++ +++
Sbjct: 251 KADMWSLGVILYELLTLHRPFKGPSQREIM 280
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 445
+V+G+G++G L+ + V +K L + + KR F ++ +++ G + +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITT 65
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L + ++ LV DY+ G L TLL ++ R P E + L A V I S+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYL--AEMVIAIDSV 118
Query: 506 GGPKFTHGNIKASNVLINQDLDGCI--SDFG--LTPLMNVPATPSRSAG---YRAPEVIE 558
+ H +IK N+L+ D++G I +DFG L + + S + G Y +PE+++
Sbjct: 119 HQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 559 TR-----KHSHKSDVYSFGVLLLEMLTGKAPL 585
K+ + D +S GV + EML G+ P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRAPEVIETRKH 562
F H ++ A NVL+ ISDFGL+ + ++ + APE + K
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 563 SHKSDVYSFGVLLLEMLT-GKAP 584
S KSDV+SFGVL+ E + G+ P
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 9e-06
Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 63/248 (25%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---------QMEIVGRVGQHP 441
++LGKG G + ++ T + LK V+ K++ + + EI+ + HP
Sbjct: 7 KLLGKGDVGRVF--LVRLKGTGKLFALK--VLDKKEMIKRNKVKRVLTEQEILATL-DHP 61
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTA 496
+ L A + ++ LV DY G L LL G E + +LL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG-KCLS---EEVARFYAAEVLLA-- 115
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-PATPSRSAG----- 550
+ ++H +G + ++K N+L+++ +SDF L+ +V P S++
Sbjct: 116 --LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 551 ---------------------------YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 583
Y APEVI H D ++ G+LL EML G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 584 PLQSPTRD 591
P + RD
Sbjct: 231 PFKGSNRD 238
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 23/101 (22%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 550
RG+ +IHS H ++K SN+L+N + D I DFGL A + G
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL-------ARTTSEKGDFMTEY 168
Query: 551 -----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
YRAPE++ +++ DV+S G + E+L K PL
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 479 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538
+ PL E + ARG+ + S K H ++ A N+L++++ I DFGL
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARD 222
Query: 539 MNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592
+ R R APE I + ++ +SDV+SFGVLL E+ + A SP
Sbjct: 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA---SPYPGV 279
Query: 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652
+D EE+ + + MR E ++ I + C P+ RP E+V
Sbjct: 280 QID----------EEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPEDRPTFSELV 327
Query: 653 RMIEEVRQSD 662
++ ++ Q +
Sbjct: 328 EILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
+PN + L + +L+ DY G L LL L KI+ +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEAL 122
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAGYRAPEVIE 558
+H H +IK NVL ++ D + D+GL ++ P+ + Y +PE I+
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIK 179
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
+ D ++ GVL E+LTGK P + D+ +DL
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKE-DEDEELDL 216
|
Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 26/188 (13%)
Query: 480 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539
++PL E + ARG+ + S K H ++ A N+L++++ I DFGL +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 540 NVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDD 592
R R APE I + ++ +SDV+SFGVLL E+ + G +P
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG----- 279
Query: 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652
VQ + EE+ + D MR E ++ +I +AC P RP +V
Sbjct: 280 -------VQ--INEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPTFSALV 328
Query: 653 RMIEEVRQ 660
++ ++ Q
Sbjct: 329 EILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 35/210 (16%)
Query: 392 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
++G GS+G Y+A+ ++ S V +K+ V+ ++ + ++ + H N++ L+ YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 451 YS----KDEKLL----VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL-LGTARGVAH 501
Y+ K+EK + V ++ + H R PL VK+ R +A+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL---FLVKLYSYQLCRALAY 185
Query: 502 IHSMGGPKFT-HGNIKASNVLIN---QDLDGCISDFG-----LTPLMNVPATPSRSAGYR 552
IHS KF H ++K N+LI+ L C DFG L +V SR YR
Sbjct: 186 IHS----KFICHRDLKPQNLLIDPNTHTLKLC--DFGSAKNLLAGQRSVSYICSRF--YR 237
Query: 553 APEV-IETRKHSHKSDVYSFGVLLLEMLTG 581
APE+ + ++ D++S G ++ EM+ G
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEI-VGRVGQHPNVVPL 446
+ LG+GSY T YK + + +V LKE+ + + F E + + +H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVA--LKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILL-GTARGVAHIH 503
++K LV++Y + L + G G + V++ L RG+A+ H
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG---GLSM----HNVRLFLFQLLRGLAYCH 120
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEVI-E 558
+ H ++K N+LI++ + ++DFGL +VP+ T S + YR P+V+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKA 583
+ ++S D++ G + EM TG+
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 393 LGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEI--VGRVGQHPNVVPLRAY 449
+G+G++ KA + +K +K+ EI + R+ HPN++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 450 YYSKDEKLLVYDYFASGSLS---TLLHGN-----RGAGRTPLDWETRVK-ILLGTARGVA 500
+ D K +G L+ L+ N +G + PL E RVK + + +
Sbjct: 67 LF--DRK--------TGRLALVFELMDMNLYELIKGR-KRPLP-EKRVKSYMYQLLKSLD 114
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAG-YRAPEVI 557
H+H G H +IK N+LI D+ ++DFG + P T S YRAPE +
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170
Query: 558 ETR-KHSHKSDVYSFGVLLLEMLT 580
T + K D+++ G + E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRD---FEQQMEIVGRVGQHPNVVP 445
+V+G+G++G + S V +L K ++ + D F ++ +I+ P VV
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQ 107
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 503
L + +V +Y G L L+ P W +++L + IH
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLA----LDAIH 159
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPSRSAGYRAPEVIE 558
SMG H ++K N+L+++ ++DFG M+ T + Y +PEV++
Sbjct: 160 SMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 559 TRK----HSHKSDVYSFGVLLLEMLTGKAPL 585
++ + + D +S GV L EML G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVPATPS-------RS 548
RG+ +IHS H ++K +NV IN DL I DFGL +++ + +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 549 AGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 582
YR+P ++ + + K+ D+++ G + EMLTGK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFE----QQMEIVGRVGQHPNVVPL 446
+G+G++G +KA +++ +V LK+V++ K F ++++I+ + +H NVV L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVA--LKKVLMENEKEGFPITALREIKILQLL-KHENVVNL 76
Query: 447 RAYYYSKDEK--------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
+K LV++ F L+ LL N+ T + + +K+LL G
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFE-FCEHDLAGLLS-NKNVKFTLSEIKKVMKMLLN---G 131
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAG 550
+ +IH K H ++KA+N+LI +D ++DFGL ++ +
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 551 YRAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589
YR PE+ + R + D++ G ++ EM T +Q T
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 37/225 (16%)
Query: 393 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLR 447
+GKG G Y A S V +K+++E + K+ F ++ +I + HP +VP+
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVY 68
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE--TRVKILLG----TARGVAH 501
+ D Y +L +LL + T V L + +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL----------------------M 539
+HS G H ++K N+L+ + I D+G M
Sbjct: 129 VHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 540 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+P + Y APE + S +D+Y+ GV+L +MLT P
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 23/150 (15%)
Query: 449 YYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+Y +DE LV DY+ G L TLL ++ R P E + L A V I S+
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYL--AEMVLAIDSVH 119
Query: 507 GPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG-----YRAPEVIE- 558
+ H +IK NVL+ D +G I +DFG + T + Y +PE+++
Sbjct: 120 QLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 559 ----TRKHSHKSDVYSFGVLLLEMLTGKAP 584
++ + D +S GV + EML G+ P
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 24/94 (25%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRA 553
G+ H+H + + ++K NVL++ D + ISD GL + + ++ + G+ A
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 587
PE+++ ++ D ++ GV L EM+ + P ++
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVPLR 447
LG+G+Y T YK + + +V LKE+ + + +++ ++ + +H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVA--LKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLH 70
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
+++ LV++Y L L GN ++ L RG+ + H
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS------INMHNVKLFLFQLLRGLNYCHRR 123
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATPSRSAGYRAPEV-IETR 560
K H ++K N+LIN+ + ++DFGL ++P + + YR P++ + +
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPL 585
+S + D++ G + EM TG+ PL
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR-PL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----Y 551
RG+ ++HS G H +IK N+L+N + I DFGL + + + Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 552 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQS 587
RAPE++ +H + D++S G + E+L + Q+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 47/162 (29%), Positives = 64/162 (39%), Gaps = 28/162 (17%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS--FSPQLVVLDL 194
L L L+ L L N L+ LP +++L +L L L N S +P L LDL
Sbjct: 159 LRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQ----------------------SNNLSGSIPNFD- 231
S NS + S+ NL L+GL L SNN SI +
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGS 275
Query: 232 IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 273
+ LR L+LS N L ++P + N LL L+
Sbjct: 276 LTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALE 317
|
Length = 394 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 11/116 (9%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY----- 551
R + ++H + H +IKA N+ IN D C+ DFG V ++ G+
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248
Query: 552 -RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL-QSPTRDDMVDLPRWVQSVVR 605
APE++ + D++S G++L EM T L + D D R ++ ++R
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
|
Length = 391 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 32/197 (16%)
Query: 424 KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL----------H 473
+ DF ++++I+ R+ + PN++ L +D ++ +Y +G L+ L +
Sbjct: 63 RNDFLKEVKILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 474 GNRGAGRT----PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529
GN + + + + + L A G+ ++ S+ F H ++ N L+ ++L
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIK 178
Query: 530 ISDFGLTP---------LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 580
I+DFG++ + P R + A E I K + SDV++FGV L E+L
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIR---WMAWECILMGKFTTASDVWAFGVTLWEILM 235
Query: 581 --GKAPLQSPTRDDMVD 595
+ P T + +++
Sbjct: 236 LCKEQPYGELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 18/98 (18%)
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATPS 546
GV+++HS H +IK +N+L + + + DFG T + +V TP
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 547 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ +PEVI + K+D++S G ++EMLT K P
Sbjct: 175 ----WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 393 LGKGSYGTAYKAVLEESTTV-VVKRLKEV-VVGKRDFEQQME---IVGRVGQHPNVVPLR 447
+GKGS+G + ++ + +K +++ +V + + + ++ +V P +VPL+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR-GVAHIHSMG 506
+ S ++ LV + G L H + GR +R + + ++H
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL---FHHLQREGRFD---LSRARFYTAELLCALENLHKF- 112
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRKH 562
+ ++K N+L++ + DFGL L M + G Y APE++ +
Sbjct: 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 563 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
+ D ++ GVLL EMLTG P ++M
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 18/98 (18%)
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATPS 546
G++++H H +IK +N+L + + + DFG T + +V TP
Sbjct: 118 GMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 547 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ +PEVI + K+DV+S G ++EMLT K P
Sbjct: 175 ----WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVG-QHPNVVPL 446
E LG+GSY T YK + + +V LK + + + F E G +H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVA--LKVISMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
++K+ V++Y + L+ + + G G P + + LL RG+A+IH
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPG-GLHPYNVRLFMFQLL---RGLAYIH--- 120
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVI-ETRK 561
G H ++K N+LI+ + ++DFGL ++P+ S YR P+V+
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 562 HSHKSDVYSFGVLLLEMLTGK 582
+S D++ G + +EML G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 52/242 (21%), Positives = 105/242 (43%), Gaps = 36/242 (14%)
Query: 355 KEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVL--EESTTV 412
K++ S + KNK+ + + +NF LG GS+G A E+ V
Sbjct: 12 KKDSDSTKEPKRKNKMKYED---FNF---------IRTLGTGSFGRVILATYKNEDFPPV 59
Query: 413 VVKRL-KEVVVGKRDFEQ---QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468
+KR K ++ ++ + + +I+ + HP V L + + LV ++ G
Sbjct: 60 AIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 469 STLLHGNRGAGRTPLD----WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 524
T L N+ R P D + ++ ++ ++ S+ + ++K N+L+++
Sbjct: 119 FTFLRRNK---RFPNDVGCFYAAQIVLIF------EYLQSL---NIVYRDLKPENLLLDK 166
Query: 525 DLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 583
D ++DFG +++ T + Y APE++ H +D ++ G+ + E+L G
Sbjct: 167 DGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
Query: 584 PL 585
P
Sbjct: 227 PF 228
|
Length = 340 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 53/290 (18%)
Query: 393 LGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 444
+G G +G K +L E T VVVK LK K +F QQ + R+ QHPN++
Sbjct: 3 IGNGWFG---KVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPY-RILQHPNIL 58
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGN---RGAGRTPLDWETRVKILLGTARGVAH 501
LLV++Y G L + L R + L +I A GV H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTH 114
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRSAGYR 552
+H F H ++ N + DL + D+G+ P + P R +
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR---WL 168
Query: 553 APEVIETR-------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 605
APE++ + + S+V++ GV L E+ A S D V + V++
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-----LNHVIK 223
Query: 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655
++ ++F +L E ++LQ C P+ R +EV R++
Sbjct: 224 DQQV-KLFKPQLE--LPYSERWYEVLQF---CWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 24/189 (12%)
Query: 480 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539
+ L E + A+G+ + S K H ++ A N+L++++ I DFGL +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 540 NVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
R R APE I R ++ +SDV+SFGVLL E+ + A SP
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVK 286
Query: 594 VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+D EE+ + E R + + +M Q + C P RP E+V
Sbjct: 287 ID----------EEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
Query: 654 MIEEVRQSD 662
+ + Q++
Sbjct: 335 HLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 37/170 (21%)
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 497
++P VV + + +K +V +Y G +TLL + G P+D ++ T
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVD---MARMYFAETVL 112
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP--LMN--------------- 540
+ ++H+ G H ++K N+LI ++DFGL+ LM+
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 541 ------VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
V TP Y APEVI + + D ++ G++L E L G P
Sbjct: 170 EFLDKQVCGTPE----YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 18/99 (18%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATP 545
+GV+++HS H +IK +N+L + + + DFG T + +V TP
Sbjct: 117 QGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ +PEVI + K+DV+S ++EMLT K P
Sbjct: 174 Y----WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 412 VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469
V VK L+E + DF ++++I+ R+ + PN++ L A + D ++ +Y +G L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 470 TLL--HGNRGAG----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 523
L H + A + + T + + A G+ ++ S+ F H ++ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164
Query: 524 QDLDGCISDFGLTP---------LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVL 574
++ I+DFG++ + P R + + E I K + SDV++FGV
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR---WMSWESILLGKFTTASDVWAFGVT 221
Query: 575 LLEMLT 580
L E+LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 62/291 (21%)
Query: 393 LGKGSYGTAYKAVLEE------STTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVV 444
+G G +G K +L E VVVK L+ V + F ++ + R QH N++
Sbjct: 3 IGNGWFG---KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPY-RSLQHSNLL 58
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
LLV ++ G L L R A D T ++ A G+ H+H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSR---SAGYRAPEVIE 558
F H ++ N L+ DL I D+GL+ + TP + + APE+++
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 559 -------TRKHSHKSDVYSFGVLLLEMLT-GKAP---------LQSPTRDDMVDLPR-WV 600
+ +S+V+S GV + E+ G P L R+ + LP+ +
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235
Query: 601 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 651
+ + + W E+M+F ++ P+ RP+ +EV
Sbjct: 236 KLPLSDRW------YEVMQFCWLQ-----------------PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 55/197 (27%), Positives = 76/197 (38%), Gaps = 60/197 (30%)
Query: 440 HPNVVPLRAYYYS-KDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 496
+P VV L YYS +DE L+ +Y G + TLL T + ETR I A
Sbjct: 60 NPWVVKL---YYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYI----A 108
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGL-TPL--------------- 538
+ I S+ + H +IK N+L+ D G I SDFGL T L
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 539 -----MNVPATPSRSAG---------------------YRAPEVIETRKHSHKSDVYSFG 572
++ + P S Y APEV ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 573 VLLLEMLTGKAPLQSPT 589
V++ EML G P S
Sbjct: 227 VIMYEMLVGYPPFCSDN 243
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 428 EQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 487
E+ M + G P +V + +++ D+ + D G L L + + +
Sbjct: 44 ERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYA 103
Query: 488 RVKILLGTARGVAHIHSMGGPKFT-HGNIKASNVLINQDLDGCISDFGLTPLMN--VPAT 544
IL G+ H+H+ +F + ++K +N+L+++ ISD GL + P
Sbjct: 104 TEIIL-----GLEHMHN----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154
Query: 545 PSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPL-QSPTRD 591
+ GY APEV++ + +D +S G +L ++L G +P Q T+D
Sbjct: 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 55/214 (25%), Positives = 76/214 (35%), Gaps = 62/214 (28%)
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
VV L + KD V DY G + +LL G P D L A V +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCA--VESV 117
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG---------------------------- 534
H MG F H +IK N+LI++D ++DFG
Sbjct: 118 HKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 535 --------------LTPLMNVPATPSR---------SAGYRAPEVIETRKHSHKSDVYSF 571
L PL A + + Y APEV+ ++ D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 572 GVLLLEMLTGKAPL--QSPTRDDMVDLPRWVQSV 603
GV+L EML G+ P Q+P M + W S+
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQM-KVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 23/202 (11%)
Query: 393 LGKGSYGTAYKAVL---EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
L GS G + E+ V+VK V G + ++++I+ + H ++ L
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVK----AVTGGKTPGREIDILKTI-SHRAIINLIHA 154
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
Y K +V + L T + PL E + I +A++H G
Sbjct: 155 YRWKSTVCMVMPKYKC-DLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG--- 205
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP-----SRSAGYRAPEVIETRKHS 563
H ++K N+ +++ + + DFG L P TP S + +PE++ +
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 564 HKSDVYSFGVLLLEMLTGKAPL 585
K+D++S G++L EM L
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 392 VLGKGSYGTAYKAVLEESTTV----VVKRLKEVVVGKRDF---EQQMEIVGRVGQHPNVV 444
V+G+GSY L+++ + V+K KE+V D + + + HP +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK--KELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 503
L + + ++ V ++ + G L + H R + P E + + +H
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDL--MFHMQR-QRKLP---EEHARFYSAEISLALNFLH 113
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIET 559
G + ++K NVL++ + ++D+G+ P T S G Y APE++
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAP 584
+ D ++ GVL+ EM+ G++P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 482 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN 540
PLD + ++ A+G+ + S H ++ A NVL+ I DFGL +MN
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 541 -----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
V + APE I ++ +SDV+S+G+LL E+ + GK+P
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 17/104 (16%)
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY------- 551
+ +IH G H +IK NVL+N D C+ DFG A S S +
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF----ARGSWSTPFHYGIAGT 325
Query: 552 ---RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592
APEV+ ++ D++S G+++ E A L S +R D
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369
|
Length = 461 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 393 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------QHPNVV 444
+G G+YGT YKA S V LK V V + + V V HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVA--LKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 445 PLRAYYYS----KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
L + ++ K+ LV+++ L T L G L ET ++ RG+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPG---LPAETIKDLMRQFLRGL 121
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--VPATPSR-SAGYRAPEV 556
+H+ H ++K N+L+ ++DFGL + + + TP + YRAPEV
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ ++ D++S G + EM K PL
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK-PL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 61/249 (24%)
Query: 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP--- 445
S +V+G+G++G ++++ T V +K ++ K D ++ E VG + +++
Sbjct: 5 SLKVIGRGAFGEV--RLVQKKDTGHVYAMK--ILRKADMLEK-EQVGHIRAERDILVEAD 59
Query: 446 ---LRAYYYSKDEKL---LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
+ +YS +KL L+ ++ G + TLL + L E + T +
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-----MKKDTLTEEETQFYIAETVLAI 114
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPAT----------PS-- 546
IH +G F H +IK N+L++ +SDFGL T L T PS
Sbjct: 115 DSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 547 --------RSA------------------GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 580
R A Y APEV ++ D +S GV++ EML
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 581 GKAPLQSPT 589
G P S T
Sbjct: 232 GYPPFCSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 27/109 (24%), Positives = 54/109 (49%), Gaps = 6/109 (5%)
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAGYRAPE 555
G+ H+H+ + ++K +N+L+++ ISD GL + P + GY APE
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165
Query: 556 VIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 603
V++ + +D +S G +L ++L G +P + D ++ R ++
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 38/132 (28%), Positives = 51/132 (38%), Gaps = 24/132 (18%)
Query: 139 KLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSF--------- 185
KL L+VL L N L L S + PSL+ L L N +G+IP
Sbjct: 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCL-SLNETGRIPRGLQSLLQGLTK 79
Query: 186 SPQLVVLDLSFNSFTGNIPQSIQNLTQ---LTGLSLQSNNLSGSIPNFDI-------PKL 235
L LDLS N+ + +++L + L L L +N L P L
Sbjct: 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139
Query: 236 RHLNLSYNGLKG 247
L L N L+G
Sbjct: 140 EKLVLGRNRLEG 151
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 17/39 (43%), Positives = 25/39 (64%)
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589
Y APEV+ + ++ D +S GV+L EML G+ P +PT
Sbjct: 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPT 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 682 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.43 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.32 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.27 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.22 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.21 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.05 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.03 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.84 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.71 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.67 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.66 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.65 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.59 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.32 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.2 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.05 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.04 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.03 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-59 Score=562.14 Aligned_cols=270 Identities=27% Similarity=0.482 Sum_probs=215.7
Q ss_pred CCHHHHHHHh--hccccccCeEEEEEEEE-cCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCce
Q 005693 380 FDLEDLLRAS--AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 456 (682)
Q Consensus 380 ~~~~~l~~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 456 (682)
++.+++.... .+.||+|+||.||+|+. .++..||+|+++.... ....|+++++++ +|||||+++++|.+++..
T Consensus 683 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL-QHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC-CCCCcceEEEEEEcCCCC
Confidence 3444443333 45899999999999997 4688999999865432 223467888888 999999999999999999
Q ss_pred EEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 457 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
++||||+++|+|.++++. ++|..+.+++.|+++|++|||+.+.++|+||||||+||+++.++..++. ||.+
T Consensus 759 ~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred EEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 999999999999999962 8899999999999999999997655669999999999999999988875 6666
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 537 PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 537 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
..........+++.|+|||++.+..++.++|||||||++|||+||+.||+... .....+.+|.+....+.......|+.
T Consensus 830 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 830 GLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred cccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCcc
Confidence 55444444567889999999999999999999999999999999999996432 23345677776655444444445544
Q ss_pred hccc-cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 617 LMRF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 617 l~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
+... ....++...+.+++.+||+.+|++||||+|+++.|+++.+..+
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 4322 2234567788999999999999999999999999999876544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=429.19 Aligned_cols=281 Identities=38% Similarity=0.678 Sum_probs=249.4
Q ss_pred CCCCCHHHHHHHh-----hccccccCeEEEEEEEEcCCceEEEEEeeccccC-hhhHHHHHHHHHHhcCCCceeceEEEE
Q 005693 377 SYNFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYY 450 (682)
Q Consensus 377 ~~~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~ 450 (682)
...|++.++..+| .+.||+|+||.||+|.+.+++.||||++...... .++|..|++++.++ +|||+|+++|||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYC 140 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEE
Confidence 3468999999998 4699999999999999999999999988776554 67799999999999 799999999999
Q ss_pred EecC-ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeE
Q 005693 451 YSKD-EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529 (682)
Q Consensus 451 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 529 (682)
.+.+ +.+||||||++|+|.++|+..... +++|..|++||.++|+||+|||+...|+|||||||++|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 499999999999999999865432 689999999999999999999999888999999999999999999999
Q ss_pred EeecCCCCCCCC-CCCC----CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 005693 530 ISDFGLTPLMNV-PATP----SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 604 (682)
Q Consensus 530 l~DfGla~~~~~-~~~~----~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~ 604 (682)
|+|||+|+.... .... .||.+|+|||++..+..++|+|||||||++.|++||+.|.+.....+...+..|.....
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999976654 3221 68999999999999999999999999999999999999988665555566999999999
Q ss_pred hhccccccchhhhccccCh-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 605 REEWTAEVFDVELMRFQNI-EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 605 ~~~~~~~~~d~~l~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.+....+++|+.+...... .+++..+.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8888999999998743333 37888999999999999999999999999999766654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=388.84 Aligned_cols=263 Identities=31% Similarity=0.484 Sum_probs=213.9
Q ss_pred CCCHHHHHHHhhccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC-
Q 005693 379 NFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD- 454 (682)
Q Consensus 379 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~- 454 (682)
..+..++. ..+.||+|+||+||+|.+.+...||||++.....+ .++|.+|+.++.++ +|||||+++|+|.+..
T Consensus 37 ~i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC
Confidence 34555553 34569999999999999986666999999876543 34899999999999 9999999999999887
Q ss_pred ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeec
Q 005693 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDF 533 (682)
Q Consensus 455 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~Df 533 (682)
..++||||+++|+|.++++.. ....+++..+++++.|||+||.|||+++ + |||||||++|||++.++ ++||+||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCC
Confidence 789999999999999999864 2345999999999999999999999986 2 99999999999999998 9999999
Q ss_pred CCCCCCCC---CCC-CCCCCcccCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 005693 534 GLTPLMNV---PAT-PSRSAGYRAPEVIE--TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607 (682)
Q Consensus 534 Gla~~~~~---~~~-~~~~~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 607 (682)
|+++.... ..+ ..||+.|||||++. ...|+.|+||||||+++|||+||+.||.+.... . .........
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~---~~~~v~~~~ 262 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---Q---VASAVVVGG 262 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHhcC
Confidence 99977653 223 56899999999999 568999999999999999999999999865431 1 111111111
Q ss_pred cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 608 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
. +......+...+..++.+||+.||+.||++.|++..|+.+.......
T Consensus 263 ~----------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 263 L----------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred C----------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 1 11112225667778888999999999999999999999988755543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=389.88 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=218.3
Q ss_pred CCCCHHHHHHHhhccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceE
Q 005693 378 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL 457 (682)
Q Consensus 378 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 457 (682)
+.++.+++ ...+.||+|.||+||.|.++....||+|.++......++|.+|+++|+++ +|+|||+++|+|..++..+
T Consensus 201 wei~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 201 WEIPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred eeecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceE
Confidence 44555555 44678999999999999999888999999998877889999999999999 9999999999999988999
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
||||||+.|+|.++|+... +..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+
T Consensus 278 IVtE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccc
Confidence 9999999999999998632 344888999999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCCCC-----CCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 538 LMNVPATPS-----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 538 ~~~~~~~~~-----~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
......... -...|.|||.+....++.|||||||||+||||+| |+.||.+....+. +.. +.+++
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev------~~~-le~Gy--- 421 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV------LEL-LERGY--- 421 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH------HHH-HhccC---
Confidence 544332211 2346999999999999999999999999999999 8999987654332 111 22221
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
+...++.+...+.++|..||+.+|++|||++.+...|+++....
T Consensus 422 -------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 422 -------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 22233456777888999999999999999999999999887543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=360.19 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=205.8
Q ss_pred CCHHHHHHHhhccccccCeEEEEEEEEcC-CceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecC-c
Q 005693 380 FDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-E 455 (682)
Q Consensus 380 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~ 455 (682)
+...+++ ..+.||+|..|+|||++++. ++.+|+|.+.... ..++++.+|++++++. +||+||.++|.|+.+. +
T Consensus 76 i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 76 ISLSDLE--RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cCHHHhh--hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCce
Confidence 3455553 35789999999999999875 5668899884332 2357889999999999 9999999999999999 4
Q ss_pred eEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 456 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 456 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
..++||||++|+|.+++... ..+++....+|+.+|++||.|||+ .+ ||||||||+|||++..|.+||+|||
T Consensus 153 isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccc
Confidence 99999999999999999753 348999999999999999999996 54 9999999999999999999999999
Q ss_pred CCCCCCCC--CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 535 LTPLMNVP--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 535 la~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
.++.+... .+..||..|||||.+.+..|+.++||||||++++|+.+|+.||.... ....+....+..+..+...
T Consensus 225 VS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~ppP--- 300 (364)
T KOG0581|consen 225 VSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEPPP--- 300 (364)
T ss_pred ccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCCCC---
Confidence 99876543 46779999999999999999999999999999999999999998652 2223333333333332211
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.+ ... ....++..++..|+++||.+||+++|++++=
T Consensus 301 ---~l--P~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 301 ---RL--PEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred ---CC--Ccc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 11 111 2344566666799999999999999999853
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=397.67 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=214.6
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|.||+||+|+.. +.+.||||.+++.... +++|++|++++..+ +|||||+++|+|.+++.+++|+|
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCeeEEEEE
Confidence 577999999999999843 3567999999987543 67899999999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCC-----C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEee
Q 005693 462 YFASGSLSTLLHGNRGA-----G----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 532 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~-----~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 532 (682)
||..|||.+||+..... + ..+++..+.+.||.|||.||+||-++. +|||||..+|+||+++..|||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecc
Confidence 99999999999765421 1 334899999999999999999999987 99999999999999999999999
Q ss_pred cCCCCCCCCCCCCC------CCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 533 FGLTPLMNVPATPS------RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 533 fGla~~~~~~~~~~------~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
||+++.....+.+. -..+|||||.+..++++++||||||||+|||+++ |+.||.+...++.+.. ++
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~-------i~ 719 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC-------IR 719 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-------HH
Confidence 99997654433222 2457999999999999999999999999999999 9999998776654322 11
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
++. ...-.+.+..++..||..||+.+|++||+++||-..|+..-+..+.
T Consensus 720 ~g~----------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 720 AGQ----------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred cCC----------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 111 1233467888899999999999999999999999999988766543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=378.62 Aligned_cols=238 Identities=25% Similarity=0.462 Sum_probs=202.5
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+++||+|||+.||.++. ..|..||+|++.+.. ...+...+|+++.+++ +|||||+++++|++.++.|+|.|+|.
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEEEecC
Confidence 57899999999999997 779999999998743 2356688999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+++|.++++. ++++++.++..++.||+.||.|||+++ |+|||||..|++++++.++||+|||+|.....+
T Consensus 102 ~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 102 RGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred CccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999973 446999999999999999999999998 999999999999999999999999999887643
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.+.+|||.|+|||++....++..+||||+||+||-|+.|++||+.....+. ..++...++.. .
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~~Y~~---------P 238 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLNEYSM---------P 238 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhcCccc---------c
Confidence 467899999999999999999999999999999999999999985543222 22222222111 1
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+|+.++++.+|.+|||+++|+++
T Consensus 239 ---~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 ---SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222334566679999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=358.52 Aligned_cols=243 Identities=24% Similarity=0.402 Sum_probs=196.5
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc--------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.|-+|.. ++++.||||++.+... ...+.++|+++|+++ +|||||++.++|+..+..|+||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCceEEEE
Confidence 57899999999999985 4588999999975422 123467999999999 9999999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC---CCeEEeecCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTP 537 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~ 537 (682)
||++||+|.+.+-.+. .+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 256 E~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999997543 3777888999999999999999999 9999999999999876 678999999999
Q ss_pred CCCCC---CCCCCCCcccCccccccCCC---CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 538 LMNVP---ATPSRSAGYRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 538 ~~~~~---~~~~~~~~y~aPE~~~~~~~---~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
..... .+.+||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||.+...+. ...+++.+..+..
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----sl~eQI~~G~y~f- 401 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----SLKEQILKGRYAF- 401 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----cHHHHHhcCcccc-
Confidence 88643 46789999999999976653 347899999999999999999998654332 1122222222211
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+...+.++++.+++..||++|||++|++++
T Consensus 402 -------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 -------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 011112334455667779999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=355.13 Aligned_cols=192 Identities=27% Similarity=0.427 Sum_probs=171.9
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
+.||+|+||+||+|+++ ++.+||||.+...... .+-...|+.+++.+ +|||||+++++++.++..|+|||||+||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 44999999999999975 4788999999766432 34467899999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC------CCeEEeecCCCCCCC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD------LDGCISDFGLTPLMN 540 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~------~~~kl~DfGla~~~~ 540 (682)
||.++++... .+++..+..++.|+|.||++||+++ ||||||||.||||+.+ -.+||+|||+|+.+.
T Consensus 95 DLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 95 DLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999998543 4999999999999999999999998 9999999999999875 457999999999987
Q ss_pred CCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 005693 541 VPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 591 (682)
Q Consensus 541 ~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~ 591 (682)
... +.+|++-|||||++...+|+.|+|+||+|+++|+|++|+.||+..+..
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 543 668999999999999999999999999999999999999999865543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=341.67 Aligned_cols=238 Identities=24% Similarity=0.381 Sum_probs=196.0
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.++||+|+||+||.++.++ ++.+|+|++++... +.+....|..++.++ +||+||++...|++.+.+|+|+||+.
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEEeccC
Confidence 5789999999999999654 67799999987643 234577899999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
||+|..+|++.. .+++..+..++..|+.||.|||+++ ||||||||+|||||++|+++|+|||+++....
T Consensus 109 GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 109 GGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred CccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999997433 4899999999999999999999999 99999999999999999999999999986433
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
..+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||.+.+ ..++.+++..+... ...
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~~--------~~p 246 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKLP--------LPP 246 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcCC--------CCC
Confidence 235689999999999999999999999999999999999999998654 33344444444310 011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRP----NMDEVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~evl~ 653 (682)
...+.+. .+++.+.+..||++|. +++++.+
T Consensus 247 ~~ls~~a---rdll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 247 GYLSEEA---RDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ccCCHHH---HHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1133444 4555589999999995 4556544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=330.96 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=200.9
Q ss_pred hhccccccCeEEEEEEE-EcCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEE-EEEecCc-eEEEEee
Q 005693 389 SAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRA-YYYSKDE-KLLVYDY 462 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~-~~~~~~~-~~lV~e~ 462 (682)
+.++||+|.||+||++. ..++..+|.|.++-... ..++...|+.+++++ +|||||++++ .+.++.+ .+|||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHHHHHh
Confidence 35789999999999998 56788999999874332 245678899999999 9999999998 4444555 7899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK--FTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
+.+|||...++..+. .+..+++..+++++.|++.||+++|+.- ++ |+||||||.||+++.+|.+|++|||+++.+.
T Consensus 102 c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred hcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999987664 3556999999999999999999999842 44 9999999999999999999999999999887
Q ss_pred CCC----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 541 VPA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 541 ~~~----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
... +..|||.||+||.+.+..|+.|+||||+||++|||+.-.+||.+. ++.....++.... ...+.
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd-~~~~p--- 249 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGD-YPPLP--- 249 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCC-CCCCc---
Confidence 644 457999999999999999999999999999999999999999865 2333333333221 11111
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.+.....+..++..|+..||+.||+.-.+++.+
T Consensus 250 ------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 250 ------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 134556677888899999999999854444433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=326.80 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=199.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
..++|+|+||.||+++.++ |+.||||++.+...+ ++-..+|+++++++ +|+|+|.++++|......++|+||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEeeecch
Confidence 3679999999999999765 788999999876543 34578999999999 999999999999999999999999988
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 544 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 544 (682)
++.+-+..... .++.+...+++.|++.|+.|+|+++ +|||||||+|||++.+|.+|+||||.|+....+..
T Consensus 86 -TvL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 86 -TVLHELERYPN----GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred -HHHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 44444443332 3889999999999999999999998 99999999999999999999999999998875432
Q ss_pred ---CCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC--------hhHHHHHHhhhcc-ccc
Q 005693 545 ---PSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWVQSVVREEW-TAE 611 (682)
Q Consensus 545 ---~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~--------l~~~~~~~~~~~~-~~~ 611 (682)
+..|..|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+.+.-+... +...-++++..+. ...
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 346889999999987 679999999999999999999999998776443321 1111222222221 111
Q ss_pred cchhhhcccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 612 VFDVELMRFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 612 ~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
+.-+.....+ .++.....+++++..|++.||.+|++-+|++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111 12233446788999999999999999999886
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=366.67 Aligned_cols=249 Identities=26% Similarity=0.514 Sum_probs=214.3
Q ss_pred hccccccCeEEEEEEEEcC----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.++||.|.||+||+|+++- ...||||.+|.... .+.+|..|+.||.+. +||||++|.|+....+..+||+|||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEhhhh
Confidence 6799999999999999753 34699999987644 356899999999999 9999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
+||+|+.||+.+.+ .+++.+...|+.+||.||+||-+++ +|||||.++|||++.+..+||+|||+++......
T Consensus 713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999987654 3899999999999999999999998 9999999999999999999999999999875543
Q ss_pred -CCCC------CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 544 -TPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 544 -~~~~------~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.... ..+|.|||.+..++++.++||||||+||||.++ |..||++....+.+ +.+.+++
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-------kaIe~gy------- 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------KAIEQGY------- 851 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-------HHHHhcc-------
Confidence 2211 246999999999999999999999999999777 99999987655432 1222221
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
+.+...++...+.+||..||++|-.+||++.|++..|+++.+...
T Consensus 852 ---RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 852 ---RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ---CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 334456788899999999999999999999999999999986654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=347.73 Aligned_cols=239 Identities=20% Similarity=0.343 Sum_probs=198.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
++.||+|+|++|++|+.+ .++++|||++.+... ..+.+..|-++|.+|.+||.|++|+..|+++..+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 467999999999999955 578899999976532 224577888999999899999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.++|++.. .+++..+..++.+|+.|++|||+.| ||||||||+|||||+|+++||+|||.|+.+...
T Consensus 158 nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 158 NGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred CCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999998653 3999999999999999999999999 999999999999999999999999999876421
Q ss_pred ---------------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 005693 543 ---------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607 (682)
Q Consensus 543 ---------------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 607 (682)
....||..|++||++.+...+..+|+|||||++|+|+.|++||.+.++.-. .++
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------Fqk----- 298 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------FQK----- 298 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------HHH-----
Confidence 224578899999999999999999999999999999999999987653211 111
Q ss_pred cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 608 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+++.......++++. ..+|+.+.+..||.+|+|.+||.++
T Consensus 299 ----I~~l~y~fp~~fp~~---a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 ----IQALDYEFPEGFPED---ARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----HHHhcccCCCCCCHH---HHHHHHHHHccCccccccHHHHhhC
Confidence 222222223334444 4556669999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=380.91 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=211.1
Q ss_pred hccccccCeEEEEEEEEcC--C----ceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE--S----TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~--~----~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|.||.||.|.+.+ + ..||+|.++... ....+|.+|..+|+.+ +|||||+++|++.+....++++|
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcEEEeh
Confidence 6789999999999999754 3 248999998763 3457899999999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
||++|||..+|++.+.. ....++..+.+.++.|||+|+.||++++ +|||||.++|+||+....|||+|||+|+..
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhh
Confidence 99999999999876432 1345889999999999999999999997 999999999999999999999999999843
Q ss_pred CCC-CCCC-----CCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 540 NVP-ATPS-----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 540 ~~~-~~~~-----~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
... .... -...|||||.+..+.++.|+|||||||++||++| |..||.+....+... ......
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg----- 921 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG----- 921 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC-----
Confidence 322 2111 1346999999999999999999999999999999 899998765443211 011111
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
+...++.+...+.++|.+||+.+|++||++..+++.+.++.+....+
T Consensus 922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 33445667788899999999999999999999999999888665443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=345.88 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=207.5
Q ss_pred CCCCHHHHHHHhhccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC
Q 005693 378 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 454 (682)
Q Consensus 378 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 454 (682)
+.+..+++ ..++.||+|.||+||+|++. ..||||+++-.... .+.|+.|+.++++- +|.||+-+.|+|..+.
T Consensus 387 WeIp~~ev--~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 387 WEIPPEEV--LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPP 461 (678)
T ss_pred cccCHHHh--hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCc
Confidence 33444444 44789999999999999986 46999999765433 35799999999999 9999999999998877
Q ss_pred ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 455 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
. .||+.+|+|-+|+.+++..+ ..++..+.+.|+.|||+||.|||.++ |||||||..||++.++++|||+|||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred e-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 6 99999999999999998644 44888999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 535 LTPLMNVP------ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 535 la~~~~~~------~~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
++..-..- ....+...|||||++.. ..|++++||||||+|+|||+||..||.....+.++-.+ .
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-------G 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-------G 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------c
Confidence 98654321 12335567999999964 35899999999999999999999999954444332111 1
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.++.. .|. ......+.+++.+|+..||..++++||.+.+++..|+++....+
T Consensus 607 rG~l~--pd~----s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 607 RGYLM--PDL----SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred ccccC--ccc----hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 11100 111 11224556677788889999999999999999999999987543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.65 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=208.1
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.++||+|-||+|.++....+..||||.++.... ..++|.+|+++|.++ +|||||+++|+|..++..++|+|||++|+
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 789999999999999999889999999987644 347899999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCCC-
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS- 546 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~- 546 (682)
|.+++.+.... .+..+...+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||+++-+.....+.
T Consensus 622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999865422 1455677889999999999999987 9999999999999999999999999998655443332
Q ss_pred -----CCCcccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 547 -----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 547 -----~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
-..+|||+|.+.-+++++++|||+||+++||+++ ...||.....++. ++......+.....-+
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~------- 765 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVV------- 765 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCccee-------
Confidence 2467999999999999999999999999999887 7789986654432 2223333332221111
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
......+...+.+++.+||+.|.++||+++++...|.+.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122345666788999999999999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.16 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=197.3
Q ss_pred HhhccccccCeEEEEEEEEcC-CceEEEEEeeccccC-hhhHHHHHHHHHHhcCCCceeceEEEEEecC--ceEEEEeec
Q 005693 388 ASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYF 463 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~ 463 (682)
...+.||+|+||+||++...+ |...|||........ .+.+++|+.++.++ +|||||+++|.....+ ..++.|||+
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeeeecc
Confidence 346889999999999999765 788999998765222 35589999999999 6999999999865555 588999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCCCCC-
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNV- 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~- 541 (682)
++|+|.+++.+..+ .+++..+.++..||++||+|||++| |+||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred CCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999986543 4999999999999999999999998 999999999999999 79999999999876652
Q ss_pred ------CCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 542 ------PATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 542 ------~~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
.....||+.|||||++..+. ...++||||+||++.||+||+.||... .....+.-.+..+.....
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~--- 243 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPE--- 243 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCC---
Confidence 22356899999999998643 345899999999999999999999753 122233333333321111
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
....++++.. +++.+|+..+|++||||+|++++--...
T Consensus 244 ----ip~~ls~~a~---~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 244 ----IPDSLSDEAK---DFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ----CCcccCHHHH---HHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 1122344444 4555999999999999999999765444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=337.23 Aligned_cols=256 Identities=21% Similarity=0.367 Sum_probs=202.2
Q ss_pred hhccccccCeEEEEEEEE-cCCceEEEEEeeccccChhh--HHHHHHHHHHhcCCCceeceEEEEEecC-ceEEEEeecc
Q 005693 389 SAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVYDYFA 464 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~--~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~e~~~ 464 (682)
+.+.||.|.||+||+|+. ..+..||||+++......++ -.+|+..++++..||||+++.+++.+.+ .+++|||||+
T Consensus 14 ~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 14 VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 356799999999999995 45788999999987665444 4579999999955999999999999888 8999999997
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
. +|.++++.. ...+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+|+......
T Consensus 94 ~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 94 C-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred h-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCC
Confidence 5 999999854 456999999999999999999999999 9999999999999999999999999999876433
Q ss_pred --CCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhcccc-----cc
Q 005693 544 --TPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTA-----EV 612 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~~~-----~~ 612 (682)
.+..|..|+|||++. +..|+.+.||||+|||++|+.+-++-|.+..+.|. +.+.+.-+. .+.|.. ..
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq--i~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ--IYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH--HHHHHHHhCCCccccchhHHHHHHH
Confidence 344688899999985 45689999999999999999999999998764432 222222111 111111 11
Q ss_pred chhhhcc------ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 FDVELMR------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ~d~~l~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+...+.. ..-.+....+.++++.+|+..||.+|||++|++++
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111110 01123356677888899999999999999999984
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.58 Aligned_cols=255 Identities=17% Similarity=0.333 Sum_probs=203.7
Q ss_pred CCHHHHHHHhhccccccCeEEEEEEEEcCCceEEEEEeeccccCh----hhHHHHHHHHHHhcCCCceeceEEEEEe---
Q 005693 380 FDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYS--- 452 (682)
Q Consensus 380 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~~h~niv~l~~~~~~--- 452 (682)
++.+++.......||+|++|.||+|.+ +++.||+|+++...... +.+.+|+.++.++ +||||+++++++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVD 92 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEeccc
Confidence 455566444457899999999999998 48899999997654332 5677999999999 99999999999876
Q ss_pred -cCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEE
Q 005693 453 -KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCI 530 (682)
Q Consensus 453 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl 530 (682)
....++||||+++|+|.+++... ..+++....+++.|++.|+.|||+. + ++||||||+||++++++.+||
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEE
Confidence 34678999999999999999743 3488999999999999999999985 5 789999999999999999999
Q ss_pred eecCCCCCCCCCC-CCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 005693 531 SDFGLTPLMNVPA-TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607 (682)
Q Consensus 531 ~DfGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 607 (682)
+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..........
T Consensus 165 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~ 238 (283)
T PHA02988 165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKN 238 (283)
T ss_pred cccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcC
Confidence 9999988654432 3457888999999976 67899999999999999999999999854321 1122222111
Q ss_pred cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 608 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
.... .. ......+.+++.+||+.||++|||++|+++.|++++.
T Consensus 239 ~~~~-------~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 239 NSLK-------LP---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCC-------CC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1100 00 1233456778889999999999999999999998864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.32 Aligned_cols=239 Identities=22% Similarity=0.366 Sum_probs=198.3
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccChh-hHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKR-DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~-~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+.|.||.|.. ..++.||||++....+.++ -...|+.+++.. +|+|||+++..|...++.|.|||||++|+
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 46799999999999984 4578899999987766544 467899999998 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+.+... .+++.+...|+.++++||+|||.+| |+|||||.+|||++.+|.+||+|||++...... .
T Consensus 357 LTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 357 LTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred hhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 99999744 3899999999999999999999998 999999999999999999999999998766543 4
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
+..|||.|||||+.....|++|+||||||++++||+.|.+||-.+..- +.... +...- .+.++....+
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyL-Ia~ng-----~P~lk~~~kl 495 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYL-IATNG-----TPKLKNPEKL 495 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHH-HhhcC-----CCCcCCcccc
Confidence 567999999999999999999999999999999999999999753211 11111 11111 1222233333
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
+ ..+.++..+||+.|+++|+++.|+++
T Consensus 496 S---~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 496 S---PELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred C---HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3 44555556999999999999999998
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=341.38 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=197.8
Q ss_pred hhccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecC-ceEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLV 459 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV 459 (682)
..+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++..+.+||||+++++++...+ ..++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 3578999999999999742 245799999875432 23468889999999988999999999987654 57899
Q ss_pred EeeccCCchhHhhccCCCC---------------------------------------------------------CCCC
Q 005693 460 YDYFASGSLSTLLHGNRGA---------------------------------------------------------GRTP 482 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~~~ 482 (682)
|||+++|+|.+++...... ...+
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 9999999999999753210 0234
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC------CCCCCCcccCccc
Q 005693 483 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEV 556 (682)
Q Consensus 483 l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~ 556 (682)
+++.++..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...++..|+|||+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 788899999999999999999998 9999999999999999999999999997653221 1224567999999
Q ss_pred cccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHH
Q 005693 557 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGM 635 (682)
Q Consensus 557 ~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~ 635 (682)
+.+..++.++|||||||++|||++ |..||.+....+ . ......+..... ........+.+++.
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~-~~~~~~~~~~~~----------~~~~~~~~l~~li~ 311 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----E-FCQRLKDGTRMR----------APENATPEIYRIML 311 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----H-HHHHHhcCCCCC----------CCCCCCHHHHHHHH
Confidence 999899999999999999999997 999997643221 1 111111111000 01122345778888
Q ss_pred HcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 636 ACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 636 ~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
+||+.||++|||+.|+++.|+++.+.
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.18 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=204.1
Q ss_pred hccccccCeEEEEEEEEcCC----ce-EEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TT-VVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~-vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||+||+|+++.+ .. ||+|..+... ....+|.+|+++++++ +|||||+++|++..++..++||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCccEEEE
Confidence 48899999999999997542 23 8999988522 2356799999999998 9999999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
|+|+||+|.++|+++.+ .++..++.+++.++|.||+|||+++ ++||||.++|+|++.++.+||+|||+++...
T Consensus 241 El~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999987653 4899999999999999999999998 9999999999999999999999999987764
Q ss_pred CCCC----CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 541 VPAT----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 541 ~~~~----~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.-.. ..-...|+|||.+....|++++|||||||++||+++ |..||.+....+ ....+....+.....
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~kI~~~~~r~~~~-- 385 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKAKIVKNGYRMPIP-- 385 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHHHHHhcCccCCCC--
Confidence 2111 123467999999999999999999999999999999 888998765331 122222333322211
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
......+..++.+||..+|++||+|.++.+.++.+.....
T Consensus 386 --------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 386 --------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1233445566669999999999999999999999987655
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=309.20 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=202.9
Q ss_pred hhccccccCeEEEEEEEE-cCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 389 SAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.+.+|+|.||.||+|+. +.++.||||+++..... .....+|++.++.+ +|+||+.++++|...+...+|+|||+
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEEEEecc
Confidence 346799999999999995 46889999999876443 45678999999999 89999999999999999999999998
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
. ||...++.. ...++..+...++.++.+|++|||++. |+||||||.|+|++++|.+||+|||+|+....+..
T Consensus 85 t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 85 T-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred c-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 7 999999754 345899999999999999999999998 99999999999999999999999999998876543
Q ss_pred C----CCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---hhhcccc--ccch
Q 005693 545 P----SRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEWTA--EVFD 614 (682)
Q Consensus 545 ~----~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~---~~~~~~~--~~~d 614 (682)
. ..|..|+|||.+.+ +.|+..+||||.||++.||+-|.+-|.+.+.-|. +....+.. ..+.|.. ...|
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCcccccccc
Confidence 2 35778999999876 4589999999999999999999988887654332 21112111 1222221 1111
Q ss_pred hhh-------ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VEL-------MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l-------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..- ....-++.+....++++..++..||.+|+|+.|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 100 0111234455667899999999999999999999885
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=321.59 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=200.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhc-CCCceeceEEEEEecC----ceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKD----EKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~----~~~lV~e~~~ 464 (682)
.++||+|+||.||||++. ++.||||++... .++.|..|.++..... +|+||++++++-...+ +.+||+||.+
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 467999999999999987 589999999753 3567888888776532 7999999999987666 8899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------GPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
.|+|.++|..+ .++|.+.-+|+..+++||+|||+.. +|+|+|||||.+|||+.+|+.+.|+|||+|..
T Consensus 292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999854 3999999999999999999999743 57899999999999999999999999999977
Q ss_pred CCCCC------CCCCCCcccCccccccCCC------CCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-C----------C
Q 005693 539 MNVPA------TPSRSAGYRAPEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-V----------D 595 (682)
Q Consensus 539 ~~~~~------~~~~~~~y~aPE~~~~~~~------~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~-~----------~ 595 (682)
+.... ...||.+|||||++.+... -.+.||||+|.|+|||+++..-+......+. . .
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 65332 3568999999999976432 2368999999999999997655532111111 0 1
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
+.+-....++++ .+..+......+ ..+..+.+.+..||+.||+.|.|+.-|.+.+.++....+.
T Consensus 446 ~e~mq~~VV~kK-~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 446 LEEMQELVVRKK-QRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHHHhhc-cCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111222222 222222222222 4566778888999999999999999999999999877654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=330.84 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=196.1
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 463 (682)
.+.||+|.||.||+|+. .+|+.||+|++.-.... .....+|+.+++++ +||||+++.+...+. ...|+|+|||
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEEEEEecc
Confidence 36799999999999995 56888999999755422 34567899999999 999999999999877 6899999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++ ||.-++... ...+++.+++.++.|++.||+|||.+| |+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 201 dh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 201 DH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred cc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 88 999888642 334999999999999999999999999 9999999999999999999999999999876544
Q ss_pred CC-----CCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC-hhHHHHHHhhhcccc------
Q 005693 544 TP-----SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPRWVQSVVREEWTA------ 610 (682)
Q Consensus 544 ~~-----~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~-l~~~~~~~~~~~~~~------ 610 (682)
.. ..|..|+|||.+.+. .|+.++|+||.||||.||++|++.|.+.++-+.+. +.+.+.+.-.+.|..
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 22 247789999999875 58999999999999999999999999876433322 111111112222220
Q ss_pred ccchhhhccccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 611 EVFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 611 ~~~d~~l~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
..+.+.-.-... +.......++|+..+|..||++|.|+.++++
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 001100000001 1111233567777999999999999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.64 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=204.4
Q ss_pred CCCCHHHHHHHhhccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceE
Q 005693 378 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL 457 (682)
Q Consensus 378 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 457 (682)
+++.++++.. .+-||.|+-|.||+|+++ +..||||+++. .-+.+++-+++| +||||+.+.|+|...-.++
T Consensus 119 WeiPFe~IsE--LeWlGSGaQGAVF~Grl~-netVAVKKV~e------lkETdIKHLRkL-kH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 119 WEIPFEEISE--LEWLGSGAQGAVFLGRLH-NETVAVKKVRE------LKETDIKHLRKL-KHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred ccCCHHHhhh--hhhhccCcccceeeeecc-CceehhHHHhh------hhhhhHHHHHhc-cCcceeeEeeeecCCceeE
Confidence 4455555522 467999999999999987 67899999854 224567788898 9999999999999999999
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
||||||..|-|.++|+.. .++.....+.+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++
T Consensus 189 IiMEfCa~GqL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred EeeeccccccHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 999999999999999853 34778888999999999999999987 9999999999999999999999999987
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 538 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 538 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
..... ..+.||..|||||++.....++|+||||||||||||+||..||..-....++ | -+-
T Consensus 261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w------------GVG 324 (904)
T KOG4721|consen 261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W------------GVG 324 (904)
T ss_pred hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E------------ecc
Confidence 76543 3457899999999999999999999999999999999999999753321110 0 001
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.+.....-.+.+..-|.-|+++||+..|..||++.+++.+|+-....
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 11112333456666777788899999999999999999999865543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=339.84 Aligned_cols=241 Identities=25% Similarity=0.368 Sum_probs=201.8
Q ss_pred hhccccccCeEEEEEEEE-cCCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 389 SAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.++.||+|+.|.|-+|++ .+|+.+|||++.+.. .....+++|+.+|+.+ .||||++++++|++.+++|+|.||+
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEEEec
Confidence 367899999999999995 468999999997652 2345688999888887 9999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 542 (682)
++|.|++++-. +.++++.++++++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.....+
T Consensus 95 ~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 95 PGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred CCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999963 345999999999999999999999998 999999999999999999999999999876554
Q ss_pred --CCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 --ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
.+.+|++.|.|||++.+..| +.++||||.|||||-|+||+.||++.+ +...+.++.+..+
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~~G~f----------- 229 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQRGVF----------- 229 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCcc-----------
Confidence 47789999999999999998 678999999999999999999998432 2223333322221
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.-......+..+|+.+|+..||+.|.|++||+++-.
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 111233345566777999999999999999999654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=335.37 Aligned_cols=239 Identities=23% Similarity=0.380 Sum_probs=196.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecc----c--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEV----V--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|.||.|+.|... ++..||+|++... . ...+...+|+.+++++..||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 578999999999999854 5789999976553 1 12445678999999995599999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecCCCCCCC-
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMN- 540 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~- 540 (682)
+.+|+|.+++.. ...+.+.++.+++.|++.|++|||+.| |+||||||+|||++.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 102 CSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred cCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999985 234888999999999999999999998 9999999999999999 999999999998772
Q ss_pred ---CCCCCCCCCcccCccccccCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 541 ---VPATPSRSAGYRAPEVIETRK-HS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 541 ---~~~~~~~~~~y~aPE~~~~~~-~~-~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
...+.+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .+.....+......
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~~~~~------ 241 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRKGEFK------ 241 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhcCCcc------
Confidence 345678999999999999977 85 78999999999999999999998632 22222222222111
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
...... ...+.+++.+|+..+|.+|+|+.|++.
T Consensus 242 ---~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 242 ---IPSYLL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---CCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111110 345667777999999999999999995
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=311.55 Aligned_cols=192 Identities=22% Similarity=0.340 Sum_probs=173.1
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||.|+||.|.+++.+. |..+|+|++++... ..+...+|..+++.+ .||+++++++.+.+.+..|+||||++
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEEEEeccC
Confidence 5789999999999999764 67789999976532 124567788999999 79999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-C
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 543 (682)
||.|.+++++.. .+++..+..++.||+.|++|||+.+ |++|||||+|||+|.+|.+||+|||.|+..... .
T Consensus 128 GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 128 GGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred CccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 999999998543 4999999999999999999999998 999999999999999999999999999877654 4
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 590 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~ 590 (682)
+.+|||.|+|||++.+..|..++|+|||||++|||+.|.+||...++
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 67899999999999999999999999999999999999999986654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.78 Aligned_cols=232 Identities=25% Similarity=0.351 Sum_probs=193.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.++||+|.||.|+++..+. +..+|||++++... +-+....|.+|+..+.+||.++.++.+|+.+++.|.||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 5789999999999999765 56789999987743 224466788888888789999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC----
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN---- 540 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~---- 540 (682)
|||+..+.+. ..+++..+..++..|+.||+|||+++ |||||||.+|||||.+|.+||+|||+++..-
T Consensus 453 Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 453 GGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred CCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 9996555542 34999999999999999999999998 9999999999999999999999999997643
Q ss_pred CCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 541 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 541 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...+.+|||.|||||++.+..|+.++|+|||||+||||+.|..||.+.++++..+ +++.+...
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------sI~~d~~~----------- 586 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------SIVNDEVR----------- 586 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHhcCCCC-----------
Confidence 3356789999999999999999999999999999999999999999877655422 22222211
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNM 648 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 648 (682)
.+.....+.+.++.+.+..+|++|.-+
T Consensus 587 -yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 -YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111233455667779999999999866
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.45 Aligned_cols=239 Identities=24% Similarity=0.390 Sum_probs=191.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+-++ |..+|+|++++...- -+....|..+|... .+|+||+++..|++.+.+||||||++
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEEEecC
Confidence 5789999999999999654 778999999877542 24567788899886 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
|||+..+|.. ...|++..+..++.+++.|+.-||+.| +|||||||+|+|||..|++||+|||++.-...
T Consensus 225 GGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 225 GGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred CccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 9999999974 345999999999999999999999999 99999999999999999999999999832100
Q ss_pred ----------------------C--------------------------CCCCCCCcccCccccccCCCCCcchHHHHHH
Q 005693 542 ----------------------P--------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 573 (682)
Q Consensus 542 ----------------------~--------------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv 573 (682)
. ....|||.|||||++.+..|+..+|+||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 0123688899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCC-CChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 005693 574 LLLEMLTGKAPLQSPTRDDM-VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MD 649 (682)
Q Consensus 574 vl~elltg~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ 649 (682)
|||||+.|.+||.+.+..+. ..+..|-..+... ...... .+..++|.+|+. ||++|.- ++
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------------~~~~~s---~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP------------EEVDLS---DEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------------CcCccc---HHHHHHHHHHhc-CHHHhcCcccHH
Confidence 99999999999998776543 2233333221110 111122 344566668888 9999975 66
Q ss_pred HHHH
Q 005693 650 EVVR 653 (682)
Q Consensus 650 evl~ 653 (682)
||.+
T Consensus 441 EIK~ 444 (550)
T KOG0605|consen 441 EIKK 444 (550)
T ss_pred HHhc
Confidence 6655
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.41 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=214.1
Q ss_pred CCCHHHHHHHhhccccccCeEEEEEEEEcC---C--ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEE
Q 005693 379 NFDLEDLLRASAEVLGKGSYGTAYKAVLEE---S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY 451 (682)
Q Consensus 379 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 451 (682)
+|.+..-.....++||.|.||.||+|.+.+ | -.||||.-+.... +.+.|.+|..+++++ +||||++++|+|.
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~ 461 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCV 461 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeee
Confidence 344444344568899999999999999643 2 2478888776432 356799999999999 9999999999996
Q ss_pred ecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEe
Q 005693 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 531 (682)
Q Consensus 452 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 531 (682)
+ ...++|||.++-|.|.++++.++. .++......++.||+.||+|||+.. +|||||.++|||+....-+|++
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeec
Confidence 5 578999999999999999987654 3888999999999999999999987 9999999999999999999999
Q ss_pred ecCCCCCCCCCCCCCCC-----CcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 532 DFGLTPLMNVPATPSRS-----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 532 DfGla~~~~~~~~~~~~-----~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
|||+++.+.....+..+ ..|||||.+.-++++.++|||.|||.+||++. |..||.+-...+.+... .
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------E 606 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------E 606 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------c
Confidence 99999998776544433 35999999999999999999999999999888 99999987665543210 0
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.-.+.+-.+.+...+..++.+||.++|.+||.+.|+...|.++.+.+.
T Consensus 607 ----------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 607 ----------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred ----------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 011333456677888899999999999999999999999999887443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=344.35 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=205.2
Q ss_pred HhhccccccCeEEEEEEEEcCC-ceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEE-EEe------cCceEE
Q 005693 388 ASAEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAY-YYS------KDEKLL 458 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~-~~~------~~~~~l 458 (682)
...+.|.+|||+.||.|....+ ..+|+|++-.... .-+..++|++++++|..|+|||.+++. ... ..+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3457899999999999998776 9999999876532 245688999999999889999999993 321 236789
Q ss_pred EEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
.||||.||.|-+++..... ..|++.++++|+.|+++|+++||... |||||||||.|||||+.++..||||||.|..
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred ehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 9999999999999985442 23999999999999999999999985 8899999999999999999999999998865
Q ss_pred CCCCC-------------CCCCCCcccCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH
Q 005693 539 MNVPA-------------TPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 602 (682)
Q Consensus 539 ~~~~~-------------~~~~~~~y~aPE~~---~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~ 602 (682)
.-... ....|+.|+|||++ .+...++|+|||||||+||-|+....||+....-.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------- 265 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------- 265 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----------
Confidence 33222 12358889999987 46678999999999999999999999998653221
Q ss_pred HhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 603 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 603 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
|++... .+...+.....+.+||..||+.+|.+||++.+|+..+-++......
T Consensus 266 ---------Ilng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 266 ---------ILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ---------EEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 122111 2223356677788888899999999999999999999988865544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=327.10 Aligned_cols=237 Identities=22% Similarity=0.384 Sum_probs=198.4
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChh---hHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKR---DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~---~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|.||.||||+-+. .+.||+|.+.+....++ ...+|+++++++ +|||||.++++|+...+.++|+||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEehhhhh
Confidence 4679999999999999664 56789999877655443 477899999999 999999999999999999999999977
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+|..++.... .++++.+..++.+++.||.|||+.+ |+|||+||.|||++..+.+|++|||+|+.+....
T Consensus 86 -~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 86 -DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred -hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9999997543 3999999999999999999999998 9999999999999999999999999999887654
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...|||-|||||...++.|+..+|+||+||++|||++|++||-... +...+..+..+... .
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v~---------~-- 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPVK---------P-- 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCCC---------C--
Confidence 3468999999999999999999999999999999999999997432 22233333333211 1
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+..++...+.+||.+|.|..+++.+
T Consensus 220 -p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 -PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12334455666669999999999999999873
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=333.55 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=214.1
Q ss_pred hhccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 389 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
+..+||-|.||.||.|.|+. .-.||||.++.....-++|..|..+|+.+ +|||+|+++|+|..+-..|||+|||..|+
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 46789999999999999876 45799999999888889999999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-- 545 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~-- 545 (682)
|.++|+... +..++.-..+.|+.||+.||+||..+. +|||||.++|+|+.++..+||+|||+++.+......
T Consensus 350 LLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 350 LLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred HHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 999998765 344777788999999999999999987 999999999999999999999999999998654322
Q ss_pred ---CCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 546 ---SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 546 ---~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
.-...|.|||.+....++.|+|||+|||+|||+.| |-.||.+...... ..++...+. -.
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-------Y~LLEkgyR----------M~ 486 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YGLLEKGYR----------MD 486 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-------HHHHhcccc----------cc
Confidence 22456999999999999999999999999999999 8899986542221 122222221 22
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
..+.|...+.+||+.||+..|.+||+++|+-+.++.|....+
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 345677788999999999999999999999999998875543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.16 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=195.9
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||.|..++||+|+. ..+..||||++...... -+.+.+|+..++.+ +||||++++..|..+..+|+||.||.+|
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeehhhcCC
Confidence 47899999999999994 45788999999765443 36788899998888 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
++.++++..-.. .+++..+..|..++++||.|||++| .||||+|+.||||+++|.|||+|||.+..+...
T Consensus 110 S~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 110 SLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999865433 3899999999999999999999999 999999999999999999999999976544322
Q ss_pred ----CCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc--cch
Q 005693 543 ----ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE--VFD 614 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~--~~d 614 (682)
.+..+++.|||||++.. ..|+.|+||||||++..||.+|..||....+.++ ....+-....... ..+
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----Ll~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----LLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----HHHHhcCCCCCcccccCC
Confidence 34468999999999644 4589999999999999999999999985432221 0111111111100 011
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
. .......+.+.+++..|+++||++|||++++++
T Consensus 259 ~-----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 K-----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred h-----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1 011122336778888999999999999999987
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.46 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=194.7
Q ss_pred hccccccCeEEEEEEEEcC-----------------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY 450 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 450 (682)
.+.||+|+||.||++.+++ +..||+|.+..... ...++.+|++++.++ +||||+++++++
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 88 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVC 88 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEE
Confidence 4679999999999998542 23689998875432 245788999999999 999999999999
Q ss_pred EecCceEEEEeeccCCchhHhhccCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 005693 451 YSKDEKLLVYDYFASGSLSTLLHGNRG--------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 516 (682)
Q Consensus 451 ~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk 516 (682)
.+.+..++||||+++|+|.+++..... .....+++..+.+++.|++.||+|||+.+ |+|||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlk 165 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLA 165 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcc
Confidence 999999999999999999999864321 11234788999999999999999999998 9999999
Q ss_pred CCCeEecCCCCeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 005693 517 ASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSP 588 (682)
Q Consensus 517 ~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--g~~Pf~~~ 588 (682)
|+||++++++.+||+|||+++...... ...++..|+|||++....++.++||||||+++|||++ +..||...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999999999999999987653322 2234667999999988889999999999999999997 55677654
Q ss_pred CCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 589 TRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 589 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
...+ .............. ... ......+...+.+++.+||+.+|++|||++|+.+.|++
T Consensus 246 ~~~~---~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 TDEQ---VIENAGEFFRDQGR-QVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CHHH---HHHHHHHHhhhccc-ccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 3221 11222211111100 000 00111234567888899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.20 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=201.0
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHh-cCCCceeceEEEEEecC----ceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSKD----EKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~~----~~~lV~e~~~ 464 (682)
.+.||+|.||+||+|.+. |..||||++... +++.+.+|.++++.+ .+|+||..+++.-..++ +++||++|.+
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 578999999999999998 788999999754 356788888887643 39999999998865433 6799999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-----MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-----~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+|+|+|+|.. ..++.+..++++..+|.||+|||. +|+|.|+|||||+.|||+..++.+.|+|+|+|-..
T Consensus 293 ~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 293 HGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred CCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 9999999974 349999999999999999999994 67899999999999999999999999999999654
Q ss_pred CCC--------CCCCCCCcccCccccccCC------CCCcchHHHHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 005693 540 NVP--------ATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTG----------KAPLQSPTRDDMVD 595 (682)
Q Consensus 540 ~~~--------~~~~~~~~y~aPE~~~~~~------~~~~sDvwS~Gvvl~elltg----------~~Pf~~~~~~~~~~ 595 (682)
... ....||-+|||||++...- .-..+||||||.|+||+.-+ +.||.+....+..
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs- 445 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS- 445 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-
Confidence 332 2456899999999996532 12458999999999998873 4566543322210
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.+-.+..+-.. ...+.....-...+++..+.++|+.||..+|.-|-|+-.+-+.|.++.+..+
T Consensus 446 -~eeMrkVVCv~----~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 446 -FEEMRKVVCVQ----KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred -HHHHhcceeec----ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 00111111111 1222333333456788999999999999999999999999999999986443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.88 Aligned_cols=238 Identities=22% Similarity=0.352 Sum_probs=186.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++..+ +|+||+++++++..++..++||||+++|
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 578999999999999965 578999999865432 245688999999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 986533 2567788899999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 543 ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
....++..|+|||++.. ...+.++|||||||++|||++|+.||......+. ........... .
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~-~-------- 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMSQ-P-------- 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhccC-C--------
Confidence 23457889999998853 2235689999999999999999999974332221 11111110000 0
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..........+.+++.+||+.||++||+++|++++
T Consensus 294 --~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 --PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111233456778889999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.09 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=197.0
Q ss_pred hhccccccCeEEEEEEEE------cCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 389 SAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
..+.||+|+||.||+|.. ..+..||+|+++.... ..+.+.+|++++..+.+||||+++++++...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 368899999999999973 2355799999875432 24568889999999988999999999999999999999
Q ss_pred eeccCCchhHhhccCCCC--------------------------------------------------------------
Q 005693 461 DYFASGSLSTLLHGNRGA-------------------------------------------------------------- 478 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~-------------------------------------------------------------- 478 (682)
||+++|+|.++++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999999643210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC------
Q 005693 479 --------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT------ 544 (682)
Q Consensus 479 --------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~------ 544 (682)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 0124788999999999999999999988 99999999999999999999999999876543221
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++.+..++.++|||||||++|||++ |..||....... . ......+..... ..
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~-------~~--- 339 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRML-------SP--- 339 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccCC-------CC---
Confidence 223456999999999999999999999999999998 888987543211 1 111111111100 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
......+.+++.+||+.||++||+++|+++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11234577888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.20 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=193.2
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||++.. .+++.||+|.+..... ....+.+|++++.++ +|+||+++++++.+++..++||||++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEEecC
Confidence 36799999999999996 4678999999865432 234577899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 84 ~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 84 GGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999998885422 234889999999999999999999998 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...++..|+|||++.+..++.++|||||||++|||++|+.||......... .......... ......
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~--------~~~~~~ 226 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKED--------QEEYSE 226 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcc--------cccCCc
Confidence 345788999999999999999999999999999999999999865432111 1111111100 000011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
.....+.+++.+||+.||++||+ ++|++++
T Consensus 227 ---~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 227 ---KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 12335667778999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.18 Aligned_cols=241 Identities=24% Similarity=0.401 Sum_probs=197.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||++..+++..+|+|.++......+++.+|+++++++ +||||+++++++..++..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 467999999999999998888899999876655677899999999999 8999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-----
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----- 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 544 (682)
++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++.......
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 88 NYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9987432 24889999999999999999999998 99999999999999999999999999876533221
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++.+..++.++||||||+++|||++ |+.||..... ............. .. .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~~~---~~--------~ 223 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGFRL---YR--------P 223 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCCC---CC--------C
Confidence 123457999999988889999999999999999999 8999975432 1112222111110 00 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
......+.+++.+||+.+|++||+++|+++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11234577888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.67 Aligned_cols=242 Identities=21% Similarity=0.362 Sum_probs=203.4
Q ss_pred HhhccccccCeEEEEEEEE-cCCceEEEEEeeccccC-hh---hHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 388 ASAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG-KR---DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~---~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
+..+.||+|.||.|-+|.. ..|+.||||.+++.... ++ .+.+|++++..+ +||||+.++.+|++.+...+||||
T Consensus 56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEEEe
Confidence 3457799999999999985 67999999999766442 32 478899999999 999999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
..+|+|++++... ..+++.++..++.||..|+.|+|.++ ++|||||.+|||+|+++++||+|||++-.+...
T Consensus 135 aS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 135 ASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred cCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999753 34999999999999999999999998 999999999999999999999999999877654
Q ss_pred C---CCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 A---TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 ~---~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
. +++|++-|.+||++.+..| ++.+|-||+||+||.|+.|..||++.. .-..++++....+..
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~GaYrE-------- 272 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRGAYRE-------- 272 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhcccccC--------
Confidence 3 6789999999999999998 678999999999999999999998643 333344443333221
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
.... ....-||++|+..+|++|-|+++|..+.+-
T Consensus 273 -P~~P----SdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 273 -PETP----SDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -CCCC----chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 1111 223346679999999999999999998874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=321.41 Aligned_cols=238 Identities=25% Similarity=0.414 Sum_probs=196.4
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
+.||+|.||.||+|.... ++.||+|++.-... ..++.++|+.++..+ +++||.++++.|..+..++++|||+.||+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 679999999999999654 67789999876543 346789999999999 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----CC
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PA 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----~~ 543 (682)
+.+.+... ..+++....-++.++..|+.|||.++ .+|||||+.|||+..+|.+|++|||++..+.. ..
T Consensus 98 v~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 98 VLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999743 23578888889999999999999998 99999999999999999999999999876643 35
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
+..||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.....+ +.+. ..+.+ .+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------Ipk~-----~PP~L---~~- 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------IPKS-----APPRL---DG- 233 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------ccCC-----CCCcc---cc-
Confidence 67899999999999988999999999999999999999999986544222110 0111 01111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++..|++++|+.||++.+++++
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 333446677779999999999999999873
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.43 Aligned_cols=237 Identities=20% Similarity=0.288 Sum_probs=191.1
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+++.+ +++.+|+|+++.... ....+.+|++++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 578899999975432 124567788999998 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 9999998743 24889999999999999999999998 999999999999999999999999998754221
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..+.. . ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~-------~--~p~ 216 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI-------R--FPR 216 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCCC-------C--CCC
Confidence 2345789999999999999999999999999999999999999754311 11111111110 0 011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
.....+.+++.+||+.||++|| ++++++++
T Consensus 217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 ---TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1233456777799999999999 79999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=331.25 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=196.8
Q ss_pred hhccccccCeEEEEEEEEc------CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
..+.||+|+||.||+|... ++..||+|+++..... ...+.+|+++++.+.+|+||+++++++......++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 4688999999999998742 2347999999754322 3457889999999878999999999999999999999
Q ss_pred eeccCCchhHhhccCCC---------------------------------------------------------------
Q 005693 461 DYFASGSLSTLLHGNRG--------------------------------------------------------------- 477 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~--------------------------------------------------------------- 477 (682)
||+++|+|.++++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999999864211
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC------CCCCC
Q 005693 478 --AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT------PSRSA 549 (682)
Q Consensus 478 --~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~------~~~~~ 549 (682)
.....+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..++.
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 01124788999999999999999999998 99999999999999999999999999876543221 12345
Q ss_pred cccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHH
Q 005693 550 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV 628 (682)
Q Consensus 550 ~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 628 (682)
.|+|||++.+..++.++|||||||++|||++ |+.||........ ............ ... ....
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~~-------~~~---~~~~ 342 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQMS-------RPD---FAPP 342 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCcc-------CCC---CCCH
Confidence 7999999998899999999999999999997 9999975432110 111111111000 000 1124
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 629 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 629 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
.+.+++.+||+.||++|||++++++.|+++.
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 5677888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=303.25 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=193.7
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~ 463 (682)
.+.|++|.||.||+|+.+. +..||+|+++-.... .-.-.+|+.++.+. +|||||.+-.+... -+..|+|||||
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceeeeeHHHH
Confidence 4789999999999999764 567899999754321 12357899999999 89999999888763 45789999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
+. ||.+++...+ +++...++..++.|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.++.+.
T Consensus 160 Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 160 EH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred Hh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 87 9999998643 46899999999999999999999998 9999999999999999999999999999998774
Q ss_pred CC----CCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--hhccccccchh-
Q 005693 544 TP----SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV--REEWTAEVFDV- 615 (682)
Q Consensus 544 ~~----~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~--~~~~~~~~~d~- 615 (682)
.. ..|..|+|||.+.+. .|+++.|+||+|||+.||+++++-|.+..+-+..+ +.++-.- .+.........
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~--~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD--KIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH--HHHHHhCCCccccCCCccccc
Confidence 32 357889999999875 58999999999999999999999999876544322 2221110 11100000000
Q ss_pred -------------hh-ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 616 -------------EL-MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 616 -------------~l-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+ +.+.... ....-.+++...+..||.+|.|++|.+++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 0111111 11344566779999999999999999884
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.27 Aligned_cols=245 Identities=27% Similarity=0.444 Sum_probs=199.7
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|...+++.||+|.+.......+.+.+|+.+++.+ +|+||+++++++...+..++||||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 578999999999999988888999999876555567889999999999 8999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-----
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----- 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 544 (682)
++++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 90 ~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 90 DFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 9997532 234788999999999999999999987 99999999999999999999999999976643221
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++....++.++|||||||++|||+| |+.||......+ ........+.. ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~----------~~~ 226 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRM----------PRM 226 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC----------CCC
Confidence 123457999999988889999999999999999998 999997543211 11111111110 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
......+.+++.+|++.+|++||+++++.+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 12234567788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=324.30 Aligned_cols=245 Identities=19% Similarity=0.292 Sum_probs=192.6
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+++.. +++.||+|+++.... ..+.+..|..++..+.+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999975 467899999976432 1234778888888887899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 541 (682)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 9999888643 24899999999999999999999998 99999999999999999999999999865321
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC--CCChhHHHHHHhhhccccccchhhhcc
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD--MVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ......+......+... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--------RI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--------CC
Confidence 223457889999999999999999999999999999999999997433222 11122222222221110 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPN------MDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~~ 654 (682)
... ....+.+++.+|++.||.+||+ ++|++++
T Consensus 225 p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRS---LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111 2234567778999999999997 6777753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.37 Aligned_cols=244 Identities=24% Similarity=0.426 Sum_probs=194.9
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|.++ .+..||+|.++..... ...+.+|+.++.++ +||||+++++++..++..++||||+
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEEEEEeC
Confidence 578999999999999864 3567999998765322 34688899999998 9999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++++|||.+.......
T Consensus 89 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 89 SNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999876542221
Q ss_pred -----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 -----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
...++..|+|||++.+..++.++|||||||++||+++ |+.||......+ .... ..+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~-~~~~~~-------- 226 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKA-VEDGFR-------- 226 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHH-HHCCCC--------
Confidence 1123467999999999999999999999999999875 999997543211 1111 111110
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
..........+.+++.+||+.+|++||+++|+.+.|+.+
T Consensus 227 --~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 --LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011122345577788899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=316.59 Aligned_cols=247 Identities=27% Similarity=0.478 Sum_probs=197.0
Q ss_pred hccccccCeEEEEEEEEcCC------ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|..... ..+++|.++.... ...++.+|++++.++ +||||+++++++...+..+++||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCceEEEEe
Confidence 57799999999999986432 4689998865432 235688999999998 99999999999999899999999
Q ss_pred eccCCchhHhhccCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEE
Q 005693 462 YFASGSLSTLLHGNRGAG-----------RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 530 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 530 (682)
|+++|+|.+++....... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEE
Confidence 999999999997543211 145889999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 005693 531 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 603 (682)
Q Consensus 531 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~ 603 (682)
+|||+++...... ...+++.|+|||.+....++.++|||||||++|||++ |..||.+....+ + ...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~---~~~- 238 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V---IEM- 238 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHH-
Confidence 9999987543221 2234677999999988899999999999999999998 999997543221 1 111
Q ss_pred hhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 604 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
+...... .........+.+++.+||+.+|.+||+++|++++|+.
T Consensus 239 i~~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111110 0112344567788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=315.22 Aligned_cols=242 Identities=29% Similarity=0.520 Sum_probs=188.2
Q ss_pred hccccccCeEEEEEEEEc-----CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||.|.||.||+|.+. .+..|+||.++.... ..+++.+|++.+.++ +||||++++|++...+..++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccccccccccccc
Confidence 467999999999999987 256799999965432 246789999999999 999999999999988889999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ...+++..+..|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999998652 234899999999999999999999987 999999999999999999999999998776322
Q ss_pred ------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 ------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
........|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~~~~~~~-~~---- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEKLKQGQR-LP---- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHHHHTTEE-TT----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccc-ce----
Confidence 12224567999999999889999999999999999999 678886432 2222223221111 11
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
........+.+++.+||+.+|++||+++++++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112344567788899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=322.34 Aligned_cols=235 Identities=20% Similarity=0.302 Sum_probs=188.7
Q ss_pred ccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 393 LGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
||+|+||.||+|...+ ++.||+|+++... .....+.+|++++.++ +||||+++++++..++..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 7999999999999764 6789999987542 1234577899999998 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 80 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 80 LFHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 99999743 24899999999999999999999998 999999999999999999999999998754221 2
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...|++.|+|||++.+..++.++|||||||++|||++|+.||.... ............. .....
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~~---------~~~~~- 215 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEPL---------RFPDG- 215 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCCC---------CCCCc-
Confidence 3457889999999999999999999999999999999999997543 1222222222111 01111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 654 (682)
....+.+++.+||+.||++||+ +.|++.+
T Consensus 216 --~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 --FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred --CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 2234567778999999999985 5666653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.66 Aligned_cols=245 Identities=26% Similarity=0.436 Sum_probs=200.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|..++++.||+|.++......+++.+|++++.++ +|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 478999999999999988888899999976655667899999999999 8999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC--CCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSR 547 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~--~~~ 547 (682)
+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.+||+|||+++....... ..+
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 9997533 234899999999999999999999998 99999999999999999999999999876543221 112
Q ss_pred ---CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 548 ---SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 548 ---~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
+..|+|||++.+..++.++||||||+++|||+| |+.||.+....+ ... ........ ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~-~~~~~~~~----------~~~ 226 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQ-QVDQGYRM----------PCP 226 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHH-HHHcCCCC----------CCC
Confidence 346999999998899999999999999999999 999997543211 111 11111100 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
......+.+++.+|++.+|++||+++++++.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 12345677888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=319.47 Aligned_cols=238 Identities=17% Similarity=0.239 Sum_probs=193.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.+|+|++..... ..+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 467999999999999976 578899999865321 234678899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 85 GGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence 99999999743 24889999999999999999999998 9999999999999999999999999987664432
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+..... .....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~---------~~~~~- 220 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAGKL---------EFPRH- 220 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCc---------CCCcc-
Confidence 345788999999999988999999999999999999999999754321 11122211110 00011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
....+.+++.+|++.||.+||+ ++|++++
T Consensus 221 --~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 --LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1234567788999999999995 8888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.67 Aligned_cols=237 Identities=21% Similarity=0.301 Sum_probs=191.1
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+++.. +++.||+|++..... ....+.+|+++++.+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999965 578899999975432 234577888999988 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 80 GELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 9999888643 24899999999999999999999998 999999999999999999999999998754321
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||...... ........... . ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~~-------~--~p~ 216 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEDI-------K--FPR 216 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCCc-------c--CCC
Confidence 2345788999999999889999999999999999999999999754321 11111111110 0 011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
. ....+.+++.+|++.||++|| +++|++++
T Consensus 217 ~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 T---LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred C---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1 223456777799999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.07 Aligned_cols=245 Identities=19% Similarity=0.295 Sum_probs=191.2
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+++.. +++.+|+|+++.... ..+.+.+|+.++.++.+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 467899999976432 1234667888888877899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 541 (682)
|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 9999888643 24899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC--CChhHHHHHHhhhccccccchhhhcc
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--VDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+. .....+.......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~~ 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------RI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------CC
Confidence 1234578899999999999999999999999999999999999964322211 1112222222211110 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPN------MDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~~ 654 (682)
. ......+.+++.+||+.||++||+ +++++++
T Consensus 225 p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 P---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1 112334567788999999999998 4677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.39 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=204.9
Q ss_pred CCHHHHHHHhhccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecC
Q 005693 380 FDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 454 (682)
Q Consensus 380 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 454 (682)
++++++ ..++.||+|-||.||.|+.+. +..||+|++.+.+. -+.++.+|+++-..+ +||||.+++++|.++.
T Consensus 19 ~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 19 WTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSK 95 (281)
T ss_pred cchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccc
Confidence 444444 347899999999999999764 56799999977643 356788999999999 9999999999999999
Q ss_pred ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 455 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
..|+++||..+|++...|+..+. ..+++.....++.|+|.|+.|+|..+ |+||||||+|+|++.++..|++|||
T Consensus 96 riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred eeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCC
Confidence 99999999999999999985442 34888899999999999999999987 9999999999999999999999999
Q ss_pred CCCCCC--CCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 535 LTPLMN--VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 535 la~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
-+.... ...+.+||..|.+||...+..++..+|+|++|++.||++.|.+||.....++.. +++.+ .++
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY------krI~k----~~~ 239 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY------KRIRK----VDL 239 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH------HHHHH----ccc
Confidence 875543 345678999999999999999999999999999999999999999876533221 11111 011
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.+ . +.......+++.+|+..+|.+|.+..|++++-.
T Consensus 240 ~~-----p---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 240 KF-----P---STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred cC-----C---cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11 1 223345567778999999999999999998754
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.81 Aligned_cols=245 Identities=20% Similarity=0.289 Sum_probs=193.2
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||+||+++.. +++.+|+|+++.... ..+.+.+|+.++.++.+|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 467899999976432 1235778888888887899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 541 (682)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 9999888643 24899999999999999999999998 99999999999999999999999999875321
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.............+.......... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~p~ 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--------RIPR 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--------CCCC
Confidence 12345788999999999999999999999999999999999999754433332322333322222110 0011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 654 (682)
. ....+.+++.+|++.||++|+++ +++.++
T Consensus 225 ~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 F---LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred C---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1 12345677789999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.39 Aligned_cols=191 Identities=22% Similarity=0.370 Sum_probs=166.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+++.. ++..+|+|.+..... ..+.+.+|++++.++ +||||+++++++..++..++||||+++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 467999999999999976 466788888765422 235688999999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--CC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT 544 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 544 (682)
+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+||++++++.+||+|||++...... ..
T Consensus 89 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (331)
T cd06649 89 SLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (331)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence 999999743 24889999999999999999999853 3999999999999999999999999998765432 23
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 588 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~ 588 (682)
..++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 45788999999999989999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.25 Aligned_cols=237 Identities=21% Similarity=0.283 Sum_probs=190.4
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+++.. +++.||+|+++.... ....+.+|++++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999965 578899999976422 223566788999998 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 80 GELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 9999888643 24899999999999999999999998 999999999999999999999999998753221
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ .......... ....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~~---------~~p~ 216 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEI---------RFPR 216 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCC---------CCCC
Confidence 23457889999999999899999999999999999999999997543211 1111111110 0011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
. ....+.+++.+||+.||++|| ++.+++++
T Consensus 217 ~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 T---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C---CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1 223456777799999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=323.50 Aligned_cols=238 Identities=20% Similarity=0.269 Sum_probs=193.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 578999999999999976 477899999875421 234678899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 102 GGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred CChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999743 24788999999999999999999998 9999999999999999999999999997664432
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+..... ......
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~---------~~p~~~ 238 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGRL---------KFPNWF 238 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCc---------CCCCCC
Confidence 346888999999999999999999999999999999999999754311 11111111110 001111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
...+.+++.+||+.||++||+ +++++.+
T Consensus 239 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 ---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 234567778999999999997 6888765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.11 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=199.0
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|..++ ++.+++|.++.......++.+|++++.++ +|+||+++++++..+...++||||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 4679999999999999654 77899999876555566788999999998 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 544 (682)
.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 90 LDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred HHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 99996532 234899999999999999999999998 99999999999999999999999999877654321
Q ss_pred -CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 545 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 545 -~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...+..|+|||++.+..++.++|||||||++|||++ |..||.+.... ....... ..... ..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~-~~~~~----------~~ 226 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLE-KGYRM----------ER 226 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH-CCCCC----------CC
Confidence 123457999999998899999999999999999998 99998754321 1111111 11100 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112234577788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.55 Aligned_cols=256 Identities=20% Similarity=0.309 Sum_probs=189.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|..+ ++..||+|+++.... ....+.+|++++.++ +||||+++++++..++..++||||+++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~- 87 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDS- 87 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence 467999999999999965 577899999865432 234677899999999 999999999999999999999999975
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 88 DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 9998886432 24788999999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH-HHHHHhhhcccc--------cc
Q 005693 543 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR-WVQSVVREEWTA--------EV 612 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~-~~~~~~~~~~~~--------~~ 612 (682)
....+++.|+|||++.+ ..++.++||||+||++|||+||+.||.+....+...... .......+.|.. ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 22346788999999865 568999999999999999999999997654322111000 000000000000 00
Q ss_pred chhhhcccc---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 FDVELMRFQ---NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ~d~~l~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+...... ..........+++.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 000112346678889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.69 Aligned_cols=256 Identities=17% Similarity=0.234 Sum_probs=192.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+++.+ +++.+|+|+++.... ..+.+.+|++++..+ +|+||+++++++..++..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEEecCCC
Confidence 467999999999999976 467899999875432 235678899999998 999999999999999999999999998
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 85 NMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 777655432 224889999999999999999999998 9999999999999999999999999997754322
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC-hhH--------HHHHHhhhccccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPR--------WVQSVVREEWTAE 611 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~-l~~--------~~~~~~~~~~~~~ 611 (682)
...+++.|+|||++.+..++.++|||||||++|||++|+.||......+... +.. +............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 2346888999999998889999999999999999999999998653221100 000 0000000000000
Q ss_pred cchhhhccccC-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDVELMRFQN-----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+....... .......+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 01123457888899999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.57 Aligned_cols=237 Identities=24% Similarity=0.358 Sum_probs=189.7
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||+||+|+.+ +++.||+|+++.... ..+.+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 467899999875421 2345667888888776899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 541 (682)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 99999887432 4889999999999999999999998 99999999999999999999999999875422
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~---------~~~ 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEVV---------YPT 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCCC---------CCC
Confidence 12345788999999999989999999999999999999999999754321 112222211100 011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR 653 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~ 653 (682)
. ....+.+++.+|++.||++||++ +++++
T Consensus 218 ~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 218 W---LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred C---CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 1 22345677789999999999998 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=324.48 Aligned_cols=246 Identities=19% Similarity=0.285 Sum_probs=195.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+..+ ++.||+|+++.... ..+.+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 4679999999999999764 78899999975432 234577899999998 79999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-CC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-PA 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-~~ 543 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ..
T Consensus 85 g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 85 GGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence 99999999643 24889999999999999999999998 99999999999999999999999999976544 23
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.... .....+.. ....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~--~~~~~~~~--~~~~ 226 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWK--ETLQRPVY--DDPR 226 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhcc--ccccCCCC--Cccc
Confidence 45688999999999999999999999999999999999999976432221 11111000 00000000 0000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+|+..+|++||+++|++++
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1223456677779999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.90 Aligned_cols=237 Identities=24% Similarity=0.362 Sum_probs=188.0
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|...+ ++.||+|+++... ...+.+..|..++....+||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999764 6789999997642 12344666777887766999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 541 (682)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 9999999642 24889999999999999999999998 99999999999999999999999999865322
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ .......... .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~~---~~------~~ 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE------LFQSIRMDNP---CY------PR 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC---CC------Cc
Confidence 123457889999999999899999999999999999999999997543211 1111111100 00 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR 653 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 653 (682)
.....+.+++.+||+.+|++||++. ++.+
T Consensus 218 ---~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 ---WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1223456777899999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.88 Aligned_cols=238 Identities=18% Similarity=0.259 Sum_probs=192.1
Q ss_pred hccccccCeEEEEEEEEcC--CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|...+ +..||+|++..... ..+.+.+|++++..+ +||||+++++++.+++..++||||+
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEEEEEeCC
Confidence 5789999999999998654 35799999865421 234677899999999 8999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 542 (682)
++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 114 IGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 999999999743 24889999999999999999999998 999999999999999999999999999766432
Q ss_pred CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... .....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~~~~---------~~p~~ 250 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILEGII---------YFPKF 250 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhcCCC---------CCCCC
Confidence 24468889999999998889999999999999999999999997543211 1111111110 00111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
.. ..+.+++.+|++.+|++|+ +++|++++
T Consensus 251 ~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 LD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 22 2345677799999999995 89998875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=315.83 Aligned_cols=237 Identities=25% Similarity=0.354 Sum_probs=186.9
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|...+ ++.||+|+++.... ..+.+..|.+++....+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 67899999975432 2234556677777666899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 9999998643 24889999999999999999999998 999999999999999999999999998754321
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+..... .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~---~~------~~ 217 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILNDRP---HF------PR 217 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC---CC------CC
Confidence 23457889999999999899999999999999999999999998643211 1111111110 00 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR 653 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 653 (682)
. ....+.+++.+||+.+|++||++. ++.+
T Consensus 218 ~---~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 W---ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C---CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 223456777799999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=305.72 Aligned_cols=242 Identities=23% Similarity=0.353 Sum_probs=196.9
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|...++..+|+|.++......+++.+|+.++.++ +||||+++++++...+..++||||+.+|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 467999999999999988777899999876655567899999999999 8999999999999888999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-----
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----- 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 544 (682)
+++.... ..+++..++.++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||.++.......
T Consensus 88 ~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 88 NYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9997532 24899999999999999999999998 99999999999999999999999999875533221
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||.+.+..++.++||||||+++|||++ |..||...... ............ ...
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~-----------~~~ 223 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKVSQGLRL-----------YRP 223 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHhcCCCC-----------CCC
Confidence 123456999999988889999999999999999999 99998754321 111111111110 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112356778888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.84 Aligned_cols=238 Identities=23% Similarity=0.351 Sum_probs=191.0
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|+..+ ++.||+|+++.... ..+.+..|.+++..+.+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999764 67899999876422 2344667888888776899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 9999988643 23889999999999999999999998 999999999999999999999999998753221
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~~~~---------~p~ 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHDDVL---------YPV 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCC---------CCC
Confidence 23347889999999999899999999999999999999999997553221 12222211110 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRP-------NMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~evl~~ 654 (682)
.....+.+++.+|++.||++|| ++++++++
T Consensus 218 ---~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 ---WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1123566778899999999999 88888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=292.71 Aligned_cols=243 Identities=21% Similarity=0.363 Sum_probs=195.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.+|+|..++|-++..+ ++++.|+|++...... .+...+|+.+++++..||+|+.+.++|+.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 457999999999888754 5788999998644221 134567999999999999999999999999999999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+|.|+.|.|.+++.. ...+++.+..+|+.|+.+|++|||... ||||||||+|||+|++.++||+|||.|...
T Consensus 102 Fdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999973 456999999999999999999999987 999999999999999999999999999988
Q ss_pred CCCCC---CCCCCcccCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 005693 540 NVPAT---PSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610 (682)
Q Consensus 540 ~~~~~---~~~~~~y~aPE~~~~------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 610 (682)
..+.. .+|||+|.|||.+.. ..|+..+|+||.||+||.++.|.+||......- .++.+...+
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml------MLR~ImeGk--- 244 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML------MLRMIMEGK--- 244 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH------HHHHHHhcc---
Confidence 77653 579999999999853 457889999999999999999999997532110 011111111
Q ss_pred ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 611 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+......+.+++ ....+|+.+|++.||++|.|++|++++
T Consensus 245 --yqF~speWadis---~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 --YQFRSPEWADIS---ATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred --cccCCcchhhcc---ccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111111223333 344566679999999999999999983
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=307.46 Aligned_cols=242 Identities=25% Similarity=0.428 Sum_probs=196.7
Q ss_pred hhccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
..+.||+|+||.||++..+++..+|+|.+........++.+|+++++++ +|+||+++++++...+..++||||+++++|
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 3567999999999999988777899999876555567788999999998 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCC---
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP--- 545 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~--- 545 (682)
.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 87 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 87 LNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred HHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99997432 24899999999999999999999998 999999999999999999999999998765432211
Q ss_pred --CCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 546 --SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 546 --~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
..+..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . .... .... .. ...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~-~~~~-----~~--~~~-- 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VESV-SAGY-----RL--YRP-- 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHHH-HcCC-----cC--CCC--
Confidence 12346999999998899999999999999999999 899997543211 1 1111 1110 00 001
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
......+.+++.+||+.+|++|||++|+++.|
T Consensus 224 -~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 -KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12344677888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=301.29 Aligned_cols=261 Identities=21% Similarity=0.342 Sum_probs=200.1
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCc-eeceEEEEEecC------ceEEE
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~------~~~lV 459 (682)
++||+|+||+||+|+.+ +|+.||+|++..... -.....+|+.++.++ +|+| ||++++++...+ ..++|
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccccceEEEE
Confidence 56999999999999954 577999999976544 234578999999999 8999 999999999887 78899
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+||++. ||..++....... ..++...++.++.|++.||+|||+++ |+||||||.|||++++|.+||+|||+|+..
T Consensus 96 fe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHh
Confidence 999976 9999998654321 34777889999999999999999998 999999999999999999999999999877
Q ss_pred CCCCC----CCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---hhhccccc
Q 005693 540 NVPAT----PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEWTAE 611 (682)
Q Consensus 540 ~~~~~----~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~---~~~~~~~~ 611 (682)
..+.. ..+|..|+|||++.+. .|+...||||+||+++||++++.-|.+..+.+. +.+..+.. -.+.|...
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHHHcCCCCccCCCCc
Confidence 64432 3467889999999876 689999999999999999999999987654221 11111111 11223221
Q ss_pred cc----hhhhccc---cChHHH----HHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005693 612 VF----DVELMRF---QNIEEE----MVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 659 (682)
Q Consensus 612 ~~----d~~l~~~---~~~~~~----~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~ 659 (682)
.. +...... .....+ .....+++.+|++++|.+|.|++.++.+ +..+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 11 1111111 111111 1357788889999999999999999986 55443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.58 Aligned_cols=243 Identities=20% Similarity=0.271 Sum_probs=190.6
Q ss_pred ccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 393 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
||+|+||+||++... +++.+|+|++...... .+.+..|+++++.+ +|+||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999865 5778999998754321 24567789999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 543 (682)
|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 80 L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 80 LRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 9988754322 2345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||++.+..++.++|||||||++|||++|+.||........ ........... .... .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~---------~~~~---~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILND---------SVTY---P 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhccc---------CCCC---c
Confidence 23578899999999999999999999999999999999999975432211 00111111100 0000 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
......+.+++.+|++.||++|| ++++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 12334566777899999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=307.50 Aligned_cols=244 Identities=25% Similarity=0.445 Sum_probs=197.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|..+++..||+|+++......+++.+|++++..+ +|+||+++++++. ....++||||+++|+|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence 567999999999999988777899999986555667899999999998 8999999999874 45689999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-----
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----- 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 544 (682)
+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.++.......
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 89 DFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred HHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 9997532 234789999999999999999999988 99999999999999999999999999876543321
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||+..+..++.++||||||+++|||+| |..||.+....+. .... ..... ....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~~-~~~~~----------~~~~ 225 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQV-ERGYR----------MPCP 225 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHHH-hcCCC----------CCCc
Confidence 224557999999988889999999999999999999 8888875432111 1111 11000 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.+....+.+++.+|++.+|++||+++++++.|++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 23445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.37 Aligned_cols=246 Identities=25% Similarity=0.440 Sum_probs=197.0
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|...+ +..||+|.++..... .+.+.+|++++.++ +|+||+++++++......++|||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCCeEEEEe
Confidence 4679999999999998643 367999998765433 46789999999999 89999999999999999999999
Q ss_pred eccCCchhHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEee
Q 005693 462 YFASGSLSTLLHGNRG---------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 532 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 532 (682)
|+++|+|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECC
Confidence 9999999999975421 12345789999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCC------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 533 FGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 533 fGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
||++...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ......
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~~~~~- 238 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECIT- 238 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHH-
Confidence 9998754321 12224567999999999999999999999999999999 999987543221 111111
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
...... ........+.+++.+||+.+|++||+++|+++.|+
T Consensus 239 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 QGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111000 01123345678888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.37 Aligned_cols=236 Identities=24% Similarity=0.326 Sum_probs=187.3
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|+.+ ++..||+|.++... ...+....|.+++....+||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 46789999997642 12345666777777666899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 541 (682)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 9999998642 24889999999999999999999998 99999999999999999999999999864321
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.... +.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~~~-------~~~--~~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRVDT-------PHY--PR 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------CCC--CC
Confidence 22345789999999999999999999999999999999999999754321 1111111110 000 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVV 652 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 652 (682)
. ....+.+++.+|++.||++||++. ++.
T Consensus 218 ~---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 W---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 223456677799999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=288.56 Aligned_cols=253 Identities=19% Similarity=0.322 Sum_probs=198.8
Q ss_pred hccccccCeEEEEEEE-EcCCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEec-----CceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~e~ 462 (682)
.+.+|+|||+-||+++ ..++..+|+|++.-.. .+.+...+|++..+++ +||||++++++...+ ...|+++.|
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~~yll~Py 104 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHEAYLLLPY 104 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence 5779999999999999 5567889999997654 4566788999999999 999999998887543 348999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
...|+|.+.+...+. +...+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+++.+++.|||.++.....
T Consensus 105 y~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 105 YKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 999999999986554 3456999999999999999999999985 68999999999999999999999999998776432
Q ss_pred CC-------------CCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 005693 543 AT-------------PSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 606 (682)
Q Consensus 543 ~~-------------~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 606 (682)
.. ..-|..|+|||.+.- ...++++|||||||++|+|+.|..||+..-.... .
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-S----------- 250 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-S----------- 250 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-e-----------
Confidence 11 123677999999864 3468999999999999999999999974322110 0
Q ss_pred ccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 607 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 607 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
....+....+. .+.-......+.+++.+|++.||.+||++.+++..++.+.
T Consensus 251 -laLAv~n~q~s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 -LALAVQNAQIS-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -EEEeeeccccc-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01111111111 1111224556677778999999999999999999998764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=325.12 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=198.2
Q ss_pred hhccccccCeEEEEEEEEcC------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
..+.||+|+||.||+|.... ...||+|+++.... ..+.+.+|++++.++..||||+++++++......++||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 35789999999999998532 23699999975432 24568899999999956999999999999999999999
Q ss_pred eeccCCchhHhhccCCCC--------------------------------------------------------------
Q 005693 461 DYFASGSLSTLLHGNRGA-------------------------------------------------------------- 478 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~-------------------------------------------------------------- 478 (682)
||+++|+|.++++.....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999998653210
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeE
Q 005693 479 -----------------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529 (682)
Q Consensus 479 -----------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 529 (682)
....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEE
Confidence 0124788889999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 005693 530 ISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS 602 (682)
Q Consensus 530 l~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~ 602 (682)
|+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+. ...
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------~~~ 351 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------FYN 351 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------HHH
Confidence 99999987653221 1234567999999998889999999999999999997 9999975432111 111
Q ss_pred HhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 603 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 603 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
....... ..........+.+++.+||+.+|++||++.++.++|+++.+
T Consensus 352 ~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIKSGYR----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHhcCCC----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111110 00112234567788889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.30 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=195.0
Q ss_pred ccccccCeEEEEEEEEcCC-c--eEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEES-T--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~-~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|..+++ . .+++|.++.... ..+.+.+|++++.++.+||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3689999999999997643 3 467888764322 2457888999999998899999999999999999999999999
Q ss_pred CchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 466 GSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 466 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
|+|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 11234789999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 005693 535 LTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610 (682)
Q Consensus 535 la~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 610 (682)
++...... .....+..|+|||++....++.++||||||+++|||++ |..||...... ....... ..+..
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~-~~~~~ 230 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLP-QGYRL 230 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHh-CCCCC
Confidence 98533211 11223456999999988889999999999999999997 99999653321 1111111 11110
Q ss_pred ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 611 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
+ ........+.+++.+||+.+|.+|||+.|++..|+++.
T Consensus 231 ~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 E----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 01112345678888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.34 Aligned_cols=237 Identities=22% Similarity=0.346 Sum_probs=190.0
Q ss_pred ccccccCeEEEEEEEEc----CCceEEEEEeecccc-----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 391 EVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
+.||+|+||.||+++.. .++.||+|.++.... ....+..|++++..+ +||||+++++++..++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence 57999999999999853 467899999875421 234567899999999 89999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 81 YLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999998643 24788889999999999999999998 99999999999999999999999999864322
Q ss_pred C----CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 542 P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 542 ~----~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
. ....+++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~~--------- 217 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGKL--------- 217 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC---------
Confidence 1 2235788999999999888999999999999999999999999754321 11222211110
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
..... ....+.+++.+|++.+|++|| ++++++++
T Consensus 218 ~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPY---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCC---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 00111 123456777899999999999 88888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.32 Aligned_cols=246 Identities=23% Similarity=0.419 Sum_probs=200.9
Q ss_pred hhccccccCeEEEEEEEEcCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
..+.||+|+||.||+|...++..+++|.+..... ...++.+|+.+++.+ +|+||+++++++...+..++||||+++|+
T Consensus 10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (261)
T cd05148 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGS 88 (261)
T ss_pred HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEeecccCC
Confidence 3578999999999999998889999999876544 456788999999999 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 543 (682)
|.++++... ...+++..+.+++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 89 L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 89 LLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred HHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 999997543 234899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...++..|+|||.+....++.++||||||+++|+|++ |+.||......+ ...... .... ...
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------~~~~~~-~~~~----------~~~ 225 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------VYDQIT-AGYR----------MPC 225 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHH-hCCc----------CCC
Confidence 1224567999999988889999999999999999998 899997543211 111111 1100 001
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.......+.+++.+||+.+|++|||++++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 122335577888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.97 Aligned_cols=248 Identities=22% Similarity=0.369 Sum_probs=195.4
Q ss_pred hccccccCeEEEEEEEEcC-Cc----eEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|.+.. +. .||+|.++.... ..+++.+|+.+++.+ +|+||+++++++... ..++|+||
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Cceeeeec
Confidence 4679999999999998643 33 389999865432 245788899999998 999999999999764 57799999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..+.+++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 90 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred CCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999997543 24889999999999999999999998 999999999999999999999999999876533
Q ss_pred CC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.. ...+..|+|||++....++.++|||||||++|||++ |+.||.+....+ . .........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~-~~~~~~~~~------ 229 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------I-SSILEKGER------ 229 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHhCCCC------
Confidence 22 123457999999999999999999999999999998 999997542111 1 111111110
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
......+...+.+++.+||..+|++||++.+++..+.++.+...
T Consensus 230 ----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 230 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 00011123456788889999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=306.58 Aligned_cols=239 Identities=21% Similarity=0.325 Sum_probs=186.8
Q ss_pred ccccccCeEEEEEEEEcC-------------CceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCce
Q 005693 391 EVLGKGSYGTAYKAVLEE-------------STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 456 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 456 (682)
+.||+|+||.||+|.... ...|++|.+..... ....+.+|+.++..+ +||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence 368999999999998532 22478888765432 234677788888888 999999999999999999
Q ss_pred EEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC-------eE
Q 005693 457 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-------GC 529 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-------~k 529 (682)
++||||+++|+|..++.... ..+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. ++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeE
Confidence 99999999999998886432 34899999999999999999999998 999999999999987664 89
Q ss_pred EeecCCCCCCCCCCCCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 005693 530 ISDFGLTPLMNVPATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEML-TGKAPLQSPTRDDMVDLPRWVQSVVREE 607 (682)
Q Consensus 530 l~DfGla~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~ell-tg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 607 (682)
++|||++..........++..|+|||++. +..++.++|||||||++|||+ +|..||......+. .......
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~~~~ 225 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFYEGQ 225 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHHhcC
Confidence 99999987766555556788899999986 466899999999999999998 58888864321110 0000000
Q ss_pred cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 608 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
. . . .......+.+++.+||+.||++||+++++++.++
T Consensus 226 ~--~-------~---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 226 C--M-------L---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred c--c-------C---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0 0 0112245678888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.61 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=196.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---------------ChhhHHHHHHHHHHhcCCCceeceEEEEEec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 453 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 453 (682)
.+.||+|.||.|-+|+.. +++.||+|++.+... ..+...+|+.+++++ +|||||+++++..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEEEeecCc
Confidence 467999999999999954 578899999964421 124688999999999 999999999999864
Q ss_pred --CceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEe
Q 005693 454 --DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 531 (682)
Q Consensus 454 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 531 (682)
+..|+|+|||..|.+...=. ....+++.++.+++.+++.||+|||.+| ||||||||+|+||+++|.+||+
T Consensus 181 ~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred ccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEee
Confidence 57899999999988754432 1223899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCCCC---------CCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 005693 532 DFGLTPLMNVP---------ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 598 (682)
Q Consensus 532 DfGla~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~ 598 (682)
|||.+...... ....|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-+....+
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~------ 326 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE------ 326 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH------
Confidence 99998765322 1356899999999997743 3567899999999999999999997654221
Q ss_pred HHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 599 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 599 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
...+++.+ .+ .+...++....+.+|+.+++++||++|.+..+|..+....+..+.
T Consensus 327 l~~KIvn~---------pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 327 LFDKIVND---------PL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred HHHHHhcC---------cc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 12222211 11 222223456667788889999999999999999998876665443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=302.97 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=197.9
Q ss_pred hccccccCeEEEEEEEEcCC-ceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|.-|+||+++..+. ..+|+|++.+.... -.+.+.|.+||+.+ +||.++.+|+.++.++..++|||||+
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEEEecCC
Confidence 57899999999999998764 78999999766432 23567788899999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
||+|..++++..+ ..+++..+..++.+|+-||+|||-.| ||+|||||+||||-++|++.|+||.++.....
T Consensus 161 GGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 161 GGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999987653 45999999999999999999999999 99999999999999999999999998632100
Q ss_pred ------------------------------C-C--------------------------CCCCCCcccCccccccCCCCC
Q 005693 542 ------------------------------P-A--------------------------TPSRSAGYRAPEVIETRKHSH 564 (682)
Q Consensus 542 ------------------------------~-~--------------------------~~~~~~~y~aPE~~~~~~~~~ 564 (682)
. . ...||-.|+|||++.+..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 012355599999999999999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCC
Q 005693 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDM 644 (682)
Q Consensus 565 ~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 644 (682)
++|+|+|||++|||+.|..||.+.+..+... .++.+ .+ .+....+......+||++.+.+||++
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~------NIv~~---------~l-~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLR------NIVGQ---------PL-KFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHH------HHhcC---------CC-cCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999999999887665421 11111 11 12222345566778888999999999
Q ss_pred CCC----HHHHHHH
Q 005693 645 RPN----MDEVVRM 654 (682)
Q Consensus 645 RPt----~~evl~~ 654 (682)
|.- ++||-++
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 998 8888773
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=317.20 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=197.0
Q ss_pred hhccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec-CceEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLV 459 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV 459 (682)
..+.||+|+||.||+|... .++.||+|+++.... ..+.+.+|++++.++.+|+||+++++++... ...+++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 3578999999999999742 246799999875432 2245678999999997899999999988654 567899
Q ss_pred EeeccCCchhHhhccCCCC--------------------------------------------------------CCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGA--------------------------------------------------------GRTPL 483 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~~l 483 (682)
|||+++|+|.+++...... ....+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999998643210 01258
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccc
Q 005693 484 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVI 557 (682)
Q Consensus 484 ~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~ 557 (682)
++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||++....... ...++..|+|||++
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 99999999999999999999998 9999999999999999999999999997653221 12345679999999
Q ss_pred ccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHH
Q 005693 558 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMA 636 (682)
Q Consensus 558 ~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~ 636 (682)
.+..++.++|||||||++|||++ |..||.+....+. ........... .........+.+++.+
T Consensus 248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM----------RAPEYATPEIYSIMLD 311 (337)
T ss_pred cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC----------CCCccCCHHHHHHHHH
Confidence 99999999999999999999998 9999975432211 11111111100 0011223457788889
Q ss_pred cccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 637 CVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 637 Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
||+.+|++||+++|++++|+++.+.
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=314.47 Aligned_cols=238 Identities=25% Similarity=0.354 Sum_probs=190.9
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|.... ++.+|+|+++.... ....+.+|.+++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999764 67899999976421 2345667888888877899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 9999988643 24899999999999999999999998 999999999999999999999999998653221
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~~~~---------~~- 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILEDEVR---------YP- 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCC---------CC-
Confidence 1234788999999999999999999999999999999999999754311 111111111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 654 (682)
......+.+++.+||+.||++||++ .+++++
T Consensus 217 --~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 --RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1123456778889999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=317.60 Aligned_cols=243 Identities=21% Similarity=0.313 Sum_probs=190.5
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeecccc-----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.||+++.. +++.+|+|++..... ..+.+..|++++..+.+|+||+++++++..++..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 468999999999999853 578899999875421 23457789999999977999999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 85 DYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999998643 34889999999999999999999998 9999999999999999999999999987643
Q ss_pred CCC-----CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 541 VPA-----TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 541 ~~~-----~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
... ...|++.|+|||++.+.. ++.++|||||||++|||+||+.||........ ........... +
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~-------~ 227 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILKC-------D 227 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhcC-------C
Confidence 221 235788999999997654 78899999999999999999999975432221 11111111111 0
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
+.. .. .....+.+++.+|++.||++|| ++++++++
T Consensus 228 ~~~--~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PPF--PS---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC--CC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000 01 1223456777899999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=312.27 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=188.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|+.. +++.+|+|+++.... ....+.+|+.+++.+ +||||+++++++.+++..++||||+. +
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 467999999999999976 578899999875432 234577899999999 99999999999999999999999995 6
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 88 DLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 8888876432 34888999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccccc----cc
Q 005693 543 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAE----VF 613 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~~----~~ 613 (682)
....+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ............ +.+... .+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcccc
Confidence 22346788999999865 45788999999999999999999999754211 000000100000 000000 00
Q ss_pred hhh-h--ccccChHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 614 DVE-L--MRFQNIEE------EMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 614 d~~-l--~~~~~~~~------~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
++. . ........ ....+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 0 00000110 1234567888999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=329.33 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=210.1
Q ss_pred HHHHHhhccccccCeEEEEEEEE-cCC----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCce
Q 005693 384 DLLRASAEVLGKGSYGTAYKAVL-EES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 456 (682)
Q Consensus 384 ~l~~~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 456 (682)
|.+....++||+|+||+||+|.+ .++ .+||+|++.+... ...++.+|+.+|.++ +|||+++++|+|.... .
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-H
Confidence 33344578999999999999985 333 3688998876643 356889999999999 9999999999998766 8
Q ss_pred EEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 457 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
.||++||+.|.|.++++..++ .+-....+.|..|||+||.|||++. ++||||.++|||+.....+||.|||++
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence 899999999999999987553 4778899999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCCCC------CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNVPATPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~~~~~~~------~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
+.......... .+.|||=|.+..+.|+.++|||||||++||++| |..||++...+++.++.+ ..
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~g-- 916 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KG-- 916 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cc--
Confidence 98876554432 345999999999999999999999999999999 999999877655433221 11
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.+....+.+..++..++.+||..|++.||+++++...+.++.+.
T Consensus 917 --------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 --------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred --------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 12334456777888999999999999999999999998887644
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.48 Aligned_cols=244 Identities=26% Similarity=0.453 Sum_probs=197.3
Q ss_pred hhccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
..+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+.++.++ +|+|++++++++. ....++||||+++++|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence 3578999999999999988888999999987655667899999999999 8999999999875 4568999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 544 (682)
.++++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 88 LDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 99997532 234889999999999999999999998 99999999999999999999999999876543221
Q ss_pred -CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 545 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 545 -~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
..++..|+|||++.+..++.++||||||+++|||++ |..||.+.... ........ .... ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~-~~~~----------~~ 224 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQVER-GYRM----------PC 224 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCCC----------CC
Confidence 123456999999988889999999999999999999 88999753311 11111111 1000 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
.......+.+++.+|++.+|++|||++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11233457788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.23 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=194.1
Q ss_pred hccccccCeEEEEEEEE-----cCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 460 (682)
.+.||+|+||+||++.. .++..||+|.++.... ....+.+|++++.++ +||||+++++++... ...++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEEEEe
Confidence 46799999999988753 3467899999875432 345788899999999 999999999988654 3578999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++... .+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999642 3899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCC-------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VPAT-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~~~-------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.... ..++..|+|||.+....++.++||||||+++|||+||+.||...... ......+...........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence 3221 12345699999998888999999999999999999999998653211 000000000000000000000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
+... ...........+.+++.+||+.+|++|||++++++.|+++.
T Consensus 238 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000 00011123456778888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.20 Aligned_cols=191 Identities=21% Similarity=0.376 Sum_probs=165.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++... ++..+|+|.+..... ....+.+|+++++.+ +|+||+++++++.+++..++||||+++|
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEEecCCCC
Confidence 467999999999999976 466788888765422 235688999999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--CC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT 544 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 544 (682)
+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+||++++++.+||+|||++...... ..
T Consensus 89 ~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 89 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcccc
Confidence 999999743 24788999999999999999999752 3999999999999999999999999998755332 23
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 588 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~ 588 (682)
..++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 45788999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.73 Aligned_cols=243 Identities=25% Similarity=0.449 Sum_probs=198.1
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.++||+|+||.||+|..++++.+|+|.+........++.+|+++++++ +|+||+++++++. ++..++||||+++|+|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 478999999999999988899999999987666677899999999999 8999999999874 56789999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ...+++.++..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++....... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 89 DFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 9986533 234889999999999999999999988 9999999999999999999999999987654222 1
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++....++.++||||||+++|||++ |+.||.+.... ....... ...... ..
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~-~~~~~~----------~~ 225 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNLE-RGYRMP----------RP 225 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHH-cCCCCC----------CC
Confidence 223567999999998889999999999999999999 99999754321 1111111 111000 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
......+.+++.+|++.+|++||+++++++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1123457788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=308.27 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=194.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCc-----eEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lV~e~~ 463 (682)
.+++|+|+||.||+|...+ +..||||+.-... +.-.+|.++|+++ .|||||++..+|..... ..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---RYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCC---CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 4789999999999999654 5889999986532 3345688899987 99999999998875432 34899999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP 542 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~ 542 (682)
+. +|.++++.... ....++...++-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.....
T Consensus 105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 87 99999975322 2334777888889999999999999988 9999999999999976 99999999999988655
Q ss_pred CCC---CCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccc------
Q 005693 543 ATP---SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWT------ 609 (682)
Q Consensus 543 ~~~---~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~~------ 609 (682)
... .-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..+. +...+.-.. ++...
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCccc
Confidence 433 346779999999775 589999999999999999999999998654332 211111110 00000
Q ss_pred cccchhhhcccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhc
Q 005693 610 AEVFDVELMRFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQS 661 (682)
Q Consensus 610 ~~~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i~~~ 661 (682)
.+.-.+.++... .......+.++++.++++++|.+|.++.|++. ..++++..
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000001111111 12233456778888999999999999999997 56666655
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.12 Aligned_cols=237 Identities=20% Similarity=0.279 Sum_probs=189.1
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||++... +++.||+|.++.... ....+..|++++..+ +||||+++.+++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 578899999976432 124566788888888 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9999988643 248999999999999999999997 66 999999999999999999999999998653221
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ .......... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~i~~~~~---------~~p 216 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEEI---------RFP 216 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHHHhcCCC---------CCC
Confidence 23357889999999999899999999999999999999999997543211 1111111100 001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
.. ....+.+++.+|++.||++|+ ++++++++
T Consensus 217 ~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RT---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CC---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11 223456777799999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=303.83 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=191.9
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
+.||+|+||.||+|... +++.+|+|....... ....+.+|++++.++ +|+||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999975 578899998764422 245688999999998 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-- 545 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~-- 545 (682)
|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 80 L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99999642 234889999999999999999999998 999999999999999999999999998754422111
Q ss_pred ----CCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 546 ----SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 546 ----~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
..+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ...........
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~---------- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRL---------- 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC----------
Confidence 12345999999998889999999999999999998 888886432211 11111111000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.........+.+++.+|++.+|++|||++|+.+.|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 011122346778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.95 Aligned_cols=241 Identities=22% Similarity=0.381 Sum_probs=203.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCc-eEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-KLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lV~e~~~ 464 (682)
.+.+|+|+||.++.++.+ +++.+|+|.+.-.... ++..++|+.+++++ +|||||.+.+.|..++. .+|||+|++
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEEEEeecC
Confidence 467999999999999865 4678999998765432 34678999999998 99999999999999988 899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
||++.+.+...+ ...++++...+++.|++.|+.|||++. |+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999998655 345899999999999999999999887 9999999999999999999999999999987654
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
+..||+.||.||++.+..|..|+||||+||++|||++-+++|.+.+ +...+.++.+.. ++
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~~~-----~~------ 224 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINRGL-----YS------ 224 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhhcc-----CC------
Confidence 4569999999999999999999999999999999999999998654 222333333322 11
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+..++..|++.+|+.||++.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1123344566677779999999999999999984
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.08 Aligned_cols=244 Identities=26% Similarity=0.485 Sum_probs=196.4
Q ss_pred hccccccCeEEEEEEEEcC----CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|.+.. ...|++|.++..... ..++.+|+.++.++ +|+||+++++++...+..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEEEEEcC
Confidence 5789999999999999753 357899988654332 45688899999999 8999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++++|.+++.... ..+++..+.+++.|++.|++|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 88 ENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999997533 24899999999999999999999988 9999999999999999999999999998764211
Q ss_pred C------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 544 T------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 544 ~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
. ..++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .... ..+.+..
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~~~~-~~~~~~~------ 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VIKA-VEDGYRL------ 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------HHHH-HHcCCCC------
Confidence 1 123457999999998899999999999999999998 999986432111 1111 1111100
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.........+.+++.+||+.+|++||+++|++++|+++
T Consensus 228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112345677888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.57 Aligned_cols=191 Identities=25% Similarity=0.379 Sum_probs=166.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||++... +++.+|+|++..... ....+.+|+.++.++ +|+||+++++.+.+....++||||++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEEcCCC
Confidence 467999999999999865 478899999975432 124577888999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 85 GGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999743 34899999999999999999999998 999999999999999999999999998654211
Q ss_pred -------------------------------------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 005693 543 -------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585 (682)
Q Consensus 543 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf 585 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 1235788999999999999999999999999999999999999
Q ss_pred CCCC
Q 005693 586 QSPT 589 (682)
Q Consensus 586 ~~~~ 589 (682)
.+..
T Consensus 237 ~~~~ 240 (363)
T cd05628 237 CSET 240 (363)
T ss_pred CCCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.35 Aligned_cols=233 Identities=26% Similarity=0.385 Sum_probs=187.4
Q ss_pred ccccccCeEEEEEEEE----cCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
+.||+|+||.||+++. ..++.+|+|+++.... ....+.+|++++.++ +||||+++++++..++..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5699999999999875 3578899999976432 234567789999999 8999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 542 (682)
++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 81 RGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999998642 34899999999999999999999998 999999999999999999999999998765433
Q ss_pred ---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... ..
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~~~---------~~ 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAKL---------GM 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcCCC---------CC
Confidence 2335788999999999888999999999999999999999999754321 11111111110 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 650 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 650 (682)
... ....+.+++.+||+.||++||++.+
T Consensus 218 p~~---~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQF---LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC---CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111 2234567778999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.24 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=192.2
Q ss_pred hccccccCeEEEEEEEEcCCc---eEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec------CceE
Q 005693 390 AEVLGKGSYGTAYKAVLEEST---TVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~ 457 (682)
++.||+|+||.||+|.+.++. .+|+|.++.... ..+.+.+|++++..+ +|+||+++++++... ...+
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCCcE
Confidence 467999999999999976543 588998865432 235678899999998 999999999987532 2468
Q ss_pred EEEeeccCCchhHhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
+||||+++|+|.+++..... .....+++.....++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988743221 12345899999999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
+...... ...+++.|+|||+..+..++.++||||||+++|||++ |+.||...... ...... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~-~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDYL-RQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH-HcCCC
Confidence 8764322 1234567999999999899999999999999999999 78999753221 111111 11111
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
. .........+.+++.+||+.+|++|||++|+++.|+++
T Consensus 233 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 L----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00112234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.15 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=189.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC-----ceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~ 460 (682)
.+.||+|+||.||+|... ++..||+|++..... ....+.+|+++++++ +||||+++++++.... ..++||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceEEEEE
Confidence 467999999999999965 578899999875322 234678899999999 9999999999886432 479999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+. ++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 84 ELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred ecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9995 6899988643 24899999999999999999999998 9999999999999999999999999987543
Q ss_pred CC-------CCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh---------hHHHHH
Q 005693 541 VP-------ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL---------PRWVQS 602 (682)
Q Consensus 541 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l---------~~~~~~ 602 (682)
.. ....+++.|+|||++.+ ..++.++|||||||++|||+||+.||.+......... ..+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 21 12357888999999875 5789999999999999999999999976432111000 000000
Q ss_pred Hhhhccccccchhhhc-cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005693 603 VVREEWTAEVFDVELM-RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 659 (682)
Q Consensus 603 ~~~~~~~~~~~d~~l~-~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~ 659 (682)
+.... .....+.... .... .......+.+++.+||+.+|++|||++|++++ ++.+.
T Consensus 235 i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 235 VRNEK-ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhhh-HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 00000 0000000000 0000 01122346788889999999999999999984 44433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.63 Aligned_cols=251 Identities=24% Similarity=0.435 Sum_probs=198.5
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||++... ++..+|+|.+..... ..+.+.+|++++.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEc
Confidence 567999999999999842 234588888865432 345788999999999 899999999999999999999999
Q ss_pred ccCCchhHhhccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 463 FASGSLSTLLHGNRG--------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
+++++|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCC
Confidence 999999999974321 12234899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhc
Q 005693 535 LTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 607 (682)
Q Consensus 535 la~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~ 607 (682)
+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||......+ .........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~~i~~~~ 239 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECITQGR 239 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCC
Confidence 987553221 1223567999999998889999999999999999999 899987543211 111111111
Q ss_pred cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 608 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
... .. ......+.+++.+||+.+|.+|||++|+.+.|+++...
T Consensus 240 -~~~-------~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 240 -VLQ-------RP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -cCC-------CC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 00 11234578888899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=311.60 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=187.4
Q ss_pred hccccccCeEEEEEEEEc--CCceEEEEEeeccccC---hhhHHHHHHHHHHhc--CCCceeceEEEEEe-----cCceE
Q 005693 390 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVG--QHPNVVPLRAYYYS-----KDEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~ 457 (682)
.+.||+|+||.||+|+.. +++.||+|+++..... ...+.+|+.++..+. +||||+++++++.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 467999999999999863 3578999988754322 235667888777764 69999999999852 34678
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 86 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 9999996 59999986433 234889999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHHhhhcccccc-
Q 005693 538 LMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEV- 612 (682)
Q Consensus 538 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~~- 612 (682)
...... ...+++.|+|||.+.+..++.++|||||||++|||++|+.||.+....+.. .+.........+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 654332 334688899999998888999999999999999999999999865432111 000000000001110000
Q ss_pred -chhhh--ccccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 613 -FDVEL--MRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 613 -~d~~l--~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
....+ ...... .+....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000 112234567888999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.49 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=188.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||++... .++.||+|... ...+.+|+++++++ +||||+++++++..+...++|+|++. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 468999999999999965 46788998653 34578899999999 99999999999999999999999995 689
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-----C
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----A 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~ 543 (682)
.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 170 ~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 170 YCYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 8888643 24889999999999999999999998 999999999999999999999999998654221 2
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC-CCChhHHHHHHhhh------ccc-------
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD-MVDLPRWVQSVVRE------EWT------- 609 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~-~~~l~~~~~~~~~~------~~~------- 609 (682)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+.......++.. .+.
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 3458899999999999899999999999999999999998875432111 10100001111000 000
Q ss_pred cccc---------hhhh-ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 AEVF---------DVEL-MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 ~~~~---------d~~l-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+ .+.. ............+.+++.+|++.||++|||++|++++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 0000 0001112234567788999999999999999999973
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.68 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=200.6
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCC-----CceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-----PNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-----~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.|-+|.... ++.||||+++....-..+...|+.+|..+.+| -|+|+++++|...++.|||+|.+
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL 270 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL 270 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence 5789999999999999654 78899999987655455667788999998644 38999999999999999999998
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC--CCeEEeecCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMNV 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~--~~~kl~DfGla~~~~~ 541 (682)
.. +|.++++.++ ...++...+..|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|.+...
T Consensus 271 ~~-NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 271 ST-NLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred hh-hHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 55 9999998765 345999999999999999999999998 9999999999999764 4799999999987664
Q ss_pred CC-CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh--------hHHHH-------HHhh
Q 005693 542 PA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL--------PRWVQ-------SVVR 605 (682)
Q Consensus 542 ~~-~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l--------~~~~~-------~~~~ 605 (682)
.. ++..+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.++.+.+.. +.+.- +.+.
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~ 423 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFT 423 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehh
Confidence 43 45567889999999999999999999999999999999999988765443211 11110 0011
Q ss_pred h-cccccc-----------------------ch---h-hhccc-cChH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 606 E-EWTAEV-----------------------FD---V-ELMRF-QNIE-EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 606 ~-~~~~~~-----------------------~d---~-~l~~~-~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. .+.... .+ + ..... .... ..-..+++++.+|+..||.+|+|+.|++++
T Consensus 424 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 424 SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1 000000 00 0 00000 0111 344568999999999999999999999984
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.17 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=200.6
Q ss_pred HhhccccccCeEEEEEEEEc--------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceE
Q 005693 388 ASAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL 457 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 457 (682)
...+.||+|+||.||+|+.. ++..+|+|.++.... ..+++.+|+.++..+.+|+||+++++++......+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 97 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence 34678999999999999742 234689998865422 24568899999999878999999999999999999
Q ss_pred EEEeeccCCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL 526 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~ 526 (682)
+||||+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~ 174 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENN 174 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCC
Confidence 999999999999999754321 1235788999999999999999999998 99999999999999999
Q ss_pred CeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 005693 527 DGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW 599 (682)
Q Consensus 527 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~ 599 (682)
.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||.+... ...
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~ 248 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EEL 248 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------HHH
Confidence 99999999987664322 1223567999999988889999999999999999999 7888865431 112
Q ss_pred HHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 600 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 600 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.... ...... .........+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 249 ~~~~-~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 249 FKLL-KEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHH-HcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 2211 111110 011123456677888999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.62 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=200.6
Q ss_pred HhhccccccCeEEEEEEEEcC--------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceE
Q 005693 388 ASAEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL 457 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 457 (682)
...+.||+|+||.||+++..+ ...+|+|.++.... ...++.+|++++..+.+|+||+++++++...+..+
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 100 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 346789999999999998532 24699999875432 23467789999999878999999999999999999
Q ss_pred EEEeeccCCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL 526 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~ 526 (682)
+||||+++|+|.+++...... ....+++.++++++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~ 177 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDN 177 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCC
Confidence 999999999999999754321 1234889999999999999999999988 99999999999999999
Q ss_pred CeEEeecCCCCCCCCCC----CC--CCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 005693 527 DGCISDFGLTPLMNVPA----TP--SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW 599 (682)
Q Consensus 527 ~~kl~DfGla~~~~~~~----~~--~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~ 599 (682)
.+||+|||.++...... .. .++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~------~~ 251 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------EL 251 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HH
Confidence 99999999987654321 11 12457999999998889999999999999999998 88888643211 11
Q ss_pred HHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 600 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 600 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.. ........ .........+.+++.+||+.+|++||+++|+++.|+++.+...
T Consensus 252 ~~-~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 252 FK-LLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HH-HHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11 11111110 1112233566778889999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.12 Aligned_cols=251 Identities=24% Similarity=0.436 Sum_probs=199.2
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|+.. ++..+++|.++.... ..+.+.+|++++.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCceEEEEec
Confidence 467999999999999843 245688888865433 235788999999998 899999999999999999999999
Q ss_pred ccCCchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEe
Q 005693 463 FASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 531 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 531 (682)
+++++|.+++..... .....+++..++.++.|++.|++|||+++ |+||||||+||++++++.++|+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEEC
Confidence 999999999965321 11234899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHh
Q 005693 532 DFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 604 (682)
Q Consensus 532 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~ 604 (682)
|||++....... ...++..|+|||++.+..++.++||||||+++|||+| |+.||......+ .....
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~- 238 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIECI- 238 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-
Confidence 999987653321 2234567999999999899999999999999999999 999986543211 11111
Q ss_pred hhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 605 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 605 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
....... ........+.+++.+||+.+|++||+++++++.|+++...
T Consensus 239 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hCCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111100 0112334577888899999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=292.43 Aligned_cols=242 Identities=22% Similarity=0.353 Sum_probs=196.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|.|+.||++... .|+.+|+|++.... .+.++.++|+++.+.+ +|||||++...+.+....|+|+|+|+|
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEEecccc
Confidence 467999999999998754 57788888775432 3567788999999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~ 542 (682)
|+|..-+-. +...++..+-..+.||+++|.|+|.++ |||||+||+|+++.. ...+|++|||+|......
T Consensus 95 ~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 95 GELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred hHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 999754432 234788888999999999999999998 999999999999964 346899999999887744
Q ss_pred C---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
. ...|||+|||||++...+|+..+|||+.||+||-++.|++||.+.+.. +..+++.. ..+|.....
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~------rlye~I~~-----g~yd~~~~~ 235 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYEQIKA-----GAYDYPSPE 235 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH------HHHHHHhc-----cccCCCCcc
Confidence 3 345799999999999999999999999999999999999999975432 22233322 223444444
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+..+.++.+.++ .+|+..||.+|.|+.|++++
T Consensus 236 w~~is~~Ak~Lv---rrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 236 WDTVTPEAKSLI---RRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCcCCHHHHHHH---HHHhccChhhhccHHHHhCC
Confidence 556666666555 49999999999999998864
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.69 Aligned_cols=232 Identities=22% Similarity=0.302 Sum_probs=183.0
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHH-HHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIV-GRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l-~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||+||+|... +++.||+|++..... ...++..|...+ +.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36999999999999975 578899999875422 123444555544 445 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999998643 24889999999999999999999998 999999999999999999999999998754221
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~---------~~~ 216 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKPL---------RLK 216 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCCC---------CCC
Confidence 2235788999999999989999999999999999999999999754321 11222221110 011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMD 649 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 649 (682)
.. ....+.+++.+|++.||++||+++
T Consensus 217 ~~---~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PN---ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC---CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 134466777899999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.21 Aligned_cols=240 Identities=25% Similarity=0.362 Sum_probs=190.6
Q ss_pred cccccCeEEEEEEEEc---CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 392 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.||+|+||.||+|.++ ++..+|+|+++..... .+++.+|+.++..+ +|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 5899999999999753 4678999998654322 35688899999998 9999999999875 4567899999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 544 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 544 (682)
|+|.+++... ..+++..+.+++.|++.|++|||+.+ |+||||||.||++++++.+||+|||++........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 80 GPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999642 24889999999999999999999998 99999999999999999999999999876643321
Q ss_pred ------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 545 ------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 545 ------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
..++..|+|||.+....++.++|||||||++|||++ |+.||......+ +... +.......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~-i~~~~~~~------ 218 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQM-IESGERME------ 218 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHCCCCCC------
Confidence 112467999999988889999999999999999998 999997543221 1111 11111100
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.. ......+.+++.+||+.+|++||++++|++.|+..
T Consensus 219 -~~---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 -CP---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CC---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01 12234567788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.94 Aligned_cols=243 Identities=26% Similarity=0.441 Sum_probs=195.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+++++++ +|+|++++++++. .+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 467999999999999988777899998876555567789999999999 8999999998875 45688999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
++++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 89 DFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 9997532 234789999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||+..+..++.++||||||+++|||+| |..||.+....+ ..... ...... ...
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~-~~~~~~----------~~~ 225 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQV-ERGYRM----------PCP 225 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-HcCCCC----------CCC
Confidence 224567999999998889999999999999999999 899997543211 11111 111100 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
......+.+++.+||+.+|++||+++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1234567778889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.00 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=197.9
Q ss_pred hccccccCeEEEEEEEEcCC---ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|..+++ ..+++|.++.... ..+.+.+|++++.++.+||||+++++++......++|+||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 46799999999999987543 2468888764322 245688899999999789999999999999999999999999
Q ss_pred CCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeec
Q 005693 465 SGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 533 (682)
Q Consensus 465 ~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 533 (682)
+|+|.++++..... ....+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCc
Confidence 99999999753211 1234889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 534 GLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 534 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
|++....... ....+..|+|||++.+..++.++|||||||++|||++ |..||...... ........ ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~~~~-~~~ 236 (297)
T cd05089 164 GLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEKLPQ-GYR 236 (297)
T ss_pred CCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHhc-CCC
Confidence 9986433211 1122446999999998889999999999999999998 99999754321 11111111 100
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.. . .......+.+++.+||+.+|.+||+++++++.|+.+.+...
T Consensus 237 ~~-------~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 237 ME-------K---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred CC-------C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 0 01123456788889999999999999999999999886553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=301.27 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=200.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.. +++.||+|.++.... ...++.+|+++++.+ +||||+++++++...+..++|+||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEEEEecC
Confidence 467999999999999964 578899998764322 134678899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999998864322 2344789999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+.......... .
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~----------~ 227 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDYP----------P 227 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCCC----------C
Confidence 23567789999999888899999999999999999999999964321 112222221111100 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
.........+.+++.+||+.+|++||+++|+++.+++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 011223456778888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.67 Aligned_cols=238 Identities=22% Similarity=0.361 Sum_probs=190.2
Q ss_pred ccccccCeEEEEEEEEcCCc-----------eEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 391 EVLGKGSYGTAYKAVLEEST-----------TVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
+.||+|+||.||+|...+.. .+++|.+.........+.+|+.+++++ +|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEEE
Confidence 46899999999999976543 477777765443367788999999998 89999999999988 778999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-------CeEEee
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-------DGCISD 532 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-------~~kl~D 532 (682)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999975331 4889999999999999999999988 99999999999999888 799999
Q ss_pred cCCCCCCCCCCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 533 FGLTPLMNVPATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 533 fGla~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
||++..........++..|+|||++... .++.++||||||+++|||++ |..||......+. ..... ....
T Consensus 152 fg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------~~~~~-~~~~ 224 (259)
T cd05037 152 PGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------ERFYQ-DQHR 224 (259)
T ss_pred CCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH------HHHHh-cCCC
Confidence 9999876654455567789999999876 78999999999999999999 5777765432111 11000 0000
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
. .. .....+.+++.+||..+|++|||+.|+++.|+
T Consensus 225 --~------~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 --L------PM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --C------CC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 01156778888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=323.21 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=187.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.+|+|++..... ..+.+.+|++++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence 467999999999999865 467899999976432 134578899999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 85 GGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999743 24888999999999999999999998 99999999999999999999999998753210
Q ss_pred ------------------------------------------------CCCCCCCCcccCccccccCCCCCcchHHHHHH
Q 005693 542 ------------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 573 (682)
Q Consensus 542 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv 573 (682)
.....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 01235788999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 005693 574 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMA--CVAKVPDMRPNMDEV 651 (682)
Q Consensus 574 vl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~ev 651 (682)
++|||++|+.||......+. ...+.. +... ...........+ +.+++.+ |+..+|..||+++|+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~--~~~~---~~~~~~~~~s~~---~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET------QLKVIN--WENT---LHIPPQVKLSPE---AVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH------HHHHHc--cccc---cCCCCCCCCCHH---HHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999976432211 111110 0000 001111122333 3444445 666777779999999
Q ss_pred HHH
Q 005693 652 VRM 654 (682)
Q Consensus 652 l~~ 654 (682)
+++
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 885
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.23 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=198.3
Q ss_pred hhccccccCeEEEEEEEEcC------CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
..+.||+|+||.||++...+ ...+|+|.+...... ..++.+|++++.++.+|+||+++++++..+...++||
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 35789999999999998643 357899988754322 2457789999999878999999999999999999999
Q ss_pred eeccCCchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeE
Q 005693 461 DYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 529 (682)
||+++|+|.++++.... .....+++..++.++.|++.|++|||+.+ |+||||||+||++++++.+|
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEE
Confidence 99999999999964321 12345899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 005693 530 ISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS 602 (682)
Q Consensus 530 l~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~ 602 (682)
|+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||......+ ...
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~- 245 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LFK- 245 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH------HHH-
Confidence 99999997654322 1123457999999988889999999999999999998 999987543211 111
Q ss_pred HhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 603 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 603 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
........ .........+.+++.+||+.+|++|||++|+++.|+.+.
T Consensus 246 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111100 011123346778888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.48 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=194.4
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|...+ +..||+|+++..... .+.+.+|+.++..+ +||||+++++++...+..++++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceEEEEE
Confidence 5779999999999998643 467999998754332 34678888888888 89999999999999999999999
Q ss_pred eccCCchhHhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEE
Q 005693 462 YFASGSLSTLLHGNR-----------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 530 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 530 (682)
|+.+++|.+++.... ......+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEe
Confidence 999999999985321 011234888999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 005693 531 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 603 (682)
Q Consensus 531 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~ 603 (682)
+|||+++...... ...+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.... .+...+
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~i 239 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVIEMI 239 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence 9999987653322 2224568999999988889999999999999999998 88888754321 122222
Q ss_pred hhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 604 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
..... .. ........+.+++.+||+.+|++||+++|+++.|+.
T Consensus 240 ~~~~~-~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RNRQV-LP----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcCCc-CC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11110 00 011234456788889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.28 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=195.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEe-----cCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-----KDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lV~ 460 (682)
.+.||+|+||.|+.+..+ ++..||+|++..... ..++..+|+++++.+ +|+||+.+.+++.. -+..|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccccceeEEeh
Confidence 367999999999999965 478899999975433 356788899999999 79999999999865 34679999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
|+|+ .||...++.. +.++......++.|+++|++|+|+.+ |+||||||+|++++.+..+||+|||+|+...
T Consensus 106 elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 106 ELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred hHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecc
Confidence 9994 4999999743 34999999999999999999999998 9999999999999999999999999999885
Q ss_pred CC------CCCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHH--------HHHHhh
Q 005693 541 VP------ATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW--------VQSVVR 605 (682)
Q Consensus 541 ~~------~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~--------~~~~~~ 605 (682)
.. ..+..|..|.|||++. ...|+.+.||||.||++.||++|++-|.+...-+...++-. ....+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32 2234578899999985 45689999999999999999999999987654332211100 000011
Q ss_pred hccccccchhhhc-ccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005693 606 EEWTAEVFDVELM-RFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 659 (682)
Q Consensus 606 ~~~~~~~~d~~l~-~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~ 659 (682)
.......+..... ... .++..-...++|..+++..||.+|+|++|++++ |....
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 0000001100000 000 111223345677779999999999999999984 44444
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.06 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=197.7
Q ss_pred hhccccccCeEEEEEEEEc------CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
..+.||+|+||.||+|.+. .+..||+|+++..... .+.+.+|++++.++.+||||+++++++..+...++||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 4688999999999999864 2457999999765322 3468889999999955999999999999999999999
Q ss_pred eeccCCchhHhhccCCC---------------------------------------------------------------
Q 005693 461 DYFASGSLSTLLHGNRG--------------------------------------------------------------- 477 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~--------------------------------------------------------------- 477 (682)
||+++|+|.++++..+.
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975421
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC
Q 005693 478 ------------------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 527 (682)
Q Consensus 478 ------------------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~ 527 (682)
.....+++...++++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCE
Confidence 01124678889999999999999999987 999999999999999999
Q ss_pred eEEeecCCCCCCCCC------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 005693 528 GCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 600 (682)
Q Consensus 528 ~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~ 600 (682)
+||+|||+++..... ....++..|+|||.+....++.++|||||||++|||++ |..||......+ ..
T Consensus 278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~ 351 (401)
T cd05107 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QF 351 (401)
T ss_pred EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HH
Confidence 999999998754321 12235677999999998889999999999999999998 889987543211 11
Q ss_pred HHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 601 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 601 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
...+....... .. ......+.+++.+||+.+|++||+++|+++.|+++.
T Consensus 352 ~~~~~~~~~~~-------~p---~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAIKRGYRMA-------KP---AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHcCCCCC-------CC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111000 01 112345677888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.25 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=187.0
Q ss_pred ccccccCeEEEEEEEEcC---CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|...+ +..+++|.++.... ....+.+|+.+++++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 358999999999998653 34688998865432 234688899999999 899999999999998999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
|+|.++++..........++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997543322334677888899999999999999998 9999999999999999999999999986543221
Q ss_pred ----CCCCCCcccCccccccC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 544 ----TPSRSAGYRAPEVIETR-------KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~~-------~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
...++..|+|||++... .++.++||||||+++|||++ |+.||......+. ....... ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~-~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV------LTYTVRE-QQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH------HHHHhhc-ccCC
Confidence 22356679999998642 35789999999999999996 9999975432211 0000110 0011
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
..++... ......+.+++.+|| .+|++|||++||++.|+
T Consensus 230 ~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111110 011234566777999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.47 Aligned_cols=242 Identities=26% Similarity=0.395 Sum_probs=193.3
Q ss_pred ccccccCeEEEEEEEEcC----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||.||+|.+.. +..+|+|.+..... ..+++.+|+++++.+ +|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999998543 25799999876544 356788899999998 8999999999876 456899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
+|+|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999997432 4899999999999999999999988 99999999999999999999999999876543322
Q ss_pred C-------CCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 545 P-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 545 ~-------~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
. .++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+..+. ......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~----~~~~~~------ 217 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML----ESGERL------ 217 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HcCCcC------
Confidence 1 12346999999998899999999999999999998 99999754321 111111 111100
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
.........+.+++.+||..+|++||++.++++.|+.+.
T Consensus 218 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011123356778888999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.28 Aligned_cols=242 Identities=20% Similarity=0.283 Sum_probs=192.1
Q ss_pred hccccccCeEEEEEEEEcC--CceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|.... +..||+|.+..... ....+.+|+++++.+ +|||||++++++..++..++||||+++|
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 4789999999999998543 46678887644322 234577899999998 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.++++.... ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 99998864321 2345889999999999999999999988 999999999999999999999999999765432
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....||++|+|||++.+..++.++|||||||++|||++|+.||...... ............ +
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~-----~----- 290 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKYD-----P----- 290 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-----C-----
Confidence 2335889999999999999999999999999999999999999754321 112221111110 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
........+.+++.+||+.+|++||++++++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00112245677788999999999999999875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.59 Aligned_cols=241 Identities=23% Similarity=0.334 Sum_probs=188.9
Q ss_pred ccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 393 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
||+|+||+||++..+ +++.+|+|++..... ....+..|++++.++ +||||+++++++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999865 478899999864322 233456789999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---T 544 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 544 (682)
|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... .
T Consensus 80 L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 80 LKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 998886432 234889999999999999999999998 9999999999999999999999999987654332 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..++..|+|||++.+..++.++||||+||++|||++|+.||....... .............. .. ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~-----~~---~~~--- 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDEV-----KF---EHQ--- 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcccc-----cc---ccc---
Confidence 357889999999998889999999999999999999999997533211 11111111111110 00 011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.....+.+++.+||+.||++||+++|+++
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 12334677888999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.44 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=198.4
Q ss_pred CHHHHHHHhhccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCc
Q 005693 381 DLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE 455 (682)
Q Consensus 381 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~ 455 (682)
|.+.+.... +.||+|+||.||-|+... ...||||++.-.. ....++..|+.++..+ +|||++.+.|+|..+..
T Consensus 23 DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 23 DPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHT 100 (948)
T ss_pred CHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccch
Confidence 555555443 459999999999999654 5678999986432 1246789999999999 99999999999999999
Q ss_pred eEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 456 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 456 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
.|+|||||-| +-.|++.-. ++++-+.++..|+.+.+.||+|||+.+ .||||||+.|||+++.|.||++|||.
T Consensus 101 aWLVMEYClG-SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 101 AWLVMEYCLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred HHHHHHHHhc-cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccc
Confidence 9999999954 777777532 356889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 536 TPLMNVPATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 536 a~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
|.......++.|||.|||||++. .+.|+-++||||+|+++.|+...++|+-..+. ...+..+.. +...
T Consensus 173 Asi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQ-NesP-- 243 (948)
T KOG0577|consen 173 ASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESP-- 243 (948)
T ss_pred hhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHh-cCCC--
Confidence 99999999999999999999984 57799999999999999999999999864431 111111111 1111
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+ .. .+-...|..++..|+++-|.+|||.++++++
T Consensus 244 ---tL-qs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 ---TL-QS---NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CC-CC---chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 01 11 1223344555569999999999999998875
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.30 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=193.4
Q ss_pred hccccccCeEEEEEEEE-----cCCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|.. ..+..+++|.++..... ..++.+|+++++++ +|+||+++++++..++..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCceEEEEEc
Confidence 46799999999999984 24567999998754322 24688899999999 899999999999999999999999
Q ss_pred ccCCchhHhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEE
Q 005693 463 FASGSLSTLLHGNRG------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 530 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 530 (682)
+++|+|.+++..... .....+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEe
Confidence 999999999853221 11234788999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 005693 531 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 603 (682)
Q Consensus 531 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~ 603 (682)
+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||.+....+ .. ..
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------~~-~~ 238 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------VI-EM 238 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HH-HH
Confidence 9999997653221 2234557999999988889999999999999999999 999987543211 11 11
Q ss_pred hhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 604 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
........ .. ......+.+++.+||+.+|++||++.++.++|..
T Consensus 239 ~~~~~~~~-------~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQLLP-------CS---EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCC-------CC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111100 01 1123456677789999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.43 Aligned_cols=237 Identities=21% Similarity=0.308 Sum_probs=184.5
Q ss_pred cccccCeEEEEEEEEcC-------------------------CceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceec
Q 005693 392 VLGKGSYGTAYKAVLEE-------------------------STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVP 445 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~ 445 (682)
.||+|+||.||+|.+.. ...|++|.+..... ...++.+|+.+++.+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 59999999999997521 13478888865432 234677788888888 8999999
Q ss_pred eEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC
Q 005693 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525 (682)
Q Consensus 446 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~ 525 (682)
+++++.++...++||||+++|+|..++.... ..+++..+.+++.|+++||+|||+.+ |+||||||+||+++..
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEecc
Confidence 9999999999999999999999999986432 34889999999999999999999987 9999999999999865
Q ss_pred C-------CeEEeecCCCCCCCCCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCCCCCh
Q 005693 526 L-------DGCISDFGLTPLMNVPATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEML-TGKAPLQSPTRDDMVDL 596 (682)
Q Consensus 526 ~-------~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~ell-tg~~Pf~~~~~~~~~~l 596 (682)
+ .+|++|||++..........++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--- 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--- 230 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---
Confidence 4 379999998865544444456788999998865 55799999999999999985 69999975432221
Q ss_pred hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 597 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.. ....... . . ......+.+++.+||+.+|++||+++++++.|
T Consensus 231 ~~----~~~~~~~-------~--~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ER----FYEKKHR-------L--P---EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH----HHHhccC-------C--C---CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 1111100 0 0 11123567888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.41 Aligned_cols=242 Identities=23% Similarity=0.375 Sum_probs=202.0
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|.||.||+++.+. |+.+|+|.+++... ....+.+|+.+++++..|||||.+.+.|++.+..++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 3679999999999999765 88999999977643 235899999999999669999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC----CCeEEeecCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTPLMN 540 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~----~~~kl~DfGla~~~~ 540 (682)
||.|.+.+... .+++..+..++.|++.+++|||+.| |+||||||+|+|+... +.+|++|||++....
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999754 2899999999999999999999998 9999999999999754 479999999998887
Q ss_pred CC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 541 VP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 541 ~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
.. ....||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+..+... .+....+ +...
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~-----~f~~ 259 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF-----DFTS 259 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-----CCCC
Confidence 63 24579999999999999999999999999999999999999999776443211 2222221 2222
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+..+.+.++ +++..++..||.+|+|+.+++++
T Consensus 260 ~~w~~is~~ak---d~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 260 EPWDDISESAK---DFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCccccCHHHH---HHHHHhcccCcccCCCHHHHhcC
Confidence 23344444444 45559999999999999999996
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.13 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=193.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||++... +++.||+|++..... ....+.+|+++++++ +|+||+++++++..++..++||||++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEEeccC
Confidence 467999999999999965 578899999875422 224567899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 84 GGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999998886432 234899999999999999999999998 9999999999999999999999999987654332
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...++..|+|||++.+..++.++||||+||++|||++|+.||.+...... .......+.... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~-----------~~ 223 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ-----------EE 223 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc-----------cc
Confidence 23578899999999988899999999999999999999999985432111 111111111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
........+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0112234566788899999999999 78888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.96 Aligned_cols=254 Identities=23% Similarity=0.409 Sum_probs=197.7
Q ss_pred hccccccCeEEEEEEEEcC-Cc--eEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-ST--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|..++ +. .+++|.++.... ..+.+.+|++++.++.+|+||+++++++..++..++||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 4779999999999999753 33 457777654322 235688899999999889999999999999999999999999
Q ss_pred CCchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeec
Q 005693 465 SGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 533 (682)
Q Consensus 465 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 533 (682)
+|+|.++++.... .....+++.+++.++.|++.|++|||+.+ ++||||||+||++++++.+||+||
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCcc
Confidence 9999999975431 11235889999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 534 GLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 534 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
|++....... ....+..|+|||++.+..++.++|||||||++|||+| |..||......+ ..... .....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~-~~~~~ 241 (303)
T cd05088 169 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL-PQGYR 241 (303)
T ss_pred ccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHHHH-hcCCc
Confidence 9986432211 1123456999999988889999999999999999998 999997543221 11111 11100
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.. .. ......+.+++.+||+.+|++||+++++++.|+.+.+...
T Consensus 242 ~~-------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 242 LE-------KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CC-------CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00 00 1123356788889999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=298.33 Aligned_cols=245 Identities=29% Similarity=0.482 Sum_probs=198.7
Q ss_pred ccccccCeEEEEEEEEcC----CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||.||+|...+ +..+++|.++..... .+.+.+|++.+..+ +|+||+++++++..+...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999999764 778999999766443 56788999999999 69999999999999999999999999
Q ss_pred CCchhHhhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 465 SGSLSTLLHGNRGA----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 465 ~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
+++|.+++...... ....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999754211 0245899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
... ...++..|+|||.+....++.++||||+|+++|||++ |..||...... ........ ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~-~~~---- 225 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRK-GYR---- 225 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCC----
Confidence 432 2345778999999988889999999999999999999 69999765211 11111111 110
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
..........+.+++.+||+.+|++||+++|++++|+
T Consensus 226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222456778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=296.91 Aligned_cols=241 Identities=26% Similarity=0.421 Sum_probs=194.1
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
++||+|+||.||+|...+++.+|+|.+...... ...+.+|++++..+ +||||+++++++...+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 369999999999999888889999998754322 34688899999998 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 543 (682)
.+++.... ..+++..+..++.|++.|+.|+|+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99986432 24789999999999999999999988 9999999999999999999999999986543322
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....+..|+|||++.+..++.++||||||+++||+++ |..||......+ ............ .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~----------~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRMS----------C 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCCC----------C
Confidence 1123456999999998889999999999999999999 999997543211 111111111100 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.......+.+++.+|++.+|++||++.|+++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1123356778888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.11 Aligned_cols=246 Identities=22% Similarity=0.384 Sum_probs=192.6
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... .+..+|+|++..... ...++.+|+.+++.+ +|+||+++++++..+...++|||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCeEEEEe
Confidence 567999999999999854 245799998864322 234678899999998 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 462 YFASGSLSTLLHGNRGA-----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
|+++|+|.+++...... ....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCc
Confidence 99999999998653211 1234678899999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
+...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... .......... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~ 239 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRFVMEGG-L 239 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCC-c
Confidence 7543221 1233567999999998889999999999999999999 78898754321 1111111111 0
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
... .......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 240 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 LDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000 1122345778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.50 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=188.7
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|...+ ++.+|+|+++.... ..+.+..|..++..+.+|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 4679999999999999764 56899999875432 123456677788777689999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 85 GGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999998643 24889999999999999999999998 99999999999999999999999999875432
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||.+....+ ....+..... ...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~i~~~~~---------~~p 221 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHNV---------AYP 221 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC---------CCC
Confidence 123457889999999999999999999999999999999999997543211 1111111110 001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 653 (682)
. .....+.+++.+|++.+|++|++. +++.+
T Consensus 222 ~---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 222 K---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred C---cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1 123345677789999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.25 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=200.1
Q ss_pred hhccccccCeEEEEEEEEc--------CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEE
Q 005693 389 SAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 458 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 458 (682)
..+.||+|+||.||+++.. ....+|+|.++..... ..++.+|++++.++.+||||+++++++..+...++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 4688999999999999742 2346889988754322 34678899999998679999999999999889999
Q ss_pred EEeeccCCchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC
Q 005693 459 VYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 527 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~ 527 (682)
||||+++|+|.+++..... .....+++.++.+++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCc
Confidence 9999999999999975321 11235889999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCCCCCCCCC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 005693 528 GCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 600 (682)
Q Consensus 528 ~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~ 600 (682)
+||+|||+++....... ..++..|+|||++.+..++.++||||||+++|||++ |..||......+ ..
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~~ 246 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE------LF 246 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence 99999999976543211 112356999999988889999999999999999999 889986543211 11
Q ss_pred HHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 601 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 601 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
. ......... ........+.+++.+||+.+|++||++.|+++.|+++.....+
T Consensus 247 ~-~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 247 K-LLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred H-HHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 1 111111100 0112234566788899999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.37 Aligned_cols=244 Identities=27% Similarity=0.461 Sum_probs=199.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|..+++..+++|.+.......+++.+|+.+++++ +|+||+++++++......++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 578999999999999988888899999987666678899999999999 8999999999999888999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+|++|||++....... .
T Consensus 90 ~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred HHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 9997543 234899999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+..|+|||.+.+..++.++||||+|+++|||++ |+.||.+....+ ....... ... ....
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~-~~~-------~~~~--- 226 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------VLEQVER-GYR-------MPRP--- 226 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHc-CCC-------CCCC---
Confidence 223457999999998889999999999999999999 999996543211 1111111 100 0001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1123457788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.13 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=189.7
Q ss_pred hccccccCeEEEEEEEEcC-Cc----eEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|.+.. +. .+++|.+..... ...++..|+..+.++ +||||+++++++. ....++++||
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCccEEEEEe
Confidence 4789999999999999643 33 367777653322 124566677777787 8999999999875 4567899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 90 SPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999997432 34899999999999999999999988 999999999999999999999999999765322
Q ss_pred C------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ...++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+ ........... ..+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERL--AQP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcC--CCC
Confidence 1 1234567999999998899999999999999999998 999997543211 11111111100 000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
..+...+.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus 234 --------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 234 --------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11223456788899999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.93 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=188.4
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+..+ ++.||+|+++.... ..+.+..|.+++..+.+|++|+.+++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 4679999999999999764 56899999975421 234567788888888566779999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 85 GGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999998643 24889999999999999999999998 999999999999999999999999998653221
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....|++.|+|||++.+..++.++||||+||++|||+||+.||.+....+ ....+..... ...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~~---------~~~ 221 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHNV---------SYP 221 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC---------CCC
Confidence 22357889999999999999999999999999999999999997543211 1111111110 001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 654 (682)
.. ....+.+++.+|++.+|++|++. +++.++
T Consensus 222 ~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 222 KS---LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 22345677789999999999976 566553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=309.58 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=201.7
Q ss_pred HHhhccccccCeEEEEEEEEcC--------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCce
Q 005693 387 RASAEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 456 (682)
Q Consensus 387 ~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 456 (682)
....+.||+|+||.||++...+ ...+|+|.++.... ..+++.+|++++.++.+|+||+++++++..++..
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 93 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence 3456889999999999997421 23689998875432 2357888999999997899999999999999999
Q ss_pred EEEEeeccCCchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC
Q 005693 457 LLVYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~ 525 (682)
+++|||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~ 170 (334)
T cd05100 94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTED 170 (334)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCC
Confidence 999999999999999975321 11234889999999999999999999998 9999999999999999
Q ss_pred CCeEEeecCCCCCCCCCCC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhH
Q 005693 526 LDGCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 598 (682)
Q Consensus 526 ~~~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~ 598 (682)
+.+||+|||+++....... ..++..|+|||++.+..++.++||||||+++|||++ |..||.+... ..
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~ 244 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------EE 244 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------HH
Confidence 9999999999876543211 122456999999999899999999999999999999 8888875432 12
Q ss_pred HHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 599 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 599 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
...... .....+ ........+.+++.+||+.+|++||++.|+++.|+++......
T Consensus 245 ~~~~~~-~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 245 LFKLLK-EGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHH-cCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 222211 111100 1112234677888899999999999999999999999855543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=318.79 Aligned_cols=241 Identities=23% Similarity=0.377 Sum_probs=193.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|... +++.||+|+++.... ....+.+|++++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEEEcCCC
Confidence 467999999999999976 578899999975432 234678899999998 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 85 GGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999753 34899999999999999999999988 9999999999999999999999999987654332
Q ss_pred --------------------------------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 005693 544 --------------------------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 591 (682)
Q Consensus 544 --------------------------------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~ 591 (682)
...+++.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 234788899999999999999999999999999999999999764421
Q ss_pred CCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 005693 592 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVRM 654 (682)
Q Consensus 592 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 654 (682)
+ ....+.. +.... ....... ....+.+++.+|++ +|++||+ ++|++++
T Consensus 237 ~------~~~~i~~--~~~~~---~~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E------TYNKIIN--WKESL---RFPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H------HHHHHhc--cCCcc---cCCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1111111 00000 0001111 23456667779997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=301.50 Aligned_cols=251 Identities=21% Similarity=0.375 Sum_probs=200.1
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++.. .++..+++|.+..... ...++.+|+++++.+ +|+||+++++++..++..+++|||++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEEEEecC
Confidence 46799999999999995 4688999998865322 234678899999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.+++..... ....+++..+..++.|+++|++|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 9999999864322 2345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...++..|+|||.+.+..++.++||||||+++|||++|..||...... ............. +..
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~------~~~--- 228 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCDY------PPL--- 228 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcCCC------CCC---
Confidence 234677899999998888999999999999999999999999754321 1111111111000 000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
........+.+++.+||+.+|++|||+++|++.++++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01123345677888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=299.84 Aligned_cols=248 Identities=22% Similarity=0.409 Sum_probs=195.0
Q ss_pred hccccccCeEEEEEEEEcC----CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCc------e
Q 005693 390 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------K 456 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~ 456 (682)
.+.||+|+||.||+|.... +..+|+|+++..... ...+.+|++.+..+ +|+||+++++++...+. .
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccCccc
Confidence 4679999999999998643 357999998754332 24678899999998 89999999999876554 6
Q ss_pred EEEEeeccCCchhHhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 457 LLVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
++|+||+++|+|..++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccc
Confidence 899999999999999854321 12345899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 536 TPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 536 a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
++....... ...+..|+|||++.+..++.++|||||||++|||++ |..||.+.... +..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~ 233 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLRHGNR 233 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC
Confidence 876543321 123457999999988889999999999999999999 88998654321 11111111110
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
. .........+.+++.+||+.||++||++.|+++.|+++
T Consensus 234 ~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 L-----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01122345678888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.77 Aligned_cols=241 Identities=23% Similarity=0.382 Sum_probs=190.1
Q ss_pred cccccCeEEEEEEEEc---CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 392 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.||+|+||.||+|.+. ++..||+|.+..... ..+++.+|+.+++++ +|+||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999864 345689998875532 235688999999998 9999999999885 45789999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-- 544 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 544 (682)
+|.+++.... ..+++..+++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999986432 34899999999999999999999998 99999999999999999999999999875533221
Q ss_pred -----CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 545 -----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 545 -----~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
..++..|+|||.+....++.++|||||||++||+++ |..||......+ ... .+......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~~~~~-------- 217 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMS-FIEQGKRL-------- 217 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHHCCCCC--------
Confidence 112457999999988889999999999999999996 999997543211 111 11111100
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.....+...+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 218 --~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 --DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 01112345666788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.60 Aligned_cols=251 Identities=22% Similarity=0.397 Sum_probs=201.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.+++|.++.... ..+.+.+|+++++++ +|+|++++++++..++..++||||++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIVLELAD 85 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEEEecCC
Confidence 467999999999999976 688999998864321 245788999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++..... ....+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 86 AGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999865332 2345889999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||.... .+............. ..
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~-~~--------- 227 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCDY-PP--------- 227 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCCC-CC---------
Confidence 2346778999999998889999999999999999999999996433 122222211111100 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
...+.....+.+++.+||+.+|++||++.++++.|+++.
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001123345678888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.60 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=196.9
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|.... ...+++|.+..... ..+++.+|+.++..+ +||||+++++.+..++..++|+|
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcEEEEE
Confidence 4679999999999998532 24688888765432 234688899999998 89999999999999999999999
Q ss_pred eccCCchhHhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe
Q 005693 462 YFASGSLSTLLHGNRG-------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 522 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 522 (682)
|+.+|+|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEE
Confidence 9999999999864321 11235889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005693 523 NQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 595 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~ 595 (682)
++++.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---- 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 999999999999987543221 1224567999999988889999999999999999999 99999754321
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
+ ............ ........+.+++.+|++.+|++||+++|+++.|+++...
T Consensus 237 --~-~~~~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 --R-LFNLLKTGYRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --H-HHHHHhCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1 111111111100 0112234577888899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.46 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=192.4
Q ss_pred hccccccCeEEEEEEEEc-----CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e 461 (682)
.+.||+|+||.||++..+ ++..|++|+++.... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCceEEEEE
Confidence 467999999999999753 467899999865432 245788999999999 999999999987543 46789999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 88 YLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999996432 24899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCC-------CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC---------CChhHHHHHHhh
Q 005693 542 PATP-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM---------VDLPRWVQSVVR 605 (682)
Q Consensus 542 ~~~~-------~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~---------~~l~~~~~~~~~ 605 (682)
.... .++..|+|||++.+..++.++|||||||++|||++|..|+......-. ............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 3221 123359999999988899999999999999999998877643321100 000000001111
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
+.. ...........+.+++.+||+.+|++|||++|+++.|++++
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 241 NNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 100 00111123345778888999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.28 Aligned_cols=234 Identities=21% Similarity=0.284 Sum_probs=182.4
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHH-HHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||+||+|+... ++.+|+|++..... ....+..|... +..+ +|+||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 369999999999999764 56799999875422 12334445444 4445 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 80 GGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999999743 23778888899999999999999998 99999999999999999999999999875422
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~---------~~~ 216 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPL---------QLK 216 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCc---------CCC
Confidence 12345789999999999999999999999999999999999999754321 11122111110 011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 651 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 651 (682)
.. ....+.+++.+|++.+|++||++.+.
T Consensus 217 ~~---~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 217 PN---ITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CC---CCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 11 22345667779999999999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.42 Aligned_cols=238 Identities=23% Similarity=0.313 Sum_probs=187.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhc--CCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++..+. +||||+++++++...+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 367999999999999965 478899999975431 1234666666654332 799999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 541 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 541 (682)
+++|+|..+++. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 84 AAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999988863 24899999999999999999999998 99999999999999999999999999865322
Q ss_pred ---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 542 ---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 542 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+......
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~~--------- 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEVR--------- 219 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---------
Confidence 12345788999999999999999999999999999999999999754322 111221111110
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
... .....+.+++.+|++.||++|| ++++++++
T Consensus 220 ~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 YPR---FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCC---CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011 1234456778899999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=304.58 Aligned_cols=239 Identities=24% Similarity=0.395 Sum_probs=187.0
Q ss_pred ccccccCeEEEEEEEEcC--------CceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 391 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
+.||+|+||+||+|.... ...+++|.+..... ..+.+..|+.++..+ +||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999998643 23477777754332 235677888888888 89999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC--------eEEeec
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--------GCISDF 533 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--------~kl~Df 533 (682)
|+++|+|.++++... ..+++..++.++.||+.|++|||+.+ |+||||||+||+++.++. ++++||
T Consensus 80 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 80 YVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred cCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999997543 24889999999999999999999998 999999999999987765 599999
Q ss_pred CCCCCCCCCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 534 GLTPLMNVPATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 534 Gla~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~-~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
|++..........++..|+|||++.+. .++.++||||||+++|||++|. .||....... .. ....... .
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~~~~--~ 223 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYEDRH--Q 223 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHHccc--c
Confidence 998776665556678889999999864 5789999999999999999985 5554322111 00 0111100 0
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
+ .......+.+++.+||+.+|++|||++++++.|+
T Consensus 224 -----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 -----L-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----C-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0112245678888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.18 Aligned_cols=234 Identities=21% Similarity=0.304 Sum_probs=183.4
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||+||+|... +++.+|+|++..... ....+..|..++.+..+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 578899999975422 2234555655544433999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 541 (682)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence 9999888643 34899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~---------~~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKP---------LVLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCC---------ccCCC
Confidence 12345788999999999999999999999999999999999999754321 1112221111 00011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDE 650 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 650 (682)
. ....+.+++.+|++.+|++||++++
T Consensus 218 ~---~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 G---ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred C---CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1 2234566777999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.33 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=194.3
Q ss_pred ccccccCeEEEEEEEEcC--C--ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||.||+|.+.+ + ..+|+|.+..... ..+++.+|+.+++++ +|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998643 2 2589999876644 345788999999999 99999999999988 88899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++..... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999975431 35899999999999999999999998 9999999999999999999999999987664421
Q ss_pred ------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 544 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 544 ------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ...........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~------- 219 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGER------- 219 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCc-------
Confidence 1234567999999998899999999999999999999 999996443221 11111111100
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
..........+.+++.+|++.+|++||+++|+++.|.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 ---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011123356778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.97 Aligned_cols=241 Identities=20% Similarity=0.337 Sum_probs=189.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.||+|+++.... ....+.+|++++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEEECCCC
Confidence 467999999999999975 478899999975421 234577899999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 85 GGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999743 24899999999999999999999998 999999999999999999999999998653211
Q ss_pred ----------------------------------------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC
Q 005693 543 ----------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 582 (682)
Q Consensus 543 ----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~ 582 (682)
....||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0124788999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 005693 583 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM 654 (682)
Q Consensus 583 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 654 (682)
.||......+ ....+.... ... .........+ .+.+++.+|+. +|.+|++ ++|++++
T Consensus 237 ~Pf~~~~~~~------~~~~i~~~~--~~~---~~~~~~~~s~---~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQE------TYRKIINWK--ETL---QFPDEVPLSP---EAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHH------HHHHHHcCC--Ccc---CCCCCCCCCH---HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997543211 111111100 000 0001111223 34556668886 8999998 9998874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.37 Aligned_cols=247 Identities=23% Similarity=0.395 Sum_probs=193.9
Q ss_pred hccccccCeEEEEEEEEc-CCc----eEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-EST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|.+. ++. .||+|.++.... ..+++.+|+.++..+ +|+||+++++++.. ...++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-CCcEEEEEc
Confidence 478999999999999854 333 478998865432 245678888888888 89999999999875 457899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 90 MPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999997532 24899999999999999999999998 999999999999999999999999999766432
Q ss_pred CC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.. ..++..|+|||...+..++.++|||||||++|||++ |..||......+ +..+ +......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~----- 230 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL----LEKGERL----- 230 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCcC-----
Confidence 21 123457999999998889999999999999999998 899986533211 1111 1111000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.........+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 001123345678888999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=301.69 Aligned_cols=242 Identities=21% Similarity=0.360 Sum_probs=190.6
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|.. .+++.+|+|.+..... ..+++.+|++++.++ +||||+++++++..++..++||||+++|
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 36799999999999986 4577899998865422 235688899999998 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--CC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT 544 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 544 (682)
+|..+.. +++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...... ..
T Consensus 85 ~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 85 SLDVYRK---------IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred ChHHhhc---------CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 9976532 778889999999999999999998 999999999999999999999999998765433 23
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh-hHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-PRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l-~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++.+..++.++||||||+++|+|++|+.||......+.... ............ .... .
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~-~--- 222 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------PVLP-V--- 222 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC------CCCC-C---
Confidence 4578889999999988899999999999999999999999975432221111 111111111100 0000 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+|++.+|++||+++|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122346778889999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.72 Aligned_cols=194 Identities=22% Similarity=0.406 Sum_probs=158.8
Q ss_pred hccccccCeEEEEEEEEc---CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~ 464 (682)
++.||+|+||+||+|... +++.+|+|.++.... ...+.+|+++++++ +||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999865 357899999865432 34578899999999 99999999999864 346789999986
Q ss_pred CCchhHhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe----cCCCCeEEeecCCC
Q 005693 465 SGSLSTLLHGNRG----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLT 536 (682)
Q Consensus 465 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla 536 (682)
+ +|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 88888753321 12235889999999999999999999998 9999999999999 45678999999999
Q ss_pred CCCCCCC-------CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 537 PLMNVPA-------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 537 ~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
+...... ...+|+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 7654321 23468889999998764 58899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.82 Aligned_cols=241 Identities=21% Similarity=0.305 Sum_probs=190.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.+++.+ +||||+++++++.+++..++||||++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEcCCC
Confidence 578999999999999975 47789999987532 1234567889999988 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999998642 3788889999999999999999998 999999999999999999999999998765432
Q ss_pred ---CCCCCCCcccCccccccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 ---ATPSRSAGYRAPEVIETR----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~----~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
....|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.... .....+.......
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~----- 266 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSL----- 266 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcC-----
Confidence 234578999999998653 3788999999999999999999999754321 1112221111000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 654 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 654 (682)
...........+.+++.+|++.+|++ ||+++|++++
T Consensus 267 ---~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 ---TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00111112345566777999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.87 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=196.2
Q ss_pred HhhccccccCeEEEEEEEE------cCCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEec-CceEE
Q 005693 388 ASAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLL 458 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~l 458 (682)
...+.||+|+||.||+|.. .+++.||||+++..... ...+.+|+.++.++.+|+||+++++++... ...++
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence 3467899999999999974 24678999999754322 345788999999998899999999988654 46789
Q ss_pred EEeeccCCchhHhhccCCCC------------------------------------------------------------
Q 005693 459 VYDYFASGSLSTLLHGNRGA------------------------------------------------------------ 478 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~------------------------------------------------------------ 478 (682)
||||+++|+|.++++.....
T Consensus 90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T cd05103 90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE 169 (343)
T ss_pred EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence 99999999999998643210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC------CCCCCCc
Q 005693 479 --GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAG 550 (682)
Q Consensus 479 --~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~ 550 (682)
....+++..+.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++....... ...++..
T Consensus 170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 0124688889999999999999999998 9999999999999999999999999987643221 1223567
Q ss_pred ccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHH
Q 005693 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ 629 (682)
Q Consensus 551 y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 629 (682)
|+|||.+.+..++.++||||||+++|||++ |..||......+ .......+...... .. .....
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-------~~---~~~~~ 310 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-------PD---YTTPE 310 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC-------CC---CCCHH
Confidence 999999988889999999999999999997 999987543211 11111111111000 00 11235
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 630 MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 630 l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
+.+++.+||+.+|++|||+.|++++|+.+.+.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 67888899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.95 Aligned_cols=243 Identities=22% Similarity=0.385 Sum_probs=190.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEec------CceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV~e~ 462 (682)
.+.||+|+||.||+|... +++.+|+|.+........++.+|+.++.++.+|+||+++++++... ...++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 467999999999999965 4678899998766555677889999999987899999999998753 357899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 99999999997532 234889999999999999999999998 999999999999999999999999998755322
Q ss_pred ----CCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 ----ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... ... . .........
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~-~-~~~~~~~~~- 236 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF-L-IPRNPAPRL- 236 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH-H-HhcCCCCCC-
Confidence 2344678899999986 3357889999999999999999999996432110 000 0 001000000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ......+.+++.+||..+|++|||++|++++
T Consensus 237 -----~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 237 -----KS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -----CC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 1123456788889999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.10 Aligned_cols=241 Identities=24% Similarity=0.454 Sum_probs=196.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||++...++..+++|.++.......++.+|+++++.+ +|||++++++++......++||||+++|+|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 467999999999999987788899999886666677899999999999 9999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ..++++.+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.+....... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 88 DYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9987432 24789999999999999999999998 9999999999999999999999999987543221 1
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+.+|+|||++.+..++.++||||||+++|||++ |..||...... ...... .+... ...+
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~~~--~~~~-------- 223 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETI-NAGFR--LYKP-------- 223 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHH-hCCCC--CCCC--------
Confidence 223467999999998889999999999999999998 99999753321 111111 11100 0001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
......+.+++.+||+.+|++|||++|++++|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11234677888999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.72 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=193.1
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|.+.+ +..|++|.+..... ....+.+|+.+++++ +|+||+++++++.+.+..++|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCcEEEEe
Confidence 4689999999999999754 45688888764432 235688899999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC---CeEEeecCCC
Q 005693 462 YFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT 536 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla 536 (682)
|+++|+|.+++...... ....+++..+.+++.||+.|++|||+.+ ++||||||+||++++++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccc
Confidence 99999999999754321 1235899999999999999999999998 99999999999998765 5899999998
Q ss_pred CCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
+...... ....+..|+|||++.+..++.++|||||||++|||++ |..||......+ ...........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~ 240 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTGGGRL 240 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHcCCcC
Confidence 7653221 1122457999999998899999999999999999997 999997543221 11111111000
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.........+.+++.+|++.+|++||++.+++++|+
T Consensus 241 -----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 -----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 001122346778888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=332.76 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=199.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... .++.||+|++..... ..+++.+|++++.++ +||||+++++++.+++..++||||++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 468999999999999975 478899999875422 135688899999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 465 SGSLSTLLHGNRG------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 465 ~g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
+|+|.+++..... ......++..+++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCccee
Confidence 9999999864211 11233667888999999999999999998 99999999999999999999999999876
Q ss_pred CCC----------------------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 005693 539 MNV----------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596 (682)
Q Consensus 539 ~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l 596 (682)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+...
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~- 241 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY- 241 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh-
Confidence 511 011347889999999999999999999999999999999999997533211100
Q ss_pred hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCCC
Q 005693 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 597 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~i~~~~~~ 664 (682)
... ..++. ......+....+.+++.+|++.||++|| +++++.+.|+...+..++
T Consensus 242 ---------~~~---i~~P~--~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 242 ---------RDV---ILSPI--EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred ---------hhh---ccChh--hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 000 00000 0000112234566788899999999996 577888889888776554
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=298.84 Aligned_cols=244 Identities=24% Similarity=0.488 Sum_probs=195.1
Q ss_pred hccccccCeEEEEEEEEcC-C---ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-S---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|.... + ..+++|.++.... ..+++.+|++++.++ +|+|++++.+++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEEEEEcC
Confidence 5789999999999999753 2 2688988865432 245688899999998 8999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||++.......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999996432 34899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CC-------CCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 544 TP-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 544 ~~-------~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.. ..+..|+|||++....++.++|||||||++|||++ |+.||...... .....+. ...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~-~~~------- 227 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIN-DGF------- 227 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHh-cCC-------
Confidence 11 12346999999998889999999999999999998 99999754321 1111111 110
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
......+....+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111122345678888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.15 Aligned_cols=232 Identities=22% Similarity=0.311 Sum_probs=181.9
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHH-HHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||.||+|+.. +++.+|+|++..... ...++..|... ++.+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999975 467899999875422 12345555554 4555 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|...+... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 80 GGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99999888642 34788899999999999999999998 999999999999999999999999998753221
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~---------~~~~ 216 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHKP---------LQLP 216 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcCC---------CCCC
Confidence 223478899999999988899999999999999999999999975431 11122221111 0001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMD 649 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 649 (682)
......+.+++.+|++.+|.+||++.
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 ---GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11233566778899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.42 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=183.5
Q ss_pred cccccCeEEEEEEEEcCC---ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 392 VLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.||+|+||+||+|...++ ..+++|.+..... ....+.+|+++++.+ +|+||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 589999999999975433 4577777654322 234677899998888 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++...........++.....++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997654332334567888999999999999999998 999999999999999999999999998654221
Q ss_pred --CCCCCCCcccCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 543 --ATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
....++..|+|||++.. ..++.++|||||||++|||++ |..||......+ .......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccC
Confidence 12234567999998743 346789999999999999999 788886543211 1111111110 011
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.++.. .......+.+++..|| .||++|||++||++.|
T Consensus 231 ~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 231 PKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111 1122234455667888 5999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.85 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=194.7
Q ss_pred HhhccccccCeEEEEEEEEc-----CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEE
Q 005693 388 ASAEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLL 458 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~l 458 (682)
...+.||+|+||.||++++. .+..||+|.++.... ..+.+.+|+++++.+ +|+||+++.+++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCceEE
Confidence 34577999999999999842 467899999875432 235788999999999 999999999998875 56789
Q ss_pred EEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.
T Consensus 86 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999986432 24899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---------CCCChhHHHHH
Q 005693 539 MNVPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD---------DMVDLPRWVQS 602 (682)
Q Consensus 539 ~~~~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~---------~~~~l~~~~~~ 602 (682)
..... ...++..|+|||++.+..++.++||||||+++|||+|++.|+...... .......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 54322 223455699999998888999999999999999999988765432110 00011111111
Q ss_pred HhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 603 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 603 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
..+.. ...........+.+++.+||+.+|++|||++++++.|+++
T Consensus 239 -~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -LEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11110 0011122345678888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=317.35 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=190.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||++... +++.+|+|+++.... ..+.+.+|+.++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEECCCC
Confidence 467999999999999965 578899999986533 234577888888877 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999997542 34899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ----CCCCCCcccCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 544 ----TPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~------~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
...+++.|+|||++. ...++.++|||||||++|||++|+.||...... .....+.......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~--- 228 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFL--- 228 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCcc---
Confidence 235788999999986 456789999999999999999999999754321 1112221111000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...........+.+++.+|++ +|++||++++++++
T Consensus 229 -----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 -----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000111123345667778997 99999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.88 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=193.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEE-ecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY-SKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~-~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||++... +..+++|.++... ..+.+.+|+.+++++ +|+|++++++++. .+...++||||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 578999999999999865 6778999886432 356788999999999 9999999999765 44578999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-CCCC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR 547 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 547 (682)
.++++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||++....... ....
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 161 (256)
T cd05082 88 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161 (256)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence 99997533 234889999999999999999999998 9999999999999999999999999987654322 2234
Q ss_pred CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHH
Q 005693 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 626 (682)
Q Consensus 548 ~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 626 (682)
+..|+|||++....++.++|||||||++|||++ |+.||.... ........ ...+.... ....
T Consensus 162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~~~~~----------~~~~ 224 (256)
T cd05082 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYKMDA----------PDGC 224 (256)
T ss_pred ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCCCCCC----------CCCC
Confidence 567999999998889999999999999999998 999986432 11111111 11111110 1123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 627 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 627 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
...+.+++.+|++.+|++|||++++++.|+++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 34567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.75 Aligned_cols=244 Identities=21% Similarity=0.318 Sum_probs=190.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|... +++.+|+|++..... ....+++|+.++.++ +|+||+++++++..++..++||||+++++
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 467999999999999964 577899999865432 334677899999988 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.++++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++...... .
T Consensus 93 L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 93 LQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99998642 24889999999999999999999988 999999999999999999999999998765422 2
Q ss_pred CCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...++..|+|||.+. ...++.++|||||||++|||++|+.||......+... ........ .+ ..
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~----~~---~~ 231 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSNFQ----PP---KL 231 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCCCC----CC---CC
Confidence 234677899999884 3447889999999999999999999986443211100 00000000 00 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.........+.+++.+||+.+|++||+++++++++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11112234667888899999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=324.85 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=192.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC--------ceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--------EKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 457 (682)
.+.||+|+||+||+|+.. +++.||+|++...... ...+.+|+..+..+ +|+||+++.+.+...+ ..+
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcccceEEE
Confidence 467999999999999854 5889999998755332 34577888888888 8999999988775432 257
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+||||+++|+|.++++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 99999999999999975332 2345899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCC------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 538 LMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 538 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ............
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~~~~--- 262 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLAGRY--- 262 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC---
Confidence 65421 234578899999999999999999999999999999999999975432 222222221111
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
++ ........+.+++.+||+.+|++||++.+++++
T Consensus 263 --~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 --DP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --CC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 011223456678889999999999999999874
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.37 Aligned_cols=245 Identities=25% Similarity=0.402 Sum_probs=187.8
Q ss_pred ccccccCeEEEEEEEEcC----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEe-cCceEEEEeec
Q 005693 391 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYF 463 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e~~ 463 (682)
+.||+|+||.||+|...+ ...+|+|++..... ..+.+.+|+.+++.+ +||||+++++++.. +...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998642 34689998754322 235677888888888 99999999998764 55678999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
.+|+|.+++.... ...++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999997432 23677888999999999999999987 9999999999999999999999999987543211
Q ss_pred --------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 544 --------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 544 --------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...++..|+|||.+....++.++||||||+++|||++| .+||..... .............
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~----- 221 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRRL----- 221 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCCCC-----
Confidence 12235679999999888899999999999999999995 556653221 1111111111000
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
.........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 222 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 ------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0001123457788889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=305.03 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=196.4
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||++... .+..+|+|.++..... .+.+.+|+++++++.+|+||+++++++...+..++|||
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 578999999999999742 2346899988754322 35688999999999789999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++|+|.++++... ...+++.++..++.|++.|++|||+.+ |+|+||||+||++++++.++++|||+++....
T Consensus 120 ~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 120 YCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred cCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999997433 123899999999999999999999988 99999999999999999999999999876543
Q ss_pred CC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 542 PA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 542 ~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
.. ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .........+...
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~--- 264 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRMA--- 264 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcCC---
Confidence 22 1234567999999999899999999999999999998 999997543211 1111111111100
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.. ......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 265 ----~~---~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 ----QP---EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 11234577788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.59 Aligned_cols=244 Identities=26% Similarity=0.440 Sum_probs=198.9
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|... ++.|++|.++......+++.+|+.++.++ +|+||+++++++......++||||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 578999999999999876 78899999987655566788999999999 8999999999999989999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-CCCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRS 548 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~ 548 (682)
+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.+||+|||.++....... ...+
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 89 DYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 9997433 224899999999999999999999998 99999999999999999999999999987643322 2234
Q ss_pred CcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHH
Q 005693 549 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 627 (682)
Q Consensus 549 ~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 627 (682)
..|+|||++....++.++||||||+++|||++ |..||......+ ........+... ......
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~----------~~~~~~ 225 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRME----------APEGCP 225 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCC----------CccCCC
Confidence 56999999988889999999999999999997 999997443211 111111111100 011223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 628 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 628 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
..+.+++.+|+..+|++||+++|+++.|+.+
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 5667888899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=307.81 Aligned_cols=233 Identities=24% Similarity=0.319 Sum_probs=186.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|... +++.||+|+++.... ..+.+..|.+++..+.+|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 367999999999999965 477899999875422 224566788888888678889999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 85 GGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999998643 34899999999999999999999998 999999999999999999999999998754322
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+..... ...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~~---------~~p 221 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHNV---------SYP 221 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC---------CCC
Confidence 2334788999999999988999999999999999999999999754321 11122111110 001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNM 648 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 648 (682)
......+.+++.+|++.+|++|++.
T Consensus 222 ---~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 ---KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122345677889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.02 Aligned_cols=241 Identities=19% Similarity=0.321 Sum_probs=187.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++... +++.||+|++..... ..+.+++|++++..+ +||||+++++++.+++..|+||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 467999999999999865 578899999865422 124577899999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 85 GGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999643 34888999999999999999999998 999999999999999999999999998632110
Q ss_pred -------------------------------------------------CCCCCCCcccCccccccCCCCCcchHHHHHH
Q 005693 543 -------------------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 573 (682)
Q Consensus 543 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv 573 (682)
....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0134788899999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCC---CCHHH
Q 005693 574 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR---PNMDE 650 (682)
Q Consensus 574 vl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~e 650 (682)
++|||++|..||......+ ....+.. +.... ....... ....+.+++.+|+. +|.+| +++.|
T Consensus 237 il~elltG~~Pf~~~~~~~------~~~~i~~--~~~~~---~~p~~~~---~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE------TYRKIIN--WRETL---YFPDDIH---LSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH------HHHHHHc--cCCcc---CCCCCCC---CCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999997543211 1111111 00000 0001111 12345566778887 66665 69999
Q ss_pred HHHH
Q 005693 651 VVRM 654 (682)
Q Consensus 651 vl~~ 654 (682)
++++
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 9885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=303.33 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=195.2
Q ss_pred hccccccCeEEEEEEEEcC-----------------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY 450 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 450 (682)
.+.||+|+||.||++...+ +..||+|.+..... ..+++.+|++++.++ +|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVC 88 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEeEEEEEE
Confidence 4679999999999998643 23578998875432 245788899999999 899999999999
Q ss_pred EecCceEEEEeeccCCchhHhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC
Q 005693 451 YSKDEKLLVYDYFASGSLSTLLHGNRGA------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 524 (682)
Q Consensus 451 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 524 (682)
..++..++||||+++++|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecC
Confidence 9999999999999999999999764421 1235899999999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCCCCh
Q 005693 525 DLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDL 596 (682)
Q Consensus 525 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--g~~Pf~~~~~~~~~~l 596 (682)
++.++|+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||......+ .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~ 242 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---V 242 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---H
Confidence 9999999999987543221 2234567999999988889999999999999999998 677876433211 1
Q ss_pred hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 597 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
................ ..........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 243 IENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111111100000 0011122356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.71 Aligned_cols=191 Identities=27% Similarity=0.392 Sum_probs=164.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.+|+|++..... ....+.+|+++++++ +|+||+++++.+.+++..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999965 467899999875432 234678899999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 85 GGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999998643 24788999999999999999999998 99999999999999999999999999753210
Q ss_pred ------------------------------------------------CCCCCCCCcccCccccccCCCCCcchHHHHHH
Q 005693 542 ------------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 573 (682)
Q Consensus 542 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv 573 (682)
.....||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 01124788899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 005693 574 LLLEMLTGKAPLQSPT 589 (682)
Q Consensus 574 vl~elltg~~Pf~~~~ 589 (682)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.46 Aligned_cols=256 Identities=20% Similarity=0.342 Sum_probs=189.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|+.+ +++.||+|.++.... ....+.+|++++.++ +|+||+++++++..++..++||||+++
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 467999999999999965 467799999875432 234577899999999 999999999999999999999999975
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 89 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 89 DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 8888876432 34788999999999999999999998 9999999999999999999999999987643322
Q ss_pred -CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-HHhhhcccc-----ccchh
Q 005693 544 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ-SVVREEWTA-----EVFDV 615 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~-~~~~~~~~~-----~~~d~ 615 (682)
...+++.|+|||++.+ ..++.++|||||||++|||+||+.||.+....+......... ....+.|.. ...+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 2346788999999865 457899999999999999999999998654322211100000 000000000 00000
Q ss_pred hhccc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 616 ELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 616 ~l~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... .........+.+++.+|++.||.+|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000 0001122345678889999999999999999883
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=302.09 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=192.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||++... +++.+|+|.+...... .+.+.+|+.++.++ +|+||+.+++.+.+++..++||||++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEEecC
Confidence 367999999999999965 4778999998654321 23467799999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 84 g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 84 GGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999886432 234889999999999999999999988 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...++..|+|||++.+..++.++||||||+++|||++|+.||......... ......... ... . ..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~-~~~-----~--~~- 225 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE-VQE-----E--YS- 225 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhh-hhh-----h--cC-
Confidence 235788899999999989999999999999999999999999754321110 001111100 000 0 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
......+.+++.+||+.||++||| ++|++++
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 226 --EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 112234667788999999999999 8898884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.72 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=197.8
Q ss_pred hccccccCeEEEEEEEEcC-----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEe-cCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e 461 (682)
.+.||+|+||.||+|...+ +..|++|+++.... ..+.+.+|+.++.++ +|+||+++++++.. +...++++|
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCCEEEEE
Confidence 4789999999999999765 67889998865422 245678899999999 99999999998776 467899999
Q ss_pred eccCCchhHhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 462 YFASGSLSTLLHGNRGA---GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999998654321 1245899999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 539 MNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 539 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
+.... ...++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+..... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~-~~~~-- 237 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------EMAAYLK-DGYR-- 237 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------HHHHHHH-cCCC--
Confidence 53321 2234567999999988889999999999999999999 99999754321 1111111 1110
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
..........+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 --------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00011223456788889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.37 Aligned_cols=241 Identities=22% Similarity=0.346 Sum_probs=187.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+++.. +++.+|+|++..... ....+.+|++++.++ +|+||+++++.+.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 467999999999999965 478899999865321 234578899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 85 GGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999743 24788899999999999999999998 99999999999999999999999999753210
Q ss_pred --------------------------------------------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHH
Q 005693 542 --------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 577 (682)
Q Consensus 542 --------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~e 577 (682)
.....||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 012357889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 005693 578 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP---NMDEVVRM 654 (682)
Q Consensus 578 lltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl~~ 654 (682)
|++|+.||.+....+ ....+.. +.... .......... .+.+++.+|+ .+|++|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~~------~~~~i~~--~~~~~---~~~~~~~~s~---~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE------TQLKVIN--WETTL---HIPSQAKLSR---EASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH------HHHHHhc--cCccc---cCCCCCCCCH---HHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997654221 1111110 10000 0001111222 3444555665 4999999 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.05 Aligned_cols=241 Identities=20% Similarity=0.293 Sum_probs=186.7
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+++... ++.+|+|.+..... ..+.+.+|+.++..+ +||||+++++++.+++..++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 4679999999999999764 67899999865321 234577888888887 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999632 3788999999999999999999998 999999999999999999999999999765432
Q ss_pred ---CCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
....||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .....+.......
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~----- 266 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSL----- 266 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCccc-----
Confidence 2345889999999987543 788999999999999999999999754321 1112221111000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 654 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 654 (682)
....... ....+.+++..|+..++.+ |++++|++++
T Consensus 267 ~~p~~~~---~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPEDVE---ISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCccc---CCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0001111 2233455666888765544 8999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=326.65 Aligned_cols=256 Identities=18% Similarity=0.269 Sum_probs=184.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhc-----CCCceeceEEEEEec-CceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSK-DEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~-~~~~lV~e~ 462 (682)
.+.||+|+||+||+|... .++.||||+++......+++..|++++..+. +|.+++++++++..+ ...++|||+
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~ 213 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK 213 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence 468999999999999965 4678999999754333455677777777762 345688899988765 467899998
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCC---------------
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDL--------------- 526 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~--------------- 526 (682)
+ +++|.+++... ..+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 214 ~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 214 Y-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred c-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 7 77898888643 2489999999999999999999974 7 99999999999998765
Q ss_pred -CeEEeecCCCCCCCCC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 005693 527 -DGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 604 (682)
Q Consensus 527 -~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~ 604 (682)
.+||+|||.+...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...........+
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 4999999987654332 24468899999999999999999999999999999999999998654322111100000000
Q ss_pred hhcccc--------ccc----------hhh-h---ccccChH--HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 605 REEWTA--------EVF----------DVE-L---MRFQNIE--EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 605 ~~~~~~--------~~~----------d~~-l---~~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...|.. +++ ++. + ....... .....+.+++.+||+.||++|||++|++++
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 000000 000 000 0 0000000 112457789999999999999999999983
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.42 Aligned_cols=243 Identities=24% Similarity=0.452 Sum_probs=195.9
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||++...++..+++|.++......+.+.+|+++++++ +|+||+++++++.. ...+++|||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 478999999999999988788899998876544456788999999998 89999999999877 7789999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-----
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----- 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 544 (682)
+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+........
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 89 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred HHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 9997533 234788999999999999999999988 99999999999999999999999999876543221
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++....++.++|+|||||++|+++| |+.||......+ + .. ......... ..
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~---~~-~~~~~~~~~----------~~ 225 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V---IR-ALERGYRMP----------RP 225 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H---HH-HHhCCCCCC----------Cc
Confidence 123456999999998889999999999999999999 899997543211 1 11 111111100 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1233457788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.60 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=203.4
Q ss_pred hhccccccCeEEEEEEEEcC--C--ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 389 SAEVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
..++||+|.||.|++|.|+. | -.||||.++.... ...+|.+|+.+|.++ +|+|++++||+..+ ....+|+|+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhHHhhh
Confidence 36889999999999999763 3 3589999987644 357899999999999 99999999999987 788899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
++.|+|.+.|++. .+..+-....-.++.|||.||.||..++ +|||||.++|+|+-....+||+|||+.+.+...
T Consensus 192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999862 2445778888899999999999999988 999999999999999999999999999988765
Q ss_pred CCCC-------CCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 543 ATPS-------RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 543 ~~~~-------~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
.... -...|.|||.+..+.++.++|||+|||++|||+| |..||.+....+++ +.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------Hhcc
Confidence 5433 2345999999999999999999999999999999 77888765422211 1122
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
.-.+......+.+++++++..||..+|.+|||+..+.+.+-...
T Consensus 330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 11233445678888999999999999999999999985444333
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.84 Aligned_cols=244 Identities=25% Similarity=0.491 Sum_probs=194.2
Q ss_pred hccccccCeEEEEEEEEcC-C---ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-S---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|.... + ..|++|.++.... ..+++..|+.+++.+ +||||+++++++.++...++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEEEEecC
Confidence 5789999999999999653 2 3599999875422 245788999999998 9999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++.+++.++.|++.|++|||+.+ ++|+||||+||+++.++.+|++|||++.......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 88 ENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999997432 24899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CC------CC---CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 544 TP------SR---SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 544 ~~------~~---~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. .+ +..|+|||++.+..++.++|||||||++|||++ |..||...... +...+. ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~~---- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDYR---- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCc----
Confidence 11 11 246999999998899999999999999999987 99999754321 111111 11110
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.....+....+.+++.+||+.+|++||++++++..|+++
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001122344567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.97 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=194.5
Q ss_pred hccccccCeEEEEEEEEcC-----------------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY 450 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 450 (682)
.+.||+|+||.||++...+ ...+|+|.+..... ...++.+|++++..+ +|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~ 88 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVC 88 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence 4679999999999986432 33588998875432 245788999999999 999999999999
Q ss_pred EecCceEEEEeeccCCchhHhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC
Q 005693 451 YSKDEKLLVYDYFASGSLSTLLHGNRGA------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 524 (682)
Q Consensus 451 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 524 (682)
..++..++||||+++|+|.+++...... ....+++..+..++.|++.|++|||+.+ ++||||||+||++++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcC
Confidence 9999999999999999999999754321 1234788899999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCCCCh
Q 005693 525 DLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDL 596 (682)
Q Consensus 525 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--g~~Pf~~~~~~~~~~l 596 (682)
++.++|+|||+++...... ....+..|+|||....+.++.++|||||||++|||++ |..||......+.
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~--- 242 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV--- 242 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---
Confidence 9999999999987653322 1223467999999888889999999999999999998 7788865432221
Q ss_pred hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 597 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
................. .....+...+.+++.+||+.||++||++.|+++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111110000 0011233567788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=296.25 Aligned_cols=241 Identities=27% Similarity=0.433 Sum_probs=194.4
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
++||+|+||.||++...+++.|++|.+..... ....+.+|+++++++ +|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36999999999999987789999999876543 245788999999998 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 544 (682)
.+++.... ..+++..+..++.+++.|++|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99996432 24788999999999999999999998 99999999999999999999999999876542211
Q ss_pred --CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 --PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 --~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...+..|+|||.+.+..++.++|+||||+++|||+| |..||....... .... ...... ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~-~~~~~~----------~~ 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRER-IESGYR----------MP 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHH-HhcCCC----------CC
Confidence 112446999999988889999999999999999999 888886543211 1111 111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
........+.+++.+|++.+|++|||++|+++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11123346788888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.20 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=193.3
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||++... ++..+++|.++.... ..+++.+|++++..+ +|+||+++++++......++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCceEEEEec
Confidence 578999999999999742 345788888765432 345789999999999 999999999999999999999999
Q ss_pred ccCCchhHhhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEee
Q 005693 463 FASGSLSTLLHGNRG----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 532 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 532 (682)
+++|+|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECC
Confidence 999999999975431 11134889999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 533 FGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 533 fGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
||++....... ...+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .......
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~ 239 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIECITQ 239 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHHHHHc
Confidence 99986543221 1223567999999999899999999999999999998 899986443211 1111111
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
. ... .........+.+++.+||+.||++||+++|+++.|+
T Consensus 240 ~-~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 G-REL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred C-ccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 000 001122345667888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.82 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=194.7
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|...+ +..+++|.+..... ....+.+|+.++..+ +|+||+++++++......++|||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCCCcEEEEe
Confidence 5789999999999998653 35799999865432 234678899999998 89999999999999999999999
Q ss_pred eccCCchhHhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 462 YFASGSLSTLLHGNRGA-----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
|+++|+|.+++...... ....+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccc
Confidence 99999999999653321 1234788999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
+...... ...++..|+|||.+.+..++.++|||||||++||+++ |..||......+. ... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~~~-~~~~~~ 239 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV------LKF-VIDGGH 239 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH------HHH-HhcCCC
Confidence 7543321 2234678999999988889999999999999999998 9999975432211 111 111111
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.. ........+.+++.+||+.+|++|||+.|+++.|+
T Consensus 240 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 LD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00 01112456778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.37 Aligned_cols=240 Identities=23% Similarity=0.347 Sum_probs=192.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+.++..+ +|+||+++++.+..+...++||||+++++
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 367999999999999864 578899998875433 345688899999887 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 543 (682)
|.+++... .+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 104 L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 99998632 3788999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||.+.+..++.++|||||||++|||++|+.||......+. +.. ..... .. . ....
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~~-~~~~~-~~-----~---~~~~ 239 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYL-IATNG-TP-----E---LQNP 239 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HHH-HhcCC-CC-----C---CCCc
Confidence 23567789999999988899999999999999999999999975432111 110 00000 00 0 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||..+|++||+++|++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2233456778889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.97 Aligned_cols=246 Identities=27% Similarity=0.456 Sum_probs=192.8
Q ss_pred ccccccCeEEEEEEEEcC-------CceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 391 EVLGKGSYGTAYKAVLEE-------STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
+.||+|+||.||+|+..+ +..+++|.+.... ....++.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998653 2468888876543 2345788899999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-----CeEEeecC
Q 005693 462 YFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-----DGCISDFG 534 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-----~~kl~DfG 534 (682)
|+++|+|.+++...... ....+++.+++.++.|++.|++|||+.+ ++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999753221 1234789999999999999999999988 99999999999999887 89999999
Q ss_pred CCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhc
Q 005693 535 LTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 607 (682)
Q Consensus 535 la~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~ 607 (682)
+++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||...... ...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~~~-~~~ 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQHV-TAG 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHHHH-hcC
Confidence 987543221 1234567999999999999999999999999999998 99999743311 111111 110
Q ss_pred cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 608 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
. ...........+.+++.+||+.+|++||+++++++.|++
T Consensus 230 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 001111233456788889999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=292.87 Aligned_cols=241 Identities=23% Similarity=0.385 Sum_probs=195.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|..+ ++..+++|.+.... ...+++.+|+++++.+ +||||+++++++.+++..++||||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEEeCCC
Confidence 367999999999999975 57889999886432 2345688899999998 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 84 GDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999997542 235889999999999999999999988 9999999999999999999999999987654432
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...+++.|+|||+..+..++.++|+||||+++|||++|+.||...... ......... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~---------- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIRG-VFPP---------- 220 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-CCCC----------
Confidence 224677899999999988999999999999999999999999754311 111111111 0000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 011234567788889999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.11 Aligned_cols=241 Identities=25% Similarity=0.410 Sum_probs=195.1
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|+++++++ +|+||+++++++..+...++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4569999999999999765 68899999875533 67899999999999 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----C
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----T 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----~ 544 (682)
.+++.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99986432 34899999999999999999999998 9999999999999999999999999987654432 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..++..|+|||++.+..++.++||||||+++|||++|+.||......+.. .. ...... . ......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~-----~---~~~~~~ 223 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNKPP-----P---TLSDPE 223 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccCCC-----C---CCCchh
Confidence 23677899999999888999999999999999999999999754322110 00 000000 0 011111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++.+||+.+|++|||++|++++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 223456778889999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.48 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=192.2
Q ss_pred hccccccCeEEEEEEEEcCC---------------ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEES---------------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~---------------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~ 452 (682)
.+.||+|+||.||++...+. ..||+|.+..... ...++.+|++++.++ +|+|++++++++..
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~ 88 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLLGVCVS 88 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEcC
Confidence 46799999999999876431 2488998865422 235688999999999 99999999999999
Q ss_pred cCceEEEEeeccCCchhHhhccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC
Q 005693 453 KDEKLLVYDYFASGSLSTLLHGNRGA-------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525 (682)
Q Consensus 453 ~~~~~lV~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~ 525 (682)
++..++||||+++++|.+++...... ....+++..++.++.|++.|++|||+.+ ++||||||+||+++++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~ 165 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNH 165 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCC
Confidence 99999999999999999998643210 1123788999999999999999999998 9999999999999999
Q ss_pred CCeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCCCChh
Q 005693 526 LDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLP 597 (682)
Q Consensus 526 ~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--g~~Pf~~~~~~~~~~l~ 597 (682)
+.+||+|||++....... ...++..|+|||++....++.++|||||||++|||++ +..||......+ ..
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~ 242 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VI 242 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HH
Confidence 999999999987543221 1223567999999998889999999999999999998 667776543221 11
Q ss_pred HHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 598 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
................. ........+.+++.+||+.+|++||++++|++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 243 ENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111110000000 001123467888889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.28 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=198.1
Q ss_pred hccccccCeEEEEEEEEc-----CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~ 460 (682)
.+.||+|+||.||+|.+. .+..+|+|.++..... .+++.+|+++++.+ +|+||+++++++.. ....++||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCceEEEE
Confidence 377999999999999864 3578999999866553 56799999999999 99999999999877 55789999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+....
T Consensus 88 e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 88 EYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999997543 24899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCC-------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHHHh
Q 005693 541 VPAT-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---------DLPRWVQSVV 604 (682)
Q Consensus 541 ~~~~-------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~---------~l~~~~~~~~ 604 (682)
.... ...+..|+|||.+.+..++.++||||||+++|||+||+.|+......... ....+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-HH
Confidence 3221 12344599999998888999999999999999999999998654322110 0111111 11
Q ss_pred hhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 605 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 605 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
.... ...........+.+++.+||+.+|++|||+.|++++|+.++
T Consensus 240 ~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 KEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1100 00111123356788899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.14 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=190.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||++... +++.+|+|.+...... ...+.+|++++..+ +|+||+.+.+++..++..++||||++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEEecc
Confidence 367999999999999975 5778999998654321 23467899999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 84 GGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred CccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 999998886432 234899999999999999999999998 9999999999999999999999999986553322
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...++..|+|||++.+..++.++|+||||+++|||++|+.||........ ... ........ ......
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~-~~~~~~~~--------~~~~~~ 226 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REE-VDRRVLET--------EEVYSA 226 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhhhcc--------ccccCc
Confidence 23568899999999988999999999999999999999999975432111 000 11101000 000011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
.....+.+++.+|++.+|++||+ +++++.+
T Consensus 227 ---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 ---KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 12234567778999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=297.78 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=194.4
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|..++ +..||+|.++..... ..++.+|+.+++++ +|+||+++++++...+..++|||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEe
Confidence 5789999999999997542 447899987644322 34577888899988 89999999999999999999999
Q ss_pred eccCCchhHhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 462 YFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
|+++|+|.+++..... .+....++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCcc
Confidence 9999999999975321 11234677888999999999999999998 999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
+...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +...........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~~ 240 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFVMDGGYL 240 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC
Confidence 7543221 1123567999999998889999999999999999999 78898754321 111111111100
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
.........+.+++.+|++.+|++|||+.++++.|++..
T Consensus 241 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 241 -----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 001122356778888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=297.93 Aligned_cols=245 Identities=27% Similarity=0.488 Sum_probs=192.3
Q ss_pred hccccccCeEEEEEEEEcCC-ceEEEEEeeccccChhh---HHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~---~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+++...+ +.+|+|++......... ..+|+.++.++ +|+||+++++++......++||||+++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccccccccccccccccc
Confidence 46899999999999998764 57999999876543332 34588999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC----C
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----V 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~----~ 541 (682)
++|.+++.. ...+++..+..++.|+++||++||+.+ ++|+||||+||++++++.++|+|||.+.... .
T Consensus 83 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 83 GSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccc-----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999972 234899999999999999999999998 9999999999999999999999999986531 1
Q ss_pred CCCCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 PATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||......+. ........... . ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~----~-~~~~--- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKRP----L-PSSS--- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHTH----H-HHHT---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccccc----c-cccc---
Confidence 22345678899999998 78899999999999999999999999985511111 01111111000 0 0000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||+.||++||++++++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112677888889999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.77 Aligned_cols=244 Identities=26% Similarity=0.515 Sum_probs=194.4
Q ss_pred hccccccCeEEEEEEEEcC----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|.... +..+|+|.++.... ..+.+.+|+.++.++ +||||+++++++..++..++||||+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEcC
Confidence 5789999999999998642 33688998865432 235788899999998 8999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||++.......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 88 ENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999987654322
Q ss_pred C-------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 544 T-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 544 ~-------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ...+..|+|||++.+..++.++|+||||+++||+++ |..||......+ . .... .+...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~---~~~~-~~~~~------ 227 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V---IKAI-EEGYR------ 227 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H---HHHH-hCCCc------
Confidence 1 112356999999998889999999999999999887 999997543211 1 1111 11110
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
..........+.+++.+|++.+|++||++.++++.|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000112234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=322.16 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=186.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEec--------CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~lV~ 460 (682)
.+.||+|+||.||+|... .++.||+|++... .....+|+.+++.+ +|+||+++++++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 578999999999999975 4788999988543 23445799999999 999999999887532 1356899
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLM 539 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~ 539 (682)
||+++ +|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+..
T Consensus 147 E~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred ecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 99975 77776653221 2345899999999999999999999998 99999999999999665 6999999999865
Q ss_pred CCCC---CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----------h
Q 005693 540 NVPA---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----------R 605 (682)
Q Consensus 540 ~~~~---~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~----------~ 605 (682)
.... ...+++.|+|||++.+. .++.++|||||||++|||++|.+||.+....+. +........ .
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhc
Confidence 4322 34578889999998654 689999999999999999999999986543211 111111000 0
Q ss_pred hcccc----ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhh
Q 005693 606 EEWTA----EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQ 660 (682)
Q Consensus 606 ~~~~~----~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i~~ 660 (682)
..+.. .+....+.. .........+.+++.+||+.||++|||+.|+++ .++.+..
T Consensus 300 ~~~~~~~~~~~~~~~l~~-~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKK-VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hhhhcccCCccCchhHHH-HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 00000 000000000 000012245778888999999999999999997 4555443
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.68 Aligned_cols=194 Identities=22% Similarity=0.406 Sum_probs=158.0
Q ss_pred hccccccCeEEEEEEEEcC---CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~ 464 (682)
+..||+|+||+||+|...+ +..+|+|.+..... ...+.+|++++.++ +||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999653 46799998865432 34678899999999 99999999999854 456789999986
Q ss_pred CCchhHhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe----cCCCCeEEeecCCC
Q 005693 465 SGSLSTLLHGNRG----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLT 536 (682)
Q Consensus 465 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla 536 (682)
+ +|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 78777753221 12235889999999999999999999998 9999999999999 56678999999999
Q ss_pred CCCCCCC-------CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 537 PLMNVPA-------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 537 ~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
+...... ...+++.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 7654322 22457889999998764 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.32 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=188.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhc--CCCceeceEEEEEec-----CceEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSK-----DEKLL 458 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~-----~~~~l 458 (682)
.+.||+|+||+||+|... +++.||+|.++.... ....+.+|++++..+. +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 367999999999999976 477899998875422 1235667888777664 699999999988642 35789
Q ss_pred EEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
||||+++ +|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 85 v~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 85 VFEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 9999975 8988886432 234899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---hhhcccccc
Q 005693 539 MNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEWTAEV 612 (682)
Q Consensus 539 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~---~~~~~~~~~ 612 (682)
..... ...++..|+|||++.+..++.++||||+||++|||++|++||......+. +.+..... ....+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhhCcccc
Confidence 64332 23467889999999988899999999999999999999999975432211 11111000 001111000
Q ss_pred ------chhhhc-c-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 ------FDVELM-R-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ------~d~~l~-~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+..... . .....+....+.+++.+|++.||++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0 00001223456788889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.01 Aligned_cols=240 Identities=20% Similarity=0.278 Sum_probs=191.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||++... +++.+++|.+..... ..+.+++|++++.++ +||||+++++++..++..++|+||
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEEEEEE
Confidence 578999999999999864 578899998864322 124578899999998 999999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 86 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 86 MPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999998643 34888999999999999999999998 999999999999999999999999998654322
Q ss_pred -------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 -------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 -------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
....++..|+|||.+.+..++.++||||+|+++|||++|+.||......+ ............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~----- 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQPTNP----- 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HHHHHhccCCCC-----
Confidence 12335678999999999889999999999999999999999997532110 011111111000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||..+|++|||++|++++
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011223456678889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.94 Aligned_cols=255 Identities=20% Similarity=0.301 Sum_probs=188.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC-----ceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~ 460 (682)
.+.||+|+||.||++... +++.||+|++..... ..+++.+|++++..+ +|+||+++++++...+ ..++|+
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceEEEEe
Confidence 467999999999999964 678999999865422 235678899999999 8999999999998776 789999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 84 ELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9996 5888877532 34899999999999999999999998 9999999999999999999999999987653
Q ss_pred CCC-----CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChh---------HHHHHHh-
Q 005693 541 VPA-----TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP---------RWVQSVV- 604 (682)
Q Consensus 541 ~~~-----~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~---------~~~~~~~- 604 (682)
... ...+++.|+|||++.+. .++.++||||+||++|||++|+.||.+....+..... .......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 221 23457789999998774 4789999999999999999999999865432211100 0000000
Q ss_pred --hhccccccch-hhhcc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 605 --REEWTAEVFD-VELMR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 605 --~~~~~~~~~d-~~l~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......... +.... .....+....+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 00000 00001123456788889999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.12 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=197.9
Q ss_pred hhccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 389 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
..+.||+|+||+||++... +++.+|+|++..... ..+.+.+|++++..+ +||||+++++++......++||||+++
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEecCCC
Confidence 3578999999999999965 477889988765432 246788999999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
++|.+++... ..+++..+..++.+++.|+.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 88 ~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 88 GSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 9999998642 248999999999999999999997 45 9999999999999999999999999986543222
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-----CChhHHHHHHhhhccccccchhhh
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-----VDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
...++..|+|||++.+..++.++|||||||++|||++|+.||......+. ..+..+......+...
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP-------- 231 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--------
Confidence 23578889999999888899999999999999999999999986543211 1112222222211100
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.. ...+....+.+++.+|++.||++|||++|++++..-+
T Consensus 232 -~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 232 -RL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred -CC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 00 0112334577888899999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=298.10 Aligned_cols=247 Identities=23% Similarity=0.413 Sum_probs=194.5
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... ++..+|+|.+..... ..+++.+|+.++.++ +||||+++++++..++..++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCccEEEEe
Confidence 367999999999999864 357899999875432 245688899999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC
Q 005693 462 YFASGSLSTLLHGNRG-----------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 524 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 524 (682)
|+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~ 165 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGE 165 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecC
Confidence 9999999999974321 11234788999999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChh
Q 005693 525 DLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP 597 (682)
Q Consensus 525 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~ 597 (682)
++.++|+|||++....... ....+..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------ 239 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------ 239 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 9999999999987543221 1223556999999998899999999999999999998 88888644321
Q ss_pred HHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 598 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
+......... ... ........+.+++.+|++.+|++|||++|+++.|++
T Consensus 240 ~~~~~~~~~~-~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYVRDGN-VLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHhcCC-CCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1122111111 000 011223467788889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.39 Aligned_cols=182 Identities=25% Similarity=0.361 Sum_probs=155.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.... +..||+|.... .....|+.+++++ +|+||+++++++......++|+||+. |+|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 5789999999999999764 56788887432 2345688899998 99999999999999999999999995 688
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---CCC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATP 545 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~~ 545 (682)
.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 144 ~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 144 YTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 8888643 234899999999999999999999998 999999999999999999999999998754322 234
Q ss_pred CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 005693 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585 (682)
Q Consensus 546 ~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf 585 (682)
.++..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 5788999999999999999999999999999999966554
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.07 Aligned_cols=251 Identities=18% Similarity=0.267 Sum_probs=188.9
Q ss_pred hccccccCeEEEEEEEEcC---CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++...+ +..|++|.+... ....+|+++++.+ +||||+++++++......++|||++. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 4689999999999997542 467888887542 3567899999999 99999999999999999999999985 6
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 171 ~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 171 DLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 88888842 234899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc---c----cc-
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---A----EV- 612 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~---~----~~- 612 (682)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+...................... . ..
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 235788999999999999999999999999999999999999765433211111111110000000 0 00
Q ss_pred -----chhhhccccChH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 -----FDVELMRFQNIE------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 -----~d~~l~~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+..........+ .....+.+++.+|++.||++|||+.|++.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 112345677889999999999999999985
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.10 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=192.2
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++.... +..+|+|.++.... ...++.+|++++.++ +||||+++++++..++..++||||++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 4679999999999999754 56778887764322 234578899999999 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--C
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--A 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~ 543 (682)
+|.++++.. ..+++..+..++.|+++||.|||+. + ++||||||+||++++++.+||+|||++...... .
T Consensus 85 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 85 SLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 999999743 3488999999999999999999974 5 999999999999999999999999998765332 2
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc--------------
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT-------------- 609 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~-------------- 609 (682)
...++..|+|||.+.+..++.++||||||+++|||++|+.||......+. ..+..........
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccCCCCCc
Confidence 34567889999999888899999999999999999999999975432111 1100000000000
Q ss_pred ------cccchhhhcc---ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 610 ------AEVFDVELMR---FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 610 ------~~~~d~~l~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.+..+..... ..........+.+++.+||+.+|++|||++|++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000000000 0000012334778888999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=292.81 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=183.0
Q ss_pred cccccCeEEEEEEEEcCCc---eEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 392 VLGKGSYGTAYKAVLEEST---TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.||+|+||.||+|...++. .+++|.++.... ..+.+.+|+.++..+ +||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999854433 355666554322 345788898888888 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 541 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 541 (682)
+|.++++..... ....++.....++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999754321 234667788899999999999999988 99999999999999999999999999864321
Q ss_pred -CCCCCCCCcccCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 542 -PATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... .........+.. ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~-~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQQ-VKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhcc-ccc
Confidence 223346778999999853 235789999999999999997 5678764321 122222222211 112
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.++.+.. . ....+.+++..|| .+|++||+++|+++.|.
T Consensus 230 ~~~~~~~--~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL--P---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC--C---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222211 1 2234566777899 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=311.79 Aligned_cols=251 Identities=21% Similarity=0.270 Sum_probs=186.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||++.... ++.||+|... ...+.+|+++++++ +|+|||++++++..++..++|||++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 4679999999999999764 6779998632 23467899999999 99999999999999999999999995 689
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 543 (682)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 247 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 247 YTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 88886432 24899999999999999999999998 9999999999999999999999999987653221
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC-CCChhHHHHHHhhhcc------ccc----
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD-MVDLPRWVQSVVREEW------TAE---- 611 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~-~~~l~~~~~~~~~~~~------~~~---- 611 (682)
...||..|+|||++.+..++.++|||||||++|||++|..|+-...... ......-+..++.... ...
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 2347889999999999999999999999999999999887654322111 1111111111111100 000
Q ss_pred cc-----------hhhh--ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VF-----------DVEL--MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~-----------d~~l--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. .... ..+.........+.+++.+||+.||.+|||++|++++
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000 0000001112246678889999999999999999875
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.20 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=189.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEE-----ecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY-----SKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~-----~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||++... +++.+|+|.+........++..|+.++.++.+|+||+++++++. .++..++||||+
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 367999999999999865 46789999876544445678889999999877999999999884 334679999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 542 (682)
++|+|.+++..... ....+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 99999998864321 2235889999999999999999999988 999999999999999999999999998765432
Q ss_pred ---CCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 543 ---ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
....+++.|+|||++.. ..++.++||||+||++|||++|+.||........ ..... ........
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~- 250 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------LFKIP-RNPPPTLH- 250 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------Hhhcc-ccCCCccc-
Confidence 22347788999999853 4478899999999999999999999975432110 00000 00000000
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
........+.+++.+||+.+|++|||+.|++++.
T Consensus 251 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 251 -------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0111223577788899999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=308.84 Aligned_cols=236 Identities=20% Similarity=0.287 Sum_probs=182.1
Q ss_pred ccccCeEEEEEEEEc-CCceEEEEEeecccc-C---hhhHHHHHHHHHHhc--CCCceeceEEEEEecCceEEEEeeccC
Q 005693 393 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-G---KRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
||+|+||+||+|+.. +++.||+|++..... . ...+..|..++.... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 478899999865422 1 123445666666554 799999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 9999998642 34889999999999999999999998 999999999999999999999999998754221
Q ss_pred -CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 -ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....|++.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+..... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~-------~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGKV-------RFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCCC-------CCCC-
Confidence 234578899999998764 4789999999999999999999999754321 11111111110 0000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRP----NMDEVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~evl~ 653 (682)
.. ....+.+++.+||+.||++|| +++|+++
T Consensus 219 ~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01 123455677799999999998 5667666
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.39 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=194.8
Q ss_pred hccccccCeEEEEEEEEcCC----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|...+. ..+++|....... ..+.+.+|+.+++++ +|+||+++++++.+ +..++||||+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcEEEEEcC
Confidence 57899999999999986432 4688888765432 245788899999999 89999999998865 5678999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||+++......
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999997532 24899999999999999999999988 9999999999999999999999999987654332
Q ss_pred C-----CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 T-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 ~-----~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
. ..++..|+|||.+....++.++||||||+++|||++ |..||......+. ..........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERL-------- 227 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcC--------
Confidence 1 123457999999988889999999999999999996 9999975542211 1111111100
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.........+.+++.+|+..+|++|||+.++++.|+++....
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011122345777888999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=298.93 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=192.5
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.++..+ +|+||+++++++..++..++||||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 46799999999999996 4688999999875433 345678888888888 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 543 (682)
|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 103 L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 103 LTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred HHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 9999863 23788999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||.+.+..++.++|+|||||++|+|++|+.||........... ..... .+ .....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~---~~~~~ 238 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TP---ELQNP 238 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CC---CCCCc
Confidence 23467789999999988899999999999999999999999975432211100 00000 00 00011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.+|++||++++++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223445677889999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.51 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=192.5
Q ss_pred hccccccCeEEEEEEEEcC-Cc----eEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|.... +. .+|+|.+...... ..++.+|+.++..+ +|+||+++++++... ..++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Cceeeehh
Confidence 4679999999999998643 33 4688887654322 23678899999988 999999999998754 56799999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999987432 24889999999999999999999988 999999999999999999999999999765432
Q ss_pred CC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.. ..++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+ .. .........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~----- 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP----DLLEKGERL----- 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHCCCCC-----
Confidence 21 123567999999998889999999999999999998 899997543111 11 111111000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.........+.+++.+||..+|++||+++++++.|+++.+..
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 -----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 000112345678888999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.09 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=188.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEE---EEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCc--eEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVV---VKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE--KLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~va---vK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~--~~lV~e 461 (682)
.++||+|+|-+||+|.+.. |.+|| +|.-+..... -++|..|+++++.| +|+||++++.+|.+... .-+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeee
Confidence 3679999999999999653 56666 2222222222 26789999999999 99999999999987765 668999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMN 540 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~ 540 (682)
.+..|+|..|+++.+. .+....+.|+.||++||.|||++. |||||||||.+||+|+.+ |.|||+|+|+|+...
T Consensus 124 L~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999986553 778899999999999999999985 899999999999999865 899999999998887
Q ss_pred CCCC--CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 541 VPAT--PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 541 ~~~~--~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
.... -.|||.|||||++. ..|.+.+||||||+.|.||+|+..||..= .+.....++........ .+.
T Consensus 198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP~-sl~---- 266 (632)
T KOG0584|consen 198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKPA-ALS---- 266 (632)
T ss_pred ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCHH-Hhh----
Confidence 6543 46999999999997 68999999999999999999999999732 22222333332221111 100
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
... -..+.++|.+|+.. .++|||+.|+++
T Consensus 267 kV~-----dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 KVK-----DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccC-----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111 12345667799999 999999999998
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.63 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=186.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||.||++... .+..||+|++..... ....+.+|+.++..+ +||||+++++++...+ ..++|
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccccceeEEE
Confidence 478999999999999864 478899999865422 245677899999988 9999999999986543 46899
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 999975 66666642 2788899999999999999999998 999999999999999999999999999765
Q ss_pred CCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC------------ChhHHH----
Q 005693 540 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV------------DLPRWV---- 600 (682)
Q Consensus 540 ~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~------------~l~~~~---- 600 (682)
... ....+++.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. ......
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 332 2235688899999999999999999999999999999999999865321100 000000
Q ss_pred HHHhhhccc-cc-cchhhhccc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 601 QSVVREEWT-AE-VFDVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 601 ~~~~~~~~~-~~-~~d~~l~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
......... .. .+....... .........+.+++.+|++.||++|||++|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000000 00 000000000 00001124567888899999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.12 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=204.5
Q ss_pred HHHHHHHhhccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 382 LEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 382 ~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+++.. ..++||+|+||.||+|.++ .|..+|+|.+.- ..+-+++..|+.+++++ +.++||++||.|.....+++||
T Consensus 31 PEEVFD-i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 31 PEEVFD-IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred hHHHHH-HHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEeeh
Confidence 344432 3567999999999999865 478889998754 34467888999999999 9999999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
|||..|++.+.++.. ++++++.+...++...++||+|||... -||||||+.|||++.+|.+|++|||.|..+.
T Consensus 108 EYCGAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 108 EYCGAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred hhcCCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 999999999999853 456999999999999999999999987 8999999999999999999999999997765
Q ss_pred C----CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 541 V----PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 541 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
. ..+..||+.|||||++..-.|..++||||+|++..||..|++||.......-.- -+....
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------------MIPT~P 245 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------------MIPTKP 245 (502)
T ss_pred hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------------eccCCC
Confidence 4 345568999999999999999999999999999999999999997543211100 000011
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+...++-...+-+++++|+-+.|++|-|+-+++++
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12334455666678888899999999999999988764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.58 Aligned_cols=238 Identities=20% Similarity=0.324 Sum_probs=199.0
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
+.||+|.|+.|-+|++. .|..||||++.+... ....+.+|++-|+.+ +|||||++|++.......|+|+|+-++|
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEecCCc
Confidence 45999999999999843 688999999977644 345788899999888 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe-cCCCCeEEeecCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl-~~~~~~kl~DfGla~~~~~~~-- 543 (682)
||++|+.+.. ..+.+.-+.+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-+|++|||++-.+..+.
T Consensus 103 Dl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 103 DLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred hHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 9999997654 34899999999999999999999998 9999999999877 456889999999997766543
Q ss_pred -CCCCCCcccCccccccCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 -TPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
+.+|+..|-|||++.+..|+ +++||||+||+||.|+.|+.||+..+..+.+.+ ++|-...
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDCKYt--- 237 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDCKYT--- 237 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhccccc---
Confidence 56788899999999999986 578999999999999999999998776665432 2222111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
-......+..+||..|+..||++|-+.+||+..
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 223445556677779999999999999999863
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=295.14 Aligned_cols=244 Identities=22% Similarity=0.320 Sum_probs=189.5
Q ss_pred hhccccccCeEEEEEEEEcC-CceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 389 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
..+.||+|+||.||+|.... +..+++|.+.... ...+.+.+|++++..+ +|+||+++++++..+...++|+||+++|
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 45779999999999999765 5667888875432 2245678899999998 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 88 ~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 88 AVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 999888642 234899999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 543 ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
....++..|+|||++. ...++.++|||||||++|||++|+.||......+ ........... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~------~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEPP------TL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcCCC------CC
Confidence 2234678899999984 3457789999999999999999999997543111 11111111100 00
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.... .....+.+++.+||+.+|++||++++++++-
T Consensus 229 ~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 AQPS---RWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0111 1223566777899999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.71 Aligned_cols=242 Identities=21% Similarity=0.306 Sum_probs=186.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+++.+. ++.+|+|++..... ..+.+.+|+.++..+ +||||+++++++.+++..++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 126 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 5789999999999999764 67889999864321 234467788888887 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 99999998632 3788889999999999999999998 999999999999999999999999998765432
Q ss_pred ---CCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
....||+.|+|||++.... ++.++|||||||++|||++|+.||..... ......+........
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~---- 267 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSLT---- 267 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCccc----
Confidence 2345889999999986543 78899999999999999999999975432 111222221111000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRMI 655 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~L 655 (682)
...... ....+.+++.+|+..++.+ |++++|++++.
T Consensus 268 -~~~~~~---~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 -FPDDND---ISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -CCCcCC---CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111112 2334556666899844443 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.44 Aligned_cols=239 Identities=22% Similarity=0.350 Sum_probs=192.4
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||.|+||.||+|.. .+++.|++|.+..... ..+.+.+|+++++.+ +|+||+++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 36799999999999985 4678999999865433 345678899999998 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 543 (682)
|.+++... .+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 103 LTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 99998632 3899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||......+ ...... ...... ....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~-~~~~~~--------~~~~ 238 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIA-TNGTPE--------LQNP 238 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hcCCcc--------cCCc
Confidence 2346778999999998889999999999999999999999997543211 011110 000000 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
......+.+++.+||..+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122335667888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=290.07 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=193.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++... ++..+|+|.++... ...+.+.+|+.+++.+ +|+||+++++.+..++..++||||+++|
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 468999999999999965 57889999886432 2345678899999988 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.... ...+++.....++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.+.......
T Consensus 84 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 84 DLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999886432 234788999999999999999999998 9999999999999999999999999987654322
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.||..... ........... ....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~---------- 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGS-YKPL---------- 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCC-CCCC----------
Confidence 23467789999999988899999999999999999999999975321 11111111111 0000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||+.+|++||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122346778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.82 Aligned_cols=191 Identities=25% Similarity=0.388 Sum_probs=166.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++... +++.||+|++..... ....+.+|+.++..+ +|+||+++++.+.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 367999999999999975 478899999975422 234577888999988 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 85 GGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999643 34889999999999999999999998 999999999999999999999999998643211
Q ss_pred -------------------------------------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 005693 543 -------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585 (682)
Q Consensus 543 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf 585 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 1235788999999999999999999999999999999999999
Q ss_pred CCCC
Q 005693 586 QSPT 589 (682)
Q Consensus 586 ~~~~ 589 (682)
....
T Consensus 237 ~~~~ 240 (360)
T cd05627 237 CSET 240 (360)
T ss_pred CCCC
Confidence 7543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=295.99 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=191.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecC-----ceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~e~~ 463 (682)
.+.||+|+||.||++... +++.+|+|.+.........+.+|+.++.++.+|||++++++++...+ ..++||||+
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 357999999999999974 57789999987654445678889999999878999999999987543 579999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 542 (682)
++|+|.++++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 107 ~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 107 NGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 99999998864321 2334889999999999999999999988 999999999999999999999999998765432
Q ss_pred ---CCCCCCCcccCccccccCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 543 ---ATPSRSAGYRAPEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~~-----~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
....++..|+|||++.... ++.++|||||||++|||++|+.||......+ ....... ......
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~~-- 253 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK------TLFKIPR-NPPPTL-- 253 (291)
T ss_pred ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH------HHHHHhc-CCCCCC--
Confidence 2234677899999986433 6889999999999999999999997532111 0111110 000001
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+.....+.+++.+||+.+|++||++.|++++
T Consensus 254 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 ------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1112233457788889999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.42 Aligned_cols=243 Identities=22% Similarity=0.372 Sum_probs=189.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe------cCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|... .++.+|+|.+........++..|+.++.++.+|+||+++++++.. ....+++|||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 467999999999999974 467899998866544556788899999998789999999999853 4567999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ...+++..+..++.|++.|++|||+.+ |+|+||||+||++++++.++|+|||++......
T Consensus 101 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 101 CGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred CCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 99999999997543 234788889999999999999999998 999999999999999999999999998754322
Q ss_pred ----CCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 ----ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....++..|+|||.+. ...++.++|||||||++|||++|+.||......+... . ......
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~-~~~~~~---- 243 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPRNPP---- 243 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------h-HhhCCC----
Confidence 2344678899999985 3457889999999999999999999996543211100 0 000000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... ........+.+++.+||+.+|++||++.|++++
T Consensus 244 -~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 244 -PKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -CCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000 011233467788889999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.07 Aligned_cols=252 Identities=19% Similarity=0.339 Sum_probs=188.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.+++++ +|+||+++++++..++..++||||++ +
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 467999999999999875 467899999864432 234677899999999 99999999999999999999999997 5
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.... ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 89 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 89 DLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 8988886432 24789999999999999999999998 9999999999999999999999999987644322
Q ss_pred -CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----hhccccccc----
Q 005693 544 -TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----REEWTAEVF---- 613 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~----~~~~~~~~~---- 613 (682)
...+++.|+|||.+.+. .++.++|||||||++|||+||+.||......+. ........ .+.|.....
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhccccc
Confidence 23357789999998654 478899999999999999999999976542211 11111110 000000000
Q ss_pred -hhhhcccc------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 614 -DVELMRFQ------NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 614 -d~~l~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
........ ........+.+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 00012234567888999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=293.38 Aligned_cols=244 Identities=19% Similarity=0.306 Sum_probs=189.7
Q ss_pred hhccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 389 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
..+.||+|+||.||+|... +++.+|+|.++.... ....+.+|+.++..+ +||||+++++++..++..++||||++++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 3567999999999999865 477899998865432 234577888888888 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++... ..+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 92 ~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 92 SLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 999998643 24899999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
....++..|+|||++. ...++.++|||||||++|||++|+.||........ ............ ....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~----~~~~ 233 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNFQPP----KLKD 233 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCCCCC----cccc
Confidence 2335788899999974 45578899999999999999999999864332111 000000110000 0000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. .....+.+++.+|++.+|++||++++++++
T Consensus 234 ~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cC---CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 112346678889999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.11 Aligned_cols=192 Identities=26% Similarity=0.393 Sum_probs=160.0
Q ss_pred hcccccc--CeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.++||+| +||+||++..+ +++.||+|+++..... .+.+++|+++++.+ +||||+++++++..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEecc
Confidence 3579999 78999999864 5788999998754322 24567788888888 9999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC--
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-- 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-- 541 (682)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999996432 223889999999999999999999998 99999999999999999999999986433211
Q ss_pred ---------CCCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 005693 542 ---------PATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSP 588 (682)
Q Consensus 542 ---------~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~ 588 (682)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 111234567999999976 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=292.66 Aligned_cols=240 Identities=24% Similarity=0.350 Sum_probs=190.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC-------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|...+++.+|+|.++..... .+.+.+|+++++++ +|+||+++++++.+.+..++|+||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEEEEEec
Confidence 5679999999999999888889999988643221 24578899999999 899999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 541 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 541 (682)
+++++|.+++... ..+++..+..++.|++.|++|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 84 VPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999642 24788999999999999999999988 99999999999999999999999998865421
Q ss_pred ---------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 542 ---------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 542 ---------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
.....++..|+|||++.+..++.++||||||+++|||++|+.||......+ . ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~~--- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRGL--- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccCC---
Confidence 112346778999999998889999999999999999999999997432111 0 0000000000
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.+.. . ......+.+++.+||+.+|++||++.|+++
T Consensus 227 -~~~~--~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -MPRL--P---DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCC--C---CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0 112344567778999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=298.73 Aligned_cols=244 Identities=18% Similarity=0.297 Sum_probs=192.3
Q ss_pred HHHhhccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 386 LRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 386 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
+....+.||+||.+.||++...+.+.+|+|++.....+ -..|.+|+..|.++.+|.+||++++|-..++..|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 33456789999999999999988889999988765443 346899999999999999999999999999999999997
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
- ..||..+|+.... . .+...++.+..|++.++.++|++| |||.||||.|+|+- .|.+||+|||+|......
T Consensus 442 G-d~DL~kiL~k~~~---~-~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 442 G-DIDLNKILKKKKS---I-DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred c-cccHHHHHHhccC---C-CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 6 4599999985432 1 332378889999999999999999 99999999999985 578999999999877654
Q ss_pred C------CCCCCCcccCccccccCC-----------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 543 A------TPSRSAGYRAPEVIETRK-----------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 543 ~------~~~~~~~y~aPE~~~~~~-----------~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
. ...||+.||+||.+.... .+.++||||+||++|+|+.|+.||..- .....+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------~n~~aK--- 581 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------INQIAK--- 581 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------HHHHHH---
Confidence 3 456999999999985332 567999999999999999999999732 111111
Q ss_pred hccccccchhhhc-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 606 EEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 606 ~~~~~~~~d~~l~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
...+.|+.-. .+...+ ....+++++..|+..||++||+..|+++
T Consensus 582 ---l~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 ---LHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---HHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1223333211 111111 1122889999999999999999999987
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.69 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=191.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.+|+|++..... ..+.+.+|++++..+ +|+|++++++++......++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 357999999999999976 478899999865432 235678899999998 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+.|..++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 85 TVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred cHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 9888877532 23899999999999999999999988 9999999999999999999999999997765433
Q ss_pred --CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------------hcc
Q 005693 544 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR------------EEW 608 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~------------~~~ 608 (682)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+.. ....+... ..+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL---YLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhcccccc
Confidence 2345678999999876 45789999999999999999999999765422110 00000000 000
Q ss_pred ccccchhhhccccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 TAEVFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 ~~~~~d~~l~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+....... .......+.+++.+||+.+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000000 01123457788889999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=323.25 Aligned_cols=263 Identities=27% Similarity=0.397 Sum_probs=210.8
Q ss_pred CCCCCHHHHHHHhhccccccCeEEEEEEEEc--------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceece
Q 005693 377 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPL 446 (682)
Q Consensus 377 ~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l 446 (682)
.++++.+.+ ...+.||+|.||.|++|... ....||||.++.... ..+.+..|++++..+++|+||+.+
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 345555555 44569999999999999843 145699999987644 356799999999999999999999
Q ss_pred EEEEEecCceEEEEeeccCCchhHhhccCC---C------CCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 005693 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNR---G------AGR--TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI 515 (682)
Q Consensus 447 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~------~~~--~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDL 515 (682)
+|+|..+...++|+||+..|+|.++++..+ . ... ..++..+.+.++.|||.||+||++.. ++||||
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDL 444 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDL 444 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhh
Confidence 999999999999999999999999998776 1 111 23889999999999999999999987 999999
Q ss_pred CCCCeEecCCCCeEEeecCCCCCCCCCCCC--C---C--CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 005693 516 KASNVLINQDLDGCISDFGLTPLMNVPATP--S---R--SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS 587 (682)
Q Consensus 516 k~~NILl~~~~~~kl~DfGla~~~~~~~~~--~---~--~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~ 587 (682)
.++|||++++..+||+|||+|+.......+ . + ...|||||.+....|+.++|||||||+|||++| |..||.+
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999865433222 1 1 234999999999999999999999999999999 8899975
Q ss_pred CCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 588 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 588 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
... .... ...++++. +......+..++.++|..||+.+|++||++.|+.+.++....
T Consensus 525 ~~~-----~~~l-~~~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 525 IPP-----TEEL-LEFLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCc-----HHHH-HHHHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 221 1111 11222222 222334556778899999999999999999999999998643
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.62 Aligned_cols=244 Identities=19% Similarity=0.288 Sum_probs=186.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+++.. +++.+|+|.+..... ....+.+|..++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 467999999999999976 467799999875321 223467778888777 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999997532 24889999999999999999999998 9999999999999999999999999987654322
Q ss_pred ----CCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 544 ----TPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~----- 226 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEER----- 226 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCc-----
Confidence 2357889999999875 46788999999999999999999999754321 112222111100
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 654 (682)
........+....+.+++.+|+..++++ |+++++++++
T Consensus 227 --~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 --FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0001111122344566667888765544 5689988875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=297.88 Aligned_cols=238 Identities=22% Similarity=0.323 Sum_probs=190.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
-++||+||||+||-++.. +|+.+|.|++.+... ++.-...|-.++.++ +.+.||.+-..|+..+.+++|+..|+
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEEEeec
Confidence 368999999999999865 477889998865533 344567788899999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
||||.-+|.+.. ...+++..++.++.+|+.||++||..+ ||+|||||+|||+|++|+++|+|.|+|..+....
T Consensus 269 GGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 269 GGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred CCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 999999887543 345999999999999999999999998 9999999999999999999999999998876544
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...||.+|||||++....|+...|+||+||++|||+.|+.||........ .+.+.+.. ....-.-..
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~--------~~~~~ey~~ 411 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRT--------LEDPEEYSD 411 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHH--------hcchhhccc
Confidence 23689999999999999999999999999999999999999975432111 00011111 111111123
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNM 648 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 648 (682)
.++++.+.+.+ ..++.||++|.-.
T Consensus 412 kFS~eakslc~---~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 412 KFSEEAKSLCE---GLLTKDPEKRLGC 435 (591)
T ss_pred ccCHHHHHHHH---HHHccCHHHhccC
Confidence 45566666665 7788999998643
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.56 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=191.5
Q ss_pred ccccccCeEEEEEEEEcCC-ceEEEEEeeccccC-hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
-+||+|.||+||.|+..++ ..+|||-+...... .+-...|+..-+.+ +|.|||+++|.+.+++..-|.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 4799999999999997654 46899998766433 34577788888888 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec-CCCCeEEeecCCCCCCC----C
Q 005693 469 STLLHGNRGAGRTPL--DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMN----V 541 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~----~ 541 (682)
.++++. ...++ .+.....+..||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+. -
T Consensus 660 SsLLrs----kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 660 SSLLRS----KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred HHHHHh----ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999974 23455 67888889999999999999987 99999999999997 57899999999876553 3
Q ss_pred CCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh-c
Q 005693 542 PATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL-M 618 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~ 618 (682)
..+..||..|||||++..+ .|+.++|||||||++.||.||++||....... ..++...+ +
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-----------------AAMFkVGmyK 795 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-----------------AAMFKVGMYK 795 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-----------------Hhhhhhccee
Confidence 3466789999999999765 48999999999999999999999997554221 11111111 1
Q ss_pred ccc-ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 619 RFQ-NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 619 ~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.++ -.++...+...++.+|+.+||..||++.++++
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 122 23344455666778999999999999999987
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=300.88 Aligned_cols=244 Identities=17% Similarity=0.281 Sum_probs=185.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+++.+. ++.+|+|++.+... ....+.+|+.++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEEeccC
Confidence 4679999999999999765 56789999865321 233477788888887 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999997532 24889999999999999999999998 9999999999999999999999999986543221
Q ss_pred ----CCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 544 ----TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...|++.|+|||++. ...++.++|||||||++|||++|+.||..... ......+........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~--- 228 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ--- 228 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcccc---
Confidence 235789999999986 34578999999999999999999999975431 222222221110000
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPD--MRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPt~~evl~~ 654 (682)
...........+.+++.+|+..+++ .|++++|++++
T Consensus 229 ----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011112233455566677755444 47899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.60 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=189.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|+.++.++ +||||+++++++.++...++||||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 367999999999999975 578899999865432 235678899999999 89999999999999999999999997
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 83 MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 689888864332 245899999999999999999999998 9999999999999999999999999987554322
Q ss_pred --CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccc--cccch-
Q 005693 544 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWT--AEVFD- 614 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~~--~~~~d- 614 (682)
...+++.|+|||++.+. .++.++||||||+++|||+||+.||.+....+. ......... ...|. ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHHH
Confidence 22357789999988654 468899999999999999999999975432110 000000000 00000 00000
Q ss_pred -hhhccc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 -VELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 -~~l~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...... ........++.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 0001123345678889999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.55 Aligned_cols=245 Identities=23% Similarity=0.377 Sum_probs=194.7
Q ss_pred hccccccCeEEEEEEEEcC-Cc----eEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|..++ +. .+++|.++.... ...++.+|+.++.++ +|+||+++++++.. ...++||||
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceEEEEec
Confidence 5789999999999998643 22 588888765533 235688899999999 99999999999987 788999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 90 MPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999997543 23899999999999999999999987 999999999999999999999999999766433
Q ss_pred CCC------CCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 ATP------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~~~------~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
... ..+..|+|||.+....++.++|+||||+++||+++ |+.||...... ....... ....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~-~~~~------ 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLE-KGER------ 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHh-CCCC------
Confidence 221 12456999999988889999999999999999999 99999754321 1111111 1100
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
......+...+.+++.+||..+|.+||++.++++.|+++.+
T Consensus 230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00011122456778889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.57 Aligned_cols=238 Identities=24% Similarity=0.375 Sum_probs=193.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... .+..+|+|.+..... ....+.+|++++..+ +|+||+++++++.++...++||||+++|
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 466999999999999975 477899998875432 245688899999998 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++... .+++.....++.|++.|++|||+.+ ++|+||+|+||++++++.++++|||++.......
T Consensus 88 ~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 88 SALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999998632 3788999999999999999999987 9999999999999999999999999986654322
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...++..|+|||++.+..++.++|+|||||++|||++|+.||......... .. ..... ....
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~~~----------~~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FL-IPKNN----------PPTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hh-hhcCC----------CCCC
Confidence 223567799999998888999999999999999999999999754322111 00 00000 0111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||+.+|++||++++++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23345667788899999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.59 Aligned_cols=242 Identities=22% Similarity=0.329 Sum_probs=189.1
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|+... +..+++|.+..... ..+++.+|+++++.+ +|+||+++++++..+...++||||+++++
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 4679999999999999765 67899999865432 235678899999998 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|..++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++...... .
T Consensus 96 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 96 VDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 988875432 24899999999999999999999988 999999999999999999999999988654322 2
Q ss_pred CCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 544 TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
...++..|+|||++. ...++.++|||||||++|||++|+.||...... ........... +..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~------~~~- 235 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP------PTL- 235 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCCC------ccC-
Confidence 234677899999985 344678999999999999999999999653211 11111111110 000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||+.+|++||+++|++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111223456778889999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.95 Aligned_cols=244 Identities=18% Similarity=0.305 Sum_probs=185.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|..++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEEecCC
Confidence 467999999999999965 47889999987532 1234577888888887 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999996422 24889999999999999999999998 9999999999999999999999999986554322
Q ss_pred ----CCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 544 ----TPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...+++.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+......... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQF-P 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccC-C
Confidence 1347889999999863 4578899999999999999999999975432 1112222211110000 0
Q ss_pred hhhccccChHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAK--VPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPt~~evl~~ 654 (682)
. .....++. +.+++.+|+.. ++..||++++++++
T Consensus 231 ~---~~~~~~~~---~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 P---DVTDVSEE---AKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C---ccCCCCHH---HHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 01112333 34445565544 44458899999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=282.02 Aligned_cols=262 Identities=21% Similarity=0.351 Sum_probs=202.4
Q ss_pred CHHHHHHHhhccccccCeEEEEEEE-EcCCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEE
Q 005693 381 DLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 458 (682)
Q Consensus 381 ~~~~l~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 458 (682)
.++++++-+.+.||+|+|+.|-.+. +..+.++|||++.+.. -...+..+|++++.....|+||+.++++|++++..|+
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 4788888899999999999999887 6779999999997652 2356788999999999999999999999999999999
Q ss_pred EEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC---CeEEeecCC
Q 005693 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGL 535 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGl 535 (682)
|||-|.||.|..++++. ..+++.++.++..+|+.||.|||.+| |.||||||+|||-.+.. -+||+||.+
T Consensus 154 VfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999853 45999999999999999999999999 99999999999997664 479999988
Q ss_pred CCCCCC-----------CCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC----CC
Q 005693 536 TPLMNV-----------PATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM----VD 595 (682)
Q Consensus 536 a~~~~~-----------~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~----~~ 595 (682)
+.-... -.++.|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||.+....+. -.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 643211 12345677899999873 23488999999999999999999999987543221 11
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
..+-.+..+-+......+...-+.+..++.+.++ ++...+..++.+|.++.+++.
T Consensus 306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakd---lisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKD---LISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHH---HHHHHHhccHHhhhhhhhccC
Confidence 2222333222222222221111223334455544 445777899999999999887
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=294.99 Aligned_cols=238 Identities=24% Similarity=0.378 Sum_probs=191.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++.++ +|+||+++++++..+...++||||++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEccCCC
Confidence 466999999999999865 467899998864432 235688999999998 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++.......
T Consensus 88 ~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 88 SALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99999863 23889999999999999999999988 9999999999999999999999999987654322
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...++..|+|||++.+..++.++||||||+++|||++|+.||......+. ... ..... .+. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~~~~~-----~~~-----~ 221 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFL-IPKNS-----PPT-----L 221 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhh-hhcCC-----CCC-----C
Confidence 22467789999999988899999999999999999999999874432211 000 11110 000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||+.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11234457788889999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=305.09 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=187.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||.||++... .++.+|+|++...... ...+.+|+.+++.+ +||||+++++++.... ..++|
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccccceeEEE
Confidence 468999999999999864 4788999998754322 34567888899888 9999999999986443 46899
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+++ ++.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 999975 67666642 2788999999999999999999998 999999999999999999999999999865
Q ss_pred CCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHH-------H
Q 005693 540 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRW-------V 600 (682)
Q Consensus 540 ~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~---------l~~~-------~ 600 (682)
.... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+....+... .+.+ .
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 4432 2357889999999999899999999999999999999999997543211100 0000 0
Q ss_pred HHHhhhccc-ccc-c-----hhhhccc-cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 601 QSVVREEWT-AEV-F-----DVELMRF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 601 ~~~~~~~~~-~~~-~-----d~~l~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......... ... + +...... .........+.+++.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 000 0 0000000 0001123456788889999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=292.13 Aligned_cols=247 Identities=20% Similarity=0.352 Sum_probs=192.7
Q ss_pred hccccccCeEEEEEEEEcC--CceEEEEEeecccc-----------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCce
Q 005693 390 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV-----------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 456 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 456 (682)
.+.||+|+||.||+|..+. ++.+|+|.+..... ...++.+|+.++.+..+|+||+++++++..++..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999999765 57799998753211 1234666777777655899999999999999999
Q ss_pred EEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 457 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
++||||+++++|.+++..... ....+++..++.++.|++.|+.|||+ .+ ++|+||+|+||++++++.++|+|||.
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999998854221 23458999999999999999999996 55 99999999999999999999999999
Q ss_pred CCCCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 536 TPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 536 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
+....... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ............+. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~ 233 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIVEAVYE-PL 233 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHhhccCC-cC
Confidence 87655432 3346778999999998889999999999999999999999996432 11112221111110 00
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
........+.+++.+||+.||++||++.|+..+++
T Consensus 234 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 ---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00112345677888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=286.08 Aligned_cols=242 Identities=24% Similarity=0.375 Sum_probs=195.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||.++.. ++..+++|.+..... ..+++.+|+++++++ +|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 468999999999999854 477899998865432 245688999999998 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
|+|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 84 GTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred CcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999997542 234889999999999999999999988 9999999999999999999999999987654332
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...+++.|+|||.+.+..++.++||||||+++|||++|..||..... ..............
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~----------- 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQGNYTP----------- 220 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCC-----------
Confidence 34467889999999888889999999999999999999999975331 12222222111110
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
........+.+++.+||+.+|++||+++|+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0012234566778899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.47 Aligned_cols=245 Identities=22% Similarity=0.383 Sum_probs=191.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++... .+..+|+|.++..... ...+.+|++++.++ +|+||+++++++..++..++||||++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 467999999999999976 5788999988654222 35688899999998 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--C
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--A 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~ 543 (682)
+|.+++.... ....+++..+..++.|++.|+.|||+. + |+||||||+||+++.++.+||+|||++...... .
T Consensus 85 ~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 85 SLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred CHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 9999987432 123589999999999999999999974 5 999999999999999999999999998765332 2
Q ss_pred CCCCCCcccCccccccCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 TPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~------~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
...++..|+|||.+.+.. ++.++|+|||||++|||++|+.||....... .......... ....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~-~~~~------- 228 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVD-GDPP------- 228 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhh-cCCC-------
Confidence 334677899999986543 4789999999999999999999997542211 1111111111 0000
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||+.+|++||++++++.+
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 ---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0112234556778889999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.07 Aligned_cols=239 Identities=23% Similarity=0.372 Sum_probs=190.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 458 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 458 (682)
.+.||+|+||.||+|... +++.+|+|.+...... .+.+++|++++.++ +||||+++++++...+..++
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCccEE
Confidence 467999999999999864 4788999988654221 13577899999999 99999999999999999999
Q ss_pred EEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
||||+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||.++.
T Consensus 84 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 84 FLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999643 34888999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCC----------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 539 MNVPA----------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 539 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
..... ...++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIG-EN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHh-cc-
Confidence 64211 1235678999999998889999999999999999999999997542110 011100 00
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+. ........+.+++.+||+.+|++||++.|++++
T Consensus 228 ----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 ----ASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----CCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000 011223456677789999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.91 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=186.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec------CceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 459 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++..+ +|+||+++++++... ...+++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccccCcEEEE
Confidence 467999999999999864 567899999875422 234577899999999 899999999887543 346899
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+|++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 99 ~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 99 TNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred eecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 9987 7799888753 23899999999999999999999998 999999999999999999999999999766
Q ss_pred CCCC-CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---cccccc-
Q 005693 540 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---WTAEVF- 613 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~~~~- 613 (682)
.... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. +..+. ...... ....+.
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIM-EVVGTPSPEVLKKISS 245 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCCHHHHHhcch
Confidence 5432 3457888999999876 5688999999999999999999999975432110 00000 000000 000000
Q ss_pred ---h---hhhcccc--Ch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 ---D---VELMRFQ--NI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 ---d---~~l~~~~--~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. ..+.... .. ......+.+++.+|++.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 00 0111246788889999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=304.89 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=186.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec------CceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 459 (682)
.+.||+|+||.||++... .++.||+|++..... ....+.+|+.+++.+ +||||+++++++... ...++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccccCeEEEE
Confidence 467999999999999865 477899999875432 234677888899888 999999999987543 346999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 999975 77777642 2788899999999999999999998 999999999999999999999999999876
Q ss_pred CCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHH-----
Q 005693 540 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQS----- 602 (682)
Q Consensus 540 ~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~---------l~~~~~~----- 602 (682)
.... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+....+... .+.+...
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 5432 3357889999999999999999999999999999999999997653211100 0000000
Q ss_pred --Hhhhccc-cc-cchhhhcc-----c-cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 603 --VVREEWT-AE-VFDVELMR-----F-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 603 --~~~~~~~-~~-~~d~~l~~-----~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....... .. .+...... . .........+.+++.+|++.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00 00000000 0 0000112356788889999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.29 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=187.1
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
..||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++.++ +|+||+++++++..++..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 47999999999999965 467799998865432 345788999999998 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCCCCCC---
Q 005693 469 STLLHGNRGAGRTPL--DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~~--- 542 (682)
.+++.... ..+ ++..+..++.|++.|++|||+.+ |+||||||+||+++. ++.++|+|||++......
T Consensus 93 ~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 93 SALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 99997432 124 78888999999999999999988 999999999999986 678999999998654321
Q ss_pred -CCCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 -ATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
....++..|+|||++.... ++.++||||||+++|||++|+.||........ ..+....... .+.
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-------~~~--- 232 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKI-------HPE--- 232 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhcc-------CCC---
Confidence 1234678899999986543 78899999999999999999999975322110 0000000000 000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+.+++.+||+.+|++|||++|++++
T Consensus 233 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 --IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011223446677889999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=288.13 Aligned_cols=244 Identities=23% Similarity=0.376 Sum_probs=193.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+++++++ +||||+++++++......+++|||+++++
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 367999999999999975 467899999875432 346788999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||.+...... .
T Consensus 87 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 87 LQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999987532 34889999999999999999999988 999999999999999999999999998765432 2
Q ss_pred CCCCCCcccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 TPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~---~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...++..|+|||.+... .++.++||||||+++|||+||+.||......+. .......... .. ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~~~~~~----~~---~~ 226 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLISKSNFP----PP---KL 226 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCC----Cc---cc
Confidence 23467789999999776 788999999999999999999999975432111 0011111000 00 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||..+|.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1112234567788889999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=286.42 Aligned_cols=240 Identities=25% Similarity=0.429 Sum_probs=191.1
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++.++ +|+|++++++++..+ ..++||||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 57899999999999975 46789999986532 346788999999998 999999999998654 579999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-CCCCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRS 548 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~ 548 (682)
+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++....... ....+
T Consensus 87 ~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (254)
T cd05083 87 NFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160 (254)
T ss_pred HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence 9997532 234789999999999999999999988 9999999999999999999999999987644322 22235
Q ss_pred CcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHH
Q 005693 549 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 627 (682)
Q Consensus 549 ~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 627 (682)
..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ........ ......
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~~~~----------~~~~~~ 223 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VEKGYRME----------PPEGCP 223 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-HhCCCCCC----------CCCcCC
Confidence 67999999988889999999999999999998 99999754321 11111 11111100 011223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 628 VQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 628 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
..+.+++.+||+.+|++||+++++++.|+
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 45677888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.67 Aligned_cols=242 Identities=22% Similarity=0.349 Sum_probs=190.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||++... ++..+|+|.+..... ..+.+.+|+++++++ +|+||+++++++..+...++||||+++++
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 467999999999999975 578899999865432 235688899999999 79999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++.... ..+++..+..++.|++.|+.|||+.+ |+|+||||+||+++.++.++|+|||++...... .
T Consensus 89 L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 89 LDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999986432 34899999999999999999999998 999999999999999999999999987654322 1
Q ss_pred CCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 544 TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
...+++.|+|||.+. ...++.++||||||+++|||++|+.||...... +.......... +.+.
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~------~~~~ 229 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSEP------PTLD 229 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCCC------CCcC
Confidence 234678899999975 334678999999999999999999999754211 11111111110 0000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ......+.+++.+||+.+|++||++++++++
T Consensus 230 ~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QP---SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc---ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01 1122356677889999999999999999885
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=296.93 Aligned_cols=239 Identities=21% Similarity=0.320 Sum_probs=191.0
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
..||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++..+ +||||+++++++..++..++|+||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 46999999999999865 57889999986543 2345688899999998 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----CC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 544 (682)
.+++.. ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 998753 23889999999999999999999998 999999999999999999999999998654322 22
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..++..|+|||++.+..++.++|||||||++|||++|+.||......+ ..... ..... .......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~~~~-----~~~~~~~--- 241 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRL-RDSPP-----PKLKNAH--- 241 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-hccCC-----CCccccC---
Confidence 346788999999998889999999999999999999999997433111 11111 11100 0000111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++.+|++.+|++||+++|++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122345677789999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.31 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=192.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV~e~ 462 (682)
.+.||+|+||.||+|..+ +++.+++|++.......+++.+|+++++++.+|+||+++++++.... ..++||||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 467999999999999975 46789999987665556789999999999978999999999997654 47999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 91 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 91 CGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred CCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 999999999865331 1245899999999999999999999998 999999999999999999999999998654322
Q ss_pred ----CCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 ----ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....++..|+|||++.. ..++.++||||||+++|+|++|+.||....... ........ ...
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~--- 236 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIPRN-PPP--- 236 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhhcc-CCC---
Confidence 23346778999998753 346789999999999999999999996432111 11111111 000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...........+.+++.+||..||++|||++|++++
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 237 -----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 011112234567788889999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.03 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=193.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||.|+||.||+|... +++.+++|.+..... ....+.+|+++++.+ +|+||+++++++.++...++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 367999999999999965 477899999865432 235688899999999 7999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 85 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 85 SCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred cHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999999743 4899999999999999999999988 999999999999999999999999998776543
Q ss_pred CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....++..|+|||++.+..++.++||||||+++|||+||+.||......+ .... .......... ..
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~-~~~~~~~~~~-----~~-- 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFL-IPKNNPPSLE-----GN-- 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHH-hhhcCCCCCc-----cc--
Confidence 23346778999999998889999999999999999999999997543211 1111 1111111100 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++.+||..+|++|||+++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 023356678889999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=285.44 Aligned_cols=242 Identities=29% Similarity=0.483 Sum_probs=194.1
Q ss_pred hccccccCeEEEEEEEEcC-----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||++...+ +..+|+|.+..... ..+.+.+|++++..+ +|+||+++++++.+.+..+++|||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEEEec
Confidence 4679999999999999764 37799999976543 356788999999999 999999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.++++|||++......
T Consensus 83 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 83 MEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred cCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999975332 11899999999999999999999998 999999999999999999999999998765433
Q ss_pred CC-----CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 543 AT-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 543 ~~-----~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
.. ..++..|+|||.+.+..++.++||||+|+++|||++ |..||..... ........... ..
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~-~~------ 223 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKKGY-RL------ 223 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCC-CC------
Confidence 11 224578999999988889999999999999999999 7888865321 11111111111 00
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.........+.+++.+|++.+|++|||+.|+++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00111344677788899999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=285.61 Aligned_cols=241 Identities=20% Similarity=0.388 Sum_probs=194.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||++... +++.+++|.+..... ..+++.+|+++++++ +|+||+++++++...+..++|+||+++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 467999999999999864 578899999875422 235788899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++.... ...+++..+.+++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 84 GDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999987432 224789999999999999999999988 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...+++.|+|||++.+..++.++|+|||||++|+|++|+.||.... .............. .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~~-----------~ 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGSYP-----------P 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCCCC-----------C
Confidence 2346778999999998889999999999999999999999997432 11222222211110 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011223456778889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.07 Aligned_cols=247 Identities=23% Similarity=0.407 Sum_probs=192.8
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||+||+|+.+. .+.+++|.+...... .+++.+|+++++++ +|+||+++++++.+....++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcceEEEE
Confidence 3579999999999999642 356888887654332 35789999999999 99999999999998889999999
Q ss_pred eccCCchhHhhccCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 462 YFASGSLSTLLHGNRGAG----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
|+++|+|.+++....... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999997544211 125899999999999999999999998 9999999999999999999999999986
Q ss_pred CCCCCC-----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 538 LMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 538 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ......... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~~~~~~-~~~ 238 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNRLQAGK-LEL 238 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHHHHcCC-cCC
Confidence 543221 1223556999999988888999999999999999999 788986432211 111111111 000
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.........+.+++.+||+.+|++||++.|+++.|.
T Consensus 239 ---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 ---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001122346777888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.73 Aligned_cols=248 Identities=23% Similarity=0.441 Sum_probs=191.8
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC------ce
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EK 456 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~ 456 (682)
.+.||+|+||.||+|... .+..+|+|.++..... .+++.+|+++++++ +||||+++++++...+ ..
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcccce
Confidence 467999999999999854 3578999998764332 34678899999999 8999999999886542 23
Q ss_pred EEEEeeccCCchhHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 457 LLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
++++||+++|+|.+++.... ......+++.....++.|++.|++|||+.+ |+||||||+||++++++.+|++|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccc
Confidence 78999999999998875322 112234788999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 536 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 536 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
++...... ...+++.|++||.+....++.++||||||+++|||++ |+.||......+ + .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~---~~~~~~~~~ 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I---YNYLIKGNR 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H---HHHHHcCCc
Confidence 87654322 1223467999999998889999999999999999999 888887543211 1 111111110
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
. .........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 234 ~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 L-----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00012335678888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=296.11 Aligned_cols=240 Identities=21% Similarity=0.336 Sum_probs=190.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
...||+|+||.||++... ++..||+|.+..... ..+.+.+|+.++..+ +|+||+++++.+...+..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 456999999999999865 577899998865432 345688899999988 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++.. ..+++.++..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++...... .
T Consensus 106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 9998853 23889999999999999999999998 999999999999999999999999998654322 1
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...++..|+|||.+.+..++.++||||||+++|||++|+.||......+ .... .... ........
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~-~~~~-----~~~~~~~~--- 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ------AMRR-IRDN-----LPPRVKDS--- 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhc-----CCCccccc---
Confidence 2346778999999988889999999999999999999999997533211 0111 1110 01111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+|+..+|++|||++|++++
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122345567779999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=283.70 Aligned_cols=241 Identities=21% Similarity=0.346 Sum_probs=191.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC-ceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~e~~~ 464 (682)
.+.||+|+||.||++..+ +++.+++|++..... ..+.+.+|+++++++ +|+|++++++.+...+ ..++||||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEecccC
Confidence 467999999999999965 467899999865432 234678899999998 8999999999876444 5789999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+++|.+++.... ...+++.++..++.|++.|+++||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999997532 234899999999999999999999998 999999999999999999999999998765432
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....+++.|+|||++.+..++.++||||||+++|||++|+.||.... .......... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~--------- 221 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIE-GKLPP--------- 221 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHh-cCCCC---------
Confidence 22346788999999999899999999999999999999999997432 1122222111 11100
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+.+++.+|++.+|++||++.|++++
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011233457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.34 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=187.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++..+ +++.||+|+++.... ...++..|+..+.+..+|+||+++++++..+...++||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 367999999999999976 578999999876532 234566677766666699999999999999999999999996 6
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+|.+++...... ...+++..+..++.|++.|++|||++ + ++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 888887643322 24589999999999999999999986 6 9999999999999999999999999987654322
Q ss_pred -CCCCCCcccCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 544 -TPSRSAGYRAPEVIET----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~----~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
...++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... . .......... ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~~~~-~~~~------ 228 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVVEEP-SPQL------ 228 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHHhcC-CCCC------
Confidence 2346778999998865 44688999999999999999999999642211 1 1111111110 0000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+.+++.+||..+|++||++++++++
T Consensus 229 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 ---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001123456778889999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.38 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=187.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... ++..+++|+++.... ....+.+|++++.++ +|+||+++++++.+....++|+||++
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~- 82 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFEYCD- 82 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEecCC-
Confidence 367999999999999975 578899999865422 234677899999999 99999999999999999999999997
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 83 QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 58888776432 34899999999999999999999998 9999999999999999999999999987654332
Q ss_pred --CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------cc-----
Q 005693 544 --TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE-------EW----- 608 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~-------~~----- 608 (682)
...++..|+|||++.+.. ++.++|||||||++|||+||+.|+...... ......+... .+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----HHHHHHHHHHhCCCChHHhHHhhh
Confidence 234577899999987644 689999999999999999999886432211 1111111000 00
Q ss_pred ---cc--ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 ---TA--EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 ---~~--~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ...................+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 00000000000011123456678889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=292.76 Aligned_cols=241 Identities=24% Similarity=0.380 Sum_probs=191.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|... +++.||+|.+..... ..+++.+|+++++.+ +||||+++.+++..++..++||||++
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 467999999999999965 578899998864322 124678899999999 89999999999999999999999997
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
|++.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 99 -g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 99 -GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred -CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 57777765322 24899999999999999999999998 99999999999999999999999999987766556
Q ss_pred CCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..++..|+|||++. ...++.++||||||+++|||+||+.||...... .......... .. . .
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~-~~-----~----~ 234 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQND-SP-----T----L 234 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcCC-CC-----C----C
Confidence 66788899999884 456888999999999999999999999654211 1111111000 00 0 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
........+.+++.+||+.+|++||++.+++++.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1122345678888899999999999999998854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=287.39 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=193.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~~ 464 (682)
.+.||.|++|.||++... +++.+|+|.+..... ...++.+|+++++++ +|+||+++++++... ...++||||++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 367999999999999975 467889998875432 345688999999998 899999999998654 36799999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.+++..... ....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 85 GGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 9999988764322 2334788999999999999999999998 9999999999999999999999999987554322
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...++..|+|||.+.+..++.++||||+|+++|||++|+.||...... ............... ... ........
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~-~~~~~~~~-- 235 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMP-NPE-LKDEPGNG-- 235 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhcCC-chh-hccCCCCC--
Confidence 234677899999999889999999999999999999999999865331 111111111111100 000 00000000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.+|++|||+.|++++
T Consensus 236 -~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 236 -IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1123456788889999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=285.39 Aligned_cols=235 Identities=21% Similarity=0.315 Sum_probs=185.3
Q ss_pred ccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchhHh
Q 005693 393 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTL 471 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~ 471 (682)
||+|+||.||++..+ ++..+|+|.+........ |......+.+|+||+++++++..++..++||||+++|+|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 699999999999965 467788888765432211 222223333799999999999999999999999999999999
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCCCCCCCCCCc
Q 005693 472 LHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPATPSRSAG 550 (682)
Q Consensus 472 l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~ 550 (682)
+.... .+++.++..++.|+++|++|||+.+ ++||||||+||+++.++ .++|+|||++..........++..
T Consensus 100 l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 171 (267)
T PHA03390 100 LKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD 171 (267)
T ss_pred HHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCc
Confidence 97432 5899999999999999999999998 99999999999999998 999999999987776666678889
Q ss_pred ccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHH
Q 005693 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM 630 (682)
Q Consensus 551 y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l 630 (682)
|+|||++.+..++.++||||||+++|||++|+.||......+ .+...+.... .. ...........+
T Consensus 172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~------------~~~~~~~~~~~~ 237 (267)
T PHA03390 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK------------KLPFIKNVSKNA 237 (267)
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc------------cCCcccccCHHH
Confidence 999999998889999999999999999999999998543222 2222222221 00 001111233456
Q ss_pred HHHHHHcccCCCCCCCC-HHHHHH
Q 005693 631 LQIGMACVAKVPDMRPN-MDEVVR 653 (682)
Q Consensus 631 ~~l~~~Cl~~dP~~RPt-~~evl~ 653 (682)
.+++.+|++.+|++||+ ++|+++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 77778999999999996 688875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=289.30 Aligned_cols=241 Identities=24% Similarity=0.402 Sum_probs=195.1
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
+.||+|+||.||+|..+ ++..+++|++.......+.+.+|++++..+ +|+|++++++++...+..++|+||+++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 57999999999999976 578899999976544456788999999999 8999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----CCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATP 545 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~~~ 545 (682)
+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 9997532 25899999999999999999999988 999999999999999999999999987655432 223
Q ss_pred CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHH
Q 005693 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 625 (682)
Q Consensus 546 ~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 625 (682)
.++..|+|||++.+..++.++|||||||++|+|++|+.||...... .......... .. .......
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~--------~~~~~~~ 241 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTKG-IP--------PLKNPEK 241 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-CC--------CCcchhh
Confidence 4677899999998888999999999999999999999999643211 1111111110 00 0111112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 626 EMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 626 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....+.+++.+|++.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 33456778889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.81 Aligned_cols=243 Identities=23% Similarity=0.291 Sum_probs=188.3
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|... +++.||+|.+...... ...+..|..++....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 4788999998654321 123445555555555899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 545 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 545 (682)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccC
Confidence 9999999643 24889999999999999999999988 999999999999999999999999998776555555
Q ss_pred CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHH
Q 005693 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 625 (682)
Q Consensus 546 ~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 625 (682)
.++..|+|||.+.+..++.++||||||+++|||++|..||......+ ........... ... .....
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~---~~~-----~~~~~ 219 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRRIN---WPE-----EVKEF 219 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcccC---CCC-----ccccc
Confidence 67888999999988888999999999999999999999997543211 11111110000 000 00112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 626 EMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 626 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
....+.+++.+||+.+|++||++.++.+.|
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 335567888899999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=293.09 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=189.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++.... ++.|++|.+..... ..+.+.+|++++..+ +|+||+++++.+..++..++||||++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence 3679999999999999754 57899998875432 234677888999888 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+++|.+++... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||+++.....
T Consensus 85 g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 85 GGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999643 24889999999999999999999998 999999999999999999999999988642110
Q ss_pred -----------------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 543 -----------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 543 -----------------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
....++..|+|||.+....++.++|+||||+++|||++|..||.+.... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~ 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVIS 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh
Confidence 0123566799999998888999999999999999999999999754321 11121111
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
... ..+ .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~----~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDI----EWP-----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccc----CCC-----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 000 0001123446778889999999999997666655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=291.91 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=190.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|... +++.|++|+++..... ...+..|+++++++ +|+||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEEEEcc
Confidence 357999999999999965 5789999999765322 33567789999998 899999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+ +|+|.+++.... ..+++..+..++.||++||+|||+++ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 ~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 84 M-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred c-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9 899999997432 24899999999999999999999998 999999999999999999999999998766443
Q ss_pred C----CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhcc-----c
Q 005693 543 A----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEW-----T 609 (682)
Q Consensus 543 ~----~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~-----~ 609 (682)
. ...++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+. +.+...... ...+ .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhcccc
Confidence 2 1234667999998854 4578899999999999999999888865432111 111110000 0000 0
Q ss_pred cccchhhhcc----ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 AEVFDVELMR----FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 ~~~~d~~l~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......... ..........+.+++.+||+.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 00112234567788899999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=286.06 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=189.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---C--------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---G--------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~--------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 457 (682)
.+.||+|+||.||+|... +++.+|+|.++.... . .+.+.+|++++..+ +|+|++++++++...+..+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccCCceE
Confidence 468999999999999864 578899998853211 0 13567888999998 8999999999999999999
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+||||+++|+|.+++... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++++|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999743 34889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCC------CCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 538 LMNVPA------TPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 538 ~~~~~~------~~~~~~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
...... ...++..|+|||.+.... ++.++||||||+++||+++|..||...... .... ...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~-~~~~~~-~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMF-KLGNKR-S 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHH-Hhhccc-c
Confidence 654321 234677899999987654 789999999999999999999999633211 1111 111000 0
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+... ...+....+.+++.+||+.+|++||+++|++++
T Consensus 230 ~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0011110 011223566778889999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=289.15 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=189.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCc-----eEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lV~ 460 (682)
.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+.++..+.+|+||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 467999999999999975 578899998765432 235678899999999778999999999987665 79999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLM 539 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~ 539 (682)
||+++ +|.+++..........+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99985 8988886543322345899999999999999999999998 999999999999998 889999999998765
Q ss_pred CCCC----CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc--ccccc
Q 005693 540 NVPA----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE--WTAEV 612 (682)
Q Consensus 540 ~~~~----~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~--~~~~~ 612 (682)
.... ...+++.|+|||++.+ ..++.++||||||+++|||++|..||.+....+ ....+.... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ------QLLHIFKLLGTPTEQV 235 (295)
T ss_pred CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHHhCCCChhh
Confidence 3321 2235678999998865 457899999999999999999999997543211 111111000 00000
Q ss_pred c----h-hh---hcc--c----cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 F----D-VE---LMR--F----QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ~----d-~~---l~~--~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+ + .. ... . ...+.....+.+++.+||+.+|++||+++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0 00 000 0 0001233456788889999999999999999763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=289.30 Aligned_cols=240 Identities=19% Similarity=0.282 Sum_probs=182.9
Q ss_pred cccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHh--cCCCceeceEEEEEecCceEEEEeecc
Q 005693 392 VLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRV--GQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.||+|+||.||++... +++.+|+|.+...... ...+.+|..++..+ .+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 4788999988654321 22334444433333 379999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999998642 34899999999999999999999998 9999999999999999999999999986543322
Q ss_pred -CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...++..|+|||.+.. ..++.++||||+||++|||++|..||........ ......... ....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~------~~~~----- 217 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT------VNVE----- 217 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhhc------CCcC-----
Confidence 2357889999999864 5578999999999999999999999975432211 111111100 0000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
........+.+++.+|++.||++|| +++|++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0112234566777899999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=285.94 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=194.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||.|+||+||+|... ++..+++|++..... ..+.+.+|++.++.+ +|+||+++++.+..++..++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 467999999999999965 567899999865432 346788999999988 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-- 544 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 544 (682)
+|.+++..... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999975321 234889999999999999999999998 99999999999999999999999999866543322
Q ss_pred ------CCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 545 ------PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 545 ------~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
..++..|+|||++... .++.++|+|||||++|||++|+.||......+. ......... ...
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~------~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDP------PSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCCC------CCc
Confidence 2367789999998877 789999999999999999999999975432211 111111110 001
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
............+.+++.+|++.+|++||+++|++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111111234556788889999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.48 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=190.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|..+ .++.+|+|++..... ..+.+.+|+++++.+ +|+||+++++++..++..++||||+++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEEecCCc
Confidence 467999999999999976 478899998865432 235678899999998 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.++.... ..+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 85 TVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9998877532 23899999999999999999999998 9999999999999999999999999987653322
Q ss_pred --CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-CChhHHHH-------HHhhhc-cccc
Q 005693 544 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-VDLPRWVQ-------SVVREE-WTAE 611 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~-~~l~~~~~-------~~~~~~-~~~~ 611 (682)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ..+..+.. ...... ....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 2235678999999875 3478899999999999999999999975432110 00000000 000000 0000
Q ss_pred cchhhhcccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDVELMRFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+...... ........+.+++.+||+.+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 011223557788889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=282.59 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=191.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++..+ +|+||+++++++..+...++|+||
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEEEEe
Confidence 367999999999999976 688899998865431 234688899999998 999999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 84 VPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999643 24889999999999999999999998 999999999999999999999999998765433
Q ss_pred C---CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 A---TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 ~---~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
. ...++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... .............. +
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~-~----- 223 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP-I----- 223 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC-c-----
Confidence 2 334677899999987766 899999999999999999999999754311 11111111000000 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||+.+|++||++++++++
T Consensus 224 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 ----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 01123455677789999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=290.15 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=192.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||++... +++.+++|.+.... ...+.+.+|+.+++++ +||||+++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 467999999999999854 57889999986433 2345678899999998 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 543 (682)
|.+++... .+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 103 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 99998632 3788999999999999999999998 9999999999999999999999999886554322
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||.+....++.++||||||+++||+++|+.||......+.... ..... . ......
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--~-------~~~~~~ 238 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--T-------PELQNP 238 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--C-------CCCCCc
Confidence 22466779999999888899999999999999999999999976543221110 00000 0 001111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||..+|++||++++++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223456678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.94 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=194.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++... ++..+|+|++..... ...++.+|+++++++ +|+|++++++++.+++..++||||++
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 467999999999999964 577899998864322 124677899999999 89999999999999999999999997
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
|++.+.+... ...+++.++..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 109 -g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (317)
T cd06635 109 -GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180 (317)
T ss_pred -CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence 4787777532 234899999999999999999999998 99999999999999999999999999887766656
Q ss_pred CCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..++..|+|||++. ...++.++|||||||++|||++|+.||...... ............ ..
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~----------~~ 244 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP----------TL 244 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccCC----------CC
Confidence 67888999999974 456889999999999999999999998653211 111111111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
........+.+++.+||+.+|++||++.++++++.....
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 111233456778889999999999999999997765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=289.99 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=187.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++.+|+||+++++++..+...+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 367999999999999965 478899999865432 2456788999999996699999999999999999999999864
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
++.++...........+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 554433211111123589999999999999999999975 5 999999999999999999999999998755432
Q ss_pred CCCCCCCcccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 ATPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~---~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.... .............. +.+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~------~~~~- 232 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDP------PILS- 232 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCC------CcCC-
Confidence 223467789999999776 68899999999999999999999997432 11111111111100 0000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..........+.+++.+||+.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00101234457788889999999999999999884
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=285.85 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=195.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++..+ +++.+++|.+..... ..+++.+|+++++++ +||||+++++.+..+...++|+||++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEEecCCC
Confidence 467999999999999976 478899998876532 345688899999998 7999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+|.+++.... ..+++.....++.|++.|++|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999997532 358899999999999999999999 77 9999999999999999999999999986553221
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ................. . . ..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~-~-----~----~~ 226 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPPP-R-----L----PS 226 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCCC-C-----C----Ch
Confidence 245677899999999989999999999999999999999999754321 11122222222211100 0 0 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||..+|++|||+.|++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1134456778889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=284.58 Aligned_cols=241 Identities=24% Similarity=0.386 Sum_probs=191.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.+++|.++.... ..+.+.+|+++++++ +|+||+++++.+...+..++|+||+++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEecCCC
Confidence 467999999999999865 578899999876544 245688899999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 544 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 544 (682)
++|.+++... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 84 GTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999742 23788999999999999999999998 99999999999999999999999999876643322
Q ss_pred -------CCCCCcccCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 545 -------PSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 545 -------~~~~~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
..++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ......... . . .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~-~----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-G-H----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-C-C----C
Confidence 23567899999998766 889999999999999999999999754211 000111000 0 0 0
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
+.+ .........+.+++.+||+.+|++||+++|++.
T Consensus 225 ~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPI---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC---CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001 011112344567888999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.90 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=191.4
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|...+ ++.+|+|.+...... .+.+..|++++..+ +|+||+++++.+...+..++||||+.
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEEEecC
Confidence 3679999999999999764 788999998765322 34678899999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 85 GGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999987432 235899999999999999999999998 9999999999999999999999999876542211
Q ss_pred --------------------------------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 005693 544 --------------------------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 591 (682)
Q Consensus 544 --------------------------------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~ 591 (682)
...++..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 123567799999999888999999999999999999999999754322
Q ss_pred CCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 005693 592 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN----MDEVVR 653 (682)
Q Consensus 592 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~ 653 (682)
+. ......... ...........+.+++.+|++.+|++||+ ++|+++
T Consensus 239 ~~------~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ET------FSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH------HHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 10 111111100 00111113456777888999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=289.07 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=188.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.+|+|+++..... .....+|+.++.++.+|+|++++++++.++ +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 367999999999999965 5788999998764322 234456888888886799999999999987 88999999997
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
|++.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 58888876432 34899999999999999999999998 999999999999999 999999999987654322
Q ss_pred --CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc--------cccc
Q 005693 544 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW--------TAEV 612 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~--------~~~~ 612 (682)
...++..|+|||++.. ..++.++||||+||++|||++|+.||.+.+..+ ...+......... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccccc
Confidence 2346778999997654 457889999999999999999999997654221 1111111110000 0000
Q ss_pred chhhhcc------ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 FDVELMR------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ~d~~l~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+..... ..........+.+++.+||+.+|++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000 00011235677888899999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=286.41 Aligned_cols=239 Identities=20% Similarity=0.306 Sum_probs=184.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc------ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 460 (682)
.+.||+|+||.||+|... .+..+++|++..... ....+.+|+.+++++ +|+||+++++++... ...++++
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEEEEEE
Confidence 467999999999999865 478899998864321 124578899999999 899999999998753 5678999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 86 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 86 EYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 999999999999642 23788999999999999999999988 9999999999999999999999999987543
Q ss_pred CC-------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~-------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. ....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC-----
Confidence 21 1233677899999999888999999999999999999999999743211 11111111100
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+.. .......+.+++ +||..+|++||+++|++++
T Consensus 227 ~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 NPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0100 111122334444 6888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=286.48 Aligned_cols=240 Identities=23% Similarity=0.390 Sum_probs=190.7
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc--ChhhHHHHHHHHHHhc--CCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|.. .+++.+++|.+..... ..+++.+|+.+++++. .|||++++++++..+...++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 36799999999999996 4578899998865422 2456888999999984 49999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999998632 4889999999999999999999998 9999999999999999999999999987654332
Q ss_pred ---CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 544 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
...++..|+|||.+.++ .++.++|||||||++|+|++|+.||........ .... .... .+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~~-~~~~-----~~~~~~ 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MMLI-PKSK-----PPRLED 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhcc-ccCC-----CCCCCc
Confidence 23467789999998654 468899999999999999999999975432111 1000 0000 000100
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 ----NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1133456778889999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=285.67 Aligned_cols=242 Identities=21% Similarity=0.350 Sum_probs=191.3
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc-------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+++++++ +|+||+++++++.+.+..++|+|
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEEEEEe
Confidence 46799999999999986 4578899999864331 134678899999998 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMN 540 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~ 540 (682)
|+++++|.+++... .++++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||.+....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 84 WMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred ccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999642 34889999999999999999999998 99999999999998776 58999999987654
Q ss_pred CCC--------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 541 VPA--------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 541 ~~~--------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
... ...++..|+|||.+.+..++.++||||+|+++|+|++|..||........ .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~--- 229 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATTA--- 229 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCCC---
Confidence 321 12356789999999888899999999999999999999999964332211 1111111100000
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
..........+.+++.+|++.+|++||++.|+++
T Consensus 230 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 -------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111223456777888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=283.54 Aligned_cols=238 Identities=24% Similarity=0.395 Sum_probs=191.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... ++..+|+|.+..... ..+.+.+|++++.++ +|+||+++++++..++..++||||++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 467999999999999864 567899998764432 235688899999998 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 88 SALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 999998632 3889999999999999999999988 9999999999999999999999999986554321
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...++..|+|||.+.....+.++|+|||||++|+|++|..||...... .......... .. . .
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~-~---------~ 221 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPKNN-PP-T---------L 221 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhcCC-CC-C---------C
Confidence 234677899999998888899999999999999999999999643211 1111111110 00 0 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223456678889999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.39 Aligned_cols=238 Identities=20% Similarity=0.300 Sum_probs=191.6
Q ss_pred ccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 393 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
||+|+||.||++.... ++.+++|.+..... ..+.+.+|+++++++ +|+||+++++++.++...++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 6999999999999764 78899999875432 235688899999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---CC
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---AT 544 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~ 544 (682)
|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 80 L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 80 LWTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 99999743 23889999999999999999999988 999999999999999999999999998876543 22
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..++..|+|||.+.+..++.++|+||+|+++|||++|..||..... +.............. .....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~----------~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGK----------LEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCC----------CCCCc
Confidence 3467889999999888899999999999999999999999976542 112222222210000 00011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPN-----MDEVVR 653 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 653 (682)
.....+.+++.+||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11346778888999999999999 677766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=288.04 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=187.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|..+ +++.||+|.+...... ...+.+|+++++++ +|+||+++++++.+++..++||||+++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 467999999999999975 5788999998654322 34567899999999 999999999999999999999999985
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 88 ~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 88 DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9999886433 24889999999999999999999998 9999999999999999999999999986543221
Q ss_pred -CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----hhccc--------
Q 005693 544 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----REEWT-------- 609 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~----~~~~~-------- 609 (682)
...++..|+|||++.+ ..++.++||||+|+++|||++|+.||....... +......... .+.+.
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 2235677999999875 457899999999999999999999997543100 0000000000 00000
Q ss_pred ----cccc-hhhhc-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 610 ----AEVF-DVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 610 ----~~~~-d~~l~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.... ...+. ...... ....+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLD-RIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCC-CchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 000000 1245677888999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=281.35 Aligned_cols=241 Identities=18% Similarity=0.383 Sum_probs=192.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+++++++ +|+||+++++.+..++..++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEecCCC
Confidence 467999999999999864 567899999865432 245688899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~~- 543 (682)
++|.+++.... ...+++..+..++.|++.|++|||+++ ++|+||||+||++++++ .+|++|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999997532 234889999999999999999999998 99999999999998654 57999999987665432
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~-~~~--------- 221 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGTF-API--------- 221 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcCC-CCC---------
Confidence 234677899999999888999999999999999999999999754321 11221111110 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||+.+|++|||++|++++
T Consensus 222 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 -SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01123456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.81 Aligned_cols=242 Identities=25% Similarity=0.376 Sum_probs=196.7
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|++|.||+|...+ ++.+++|++..... ..+++.+|++.+.++ +|+|++++++++......++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 4689999999999999765 88899999876543 356788999999999 7999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 544 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 544 (682)
+|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999743 348999999999999999999999 88 99999999999999999999999999876644332
Q ss_pred ---CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 ---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ---~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..++..|+|||.+.+..++.++|+||||+++|||+||+.||......+. ........... .. .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~-~~-----~----- 222 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAICDGP-PP-----S----- 222 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHHhcCC-CC-----C-----
Confidence 2356789999999998899999999999999999999999976543111 11111111110 00 0
Q ss_pred ChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEE-EMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.... ....+.+++.+|++.+|++||++.|++++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011 33567778889999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=288.61 Aligned_cols=240 Identities=21% Similarity=0.349 Sum_probs=191.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|++|.||++... +++.+++|++..... ..+.+.+|+.++..+ +|+||+++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 368999999999999864 578899998864432 245578899999988 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++.. ..+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++++|||.+...... .
T Consensus 103 L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 103 LTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred HHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9999864 23889999999999999999999998 999999999999999999999999987654322 1
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...++..|+|||.+.+..++.++|||||||++|||++|+.||..... .......... .. +.....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~~-----~~~~~~--- 238 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-LP-----PKLKNL--- 238 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-CC-----CCCccc---
Confidence 23467889999999888899999999999999999999999975321 1111111111 00 000011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1123457788889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=318.86 Aligned_cols=250 Identities=17% Similarity=0.312 Sum_probs=189.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 463 (682)
.+.||+|+||+||++.... +..+|+|.+..... ....+..|+.++..+ +|||||+++++|... ...|+||||+
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 4689999999999999765 55688888765432 235688899999999 999999999988653 4688999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCcEecCCCCCCeEecC---------------
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG----PKFTHGNIKASNVLINQ--------------- 524 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~----~~ivHrDLk~~NILl~~--------------- 524 (682)
++|+|.+++..... ....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999975322 12358999999999999999999998542 34999999999999964
Q ss_pred --CCCeEEeecCCCCCCCCC---CCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChh
Q 005693 525 --DLDGCISDFGLTPLMNVP---ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP 597 (682)
Q Consensus 525 --~~~~kl~DfGla~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~ 597 (682)
.+.+||+|||++...... ....+++.|+|||++.+ ..++.++|||||||++|||+||+.||..... ..
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~ 250 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FS 250 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HH
Confidence 345899999999766432 23357899999999854 4578999999999999999999999974321 11
Q ss_pred HHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 005693 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV 658 (682)
Q Consensus 598 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i 658 (682)
..... +.... + + ........+.+++..||+.+|.+||++.|++. .+..+
T Consensus 251 qli~~-lk~~p-----~--l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 251 QLISE-LKRGP-----D--L----PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHH-HhcCC-----C--C----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 11111 11110 0 0 00112345677888999999999999999995 44433
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=286.56 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=188.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.+++|++..... ....+.+|++++.++ +||||+++++++.+++..++||||+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEeeccc-
Confidence 367999999999999875 578899998865432 234688899999999 99999999999999999999999996
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 83 ~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 83 QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 68988886533 234899999999999999999999998 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ccc--cccc--
Q 005693 544 --TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWT--AEVF-- 613 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~--~~~~-- 613 (682)
...++..|+|||++.+.. ++.++||||||+++|||+||+.||......+ ...+........ .+. ....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 223567899999887644 5889999999999999999999997543211 111111000000 000 0000
Q ss_pred hhhhc--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~--~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... ..... ......+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000 00000 0112345678889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=290.52 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=191.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.|++|+++.... ..+.+.+|+++++++ +|+||+++++++..++..++||||+++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEEecCCC
Confidence 467999999999999976 467899998875432 245788999999999 799999999999999999999999998
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+.+..+... ...+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 85 TLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 777766543 223889999999999999999999998 9999999999999999999999999987765433
Q ss_pred ---CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh------------hhc
Q 005693 544 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV------------REE 607 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~------------~~~ 607 (682)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||.+....+. ........ ...
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCc
Confidence 23456779999999888 789999999999999999999999975432110 00000000 000
Q ss_pred ccc-----ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 608 WTA-----EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 608 ~~~-----~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... ...+...............+.+++.+||..+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 00000000000011124667888889999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=291.08 Aligned_cols=260 Identities=21% Similarity=0.307 Sum_probs=190.6
Q ss_pred hccccccCeEEEEEEEEcC---CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 460 (682)
.+.||+|+||.||+|.... +..+|+|.+.... ...+.+.+|+.++..+ +||||+++++++... +..++||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEEEEE
Confidence 3579999999999999754 6889999987632 1235677899999998 899999999999988 7899999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC----CCCeEEeecCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ----DLDGCISDFGLT 536 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~----~~~~kl~DfGla 536 (682)
||+++ ++.+++..........+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99975 7777775443323346889999999999999999999998 999999999999999 999999999998
Q ss_pred CCCCCCC-------CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH-------HHH
Q 005693 537 PLMNVPA-------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR-------WVQ 601 (682)
Q Consensus 537 ~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~-------~~~ 601 (682)
....... ...++..|+|||++.+. .++.++||||||+++|||++|+.||...........+. .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 7654322 22357789999988664 57899999999999999999999998665433111100 000
Q ss_pred HHhh---hcc-----ccccch---h-hhccc--cChH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 602 SVVR---EEW-----TAEVFD---V-ELMRF--QNIE-------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 602 ~~~~---~~~-----~~~~~d---~-~l~~~--~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+.. ..+ ..+..+ . ..... .... .....+.+++.+|++.||++|||++|++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 000 000000 0 00000 0001 223457888999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.05 Aligned_cols=243 Identities=21% Similarity=0.346 Sum_probs=193.1
Q ss_pred hhccccccCeEEEEEEEEcCCceE-EEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 389 SAEVLGKGSYGTAYKAVLEESTTV-VVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~~~v-avK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
+...||-|+||.||+|..++.... |.|++..... .-+++.-|++|+..+ +||+||++++.|+.++.++++.|||.||
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEeecCCc
Confidence 345589999999999998876654 4555543322 346788899999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC----CC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VP 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~----~~ 542 (682)
.+..++-... .++.+.++..+++|++.||.|||++. |||||||+.|||++-+|.++++|||.+.... ..
T Consensus 115 AVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 115 AVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred hHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 9988876432 34999999999999999999999987 9999999999999999999999999875432 34
Q ss_pred CCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 543 ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
..+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|.+..+. .+.+-++..... +
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKSeP------P-- 253 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP------P-- 253 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhcCC------C--
Confidence 5678999999999874 56799999999999999999999999875432 222222221111 1
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.-...+.++..+|+..+|..||++++++++
T Consensus 254 -TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 -TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 111223344566777779999999999999998863
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.83 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=192.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.|++|++..... ..+.+.+|+.+++++ +|+||+++++++..+...++||||+ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEeccc-C
Confidence 467999999999999975 578899999876532 245788999999999 7999999999999999999999999 9
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 83 SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999986432 34899999999999999999999998 9999999999999999999999999987665432
Q ss_pred ---CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------------
Q 005693 544 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------------- 606 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~------------- 606 (682)
...++..|+|||.+.+. .++.++||||+|+++|||++|.+||.+....+ ...+.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence 23467789999998654 46899999999999999999988886543211 01111110000
Q ss_pred ccccccchhhh--ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 607 EWTAEVFDVEL--MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 607 ~~~~~~~d~~l--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+....+.... ......++....+.+++.+|++.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0000011223667788889999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=283.54 Aligned_cols=239 Identities=19% Similarity=0.254 Sum_probs=184.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc------ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 460 (682)
.+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.++.++ +|+||+++++++.+. ...++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCceEEEEE
Confidence 468999999999999975 478899998753221 124677899999999 999999999998764 4578999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++++|.+++... ..+++....+++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 86 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 86 EHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999998632 23788889999999999999999998 9999999999999999999999999987543
Q ss_pred C-------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 V-------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
. .....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCCC-----
Confidence 2 11234677899999998888999999999999999999999999643211 11111111100
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...........+.+++.+|+. +|++||+++|++++
T Consensus 227 -----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 -----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 001112233455667778885 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.96 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=185.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.+++|.+...... ...+.+|++++..+ +|+||+++.+++..++..++||||+. +
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 467999999999999864 5788999998654322 34577899999998 89999999999999999999999996 6
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
++.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 88 DLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 7777765322 23778889999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----------------
Q 005693 543 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---------------- 605 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~---------------- 605 (682)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...... .+.......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhhhhhhc
Confidence 122357789999998754 4788999999999999999999999754321 000000000
Q ss_pred hccccccc----hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 606 EEWTAEVF----DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 606 ~~~~~~~~----d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+..... ...+............+.+++.+|+..||++|||++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000 00000000000113456678889999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.52 Aligned_cols=245 Identities=21% Similarity=0.360 Sum_probs=191.4
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~ 464 (682)
+.||.|+||.||++... +++.+++|.++.... ..+.+..|+++++.+ +|+||+++++++.. +...+++|||++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEEehhcc
Confidence 67999999999999864 567899998865432 234577899999999 99999999998764 345789999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|.+++..... ....+++..++.++.|++.|++|||..+ ...++|+||||+||++++++.+||+|||++......
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 9999999975432 2345899999999999999999999322 223999999999999999999999999998876543
Q ss_pred C----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 A----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 ~----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
. ...+++.|+|||++.+..++.++|+||||+++|+|++|+.||...... ...... ......
T Consensus 164 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~-------- 228 (265)
T cd08217 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLASKI-KEGKFR-------- 228 (265)
T ss_pred cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHHHHH-hcCCCC--------
Confidence 3 235678899999999888999999999999999999999999754311 111111 111000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+|++.+|++||+++|++++
T Consensus 229 --~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 --RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0111233567788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=313.28 Aligned_cols=260 Identities=18% Similarity=0.248 Sum_probs=178.7
Q ss_pred hccccccCeEEEEEEEEcCCc--eEEEE------------------EeeccccChhhHHHHHHHHHHhcCCCceeceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEEST--TVVVK------------------RLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~--~vavK------------------~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~ 449 (682)
.+.||+|+||+||++..+... ..+.| .++........+++|++++.++ +|+||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 231 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEI 231 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCcCcEeEE
Confidence 578999999999998754211 11111 1111111234578899999999 99999999999
Q ss_pred EEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeE
Q 005693 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529 (682)
Q Consensus 450 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 529 (682)
+...+..++|+|++. ++|.+++..................++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999985 57877775432111222345677889999999999999998 99999999999999999999
Q ss_pred EeecCCCCCCCCCC-----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCCCCCCChhHHHHHH
Q 005693 530 ISDFGLTPLMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP-LQSPTRDDMVDLPRWVQSV 603 (682)
Q Consensus 530 l~DfGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~P-f~~~~~~~~~~l~~~~~~~ 603 (682)
|+|||+++...... ...|+..|+|||++.+..++.++|||||||++|||++|..+ +..........+.+.....
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 99999997664322 23578899999999999999999999999999999998754 4332211111111111100
Q ss_pred h--hhcccc---ccchh----hhc-cccChHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 604 V--REEWTA---EVFDV----ELM-RFQNIEE------EMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 604 ~--~~~~~~---~~~d~----~l~-~~~~~~~------~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. .+.+.. ..++. ... ....+.. ....+.+++.+|++.||++|||++|++++
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000000 00000 000 0000011 11245667789999999999999999874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.44 Aligned_cols=242 Identities=26% Similarity=0.434 Sum_probs=196.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|++|.||++... ++..+++|++..... ..+.+.+|+++++.+ +|+|++++++++..+...++++||+++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 367999999999999976 578899999876543 456788999999999 79999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---T 544 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 544 (682)
|.+++.... ..+++..+..++.|++.|+++||+.+ ++|+||+|+||++++++.++|+|||.+....... .
T Consensus 84 L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 84 LKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999987532 34899999999999999999999987 9999999999999999999999999987765542 3
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ...... ....
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~--------~~~~ 221 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPPGL--------RNPE 221 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCCCc--------Cccc
Confidence 45677899999998888999999999999999999999999754211 11111111 000000 0001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++.+|++.+|++|||++|++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 113457778889999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=288.44 Aligned_cols=246 Identities=20% Similarity=0.353 Sum_probs=188.0
Q ss_pred HhhccccccCeEEEEEEEEcC-CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 388 ASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
...+.||+|+||.||+|..++ ++.+|+|.++.... ...++..|+.++.+..+|+||+++++++.++...++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 346789999999999999875 78899999875432 234566677777777579999999999999999999999985
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
+++.+++.... ..+++..+..++.|++.|++|||+. + |+||||+|+||++++++.+||+|||++.......
T Consensus 98 -~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 98 -TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred -cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 47777765422 2589999999999999999999974 5 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 544 ---TPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ............ .
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~-~------ 237 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP-P------ 237 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC-C------
Confidence 223567899999987654 788999999999999999999999643211 111111111110 0
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
...........+.+++.+||+.+|++||++++++++-
T Consensus 238 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 --SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000011234567788899999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.81 Aligned_cols=240 Identities=21% Similarity=0.293 Sum_probs=187.0
Q ss_pred ccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 393 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
||+|+||+||++... +++.+++|.+..... ....+..|+++++.+ +||||+++++++...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999865 577899999865321 234567899999999 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---T 544 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 544 (682)
|.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||.+....... .
T Consensus 80 L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 80 LKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 9999975432 34899999999999999999999998 9999999999999999999999999987654321 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..++..|+|||++.+..++.++||||||+++|+|++|+.||........ ... ... ..... ..... .
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~~----~~~~~----~~~~~---~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEE-LKR----RTLEM----AVEYP---D 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHH-HHh----ccccc----cccCC---c
Confidence 3456789999999888899999999999999999999999975442111 000 000 00000 00001 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 653 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 653 (682)
.....+.+++.+||+.+|++|| ++.+++.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1233456777899999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=268.58 Aligned_cols=257 Identities=21% Similarity=0.355 Sum_probs=193.4
Q ss_pred CCCCCCCHHHHHHHhhccccccCeEEEEEEEEcC-CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEE
Q 005693 375 GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY 451 (682)
Q Consensus 375 ~~~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 451 (682)
+..+.-|+.++. ....||.|..|.|++++... +..+|||.+..... +.+++...++++..-...|.||+.+|||.
T Consensus 84 g~r~~~dindl~--~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 84 GQRYQADINDLE--NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred CcccccChHHhh--hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 344556777763 35679999999999999764 67889999876532 23456666677666646899999999999
Q ss_pred ecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEe
Q 005693 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 531 (682)
Q Consensus 452 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 531 (682)
.+...++.||.|.. -+..+++.. ..++++.-+-++...+++||.||.++. .|+|||+||+|||+|+.|++|++
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence 99999999999854 445555533 234888888899999999999998765 59999999999999999999999
Q ss_pred ecCCCCCCCCCC---CCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 532 DFGLTPLMNVPA---TPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 532 DfGla~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
|||++..+..+. ...|-+.|||||.+.- ..|+.++||||||+.++||.||..||.+-..+ .+ -+..+..
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe---~ltkvln 309 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FE---VLTKVLN 309 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HH---HHHHHHh
Confidence 999998775543 3346677999999953 46899999999999999999999999864321 11 1122222
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+.. +.+..... ....++++...|+++|+.+||...+++++
T Consensus 310 ~eP------P~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EEP------PLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCC------CCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111 11222222 33456677779999999999999988763
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.29 Aligned_cols=239 Identities=21% Similarity=0.353 Sum_probs=190.2
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
..||+|+||.||++..+ ++..+|+|++..... ....+.+|+.+++.+ +|+||+++++++...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57999999999999874 578899998754332 345688899999998 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----C
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----T 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----~ 544 (682)
.+++... .+++.....++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 9987532 3789999999999999999999998 9999999999999999999999999876543322 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..++..|+|||.+.+..++.++|+||+|+++|||++|..||......+ .... ..+... .... ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~------~~~~-~~~~~~-----~~~~---~~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKM-IRDNLP-----PKLK---NLH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhhCC-----cccC---Ccc
Confidence 346788999999988888999999999999999999999997532211 1111 111100 0000 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 223345677889999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=283.35 Aligned_cols=239 Identities=21% Similarity=0.303 Sum_probs=192.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... .++.+++|.+..... ..+.+.+|+++++++ +||||+++++++..+...++|+||+.
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 468999999999999976 478899999875432 245788899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+++|.+++... ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 84 GGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999643 34889999999999999999999998 999999999999999999999999998765443
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...+....... .. ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~---------~~ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--AD---------VL 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--cc---------cc
Confidence 2334677899999998888999999999999999999999999865432 11111111111 00 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNM--DEVV 652 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~evl 652 (682)
........+.+++.+||+.+|++||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111223566778889999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=285.50 Aligned_cols=238 Identities=18% Similarity=0.242 Sum_probs=191.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEEEecCC
Confidence 467999999999999975 478899999865422 235678899999999 79999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 85 GGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156 (290)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence 99999999743 34889999999999999999999988 9999999999999999999999999987765432
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ........... .....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~---------~~~~~- 220 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEGKV---------RFPSF- 220 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCc---------cCCcc-
Confidence 334778899999998888899999999999999999999999754311 11111111110 00111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
....+.+++.+||..+|++|+ +++|++++
T Consensus 221 --~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 221 --FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 124556777899999999999 77777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=280.56 Aligned_cols=241 Identities=22% Similarity=0.392 Sum_probs=192.8
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||++..+. +..+|+|.+.... ...+.+.+|+++++.+ +|+||+++++.+..+...++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEecCCC
Confidence 4679999999999999764 6789999986542 2345678899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC-eEEeecCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-GCISDFGLTPLMNVPA- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-~kl~DfGla~~~~~~~- 543 (682)
++|.+++.... ...+++..+..++.|+++|++|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 84 GDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999997533 234789999999999999999999998 999999999999998864 6999999987664432
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...+++.|+|||++.+..++.++||||||+++|||++|..||.... ..++......... ...
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~~-------- 222 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGYF-API-------- 222 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcccC-CCC--------
Confidence 2246778999999988889999999999999999999999997432 1222222221111 000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||..+|++|||++|++++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01122356777889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.35 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=188.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|..+ +++.+++|.++..... ...+.+|++++.++ +||||+++++++... ...++||||+
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 467999999999999976 4778999998754322 23567899999999 799999999999877 7899999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++ +|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 89 ~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 89 EH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred Cc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 74 9998886432 24899999999999999999999998 9999999999999999999999999987665432
Q ss_pred ----CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------cc---
Q 005693 544 ----TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE-------EW--- 608 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~-------~~--- 608 (682)
...+++.|+|||.+.+.. ++.++|+||+|+++|||++|+.||......+. ..+.... .|
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ------LNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHHHhCCCchHHHHHh
Confidence 233577899999987644 68899999999999999999999975432111 1110000 00
Q ss_pred ----------ccccchhhhccccChHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 ----------TAEVFDVELMRFQNIEE--EMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 ----------~~~~~d~~l~~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+ ...+.. ....+.+++.+||+.+|++|||++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQL--RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhh--hccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 000111 24456778889999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=279.17 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=199.2
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEec-CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV~ 460 (682)
.-++-+|.||.||.|.+. +.+.|.+|.++..... -..+.+|--.+..+ .|||+..+.+++.++ +..+.+|
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeeccCcceEEE
Confidence 346889999999999653 3456778887765432 23455565556666 799999999998654 5678999
Q ss_pred eeccCCchhHhhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 461 DYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
.++.-|+|..++.-.++ ...+.++..+...++.|++.|++|||.++ |||.||.++|++||+...+||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999984332 23455788899999999999999999998 9999999999999999999999999987
Q ss_pred CCCCC------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 005693 538 LMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610 (682)
Q Consensus 538 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 610 (682)
.+-.. ....+...||+||.+....|+.++|||||||+||||+| |+.||...++.|+ ...+.+++
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------~~ylkdGy-- 515 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------EHYLKDGY-- 515 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------HHHHhccc--
Confidence 65433 33446678999999999999999999999999999999 9999986554332 22222222
Q ss_pred ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 611 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
+....-++..+++.+|.-||...|++||+++|++..|.++...
T Consensus 516 --------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 516 --------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 2334456777889999999999999999999999999887643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=283.14 Aligned_cols=239 Identities=19% Similarity=0.296 Sum_probs=182.9
Q ss_pred cccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHh--cCCCceeceEEEEEecCceEEEEeecc
Q 005693 392 VLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRV--GQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.||+|+||.||++... .++.||+|.+...... ...+..|..++..+ .+|+||+.+.+++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 4788999998654321 12234444433332 379999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999988632 34899999999999999999999988 999999999999999999999999998755322
Q ss_pred CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....++..|+|||++.++ .++.++||||+|+++|||++|+.||........... ...... .+..+ .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~--~- 219 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVEL--P- 219 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCC--C-
Confidence 234578889999999754 588999999999999999999999976532221110 000000 00000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 653 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 653 (682)
......+.+++.+|+..+|++|| ++.|+++
T Consensus 220 --~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 --DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11234567777899999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=284.35 Aligned_cols=256 Identities=21% Similarity=0.364 Sum_probs=190.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|++|.||+|+.. ++..||+|+++.... ....+.+|+++++++ +|+||+++++++...+..++||||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 367999999999999975 478899999875432 245677899999999 899999999999999999999999985
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++++|||++.......
T Consensus 83 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 83 DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 88888864331 235899999999999999999999998 9999999999999999999999999987554321
Q ss_pred -CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---hhhcc----ccccch
Q 005693 544 -TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEW----TAEVFD 614 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~---~~~~~----~~~~~d 614 (682)
...++..|++||++.+. .++.++||||||+++|||++|+.||.+....+.. .+..... ..+.+ ....+.
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL--LKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHhCCCChhhHHHHhcCchhc
Confidence 23457789999998654 5688999999999999999999999765432110 0000000 00000 000000
Q ss_pred hhhcc------ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VELMR------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... ....+.....+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 00011223456788889999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.83 Aligned_cols=246 Identities=13% Similarity=0.216 Sum_probs=171.1
Q ss_pred hccccccCeEEEEEEEEcCC----ceEEEEEeeccccC---hh---------hHHHHHHHHHHhcCCCceeceEEEEEec
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVG---KR---------DFEQQMEIVGRVGQHPNVVPLRAYYYSK 453 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~---~~---------~~~~e~~~l~~l~~h~niv~l~~~~~~~ 453 (682)
.+.||+|+||.||+|...++ ..+|+|+....... +. ....+...+..+ +|+|++++++++...
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYGCGSFK 95 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEEeeeEe
Confidence 46899999999999997654 34455543221110 00 011111223334 799999999987654
Q ss_pred C----ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeE
Q 005693 454 D----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529 (682)
Q Consensus 454 ~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 529 (682)
. ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++
T Consensus 96 ~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 96 RCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred cCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 4 33677777643 666666432 12567888999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCC-----------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 005693 530 ISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 598 (682)
Q Consensus 530 l~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~ 598 (682)
|+|||+|+..... ....+|+.|+|||+..+..++.++|||||||++|||++|+.||.+...... ...
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~~~ 244 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--LIH 244 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--HHH
Confidence 9999998765321 123478899999999999999999999999999999999999986532221 111
Q ss_pred HHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 599 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 599 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.... .....+..... ........+.+++..|++.+|++||+++++.+.+
T Consensus 245 ~~~~----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKC----DFIKRLHEGKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHH----HHHHHhhhhhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 00000000000 1122345677888899999999999999999876
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.75 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=184.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCc--------eE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE--------KL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~--------~~ 457 (682)
.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+++++++ +||||+++++++..... .+
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccCCCceEE
Confidence 467999999999999975 4788999988644322 23456799999999 99999999999876543 49
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+||||+.+ +|.+.+.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 96 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 96 LVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 99999964 8888876422 24899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCC--------CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 538 LMNVPA--------TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 538 ~~~~~~--------~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
...... ...++..|+|||.+.+.. ++.++||||||+++|||++|..||.+.....................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 654322 123466799999886644 68899999999999999999999976542211111000000000000
Q ss_pred cccc-----chh-hhcc--ccChH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 TAEV-----FDV-ELMR--FQNIE------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 ~~~~-----~d~-~l~~--~~~~~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.... .+. .... ..... .....+.+++.+||+.+|++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 000 0000 00000 012345688899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=288.26 Aligned_cols=262 Identities=22% Similarity=0.359 Sum_probs=190.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEecC--ceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~ 463 (682)
.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.++.++.+|+||+++++++...+ ..++||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 467999999999999975 47789999885432 223457789999999978999999999986543 579999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
+ ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 7 5999888632 4789999999999999999999988 9999999999999999999999999987553322
Q ss_pred ---------CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh-hHHH-------HHHhh
Q 005693 544 ---------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-PRWV-------QSVVR 605 (682)
Q Consensus 544 ---------~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l-~~~~-------~~~~~ 605 (682)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+.... .... .....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1236778999998765 4578899999999999999999999975432211000 0000 00000
Q ss_pred hccccccch----hhhcc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 005693 606 EEWTAEVFD----VELMR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQS 661 (682)
Q Consensus 606 ~~~~~~~~d----~~l~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~~~ 661 (682)
........+ ..... ..........+.+++.+||+.+|++|||+.+++++ ++.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 000000000 00000 00011124567788889999999999999999985 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.14 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=190.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|...+ ++.+|+|++.... .....+.+|++++.++ +|+|++++++++... +..++|+||+
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEeccc
Confidence 3679999999999999764 7889999998653 1235678899999999 899999999999988 7899999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++ +|.+++.... ..+++..+..++.|+++|++|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 83 DH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 75 8988886432 35899999999999999999999998 9999999999999999999999999987665432
Q ss_pred -----CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcccc--c
Q 005693 544 -----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA--E 611 (682)
Q Consensus 544 -----~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~--~ 611 (682)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ......... ..+.. .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccccc
Confidence 2234667999998765 4578999999999999999999999975442111 000000000 00000 0
Q ss_pred c-----chhhhccc----cChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 V-----FDVELMRF----QNIEE-EMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~-----~d~~l~~~----~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. ........ ..... +...+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00000000 00011 24567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=292.38 Aligned_cols=239 Identities=21% Similarity=0.338 Sum_probs=196.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccCh---hhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|.|+.|.+|++. .+..||+|.+.+..-+. +.+.+|++++..+ +|||||+++.+.......|+||||+.+
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEEEeccC
Confidence 467999999999999954 57899999998765432 3478899999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|.+++++.+... ..+..+..++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++.++...
T Consensus 140 ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 140 GELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred chhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccccc
Confidence 999999986543 555888899999999999999998 999999999999999999999999999887654
Q ss_pred CCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
.+.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.+... + ++...++...
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------r---------vl~gk~rIp~ 276 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------R---------VLRGKYRIPF 276 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------h---------heeeeecccc
Confidence 46789999999999999887 688999999999999999999999765333211 1 1111111122
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
....+.+. ++++.+-.+|.+|++++++.+.-
T Consensus 277 ~ms~dce~---lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 277 YMSCDCED---LLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeechhHH---HHHHhhccCccccCCHHHhhhhc
Confidence 22333443 44588899999999999998743
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=286.91 Aligned_cols=255 Identities=21% Similarity=0.258 Sum_probs=185.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
++.+|.|+++.||++.. +++.+|+|++.... ...+.+.+|+++++.+ +|+||+++++++..++..+++|||+++|
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCC
Confidence 44455556666666554 58899999987542 2335788999999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||.+......
T Consensus 85 ~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 85 SCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999975432 24888999999999999999999998 999999999999999999999999987544221
Q ss_pred -------CCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccc
Q 005693 543 -------ATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 609 (682)
Q Consensus 543 -------~~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~ 609 (682)
....++..|+|||++... .++.++|||||||++|||++|+.||....... ........... ....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 122345679999998763 57899999999999999999999997543111 00000000000 0000
Q ss_pred -------cc----cchhhh---ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 -------AE----VFDVEL---MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 -------~~----~~d~~l---~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ..+... ............+.+++.+||+.+|++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 000000 0001111223457788889999999999999999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=271.22 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=194.7
Q ss_pred HHhhccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEe
Q 005693 387 RASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYD 461 (682)
Q Consensus 387 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e 461 (682)
..+.++||-|-.|.|-.+..+. +..+|+|++.+. ...++|++.--....|||||.++++|.+ ...+++|||
T Consensus 64 ~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 64 SISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred eehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 3446789999999999888654 667899998653 4456788877777789999999999864 346789999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPL 538 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~ 538 (682)
.|+||+|++.++... ...+++.++..|+.||+.|+.|||+.. |.||||||+|+|... |..+|++|||+|+.
T Consensus 140 ~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred cccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccc
Confidence 999999999998543 456999999999999999999999998 999999999999975 45789999999987
Q ss_pred CCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 539 MNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 539 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
...+ .+.+-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||....- ..+....+..++.+. ++.
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq----y~F 286 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ----YEF 286 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC----ccC
Confidence 6533 356779999999999999999999999999999999999999975432 112111222121111 111
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.-.+ .+...+...++++..++.+|++|.|++|++.+=.
T Consensus 287 P~pE---Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 287 PEPE---WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred CChh---HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 1111 2344455566777999999999999999987543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=285.61 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=190.0
Q ss_pred ccccc--CeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 392 VLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 392 ~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.||+| +||+||+++.. .++.||+|.+...... .+.+++|+.+++.+ +||||+++++++..++..++|+||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 99999999964 6889999998754332 24577788888777 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|++.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+......
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999999875432 24889999999999999999999988 999999999999999999999999754322110
Q ss_pred --------CCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-----------
Q 005693 543 --------ATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ----------- 601 (682)
Q Consensus 543 --------~~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~----------- 601 (682)
....++..|+|||++.+. .++.++|||||||++|||++|+.||......+. +.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 111234569999999764 478999999999999999999999975432110 000000
Q ss_pred -----HHh----------------hhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 005693 602 -----SVV----------------REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV 658 (682)
Q Consensus 602 -----~~~----------------~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i 658 (682)
... ...+.....+..+ ...........+.+++.+||+.||++|||++|+++ .++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 000 0000000000000 11112234567888999999999999999999987 55555
Q ss_pred hhc
Q 005693 659 RQS 661 (682)
Q Consensus 659 ~~~ 661 (682)
++.
T Consensus 315 ~~~ 317 (328)
T cd08226 315 KEQ 317 (328)
T ss_pred HHh
Confidence 543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.82 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=189.3
Q ss_pred ccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 393 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
||+|+||.||++...+ ++.+++|.+..... ..+.+.+|++++.++ +|+||+++++.+..+...++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999865 88899999865432 245678888999999 79999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 543 (682)
|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 80 LASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 999997432 4899999999999999999999998 9999999999999999999999999986543321
Q ss_pred --------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 544 --------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 544 --------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
...++..|+|||.......+.++||||||+++||+++|+.||...... ........... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~-----~- 219 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILNGKI-----E- 219 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCc-----C-
Confidence 123567799999998888999999999999999999999999754321 11111111000 0
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
..........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000011355677888999999999999955554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=274.33 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=195.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 463 (682)
.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++++ +|+||+++++.+... +..++|+||+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 367999999999999976 578899999876542 356788899999999 899999999999988 8899999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++++|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 84 SGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999997432 5899999999999999999999988 9999999999999999999999999987665432
Q ss_pred ------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 ------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
...++..|+|||.+.+...+.++||||||+++|+|++|..||.... +...............
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~------- 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP------- 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc-------
Confidence 2346778999999988889999999999999999999999997544 1111111111000000
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+|++.+|++||++.|++++
T Consensus 224 ---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 ---EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0111224567778889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.72 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=187.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|... ++..||+|+++..... ...+.+|+.++.++ +|+||+++++++... +..++||||+
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEEEEEecC
Confidence 467999999999999975 4788999998754322 23456799999999 999999999998765 4579999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
.+ +|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 91 ~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 91 EQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred CC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 75 8888886432 34899999999999999999999998 9999999999999999999999999987665432
Q ss_pred ----CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cccc-----
Q 005693 544 ----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTA----- 610 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~----- 610 (682)
...++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+. .......... ....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhhcc
Confidence 1224667999999865 4578999999999999999999999975432211 0001110000 0000
Q ss_pred ---ccchhhhccccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 611 ---EVFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 611 ---~~~d~~l~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+.......... ......+.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000000 1123456778889999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.24 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=188.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccCh---------------hhHHHHHHHHHHhcCCCceeceEEEEEec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---------------RDFEQQMEIVGRVGQHPNVVPLRAYYYSK 453 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---------------~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 453 (682)
.+.||+|+||+||+|... +++.||+|+++...... ..+.+|++++..+ +|+||+++++++..+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLVDVYVEG 92 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeeeEEEecC
Confidence 567999999999999965 57889999986543221 2467899999999 999999999999999
Q ss_pred CceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeec
Q 005693 454 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 533 (682)
Q Consensus 454 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 533 (682)
+..++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++++||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 99999999997 6999988632 24889999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCC------------------CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 005693 534 GLTPLMNVP------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 594 (682)
Q Consensus 534 Gla~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~ 594 (682)
|++...... ....++..|+|||++.+. .++.++||||+||++|||++|+.||......+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ- 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 998765411 012246679999998764 468999999999999999999999976543211
Q ss_pred ChhHHHHHHhh----hccccccchhhh-----ccccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 595 DLPRWVQSVVR----EEWTAEVFDVEL-----MRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 595 ~l~~~~~~~~~----~~~~~~~~d~~l-----~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......... ..|......+.. ..... .......+.+++.+|++.+|++||+++|++.+
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 243 --LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred --HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111111100 001000000000 00000 11123456788889999999999999999874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=280.10 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=189.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|++|.||+|... ++..|++|++..... ..+.+.+|+++++.+ +|+|++++++++.+++..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEeccC-
Confidence 467999999999999865 688999999875432 235678899999999 89999999999999999999999995
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 82 LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 689999875431 34899999999999999999999987 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccccccchhh-
Q 005693 544 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAEVFDVE- 616 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~~~~~~d~~- 616 (682)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......+ .+.+..+... ...+......+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 22346789999988664 46889999999999999999999997543211 0111110000 000000000000
Q ss_pred ---hcc--c----cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 617 ---LMR--F----QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 617 ---l~~--~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... . .........+.+++.+|++.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0 0001122456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=277.62 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=191.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC---hhhHHHHHHHHHHhc--CCCceeceEEEEEecCc-----eEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDE-----KLL 458 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~-----~~l 458 (682)
.+.||+|+||.||+|..+. ++.+|+|+++..... ...+.+|+.++.++. +|+|++++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 3679999999999999865 789999999754322 235667888777764 59999999999988776 899
Q ss_pred EEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
+|||+++ +|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 84 ~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 84 VFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred Eehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999975 89888865332 24899999999999999999999998 99999999999999999999999999877
Q ss_pred CCCCCC---CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhcccccc
Q 005693 539 MNVPAT---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAEV 612 (682)
Q Consensus 539 ~~~~~~---~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~~~~~ 612 (682)
...... ..++..|+|||++.+..++.++|||||||++|||++|+.||......+. +.+...... ...+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcCCCc
Confidence 644322 2356779999999988899999999999999999999999975442211 111111100 00000000
Q ss_pred ------chhhhc-c-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 ------FDVELM-R-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ------~d~~l~-~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+..... . .....+....+.+++.+||+.||++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000 0 00112334566788899999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=286.18 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=192.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... ++..+++|.+..... ..+++.+|+++++.+ +|+|++++.+++......++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEEEccC
Confidence 467999999999999965 467799998864321 124577899999998 89999999999999999999999996
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
|++.+++.... ..+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 99 -~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 99 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred -CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 58887775322 34889999999999999999999988 99999999999999999999999999887766556
Q ss_pred CCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..++..|+|||.+. ...++.++|||||||++|||++|+.||......+ ......... ... .
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~---------~ 234 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SPA---------L 234 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhcC-CCC---------c
Confidence 66788999999974 3457889999999999999999999986432111 111111110 000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
........+.+++.+||+.+|++||++++++++-..+.
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 01123345677888999999999999999998755444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=271.70 Aligned_cols=195 Identities=27% Similarity=0.445 Sum_probs=166.1
Q ss_pred hccccccCeEEEEEEEEcC-----CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEe-cCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~ 460 (682)
...||+|.||.||+|.-++ +..+|+|+++..... .....+|+..++.+ +||||+.+..++.+ +...++++
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCceEEEEe
Confidence 4679999999999996332 336899999865321 34578899999999 99999999999877 77889999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC----CCeEEeecCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLT 536 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~----~~~kl~DfGla 536 (682)
||.+. ||.+.++..+......++...+..|+.||+.|+.|||++= |+||||||.|||+..+ |.|||+|||++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99987 9999998776655667999999999999999999999987 9999999999999877 99999999999
Q ss_pred CCCCCCCCC-------CCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 537 PLMNVPATP-------SRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 537 ~~~~~~~~~-------~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
+.+..+-.+ ..|..|+|||.+.+.+ |+.+.||||.||++.||+|-++-|.+..
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 988665432 2477899999998865 7888999999999999999998887654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=283.92 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=192.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|++|.||++... +++.+++|.++..... ...+.+|+++++++ +|+||+++++++..++..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEeccCC
Confidence 357999999999999975 5788999998765332 45678899999999 799999999999999999999999975
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++.+++.... ..+++..+..++.|++.|++|||+.+ |+|+||||+||++++++.++|+|||.+.......
T Consensus 83 -~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 83 -DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred -CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 8888886432 34899999999999999999999998 9999999999999999999999999987665433
Q ss_pred --CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ccccccch---
Q 005693 544 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTAEVFD--- 614 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d--- 614 (682)
...++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||......+. .......... .......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhh
Confidence 23356679999998776 689999999999999999999999975442111 0000000000 00000000
Q ss_pred ---hhh------ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 ---VEL------MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ---~~l------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... ......++....+.+++.+||+.||++||++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0000112345567888999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.87 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=188.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecC-----ceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~e 461 (682)
.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++.... ..++|+|
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccceEEEEeh
Confidence 468999999999999864 57889999986432 2235677899999999 8999999998876543 4789999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+.+ +|.+.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 89 LMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred hccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9975 88888753 24899999999999999999999998 99999999999999999999999999876543
Q ss_pred CC-------CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc---c
Q 005693 542 PA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---A 610 (682)
Q Consensus 542 ~~-------~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~---~ 610 (682)
.. ...++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+..... .............. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHH
Confidence 21 2346778999998754 468899999999999999999999997543111 00111110100000 0
Q ss_pred ccchhh-------hc--ccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005693 611 EVFDVE-------LM--RFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 659 (682)
Q Consensus 611 ~~~d~~-------l~--~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~ 659 (682)
.+.+.. .. ... ........+.+++.+||+.+|++|||+.|++++ ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 00 000 011224557788999999999999999999996 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=270.33 Aligned_cols=237 Identities=23% Similarity=0.359 Sum_probs=190.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-Chhh---HHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRD---FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~---~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.++||+|.||.|-+++.+ .++.+|+|++++... .+.+ ...|-++++.. +||.+..+-..|+..++.+.||||.+
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEEEEEEcc
Confidence 367999999999999965 477899999987643 2332 34577888888 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC----C
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----N 540 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~----~ 540 (682)
||.|.-++.+. ..+++.....+-..|+.||.|||+.+ ||+||||.+|.|+|.+|++||+|||+++.- .
T Consensus 252 GGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 252 GGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred CceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999998753 34888888889999999999999987 999999999999999999999999999753 2
Q ss_pred CCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 541 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 541 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...+.+|||.|.|||++....|+.++|+|.+||+||||+.|+.||.....+....+ +. -..++-.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL------Il---------~ed~kFP 388 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL------IL---------MEDLKFP 388 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH------HH---------hhhccCC
Confidence 34567899999999999999999999999999999999999999975432221111 11 1112223
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 653 (682)
.....+.+.++. ..+.+||.+|. .+.||.+
T Consensus 389 r~ls~eAktLLs---GLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 389 RTLSPEAKTLLS---GLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ccCCHHHHHHHH---HHhhcChHhhcCCCchhHHHHHh
Confidence 344555555544 78889999995 3566655
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.48 Aligned_cols=255 Identities=19% Similarity=0.322 Sum_probs=189.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEec-----CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 460 (682)
.+.||+|+||+||+|... +++.||+|.+.... .....+.+|+.++..+ +|+||+++++++... ...++|+
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCcEEEEE
Confidence 467999999999999964 57889999987532 2234567899999998 899999999987644 3479999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 89 ELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred eCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 9996 6898888642 24899999999999999999999998 9999999999999999999999999987654
Q ss_pred CC----CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----------
Q 005693 541 VP----ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---------- 605 (682)
Q Consensus 541 ~~----~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~---------- 605 (682)
.. ....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+....+. .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhc
Confidence 33 12346778999998865 4688999999999999999999999975431110 000000000
Q ss_pred -hccccccc-------hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005693 606 -EEWTAEVF-------DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 659 (682)
Q Consensus 606 -~~~~~~~~-------d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~ 659 (682)
........ +.... .........+.+++.+||+.+|++|||++|++++ ++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred CchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000000 00000 0011234556788889999999999999999997 66554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=280.97 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=192.5
Q ss_pred CCHHHHHHHhhccccccCeEEEEEEEEc-CCceEEEEEeecccc-C---hhhHHHHHHHHHHhcCCCceeceEEEEEecC
Q 005693 380 FDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-G---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 454 (682)
Q Consensus 380 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 454 (682)
.+.+++. ...+.||+|+||.||+|... ++..+++|++..... . .+.+.+|+++++.+ +|+|++++++++.+++
T Consensus 17 ~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 17 DDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEH 94 (313)
T ss_pred CCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCC
Confidence 3444442 22466999999999999964 577899999864322 1 24577899999999 8999999999999999
Q ss_pred ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 455 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
..++||||+. |++.+++.... .++++.++..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecC
Confidence 9999999996 57877775322 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 535 LTPLMNVPATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 535 la~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
++..........++..|+|||++. ...++.++|||||||++|||++|..||...... ............ .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~-~ 239 (313)
T cd06633 167 SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNDSP-T 239 (313)
T ss_pred CCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCCC-C
Confidence 987665555566788899999984 356788999999999999999999998754311 111111111100 0
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. . .......+.+++.+||+.+|++||++.+++++
T Consensus 240 ~------~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 L------Q---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C------C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 01112346678889999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=283.46 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=185.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.+|+|.+..... ..+.+.+|+++++++ +|+||+++++++..++..++||||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 467999999999999975 578899998865432 235678899999999 99999999999999999999999996
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~~~- 543 (682)
++|.+++.... ...+++..+..++.||+.||+|||+++ ++||||+|+||+++. ++.+||+|||++.......
T Consensus 85 ~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 85 LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 58888775432 223578888899999999999999988 999999999999985 5578999999987653321
Q ss_pred ---CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcccc--ccc
Q 005693 544 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA--EVF 613 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~--~~~ 613 (682)
...+++.|+|||++.+. .++.++||||+|+++|+|+||+.||......+. +.... .... +.|.. ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIF-RILGTPNEETWPGVTSLP 235 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChhhccccccch
Confidence 23456789999988664 578999999999999999999999975432111 00000 0000 00000 000
Q ss_pred hhh--hcc--cc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVE--LMR--FQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~--l~~--~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+.. ... .. ........+.+++.+|++.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000 00 001123346778889999999999999999873
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=290.95 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=187.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e 461 (682)
.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|+.++.++ +|+||+++++++.. ....++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCceEEEEEe
Confidence 467999999999999965 578899999875422 245677899999999 89999999988763 346799999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+. |+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 89 ~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 89 LME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred hhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 995 6899988632 23899999999999999999999988 99999999999999999999999999865532
Q ss_pred CC--------CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-------
Q 005693 542 PA--------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR------- 605 (682)
Q Consensus 542 ~~--------~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~------- 605 (682)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEVL 236 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHhh
Confidence 21 2246778999999865 4578999999999999999999999975432111 000000000
Q ss_pred ----hccccccchh-hhccccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 606 ----EEWTAEVFDV-ELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 606 ----~~~~~~~~d~-~l~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
........+. ....... .......+.+++.+|++.+|++||++++++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000000000 0000000 112345678888899999999999999999843
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-34 Score=274.34 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=189.7
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
..||.|+||+|+|-.++ .|+..|||++..... +++++..|.+..++-.+.||||+++|.+..+...|+.||+|+- +
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 56999999999998865 478899999987644 4567888999888887999999999999999999999999964 6
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---T 544 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 544 (682)
+..+-+.-.......+++.-.-.|....+.||.||.+.- +|||||+||+|||++..|.+|+||||.+..+..+. .
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~ 226 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV 226 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence 655443222223345888888888888999999998754 69999999999999999999999999987765432 2
Q ss_pred CCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 545 PSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
..|-..|||||.+.. ..|+.++||||+|++|||+.||+.||..-. ++.+.+..........-..+ ..
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~l~~~------~~ 295 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPILLFD------KE 295 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCeecCc------cc
Confidence 235567999999953 358999999999999999999999997432 12222222222221111111 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.-+....+.+++-.|+.+|-+.||...++.+
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1234456777777999999999999999877
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=287.73 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=187.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++.++ +|+||+++++++.... ..++|
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccCcEEEE
Confidence 467999999999999965 578899999865322 234567899999998 9999999999986443 46999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 100 MELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 99996 488888752 1788899999999999999999998 999999999999999999999999999766
Q ss_pred CCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHH-----
Q 005693 540 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---------DLPRWVQS----- 602 (682)
Q Consensus 540 ~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~---------~l~~~~~~----- 602 (682)
.... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||......+.. ....+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 4432 234677899999999999999999999999999999999999754321100 00000000
Q ss_pred --Hhhhccc------cccchhhhcc---ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 603 --VVREEWT------AEVFDVELMR---FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 603 --~~~~~~~------~~~~d~~l~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....... ...+...... ..........+.+++.+|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000000000 00011234456788889999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=279.03 Aligned_cols=243 Identities=22% Similarity=0.345 Sum_probs=188.6
Q ss_pred hccccccCeEEEEEEEE----cCCceEEEEEeecccc-----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.||++.. .++..||+|+++.... ..+.+.+|+.++.++.+|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46799999999999986 3578899999875321 23567889999999977999999999999988999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 85 DYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999643 24788999999999999999999998 9999999999999999999999999987654
Q ss_pred CCC-----CCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VPA-----TPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~~-----~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
... ...++..|+|||.+... .++.++||||||+++|+|++|..||...... ...............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~----- 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP----- 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC-----
Confidence 322 23467789999998753 4678999999999999999999999743221 111111111111100
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
. ........+.+++.+|++.+|++|| ++++++.+
T Consensus 230 --~-----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 --P-----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --C-----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 0011233556778899999999997 66777663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=290.58 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=189.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||.||+|... +++.||+|+++.... ....+.+|++++.++ +|+||+++++++.... ..++|
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCceEEEE
Confidence 468999999999999964 578999999875422 234578899999998 9999999999987543 45899
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+||+.. +|.++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 999964 7776652 13889999999999999999999998 999999999999999999999999998765
Q ss_pred CCCC-CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh-----------hh
Q 005693 540 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV-----------RE 606 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~-----------~~ 606 (682)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+. ........ .+
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhcc
Confidence 4332 2345778999999876 4588999999999999999999999975432110 00000000 00
Q ss_pred ccccccchh-hhccccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhcCCC
Q 005693 607 EWTAEVFDV-ELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSE 664 (682)
Q Consensus 607 ~~~~~~~d~-~l~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~~~~~~ 664 (682)
.......+. ....... .......+.+++.+||+.||++||+++|++.+ ++.++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~ 309 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence 000000000 0000000 01123456788889999999999999999964 7777654433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=294.11 Aligned_cols=194 Identities=26% Similarity=0.426 Sum_probs=167.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV~ 460 (682)
.+.||+|+||.||+|+++ .|+.||||.+..... ..+...+|+++++++ +|+|||+++++-+... ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccceEEE
Confidence 467999999999999954 588999999987543 456788999999999 7999999999876544 567999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec--CCC--CeEEeecCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDL--DGCISDFGLT 536 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~--~~kl~DfGla 536 (682)
|||.+|||...++... +...+++.+.+.+..+++.||.|||+++ |+||||||.||++- .+| .-||+|||.|
T Consensus 97 EyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred eecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999998654 4566999999999999999999999998 99999999999993 334 3599999999
Q ss_pred CCCCCCC---CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 537 PLMNVPA---TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 537 ~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
+...... ...||..|.+||.+.. +.|+..+|.|||||++||++||..||....
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9988765 3458999999999984 788999999999999999999999997543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=280.40 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=192.3
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeecccc-----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.||++... ++..+|+|.++.... ..+.+.+|++++.++.+|+||+++.+.+..+...++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 467999999999999843 467899999875321 23567889999999978999999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 85 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 85 DYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred ecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999998642 24889999999999999999999988 9999999999999999999999999987654
Q ss_pred CCC-----CCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VPA-----TPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~~-----~~~~~~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
... ...++..|+|||.+.+.. .+.++||||||+++|||++|..||...... ...............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~----- 229 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSKP----- 229 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccCC-----
Confidence 322 124677899999987665 788999999999999999999999643211 111111111111100
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
. ... .....+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 230 --~--~~~---~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 --P--FPK---TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --C--CCc---ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 011 1223456777899999999999998888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=280.50 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=190.4
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|...+ ++.|++|++...... .....+|+..+.++.+|+||+++++++..++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 4679999999999999864 678999998765432 2345568888889844999999999999999999999999 88
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 9999887543 234899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC-h---------hHHHHHHhhhcccccc
Q 005693 544 TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-L---------PRWVQSVVREEWTAEV 612 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~-l---------~~~~~~~~~~~~~~~~ 612 (682)
...++..|+|||++.+ ..++.++|+||||+++|||++|+.||......+... . ..|.............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 2345778999998854 457899999999999999999999997554221100 0 0011100000000000
Q ss_pred chhhhcc--ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 FDVELMR--FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ~d~~l~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+...... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00011123567788899999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=271.47 Aligned_cols=243 Identities=20% Similarity=0.385 Sum_probs=196.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||++... ++..+++|++..... ..+.+.+|+++++.+ +|+|++++.+.+......++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEEecCC
Confidence 367999999999999975 478899999876533 345688899999999 799999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++..... ....+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 84 GDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred CcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999975431 1245899999999999999999999998 9999999999999999999999999987654432
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...+++.|+|||...+..++.++||||+|+++|+|++|+.||.... ............. .. +
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~-----~---- 223 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQY-PP-----I---- 223 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCCC-CC-----C----
Confidence 2346778999999988889999999999999999999999996543 1122222211110 00 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||..+|++|||+.|++++
T Consensus 224 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01223456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=274.97 Aligned_cols=258 Identities=22% Similarity=0.335 Sum_probs=198.2
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCC-----ceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-----NVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-----niv~l~~~~~~~~~~~lV~e~~ 463 (682)
...+|+|.||.|-.+.... +..||+|+++....-.+...-|+++++++.++. -+|.+.++|+-.++.++|+|.+
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 4679999999999998654 578999999877665667788999999985433 3778888899999999999988
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-------------------
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ------------------- 524 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~------------------- 524 (682)
|-++.+++..+. ..+++...+..|+.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 174 -G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 174 -GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred -ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 459999998654 456889999999999999999999998 999999999999942
Q ss_pred -CCCeEEeecCCCCCCCCCC-CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh------
Q 005693 525 -DLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL------ 596 (682)
Q Consensus 525 -~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l------ 596 (682)
+..++|+|||.|++..... +...|..|+|||++.+-..+.++||||+||||+|+.||..-|......|-+.+
T Consensus 247 ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG 326 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG 326 (415)
T ss_pred CCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC
Confidence 3458899999998876654 34568889999999999999999999999999999999999986543331111
Q ss_pred --hHHHH------HHhhhc---ccc--------ccc---hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 597 --PRWVQ------SVVREE---WTA--------EVF---DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 597 --~~~~~------~~~~~~---~~~--------~~~---d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+.... +.+..+ |.. .+. .+.-......+++...+++|+.+++..||.+|+|+.|++.+
T Consensus 327 p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 327 PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 11111 111100 000 000 00001112345677789999999999999999999999873
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=270.24 Aligned_cols=238 Identities=24% Similarity=0.443 Sum_probs=192.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++++.++ +|+|++++++++.++...++||||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 467999999999999865 567899999976643 345688899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 544 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 544 (682)
++|.+++... ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 84 GSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998743 34899999999999999999999998 99999999999999999999999999876654332
Q ss_pred ---CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 ---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ---~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..++..|+|||...+..++.++||||+|+++|+|++|+.||..... ...... ..... ...
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~~--~~~--------- 218 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR-IVQDD--HPP--------- 218 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-HhccC--CCC---------
Confidence 3467789999999888889999999999999999999999974331 111111 11000 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
........+.+++.+|+..+|++||+++|++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01112345667788999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-33 Score=316.33 Aligned_cols=239 Identities=25% Similarity=0.367 Sum_probs=186.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+..||.|.||.||.|... +|.-.|+|-++-... .-+...+|+.++..+ +|||+|+++|+-.+++..+|.||||++
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHHHHHhcc
Confidence 568999999999999854 466678887764322 235678899999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
|+|.+.+...+ -.++.....+..|++.|++|||++| ||||||||.||+++.+|.+|.+|||.|.....+.
T Consensus 1319 GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1319 GSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred CcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 99999997433 2556666778899999999999999 9999999999999999999999999997765443
Q ss_pred ------CCCCCCcccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 544 ------TPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 544 ------~~~~~~~y~aPE~~~~~---~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...||+.|||||++.+. ....++||||+|||..||+||+.||.....+ |.- ++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aI----------My~ 1453 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAI----------MYH 1453 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHH----------HhH
Confidence 23489999999999654 4677899999999999999999999754311 111 011
Q ss_pred hhhcc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VELMR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... .+.++.....-.+++.+|+..||++|.++.|++++
T Consensus 1454 V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11111 11112223334456669999999999988877654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=271.33 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=194.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||++... ++..+++|.+..... ...++.+|+++++++ +|+||+++.+++......++||||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEehhcCC
Confidence 467999999999999865 567899999875432 234677888999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++..... ....+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+|++|||++.......
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 999999865321 2345899999999999999999999998 9999999999999999999999999987665432
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... ....... ..... ...
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~----------~~~ 222 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKVQ-RGKYP----------PIP 222 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-cCCCC----------CCc
Confidence 234677899999999888999999999999999999999999754321 1111111 11000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+|++.+|++||++.|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2334557888889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=287.27 Aligned_cols=259 Identities=20% Similarity=0.323 Sum_probs=195.7
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC-----ceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~ 460 (682)
.+.||+|+||.||+|...+ +..+++|++..... ..+.+.+|+++++.+ +|+||+++.+++...+ ..++||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccceEEEe
Confidence 4679999999999999754 78899999876432 345788899999999 8999999999988765 789999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||++ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 84 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 84 ELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred cchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9997 4898888642 25899999999999999999999998 9999999999999999999999999987665
Q ss_pred CCC-------CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------
Q 005693 541 VPA-------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------ 606 (682)
Q Consensus 541 ~~~-------~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~------ 606 (682)
... ...++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+....+.. +........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence 432 22356779999999887 7899999999999999999999999765422110 000000000
Q ss_pred -----ccccccchh-hhcc----ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 005693 607 -----EWTAEVFDV-ELMR----FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQS 661 (682)
Q Consensus 607 -----~~~~~~~d~-~l~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~~~ 661 (682)
......... .... ..........+.+++.+||+.+|++||++++++++ ++.+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 000000000 0000 00011123456788889999999999999999994 6666553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.92 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=185.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC----------c
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----------E 455 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----------~ 455 (682)
.+.||+|+||.||+|..+ +++.||+|+++.... ....+.+|+++++++ +||||+++++++.+.. .
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhccccCCc
Confidence 468999999999999976 477899999865422 234677899999999 8999999999987654 7
Q ss_pred eEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 456 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 456 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
.++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred EEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccc
Confidence 8999999986 777776532 234899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCC-----CCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc-
Q 005693 536 TPLMNVPAT-----PSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW- 608 (682)
Q Consensus 536 a~~~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~- 608 (682)
+........ ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~ 239 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRLCGSPCP 239 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCh
Confidence 876543321 224667999998865 356889999999999999999999997543211 1111111110000
Q ss_pred --ccccc--------hhhhc----cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 --TAEVF--------DVELM----RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 --~~~~~--------d~~l~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+. +.... ...........+.+++.+||+.+|++||++++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 00000 000001123456788889999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=279.89 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=187.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEe-cCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++... +++.+|+|++..... ..+.+.+|++++..+ +||||+++.+++.. .+..++|+||+
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 467999999999999865 678899998864322 245677899999999 89999999999875 45788999998
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.++++.. .+++.....++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||.+.......
T Consensus 93 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 93 GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 56898888632 3788888899999999999999998 9999999999999999999999999987654332
Q ss_pred CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHHHhhhccccccc
Q 005693 544 TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---------DLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~---------~l~~~~~~~~~~~~~~~~~ 613 (682)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||......... ...++..............
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 2346778999999866 56899999999999999999999999754321100 0011111111110000000
Q ss_pred hhhhccccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........... .....+.+++.+|++.+|++||++++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000111 123567788889999999999999999885
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=305.32 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=180.0
Q ss_pred CCCCHHHHHHHhhccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec-
Q 005693 378 YNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK- 453 (682)
Q Consensus 378 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~- 453 (682)
+.-|++++ ++||+||||.||+++.+ ||+.+|||++..... ......+|+..++++ +|||||+++..|.+.
T Consensus 477 Y~~DFEEL-----~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEEL-----ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHH-----HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccC
Confidence 44567777 67999999999999976 799999999987642 234578899999999 999999987654110
Q ss_pred --------------------------------------------------------------------------------
Q 005693 454 -------------------------------------------------------------------------------- 453 (682)
Q Consensus 454 -------------------------------------------------------------------------------- 453 (682)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred --------------------------------------CceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHH
Q 005693 454 --------------------------------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495 (682)
Q Consensus 454 --------------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i 495 (682)
...||-||||+...+.++++.+.-. -.....++++.+|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI 706 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence 0135678888887777777654310 0356788999999
Q ss_pred HHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC----------------------CCCCCCCCCcccC
Q 005693 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----------------------VPATPSRSAGYRA 553 (682)
Q Consensus 496 a~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~----------------------~~~~~~~~~~y~a 553 (682)
++||+|+|++| ||||||||.||++|++..|||+|||+|+... ......||.-|+|
T Consensus 707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 99999999999 9999999999999999999999999997721 0112346777999
Q ss_pred ccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHH
Q 005693 554 PEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM 630 (682)
Q Consensus 554 PE~~~~~~---~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l 630 (682)
||++.+.. |+.|+|+||+|||++||+.- |....+ -...+..+ +......- .....+.+..-
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsME-----Ra~iL~~L-R~g~iP~~-------~~f~~~~~~~e 847 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSME-----RASILTNL-RKGSIPEP-------ADFFDPEHPEE 847 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHH-----HHHHHHhc-ccCCCCCC-------cccccccchHH
Confidence 99997654 99999999999999999853 542211 11111111 11111100 00112333444
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 005693 631 LQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 631 ~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.+++.++++.||.+|||+.|++.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhh
Confidence 56777999999999999999976
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=282.44 Aligned_cols=255 Identities=21% Similarity=0.275 Sum_probs=184.1
Q ss_pred hccccccCeEEEEEEEEcC---CceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec----CceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK----DEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~----~~~~lV 459 (682)
.+.||+|+||.||++.... +..+|+|++..... ..+.+.+|+++++++.+|+||+++++.+... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 4679999999999999653 56899999865322 2356778999999987799999999875432 356788
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 85 EELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred Eeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 88886 6899888632 34899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCC--------CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHH
Q 005693 540 NVPA--------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQ 601 (682)
Q Consensus 540 ~~~~--------~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~---------l~~~~~ 601 (682)
.... ...++..|+|||++.+ ..++.++||||+||++|+|++|+.||......+... ...+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 3221 2346788999998765 468899999999999999999999997543211000 000111
Q ss_pred HHhhhccccccchhhhccccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 602 SVVREEWTAEVFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
...................... ......+.+++.+|++.+|++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1000000000000000000000 112345778888999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-33 Score=278.07 Aligned_cols=195 Identities=27% Similarity=0.380 Sum_probs=168.2
Q ss_pred hccccccCeEEEEEEEEcCC-ceEEEEEeeccccC-hh---hHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG-KR---DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~-~~---~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
..+||+|+||.|-+|.-+++ ..+|||++++...- .+ -...|-+++....+-|.++++..+|+.-+.+|.||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 36899999999999987654 45899999876432 22 234566777777788999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
||+|--+++... .+.+..++.+|..||-||-+||++| ||+||||..|||+|.+|++||+|||+++.--.
T Consensus 434 GGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 434 GGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred CchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999998887543 3778889999999999999999999 99999999999999999999999999976432
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~ 592 (682)
..+.+|||.|+|||++....|+..+|+|||||+||||+.|++||+++.+++
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 235679999999999999999999999999999999999999999876544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=268.36 Aligned_cols=231 Identities=24% Similarity=0.331 Sum_probs=187.0
Q ss_pred ccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 393 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
||+|+||.||++... +++.+++|.+..... ....+..|+++++++ +|+||+++++.+..+...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999976 478899999876533 234688899999998 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++.... .+++.....++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++...... .
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 80 LFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 999997432 4899999999999999999999987 999999999999999999999999998765432 2
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...++..|+|||...+...+.++|+||||+++||+++|..||..... ............ ....
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~---------~~~~-- 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDPL---------RFPE-- 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC---------CCCC--
Confidence 23467789999999888889999999999999999999999975432 111222111110 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDE 650 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~e 650 (682)
.....+.+++.+||..||++||++++
T Consensus 215 -~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 -FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11345677888999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=268.83 Aligned_cols=239 Identities=18% Similarity=0.258 Sum_probs=184.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc------cChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 460 (682)
.+.||+|+||.||+|... ++..+++|.+.... .....+++|+++++++ +|+||+++++++.+. ...++|+
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCEEEEEE
Confidence 468999999999999965 47889999875321 1124678899999999 899999999998764 3578999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++++|.+++... ..+++....+++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||+++...
T Consensus 86 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 86 EYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999998632 23788999999999999999999998 9999999999999999999999999987543
Q ss_pred CC-------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~-------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. ....++..|+|||++.+..++.++|+|||||++|||++|+.||...... ....+....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-~~- 229 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQPTK-PM- 229 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCCCC-CC-
Confidence 21 1234677899999999888899999999999999999999999743211 111111111100 00
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+.+++.+|++ +|..||++.+++.+
T Consensus 230 --------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 --------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --------CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 011223445666779999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=284.42 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=184.2
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec------CceEEE
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 459 (682)
.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|++++.++ +|+||+++++++... ...+++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccccccEEEE
Confidence 46799999999999985 4578899999875432 235577899999999 999999999988643 246788
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
++++ +++|.+++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 101 ~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 101 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence 8876 7899888753 23899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCC-CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--hhccccccchh
Q 005693 540 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV--REEWTAEVFDV 615 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~--~~~~~~~~~d~ 615 (682)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ........ .......+.+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL--KLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHHhhcccH
Confidence 4432 2346778999999866 46788999999999999999999999654321100 00000000 00000000000
Q ss_pred -------hhccc--cChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 616 -------ELMRF--QNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 616 -------~l~~~--~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+... .... .....+.+++.+|++.||++||++.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000 123346788889999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=279.08 Aligned_cols=238 Identities=21% Similarity=0.347 Sum_probs=190.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++... ++..+++|++.... ...+.+.+|.+++.++.+|+||+++++++..++..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 467999999999999975 57889999986532 1235678889999999449999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999997432 4899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ------------------------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 005693 545 ------------------------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 600 (682)
Q Consensus 545 ------------------------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~ 600 (682)
..++..|+|||+.....++.++||||||++++++++|+.||....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~ 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------TF 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------HH
Confidence 124677999999988889999999999999999999999998553110 11
Q ss_pred HHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 005693 601 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM----DEVVR 653 (682)
Q Consensus 601 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~ 653 (682)
.......+ .........+.+++.+||+.+|++||++ +|+++
T Consensus 232 ~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111110 0011123456788889999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=276.86 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=191.4
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
+.||+|+||.||+|...+ ++.+++|.+.... ...+.+..|+++++++ +|+|++++++++.+.+..++||||++ +
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 569999999999999764 7889999987653 2235677899999998 89999999999999999999999998 5
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.... ..+++..+..++.|++.|++|||+.+ |+||||+|+||++++++.++|+|||+++......
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 9999997532 34899999999999999999999998 9999999999999999999999999987664432
Q ss_pred -CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccc--ccc--c
Q 005693 544 -TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWT--AEV--F 613 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~--~~~--~ 613 (682)
....+..|+|||.+.+. .++.++||||||+++|||++|+.||......+. ......... +.|. ... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccccc
Confidence 22345679999998776 789999999999999999999999976442111 000000000 0000 000 0
Q ss_pred hhhhccc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+...... .........+.+++.+||+.+|++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 0011124467888899999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=286.39 Aligned_cols=236 Identities=22% Similarity=0.308 Sum_probs=189.5
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
..+|.|+|+.|-.+... +++..++|++.+. ..+..+|+.++....+||||+++.+.+.+..+.|+|||++.++-+.
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 45999999999988854 5678899998765 3445667888888889999999999999999999999999999998
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe-cCCCCeEEeecCCCCCCCCC-CCCCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCISDFGLTPLMNVP-ATPSR 547 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl-~~~~~~kl~DfGla~~~~~~-~~~~~ 547 (682)
+.+...+ ....++..|+.+|+.|+.|||++| ||||||||+|||+ ++.++++|+|||.++..... .+.+-
T Consensus 405 ~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~ 475 (612)
T KOG0603|consen 405 RRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL 475 (612)
T ss_pred HHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence 8886433 333677889999999999999998 9999999999999 68999999999999887765 24456
Q ss_pred CCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHH
Q 005693 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 627 (682)
Q Consensus 548 ~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 627 (682)
|..|.|||++....|++++||||||++||+|++|+.||.....+ .++ ...+..... ...+++++
T Consensus 476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei---~~~i~~~~~-----------s~~vS~~A 539 (612)
T KOG0603|consen 476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI---HTRIQMPKF-----------SECVSDEA 539 (612)
T ss_pred hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH---HHhhcCCcc-----------ccccCHHH
Confidence 77899999999999999999999999999999999999865433 111 111111000 02234444
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 628 VQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 628 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
+ +|+.+|++.||.+||+|.++..+=.-
T Consensus 540 K---dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 540 K---DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred H---HHHHHhccCChhhCcChhhhccCcch
Confidence 4 45559999999999999999875443
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=280.77 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=182.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC--------ceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--------EKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 457 (682)
.+.||+|+||.||+|... +++.+|+|++..... ....+.+|++++.++ +|+||+++++++.... ..+
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccccCceEE
Confidence 467999999999999965 478899998865432 134577899999999 8999999998875443 458
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+|+||+.+ ++...+... ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||+++
T Consensus 92 lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 92 MVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 99999975 777777542 234899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCCC---------------CCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh-hHHH
Q 005693 538 LMNVPAT---------------PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-PRWV 600 (682)
Q Consensus 538 ~~~~~~~---------------~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l-~~~~ 600 (682)
....... ..+++.|+|||.+.+. .++.++||||||+++|||++|+.||.+......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 5533211 1235679999988654 578999999999999999999999975432111000 0000
Q ss_pred HHHhhhcc-----cccc--------chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 601 QSVVREEW-----TAEV--------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 601 ~~~~~~~~-----~~~~--------~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+ .... ....+.. ........+.+++.+|++.+|++|||+.|++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 0000 0000000 001122457788889999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=270.98 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=186.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||++.... +..+++|.++.... ...++.+|+.++..+ +||||+++++++.+.+..++||||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEEEEe
Confidence 4679999999999998654 33455555543211 223566788888888 999999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++++|.+++..... ....+++..++.++.|++.|+.|||+.+ ++|+||||+||++++ +.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 999999998864322 2345899999999999999999999998 999999999999975 56999999998765332
Q ss_pred C----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 A----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 ~----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
. ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ............ ..
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~~-~~-------- 223 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEGP-TP-------- 223 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCC-CC--------
Confidence 2 2346778999999988888999999999999999999999996432 111111111110 00
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||+.+|++||++.|++++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0112334567788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=282.52 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=189.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||.||++... ++..||+|++...... ...+.+|+++++++ +|+||+++++++..+. ..++|
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccccceEEEE
Confidence 467999999999999854 5788999998643222 34577899999999 9999999999987554 35899
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++|||++...
T Consensus 99 ~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 99 MPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 9998 7799888853 23899999999999999999999998 999999999999999999999999998766
Q ss_pred CCCC-CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC-C--------hhHHHHHHhhhcc
Q 005693 540 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-D--------LPRWVQSVVREEW 608 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~-~--------l~~~~~~~~~~~~ 608 (682)
.... ...+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||......... . ...+.........
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 4432 2346788999999876 45789999999999999999999999754321000 0 0000000000000
Q ss_pred ---cc---ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhc
Q 005693 609 ---TA---EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQS 661 (682)
Q Consensus 609 ---~~---~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i~~~ 661 (682)
.. ......+.. ........+.+++.+|++.||++|||+.++++ .++.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 249 KNYVKKLPRFRKKDFRS--LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHHHHhccccCcchHHH--hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 00 000000000 00122334678888999999999999999995 55555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=282.37 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=187.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCc------eEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lV 459 (682)
.+.||+|+||.||+|+.. ++..+|+|++..... ..+.+.+|+.+++.+ +|+|++++.+++...+. .++|
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccccEEEE
Confidence 467999999999999975 467899999865322 234567799999998 99999999988876554 8999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+||+ +++|.+++.. ..+++..+..++.|+++|++|||+.+ |+||||||+||++++++.++|+|||++...
T Consensus 99 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 99 THLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 9998 6699999863 24899999999999999999999998 999999999999999999999999998776
Q ss_pred CCCC-CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHHHhhhcc
Q 005693 540 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQSVVREEW 608 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~---------l~~~~~~~~~~~~ 608 (682)
.... ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ...+......+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 5432 3346778999999865 367899999999999999999999997543211100 0000000000000
Q ss_pred ccccch-hhhccccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 TAEVFD-VELMRFQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 ~~~~~d-~~l~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... .......... .....+.+++.+|++.+|++|||+.|++++
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 -RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred -HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 0000000011 124567788889999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=282.22 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=181.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEec--------------
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-------------- 453 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-------------- 453 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++++ +||||+++++++...
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccccccccc
Confidence 467999999999999975 477899999865533 345688899999999 999999999776543
Q ss_pred CceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEee
Q 005693 454 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISD 532 (682)
Q Consensus 454 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~D 532 (682)
...++||||++ ++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+|++|
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence 34689999997 5898888532 3889999999999999999999998 999999999999984 56789999
Q ss_pred cCCCCCCCCCC-------CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH-
Q 005693 533 FGLTPLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV- 603 (682)
Q Consensus 533 fGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~- 603 (682)
||++....... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. .......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~~~~~ 236 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLILESVP 236 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcC
Confidence 99987543221 1235677999998754 45788999999999999999999999754321110 0000000
Q ss_pred ---------hhhccccccchhhhccccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 604 ---------VREEWTAEVFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 604 ---------~~~~~~~~~~d~~l~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
................... .......+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000000000 0112345677888999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=265.56 Aligned_cols=219 Identities=17% Similarity=0.201 Sum_probs=171.7
Q ss_pred cCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchhHhhcc
Q 005693 396 GSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG 474 (682)
Q Consensus 396 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 474 (682)
|.||.||+++.. +++.+|+|++.... .+.+|...+... .||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999965 56789999987542 233444444444 699999999999999999999999999999999864
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-CCCCCCcccC
Q 005693 475 NRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRA 553 (682)
Q Consensus 475 ~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~a 553 (682)
. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+....... ...++..|+|
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a 150 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence 3 23899999999999999999999998 9999999999999999999999999876554322 2335667999
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHH
Q 005693 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI 633 (682)
Q Consensus 554 PE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l 633 (682)
||.+.+..++.++||||+|+++|||++|+.|+...... . ... ..... . ......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----------~~~-----~~~~~--~---~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----------NTH-----TTLNI--P---EWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----------ccc-----cccCC--c---ccCCHHHHHH
Confidence 99998888999999999999999999999887532110 0 000 00000 0 1122345677
Q ss_pred HHHcccCCCCCCCCHH
Q 005693 634 GMACVAKVPDMRPNMD 649 (682)
Q Consensus 634 ~~~Cl~~dP~~RPt~~ 649 (682)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 7899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=300.13 Aligned_cols=139 Identities=24% Similarity=0.371 Sum_probs=122.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|+++..... ...+.+|+.++..+ +|+||+++++++......++||||+.
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 467999999999999976 5788999999754321 24677888888888 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999643 23788999999999999999999988 9999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=285.83 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=199.2
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe-----cCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-----KDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lV~e~~ 463 (682)
.+.||.|.+|.||+++. ++++.+|+|++......+++.+.|.++++...+|||++.++|+|.. ++++|||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 46799999999999995 4577888998877777788899999999999999999999999963 56899999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC--
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-- 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-- 541 (682)
.+|+..|++++.. ...+.|+....|+..++.|+.+||... ++|||+|-.|||++.++.||+.|||++.....
T Consensus 104 ~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred CCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 9999999998766 345899999999999999999999987 99999999999999999999999999876643
Q ss_pred --CCCCCCCCcccCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 542 --PATPSRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 542 --~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
..+..||+.|||||++... .|+.++|+||+|++..||--|.+|+.+..+.. .+-.+.+ .-.
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------aLF~IpR------NPP 245 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIPR------NPP 245 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------hhccCCC------CCC
Confidence 3456789999999999643 36788999999999999999999997543211 0111111 011
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
+.+ ...+.-.+++.+++..|+.+|-++||++.++++
T Consensus 246 PkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 246 PKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111 223445667888888999999999999998875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=299.03 Aligned_cols=241 Identities=22% Similarity=0.332 Sum_probs=188.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.++||+|+||.|..++.+. ++.+|+|++.+.. .....|..|.+++..- +.+.|+.+...|+++.++|+|||||+
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEEeccc
Confidence 4789999999999999765 5678999998743 2345577777777765 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
||||..++.+.. .+++..+..++..|+.||.-||+.| +|||||||+|||||..|++|++|||.+-.+...
T Consensus 159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999997543 4999999999999999999999999 999999999999999999999999988766543
Q ss_pred ---CCCCCCCcccCccccc----c-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 543 ---ATPSRSAGYRAPEVIE----T-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~----~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
....|||.|++||++. + +.|+..+|+||+||++|||+.|..||.... ++.=..++...+.. +.
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk~~---l~ 301 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHKES---LS 301 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchhhh---cC
Confidence 3567999999999984 2 568999999999999999999999997543 22222222222111 00
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 654 (682)
++....++++++.+++ +.+ -+|+.|.. ++++-.+
T Consensus 302 --FP~~~~VSeeakdLI~---~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 302 --FPDETDVSEEAKDLIE---ALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred --CCcccccCHHHHHHHH---HHh-cChhhhcccccHHHHHhC
Confidence 0111234555655554 333 35777777 8888764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=260.06 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=190.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecc--ccC-hhhHHHHHHHHHHhcCCCceeceEEEEEec--------CceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEV--VVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~ 457 (682)
..+||+|.||+||+|+.+ +++.||+|+.--. ..+ .....+|++++..+ +|+|++.+++.|... ...|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccccceee
Confidence 467999999999999965 4666787765321 111 34567899999999 999999999888532 2478
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+||++|+. ||.-++.... ..++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+++
T Consensus 101 lVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 99999987 9998886432 34889999999999999999999987 9999999999999999999999999997
Q ss_pred CCCCCCCC--------CCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH-HHHhhhc
Q 005693 538 LMNVPATP--------SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV-QSVVREE 607 (682)
Q Consensus 538 ~~~~~~~~--------~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~-~~~~~~~ 607 (682)
.+..+... ..|..|++||.+.+. .|+++.|||+-||++.||+||.+-+.+.++.....+++.+ .++-++-
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 76544322 136789999998764 5899999999999999999999999887655443332221 1222222
Q ss_pred cccc-------cchhh-h--ccccChHHHHH------HHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 608 WTAE-------VFDVE-L--MRFQNIEEEMV------QMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 608 ~~~~-------~~d~~-l--~~~~~~~~~~~------~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
|..- .+..+ + .....+++..+ ...+++.+++..||.+|+++.+++.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2110 00000 0 01112333333 45678889999999999999998764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=237.76 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=191.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
-++||+|.||+||+|+..+ +..||+|++.....+ .....+|+-+++.+ +|.|||+++++...++..-+|+|||+.
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeHHHhhH
Confidence 3679999999999999655 566899998754332 34578899999999 999999999999999999999999966
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+|..+.....+ .++.+.+..++.|+.+|+.++|++. +.|||+||.|.+++.+|..|++|||+++..+.+.
T Consensus 86 -dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 86 -DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred -HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 89888875544 3888999999999999999999998 9999999999999999999999999998877654
Q ss_pred --CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH-HHhhhcccc--ccchhh
Q 005693 544 --TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ-SVVREEWTA--EVFDVE 616 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~-~~~~~~~~~--~~~d~~ 616 (682)
....|..|.+|.++.+.+ |++..|+||-||++.|+.. |++-|.+...++...-+-|.- ..-.+.|.. ...|..
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 234578899999998765 7889999999999999998 566677665444322222221 112233321 111111
Q ss_pred hc-ccc-------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 617 LM-RFQ-------NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 617 l~-~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. .+. -.+..-..-.++..+.+.-+|.+|.++++++++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 10 000 011111122456667778899999999988764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=266.76 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=185.5
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccCh--------hhHHHHHHHHHHhcCCCceeceEEEEEec-CceEEE
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGK--------RDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~--------~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV 459 (682)
..+||+|||++||+|.. .+.+.||+|+-.....++ +...+|.+|-+.+ .||.||++|+|+.-+ +..+-|
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeeccccceee
Confidence 35799999999999994 456778888754322221 2355788888888 999999999999754 567899
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLT 536 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla 536 (682)
+|||+|.||.-+|+..+ .+++.++..|+.||+.||.||.+.. |||||-||||.|||+-+ -|.+||+|||++
T Consensus 547 LEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999998544 4899999999999999999999874 88999999999999954 478999999999
Q ss_pred CCCCCCCC-----------CCCCCcccCccccccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 005693 537 PLMNVPAT-----------PSRSAGYRAPEVIETR----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 537 ~~~~~~~~-----------~~~~~~y~aPE~~~~~----~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~ 601 (682)
+.+..... ..||..|++||.+.-+ +.+.|+||||.||++|..+.|+.||.......
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--------- 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--------- 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---------
Confidence 98865432 2367889999988533 46889999999999999999999998653221
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.++.++.....-...+...+.+..+.+ .+|++|+++.-++|....++..
T Consensus 692 dILqeNTIlkAtEVqFP~KPvVsseAk---aFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 DILQENTILKATEVQFPPKPVVSSEAK---AFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHhhhchhcceeccCCCCCccCHHHH---HHHHHHHHhhhhhhhhHHHHcc
Confidence 122222222221222222223334444 4556999999999998888765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=271.83 Aligned_cols=250 Identities=18% Similarity=0.323 Sum_probs=195.3
Q ss_pred CCHHHHHHHh-hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecC
Q 005693 380 FDLEDLLRAS-AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 454 (682)
Q Consensus 380 ~~~~~l~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 454 (682)
.++..+++.. .++||.|.||+||-|+.+ .|+.||||++.+... .+...+.|+.|++++ +||.||.+...|+..+
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPE 636 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCc
Confidence 4555555544 789999999999999964 589999999977643 345688999999999 9999999999999999
Q ss_pred ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC---CCeEEe
Q 005693 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCIS 531 (682)
Q Consensus 455 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~ 531 (682)
..+.|||-+.| |..+.+-... ...+++...+.++.||+.||.|||.++ |+|+||||+|||+.+. -.+||+
T Consensus 637 rvFVVMEKl~G-DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 637 RVFVVMEKLHG-DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred eEEEEehhhcc-hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeec
Confidence 99999999955 6655553322 334889999999999999999999998 9999999999999765 368999
Q ss_pred ecCCCCCCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 532 DFGLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 532 DfGla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
|||.|++.+... ...|||.|.|||++....|...-|+||.||++|.-++|..||.... ++.+-+
T Consensus 710 DFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQI-------- 776 (888)
T KOG4236|consen 710 DFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQI-------- 776 (888)
T ss_pred cccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHh--------
Confidence 999999987654 4468999999999999999999999999999999999999997432 111111
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
....+-. ......+.....+++|...++..-.+|-+.++.+.
T Consensus 777 QNAaFMy---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 777 QNAAFMY---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hcccccc---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1111111 11112334445566666888888888888877665
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=275.21 Aligned_cols=241 Identities=17% Similarity=0.248 Sum_probs=195.0
Q ss_pred hccccccCeEEEEEEEEcCCc-eEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEEST-TVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
...||-|+||.|-+++.+... .+|+|.+++... .++....|-.++... +.|.||++|-.|.+++..|++||-|-
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhhHHhhc
Confidence 356999999999999876544 388888876632 234466788899998 79999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
||.|...+++. ..++...+..++..+.+|++|||+++ ||+|||||+|.++|.+|-+||.|||.|+....+.
T Consensus 504 GGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 504 GGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred Cchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999743 34888899999999999999999998 9999999999999999999999999999887665
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
+.+|||.|.|||++....++.++|.||+|+++|||++|.+||.+.++....+ .+++.- +.+ .
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn------~ILkGi---d~i-------~ 639 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN------LILKGI---DKI-------E 639 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH------HHHhhh---hhh-------h
Confidence 5679999999999999999999999999999999999999998765432221 111110 000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRMI 655 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~L 655 (682)
.+....+...+++++.++.+|.+|.- ..|+.++-
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 11223344567777999999999975 66776654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=250.44 Aligned_cols=238 Identities=19% Similarity=0.314 Sum_probs=186.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccCh----hhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.++||+|+|+.|-.++++. .+.+|+|++++.-.+. .-.+.|-.+.....+||.+|-+..+|+.+..+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 4789999999999999765 5678999988764332 2356677777788899999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC----
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN---- 540 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~---- 540 (682)
||+|.-+++..+ .++++.+..+-..|..||.|||+.| ||+||||..|+|+|..|++|++|+|+++.--
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 999988776433 3999999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-CCCChhHHHHHHhhhccccccchhhhcc
Q 005693 541 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 541 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
..++.+|||.|.|||++.+..|...+|+|++||+|+||+.|+.||+--..+ ...+...++-+++-++..+ .
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--------i 478 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--------I 478 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------c
Confidence 234678999999999999999999999999999999999999999743211 1122233333333332211 1
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCC
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRP 646 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP 646 (682)
....+... ..+.+.-+.+||++|.
T Consensus 479 prslsvka---s~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKA---SHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhh---HHHHHHhhcCCcHHhc
Confidence 11112222 2334477889999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=250.65 Aligned_cols=234 Identities=24% Similarity=0.369 Sum_probs=188.7
Q ss_pred CeEEEEEEEEcC-CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchhHhhc
Q 005693 397 SYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLH 473 (682)
Q Consensus 397 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~ 473 (682)
+||.||+|...+ +..+++|++...... .+.+.+|++.++++ +|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999875 788999998765432 57889999999999 99999999999999999999999999999999987
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---CCCCCCCc
Q 005693 474 GNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATPSRSAG 550 (682)
Q Consensus 474 ~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~~~~~~~ 550 (682)
... .+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++++|||.+...... ....++..
T Consensus 80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 80 KRG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred hcc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 432 2889999999999999999999998 999999999999999999999999998876553 23446778
Q ss_pred ccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHH
Q 005693 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM 630 (682)
Q Consensus 551 y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l 630 (682)
|++||......++.++||||||+++|+|++|..||.... +................ .........+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKKIGKPKPPFP---------PPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccCCCCc---------cccccCCHHH
Confidence 999999988888999999999999999999999997531 11111111111111000 0000033467
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 005693 631 LQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 631 ~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 77888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=284.61 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=160.9
Q ss_pred hccccccCeEEEEEEEEcC-----CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEE------EEecCceEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY------YYSKDEKLL 458 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~------~~~~~~~~l 458 (682)
.+.||+|+||.||+|.+.+ +..||+|++...... +....+ .+... .+.+++.+... ...+...++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRA-CPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhh-chhhHHHHHHhhhcccccccCCceEE
Confidence 5789999999999999754 578999987643211 111111 11111 22222222211 245567899
Q ss_pred EEeeccCCchhHhhccCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec
Q 005693 459 VYDYFASGSLSTLLHGNRGA---------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 523 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~ 523 (682)
||||+.+++|.+++...... .........+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEe
Confidence 99999999999998643210 0001123445679999999999999988 99999999999998
Q ss_pred C-CCCeEEeecCCCCCCCCC-----CCCCCCCcccCccccccC----------------------CCCCcchHHHHHHHH
Q 005693 524 Q-DLDGCISDFGLTPLMNVP-----ATPSRSAGYRAPEVIETR----------------------KHSHKSDVYSFGVLL 575 (682)
Q Consensus 524 ~-~~~~kl~DfGla~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~sDvwS~Gvvl 575 (682)
+ ++.+||+|||+|+..... ....+++.|+|||.+... .++.++|||||||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 579999999999765432 234578899999965322 234567999999999
Q ss_pred HHHHhCCCCCCCCCC-------CCCCChhHHHHHHhhhccccccchhhhc-cccChHHHHHHHHHHHHHcccCCCCCCCC
Q 005693 576 LEMLTGKAPLQSPTR-------DDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPN 647 (682)
Q Consensus 576 ~elltg~~Pf~~~~~-------~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 647 (682)
|||+++..|++.... ....+...|....... ...... .+...........+++.+|++.||++|||
T Consensus 370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 999998766542100 0001122221111100 000000 00001111223457888999999999999
Q ss_pred HHHHHHH
Q 005693 648 MDEVVRM 654 (682)
Q Consensus 648 ~~evl~~ 654 (682)
++|++++
T Consensus 444 a~e~L~H 450 (566)
T PLN03225 444 AKAALAH 450 (566)
T ss_pred HHHHhCC
Confidence 9999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=268.27 Aligned_cols=194 Identities=25% Similarity=0.402 Sum_probs=165.4
Q ss_pred ccccccCeEEEEEEEEcCC-ceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||-|+||+|.+++-.++ ..+|.|.+.+... .....+.|.+||... +.+.||+|+-.|++++.+|+||||++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEeccCC
Confidence 5699999999999985554 5578998876543 123567788999998 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC-----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----- 540 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~----- 540 (682)
||+-.+|-+. ..+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||+|||+++-+.
T Consensus 714 GDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 714 GDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999998643 34788888888999999999999999 9999999999999999999999999984321
Q ss_pred ----CC-------------------------------------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 005693 541 ----VP-------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEML 579 (682)
Q Consensus 541 ----~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ell 579 (682)
.+ ....||+.|+|||++....|+..+|+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 00 0113578899999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCC
Q 005693 580 TGKAPLQSPTRDDM 593 (682)
Q Consensus 580 tg~~Pf~~~~~~~~ 593 (682)
.|+.||...+..+.
T Consensus 866 ~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 866 VGQPPFLADTPGET 879 (1034)
T ss_pred hCCCCccCCCCCcc
Confidence 99999998776654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=234.44 Aligned_cols=197 Identities=25% Similarity=0.367 Sum_probs=163.3
Q ss_pred HhhccccccCeEEEEEEEE-cCCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 388 ASAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.....||+|+||.|-+-++ ..|+..|+|++.....+ +++...|+.+.++...+|.+|.++|.+......++.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3457799999999988875 46888999999866433 45677788888888789999999999999999999999996
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
. +|..+-+.--. ....+++.-.-+|+..+..||.|||++- .++|||+||+|||++.+|++|+||||.+..+..+..
T Consensus 129 t-Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 129 T-SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred h-hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 5 77665543221 2345889999999999999999999964 699999999999999999999999999987765432
Q ss_pred ---CCCCCcccCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 005693 545 ---PSRSAGYRAPEVIET----RKHSHKSDVYSFGVLLLEMLTGKAPLQSP 588 (682)
Q Consensus 545 ---~~~~~~y~aPE~~~~----~~~~~~sDvwS~Gvvl~elltg~~Pf~~~ 588 (682)
..|-..|||||.+.. ..|+.++||||+|+++.||.+++.||+..
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 235556999999853 36899999999999999999999999743
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=279.32 Aligned_cols=239 Identities=26% Similarity=0.435 Sum_probs=184.0
Q ss_pred hccccccCeEE-EEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGT-AYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+++|.|+-|+ ||+|.++ +++||||++-... .....+|+..++.-.+|||||++++.-.+++..|+..|.|. .+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence 56799999875 7999987 7899999986432 33567899999988889999999999999999999999995 599
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---C--CCeEEeecCCCCCCCCCC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---D--LDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~--~~~kl~DfGla~~~~~~~ 543 (682)
.+++... ..............+..|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.+....
T Consensus 590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999863 111111122455778899999999999988 999999999999976 3 468999999998875432
Q ss_pred -------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 544 -------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 544 -------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
+..||-||+|||++....-+.++||||+||++|+.++| ..||...-..+. .++.......
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~---- 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLV---- 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcccee----
Confidence 34578899999999998888899999999999999996 899985432211 1111111111
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
......++ ...+||.+|++++|..||++.+|+.
T Consensus 734 ---~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 ---HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111222 5667888999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=269.78 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=170.1
Q ss_pred hccccccCeEEEEEEEE-----------------cCCceEEEEEeeccccC-h--------------hhHHHHHHHHHHh
Q 005693 390 AEVLGKGSYGTAYKAVL-----------------EESTTVVVKRLKEVVVG-K--------------RDFEQQMEIVGRV 437 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~-~--------------~~~~~e~~~l~~l 437 (682)
.++||+|+||.||+|.. .+++.||||+++..... . +....|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 47899999999999964 23467999998643221 1 2233466677777
Q ss_pred cCCCc-----eeceEEEEEe--------cCceEEEEeeccCCchhHhhccCCCC-------------------CCCCCCH
Q 005693 438 GQHPN-----VVPLRAYYYS--------KDEKLLVYDYFASGSLSTLLHGNRGA-------------------GRTPLDW 485 (682)
Q Consensus 438 ~~h~n-----iv~l~~~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~ 485 (682)
+|.+ +++++++|.. +...++||||+++|+|.++++...+. ....+++
T Consensus 230 -~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 230 -KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred -hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 4443 4677777753 35679999999999999999743210 1123567
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC-----CCCCCcccCccccccC
Q 005693 486 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-----PSRSAGYRAPEVIETR 560 (682)
Q Consensus 486 ~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-----~~~~~~y~aPE~~~~~ 560 (682)
..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ...++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 888999999999999999988 99999999999999999999999999976543221 1236789999988543
Q ss_pred C--------------------C--CCcchHHHHHHHHHHHHhCCC-CCCCCCCCC------CCChhHHHHHHhhhccccc
Q 005693 561 K--------------------H--SHKSDVYSFGVLLLEMLTGKA-PLQSPTRDD------MVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 561 ~--------------------~--~~~sDvwS~Gvvl~elltg~~-Pf~~~~~~~------~~~l~~~~~~~~~~~~~~~ 611 (682)
. + ..+.||||+||++|||++|.. ||....... ..++..|... . ..
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~-----~~ 459 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-K-----GQ 459 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-c-----cc
Confidence 2 1 134799999999999999875 765322110 0111111110 0 00
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVP---DMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~evl~~ 654 (682)
..+. ...........+++.+++..+| .+|+|++|++++
T Consensus 460 ~~~~-----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYDF-----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCCc-----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0111 1111223345566668888765 789999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=234.12 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=186.5
Q ss_pred hccccccCeEEEEEEE-EcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecC--ceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~~~g 466 (682)
.+.+|+|.|++||.|. ..++..++||+++... ++.+.+|+.++..+..||||+.++++..+.. ...+|+||+++.
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 4679999999999998 4567789999998653 5678999999999988999999999987654 457999999998
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecCCCCCCCCCCCC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPATP 545 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~~~~ 545 (682)
|...+-. .++..+....+.++++||.|+|++| |+|||+||.|+++|.. -.++++|||+|.++......
T Consensus 121 Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 121 DFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred cHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 8877654 2777889999999999999999999 9999999999999965 57899999999988766543
Q ss_pred C---CCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc------cccchh
Q 005693 546 S---RSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT------AEVFDV 615 (682)
Q Consensus 546 ~---~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~------~~~~d~ 615 (682)
. .+..|-.||.+..- .|+..-|+|||||++..|+..+.||-.... ...++++...-...++.. .-..|+
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 2 45668899998654 478889999999999999999999853321 111222222211111000 000111
Q ss_pred hh------------cccc---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 616 EL------------MRFQ---NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 616 ~l------------~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. .++- .-.-...+.++++.+.+.+|..+|+|++|+..+
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11 0000 000112345667779999999999999999873
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-30 Score=243.70 Aligned_cols=257 Identities=18% Similarity=0.276 Sum_probs=189.3
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec-----CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 460 (682)
.+.||.|+||.||.+.+ ++|+.|+.|++..... ..+.+.+|.+++... +|.||...+++.+-. ++.|.|+
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 36799999999999985 4689999999976543 356788899999988 999999998887543 3567889
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
|.|.. ||...+- +.+.++...++-+..||.+||+|||+.+ |.||||||.|.|++.+...||+|||+|+...
T Consensus 137 ELmQS-DLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 137 ELMQS-DLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHh-hhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 98855 8887775 3556888999999999999999999998 9999999999999999999999999998876
Q ss_pred CCCCC-----CCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH--------HHHhhh
Q 005693 541 VPATP-----SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV--------QSVVRE 606 (682)
Q Consensus 541 ~~~~~-----~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~--------~~~~~~ 606 (682)
..... ..|..|+|||++.+. .|+.+.||||.||++.|++..+.-|...+.-+..+++.-+ .+...+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 54332 236679999999875 5899999999999999999999999876554333221110 000001
Q ss_pred ccccccch-----hhhc---cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 607 EWTAEVFD-----VELM---RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 607 ~~~~~~~d-----~~l~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
+-...+.. +.+. ......+.-.+-+.+...++..||+.|.+.++++.++.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111 1110 01111112223344556889999999999999887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-27 Score=228.23 Aligned_cols=205 Identities=31% Similarity=0.527 Sum_probs=179.7
Q ss_pred ccccCeEEEEEEEEcC-CceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 393 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
||+|++|.||++...+ ++.+++|++...... .+.+.+|++.++.+ +|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999765 788999998765442 46789999999999 8999999999999989999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCCCCCC----CC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP----AT 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~~----~~ 544 (682)
+++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+...... ..
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 9997432 34889999999999999999999998 999999999999999 899999999998766543 23
Q ss_pred CCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+...|++||..... .++.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3456779999999887 788999999999999999
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+.+++.+|++.+|++||+++++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 355677889999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=252.13 Aligned_cols=190 Identities=23% Similarity=0.372 Sum_probs=162.6
Q ss_pred hhccccccCeEEEEEEEEcC-CceEEEEEeecccc----Chh-----hHHHHHHHHHHhc--CCCceeceEEEEEecCce
Q 005693 389 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKR-----DFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEK 456 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~-----~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~ 456 (682)
+.+.+|+|+||.|+.|.++. ..+|++|.+.+.+. +-+ ..-.|+.||..+. .|+||++++++|++++..
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 35789999999999999765 46788898876543 111 2456999999983 299999999999999999
Q ss_pred EEEEeec-cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 457 LLVYDYF-ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 457 ~lV~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
||+||-. ++.||++++... ..+++.++..|+.||+.|+++||+++ |||||||-+||.++.+|-+|++|||.
T Consensus 645 yl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred EEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 9999976 456999999743 34899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCC--CCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q 005693 536 TPLMNV--PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQ 586 (682)
Q Consensus 536 a~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~ 586 (682)
|..... -....||.+|.|||++.+..| +..-||||+|++||.++....||.
T Consensus 717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 876543 346679999999999999988 455799999999999999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=237.42 Aligned_cols=128 Identities=19% Similarity=0.226 Sum_probs=109.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCC-------CceeceEEEEEe----cCceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-------PNVVPLRAYYYS----KDEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-------~niv~l~~~~~~----~~~~~ 457 (682)
.++||.|.|++||++... ..+.||+|+.+....-.+....|+++++++..+ ..||++++.|.. +.+.+
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC 162 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC 162 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence 578999999999999964 467799999988766567788899999988643 379999999974 56889
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 523 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~ 523 (682)
+|+|++ |.+|..+|.... ...++...+.+|+.||+.||.|||.++ .|||.||||+|||+.
T Consensus 163 MVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred EEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 999998 668999887543 344899999999999999999999987 699999999999994
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=226.87 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=185.2
Q ss_pred hhccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEE-EEecCceEEEEeeccCC
Q 005693 389 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY-YYSKDEKLLVYDYFASG 466 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~-~~~~~~~~lV~e~~~~g 466 (682)
+.+.+|+|.||.+-+++++. .+.+|+|.+.......++|.+|...--.|..|.||+.-+++ |+..+....++||++.|
T Consensus 28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG 107 (378)
T ss_pred HHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence 35679999999999999765 56799999988888889999999877777789999987765 55666777999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec--CCCCeEEeecCCCCCCCCCCC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DfGla~~~~~~~~ 544 (682)
||.+-+.. ..+-+....+++.|+++|+.|+|++. +||||||.+||||- +..++|++|||+.+..+....
T Consensus 108 dL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 108 DLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred hhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 99988864 23788899999999999999999998 99999999999993 345899999999876654332
Q ss_pred C-CCCCcccCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 545 P-SRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 545 ~-~~~~~y~aPE~~~~~-----~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
. .....|.|||..... ...+.+|+|.||+++|.++||+.||+.....+ ....+|.+-..+.. .. ..+
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~~rk~--~~----~P~ 251 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWLKRKN--PA----LPK 251 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHhcccC--cc----Cch
Confidence 2 235569999987532 24677899999999999999999998443322 23333333221111 11 111
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.+..+. ..++++.++-+..+|++|-...++.++..
T Consensus 252 ~F~~fs---~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 252 KFNPFS---EKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hhcccC---HHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 222223 34445555888999999965555555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=229.81 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=183.9
Q ss_pred ccccccCeEEEEEEEE-cCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec------CceEEEE
Q 005693 391 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLVY 460 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV~ 460 (682)
+.+|.|.- .|..+.. -.+++||+|++..... ..++..+|...+..+ +|+||++++.++.-. .+.|+||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHHhHHHHH
Confidence 56788876 5555553 3478899999866533 345677888888888 999999999999643 3569999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
|||.. +|...+.. .++-+....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+...
T Consensus 101 e~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 101 ELMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred Hhhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 99965 89888862 2777889999999999999999999 9999999999999999999999999998765
Q ss_pred CC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC----------------ChhHHHH
Q 005693 541 VP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------------DLPRWVQ 601 (682)
Q Consensus 541 ~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~----------------~l~~~~~ 601 (682)
.. .....+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...-+.. ++...++
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 44 2344677899999999988999999999999999999999999864322110 0000011
Q ss_pred HHhh--hccccccc-----hhhhcc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 602 SVVR--EEWTAEVF-----DVELMR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 602 ~~~~--~~~~~~~~-----d~~l~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.... .++....+ |..+.. .....-......+++.+|+..+|++|.++++++++
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1110 01111001 110000 00111233456678889999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-27 Score=241.77 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=197.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcC-----CCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ-----HPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~-----h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
....|+|-|++|..|... .+..||||++.....-.+.=..|+++|.+|.. --|.++++-.|...+++|+|+|-+
T Consensus 437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L 516 (752)
T KOG0670|consen 437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL 516 (752)
T ss_pred EeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh
Confidence 346899999999999954 47899999998776656667789999999852 347899999999999999999987
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP 542 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~ 542 (682)
. .+|.++|++... ...|....+..++.|+..||..|-..+ |+|.||||.|||+++.- .+||||||.|......
T Consensus 517 s-lNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 517 S-LNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred h-chHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccc
Confidence 4 499999987642 344788899999999999999999988 99999999999999764 5799999999877654
Q ss_pred CCC--CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-----HHhhhc-cccccch
Q 005693 543 ATP--SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ-----SVVREE-WTAEVFD 614 (682)
Q Consensus 543 ~~~--~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~-----~~~~~~-~~~~~~d 614 (682)
... ..+..|.|||++.+..|+...|+||.||+|||+.||+..|.+.+..+++.+.--+. ++++.. +...-+|
T Consensus 591 eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD 670 (752)
T KOG0670|consen 591 EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFD 670 (752)
T ss_pred cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcc
Confidence 422 23456999999999999999999999999999999999999887665543211110 011000 0000011
Q ss_pred h--------------------------------hhccc----cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 V--------------------------------ELMRF----QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~--------------------------------~l~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. .+... ..-......|.+|...|+..||++|.|..+++++
T Consensus 671 ~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 671 QDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred cccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 0 11111 1112345567889999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=220.66 Aligned_cols=190 Identities=29% Similarity=0.478 Sum_probs=166.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|++|.||++...+ +..+++|.+..... ..+.+.+|++.+.++ +|+|++++++++...+..++++||++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEeccCCC
Confidence 3679999999999999875 78899999976543 356788899999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++..... .+++.....++.+++.++.+||+.+ ++|+|++++||+++.++.++|+|||.+......
T Consensus 83 ~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 83 DLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999975331 1788999999999999999999997 999999999999999999999999998776544
Q ss_pred -CCCCCCCcccCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 005693 543 -ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 587 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~ 587 (682)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 233466779999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=246.47 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=187.7
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
..+|.|.||.|||++.. .+...|+|+++.... .....++|+-+++.. +|+|||.++|.|-.++..+++|||+.+|+|
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 57999999999999965 467788999876532 345567788888887 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----CCC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PAT 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----~~~ 544 (682)
.+.-+. ..++++.+...++....+|++|||+.+ -+|||||-.||++++.|.+|++|||.+..+.. ...
T Consensus 100 Qdiy~~-----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 100 QDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred cceeee-----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 998773 345899999999999999999999998 89999999999999999999999998866543 445
Q ss_pred CCCCCcccCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 PSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ~~~~~~y~aPE~~---~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..||+.|||||+. ..+.|..++|||+.|+...|+-.-.+|.-....... ..-. ....+++.-. .
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~------l~Lm-----TkS~~qpp~l--k 238 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA------LFLM-----TKSGFQPPTL--K 238 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH------HHHh-----hccCCCCCcc--c
Confidence 6799999999987 356789999999999999999888877543221110 0000 1111121111 1
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
+...-...+-++++.|+.++|++||+++.++.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11122334556667999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=207.07 Aligned_cols=170 Identities=20% Similarity=0.267 Sum_probs=127.7
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 545 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 545 (682)
|+|.++++.. ...+++.+++.++.|++.||+|||+.+ ||+||++++++.+|+ ||.+....... .
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~ 64 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-S 64 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-C
Confidence 6899999743 234999999999999999999999975 999999999999999 99987765433 3
Q ss_pred CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHH
Q 005693 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 625 (682)
Q Consensus 546 ~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 625 (682)
.+++.|+|||++.+..++.++|||||||++|||+||+.||..... ................ .. .......
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~---~~--~~~~~~~ 134 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPADD---PR--DRSNLES 134 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccCC---cc--ccccHHH
Confidence 578999999999999999999999999999999999999964321 1111111111110000 00 0001111
Q ss_pred HH--HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 626 EM--VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 626 ~~--~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.. ..+.+++.+||+.+|++||++.|+++++..+...
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 22 2578888999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=223.90 Aligned_cols=187 Identities=28% Similarity=0.492 Sum_probs=158.8
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.++||+|.|++||++... ....||+|.+.... .......|++++..+..+.||+++.+++..++...+|+||++.
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 568999999999999853 35679999986543 3567899999999999999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecCCCCCC-----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLM----- 539 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~----- 539 (682)
.+..++... ++..++...++.+.+||+++|.+| |||||+||.|+|.+.. +.-.|.|||+|...
T Consensus 120 ~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 120 DRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999998863 778899999999999999999999 9999999999999854 67789999998511
Q ss_pred ------------CC----------------C---------------CCCCCCCcccCccccccC-CCCCcchHHHHHHHH
Q 005693 540 ------------NV----------------P---------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLL 575 (682)
Q Consensus 540 ------------~~----------------~---------------~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl 575 (682)
.. + ....||+||.|||++... ..++++||||.||++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00 0 011268899999999654 468899999999999
Q ss_pred HHHHhCCCCCCCC
Q 005693 576 LEMLTGKAPLQSP 588 (682)
Q Consensus 576 ~elltg~~Pf~~~ 588 (682)
..+++++.||-..
T Consensus 269 Lslls~~~PFf~a 281 (418)
T KOG1167|consen 269 LSLLSRRYPFFKA 281 (418)
T ss_pred ehhhccccccccC
Confidence 9999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-25 Score=260.12 Aligned_cols=187 Identities=20% Similarity=0.225 Sum_probs=135.2
Q ss_pred CceeceEEEE-------EecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 005693 441 PNVVPLRAYY-------YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 513 (682)
Q Consensus 441 ~niv~l~~~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHr 513 (682)
+||+++++++ ...+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+++ |+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 6788888877 2334567788987 56999999742 234899999999999999999999998 9999
Q ss_pred CCCCCCeEecC-------------------CCCeEEeecCCCCCCCCC--------------------CCCCCCCcccCc
Q 005693 514 NIKASNVLINQ-------------------DLDGCISDFGLTPLMNVP--------------------ATPSRSAGYRAP 554 (682)
Q Consensus 514 DLk~~NILl~~-------------------~~~~kl~DfGla~~~~~~--------------------~~~~~~~~y~aP 554 (682)
||||+||||+. ++.+|++|||+++..... ....+|+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 445667777766532110 012357779999
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHH
Q 005693 555 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIG 634 (682)
Q Consensus 555 E~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~ 634 (682)
|++.+..++.++|||||||++|||++|..|+.... ...... ... ...+. .........+++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~-~~~----~~~~~------~~~~~~~~~~~~ 245 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSL-RHR----VLPPQ------ILLNWPKEASFC 245 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHH-HHh----hcChh------hhhcCHHHHHHH
Confidence 99999999999999999999999999988865221 001110 000 00100 011123345677
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 005693 635 MACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 635 ~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+||+.+|.+||++.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 89999999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=252.27 Aligned_cols=186 Identities=35% Similarity=0.637 Sum_probs=152.8
Q ss_pred ChhHHHHHHHHHHhCCCC--CCcCCCCCCCCCCCcceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCC
Q 005693 74 LNSDRQALLDFADAVPHL--RKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSN 151 (682)
Q Consensus 74 ~~~~~~al~~~~~~~~~~--~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N 151 (682)
.+.|+.||++||+++... ...+|+..+++| .|.||+|+. .++|+.|+|++++++|.+|+ .+..+++|+.|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNN-SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCC-CCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCC
Confidence 347999999999998533 345898766766 899999985 46999999999999999987 7999999999999999
Q ss_pred CCCCCCCCcCC-CCCCCcEEeecccccCCcCCCCcccccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC
Q 005693 152 VLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF 230 (682)
Q Consensus 152 ~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 230 (682)
+++|.+|..+. ++++|++|+|++|+++|.+|....++|++|+|++|.+++.+|..++++++|+.|+|++|.+.+.+|..
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 99999998765 99999999999999999888766678888888888888888888888888888888888887777763
Q ss_pred --CCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 231 --DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 231 --~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
.+++|++|+|++|++++.+|..++++++|+.+
T Consensus 184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 217 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217 (968)
T ss_pred hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEE
Confidence 67777777777777777777766666665544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-23 Score=199.85 Aligned_cols=245 Identities=23% Similarity=0.376 Sum_probs=182.9
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+|.+...|+.|+|+++ |..+++|+++-... -.++|..|.-.++-. .||||..++|.|.......++..||+.|+
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCCCceEeeeeccchH
Confidence 45778888999999998 55677777764432 246788887777666 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe-cCCCCCCeEecCCCCeEEeecCCCCCCCCCCCCC
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH-GNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 546 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH-rDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 546 (682)
|+..++... ....+..++.+++.++|+|++|||+.. +++- --|....+++|++..++|. .+-+++.-......
T Consensus 274 lynvlhe~t---~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfqe~gr~ 347 (448)
T KOG0195|consen 274 LYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVGRA 347 (448)
T ss_pred HHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeeeccccc
Confidence 999998654 345788899999999999999999985 4444 4688999999999988874 12122221222223
Q ss_pred CCCcccCccccccCCC---CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 547 RSAGYRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 547 ~~~~y~aPE~~~~~~~---~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
-.|.||+||.++..+. -.++|+|||.+++||+.|...||......+.- .++.-++... ...+++
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkialeglrv-------~ippgi 414 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIALEGLRV-------HIPPGI 414 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhhhccccc-------cCCCCc
Confidence 4678999999987654 35789999999999999999999876544321 1111111110 112233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
. ..+.+++.-|+..||.+||.++.++-.|+++.
T Consensus 415 s---~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 415 S---RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred c---HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 3 34556677999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=201.61 Aligned_cols=152 Identities=19% Similarity=0.260 Sum_probs=117.3
Q ss_pred hccccccCeEEEEEEEEc--CCceEEEEEeecccc------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||+||+|... +++.+|||++..... ..+.+.+|++++.++ +|+|++..+.. ....++|||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~---~~~~~LVmE 98 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA---TGKDGLVRG 98 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE---cCCcEEEEE
Confidence 467999999999999865 466779998753311 134689999999999 89998853322 246799999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeEecCCCCeEEeecCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI-KASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDL-k~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
|+++++|... .. .. ...++.++++||+|||+.| |+|||| ||+|||++.++.+||+|||+|+...
T Consensus 99 ~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 99 WTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred ccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 9999999632 10 11 1467889999999999998 999999 9999999999999999999998654
Q ss_pred CCC------------CCCCCCcccCccccccC
Q 005693 541 VPA------------TPSRSAGYRAPEVIETR 560 (682)
Q Consensus 541 ~~~------------~~~~~~~y~aPE~~~~~ 560 (682)
... +..+++.|+|||++...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 322 12346679999998543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-20 Score=182.87 Aligned_cols=254 Identities=19% Similarity=0.225 Sum_probs=192.5
Q ss_pred hhccccccCeEEEEEEE-EcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 389 SAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+++||+|.||+.+.|+ +-++..||||.-.. .....+.+.|.+..+.|...+.|..++-+..++.+-.+|+|++ |-+
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS 109 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS 109 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence 36889999999999998 44688899987543 3445678899999999989999999998888888899999988 668
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-----CCeEEeecCCCCCCCCC
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-----LDGCISDFGLTPLMNVP 542 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-----~~~kl~DfGla~~~~~~ 542 (682)
|.|+..-.. ..++..+++.+|.|+..-++|+|++. +|+|||||+|+||... ..+.++|||+|+.+..+
T Consensus 110 LEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 110 LEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred HHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 888776443 23899999999999999999999998 9999999999999754 34789999999988765
Q ss_pred CC-----------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 543 AT-----------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 543 ~~-----------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
.+ ..||.+||+-.-..+++.+.+-|+-|+|-++++.+-|..||.+...+... ...+++-..+ ...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK---~kYeKIGe~K-r~T 258 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK---EKYEKIGETK-RST 258 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH---HHHHHhcccc-ccC
Confidence 43 34788999998889999999999999999999999999999987644321 1112221111 111
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
-++.. -.++++++...++.++ +.+-++-|..+-+...+..+...
T Consensus 259 ~i~~L---c~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 259 PIEVL---CEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred CHHHH---HhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHh
Confidence 11111 1234555555555444 35677778887777766665543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-20 Score=192.35 Aligned_cols=254 Identities=19% Similarity=0.253 Sum_probs=186.9
Q ss_pred hhccccccCeEEEEEEEEcCC--ceEEEEEeeccccC-hhhHHHHHHHHHHhcC---CCceeceEEEE-EecCceEEEEe
Q 005693 389 SAEVLGKGSYGTAYKAVLEES--TTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQ---HPNVVPLRAYY-YSKDEKLLVYD 461 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~---h~niv~l~~~~-~~~~~~~lV~e 461 (682)
..+.||+|+||.||++..... ..+|+|........ ...+..|..++..+.. -.++..+++.. ..+...++||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 357899999999999997654 36777776654322 2268889999988852 36888888888 47778899999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-----CCeEEeecCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-----LDGCISDFGLT 536 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-----~~~kl~DfGla 536 (682)
.+ |.+|.++..... ...++..+..+++.|++.+|++||+.| ++||||||.|++++.. ..+.+.|||++
T Consensus 102 l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred cc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 77 779999886543 244899999999999999999999999 9999999999999865 35899999999
Q ss_pred CCCC---C-------C----CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH
Q 005693 537 PLMN---V-------P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 602 (682)
Q Consensus 537 ~~~~---~-------~----~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~ 602 (682)
+... . . ....||..|.++....+...+.+.|+||++.++.|+..|..||......... .....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKFEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHHHH
Confidence 8221 1 1 1233788999999999999999999999999999999999999765432211 01111
Q ss_pred HhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 603 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 603 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
..... .... .....+.+ +.++...+-..+..++|....+...+++.....
T Consensus 252 ~~~~~----~~~~---~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 DPRKL----LTDR---FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred Hhhhh----cccc---ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111 0000 00112233 334444555589999999999999988877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-19 Score=188.32 Aligned_cols=253 Identities=27% Similarity=0.381 Sum_probs=188.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||.|+||.||++... ..+++|.+...... ...+.+|..++..+.+|++++++.+.+......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 357899999999999977 77899998765432 457889999999994444899999999777778999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~-- 542 (682)
+++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+......
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999777643211 24888999999999999999999998 99999999999999998 7999999998755432
Q ss_pred --------CCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 543 --------ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 543 --------~~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
....++..|+|||.+.+ ..++...|+||+|++++++++|..||...... .........+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 34457889999999987 57888999999999999999999997654321 0001111111111110
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........... ......+.+++..|+..+|..|.+..+....
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 1223456677779999999999999887775
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=211.86 Aligned_cols=148 Identities=29% Similarity=0.541 Sum_probs=103.6
Q ss_pred HHHHHHHHHhhhhcccCChhHHHHHHHHHHhCCCCCCcCCCCCCCCC----CCcceEEecCCC----CeEEEEEeCCCcc
Q 005693 57 FFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPIC----QSWVGINCTQDR----TRVFGLRLPGIGL 128 (682)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~~~~~~al~~~~~~~~~~~~~~w~~~~~~c----~~w~gv~C~~~~----~~v~~l~l~~~~l 128 (682)
++..+.++.+.+........|..||+++|.++.....++|+++ +| +.|.||.|+.+. .+|+.|+|++|++
T Consensus 353 ilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~--~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L 430 (623)
T PLN03150 353 IINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGD--PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGL 430 (623)
T ss_pred eeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCCCCC--CCCCcccccccceeeccCCCCceEEEEEECCCCCc
Confidence 4444455444454555677899999999999865444589753 34 279999996321 2588888888888
Q ss_pred cccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcc
Q 005693 129 VGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQS 206 (682)
Q Consensus 129 ~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~ 206 (682)
.|.+|+ .+++|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..++ ++|++|+|++|+|+|.+|..
T Consensus 431 ~g~ip~-~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 509 (623)
T PLN03150 431 RGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509 (623)
T ss_pred cccCCH-HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH
Confidence 888887 688888888888888888888888888888877777777777766655544 44555555555555555444
Q ss_pred h
Q 005693 207 I 207 (682)
Q Consensus 207 ~ 207 (682)
+
T Consensus 510 l 510 (623)
T PLN03150 510 L 510 (623)
T ss_pred H
Confidence 4
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.6e-20 Score=176.63 Aligned_cols=139 Identities=14% Similarity=0.179 Sum_probs=107.2
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccC----------hhh-----------------HHHHHHHHHHhcCCCce
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG----------KRD-----------------FEQQMEIVGRVGQHPNV 443 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------~~~-----------------~~~e~~~l~~l~~h~ni 443 (682)
+.||+|+||.||+|...+|+.||+|+++..... ... .+.|++.+.++ .++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTAGI 81 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHCCC
Confidence 579999999999999888999999999754221 112 23488889888 67766
Q ss_pred eceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecCCCCCCeEe
Q 005693 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI-HSMGGPKFTHGNIKASNVLI 522 (682)
Q Consensus 444 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivHrDLk~~NILl 522 (682)
.....+.. ...++||||++++++...... ...++......++.|++.+|.++ |+.+ |+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 44333322 234899999998877654321 12488899999999999999999 6887 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCC
Q 005693 523 NQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~~~~ 541 (682)
+ ++.++|+|||+|.....
T Consensus 152 ~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred E-CCcEEEEEccccccCCC
Confidence 8 47899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=173.20 Aligned_cols=182 Identities=16% Similarity=0.151 Sum_probs=139.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChh-----hHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR-----DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
...|++|+||+||.+.. .+.+++.+.+.......+ .+++|++++.++.+|+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999997765 577788777765543222 578999999999777899999886 45799999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI-KASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDL-k~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
|.+|...+.. ....++.|++.+++++|+.| |+|||| ||+|||++.++.++|+|||+|.......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9998654321 11347789999999999998 999999 7999999999999999999998554332
Q ss_pred CC-----------------CCCCcccCccccccC-CCC-CcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 005693 544 TP-----------------SRSAGYRAPEVIETR-KHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRD 591 (682)
Q Consensus 544 ~~-----------------~~~~~y~aPE~~~~~-~~~-~~sDvwS~Gvvl~elltg~~Pf~~~~~~ 591 (682)
.. ..++.|++|+-..-. ..+ .+.++++-|.-+|.++|+..+..+..+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 10 125556777654322 233 5679999999999999999998765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-21 Score=213.72 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=173.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeec---cccChhh----HHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKE---VVVGKRD----FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~----~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+++|.|.+|.|+..... .....+.|.... ....... +..|.-+-..+ +|+|++..+..+.+....+-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhhhh
Confidence 578999999988777633 222233333221 1111111 22233333445 89999888777776666666699
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++ ||..++... ..+...++-.++.|+..|++|+|+.| |.|||+|++|++++.+|.+||+|||.+.....
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 999999743 24778888999999999999999999 99999999999999999999999999866543
Q ss_pred CC--------CCCCCCcccCccccccCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 542 PA--------TPSRSAGYRAPEVIETRKHSHK-SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 542 ~~--------~~~~~~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
+. ...|+..|+|||++....|.+. .||||.|+++..|.+|+.||......+... .........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhcccccc
Confidence 32 3457778999999999999765 799999999999999999998765544321 000000000
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
........-..........++.++++.+|.+|.|+++|++
T Consensus 545 -~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 -NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000001112233444566788999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.2e-21 Score=203.10 Aligned_cols=186 Identities=29% Similarity=0.427 Sum_probs=160.0
Q ss_pred cccccCeEEEEEEE----EcCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 392 VLGKGSYGTAYKAV----LEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+|+|.||.|++++ .+.+..+|.|.+++... .+.....|..++..+.+||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 23466788888876532 122456677888888679999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
+|+|...+... ..+.+.........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999888643 33677777778888999999999998 99999999999999999999999999998877766
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 587 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~ 587 (682)
.+||..|||||++. .+..++|+||||++++||+||..||..
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 79999999999998 678899999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-19 Score=168.49 Aligned_cols=193 Identities=20% Similarity=0.261 Sum_probs=160.7
Q ss_pred hccccccCeEEEEEEE-EcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||.|+||.+|.|. ...|.+||+|.-... ........|..+...+..-..|..+..+..+.....+|||.+ |-+|
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL 97 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL 97 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence 4689999999999998 567899999986543 345567888999999977888999999999999999999988 7799
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC---CCeEEeecCCCCCCCCCC--
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~~~~~~~-- 543 (682)
.+++.-... .++..+++.++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||+|+.+....
T Consensus 98 EdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 98 EDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred HHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 888865432 2888999999999999999999998 9999999999999754 457899999998764432
Q ss_pred ---------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 005693 544 ---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 591 (682)
Q Consensus 544 ---------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~ 591 (682)
...||..|.+-....+...+.+.|+-|+|.++.+.--|..||++....
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 234677888777766777788899999999999999999999976543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=177.69 Aligned_cols=163 Identities=13% Similarity=0.180 Sum_probs=127.3
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhh----------HHHHHHHHHHhcCCCceeceEEEEEec------
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----------FEQQMEIVGRVGQHPNVVPLRAYYYSK------ 453 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~----------~~~e~~~l~~l~~h~niv~l~~~~~~~------ 453 (682)
.+++|.|+||.||+... ++..+|+|.+.......+. +++|+..+.++ .|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeeeccccccc
Confidence 57899999999999766 5778999999765433322 57888899999 999999999886643
Q ss_pred --CceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEe
Q 005693 454 --DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 531 (682)
Q Consensus 454 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 531 (682)
...++||||++|.+|.++.. ++. ....+++.++..+|+.| ++|||+||+||++++++ ++++
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999988742 332 24568999999999998 99999999999999988 9999
Q ss_pred ecCCCCCCCCCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 005693 532 DFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEML 579 (682)
Q Consensus 532 DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ell 579 (682)
|||........... ..+.....+..++|+|+||+++....
T Consensus 177 Dfg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 99987655322111 11344556778999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.7e-19 Score=171.72 Aligned_cols=139 Identities=17% Similarity=0.243 Sum_probs=109.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---------------------------hhhHHHHHHHHHHhcCCCc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------------------------KRDFEQQMEIVGRVGQHPN 442 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~~h~n 442 (682)
.+.||+|+||+||+|...+|+.||||+++..... ...+++|.+.+.++ .|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhCC
Confidence 3579999999999999878999999998754211 11235678888888 7888
Q ss_pred eeceEEEEEecCceEEEEeeccCCchhHh-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCe
Q 005693 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTL-LHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNV 520 (682)
Q Consensus 443 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NI 520 (682)
+.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++|+ .| |+||||||+||
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhE
Confidence 7554444333 34899999998855433 321 237788899999999999999999 88 99999999999
Q ss_pred EecCCCCeEEeecCCCCCCCC
Q 005693 521 LINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 521 Ll~~~~~~kl~DfGla~~~~~ 541 (682)
+++ ++.++|+|||++.....
T Consensus 150 ll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE-CCCEEEEEcccceecCC
Confidence 999 88999999999876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.2e-19 Score=188.18 Aligned_cols=211 Identities=21% Similarity=0.387 Sum_probs=159.8
Q ss_pred CCCceeceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 005693 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 518 (682)
Q Consensus 439 ~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~ 518 (682)
.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...+++.-...+..+|++||+|+|... -..|+.++..
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 7999999999999999999999999999999999752 344899999999999999999999864 2299999999
Q ss_pred CeEecCCCCeEEeecCCCCCCCCCCC-C-----CCCCcccCccccccCC-------CCCcchHHHHHHHHHHHHhCCCCC
Q 005693 519 NVLINQDLDGCISDFGLTPLMNVPAT-P-----SRSAGYRAPEVIETRK-------HSHKSDVYSFGVLLLEMLTGKAPL 585 (682)
Q Consensus 519 NILl~~~~~~kl~DfGla~~~~~~~~-~-----~~~~~y~aPE~~~~~~-------~~~~sDvwS~Gvvl~elltg~~Pf 585 (682)
|+++|..+.+|++|||+......... . ....-|.|||.+.... .+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999877643111 1 1123499999997642 356789999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 586 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 586 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
+.....+.. .+.+..+.. .....+.+.+... .+....+..++.+||..+|++||+++++-..++.+....
T Consensus 159 ~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDP--DEIILRVKK--GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCCh--HHHHHHHHh--cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 865433221 122222111 1111122222111 123336788889999999999999999999998877654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-19 Score=199.14 Aligned_cols=238 Identities=23% Similarity=0.332 Sum_probs=171.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccc--cChhhHHHHHHHHH-HhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVV--VGKRDFEQQMEIVG-RVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~e~~~l~-~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+-||.+.|=.|.+|+..+|. |+||++.+.. ..-+.|+++++-++ .+.+|||++++.-+-..+...|+|-+|+.+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 356999999999999988776 8999986543 33455665554333 344899999988777777788899899866
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.|.+. .+..+...+.+.|+.|+..|+..+|..| |+|+|||.+|||++.=.=+.|+||..-+..--+.
T Consensus 106 nLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 106 NLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8999886 3455788899999999999999999998 9999999999999987778999997543321111
Q ss_pred --------CCCCCCcccCccccccCC-----------CCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 005693 544 --------TPSRSAGYRAPEVIETRK-----------HSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 603 (682)
Q Consensus 544 --------~~~~~~~y~aPE~~~~~~-----------~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~ 603 (682)
+..+...|.|||.+.... .+++-||||.||++.|+++ |++||.-. ++
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------------QL 244 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------------QL 244 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------------HH
Confidence 122345699999885421 4567899999999999999 67888521 11
Q ss_pred hhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 604 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+.-. .....+++. ....+++ ..+.+++..|++.||++|.++++.++.
T Consensus 245 ~aYr-~~~~~~~e~-~Le~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 LAYR-SGNADDPEQ-LLEKIED--VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhHh-ccCccCHHH-HHHhCcC--ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1000 000111110 0000111 145678889999999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=173.44 Aligned_cols=193 Identities=19% Similarity=0.278 Sum_probs=136.8
Q ss_pred cCCCceeceEEEEEe---------------------------cCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHH
Q 005693 438 GQHPNVVPLRAYYYS---------------------------KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 490 (682)
Q Consensus 438 ~~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~ 490 (682)
.+|||||++.+.|.+ ....|+||..++. +|.+++..+. .+.....-
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHH
Confidence 479999999888743 1245899998865 9999997432 66677788
Q ss_pred HHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec--CCCC--eEEeecCCCCCCCC----------CCCCCCCCcccCccc
Q 005693 491 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLD--GCISDFGLTPLMNV----------PATPSRSAGYRAPEV 556 (682)
Q Consensus 491 i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~~--~kl~DfGla~~~~~----------~~~~~~~~~y~aPE~ 556 (682)
|+.|+.+|+.|||++| |.|||+|.+|||+. +|+. ..|+|||++-.-.. .....|...-||||+
T Consensus 346 ~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 9999999999999999 99999999999994 4443 56899997632211 112335666999999
Q ss_pred cccCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHH
Q 005693 557 IETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM 630 (682)
Q Consensus 557 ~~~~~------~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l 630 (682)
..... ...|+|.|+.|-+.||+++...||....+.. .+...+.+ .... .-.+.+...+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe-----~qLP----------alp~~vpp~~ 486 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQE-----SQLP----------ALPSRVPPVA 486 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhh-----hhCC----------CCcccCChHH
Confidence 86432 2468999999999999999999997633211 12111111 1111 1112334456
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 631 LQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 631 ~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.+++...++.||++|++..-+...|+
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 67778899999999999877766654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-18 Score=174.38 Aligned_cols=230 Identities=17% Similarity=0.287 Sum_probs=140.2
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC----hhhHHHHHHHHHHhcC---------CCceeceEEEEE----
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQ---------HPNVVPLRAYYY---- 451 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~---------h~niv~l~~~~~---- 451 (682)
++.||.|+++.||.+.+.+ ++++|+|++...... -+.+++|.-.+..+.+ |-.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4689999999999999875 678999988644321 2345555433333211 212222222221
Q ss_pred -----ec--C------ceEEEEeeccCCchhHhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 005693 452 -----SK--D------EKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 516 (682)
Q Consensus 452 -----~~--~------~~~lV~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk 516 (682)
.. . ..+++|+-+ .+||.+++..-.. .....+....++.+..|+++.+++||..| ++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccc
Confidence 11 1 235677766 4588877642110 01122445566778899999999999999 9999999
Q ss_pred CCCeEecCCCCeEEeecCCCCCCCCCCC-CCCCCcccCccccccC--------CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 005693 517 ASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETR--------KHSHKSDVYSFGVLLLEMLTGKAPLQS 587 (682)
Q Consensus 517 ~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~y~aPE~~~~~--------~~~~~sDvwS~Gvvl~elltg~~Pf~~ 587 (682)
|+|++++.+|.++|+||+.....+.... ...+..|.+||..... .++.+.|.|++|+++|.|+++..||..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999987655543322 2344679999977442 468899999999999999999999985
Q ss_pred CCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCC
Q 005693 588 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 645 (682)
Q Consensus 588 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 645 (682)
.......+. .+....+..+.+.+|+..+++.+|.+|
T Consensus 253 ~~~~~~~~~----------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPEW----------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSGG----------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCccccccc----------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 532211110 112222344456667779999999887
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.5e-17 Score=159.47 Aligned_cols=134 Identities=12% Similarity=0.126 Sum_probs=103.3
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecc-ccChhhHHHHHHHHHHhc----CCCceeceEEEEEecC---ceE-EEE
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEV-VVGKRDFEQQMEIVGRVG----QHPNVVPLRAYYYSKD---EKL-LVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~---~~~-lV~ 460 (682)
.+.||+|+||.||. +.+....+||++... ....+++.+|+.++..+. .||||++++|+++++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46799999999996 443344478887654 224567899999999984 4899999999998874 333 789
Q ss_pred ee--ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEecCCCCCCeEecC----CCCeEEeec
Q 005693 461 DY--FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV-AHIHSMGGPKFTHGNIKASNVLINQ----DLDGCISDF 533 (682)
Q Consensus 461 e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl-~~LH~~~~~~ivHrDLk~~NILl~~----~~~~kl~Df 533 (682)
|| +.+|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 99 5579999999642 25544 35677888777 9999998 999999999999974 347999995
Q ss_pred CCC
Q 005693 534 GLT 536 (682)
Q Consensus 534 Gla 536 (682)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-16 Score=155.42 Aligned_cols=133 Identities=20% Similarity=0.367 Sum_probs=111.8
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccC---------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
+.||+|++|.||+|.. .+..+++|+....... ...+.+|++++..+ +|++++....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEEE
Confidence 4699999999999987 5677889986543221 23567888899988 88888887777777888899999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
|++|++|.+++... .+ .+..++.+++.++.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998632 12 78899999999999999998 99999999999999 78999999998765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=153.36 Aligned_cols=130 Identities=21% Similarity=0.370 Sum_probs=105.2
Q ss_pred cccccCeEEEEEEEEcCCceEEEEEeecccc---------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 392 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.||+|+||.||+|.. ++..+++|....... ...++.+|++++..+ +|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 467899998654321 124567899999998 677666555555666778999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
++|++|.+++.... . .++.+++.+|.++|+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~---------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcH---------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998875311 0 78999999999999998 99999999999999 889999999998663
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.7e-16 Score=156.06 Aligned_cols=140 Identities=15% Similarity=0.202 Sum_probs=107.0
Q ss_pred hhccccccCeEEEEEEE--EcCCceEEEEEeeccccC-------------------------hhhHHHHHHHHHHhcCC-
Q 005693 389 SAEVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVG-------------------------KRDFEQQMEIVGRVGQH- 440 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~~h- 440 (682)
..+.||+|+||.||+|. ..+++.||+|+++..... ...+++|++.+.++ .+
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-~~~ 110 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-YEA 110 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-Hhc
Confidence 35789999999999998 567899999998743210 12356789999998 44
Q ss_pred -CceeceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 005693 441 -PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN 519 (682)
Q Consensus 441 -~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~N 519 (682)
..+.+++++ ...++||||+++++|....... ..........++.|++.++++||+.+ .|+||||||+|
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 233444443 2458999999998887654221 22556667899999999999999985 59999999999
Q ss_pred eEecCCCCeEEeecCCCCCCCC
Q 005693 520 VLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 520 ILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-16 Score=183.22 Aligned_cols=185 Identities=24% Similarity=0.327 Sum_probs=145.2
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhc--CCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|...+++.||+|+-+....++ |---.+++.+|. --+-|+.+...+.-.+..++|+||.+.|+
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence 56899999999999998889999999987665442 222223344441 12344444444555677789999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-------CCCeEEeecCCCCCCC
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-------DLDGCISDFGLTPLMN 540 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-------~~~~kl~DfGla~~~~ 540 (682)
|.++++.. +.++|.-.+.+..|++..+++||..+ |||+||||+|+||.. ...++|+|||.+-.+.
T Consensus 781 lld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 781 LLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred HHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999843 34889999999999999999999998 999999999999952 3457999999985543
Q ss_pred ---CCCC---CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 005693 541 ---VPAT---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584 (682)
Q Consensus 541 ---~~~~---~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~P 584 (682)
...+ ..+|-.+-.+|+..++..+.++|.|.++-+++-|+.|+..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2212 2356678999999999999999999999999999999743
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=7e-16 Score=173.97 Aligned_cols=131 Identities=21% Similarity=0.334 Sum_probs=107.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEE-eecccc--------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKR-LKEVVV--------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||+||+|.+.+.. +++|+ ..+... ..+.+.+|++++..+ +|++++....++......++||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCCCCEEEE
Confidence 578999999999999876544 34343 222111 124578899999999 8999998888887778889999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
||+++++|.+++. ....++.+++.++.+||+.+ ++||||||+||++ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998874 34678999999999999998 9999999999999 6789999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=149.87 Aligned_cols=133 Identities=15% Similarity=0.167 Sum_probs=104.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc-----------------------ChhhHHHHHHHHHHhcCCC--cee
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----------------------GKRDFEQQMEIVGRVGQHP--NVV 444 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------------------~~~~~~~e~~~l~~l~~h~--niv 444 (682)
.+.||+|+||.||++...+++.||||++..... ......+|..++..+ .|+ .++
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~v~ 98 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEGFPVP 98 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcCCCCC
Confidence 578999999999999988899999998754321 012356778888888 666 444
Q ss_pred ceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC
Q 005693 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 524 (682)
Q Consensus 445 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 524 (682)
..++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ |+||||||+||++++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~ 160 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDD 160 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcC
Confidence 4443 2456899999999998765420 234678899999999999988 999999999999999
Q ss_pred CCCeEEeecCCCCCCCC
Q 005693 525 DLDGCISDFGLTPLMNV 541 (682)
Q Consensus 525 ~~~~kl~DfGla~~~~~ 541 (682)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-16 Score=178.23 Aligned_cols=197 Identities=24% Similarity=0.333 Sum_probs=134.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
-++|-.|+||.||.++++. .+++|.|+-++. .+.+. ++... ..|.+| ||-
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~-----lilRn--ilt~a-~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN-----LILRN--ILTFA-GNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccc-----hhhhc--ccccc-CCccee---------------------chh
Confidence 3789999999999999775 456777432221 11111 22222 445444 566
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-------
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV------- 541 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~------- 541 (682)
...++... +++. +++.+++|+|+.+ |+|||+||+|.+|+.-|++|++|||+.+....
T Consensus 139 ~tllk~~g-----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 139 ATLLKNIG-----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhcccCC-----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 56664321 2332 2267899999998 99999999999999999999999998754211
Q ss_pred ------------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 542 ------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 542 ------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
....++|+.|+|||++....|+..+|+|++|+++||.+-|+.||.+.+.++.+. +.+.+...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd~i~ 276 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISDDIE 276 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhhhcc
Confidence 112358999999999999999999999999999999999999999887655432 22222110
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 646 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 646 (682)
..+..+....+..+++.+.++.+|.+|-
T Consensus 277 ---------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 ---------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0011122233445566688899999984
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.4e-15 Score=139.67 Aligned_cols=135 Identities=18% Similarity=0.168 Sum_probs=112.8
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCC-CceeceEEEEEecCceEEEEeeccCCchh
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..+.++ .++++++++....+..+++|||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 569999999999999865 7889998865433 56789999999999544 68999999888888899999999887765
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
.+ +......++.+++++++++|....+.++|+|++|+||++++++.++++|||.+...
T Consensus 82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 43 44566778999999999999864445999999999999999999999999987653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-17 Score=148.14 Aligned_cols=144 Identities=31% Similarity=0.502 Sum_probs=131.2
Q ss_pred CCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--ccccee
Q 005693 115 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192 (682)
Q Consensus 115 ~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L 192 (682)
..+++.|.|++|+++ .+|+ .++.|.+|+.|++++|+++ .+|.++++|++|+.|+++-|++. .+|..|+ +.|+.|
T Consensus 32 ~s~ITrLtLSHNKl~-~vpp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred hhhhhhhhcccCcee-ecCC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 357899999999999 7888 6999999999999999999 89999999999999999999999 8999998 899999
Q ss_pred ecccccCcc-cCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 193 DLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 193 ~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
||++|+++. .+|..|..|+.|+.|+|++|.+.-.+|+. ++++|+.|.+..|.+- .+|..++.++.|+-++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELH 179 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHh
Confidence 999999985 48999999999999999999999777765 9999999999999998 8999998888776554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-15 Score=161.10 Aligned_cols=118 Identities=25% Similarity=0.353 Sum_probs=102.9
Q ss_pred ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 455 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
..|+.|+++.-.+|.+|+.+.+. ....++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 56899999999999999975442 3346788899999999999999 55 9999999999999999999999999
Q ss_pred CCCCCCCCC----------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 005693 535 LTPLMNVPA----------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 580 (682)
Q Consensus 535 la~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt 580 (682)
+........ ...||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987654333 2347888999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-14 Score=138.49 Aligned_cols=137 Identities=18% Similarity=0.227 Sum_probs=98.3
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChh---h----------------------HHHHHHHHHHhcCC-Cce
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR---D----------------------FEQQMEIVGRVGQH-PNV 443 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~---~----------------------~~~e~~~l~~l~~h-~ni 443 (682)
.+.||+|+||.||+|...+++.||||++........ . ...|.+.+..+..+ -.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999988899999999875322111 1 13455555555222 234
Q ss_pred eceEEEEEecCceEEEEeeccCCchhH-hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeE
Q 005693 444 VPLRAYYYSKDEKLLVYDYFASGSLST-LLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVL 521 (682)
Q Consensus 444 v~l~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NIL 521 (682)
.+.+++ ...++||||++++++.. .+.... .. .+...++.+++.++.++|. .+ |+||||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 455543 24689999999965432 121100 11 5678899999999999999 77 999999999999
Q ss_pred ecCCCCeEEeecCCCCCCCC
Q 005693 522 INQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 522 l~~~~~~kl~DfGla~~~~~ 541 (682)
++ ++.++++|||.+.....
T Consensus 148 i~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EE-CCcEEEEECcccccccC
Confidence 99 89999999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.1e-14 Score=140.17 Aligned_cols=137 Identities=18% Similarity=0.233 Sum_probs=105.6
Q ss_pred Hhhcccc-ccCeEEEEEEEEcCCceEEEEEeeccc--------------cChhhHHHHHHHHHHhcCCCce--eceEEEE
Q 005693 388 ASAEVLG-KGSYGTAYKAVLEESTTVVVKRLKEVV--------------VGKRDFEQQMEIVGRVGQHPNV--VPLRAYY 450 (682)
Q Consensus 388 ~~~~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~~h~ni--v~l~~~~ 450 (682)
..+..|| .||.|+||.+... +..+++|.+.... .....+.+|++++..+ +|++| ++.+++.
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~ 111 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAAR 111 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeee
Confidence 3367898 8999999999876 6778888875311 1234578899999999 77664 6677765
Q ss_pred EecCc----eEEEEeeccC-CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC
Q 005693 451 YSKDE----KLLVYDYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 525 (682)
Q Consensus 451 ~~~~~----~~lV~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~ 525 (682)
..+.. .++||||+++ .+|.+++... .++.. .+.+++.++.+||+.| |+||||||+|||++.+
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~ 178 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD 178 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence 43322 2599999997 6998888532 24443 3568999999999998 9999999999999999
Q ss_pred CCeEEeecCCCCCC
Q 005693 526 LDGCISDFGLTPLM 539 (682)
Q Consensus 526 ~~~kl~DfGla~~~ 539 (682)
+.++|+|||.+...
T Consensus 179 ~~v~LIDfg~~~~~ 192 (239)
T PRK01723 179 GKFWLIDFDRGELR 192 (239)
T ss_pred CCEEEEECCCcccC
Confidence 99999999988764
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.7e-15 Score=136.69 Aligned_cols=136 Identities=30% Similarity=0.451 Sum_probs=122.3
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCC-cCCCCcc--cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~~p~~~~--~~L~~L~ 193 (682)
++..|++++|.+. .+|. .++.|++|++|+++-|++. .+|..|+.++.|+.|||++|+++. .+|..|. ..|+-|+
T Consensus 57 nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 5667899999998 7898 7999999999999999999 999999999999999999999985 6888876 7899999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFP 257 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~ 257 (682)
|++|.|. .+|+.+++|++|+.|.+..|.+-..+-+. .++.|++|++.+|+++ .+|+.++++.
T Consensus 134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~ 196 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD 196 (264)
T ss_pred hcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence 9999999 99999999999999999999998443343 8999999999999999 8888776543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1e-14 Score=164.18 Aligned_cols=243 Identities=25% Similarity=0.359 Sum_probs=175.7
Q ss_pred ccccccCeEEEEEEEEcCCc--eEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~--~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|.|+.|-........ .+++|.+...... ......|..+-..+.+|+|++.+++...+.+..+++++|.++
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 45899999999888764433 4555555433211 222334555655664599999999999999999999999999
Q ss_pred CchhHhh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCC-
Q 005693 466 GSLSTLL-HGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNV- 541 (682)
Q Consensus 466 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~- 541 (682)
|++.+.+ +... ...+.......+.|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|..+..
T Consensus 106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccCCc----cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9999888 3221 13566677889999999999999 777 99999999999999999 999999999987765
Q ss_pred CC------CCCC-CCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 542 PA------TPSR-SAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 542 ~~------~~~~-~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. ...| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+......+. ....|......
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~-------- 249 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNKGR-------- 249 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccccc--------
Confidence 22 2347 88899999998854 46788999999999999999999976544332 11111111000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.....+.... ....++..+++..+|+.|.+.+++..
T Consensus 250 -~~~~~~~~~~---~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 -FTQLPWNSIS---DQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -cccCccccCC---hhhhhcccccccCCchhccccccccc
Confidence 0000111122 23345556888899999999988765
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-14 Score=154.20 Aligned_cols=140 Identities=29% Similarity=0.385 Sum_probs=111.1
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCC----cCC---------
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG----KIP--------- 182 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g----~~p--------- 182 (682)
.+.+.|+|++|++. +||...+-+|+.|-.||||+|++. .+|+.+..|.+|++|+|++|.+.- .+|
T Consensus 126 Kn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLh 203 (1255)
T KOG0444|consen 126 KNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLH 203 (1255)
T ss_pred cCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhh
Confidence 35778999999998 899988999999999999999999 889999999999999999998752 233
Q ss_pred ------------CCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCC-CCCCCCCeEEecccCCCC
Q 005693 183 ------------SSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 183 ------------~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~l~~L~~l~ls~N~l~g 247 (682)
.++. .+|..+|||.|+|. .+|..+-++.+|+.|+||+|+|+..--. ..+.+|+.|+||+|+|+
T Consensus 204 ms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt- 281 (1255)
T KOG0444|consen 204 MSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT- 281 (1255)
T ss_pred cccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-
Confidence 2222 47889999999999 8899999999999999999998843222 25567777777777777
Q ss_pred CCCccccCCCCC
Q 005693 248 SIPSSLQKFPNS 259 (682)
Q Consensus 248 ~~p~~~~~l~~l 259 (682)
.+|+.+.+++.|
T Consensus 282 ~LP~avcKL~kL 293 (1255)
T KOG0444|consen 282 VLPDAVCKLTKL 293 (1255)
T ss_pred cchHHHhhhHHH
Confidence 566665555543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.4e-14 Score=151.05 Aligned_cols=144 Identities=30% Similarity=0.305 Sum_probs=103.2
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.+..|+|+.|+++ .+..+.+-+|++|+.||||+|.|..+-++.|.-..+|++|+|++|+|+..-+.+|. ..|++|+|
T Consensus 270 kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 KMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred ccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 4677888888887 55556788888888888888888888888888888888888888888855555554 56777777
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC-----CCCCCCeEEecccCCCCCCC-ccccCCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSYNGLKGSIP-SSLQKFPNSSFV 262 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~l~~L~~l~ls~N~l~g~~p-~~~~~l~~l~~~ 262 (682)
++|+++..-..+|..+++|+.|||++|.|++.+-+. .+++|+.|+|.+|++. .|| ..|..+.+|..+
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHL 421 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCccccee
Confidence 777777666666777777777777777777665542 5666777777777666 333 345555554443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-12 Score=140.15 Aligned_cols=141 Identities=21% Similarity=0.310 Sum_probs=99.0
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC-----------------------------------------hhhHH
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-----------------------------------------KRDFE 428 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~ 428 (682)
.+.||.|++|+||+|++++|+.||||+.+..... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3579999999999999999999999998543100 00234
Q ss_pred HHHHHHHHhc----CCCceeceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 005693 429 QQMEIVGRVG----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR-GVAHIH 503 (682)
Q Consensus 429 ~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gl~~LH 503 (682)
+|.+.+.++. ++++|.-..-+.......++||||++|++|.++...... .. .+.+++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence 4444444432 244433222223334567999999999999887643211 12 23456666665 467889
Q ss_pred hcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 504 ~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
..| ++|+|++|.||++++++.++++|||++....
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 888 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.9e-14 Score=143.61 Aligned_cols=138 Identities=31% Similarity=0.476 Sum_probs=113.0
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
+++.+++.+|++. .+|++.+. ++.|++||..+|-++ ++|+++++|.+|.-|||.+|++. .+| +|+ +.|.+|++
T Consensus 161 ~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~ 235 (565)
T KOG0472|consen 161 KLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHV 235 (565)
T ss_pred HHHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHh
Confidence 3556777788877 56664454 888888888888887 89999999999999999999998 677 565 78999999
Q ss_pred ccccCcccCCcchh-hhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 195 s~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
+.|+|. .+|.+.. +|++|..|||.+|+++..+.+. .+.+|.+||||+|.++ .+|.+++++ .|+++
T Consensus 236 g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L 302 (565)
T KOG0472|consen 236 GENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFL 302 (565)
T ss_pred cccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeeh
Confidence 999999 7887776 8999999999999999444343 7888999999999999 688888887 66655
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.4e-13 Score=145.48 Aligned_cols=144 Identities=26% Similarity=0.283 Sum_probs=117.1
Q ss_pred EEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeeccccc
Q 005693 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS 198 (682)
Q Consensus 121 l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~ 198 (682)
|.|..|++. .+.++.|-.|.++++|+|+.|+++..--.++.+|+.|+.||||+|.|...-++++. ++|++||||+|+
T Consensus 250 lklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~ 328 (873)
T KOG4194|consen 250 LKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNR 328 (873)
T ss_pred hhhhhcCcc-cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccc
Confidence 334455555 56667888899999999999999977778899999999999999999987777655 899999999999
Q ss_pred CcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCcc---cc---CCCCCCCCCCC
Q 005693 199 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS---LQ---KFPNSSFVGNS 265 (682)
Q Consensus 199 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~---~~---~l~~l~~~~n~ 265 (682)
|+...+.+|..|.+|+.|+|++|.++..-... .+++|+.|||++|.+++.|-+. |. .|.+|.+-||.
T Consensus 329 i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 329 ITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred cccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 99888999999999999999999998433332 8899999999999999887643 33 34445555554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.4e-12 Score=126.75 Aligned_cols=194 Identities=21% Similarity=0.309 Sum_probs=135.6
Q ss_pred CCCceeceEEEEEecC-----ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 005693 439 QHPNVVPLRAYYYSKD-----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 513 (682)
Q Consensus 439 ~h~niv~l~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHr 513 (682)
.|.|||++..|+.+.+ +..++.|||..|++..+|++.+. ....+......+++.||..||.|||+. .|+|+|+
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppiihg 202 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHG 202 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccC
Confidence 5999999999987654 45789999999999999986543 344578888899999999999999997 4889999
Q ss_pred CCCCCCeEecCCCCeEEeecCCCCCCC--------CCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCC-
Q 005693 514 NIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP- 584 (682)
Q Consensus 514 DLk~~NILl~~~~~~kl~DfGla~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~P- 584 (682)
++..+-|++..++-+|+.----..... ......+-++|.+||+=.....+.++|||+||....||.-+..-
T Consensus 203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~ 282 (458)
T KOG1266|consen 203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQS 282 (458)
T ss_pred CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheecc
Confidence 999999999999988874211111100 01112246789999987777778899999999999999987643
Q ss_pred CCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 585 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 585 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
-.+....+.. +....-++-.+- . .=...+.+|++..|..||+|++++.+.
T Consensus 283 tnseS~~~~e-----------e~ia~~i~~len--------~--lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 283 TNSESKVEVE-----------ENIANVIIGLEN--------G--LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred CCCcceeehh-----------hhhhhheeeccC--------c--cccCcCcccccCCCCCCcchhhhhcCc
Confidence 2211111100 000000000000 0 001345689999999999999988753
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.4e-13 Score=135.32 Aligned_cols=163 Identities=25% Similarity=0.364 Sum_probs=120.4
Q ss_pred eEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc-ccc
Q 005693 108 GINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH-NNF 177 (682)
Q Consensus 108 gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~-N~l 177 (682)
-|.|+..+ ...+.|+|..|+++ .||+++|+.+.+|+.||||+|+|+-+-|+.|.+|++|..|-+-+ |+|
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 46777532 35789999999999 89999999999999999999999988899999988877666555 777
Q ss_pred CCcCCCC-cc----------------------------------------------------------------------
Q 005693 178 SGKIPSS-FS---------------------------------------------------------------------- 186 (682)
Q Consensus 178 ~g~~p~~-~~---------------------------------------------------------------------- 186 (682)
+ .+|.. |.
T Consensus 129 ~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 129 T-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred h-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence 6 34431 10
Q ss_pred ------------------------------------------------------------------cccceeecccccCc
Q 005693 187 ------------------------------------------------------------------PQLVVLDLSFNSFT 200 (682)
Q Consensus 187 ------------------------------------------------------------------~~L~~L~ls~N~l~ 200 (682)
++|+.|+|++|+|+
T Consensus 208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~ 287 (498)
T KOG4237|consen 208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKIT 287 (498)
T ss_pred hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccc
Confidence 13555666666666
Q ss_pred ccCCcchhhhccccceeccCCcccCCCCC-C-CCCCCCeEEecccCCCCCCCccccCC---CCCCCCCCCCCCCCCC
Q 005693 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPN-F-DIPKLRHLNLSYNGLKGSIPSSLQKF---PNSSFVGNSLLCGPPL 272 (682)
Q Consensus 201 g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~-~l~~L~~l~ls~N~l~g~~p~~~~~l---~~l~~~~n~~~~~~~l 272 (682)
++-+.+|..+..|+.|+|..|+|...-.. + ++..|+.|+|.+|+|+...|..|..+ +.|.+++|++.|.+.+
T Consensus 288 ~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 288 RIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred hhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccch
Confidence 66666666666666666666666522222 1 78899999999999998888887655 4566789999997654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-11 Score=116.54 Aligned_cols=131 Identities=15% Similarity=0.114 Sum_probs=96.7
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchhH
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLST 470 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~ 470 (682)
+.++.|.++.||++... +..+++|...........+++|++++..+.+...+.+++.+. .+..++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46889999999999876 678999987654333345788999998884433344555443 344689999999987754
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 471 LLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 471 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
.- . ....++.+++++++.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 1 11235678999999999976 12369999999999999 66899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-13 Score=143.65 Aligned_cols=126 Identities=35% Similarity=0.532 Sum_probs=62.6
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCC------------------------CCCCCcCCCCCCCcEEee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT------------------------GGLPSEITSLPSLRYLYL 172 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~------------------------g~~p~~~~~l~~L~~L~L 172 (682)
+++.|.|...+|. .+|. .++.|.+|++|.+++|++. .-||+.+..|..|+.|||
T Consensus 33 ~~~WLkLnrt~L~-~vPe-EL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDL 110 (1255)
T KOG0444|consen 33 QMTWLKLNRTKLE-QVPE-ELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDL 110 (1255)
T ss_pred heeEEEechhhhh-hChH-HHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeec
Confidence 4555555555554 4554 4555555555555555554 124445555555555555
Q ss_pred cccccCCcCCCCcc--cccceeecccccCcccCC-cchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCC
Q 005693 173 QHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 173 ~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~ 246 (682)
|+|++. ..|..+. +++-.|+||+|+|. +|| +-|.+|+.|-+|+||+|+|...+|.. .|..|+.|+|++|.|.
T Consensus 111 ShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 111 SHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred chhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhh
Confidence 555554 4444443 44555555555555 233 23445555555555555555444443 4555555555555443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.9e-11 Score=135.04 Aligned_cols=123 Identities=28% Similarity=0.512 Sum_probs=95.9
Q ss_pred EEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecccc
Q 005693 118 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 197 (682)
Q Consensus 118 v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~N 197 (682)
.+.|++++++++ .+|. .+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+..+|+.|+|++|
T Consensus 180 ~~~L~L~~~~Lt-sLP~-~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N 251 (754)
T PRK15370 180 KTELRLKILGLT-TIPA-CIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSIN 251 (754)
T ss_pred ceEEEeCCCCcC-cCCc-ccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCC
Confidence 467888888888 5776 343 57999999999999 6776654 58999999999998 678877788999999999
Q ss_pred cCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccc
Q 005693 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253 (682)
Q Consensus 198 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~ 253 (682)
+++ .+|..+. ++|+.|+|++|+|+. +|..-.++|+.|+|++|+|++ +|..+
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~~sL~~L~Ls~N~Lt~-LP~~l 302 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKISC-LPENLPEELRYLSVYDNSIRT-LPAHL 302 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccCc-cccccCCCCcEEECCCCcccc-Ccccc
Confidence 988 6777664 578889999998884 565444678888888888884 55443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.3e-13 Score=136.93 Aligned_cols=153 Identities=29% Similarity=0.461 Sum_probs=132.7
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.++.+++.+|+++ ++|+ +++.+..++.|+.++|+++ .+|++++++.+|+.|++++|.+. .+|++++ ..|+.|+.
T Consensus 69 ~l~vl~~~~n~l~-~lp~-aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPA-AIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred ceeEEEeccchhh-hCCH-HHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 4788999999999 8888 7999999999999999999 99999999999999999999999 6777776 68999999
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCC---CCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCGP 270 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~---~n~~~~~~ 270 (682)
.+|+++ ..|+.++++.+|..|++.+|++...+|.. +++.|++||.-+|.++ .+|+.++.+.+|..+ .|+...-|
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP 222 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP 222 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC
Confidence 999999 88999999999999999999999877764 8999999999999998 899999888876543 45544444
Q ss_pred CCCCC
Q 005693 271 PLKAC 275 (682)
Q Consensus 271 ~l~~c 275 (682)
.+++|
T Consensus 223 ef~gc 227 (565)
T KOG0472|consen 223 EFPGC 227 (565)
T ss_pred CCCcc
Confidence 55555
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-11 Score=140.54 Aligned_cols=89 Identities=42% Similarity=0.665 Sum_probs=76.6
Q ss_pred CCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceecc
Q 005693 142 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 219 (682)
Q Consensus 142 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~ 219 (682)
.++.|+|++|.++|.+|..++.|++|+.|+|++|+|+|.+|..+. ++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 478899999999999999999999999999999999988888776 688888888888888888888888888888888
Q ss_pred CCcccCCCCCC
Q 005693 220 SNNLSGSIPNF 230 (682)
Q Consensus 220 ~N~l~g~~p~~ 230 (682)
+|+|+|.+|..
T Consensus 499 ~N~l~g~iP~~ 509 (623)
T PLN03150 499 GNSLSGRVPAA 509 (623)
T ss_pred CCcccccCChH
Confidence 88887777753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-10 Score=128.83 Aligned_cols=141 Identities=18% Similarity=0.255 Sum_probs=89.6
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeecccc---------------------------C--------------hhhHH
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---------------------------G--------------KRDFE 428 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---------------------------~--------------~~~~~ 428 (682)
+.||+|++|+||+|++++ |+.||||+...... . +-++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 99999999964310 0 01233
Q ss_pred HHHHHHHHhc---CCCceeceEEEEEe-cCceEEEEeeccCCchhHhhccC-CCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005693 429 QQMEIVGRVG---QHPNVVPLRAYYYS-KDEKLLVYDYFASGSLSTLLHGN-RGAGRTPLDWETRVKILLGTARGVAHIH 503 (682)
Q Consensus 429 ~e~~~l~~l~---~h~niv~l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~gl~~LH 503 (682)
+|..-+.++. .+.+.+.+-.++.+ ....++||||++|+.+.++-.-. .+.....+.......++. .+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~-------Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT-------QVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-------HHH
Confidence 3444333332 23333333333332 45678999999999998753211 110011122222222233 344
Q ss_pred hcCCCCcEecCCCCCCeEecCCC----CeEEeecCCCCCCCC
Q 005693 504 SMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTPLMNV 541 (682)
Q Consensus 504 ~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~~~~~ 541 (682)
..| ++|+|+||.||+++.++ .++++|||++.....
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 566 99999999999999988 999999999876643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5e-11 Score=128.58 Aligned_cols=240 Identities=18% Similarity=0.230 Sum_probs=171.7
Q ss_pred Hhhccccc--cCeEEEEEEEE---cCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 388 ASAEVLGK--GSYGTAYKAVL---EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 388 ~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.....+|. |.+|.||.+.. .++..+|+|+-+.... ....-.+|....+.+..|+|.++....+...+..++-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 34567899 99999999986 3466788888554433 2233455666777777899999999999999999999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR----GVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFG 534 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfG 534 (682)
+|++. .+|.++.+.... .++....+....+..+ |+.++|+.. ++|-|+||.||+...+ ...+++|||
T Consensus 197 tE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred ecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 99885 688888765332 2566667777777777 999999987 9999999999999999 888999999
Q ss_pred CCCCCCCCC---------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 535 LTPLMNVPA---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 535 la~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
+........ ...+..-|++||...+ .++...|+|++|.+..+..++..+...........+..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~----- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY----- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----
Confidence 887665432 1134556999999865 6788999999999999999987766543222211111100
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
+..+ ..+.-...+...+..+++.+|-.|++.+++..
T Consensus 343 -------ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 -------IPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -------Cchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 01111122333666899999999999887765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.7e-10 Score=106.60 Aligned_cols=136 Identities=13% Similarity=0.165 Sum_probs=98.3
Q ss_pred ccccccCeEEEEEEEEcC-------CceEEEEEeecccc----------C-------------hhhH----HHHHHHHHH
Q 005693 391 EVLGKGSYGTAYKAVLEE-------STTVVVKRLKEVVV----------G-------------KRDF----EQQMEIVGR 436 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~----------~-------------~~~~----~~e~~~l~~ 436 (682)
..||.|--+.||.|...+ +..+|||+.+.... + .+.+ ++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47899998852210 0 1112 368888888
Q ss_pred hcCC-CceeceEEEEEecCceEEEEeeccCCchh-HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEec
Q 005693 437 VGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLS-TLLHGNRGAGRTPLDWETRVKILLGTARGVAHI-HSMGGPKFTHG 513 (682)
Q Consensus 437 l~~h-~niv~l~~~~~~~~~~~lV~e~~~~g~L~-~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivHr 513 (682)
+... -++...+++ ...++||||+.+..+. ..++. ..++..+...+..+++.+|..+ |+.+ ++|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8543 566677765 5678999999765442 22221 1245566777889999999998 7887 9999
Q ss_pred CCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 514 NIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 514 DLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||++.||+++ ++.+.|+|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-09 Score=109.04 Aligned_cols=142 Identities=19% Similarity=0.236 Sum_probs=109.0
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeecccc--ChhhHHHHHHHHHHhcC-CCceeceEEEEEecC---ceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKD---EKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~---~~~lV~e~~~ 464 (682)
+.|+.|.++.||++...+|..+++|....... ....+.+|.+++..+.+ +.++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987668899998765432 35678899999999844 245677777766542 5689999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-------------------------------------- 506 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-------------------------------------- 506 (682)
|.++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888776531 13677778888888888888888531
Q ss_pred ---------------CCCcEecCCCCCCeEecC--CCCeEEeecCCCCC
Q 005693 507 ---------------GPKFTHGNIKASNVLINQ--DLDGCISDFGLTPL 538 (682)
Q Consensus 507 ---------------~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~ 538 (682)
...++|+|+.+.||++++ ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 56689999987754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-10 Score=133.59 Aligned_cols=135 Identities=25% Similarity=0.411 Sum_probs=91.4
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeeccc
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~ 196 (682)
.++.|+|++|+++ .+|.. +. .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+..+|+.|+|++
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~-l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~ 271 (754)
T PRK15370 200 QITTLILDNNELK-SLPEN-LQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLPSALQSLDLFH 271 (754)
T ss_pred CCcEEEecCCCCC-cCChh-hc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHhCCCCEEECcC
Confidence 5788999999988 68873 32 57889999999888 5676553 46888888888887 67777777788888888
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccc-cCCCCCCCCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL-QKFPNSSFVGN 264 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~-~~l~~l~~~~n 264 (682)
|+|+ .+|..+. ++|+.|+|++|+|++ +|..-.++|+.|+|++|++++ +|..+ .++..|.+.+|
T Consensus 272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N 335 (754)
T PRK15370 272 NKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTA-LPETLPPGLKTLEAGEN 335 (754)
T ss_pred CccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCcccc-CCccccccceeccccCC
Confidence 8887 4666553 477788888887774 333222456666666666663 44322 23444443333
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.8e-11 Score=111.66 Aligned_cols=125 Identities=27% Similarity=0.341 Sum_probs=48.0
Q ss_pred cCCCCCCcEEEccCCCCCCCCCCcCC-CCCCCcEEeecccccCCcCCCCcccccceeecccccCcccCCcch-hhhcccc
Q 005693 137 LGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLT 214 (682)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~-~~l~~L~ 214 (682)
+.+..+++.|+|++|.|+ .|. .++ .+.+|+.|||++|.|+..-.-...++|++|+|++|+|+ .++..+ ..+++|+
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 666777889999999988 443 465 57889999999999884322122278999999999998 454445 4689999
Q ss_pred ceeccCCcccCCCCC---CCCCCCCeEEecccCCCCCCCc----cccCCCCCCCCCCC
Q 005693 215 GLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGLKGSIPS----SLQKFPNSSFVGNS 265 (682)
Q Consensus 215 ~L~l~~N~l~g~~p~---~~l~~L~~l~ls~N~l~g~~p~----~~~~l~~l~~~~n~ 265 (682)
.|+|++|+|...--- ..+++|+.|+|.+|.++.. +. .+..+|+|+++|..
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence 999999999743221 2788999999999998843 32 35678888888854
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=7.3e-12 Score=132.56 Aligned_cols=136 Identities=29% Similarity=0.463 Sum_probs=103.7
Q ss_pred EEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccc
Q 005693 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 197 (682)
Q Consensus 120 ~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N 197 (682)
.+.|.+|.+. +||. .+++|..|++|||+.|+++ .+|..+..|+ |+.|.+++|+++ .+|..++ ..|..||.+.|
T Consensus 102 ~liLy~n~~r-~ip~-~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~n 176 (722)
T KOG0532|consen 102 SLILYHNCIR-TIPE-AICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKN 176 (722)
T ss_pred HHHHHhccce-ecch-hhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhh
Confidence 3445555555 6666 6777777777777777777 7777776664 777777777777 6666665 67788888888
Q ss_pred cCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 198 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
++. .+|..+++|.+|+.|.+..|++...+++..--.|..||+|+|+++ .||-.|.++..|.++
T Consensus 177 ei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l 239 (722)
T KOG0532|consen 177 EIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVL 239 (722)
T ss_pred hhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheee
Confidence 888 778888888888888888888886666655456889999999999 899999999888765
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.7e-11 Score=134.89 Aligned_cols=146 Identities=32% Similarity=0.455 Sum_probs=113.8
Q ss_pred eEEEEEeCCCcccccCCccccC-------------------------CCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEe
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLG-------------------------KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLY 171 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~-------------------------~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 171 (682)
.+..|+|..|+|. .+|+..+. .+..|+.|.|.+|.|+...-+.+.++++|+.|+
T Consensus 311 sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred eeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 4677888877776 55542221 235577888888888877777888999999999
Q ss_pred ecccccCCcCCCCcc---cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCC
Q 005693 172 LQHNNFSGKIPSSFS---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 172 L~~N~l~g~~p~~~~---~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g 247 (682)
|++|+|. .+|++.. +.|++|+||+|+|+ .+|..+.++..|++|...+|+|. ..|+. .++.|+.+|||.|+|+-
T Consensus 390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhh
Confidence 9999998 7787765 67999999999999 88999999999999999999999 55665 99999999999999974
Q ss_pred -CCCccc--cCCCCCCCCCCCC
Q 005693 248 -SIPSSL--QKFPNSSFVGNSL 266 (682)
Q Consensus 248 -~~p~~~--~~l~~l~~~~n~~ 266 (682)
.+|... .+|..|.+.||..
T Consensus 467 ~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 467 VTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhhCCCcccceeeccCCcc
Confidence 334433 3455555666664
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.3e-09 Score=97.95 Aligned_cols=132 Identities=21% Similarity=0.338 Sum_probs=100.1
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeecccc---------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
..+++|+-+.+|.+.+.+ ..+++|.-..+.. ......+|..++.++ +--.|....-+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEEE
Confidence 357899999999998753 3456665433322 123567788999888 44455555666667788899999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
|++|-.|.+.+... ...++..+-.-+.-||..| |+|+||.++||++..+. +.++|||++....
T Consensus 80 ~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 80 YIEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred EeCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 99999999888632 2456777777888999999 99999999999998775 9999999987543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-10 Score=109.53 Aligned_cols=118 Identities=34% Similarity=0.486 Sum_probs=51.3
Q ss_pred eEEEEEeCCCcccccCCccccC-CCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCc---cccccee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLG-KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SPQLVVL 192 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~---~~~L~~L 192 (682)
+...|+|.+|+++ +|. .++ .|++|+.|||++|.|+ .++ .+..+++|+.|+|++|+|+. ++..+ .++|++|
T Consensus 20 ~~~~L~L~~n~I~-~Ie--~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE--NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred ccccccccccccc-ccc--chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEE
Confidence 5788999999998 564 366 5889999999999999 454 58899999999999999994 44333 2799999
Q ss_pred ecccccCcccCC-cchhhhccccceeccCCcccCCCCCC------CCCCCCeEEec
Q 005693 193 DLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF------DIPKLRHLNLS 241 (682)
Q Consensus 193 ~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~------~l~~L~~l~ls 241 (682)
+|++|+|...-- ..+..+++|+.|+|.+|.++.. +.. .+|+|+.||-.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence 999999985322 4678899999999999999854 442 78999998843
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.7e-10 Score=127.83 Aligned_cols=136 Identities=26% Similarity=0.329 Sum_probs=73.2
Q ss_pred CeEEEEEeCCCcccccCCccccCC-----------------CCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccC
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGK-----------------LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS 178 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~-----------------l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 178 (682)
..+..|+|++|+|+ .+|. .+.+ +.+|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+
T Consensus 242 ~~Lk~LdLs~N~Lt-sLP~-lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~ 315 (788)
T PRK15387 242 PELRTLEVSGNQLT-SLPV-LPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLA 315 (788)
T ss_pred CCCcEEEecCCccC-cccC-cccccceeeccCCchhhhhhchhhcCEEECcCCccc-cccc---cccccceeECCCCccc
Confidence 36677777777766 3443 1111 123445555555555 3343 1345555555555555
Q ss_pred Cc-------------------CCCCcccccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEE
Q 005693 179 GK-------------------IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 239 (682)
Q Consensus 179 g~-------------------~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ 239 (682)
+. +|. +..+|++|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+
T Consensus 316 ~Lp~lp~~L~~L~Ls~N~L~~LP~-lp~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~-LP~l-~~~L~~Ld 388 (788)
T PRK15387 316 SLPALPSELCKLWAYNNQLTSLPT-LPSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTS-LPAL-PSGLKELI 388 (788)
T ss_pred cCCCCcccccccccccCccccccc-cccccceEecCCCccCC-CCCCC---cccceehhhcccccc-Cccc-ccccceEE
Confidence 31 221 22467778888887773 45432 355666666666663 4432 34566777
Q ss_pred ecccCCCCCCCccccCCCCCCCCCCC
Q 005693 240 LSYNGLKGSIPSSLQKFPNSSFVGNS 265 (682)
Q Consensus 240 ls~N~l~g~~p~~~~~l~~l~~~~n~ 265 (682)
|++|+|+ .+|....++..|.+.+|.
T Consensus 389 Ls~N~Lt-~LP~l~s~L~~LdLS~N~ 413 (788)
T PRK15387 389 VSGNRLT-SLPVLPSELKELMVSGNR 413 (788)
T ss_pred ecCCccc-CCCCcccCCCEEEccCCc
Confidence 7777766 355545555555555554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.2e-10 Score=126.54 Aligned_cols=94 Identities=28% Similarity=0.375 Sum_probs=52.0
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeeccc
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~ 196 (682)
+++.|++++|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|. +..+|+.|+|++
T Consensus 223 ~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~-lp~~L~~L~Ls~ 291 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPA-LPSGLCKLWIFG 291 (788)
T ss_pred CCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhh-chhhcCEEECcC
Confidence 3455556666555 3443 1355666666666666 34432 245556666666655 3333 224566666666
Q ss_pred ccCcccCCcchhhhccccceeccCCcccC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 225 (682)
|+|+ .+|.. +++|+.|+|++|+|++
T Consensus 292 N~Lt-~LP~~---p~~L~~LdLS~N~L~~ 316 (788)
T PRK15387 292 NQLT-SLPVL---PPGLQELSVSDNQLAS 316 (788)
T ss_pred Cccc-ccccc---ccccceeECCCCcccc
Confidence 6666 34432 3567777777777765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.8e-09 Score=113.29 Aligned_cols=161 Identities=18% Similarity=0.243 Sum_probs=119.3
Q ss_pred cCCceEEEEEeeccccC-hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCH
Q 005693 407 EESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 485 (682)
Q Consensus 407 ~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~ 485 (682)
.++.+|.|...+..... ....++.++-++.+ +||||++++..++.++..|+|+|-+. -|..++.. +..
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence 45677777777654331 23355666777777 99999999999999999999999874 45556643 335
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCC----CCCCcccCccccccCC
Q 005693 486 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP----SRSAGYRAPEVIETRK 561 (682)
Q Consensus 486 ~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~----~~~~~y~aPE~~~~~~ 561 (682)
......+.||+.||.|||+.+ .++|+++.-..|+++..|..||++|-++......... .--..|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 666777899999999999776 6999999999999999999999999876544322211 1112366666543322
Q ss_pred CCCcchHHHHHHHHHHHHhCC
Q 005693 562 HSHKSDVYSFGVLLLEMLTGK 582 (682)
Q Consensus 562 ~~~~sDvwS~Gvvl~elltg~ 582 (682)
-..|.|.||+++||++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.6e-11 Score=131.89 Aligned_cols=124 Identities=30% Similarity=0.409 Sum_probs=108.4
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCC-cCCCCCCCcEEeecccccCCcCCCCcc--ccccee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L 192 (682)
..+..|.|.+|.|+...=+ .+-+..+|++|+|++|+|. .+|+ .+.++..|+.|+||+|+++ .+|.++. ..|++|
T Consensus 359 ~~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL 435 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTL 435 (1081)
T ss_pred HHHHHHHHhcCcccccchh-hhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHH
Confidence 3567788899999976655 6999999999999999999 6775 4899999999999999999 7888776 789999
Q ss_pred ecccccCcccCCcchhhhccccceeccCCcccC-CCCCC-CCCCCCeEEecccC
Q 005693 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF-DIPKLRHLNLSYNG 244 (682)
Q Consensus 193 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~-~l~~L~~l~ls~N~ 244 (682)
...+|+|. ..| .+..+++|+.+||+.|+|+. .+|.. ..++|++|||++|.
T Consensus 436 ~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 436 RAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 99999999 778 99999999999999999995 44544 44899999999997
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.4e-09 Score=95.17 Aligned_cols=141 Identities=12% Similarity=0.266 Sum_probs=102.1
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccc---------cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVV---------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.++-+|+-+.|+++.+. |+..+||.-.... ..+++..+|++.+.++ +--.|.-..-++.+...-.++||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeEEEE
Confidence 56889999999999987 5555555432221 1345678899999888 44455555555666677789999
Q ss_pred eccC-CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC---eEEeecCCCC
Q 005693 462 YFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTP 537 (682)
Q Consensus 462 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~ 537 (682)
|+++ -++.+++...-. ..........++..|-+.+.-||..+ |+|+||..+||++.+++. +.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 9977 477888764321 11222333678888999999999998 999999999999976653 4799999976
Q ss_pred CC
Q 005693 538 LM 539 (682)
Q Consensus 538 ~~ 539 (682)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 54
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4e-10 Score=121.70 Aligned_cols=240 Identities=18% Similarity=0.197 Sum_probs=170.0
Q ss_pred ccccccCeEEEEEEEEc--CCceEEEEEeeccccCh---hhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
..||.|.|+.|+....+ ++..+++|.+.+..... ..-..|+.+...+..|.++++.+..|...+..|+=.||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 57999999999987744 56778888887654432 22345666667777899999999998888888999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~~- 543 (682)
+++...+. ....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.++.+....
T Consensus 351 ~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 351 GSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred cchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc
Confidence 98876652 2234778889999999999999999987 9999999999999887 778999999986433222
Q ss_pred CCCCCCccc--CccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 TPSRSAGYR--APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 ~~~~~~~y~--aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
......+++ +++......+..++|++|||..+.|.+++..--..... |. .+.........
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~----------~i~~~~~p~~~ 484 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL----------TIRSGDTPNLP 484 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce----------eeecccccCCC
Confidence 222333444 45555566788999999999999999998743221110 00 00000011111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
. ....+..+...+...++..||.+.+...+.+-..
T Consensus 485 ~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 485 G---LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred c---hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1 1244555666788899999999988877655443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.92 E-value=3e-09 Score=130.41 Aligned_cols=65 Identities=26% Similarity=0.279 Sum_probs=36.4
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCC
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 183 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 183 (682)
++..|+|++++..+.+|. ++.+++|+.|+|++|.....+|..+.+|++|+.|+|++|...+.+|.
T Consensus 635 ~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~ 699 (1153)
T PLN03210 635 GLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT 699 (1153)
T ss_pred CCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC
Confidence 455666665544445553 55666666666666554445666666666666666665433334443
|
syringae 6; Provisional |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.9e-10 Score=127.73 Aligned_cols=235 Identities=21% Similarity=0.275 Sum_probs=152.5
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeeccc---c-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---V-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+-+-+|.++.++.+.-.. +...+.|...... . ..+....+-.+.... ++|.+++....+......++|++|..+
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchhhHHhcc
Confidence 367789999998776332 2222222222111 0 011111222222222 567777766666667788999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 541 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 541 (682)
++|...++... ..+.+-.......+..+.+|||... +.|||++|.|.+...++..+++|||.......
T Consensus 889 ~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 889 GDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred CCchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999998543 2444444445566778899999875 89999999999999999999999984321100
Q ss_pred -------------------------------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 005693 542 -------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 590 (682)
Q Consensus 542 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~ 590 (682)
.....+|+.|.+||...+......+|+|+.|++++|.++|.+||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0011257789999999999999999999999999999999999987664
Q ss_pred CCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005693 591 DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD 649 (682)
Q Consensus 591 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 649 (682)
.... +.+. ...........+......+++...+..+|.+|-.+.
T Consensus 1041 q~~f------~ni~---------~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQIF------ENIL---------NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhh------hccc---------cCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 4332 1111 111111112222233344455567778888887665
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.4e-10 Score=119.40 Aligned_cols=132 Identities=25% Similarity=0.265 Sum_probs=94.9
Q ss_pred CCeEEEEEeCCCcccccCCccccCCCCC---CcEEEccCCCCCC----CCCCcCCCC-CCCcEEeecccccCCcCCCCc-
Q 005693 115 RTRVFGLRLPGIGLVGPIPNNTLGKLDA---LEVLSLRSNVLTG----GLPSEITSL-PSLRYLYLQHNNFSGKIPSSF- 185 (682)
Q Consensus 115 ~~~v~~l~l~~~~l~g~lp~~~~~~l~~---L~~L~L~~N~l~g----~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~~- 185 (682)
..+++.|+++++.+.+..+. .+..+.+ |++|+|++|++++ .+...+..+ ++|+.|+|++|.+++..+..+
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred cCceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 35788899998888765554 5555555 9999999998873 334455666 888999999999885433222
Q ss_pred ---c--cccceeecccccCccc----CCcchhhhccccceeccCCcccCCCCC------CCCCCCCeEEecccCCCC
Q 005693 186 ---S--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPN------FDIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 186 ---~--~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~------~~l~~L~~l~ls~N~l~g 247 (682)
. .+|++|+|++|.+++. ++..+..+++|+.|+|++|.+++.... ..+++|++|++++|.+++
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 2 4789999999988853 344555666899999999988743321 157889999999988875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.80 E-value=9e-11 Score=124.45 Aligned_cols=143 Identities=27% Similarity=0.413 Sum_probs=126.7
Q ss_pred EEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc-cccceeeccc
Q 005693 118 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSF 196 (682)
Q Consensus 118 v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~~L~~L~ls~ 196 (682)
.+..||+.|++. .+|. .++.+..|+.|.|..|.+. .||..+.+|..|++|||+.|+++ .+|..+. --|+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~-~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPE-EACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCch-HHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEec
Confidence 456789999998 8998 7999999999999999999 99999999999999999999999 7777666 5799999999
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCC--CCCCCCCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFP--NSSFVGNSL 266 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~--~l~~~~n~~ 266 (682)
|+++ .+|..++.+..|..|+.+.|++...++.. .+.+|+.|.+..|++. .+|+.+..|+ .|+|..|+.
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNki 223 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKI 223 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCce
Confidence 9999 89999999999999999999999766665 9999999999999999 7888877655 466666654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-07 Score=96.55 Aligned_cols=142 Identities=14% Similarity=0.143 Sum_probs=99.3
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc------------ChhhHHHHHHHHHHhcC-CCceeceEEEEEe----
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV------------GKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYS---- 452 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~---- 452 (682)
++.+-.-....|++.... |+.++||+...... ....+.+|...+.++.. .-.++..+++...
T Consensus 27 ~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 344444444456676664 67899997643221 11147788888877732 2234445556543
Q ss_pred -cCceEEEEeeccCC-chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC------
Q 005693 453 -KDEKLLVYDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ------ 524 (682)
Q Consensus 453 -~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~------ 524 (682)
....++|+|++++. +|.+++.... ....+...+..++.+++..+..||..| |+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCC
Confidence 23578999999886 8988885321 122456677889999999999999999 999999999999985
Q ss_pred -CCCeEEeecCCCCC
Q 005693 525 -DLDGCISDFGLTPL 538 (682)
Q Consensus 525 -~~~~kl~DfGla~~ 538 (682)
+..+.++||+.+..
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46789999998754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.3e-08 Score=122.75 Aligned_cols=143 Identities=24% Similarity=0.231 Sum_probs=104.5
Q ss_pred EEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCc-ccccceeeccc
Q 005693 118 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-SPQLVVLDLSF 196 (682)
Q Consensus 118 v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-~~~L~~L~ls~ 196 (682)
+..|++.++.+. .+|. .+ .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|.-- .++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~-~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPS-NF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCC-cC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecC
Confidence 555666666554 6666 34 5678888888888887 678788888888899988876556777521 27888899988
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN 264 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~n 264 (682)
|.....+|..+++|++|+.|++++|..-+.+|.. ++++|+.|+|++|...+.+|....++..|.+.+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n 735 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDET 735 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCC
Confidence 8777788888888888999998887655566653 7888888888888766666665555555554444
|
syringae 6; Provisional |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.7e-07 Score=95.51 Aligned_cols=267 Identities=14% Similarity=0.159 Sum_probs=158.6
Q ss_pred hhccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEE-------EecCceEEEEe
Q 005693 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY-------YSKDEKLLVYD 461 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~-------~~~~~~~lV~e 461 (682)
.+..||+|+-+.+|..-.- ...+.|+....-.. .-.+.+.++.....||-+-.-+.+- .......++|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa--~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPA--AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCch--HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 3577999999999965322 22345666543221 1123344555555677554422221 11222557777
Q ss_pred eccCCc-hhHhhcc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 462 YFASGS-LSTLLHG-NRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 462 ~~~~g~-L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
.+.+.. ...+.+. .+..+.....|...++.+..+|.+.+.||..| .+-+|+.++|+|+++++.+.+.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 776642 2222221 12223455789999999999999999999999 888999999999999999999875432222
Q ss_pred CCCC---CCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 005693 540 NVPA---TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTA 610 (682)
Q Consensus 540 ~~~~---~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 610 (682)
..+. -..+...|.+||.-. +-.-+...|-|.+||++++++.| +.||.+........ .-.+..+......
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap--~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP--NPLETDIAHGRFA 245 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC--Ccchhhhhcceee
Confidence 2221 234677899999764 23346678999999999999986 99998643211100 0000000000000
Q ss_pred ccchh--hh---ccccChHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 611 EVFDV--EL---MRFQNIEEEMVQMLQIGMACVAK--VPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 611 ~~~d~--~l---~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
...|. .+ .+....+-....+..+..+|+.. .+.-|||++-.+..|.++.++...
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 00000 00 01111222223344455578865 467899999999988887765543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-09 Score=107.09 Aligned_cols=120 Identities=24% Similarity=0.294 Sum_probs=83.9
Q ss_pred CCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecccccCcccCCcchhhhcccccee
Q 005693 138 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLS 217 (682)
Q Consensus 138 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ 217 (682)
..-..|+.||||+|.|+ .+.++..-+++++.|+||+|.+...-.-.+.++|+.||||+|.++ .+..+=..|.+.+.|.
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 33456888888888888 677777778888888888888874333333478888888888888 4555556777888888
Q ss_pred ccCCcccCCCCCC-CCCCCCeEEecccCCCCCC-CccccCCCCCC
Q 005693 218 LQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSI-PSSLQKFPNSS 260 (682)
Q Consensus 218 l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~-p~~~~~l~~l~ 260 (682)
|+.|.|.. +... .+-+|..||+++|++...- -..+++++-|.
T Consensus 359 La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE 402 (490)
T KOG1259|consen 359 LAQNKIET-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLE 402 (490)
T ss_pred hhhhhHhh-hhhhHhhhhheeccccccchhhHHHhcccccccHHH
Confidence 88888762 3333 6777888888888886221 13466666543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.3e-08 Score=91.88 Aligned_cols=126 Identities=20% Similarity=0.273 Sum_probs=81.8
Q ss_pred EEEEEEEcCCceEEEEEeecccc-----------------------C----hhhHHHHHHHHHHhcCC-CceeceEEEEE
Q 005693 400 TAYKAVLEESTTVVVKRLKEVVV-----------------------G----KRDFEQQMEIVGRVGQH-PNVVPLRAYYY 451 (682)
Q Consensus 400 ~Vy~~~~~~~~~vavK~l~~~~~-----------------------~----~~~~~~e~~~l~~l~~h-~niv~l~~~~~ 451 (682)
.||.|...++..+|+|+.+.... . ....++|.+.|.++... -++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999988899999998853110 0 12356788999998433 3567776552
Q ss_pred ecCceEEEEeecc--CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcEecCCCCCCeEecCCCCe
Q 005693 452 SKDEKLLVYDYFA--SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDG 528 (682)
Q Consensus 452 ~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~-LH~~~~~~ivHrDLk~~NILl~~~~~~ 528 (682)
...+||||++ |..+..+... . ++......++.++...+.. +|..| |+|+||.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 5679999998 5455443331 1 2234456677788876665 57887 9999999999999988 99
Q ss_pred EEeecCCCCCCC
Q 005693 529 CISDFGLTPLMN 540 (682)
Q Consensus 529 kl~DfGla~~~~ 540 (682)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.4e-09 Score=106.94 Aligned_cols=88 Identities=27% Similarity=0.347 Sum_probs=45.8
Q ss_pred CCCCCcCCCCCCCcEEeecccccCCcCCCCc--ccccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--
Q 005693 155 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-- 230 (682)
Q Consensus 155 g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-- 230 (682)
|..-..+.....|+.||||+|.|+ .+..+. .+.++.|++|+|.|+. + .++..|++|+.|||++|.|+ .+-.+
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHh
Confidence 333344444455666666666665 333332 2556666666666652 2 22555666666666666655 22222
Q ss_pred CCCCCCeEEecccCCC
Q 005693 231 DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 231 ~l~~L~~l~ls~N~l~ 246 (682)
.+-+.+.|.|+.|.+.
T Consensus 350 KLGNIKtL~La~N~iE 365 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIE 365 (490)
T ss_pred hhcCEeeeehhhhhHh
Confidence 5555666666666554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-08 Score=78.83 Aligned_cols=33 Identities=42% Similarity=0.511 Sum_probs=14.1
Q ss_pred ceeecccccCcccCCcchhhhccccceeccCCc
Q 005693 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNN 222 (682)
Q Consensus 190 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~ 222 (682)
++|+|++|+|+...|..|.++++|++|++++|+
T Consensus 28 ~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 28 ETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp SEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 333333333333333444444444444444444
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.3e-09 Score=112.40 Aligned_cols=140 Identities=31% Similarity=0.477 Sum_probs=104.8
Q ss_pred eEEEEEeCCCcccccCCccccCCCC-CCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCc--ccccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLD-ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~L~ 193 (682)
.++.|++.+++++ .+|+ ..+.+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|... .+.|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCcc-ccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 5788999999988 6777 567774 8999999999998 77778899999999999999998 566553 47899999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCC-CCCCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-NFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
+++|+++ .+|..++.+..|++|.+++|++.-.+. ...+.++..+.+++|++. .++..+++++++..+
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L 260 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETL 260 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhcccccccee
Confidence 9999999 778777777778888888885332332 236666666667777766 334445555544444
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.6e-08 Score=78.42 Aligned_cols=59 Identities=46% Similarity=0.633 Sum_probs=53.2
Q ss_pred cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCC
Q 005693 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGL 245 (682)
Q Consensus 187 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l 245 (682)
++|++|+|++|+|+...+..|.++++|+.|++++|+++...|.. .+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 47899999999999777789999999999999999999777764 999999999999985
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.4e-08 Score=110.56 Aligned_cols=138 Identities=33% Similarity=0.441 Sum_probs=101.7
Q ss_pred EEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCC-CCcEEeecccccCCcCC--CCcccccceeeccc
Q 005693 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIP--SSFSPQLVVLDLSF 196 (682)
Q Consensus 120 ~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~L~~N~l~g~~p--~~~~~~L~~L~ls~ 196 (682)
.+++..+.+...+. .+..++.++.|++.+|+++ .+|+....++ +|+.|++++|++. .+| -...++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCch--hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 47777777654444 3667788889999999888 7777777775 8999999999888 553 33347889999999
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|+++ .+|...+.+++|+.|++++|+++...+.. .+..|+.|.+++|++. .++..+.++.++..++
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~ 238 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE 238 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccc
Confidence 9988 67777778888889999999988444433 4555888899888654 4556666666655544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.9e-09 Score=111.27 Aligned_cols=130 Identities=29% Similarity=0.360 Sum_probs=91.8
Q ss_pred CeEEEEEeCCCcccc----cCCccccCCC-CCCcEEEccCCCCCCC----CCCcCCCCCCCcEEeecccccCCcC----C
Q 005693 116 TRVFGLRLPGIGLVG----PIPNNTLGKL-DALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKI----P 182 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g----~lp~~~~~~l-~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~----p 182 (682)
.++..|++++|++.+ .+.. .+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.. +
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~-~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 186 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAK-GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA 186 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHH-HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHH
Confidence 458888998888773 2222 35566 8889999999988843 3445667788999999999888532 2
Q ss_pred CCcc--cccceeecccccCccc----CCcchhhhccccceeccCCcccCCCCC-C------CCCCCCeEEecccCCC
Q 005693 183 SSFS--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPN-F------DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 183 ~~~~--~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~-~------~l~~L~~l~ls~N~l~ 246 (682)
..+. ++|++|+|++|.+++. ++..+..+++|+.|++++|.+++.... . ..+.|+.|++++|.++
T Consensus 187 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 2222 4899999999988744 334556678899999999988752111 0 2478999999999887
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.9e-07 Score=90.05 Aligned_cols=135 Identities=24% Similarity=0.265 Sum_probs=97.6
Q ss_pred HHhhccccccCeEEEEEEEEcCCceEEEEEeeccc-----------------------cChhhHHHHHHHHHHhcCC-Cc
Q 005693 387 RASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVV-----------------------VGKRDFEQQMEIVGRVGQH-PN 442 (682)
Q Consensus 387 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------------~~~~~~~~e~~~l~~l~~h-~n 442 (682)
.+.++.||-|--+.||.|...++.++|+|.=+.-. ......++|.++|.++..+ -.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34578999999999999999999999998642110 0123467889999998433 36
Q ss_pred eeceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe
Q 005693 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 522 (682)
Q Consensus 443 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 522 (682)
|.+.+++ +...+||||++|-.|...- ++.+..-.++..|..-+...-..| +||+|+++-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 7777765 5678999999986664332 223334445555555555555667 9999999999999
Q ss_pred cCCCCeEEeecCCCCC
Q 005693 523 NQDLDGCISDFGLTPL 538 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~ 538 (682)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999965543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.9e-06 Score=91.66 Aligned_cols=168 Identities=26% Similarity=0.354 Sum_probs=124.7
Q ss_pred EEEEEEEE-cCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEeeccC-CchhHh
Q 005693 399 GTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFAS-GSLSTL 471 (682)
Q Consensus 399 g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~~-g~L~~~ 471 (682)
.+.|++.. .+|..+++|++...+. .......-+++.+++ .|.|||++.+++.. +...++||+|+++ ++|.++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 57889884 5788999999943321 122233456788888 89999999988863 3467899999987 577776
Q ss_pred hccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 472 LHGNRGA----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 472 l~~~~~~----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
-..+... .....++...+.++.|+..||.++|+.| +.-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5443321 1234778899999999999999999999 88899999999999999999988887655543
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 583 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~ 583 (682)
... |-+.+ -.+-|.=.||.++.-|.||..
T Consensus 446 d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 321 11111 235688899999999999953
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-08 Score=103.68 Aligned_cols=159 Identities=25% Similarity=0.323 Sum_probs=119.1
Q ss_pred ceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc
Q 005693 107 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS 186 (682)
Q Consensus 107 ~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 186 (682)
.+.+|++..+ ..++=++.+|+ .+|.+ + -..-+.|+|..|+|+..-|..|+.+++||.||||+|+|+-+-|+.|.
T Consensus 39 ~pC~Cs~~~g--~~VdCr~~GL~-eVP~~-L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~ 112 (498)
T KOG4237|consen 39 APCTCSDVEG--GIVDCRGKGLT-EVPAN-L--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFK 112 (498)
T ss_pred CCcccCCCCC--ceEEccCCCcc-cCccc-C--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhh
Confidence 3447765332 33566677777 66652 2 24568899999999966667899999999999999999999999886
Q ss_pred --ccc-ceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCc-cccCCCCCC
Q 005693 187 --PQL-VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS-SLQKFPNSS 260 (682)
Q Consensus 187 --~~L-~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~-~~~~l~~l~ 260 (682)
.+| +.+++++|+|+...-..|++|.+|+.|.+.-|++.-...+. .+++|..|.|-+|.+. .++. .|..+.+++
T Consensus 113 GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~ 191 (498)
T KOG4237|consen 113 GLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIK 191 (498)
T ss_pred hhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccc
Confidence 454 44555669999666679999999999999999999444443 8999999999999998 5655 566665554
Q ss_pred ---CCCCCCCCCCCC
Q 005693 261 ---FVGNSLLCGPPL 272 (682)
Q Consensus 261 ---~~~n~~~~~~~l 272 (682)
...|++.|.+.+
T Consensus 192 tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 192 TLHLAQNPFICDCNL 206 (498)
T ss_pred hHhhhcCcccccccc
Confidence 445666665543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.8e-06 Score=83.80 Aligned_cols=140 Identities=14% Similarity=0.180 Sum_probs=85.6
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCC-ceeceEEEEEecCceEEEEeeccCCc-h
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAYYYSKDEKLLVYDYFASGS-L 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lV~e~~~~g~-L 468 (682)
..||+|..+.||+. .+..+++|.... .....+..+|.+++..+.... .+.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999984 245677777754 334566789999999884332 25777888877777889999999863 2
Q ss_pred hHhh---------------------ccCCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhc-CCCCcEecCC
Q 005693 469 STLL---------------------HGNRGAGRTPLDWETRVKILL----------GTAR-GVAHIHSM-GGPKFTHGNI 515 (682)
Q Consensus 469 ~~~l---------------------~~~~~~~~~~l~~~~~~~i~~----------~ia~-gl~~LH~~-~~~~ivHrDL 515 (682)
...+ |.... ....+... ...+.. .+.. ...+|... ..+.++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 11100 00011100 000000 0001 12222211 1235789999
Q ss_pred CCCCeEecCCCCeEEeecCCCC
Q 005693 516 KASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 516 k~~NILl~~~~~~kl~DfGla~ 537 (682)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.7e-06 Score=83.75 Aligned_cols=109 Identities=21% Similarity=0.284 Sum_probs=84.5
Q ss_pred hhhHHHHHHHHHHhcC-CCceeceEEEEEecC----ceEEEEeeccCC-chhHhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 005693 424 KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKD----EKLLVYDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTAR 497 (682)
Q Consensus 424 ~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~----~~~lV~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 497 (682)
.....+|...+..+.. .-.+++.+++.+... ..++|+|++++. +|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 4467778887777632 334666777766533 458999999884 7999987422 1556677889999999
Q ss_pred HHHHHHhcCCCCcEecCCCCCCeEecCCC---CeEEeecCCCCCCC
Q 005693 498 GVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLMN 540 (682)
Q Consensus 498 gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla~~~~ 540 (682)
.++-||+.| |+|+|+++.|||++.++ .+.++||+-++...
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999 99999999999999887 88999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.3e-06 Score=80.30 Aligned_cols=138 Identities=15% Similarity=0.167 Sum_probs=101.1
Q ss_pred ccccCeEEEEEEEEcCCceEEEEEeecc-------ccChhhHHHHHHHHHHhcC-CCceeceEEEEE-ec----CceEEE
Q 005693 393 LGKGSYGTAYKAVLEESTTVVVKRLKEV-------VVGKRDFEQQMEIVGRVGQ-HPNVVPLRAYYY-SK----DEKLLV 459 (682)
Q Consensus 393 lG~G~fg~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~e~~~l~~l~~-h~niv~l~~~~~-~~----~~~~lV 459 (682)
-|+||-+-|+...+++ ..+.+|+-... -.+...|.+|...+.++.. .-.+.+.+ ++. .. ...+||
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 3678888899987764 46888886522 1246789999999988843 22244444 332 11 245799
Q ss_pred EeeccC-CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC--eEEeecCCC
Q 005693 460 YDYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLT 536 (682)
Q Consensus 460 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DfGla 536 (682)
+|-+++ -+|.+++.... ..+.+...+..++.+++..++-||+.| +.|+|+.+.||+++.++. ++++||--+
T Consensus 104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 997764 48888875322 223577788899999999999999999 999999999999987777 899999765
Q ss_pred CC
Q 005693 537 PL 538 (682)
Q Consensus 537 ~~ 538 (682)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 43
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.1e-06 Score=93.43 Aligned_cols=141 Identities=18% Similarity=0.303 Sum_probs=92.8
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeecccc---------------------------C--------------hhhHHH
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------------------------G--------------KRDFEQ 429 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------------------------~--------------~~~~~~ 429 (682)
+.|+.++-|+||+|++++|+.||||+...... . +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67889999999999999999999999852110 0 001233
Q ss_pred HHHHHHHh----cCCCceeceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 005693 430 QMEIVGRV----GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG-VAHIHS 504 (682)
Q Consensus 430 e~~~l~~l----~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g-l~~LH~ 504 (682)
|..-+.++ .+.+++.-..-|++-.....++|||++|-.+.+...... ..++.. .++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k---~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRK---ELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHH---HHHHHHHHHHHHHHHh
Confidence 33333322 234554444444444567889999999998888743211 124433 333333322 333333
Q ss_pred cCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 505 ~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
.| +.|.|..|.||+++.++.+.+.|||+......
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 55 99999999999999999999999999876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.3e-07 Score=103.83 Aligned_cols=146 Identities=22% Similarity=0.323 Sum_probs=96.1
Q ss_pred HHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCC-------------CCCCcccCccccc
Q 005693 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-------------SRSAGYRAPEVIE 558 (682)
Q Consensus 492 ~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~-------------~~~~~y~aPE~~~ 558 (682)
+.+++.|+.|+|... ++||++|.|++|.++..+..||+.|+.+.....+... .....|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345568999999864 7999999999999999999999999976443331111 1234599999999
Q ss_pred cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHc
Q 005693 559 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMAC 637 (682)
Q Consensus 559 ~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~C 637 (682)
....+.++|+||+||++|-+.. |+.-+............. . ..+.. ......+...++.+=+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-----~-------~~~~~--~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-----N-------LLNAG--AFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-----c-------ccccc--cccccccCcHHHHHHHHHH
Confidence 9888999999999999999994 555454332221111000 0 00000 0000122233444445578
Q ss_pred ccCCCCCCCCHHHHHH
Q 005693 638 VAKVPDMRPNMDEVVR 653 (682)
Q Consensus 638 l~~dP~~RPt~~evl~ 653 (682)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8899999997777643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.7e-07 Score=95.77 Aligned_cols=130 Identities=28% Similarity=0.327 Sum_probs=66.7
Q ss_pred CeEEEEEeCCCcccccCCc-cccCCCCCCcEEEccCCCCCCCCCCcC-CCCCCCcEEeecccccCC--------------
Q 005693 116 TRVFGLRLPGIGLVGPIPN-NTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG-------------- 179 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~-~~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~L~~N~l~g-------------- 179 (682)
.+|+.|||++|-+.---|- .....|++|+.|+|+.|++.-...... ..++.|+.|.|+.+.|+-
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 3677777777754421110 124566777777777777753332221 234555555555555541
Q ss_pred -------------cCCCCcccccceeecccccCcccCC--cchhhhccccceeccCCcccCC-CCCC-------CCCCCC
Q 005693 180 -------------KIPSSFSPQLVVLDLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGS-IPNF-------DIPKLR 236 (682)
Q Consensus 180 -------------~~p~~~~~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~g~-~p~~-------~l~~L~ 236 (682)
..+..+...|++|||++|++- ..+ ...+.++.|..|+++.+.+... .|+. .+++|+
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~ 304 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE 304 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence 111111234666666666554 233 3455556666666666655531 1211 455666
Q ss_pred eEEecccCCC
Q 005693 237 HLNLSYNGLK 246 (682)
Q Consensus 237 ~l~ls~N~l~ 246 (682)
+|+++.|++.
T Consensus 305 ~L~i~~N~I~ 314 (505)
T KOG3207|consen 305 YLNISENNIR 314 (505)
T ss_pred eeecccCccc
Confidence 6666666664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.6e-05 Score=80.39 Aligned_cols=142 Identities=15% Similarity=0.151 Sum_probs=87.2
Q ss_pred ccccCe-EEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchhHh
Q 005693 393 LGKGSY-GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTL 471 (682)
Q Consensus 393 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~ 471 (682)
|-.|.. ..||+.... +..+++|+..... ..+..+|++++..+..+--+.+++++....+..++|||+++|.++...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 445555 789999765 4678888875433 346788999999886665566788877766678999999998777643
Q ss_pred h-------------------ccCCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cC
Q 005693 472 L-------------------HGNRGAGRTPLDW--ETRVKILL--------------------GTARGVAHIHS----MG 506 (682)
Q Consensus 472 l-------------------~~~~~~~~~~l~~--~~~~~i~~--------------------~ia~gl~~LH~----~~ 506 (682)
. +.... ...+... ........ .+......|-. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 2 11100 0001110 00000000 01111222211 11
Q ss_pred CCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 507 ~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
.+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 24589999999999999987788999987643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.1e-08 Score=109.31 Aligned_cols=122 Identities=32% Similarity=0.327 Sum_probs=97.1
Q ss_pred EEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCc--ccccceeecc
Q 005693 118 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLS 195 (682)
Q Consensus 118 v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~L~ls 195 (682)
+...+.+.|.|+ .+.. .+.-|+.|+.|||++|+++..- .+..|++|++|||+.|++. .+|.-- +-+|+.|+|+
T Consensus 166 L~~a~fsyN~L~-~mD~-SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDE-SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHH-HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 445666777776 4444 7888999999999999998432 7889999999999999998 566432 2469999999
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCC---CCCCCCCCCCeEEecccCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS---IPNFDIPKLRHLNLSYNGLK 246 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~---~p~~~l~~L~~l~ls~N~l~ 246 (682)
+|.++.. ..+.+|++|+.|||+.|-|++. .|-+.|..|+.|+|.+|.+.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9999843 4578999999999999998863 34457888999999999886
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.7e-08 Score=107.47 Aligned_cols=125 Identities=33% Similarity=0.428 Sum_probs=96.5
Q ss_pred CCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCc-chhhhcccccee
Q 005693 141 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLS 217 (682)
Q Consensus 141 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~ 217 (682)
..|...+.++|+|. .+..++.-++.|+.|||++|+++..- .+. ++|+.|||++|.|+ .+|. ....+. |+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 35778888999998 77778888999999999999998432 222 79999999999999 5553 455565 99999
Q ss_pred ccCCcccCCCCCCCCCCCCeEEecccCCCCCCC----ccccCCCCCCCCCCCCCCCC
Q 005693 218 LQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP----SSLQKFPNSSFVGNSLLCGP 270 (682)
Q Consensus 218 l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p----~~~~~l~~l~~~~n~~~~~~ 270 (682)
|+||.++..---.+|.+|+.|||++|-|++.-- ..+..|..|..-||+..|.+
T Consensus 239 lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 239 LRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999999955444599999999999999886432 12334445556688887754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=6.7e-05 Score=73.77 Aligned_cols=137 Identities=17% Similarity=0.243 Sum_probs=93.2
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccC----------hhh---------------HHHHHHHHHHhc-CCCcee
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG----------KRD---------------FEQQMEIVGRVG-QHPNVV 444 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------~~~---------------~~~e~~~l~~l~-~h~niv 444 (682)
..|..|--+.||+|...++..+|+|+.+..... ... ...|..-|.++. .+-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 357788888999999888999999998643211 111 223444455543 245555
Q ss_pred ceEEEEEecCceEEEEeeccCCc-hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEe
Q 005693 445 PLRAYYYSKDEKLLVYDYFASGS-LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLI 522 (682)
Q Consensus 445 ~l~~~~~~~~~~~lV~e~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl 522 (682)
+.+++. +..|||||+.... -.-.| ...++...+...+..++++.+.-|-. .+ +||+||+.-|||+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L------kDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~ 200 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL------KDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILV 200 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc------ccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEE
Confidence 666554 4469999995531 11111 12224444677788888888888876 55 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCC
Q 005693 523 NQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~~~~ 541 (682)
. ++.+.|+|||-|.....
T Consensus 201 ~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 201 H-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred E-CCeEEEEECccccccCC
Confidence 9 88999999998766553
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.5e-06 Score=59.47 Aligned_cols=37 Identities=38% Similarity=0.811 Sum_probs=26.4
Q ss_pred hhHHHHHHHHHHhCCC---CCCcCCCCC--CCCCCCcceEEec
Q 005693 75 NSDRQALLDFADAVPH---LRKLNWSST--NPICQSWVGINCT 112 (682)
Q Consensus 75 ~~~~~al~~~~~~~~~---~~~~~w~~~--~~~c~~w~gv~C~ 112 (682)
++|++||++||.++.. ....+|+.+ .++| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence 5799999999999964 234599987 4666 89999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.6e-07 Score=96.00 Aligned_cols=178 Identities=21% Similarity=0.201 Sum_probs=129.8
Q ss_pred cccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCc-eeceEEEEEecCceEEEEeeccCC-chh
Q 005693 392 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKDEKLLVYDYFASG-SLS 469 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lV~e~~~~g-~L~ 469 (682)
-.++|+++.++|.+-...+....+.+... ....-+++++.++ +||| .++.++-++.++..+++++++.+| +..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 46889999999987554555555554332 4456678899999 9999 777777777788889999999877 222
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---CCCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATPS 546 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~~~ 546 (682)
.-... ..-.+...+...+...-.++++++|+.. -+||| ||+..+ +..+..||+....+... .+..
T Consensus 324 ~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 324 LEMTV----SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred ccCCh----hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence 11110 1111333344455666678899999864 58999 776655 67899999988776654 3445
Q ss_pred CCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 005693 547 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586 (682)
Q Consensus 547 ~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~ 586 (682)
+++.|+|||+.....+....|+|+.|+-..+|--|.+|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 7889999999999999999999999998888888877754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.2e-05 Score=77.25 Aligned_cols=78 Identities=15% Similarity=0.255 Sum_probs=56.8
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCC-CceeceEEEEEec---CceEEEEeeccCC
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRAYYYSK---DEKLLVYDYFASG 466 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~---~~~~lV~e~~~~g 466 (682)
+.++.|..+.||+....+ +.+++|..... .......+|..++..+.++ ..+.+++.+.... ...+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568899999999999887 68999997654 3356778888888888544 2366777654332 3468999999998
Q ss_pred chhH
Q 005693 467 SLST 470 (682)
Q Consensus 467 ~L~~ 470 (682)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.1e-07 Score=79.00 Aligned_cols=84 Identities=25% Similarity=0.386 Sum_probs=50.1
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.+++.++|++|++. .+|+..-...+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|.
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~----------------- 113 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN----------------- 113 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-----------------
Confidence 45666666666666 455533334456666666666666 66666666666666666666665
Q ss_pred cccCcccCCcchhhhccccceeccCCccc
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLS 224 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 224 (682)
..|..+..|.+|-.|+..+|.+.
T Consensus 114 ------~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 114 ------AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ------cchHHHHHHHhHHHhcCCCCccc
Confidence 34444555555555555555554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.5e-07 Score=81.40 Aligned_cols=121 Identities=26% Similarity=0.380 Sum_probs=83.6
Q ss_pred CcEEEccCCCCCCCCCC---cCCCCCCCcEEeecccccCCcCCCCcc---cccceeecccccCcccCCcchhhhccccce
Q 005693 143 LEVLSLRSNVLTGGLPS---EITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGL 216 (682)
Q Consensus 143 L~~L~L~~N~l~g~~p~---~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L 216 (682)
+..|||+++.|- .+++ .+.....|+..+|++|.|. .+|..|. +.++.|+|++|.|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 344555555553 3333 3344455666677777776 5566554 46888999999999 889999999999999
Q ss_pred eccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccc--cCCCCCCCCCCCCC
Q 005693 217 SLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSL--QKFPNSSFVGNSLL 267 (682)
Q Consensus 217 ~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~--~~l~~l~~~~n~~~ 267 (682)
+++.|.|...+-.. .|.+|-.||..+|.+. .+|-.+ ..++.+.-++|..+
T Consensus 106 Nl~~N~l~~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl 158 (177)
T KOG4579|consen 106 NLRFNPLNAEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPL 158 (177)
T ss_pred ccccCccccchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcc
Confidence 99999999544333 7889999999999987 666442 23334444455443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.5e-05 Score=70.37 Aligned_cols=129 Identities=22% Similarity=0.336 Sum_probs=87.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|.+|.||++.+. +..+|+|+-.. ......++.|++++..+..-.--.+++.|- +.++.|||++|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 357999999999999987 55788887654 344677899999999884333344555553 234569999998887
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC--CCeEecCCCCeEEeecCCCCCCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKA--SNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~--~NILl~~~~~~kl~DfGla~~~~ 540 (682)
++-.. .+-.+ ...+++.-.-|...| |-|..|.- .||++++ ..+.|+||..|+.-.
T Consensus 101 ~~~~~--------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~k~ 157 (201)
T COG2112 101 KLEIG--------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhc--------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhhcc
Confidence 66532 11222 234445544456667 99999874 4555554 499999999887443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 682 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 2e-78
Identities = 106/291 (36%), Positives = 169/291 (58%), Gaps = 17/291 (5%)
Query: 380 FDLEDLLRA-----SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQME 432
F L +L A + +LG+G +G YK L + T V VKRLKE G+ F+ ++E
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 433 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 492
++ H N++ LR + + E+LLVY Y A+GS+++ L R + PLDW R +I
Sbjct: 80 MISMA-VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIA 137
Query: 493 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG 550
LG+ARG+A++H PK H ++KA+N+L++++ + + DFGL LM+ T + G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 551 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVR 605
+ APE + T K S K+DV+ +GV+LLE++TG+ DD V L WV+ +++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
E+ + DV+L + +EE+ Q++Q+ + C P RP M EVVRM+E
Sbjct: 258 EKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-68
Identities = 80/318 (25%), Positives = 144/318 (45%), Gaps = 26/318 (8%)
Query: 359 GSGVQEPEKNKLVFFEGCSYNFDLEDLLRA-----SAEVLGKGSYGTAYKAVLEESTTVV 413
+ + SY L DL A ++G G +G YK VL + V
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 414 VKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL 472
+KR G +FE ++E + +HP++V L + ++E +L+Y Y +G+L L
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 473 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 532
+G + WE R++I +G ARG+ ++H+ H ++K+ N+L++++ I+D
Sbjct: 127 YG-SDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITD 182
Query: 533 FGLTPLM----------NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 582
FG++ V T GY PE + + KSDVYSFGV+L E+L +
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTL----GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 583 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 642
+ + +MV+L W ++ D + + E + + + C+A
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVD-PNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 643 DMRPNMDEVVRMIEEVRQ 660
+ RP+M +V+ +E +
Sbjct: 298 EDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-66
Identities = 89/295 (30%), Positives = 144/295 (48%), Gaps = 25/295 (8%)
Query: 379 NFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEI 433
NFD E + +G+G +G YK + TTV VK+L +V K+ F+Q++++
Sbjct: 26 NFD-ERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKV 83
Query: 434 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 493
+ + QH N+V L + D+ LVY Y +GSL L G PL W R KI
Sbjct: 84 MAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQ 140
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---PSRSAG 550
G A G+ +H H +IK++N+L+++ ISDFGL A SR G
Sbjct: 141 GAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVG 197
Query: 551 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607
Y APE + + + KSD+YSFGV+LLE++TG + R+ L + + EE
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV-DEHREPQ-LLLDIKEEIEDEE 254
Query: 608 WT-AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
T + D ++ + M + C+ + + RP++ +V ++++E+ S
Sbjct: 255 KTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 40/319 (12%)
Query: 377 SYNFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM 431
+ E+L S EV +G +G +KA L V VK E ++
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEV 69
Query: 432 EIVGRVGQHPNVVPLRAY----YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 487
+ + +H N++ + L+ + GSLS L N + W
Sbjct: 70 YSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNE 122
Query: 488 RVKILLGTARGVAHIHSMGG-------PKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540
I ARG+A++H P +H +IK+ NVL+ +L CI+DFGL
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 541 VPATPSRS------AGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589
+ + Y APEV+E R + D+Y+ G++L E+ + P
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 590 RDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-----NIEEEMVQMLQIGMACVAKVPDM 644
+ M+ + E EV + R M + + C +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 645 RPNMDEVVRMIEEVRQSDS 663
R + V I ++++ +
Sbjct: 303 RLSAGCVGERITQMQRLTN 321
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 69/191 (36%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 75 NSDRQALLDFADAVPHLRKL-NWSSTNPICQ-SWVGINCTQDR--TRVFGLRLPGIGLVG 130
D+QALL + + L +W T C +W+G+ C D RV L L G+ L
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 131 --PIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 186
PIP++ L L L L + N L G +P I L L YLY+ H N SG IP S
Sbjct: 65 PYPIPSS-LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 187 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKL-RHLNLSY 242
LV LD S+N+ +G +P SI +L L G++ N +SG+IP+ KL + +S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 243 NGLKGSIPSSL 253
N L G IP +
Sbjct: 184 NRLTGKIPPTF 194
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 45/151 (29%), Positives = 62/151 (41%), Gaps = 27/151 (17%)
Query: 128 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS 186
L G IP T L+ L + L N+L G S + + ++L N+ + + S
Sbjct: 186 LTGKIPP-TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 246
L LDL N G +PQ + L L LN+S+N L
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLH----------------------SLNVSFNNLC 281
Query: 247 GSIPSS--LQKFPNSSFVGNSLLCGPPLKAC 275
G IP LQ+F S++ N LCG PL AC
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-47
Identities = 73/297 (24%), Positives = 135/297 (45%), Gaps = 27/297 (9%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH 440
D +++ EV+G+G++G KA + V +K+++ ++ F ++ + RV H
Sbjct: 6 DYKEIEVE--EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQLSRV-NH 60
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
PN+V L Y + LV +Y GSL +LHG + L ++GVA
Sbjct: 61 PNIVKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVA 116
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR-SAGYRAPEVIE 558
++HSM H ++K N+L+ I DFG + T ++ SA + APEV E
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE 176
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618
+S K DV+S+G++L E++T + P D++ + V +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGTRPPLIK---- 227
Query: 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-DSENRPSSEENKS 674
N+ + + ++ C +K P RP+M+E+V+++ + + + P +
Sbjct: 228 ---NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 49/297 (16%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK-----EVVVGKRDFEQQMEIVG 435
D +L E++G G +G Y+A V VK + ++ + Q+ ++
Sbjct: 5 DFAELTLE--EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 436 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495
+ +HPN++ LR + LV ++ G L+ +L G R + + V +
Sbjct: 62 ML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQI 114
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGL------TPLMNV 541
ARG+ ++H H ++K+SN+LI Q ++ I+DFGL T M+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174
Query: 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 601
+ APEVI S SDV+S+GVLL E+LTG+ P + D
Sbjct: 175 AGAY----AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGI-DGLAVAY 224
Query: 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
V + L E ++++ C P RP+ ++ + +
Sbjct: 225 GVAMN-------KLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 68/332 (20%), Positives = 117/332 (35%), Gaps = 50/332 (15%)
Query: 377 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 436
+ DL++L E++G+G YG YK L+E V VK +++F + I
Sbjct: 7 EPSLDLDNL--KLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFA--NRQNFINEKNIYRV 61
Query: 437 VG-QHPNVVPL-----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 490
+H N+ R + E LLV +Y+ +GSL L DW + +
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCR 115
Query: 491 ILLGTARGVAHIHSM------GGPKFTHGNIKASNVLINQDLDGCISDFGL--------- 535
+ RG+A++H+ P +H ++ + NVL+ D ISDFGL
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 536 TPLMNVPATPSRSAG---YRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAPL 585
G Y APEV+E + D+Y+ G++ E+ L
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 586 QSPTRDDMVDLP--RWVQSVVREEWTAEVFDVELMR------FQNIEEEMVQMLQIGMAC 637
+ V + E + E R ++ + + + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 638 VAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 669
+ + R + E+ N+ S
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 56/298 (18%), Positives = 127/298 (42%), Gaps = 43/298 (14%)
Query: 378 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLK--------EVVVGKRDFE 428
++ + +GKG +G +K L + +VV +K L E++ ++F+
Sbjct: 14 PTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 429 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR 488
+++ I+ + HPN+V L + +V ++ G L L P+ W +
Sbjct: 72 REVFIMSNL-NHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVK 124
Query: 489 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-----ISDFGLTPLMNVPA 543
++++L A G+ ++ + P H ++++ N+ + + ++DFGL+
Sbjct: 125 LRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183
Query: 544 TPSR-SAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RW 599
+ + + APE I ++ K+D YSF ++L +LTG+ P D+ ++
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKF 238
Query: 600 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
+ + E + + + + +++ C + P RP+ +V+ + E
Sbjct: 239 INMIREEGLRPTIPE-------DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 48/288 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLR 447
E +G GS+GT ++A + V VK L E +F +++ I+ R+ +HPN+V
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFM 100
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+V +Y + GSL LLH + R LD R+ + A+G+ ++H+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN- 157
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIETRKHS 563
P H N+K+ N+L+++ + DFGL+ L S+SA + APEV+ +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRWVQSVVREEWTAEVF 613
KSDVYSFGV+L E+ T + P + +V ++PR + V
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA-------- 269
Query: 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
++ C P RP+ ++ ++ + +S
Sbjct: 270 --AIIE----------------GCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 69/327 (21%), Positives = 123/327 (37%), Gaps = 55/327 (16%)
Query: 380 FDLEDLLRASAEVLGKGSYGTAYKAVLEEST-TVVVKRLKEV-VVGKRDFEQQMEIVGRV 437
F DL+ EVLGKG +G A K E+ +V+K L +R F ++++++ +
Sbjct: 7 FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 497
+HPNV+ Y + +Y G+L ++ W RV A
Sbjct: 65 -EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIAS 119
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 552
G+A++HSM H ++ + N L+ ++ + ++DFGL LM T
Sbjct: 120 GMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 553 -------------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 599
APE+I R + K DV+SFG++L E++
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------- 221
Query: 600 VQSVVREEWTAEVFDVELMRFQNIEEEMVQ-----MLQIGMACVAKVPDMRPNMDEVVRM 654
++ D L ++ I + C P+ RP+ ++
Sbjct: 222 -----DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 655 IEEVRQSDSENRPSSEENKSKDSNVQT 681
+E +R + + P + + D
Sbjct: 277 LETLRMHLAGHLPLGPQLEQLDRGFWE 303
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 45/294 (15%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRV 437
D + L L + G +K + +VVK LK RDF ++ +
Sbjct: 8 DFKQLNFL--TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 438 GQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495
HPNV+P+ S + + GSL +LH +D VK L
Sbjct: 65 -SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDM 120
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---TPSRSAGYR 552
ARG+A +H++ P + + +V+I++D+ IS + P P +
Sbjct: 121 ARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP----AWV 175
Query: 553 APEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609
APE ++ + + +D++SF VLL E++T + P D+ V E
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF-----ADL-SNMEIGMKVALEG-- 227
Query: 610 AEVFDVELMRF---QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660
+R I + ++++I C+ + P RP D +V ++E+++
Sbjct: 228 --------LRPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-38
Identities = 50/145 (34%), Positives = 70/145 (48%), Gaps = 9/145 (6%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
L + G L G + L++L++ SN G +P L SL+YL L N F+G+
Sbjct: 228 LDISGNKLSGDFSRA-ISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGE 284
Query: 181 IPSSFS---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPK 234
IP S L LDLS N F G +P + + L L+L SNN SG +P +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 235 LRHLNLSYNGLKGSIPSSLQKFPNS 259
L+ L+LS+N G +P SL S
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSAS 369
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-38
Identities = 52/168 (30%), Positives = 69/168 (41%), Gaps = 27/168 (16%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
+ G T ++ L + N+L+G +P EI S+P L L L HN+ SG
Sbjct: 613 CNITSRVYGGHTSP-TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 181 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 238
IP L +LDLS N G IPQ++ LT LT +
Sbjct: 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT----------------------EI 709
Query: 239 NLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKACFPVAPSPSP 284
+LS N L G IP + FP + F+ N LCG PL C P
Sbjct: 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-38
Identities = 51/135 (37%), Positives = 72/135 (53%), Gaps = 5/135 (3%)
Query: 128 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 186
L G IP++ LG L L L L N+L G +P E+ + +L L L N+ +G+IPS S
Sbjct: 430 LSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 187 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 243
L + LS N TG IP+ I L L L L +N+ SG+IP D L L+L+ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 244 GLKGSIPSSLQKFPN 258
G+IP+++ K
Sbjct: 549 LFNGTIPAAMFKQSG 563
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-37
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 13/171 (7%)
Query: 89 PHLRKLNWSSTN---PICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNN--TLGKLDAL 143
L+ LN SS P S G+ L L + G L
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSG-GLKLNSLEV----LDLSANSISGANVVGWVLSDGCGEL 180
Query: 144 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGN 202
+ L++ N ++G + ++ +L +L + NNFS IP L LD+S N +G+
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGD 238
Query: 203 IPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253
++I T+L L++ SN G IP + L++L+L+ N G IP L
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFL 289
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-37
Identities = 45/142 (31%), Positives = 60/142 (42%), Gaps = 6/142 (4%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
L + IP LG AL+ L + N L+G I++ L+ L + N F G
Sbjct: 205 LDVSSNNFSTGIP--FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPN--FDIPKLRH 237
IP L L L+ N FTG IP + LTGL L N+ G++P L
Sbjct: 263 IPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 238 LNLSYNGLKGSIP-SSLQKFPN 258
L LS N G +P +L K
Sbjct: 323 LALSSNNFSGELPMDTLLKMRG 344
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 54/138 (39%), Positives = 72/138 (52%), Gaps = 8/138 (5%)
Query: 128 LVGPIPNNTLGKLDA-LEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSS 184
G +P +L L A L L L SN +G + + +L+ LYLQ+N F+GKIP +
Sbjct: 355 FSGELPE-SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 185 FS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNL 240
S +LV L LSFN +G IP S+ +L++L L L N L G IP + L L L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 241 SYNGLKGSIPSSLQKFPN 258
+N L G IPS L N
Sbjct: 474 DFNDLTGEIPSGLSNCTN 491
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-36
Identities = 44/203 (21%), Positives = 72/203 (35%), Gaps = 32/203 (15%)
Query: 65 SLLPLAFADLNSDRQALLDFADAVPHLRKL-NWSSTNPICQSWVGINCTQDRTRVFGLRL 123
S L + L+ F D +P L +WSS C ++ G+ C +V + L
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTC--RDDKVTSIDL 57
Query: 124 PGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 183
L + S + SL L L+L +++ +G +
Sbjct: 58 SSKPLNVGF----------------------SAVSSSLLSLTGLESLFLSNSHINGSVSG 95
Query: 184 -SFSPQLVVLDLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRH 237
S L LDLS NS +G + S+ + + L L++ SN L + L
Sbjct: 96 FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155
Query: 238 LNLSYNGLKGSIPSSLQKFPNSS 260
L+LS N + G+
Sbjct: 156 LDLSANSISGANVVGWVLSDGCG 178
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-34
Identities = 47/147 (31%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSG 179
L + VGPIP L L + LSL N TG +P ++ + +L L L N+F G
Sbjct: 252 LNISSNQFVGPIPPLPLKSL---QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
Query: 180 KIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNFDI---P 233
+P F L L LS N+F+G +P ++ + L L L N SG +P
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 234 KLRHLNLSYNGLKGSIPSSLQKFPNSS 260
L L+LS N G I +L + P ++
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 31/135 (22%), Positives = 52/135 (38%), Gaps = 7/135 (5%)
Query: 128 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 187
L G IP +G+L+ L +L L +N +G +P+E+ SL +L L N F+G IP++
Sbjct: 502 LTGEIPK-WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN--NLSGSIPN--FDIPKLRHLNLSYN 243
Q ++ N G I+N N G + N++
Sbjct: 561 QS--GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
Query: 244 GLKGSIPSSLQKFPN 258
G + +
Sbjct: 619 VYGGHTSPTFDNNGS 633
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 63/302 (20%), Positives = 113/302 (37%), Gaps = 43/302 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY- 449
+ +GKG YG + V VK E ++ + +H N++ A
Sbjct: 43 KQIGKGRYGEVWMGKWRG-EKVAVKVFFTTEEASWFRETEIYQTVLM-RHENILGFIAAD 100
Query: 450 ---YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM- 505
S + L+ DY +GSL L T LD ++ +K+ + G+ H+H+
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 506 ----GGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG---YRA 553
G P H ++K+ N+L+ ++ CI+D GL + V P+ G Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 554 PEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQSPTR-----DDMVDLPRWVQS 602
PEV++ + +D+YSFG++L E+ D+V
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV----PSDP 270
Query: 603 VVREEWTAEVFD---VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659
+ + +E + QM ++ C A P R V + + ++
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
Query: 660 QS 661
+S
Sbjct: 331 ES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 65/305 (21%), Positives = 116/305 (38%), Gaps = 45/305 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-QHPNVVPLRA- 448
E +GKG +G ++ V VK +R + ++ EI V +H N++ A
Sbjct: 48 ESIGKGRFGEVWRGKWRG-EEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 449 ---YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
+ + LV DY GSL L+ R + E +K+ L TA G+AH+H
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 506 -----GGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG---YR 552
G P H ++K+ N+L+ ++ CI+D GL + + P+ G Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 553 APEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR-----DDMVDLPRWVQ 601
APEV++ + ++D+Y+ G++ E+ + D+V
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV----PSD 274
Query: 602 SVVREEWTAEVFD---VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
V E + E + M +I C R + + + ++
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 659 RQSDS 663
Q +
Sbjct: 335 SQQEG 339
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 65/309 (21%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
E +GKG YG ++ + V VK E ++ + +H N++ A
Sbjct: 14 ECVGKGRYGEVWRGSWQG-ENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASD 71
Query: 451 YSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM- 505
+ L+ Y GSL L T LD + ++I+L A G+AH+H
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 506 ----GGPKFTHGNIKASNVLINQDLDGCISDFGL-------TPLMNVPATPSR-SAGYRA 553
G P H ++K+ N+L+ ++ CI+D GL T ++V P + Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 554 PEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPL---------------QSPTRDD 592
PEV++ + D+++FG++L E+ P+ +D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 593 MVDLPRWVQSVVRE----EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM 648
M + V + F + + ++++ C + P R
Sbjct: 246 MRKV------VCVDQQRPNIPNRWFSDPTLT------SLAKLMK---ECWYQNPSARLTA 290
Query: 649 DEVVRMIEE 657
+ + + +
Sbjct: 291 LRIKKTLTK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 67/280 (23%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR---DFEQQMEIVGRVGQHPNVVPLR 447
+ +G GS+GT YK V VK L + F+ ++ ++ + +H N++
Sbjct: 30 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 86
Query: 448 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
Y S +L +V + SL LH + + + + I TARG+ ++H+
Sbjct: 87 GY--STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKS 140
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVI--- 557
H ++K++N+ +++D I DFGL + + + + APEVI
Sbjct: 141 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617
++ +S +SDVY+FG++L E++TG+ P ++ + + ++ V R + ++ V
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIEMVGRGSLSPDLSKVR- 251
Query: 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
N + M +++ C+ K D RP+ ++ IEE
Sbjct: 252 ---SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 53/309 (17%), Positives = 118/309 (38%), Gaps = 52/309 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLR 447
E++GKG +G Y V ++ + + + F++++ + +H NVV
Sbjct: 39 ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFM 95
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
S ++ +L +++ + LD +I +G+ ++H+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 508 PKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---------YRAPEVI 557
H ++K+ NV D I+DFGL + V R + APE+I
Sbjct: 149 KGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 558 ETRK---------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608
S SDV++ G + E+ + P ++ + ++ + + ++
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ---MGTGMKPN- 262
Query: 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 668
+ + +E+ +L + C A + RP +++ M+E++ + + R S
Sbjct: 263 ---------LSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEKLPKRNR--RLS 308
Query: 669 SEENKSKDS 677
+ K +
Sbjct: 309 HPGHFWKSA 317
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 447
+G+GS+ T YK + E + V L++ + K + ++ + E + + QHPN+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 448 AYYYS---KDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ S + +++ + SG+L T L + + + +G+ +H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 146
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPS--RSAGYRAPEVIET 559
+ P H ++K N+ I G I D GL L + + + APE+ E
Sbjct: 147 TRT-PPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 203
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619
K+ DVY+FG+ +LEM T + P + + R V S V+ +V E+
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 650
IE C+ + D R ++ +
Sbjct: 262 I--IEG-----------CIRQNKDERYSIKD 279
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 33/155 (21%), Positives = 49/155 (31%), Gaps = 9/155 (5%)
Query: 128 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-- 185
L + L L L + L SL L + N+F
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 186 -SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY 242
L LDLS P + +L+ L L++ NN + L+ L+ S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 243 NGLKGSIPSSLQKFPNS----SFVGNSLLCGPPLK 273
N + S LQ FP+S + N C +
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 5/140 (3%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+ + + L+VL L + SL L L L N +FS L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL-SGSIPNF--DIPKLRHLNLSYNGLK 246
L + I +L L L++ N + S +P + ++ L HL+LS N ++
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 247 GSIPSSLQKFPNSSFVGNSL 266
+ L+ + SL
Sbjct: 163 SIYCTDLRVLHQMPLLNLSL 182
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 24/121 (19%), Positives = 40/121 (33%), Gaps = 5/121 (4%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
+ L L N L S P L+ L L ++ L L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG-SIPSSLQKFP 257
+ L+ L L NL+ + L+ LN+++N ++ +P
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 258 N 258
N
Sbjct: 150 N 150
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 10/156 (6%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
L++ G + +L L L L L P+ SL SL+ L + HNNF
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 181 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNL-TQLTGLSLQSNNLSGSIPNFD----IP 233
+ L VLD S N + Q +Q+ + L L+L N+ + + + I
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 569
Query: 234 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG 269
R L + ++ + PS Q P S ++ C
Sbjct: 570 DQRQLLVEVERMECATPSDKQGMPVLSL---NITCQ 602
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-26
Identities = 34/144 (23%), Positives = 50/144 (34%), Gaps = 9/144 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF-SGKIPSSFS--PQ 188
+ L +L+ L L I L +L+ L + HN S K+P FS
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 189 LVVLDLSFNSFTGNIPQSIQNLTQLT----GLSLQSNNLSGSIPN-FDIPKLRHLNLSYN 243
L LDLS N ++ L Q+ L L N ++ P F +L L L N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 244 GLKGSIPS-SLQKFPNSSFVGNSL 266
++ +Q L
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVL 234
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-26
Identities = 28/132 (21%), Positives = 46/132 (34%), Gaps = 9/132 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I + L L L L N + + L SL+ L N + L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 190 VVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR----HLNLSY 242
L+++ N +P+ NLT L L L SN + + ++ L+LS
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 243 NGLKGSIPSSLQ 254
N + P + +
Sbjct: 187 NPMNFIQPGAFK 198
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 34/135 (25%), Positives = 51/135 (37%), Gaps = 11/135 (8%)
Query: 134 NNTLGKLDALEVLSLRS---NVLTGGLPSEITSLPSLRYLYLQHN--NFSGKIPSSFS-- 186
N G+ L++ SL+ GG LPSL +L L N +F G S
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYN 243
L LDLSFN + + L QL L Q +NL + L +L++S+
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 244 GLKGSIPSSLQKFPN 258
+ + +
Sbjct: 432 HTRVAFNGIFNGLSS 446
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 34/157 (21%), Positives = 50/157 (31%), Gaps = 26/157 (16%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
RL + + L + SL S + + + ++L L + F
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQF 319
Query: 181 IPSSFS---------------------PQLVVLDLSFN--SFTGNIPQSIQNLTQLTGLS 217
P L LDLS N SF G QS T L L
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 218 LQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSL 253
L N + NF + +L HL+ ++ LK S+
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 28/156 (17%), Positives = 51/156 (32%), Gaps = 27/156 (17%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--- 187
+ N +G L L+ L++ N++ LP ++L +L +L L N +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 188 ---QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS-----NNLSGSIPNF---DIPKLR 236
+ LDLS N P + + + L N S ++ + L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI------RLHKLTLRNNFDSLNVMKTCIQGLAGLE 228
Query: 237 HLNLSYNGLKGS------IPSSLQKFPNSSFVGNSL 266
L + S+L+ N + L
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 29/142 (20%), Positives = 46/142 (32%), Gaps = 8/142 (5%)
Query: 122 RLPGIGLVGPIPNNTLGKLDALEVLSLRSNVL---TGGLPSEITSLPSLRYLYLQHNNFS 178
G + + L L L + R L + L ++ L
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 179 GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 238
S++ L+L F +++L +LT S + N D+P L L
Sbjct: 296 RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA---FSEVDLPSLEFL 352
Query: 239 NLSYNGL--KGSIPSSLQKFPN 258
+LS NGL KG S +
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTS 374
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 30/146 (20%), Positives = 44/146 (30%), Gaps = 18/146 (12%)
Query: 130 GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY----LYLQHNNFSGKIPSSF 185
+P L LE L L SN + +++ L + L L N + P +F
Sbjct: 139 FKLPE-YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 186 S-PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPNFDIPK-----LRHL 238
+L L L N + N+ + IQ L L L K L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 239 NLSYNGLK------GSIPSSLQKFPN 258
+ L I N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTN 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 21/100 (21%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 161 ITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 220
+ +P++ Y NF KIP + LDLSFN S + +L L L
Sbjct: 4 VEVVPNITYQ-CMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 221 NNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ + L L L+ N ++ + +
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 27/147 (18%), Positives = 42/147 (28%), Gaps = 13/147 (8%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSG-----KIPSSF 185
I ++ L L+LR+N + + I L L L F K S
Sbjct: 192 IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 186 SPQLVVLDLSFNS------FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 239
L L + + +I LT ++ SL S + +HL
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 240 LSYNGLKGSIPSSLQKFPNSSFVGNSL 266
L L+ +F N
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKG 337
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 63/274 (22%), Positives = 102/274 (37%), Gaps = 41/274 (14%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 446
LG GSYG +K E+ VKR G +D ++ +VGQHP V
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV-- 120
Query: 447 RAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIH 503
+ + L + SL A L E +V L T +AH+H
Sbjct: 121 -RLEQAWEEGGILYLQTELCGPSLQQHCE----AWGASLP-EAQVWGYLRDTLLALAHLH 174
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETR 560
S G H ++K +N+ + + DFGL + G Y APE+++
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-G 230
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620
+ +DV+S G+ +LE+ P + + Q + E+TA EL
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL---PHGGE--GWQQLRQGYLPPEFTAG-LSSELRSV 284
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
+V ML+ P +R + ++ +
Sbjct: 285 ------LVMMLE-------PDPKLRATAEALLAL 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 55/302 (18%), Positives = 110/302 (36%), Gaps = 44/302 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPLR 447
+ LG+G + LK ++ ++ ++ E + R+ HPN++ L
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYA--LKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 448 AYYYSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
AY + L+ +F G+L + L + + +LLG RG+ IH
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------- 550
+ + H ++K +N+L+ + + D G + SR A
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 551 YRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607
YRAPE+ + H ++DV+S G +L M+ G+ P + V V+ +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----VALAVQNQ 263
Query: 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP 667
+ + + M+ P RP++ ++ +E ++
Sbjct: 264 LSIPQSPRHSSALWQL---LNSMMT-------VDPHQRPHIPLLLSQLEALQPPAPGQHT 313
Query: 668 SS 669
+
Sbjct: 314 TQ 315
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 63/285 (22%), Positives = 124/285 (43%), Gaps = 39/285 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ LG G +G + A + T V VK +K + F + ++ + QH +V L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV 252
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+K+ ++ ++ A GSL L + G + + A G+A I +
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 565
H +++A+N+L++ L I+DFGL ++ +R + APE I + K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 566 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 620
SDV+SFG+LL+E++T G+ P + +++ ++ R E E++++
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LERGYRMPRPENCPEELYNI----- 417
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665
M++ C P+ RP + + ++++ +
Sbjct: 418 ---------MMR----CWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 67/326 (20%), Positives = 125/326 (38%), Gaps = 68/326 (20%)
Query: 391 EVLGKGSYGTAYKAVL---EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVP 445
+V+G+G++G KA + +KR+KE RDF ++E++ ++G HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKILLG 494
L + L +Y G+L L +R P +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YR- 552
ARG+ ++ +F H ++ A N+L+ ++ I+DFGL SR Y
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL----------SRGQEVYVK 197
Query: 553 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 600
A E + ++ SDV+S+GVLL E+++ G P T ++ + +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---L 254
Query: 601 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
R EV+D+ M Q C + P RP+ +++ +
Sbjct: 255 PQGYRLEKPLNCDDEVYDL--------------MRQ----CWREKPYERPSFAQILVSLN 296
Query: 657 EVRQSDSENRPSSEENKSKDSNVQTP 682
+ + ++ K + +
Sbjct: 297 RMLEERKTYVNTTLYEKFTYAGIDCS 322
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
LG+G +G + +T V +K LK + F Q+ +++ ++ +H +V L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 248
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
S++ +V +Y + GSL L G G L V + A G+A++ M +
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 565
H +++A+N+L+ ++L ++DFGL L+ +R + APE + + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 566 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 620
SDV+SFG+LL E+ T G+ P +++D V+ R E + D+
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLHDL----- 413
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 671
M Q C K P+ RP + + +E+ S E
Sbjct: 414 ---------MCQ----CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 391 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG G YG Y+ V + S TV VK LKE + +F ++ ++ + +HPN+V L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 284
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ ++ ++ G+L L R R + + + + + ++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSH 564
F H N+ A N L+ ++ ++DFGL+ LM + + + APE + K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 565 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 619
KSDV++FGVLL E+ T G +P + +L ++ R E +V+++
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVYEL---- 451
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
M C P RP+ E+ + E + Q S
Sbjct: 452 ----------MRA----CWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/283 (23%), Positives = 122/283 (43%), Gaps = 39/283 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ LG G +G + V VK +KE + + +F Q+ + + ++ HP +V
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVC 72
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+ +V +Y ++G L L + L+ +++ G+A + S +F
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YR--APEVIETRKHSHK 565
H ++ A N L+++DL +SDFG+T + S + APEV K+S K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 566 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 620
SDV++FG+L+ E+ + GK P T ++V V R + ++ +
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---VSQGHRLYRPHLASDTIYQI----- 237
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
M C ++P+ RP +++ IE +R+ D
Sbjct: 238 ---------MYS----CWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 59/284 (20%), Positives = 115/284 (40%), Gaps = 41/284 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ LG G +G V +K +KE + + +F ++ +++ + H +V L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 88
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+ ++ +Y A+G L L R + +++ + ++ S +F
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK---QF 141
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEVIETRKHSH 564
H ++ A N L+N +SDFGL+ + + S G + PEV+ K S
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 565 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 619
KSD+++FGVL+ E+ + GK P + T + + + +R + +V+ +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQGLRLYRPHLASEKVYTI---- 253
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
M C + D RP ++ I +V +S
Sbjct: 254 ----------MYS----CWHEKADERPTFKILLSNILDVMDEES 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 446
E +G G +G+ +K V + +KR K+ + G D + +++ +GQH +VV
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74
Query: 447 RAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 502
Y+ +++D+ +L+ +Y GSL+ + N E +K +LL RG+ +I
Sbjct: 75 -RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFK-EAELKDLLLQVGRGLRYI 131
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGC-------------------ISDFGLTPLMNVPA 543
HSM H +IK SN+ I++ I D G ++ P
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 544 TPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ + A EV+ E H K+D+++ + ++ +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 39/298 (13%)
Query: 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG G YG Y+ V + S TV VK LKE + +F ++ ++ + +HPN+V L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 77
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ ++ ++ G+L L R R + + + + + ++
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSH 564
F H ++ A N L+ ++ ++DFGL+ LM + + + APE + K S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 565 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 619
KSDV++FGVLL E+ T G +P + +L ++ R E +V+++
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVYEL---- 244
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDS 677
M C P RP+ E+ + E + Q S + +E + +
Sbjct: 245 ----------MRA----CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 288
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 65/315 (20%), Positives = 119/315 (37%), Gaps = 70/315 (22%)
Query: 391 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 443
LG+G +G + V VK LK + ++Q+++I+ + H ++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHI 95
Query: 444 VPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
+ + LV +Y GSL L + + + G+A+
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAY 149
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 552
+H+ + H ++ A NVL++ D I DFGL + P YR
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-----PEGHEYYRVREDGDSPV 201
Query: 553 ---APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR-DDMVDLPRWVQSVVR-- 605
APE ++ K + SDV+SFGV L E+LT + PT+ +++ + + +V+R
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 606 ------------EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
++ AEV+ + M C RP + ++
Sbjct: 262 ELLERGERLPRPDKCPAEVYHL--------------MKN----CWETEASFRPTFENLIP 303
Query: 654 MIEEVRQSDSENRPS 668
+++ V + PS
Sbjct: 304 ILKTVHEKYQGQAPS 318
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 9/138 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----P 187
I NN K L L L N L+ L +L+ L L +N
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-----NFDIPKLRHLNLSY 242
L L+LS N P + +L GL L + L S+ +R+L+LS
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 243 NGLKGSIPSSLQKFPNSS 260
+ L + ++ ++
Sbjct: 232 SQLSTTSNTTFLGLKWTN 249
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-28
Identities = 36/133 (27%), Positives = 49/133 (36%), Gaps = 4/133 (3%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+P + L L + N ++ P LP L+ L LQHN S +F+ L
Sbjct: 40 LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG 247
L L NS L L L N LS + + L+ L LS N ++
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 248 SIPSSLQKFPNSS 260
L F NSS
Sbjct: 160 LKSEELDIFANSS 172
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 16/153 (10%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS--------GKIPSSFS 186
+ L L +L L +N + + L L L LQHNN + G
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK 533
Query: 187 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY 242
L +L+L N F + ++L +L + L NNL+ + + L+ LNL
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593
Query: 243 NGLKGSIPSSLQKFPNS----SFVGNSLLCGPP 271
N + + N C
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-26
Identities = 30/135 (22%), Positives = 45/135 (33%), Gaps = 6/135 (4%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+ + T L L L SN + + +L L L HN S + L
Sbjct: 88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL 147
Query: 190 VVLDLSFNSFTGNIPQSIQ--NLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 245
L LS N + + + L L L SN + P I +L L L+ L
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
Query: 246 KGSIPSSLQKFPNSS 260
S+ L ++
Sbjct: 208 GPSLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 37/146 (25%), Positives = 58/146 (39%), Gaps = 10/146 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEIT---SLPSLRYLYLQHNNFSGKIPSSFS-- 186
+ L L L + L L ++ + S+R L L ++ S ++F
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 187 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSY 242
L +LDLS+N+ S L QL L+ NN+ + + +R+LNL
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 243 NGLKGSIPS-SLQKFPNSSFVGNSLL 267
+ K SI SL K + SF L
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 33/120 (27%), Positives = 48/120 (40%), Gaps = 4/120 (3%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
+ VL+L N L + T L L + N S P P L VL+L N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
++ T LT L L SN++ N L L+LS+NGL + + + N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 35/152 (23%), Positives = 52/152 (34%), Gaps = 14/152 (9%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG- 179
L L + + L+ + + L N + +PSL+ L L+
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469
Query: 180 -KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--------GSIP 228
PS F L +LDLS N+ ++ L +L L LQ NNL+ G
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 229 NF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
F + L LNL NG +
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 9/136 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS------F 185
I + + L LE L++ N + G + T L +L+YL L ++ S + ++
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 186 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSY 242
L +L+L+ N + + L L L L N + + + + + LSY
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 243 NGLKGSIPSSLQKFPN 258
N +S P+
Sbjct: 440 NKYLQLTRNSFALVPS 455
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-22
Identities = 51/227 (22%), Positives = 75/227 (33%), Gaps = 41/227 (18%)
Query: 63 IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDR-TRVFGL 121
I P F + L L ++ + S C + T + L
Sbjct: 183 IKEFSPGCFHAI--------------GRLFGLFLNN-VQLGPSLTEKLCLELANTSIRNL 227
Query: 122 RLPGIGLVGPIPNNTLGKLD--ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 179
L L N T L L +L L N L LP L Y +L++NN
Sbjct: 228 SLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 180 KIPSSFS--PQLVVLDL---------SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 228
S + L+L S S S Q L L L+++ N++ G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 229 NF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 273
N + L++L+LS + SL+ N +FV L PL
Sbjct: 347 NMFTGLINLKYLSLSNSFT------SLRTLTNETFVS---LAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 22/95 (23%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
S H + ++P + VL+L+ N + +QLT L + N +S
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 226 SIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
P +P L+ LNL +N L + N
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-18
Identities = 28/138 (20%), Positives = 47/138 (34%), Gaps = 5/138 (3%)
Query: 133 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 190
P L L L +L+L SN L L+ + L NN + S F+ L
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587
Query: 191 VLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
L+L N T + LT L ++ N + + + +N ++ +
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA-WFVNWINETHTNIPELS 646
Query: 250 PSSLQKFPNSSFVGNSLL 267
L P + G +
Sbjct: 647 SHYLCNTP-PHYHGFPVR 663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-15
Identities = 30/118 (25%), Positives = 44/118 (37%), Gaps = 8/118 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---Q 188
IP L L+++ L N L S + SL+ L LQ N + F P
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 189 LVVLDLSFNSFTGNIP-----QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS 241
L LD+ FN F + N T L S+ L + P++ +R + S
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 391 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 447
E +G+G++G + L ++T V VK +E + K F Q+ I+ + HPN+V L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 178
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
K +V + G T L L +T ++++ A G+ ++ S
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK-- 232
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEVIETR 560
H ++ A N L+ + ISDFG++ + S G R APE +
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 561 KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE--- 616
++S +SDV+SFG+LL E + G +P P RE VE
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP-----------YPNLSNQQTREF-------VEKGG 332
Query: 617 -LMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
L + + + + M Q C A P RP+ + + ++ +R+
Sbjct: 333 RLPCPELCPDAVFRLMEQ----CWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 58/313 (18%), Positives = 127/313 (40%), Gaps = 48/313 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 445
+ +G+GS+G A E V +KE+ + + +++ E V +HPN+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYV--IKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
R + +V DY G L ++ +G + + + + H+H
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDR 144
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-G---YRAPEVIETRK 561
K H +IK+ N+ + +D + DFG+ ++N +R+ G Y +PE+ E +
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--EVFDVELMR 619
+++KSD+++ G +L E+ T K ++ M +L V ++ + + +L
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEA---GSMKNL---VLKIISGSFPPVSLHYSYDLRS 255
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR----------MIEEVRQSDSENRPSS 669
+ Q+ + + P RP+++ ++ + ++ +
Sbjct: 256 L------VSQLFK-------RNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTF 302
Query: 670 EENKSKDSNVQTP 682
+ S+ + P
Sbjct: 303 SKFGSQPIPAKRP 315
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-28
Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
LG+G +G + +T V +K LK + F Q+ +++ ++ +H +V L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 331
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
S++ +V +Y + GSL L G G L V + A G+A++ M +
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 565
H +++A+N+L+ ++L ++DFGL L+ +R + APE + + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 566 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 620
SDV+SFG+LL E+ T G+ P +++D V+ R E + D+
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLHDL----- 496
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 671
M Q C K P+ RP + + +E+ S E
Sbjct: 497 ---------MCQ----CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 64/281 (22%), Positives = 123/281 (43%), Gaps = 39/281 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ +G G +G + V +K ++E + + DF ++ E++ ++ HP +V L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 72
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+ LV ++ G LS L RG ET + + L G+A++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 565
H ++ A N L+ ++ +SDFG+T + S + + +PEV ++S K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 566 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 620
SDV+SFGVL+ E+ + GK P ++ + ++V+ + + R + V+ +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFRLYKPRLASTHVYQI----- 237
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
M C + P+ RP ++R + E+ +S
Sbjct: 238 ---------MNH----CWRERPEDRPAFSRLLRQLAEIAES 265
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 50/298 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
E++G G +G +KA V +K V E++++ + ++ H N+V +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYV--IKRVKYNNEKAEREVKALAKL-DHVNIVHYNGCW 73
Query: 451 YSKDEKL----------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 494
D + ++ G+L + RG LD +++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQ 130
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---Y 551
+GV +IHS K + ++K SN+ + I DFGL + +RS G Y
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 552 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611
+PE I ++ + + D+Y+ G++L E+L T + + +R+ ++
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVC-----DTAFETSKF----FTDLRDGIISD 238
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 669
+FD + + ++L K P+ RPN E++R + ++S +N +
Sbjct: 239 IFDKKEKTL------LQKLLS-------KKPEDRPNTSEILRTLTVWKKSPEKNERHT 283
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
E LG G +G + T V VK LK+ + F + ++ ++ QH +V L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVV 77
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+++ ++ +Y +GSL L G L + + A G+A I +
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YR--APEVIETRKHSHK 565
H +++A+N+L++ L I+DFGL L+ +R + APE I + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 566 SDVYSFGVLLLEMLT-GKAP 584
SDV+SFG+LL E++T G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 63/319 (19%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 442
LG+GS+G Y+ V E T V +K + E + + +F + ++ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 89
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTAR 497
VV L L++ + G L + L R P +++ A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 552
G+A++++ KF H ++ A N ++ +D I DFG+T + + YR
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY------ETDYYRKGGKG 200
Query: 553 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 604
+PE ++ + SDV+SFGV+L E+ T + P Q + + ++ V
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---VMEGG 257
Query: 605 R----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660
+ +F ELMR C P MRP+ E++ I+E +
Sbjct: 258 LLDKPDNCPDMLF--ELMR----------------MCWQYNPKMRPSFLEIISSIKEEME 299
Query: 661 SDSENRP--SSEENKSKDS 677
SEENK +
Sbjct: 300 PGFREVSFYYSEENKLPEP 318
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 57/283 (20%), Positives = 108/283 (38%), Gaps = 45/283 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 445
+G GSYG K + ++V KE+ G ++ +V V +HPN+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILV--WKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 446 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ L V +Y G L++++ + LD E ++++ + H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECH 128
Query: 504 SMGGPKFT--HGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRA 553
T H ++K +NV ++ + + DFGL ++N TP Y +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY----YMS 184
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--E 611
PE + ++ KSD++S G LL E+ P + +L + ++
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKEL---AGKIREGKFRRIPY 238
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
+ EL + +ML RP+++E++
Sbjct: 239 RYSDELNEI------ITRMLN-------LKDYHRPSVEEILEN 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 58/295 (19%), Positives = 121/295 (41%), Gaps = 36/295 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------KRDFEQQMEIVGRVGQHPNV 443
+ +G+G + Y+A V LK+V + + D ++++++ ++ HPNV
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVA--LKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNV 94
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ A + +E +V + +G LS ++ + + + T K + + H+H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRS-AG---YRAPEVI 557
S + H +IK +NV I G + D GL + T + S G Y +PE I
Sbjct: 154 SR---RVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617
++ KSD++S G LL EM ++P ++ L + ++ ++ + EL
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEEN 672
+ + + P+ RP++ V + + + + + +
Sbjct: 268 RQL------VNMCIN-------PDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/313 (20%), Positives = 117/313 (37%), Gaps = 54/313 (17%)
Query: 391 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNV 443
+VLG G +GT +K V V +K +++ + M +G + H ++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHI 77
Query: 444 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
V L LV Y GSL + +RG L + + + A+G+
Sbjct: 78 VRL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMY 129
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 554
++ H N+ A NVL+ ++DFG+ L+ + + A
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 609
E I K++H+SDV+S+GV + E++T G P ++ DL ++ R + T
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGERLAQPQICT 243
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 669
+V+ V M++ C ++RP E+ + +
Sbjct: 244 IDVYMV--------------MVK----CWMIDENIRPTFKELANEFTRMARDPPRYLVIK 285
Query: 670 EENKSKDSNVQTP 682
E+ + P
Sbjct: 286 RESGPGIAPGPEP 298
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 80/461 (17%), Positives = 156/461 (33%), Gaps = 87/461 (18%)
Query: 237 HLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACF--PVAPSPSPTYSPPPFIPR 294
+SY KG+ P+ L F + S K +A +P P
Sbjct: 247 EEGISYLTDKGANPTHLADFNQVQTIQYSNSEDKDRKGMLQLKIAGAPEP---------- 296
Query: 295 KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKP 354
+ + + +A +I YC + + + +
Sbjct: 297 -------------LTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSI 343
Query: 355 KEEFGSGVQEPEKNKLVFFEGCSYN--FDLEDLLRASA--------------EVLGKGSY 398
+ + Q + + E Y D ED + +G+G +
Sbjct: 344 PKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQF 403
Query: 399 GTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 452
G ++ + + V +K K + F Q+ + + HP++V L +
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-T 461
Query: 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 512
++ ++ + G L + L + LD + + + +A++ S +F H
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESK---RFVH 514
Query: 513 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 567
+I A NVL++ + + DFGL+ M S G + APE I R+ + SD
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574
Query: 568 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRFQN 622
V+ FGV + E+L G P Q +D++ +++ R ++ +
Sbjct: 575 VWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYSL------- 624
Query: 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
M + C A P RP E+ + + + +
Sbjct: 625 -------MTK----CWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 76/308 (24%), Positives = 121/308 (39%), Gaps = 60/308 (19%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 442
+ LG+G++G +A TV VK LKE R +++I+ +G H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 443 VVPLRAYYYSKDEKLLV-YDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVK 490
VV L L+V ++ G+LST L R + L E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 491 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG 550
A+G+ + S K H ++ A N+L+++ I DFGL + +
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY------KDPD 203
Query: 551 YR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP 597
Y APE I R ++ +SDV+SFGVLL E+ + G +P P +
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFC 261
Query: 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIE 656
R ++ R + EM Q ML C P RP E+V +
Sbjct: 262 RRLKEGTR-----------MRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 306
Query: 657 EVRQSDSE 664
+ Q++++
Sbjct: 307 NLLQANAQ 314
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 63/307 (20%), Positives = 110/307 (35%), Gaps = 68/307 (22%)
Query: 391 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 443
LG+G +G + V VK LK G D ++++EI+ + H N+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENI 85
Query: 444 VPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
V + L+ ++ SGSL L N+ ++ + ++K + +G+ +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDY 141
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 552
+ S ++ H ++ A NVL+ + I DFGLT + + Y
Sbjct: 142 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-----ETDKEYYTVKDDRDSPV 193
Query: 553 ---APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR-DDMVDLPRWVQSVVR-- 605
APE + K SDV+SFGV L E+LT + M+ +V R
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 606 ------------EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
EV+ + M + C P R + ++
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQL--------------MRK----CWEFQPSNRTSFQNLIE 295
Query: 654 MIEEVRQ 660
E + +
Sbjct: 296 GFEALLK 302
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 28/217 (12%), Positives = 75/217 (34%), Gaps = 26/217 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVV 444
+LG+G++ Y+A + V+K K + Q+ + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
+ + ++ +LV + ++ G+L ++ + + + + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 505 MGGPKFTHGNIKASNVLINQDLDG-----------CISDFGLTPLMNVPATPSR------ 547
HG+IK N ++ + D G + M + +
Sbjct: 191 CE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
++G++ E++ + +++ D + + ML G
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 66/304 (21%), Positives = 126/304 (41%), Gaps = 60/304 (19%)
Query: 391 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVV 444
+ LGKG++G+ + V VK+L+ RDFE+++EI+ + QH N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 74
Query: 445 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
+ YS + L+ +Y GSL L ++ +D ++ +G+ ++
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 130
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 552
+ ++ H ++ N+L+ + I DFGLT ++ P ++
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-----PQDKEFFKVKEPGESPIF 182
Query: 553 --APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610
APE + K S SDV+SFGV+L E+ T +SP + M + Q
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------GQM 236
Query: 611 EVFDVELMRFQNIEE------------EMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEE 657
VF + + ++ E+ M + C + RP+ ++ +++
Sbjct: 237 IVFHL----IELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQ 288
Query: 658 VRQS 661
+R +
Sbjct: 289 IRDN 292
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 57/295 (19%), Positives = 113/295 (38%), Gaps = 54/295 (18%)
Query: 391 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 443
+VLG G++GT YK + + V +K L+E ++ + ++ V +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 444 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
L L+ G L + ++ + + + + A+G+
Sbjct: 80 CRL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMN 131
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 554
++ + H ++ A NVL+ I+DFGL L+ + G + A
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 609
E I R ++H+SDV+S+GV + E++T G P ++ + ++ R T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICT 245
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
+V+ + M + C D RP E++ ++ +
Sbjct: 246 IDVYMI--------------MRK----CWMIDADSRPKFRELIIEFSKMARDPQR 282
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 63/316 (19%), Positives = 108/316 (34%), Gaps = 67/316 (21%)
Query: 391 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVV 444
LGKG++G+ V VK+L+ +RDF+++++I+ + +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 87
Query: 445 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
R Y + LV +Y SG L L +R LD + +G+ ++
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYL 143
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 552
S + H ++ A N+L+ + I+DFGL L+ P Y
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL-----PLDKDYYVVREPGQSPIF 195
Query: 553 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVRE--- 606
APE + S +SDV+SFGV+L E+ T + +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255
Query: 607 ------------EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
AEV ++ M C A P RP+ +
Sbjct: 256 LLEEGQRLPAPPACPAEVHEL--------------MKL----CWAPSPQDRPSFSALGPQ 297
Query: 655 IEEVRQSDSENRPSSE 670
++ + +
Sbjct: 298 LDMLWSGSRGCETHAF 313
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 66/327 (20%), Positives = 122/327 (37%), Gaps = 60/327 (18%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 446
VL +G + Y+A S LK ++ + + + + + ++ HPN+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYA--LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 447 RAYYYSKDEK-------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
+ E+ L+ G L L + R PL +T +KI T R V
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------- 550
H+H P H ++K N+L++ + DFG ++ S SA
Sbjct: 150 QHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 551 -------YRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 600
YR PE+I+ + K D+++ G +L + + P +
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----------K 258
Query: 601 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660
+V +++ D + F ++ + MLQ P+ R ++ EVV ++E+
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSL---IRAMLQ-------VNPEERLSIAEVVHQLQEIAA 308
Query: 661 SDSENRPS-----SEENKSKDSNVQTP 682
+ + N S E+N S +
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 60/312 (19%), Positives = 115/312 (36%), Gaps = 76/312 (24%)
Query: 391 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHP 441
E LG+G++ +K V T V++K L + F + ++ ++ H
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHK 72
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
++V DE +LV ++ GSL T L N+ ++ ++++ A +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHF 128
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGLTPLMNVPATPSRSAGYR- 552
+ HGN+ A N+L+ ++ D +SD G++ + +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQE 179
Query: 553 -----APEVIETRKH-SHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL--------- 596
PE IE K+ + +D +SFG L E+ + G PL + +
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239
Query: 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
P+ AE+ ++ + C+ PD RP+ ++R +
Sbjct: 240 PKA----------AELANL--------------INN----CMDYEPDHRPSFRAIIRDLN 271
Query: 657 EVRQSDSENRPS 668
+ D R S
Sbjct: 272 SLFTPDLVPRGS 283
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 57/289 (19%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ +GKG +G V VK +K + F + ++ ++ +H N+V L
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 83
Query: 451 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ L +V +Y A GSL L R GR+ L + +K L + ++
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYR------APEVIE 558
F H ++ A NVL+++D +SDFGL ++ + APE +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGL----------TKEASSTQDTGKLPVKWTAPEALR 187
Query: 559 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVF 613
+K S KSDV+SFG+LL E+ + G+ P D+V V+ + + V+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVY 244
Query: 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662
+V M C MRP+ ++ +E ++ +
Sbjct: 245 EV--------------MKN----CWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 58/290 (20%), Positives = 114/290 (39%), Gaps = 46/290 (15%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 444
+G+G +G ++ + + V +K K + F Q+ + + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 79
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L +++ ++ + G L + L + LD + + + +A++ S
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES 134
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 559
+F H +I A NVL++ + + DFGL+ M S G + APE I
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 560 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFD 614
R+ + SDV+ FGV + E+L G P Q +D++ +++ R ++
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYS 248
Query: 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
+ M + C A P RP E+ + + + +
Sbjct: 249 L--------------MTK----CWAYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 67/304 (22%), Positives = 125/304 (41%), Gaps = 60/304 (19%)
Query: 391 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVV 444
+ LGKG++G+ + V VK+L+ RDFE+++EI+ + QH N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 105
Query: 445 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
+ YS + L+ +Y GSL L ++ +D ++ +G+ ++
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 161
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 552
+ ++ H ++ N+L+ + I DFGLT ++ P Y+
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-----PQDKEYYKVKEPGESPIF 213
Query: 553 --APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610
APE + K S SDV+SFGV+L E+ T +SP + M + Q
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------GQM 267
Query: 611 EVFDVELMRFQNIEE------------EMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEE 657
VF + + ++ E+ M + C + RP+ ++ +++
Sbjct: 268 IVFHL----IELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQ 319
Query: 658 VRQS 661
+R
Sbjct: 320 IRDQ 323
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 63/312 (20%), Positives = 114/312 (36%), Gaps = 67/312 (21%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPN 442
+ LG G++G +A + + TV VK LK + + +++++ +G H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 495
+V L L++ +Y G L L R + ++
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 496 ------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 549
A+G+A + S H ++ A N+L+ I DFGL + +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK------NDS 199
Query: 550 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 596
Y APE I ++ +SDV+S+G+ L E+ + G +P P
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKF 257
Query: 597 PRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652
+ ++ R E AE++D+ M C P RP ++V
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDI--------------MKT----CWDADPLKRPTFKQIV 299
Query: 653 RMIEEVRQSDSE 664
++IE+ +
Sbjct: 300 QLIEKQISESTN 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 67/291 (23%), Positives = 115/291 (39%), Gaps = 43/291 (14%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNVV 444
EV+G+G +G Y L + VK L + + F + I+ HPNV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 89
Query: 445 PLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
L + L V Y G L + + + L A+G+ ++
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLA 145
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYR------APE 555
S KF H ++ A N ++++ ++DFGL M + G + A E
Sbjct: 146 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614
++T+K + KSDV+SFGVLL E++T G P D+ + R
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRR--------- 250
Query: 615 VELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
L++ + + + + ML+ C +MRP+ E+V I + +
Sbjct: 251 --LLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 62/309 (20%), Positives = 111/309 (35%), Gaps = 37/309 (11%)
Query: 391 EVLGKG--SYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVP 445
V+GKG T A V V+R+ Q E+ V ++ HPN+VP
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 446 LRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
Y + D +L +V + A GS L+ ++ IL G + + +I
Sbjct: 91 ---YRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAG---Y 551
H MG + H ++KAS++LI+ D +S + V P S +
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 552 RAPEVIETRKH--SHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMV----DLPRWVQSV 603
+PEV++ KSD+YS G+ E+ G P + T+ + +P + +
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261
Query: 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR-MIEEVRQSD 662
+ + + + + + +E+ Q +
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321
Query: 663 SENRPSSEE 671
+ RPS+
Sbjct: 322 PDARPSAST 330
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 75/328 (22%), Positives = 124/328 (37%), Gaps = 71/328 (21%)
Query: 391 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 440
+ LG+G++G A T V VK LK D +ME++ +G+H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRV 489
N++ L ++ +Y + G+L L R G L + V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 490 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 549
ARG+ ++ S K H ++ A NVL+ +D I+DFGL ++
Sbjct: 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH------HID 245
Query: 550 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 596
Y+ APE + R ++H+SDV+SFGVLL E+ T G +P +++ L
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 597 PRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652
++ R T E++ +MR C VP RP ++V
Sbjct: 306 ---LKEGHRMDKPSNCTNELY--MMMR----------------DCWHAVPSQRPTFKQLV 344
Query: 653 RMIEEVRQSDSENRPS---SEENKSKDS 677
++ + S + D
Sbjct: 345 EDLDRIVALTSNQEMGYYHHHHHHDYDI 372
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 57/313 (18%), Positives = 117/313 (37%), Gaps = 54/313 (17%)
Query: 391 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 443
+VLG G++GT YK + + V +K L+E ++ + ++ V +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 444 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
L L+ G L + ++ + + + + A+G+
Sbjct: 80 CRL----LGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMN 131
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 554
++ + H ++ A NVL+ I+DFGL L+ + G + A
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 609
E I R ++H+SDV+S+GV + E++T G P ++ + ++ R T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICT 245
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 669
+V+ + M++ C D RP E++ ++ +
Sbjct: 246 IDVYMI--------------MVK----CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
Query: 670 EENKSKDSNVQTP 682
+ + +
Sbjct: 288 GDERMHLPSPTDS 300
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 63/314 (20%), Positives = 105/314 (33%), Gaps = 66/314 (21%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 442
+VLG G++G A S V VK LKE + +++++ ++G H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 495
+V L L+++Y G L L R K L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 496 -----------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544
A+G+ + H ++ A NVL+ I DFGL +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM---- 223
Query: 545 PSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRD 591
+ Y APE + ++ KSDV+S+G+LL E+ + G P P
Sbjct: 224 --SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--YPGIP 279
Query: 592 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDE 650
+ + +Q+ + + + EE+ M C A RP+
Sbjct: 280 VDANFYKLIQNGFK-----------MDQPFYATEEIYIIMQS----CWAFDSRKRPSFPN 324
Query: 651 VVRMIEEVRQSDSE 664
+ + E
Sbjct: 325 LTSFLGCQLADAEE 338
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 62/309 (20%)
Query: 391 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 440
+ LG+G++G A +E+ TV VK LK+ D +ME++ +G+H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT----- 495
N++ L ++ +Y + G+L L R G RV T
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 496 ------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 549
ARG+ ++ S K H ++ A NVL+ ++ I+DFGL +N
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN------NID 211
Query: 550 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 596
Y+ APE + R ++H+SDV+SFGVL+ E+ T G +P +++ L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 655
++ R + + N E+ M C VP RP ++V +
Sbjct: 272 ---LKEGHR-----------MDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 313
Query: 656 EEVRQSDSE 664
+ + +
Sbjct: 314 DRILTLTTN 322
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 47/286 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ +GKG +G V VK +K + F + ++ ++ +H N+V L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 255
Query: 451 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ L +V +Y A GSL L R GR+ L + +K L + ++
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEVIETRKHS 563
F H ++ A NVL+++D +SDFGLT + S + APE + +K S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFS 364
Query: 564 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELM 618
KSDV+SFG+LL E+ + G+ P D+V V+ + + V+DV
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVYDV--- 418
Query: 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
M C RP ++ +E +R +
Sbjct: 419 -----------MKN----CWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 47/297 (15%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 444
+++G G G L + V +K LK +RDF + I+G+ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNII 113
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L ++V +Y +GSL T L + G V +L G G+ ++
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSD 169
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG---YR--APEVI 557
+G + H ++ A NVL++ +L +SDFGL+ ++ + A + + G R APE I
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 558 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEV 612
R S SDV+SFGV++ E+L G+ P + T D++ V+ R +
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS---VEEGYRLPAPMGCPHAL 283
Query: 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 669
+ ML C K RP ++V +++ + +S R ++
Sbjct: 284 HQL--------------MLD----CWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 52/294 (17%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 444
+LG+G +G Y+ V E V VK K+ + K F + I+ + HP++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIV 76
Query: 445 PLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
L ++ ++ + + G L L N+ + L T V L + +A+
Sbjct: 77 KL----IGIIEEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAY 128
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEV 556
+ S+ H +I N+L+ + DFGL+ + S + +PE
Sbjct: 129 LESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 557 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAE 611
I R+ + SDV+ F V + E+L+ GK P D++ + ++ R +
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEKGDRLPKPDLCPPV 242
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665
++ + M + C P RP E+V + +V Q + +
Sbjct: 243 LYTL--------------MTR----CWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 68/310 (21%), Positives = 108/310 (34%), Gaps = 51/310 (16%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 442
LG G++G Y+ + V VK L EV + DF + I+ + H N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 94
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--RTPLDWETRVKILLGTARGVA 500
+V + ++ + A G L + L R + L + + A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLT-PLMNVPATPSRSAGYR---- 552
++ F H +I A N L+ G I DFG+ +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 553 -APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610
PE + K+D +SFGVLL E+ + G P S + ++++ V S R
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGR----- 263
Query: 611 EVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-------- 661
+ +N + + M Q C P+ RPN ++ IE Q
Sbjct: 264 ------MDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 662 DSENRPSSEE 671
E P EE
Sbjct: 314 PIEYGPLVEE 323
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 55/301 (18%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNV 443
++LG+G +G+ + L S V VK +K +F + + HPNV
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNV 98
Query: 444 VPL-----RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTAR 497
+ L + +++ + G L T L +R G + +T +K ++ A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 552
G+ ++ + F H ++ A N ++ D+ C++DFGL+ + YR
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIY------SGDYYRQGRIA 209
Query: 553 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 604
A E + R ++ KSDV++FGV + E+ T G P +M D +
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY---LLHGH 266
Query: 605 REEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
R L + ++ +E+ + M C P RP + +E++ +S
Sbjct: 267 R-----------LKQPEDCLDELYEIMYS----CWRTDPLDRPTFSVLRLQLEKLLESLP 311
Query: 664 E 664
+
Sbjct: 312 D 312
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 40/219 (18%), Positives = 69/219 (31%), Gaps = 24/219 (10%)
Query: 63 IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLR 122
+ +++DL + LR L+ S I S + + + L
Sbjct: 362 LSFSGCCSYSDLGT------------NSLRHLDLSFNGAIIMSANFMGLEELQH----LD 405
Query: 123 LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 182
L + L+ L L + L SL L + N+F
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 183 SSF---SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRH 237
S+ + L LDLS L +L L++ NNL + + L
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525
Query: 238 LNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLK 273
L+ S+N ++ S + +F NS+ C +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 31/140 (22%), Positives = 49/140 (35%), Gaps = 5/140 (3%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+ + + L+ L L + L L L L N P SFS L
Sbjct: 47 LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF--DIPKLRHLNLSYNGLK 246
L I L L L++ N + +P + ++ L H++LSYN ++
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 247 GSIPSSLQKFPNSSFVGNSL 266
+ LQ + V SL
Sbjct: 167 TITVNDLQFLRENPQVNLSL 186
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 23/121 (19%), Positives = 41/121 (33%), Gaps = 5/121 (4%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
+ + L N L ++ L++L L ++ L L L+ N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG-SIPSSLQKFP 257
P S LT L L L+ + L+ LN+++N + +P+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 258 N 258
N
Sbjct: 154 N 154
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 31/145 (21%), Positives = 48/145 (33%), Gaps = 19/145 (13%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I + L L L L N + P + L SL L + L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 190 VVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-------LNLS 241
L+++ N +P NLT L + L N + +I D+ LR L++S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNLSLDMS 189
Query: 242 YNGLKGSIPSSLQKFPNSSFVGNSL 266
N + + +F G L
Sbjct: 190 LN--------PIDFIQDQAFQGIKL 206
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 32/130 (24%), Positives = 47/130 (36%), Gaps = 8/130 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQ 188
+ L +LE L L I L +L+ L + HN K+P+ FS
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154
Query: 189 LVVLDLSFNSFTGNIPQSIQNLTQLTG----LSLQSNNLSGSIPN-FDIPKLRHLNLSYN 243
LV +DLS+N +Q L + L + N + F KL L L N
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214
Query: 244 GLKGSIPSSL 253
+I +
Sbjct: 215 FNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 27/145 (18%), Positives = 45/145 (31%), Gaps = 10/145 (6%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
L++ G +N L L L L +L L+ L + HNN
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 181 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 238
S ++ L LD SFN + L +L +N+++ I L+ +
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICE-HQKFLQWV 570
Query: 239 NLSYNGLKG------SIPSSLQKFP 257
L + P +
Sbjct: 571 KEQKQFLVNVEQMTCATPVEMNTSL 595
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-18
Identities = 22/131 (16%), Positives = 39/131 (29%), Gaps = 5/131 (3%)
Query: 132 IPNNTLGKLDAL--EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 189
+ + L + + L + L ++ + L + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKW 309
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
L + +L L L+L N S S +P L +L+LS N L S
Sbjct: 310 QSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSG 366
Query: 250 PSSLQKFPNSS 260
S +S
Sbjct: 367 CCSYSDLGTNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 23/106 (21%), Positives = 37/106 (34%), Gaps = 4/106 (3%)
Query: 155 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 214
G L I +P++ S K+P +DLSFN S N ++L
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 215 GLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
L L + + L +L L+ N ++ P S +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-16
Identities = 36/151 (23%), Positives = 55/151 (36%), Gaps = 23/151 (15%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
+ K + LS+ L P+ LP L+ L L N S P L LDLS
Sbjct: 303 VPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSR 359
Query: 197 NSFTGNIPQSIQNL--TQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSS- 252
N+ + + S +L L L L N NF + +L+HL+ ++ LK S
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 253 ----------------LQKFPNSSFVGNSLL 267
+ + F+G + L
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 22/147 (14%), Positives = 36/147 (24%), Gaps = 16/147 (10%)
Query: 128 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLR----YLYLQHNNFSGKIPS 183
+ L L + L N + +++ L L + N
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQ 199
Query: 184 SFS-PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPNFDIP-------- 233
+F +L L L N + NI + +QNL L L
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 234 --KLRHLNLSYNGLKGSIPSSLQKFPN 258
+ L+Y N
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLAN 286
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 67/313 (21%), Positives = 107/313 (34%), Gaps = 57/313 (18%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 442
LG G++G Y+ + V VK L EV + DF + I+ + H N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 135
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR--GAGRTPLDWETRVKILLGTARGVA 500
+V + ++ + A G L + L R + + L + + A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLT-PLMNVPATPSRSAGYR---- 552
++ F H +I A N L+ G I DFG+ +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 553 -APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----E 606
PE + K+D +SFGVLL E+ + G P S + ++++ V S R +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGRMDPPK 309
Query: 607 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS----- 661
V+ +M C P+ RPN ++ IE Q
Sbjct: 310 NCPGPVY--RIMT----------------QCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351
Query: 662 ---DSENRPSSEE 671
E P EE
Sbjct: 352 TALPIEYGPLVEE 364
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 61/316 (19%), Positives = 119/316 (37%), Gaps = 28/316 (8%)
Query: 370 LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ 429
+ + +D + LG G+ G +K + S V+ ++L + + Q
Sbjct: 20 FLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ 77
Query: 430 -QMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 487
E+ V P +V +YS E + ++ GSL +L + AGR P E
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP---EQ 131
Query: 488 RV-KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA-- 543
+ K+ + +G+ ++ K H ++K SN+L+N + + DFG+ L++ A
Sbjct: 132 ILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189
Query: 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD---MVDLP 597
T S Y +PE ++ +S +SD++S G+ L+EM G+ P+ P + M
Sbjct: 190 FVGTRS----YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
Query: 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM--DEVVRMI 655
+ + M + P + + E +
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
Query: 656 EEVRQSDSENRPSSEE 671
+ + R ++
Sbjct: 306 NKCLIKNPAERADLKQ 321
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 74/309 (23%), Positives = 135/309 (43%), Gaps = 54/309 (17%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 444
+V+G G +G L ++ +V +K LK +RDF + I+G+ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L ++V +Y +GSL + L + V +L G A G+ ++
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSD 165
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGYR------APEVI 557
MG + H ++ A N+LIN +L +SDFGL L + P + G + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 558 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-------LPRWVQSVVREEWT 609
RK + SDV+S+G++L E+++ G+ P + D++ LP +
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------PMDCP 276
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSENRPS 668
A ++ + ML C K + RP +++V ++++ +R S +
Sbjct: 277 AALYQL--------------MLD----CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318
Query: 669 SEENKSKDS 677
S + +
Sbjct: 319 SAAARPSNL 327
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 72/313 (23%), Positives = 128/313 (40%), Gaps = 70/313 (22%)
Query: 391 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 440
+ LG+G +G A +E+ TV VK LK+ D +ME++ +G+H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 441 PNVVPLRAYYY---SKDEKL-LVYDYFASGSLSTLLHGNR-----------GAGRTPLDW 485
N++ L ++D L ++ +Y + G+L L R + +
Sbjct: 147 KNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 486 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 545
+ V ARG+ ++ S K H ++ A NVL+ ++ I+DFGL +N
Sbjct: 203 KDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN----- 254
Query: 546 SRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDD 592
Y+ APE + R ++H+SDV+SFGVL+ E+ T G +P ++
Sbjct: 255 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEV 651
+ L ++ R + + N E+ M C VP RP ++
Sbjct: 314 LFKL---LKEGHR-----------MDKPANCTNELYMMMRD----CWHAVPSQRPTFKQL 355
Query: 652 VRMIEEVRQSDSE 664
V ++ + +
Sbjct: 356 VEDLDRILTLTTN 368
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 56/308 (18%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNV 443
+LGKG +G+ +A L V VK LK ++ +F ++ + HP+V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHV 87
Query: 444 VPL------RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTA 496
L +++ + G L L +R G L +T V+ ++ A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---- 552
G+ ++ S F H ++ A N ++ +D+ C++DFGL+ + YR
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIY------SGDYYRQGCA 198
Query: 553 --------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 603
A E + ++ SDV++FGV + E++T G+ P ++ + +
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY---LIGG 255
Query: 604 VREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662
R L + EE+ M Q C + P RP+ + +E +
Sbjct: 256 NR-----------LKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELENILGHL 300
Query: 663 SENRPSSE 670
S S +
Sbjct: 301 SVLSTSQD 308
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 43/291 (14%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 444
V+GKG +G Y + +K L + + F ++ ++ + HPNV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVL 85
Query: 445 PLRAYYYSKDE-KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
L + ++ Y G L + + + + L ARG+ ++
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLA 141
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYR------APE 555
KF H ++ A N ++++ ++DFGL + + + R A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614
++T + + KSDV+SFGVLL E+LT G P + D+ + R
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LAQGRR--------- 246
Query: 615 VELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
L + + + + Q M Q C P +RP +V +E++ +
Sbjct: 247 --LPQPEYCPDSLYQVMQQ----CWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 65/310 (20%), Positives = 108/310 (34%), Gaps = 63/310 (20%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 442
+ LG G++G +A + V VK LK K +++I+ +GQH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR---------GAGRTPLDWETRVKILL 493
+V L L++ +Y G L L + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR- 552
A+G+A + S H ++ A NVL+ I DFGL + + Y
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM------NDSNYIV 222
Query: 553 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 600
APE I ++ +SDV+S+G+LL E+ + G P P + V
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGILVNSKFYKLV 280
Query: 601 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
+ + ++ +M+ AC A P RP ++ ++
Sbjct: 281 KDGYQMAQPAFAPKNIYS--IMQ----------------ACWALEPTHRPTFQQICSFLQ 322
Query: 657 EVRQSDSENR 666
E Q D R
Sbjct: 323 EQAQEDRRER 332
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 25/149 (16%), Positives = 53/149 (35%), Gaps = 6/149 (4%)
Query: 123 LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKI 181
+ + + ++++ + N L + + + + L L +N GK+
Sbjct: 288 GEQLKDDWQALAD-APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 182 PS-SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRH 237
P+ +L L+L++N T Q+ LS N L FD +
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSA 406
Query: 238 LNLSYNGLKGSIPSSLQKFPNSSFVGNSL 266
++ SYN + + + F G ++
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 21/190 (11%), Positives = 55/190 (28%), Gaps = 11/190 (5%)
Query: 81 LLDFADAVPHLRKLNWS--STNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLG 138
L + +++V + +D + + + I +
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS-SR 180
Query: 139 KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNS 198
+ SN +T + + L LR Y+ ++ F + + +
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA---WENENSEYAQ 236
Query: 199 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG--SIPSSLQ 254
NL LT + + + +P +P+++ +N++ N + Q
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296
Query: 255 KFPNSSFVGN 264
++
Sbjct: 297 ALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 28/147 (19%), Positives = 49/147 (33%), Gaps = 21/147 (14%)
Query: 132 IPNNT-LGKLDALEVLSLRSNVLTG-------GLPSEITSLPSLRYLYLQHNNFSGKIPS 183
IPN + + + N + L ++ + L +N S
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 184 SFS--PQLVVLDLSFNSFTG-------NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 232
FS L ++L N T + ++ +N LT + L+ N L+ +F
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT 511
Query: 233 -PKLRHLNLSYNGLKGSIPSSLQKFPN 258
P L ++LSYN P+
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSST 537
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 13/138 (9%)
Query: 134 NNTLGKLDALEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
N L + LR N LT L + T+LP L + L +N+FS P+ L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 190 VVL------DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 243
D N P+ I LT L + SN++ + P + L++ N
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDN 597
Query: 244 GLKGSIPSSLQKFPNSSF 261
S + + +
Sbjct: 598 PNISIDLSYVCPYIEAGM 615
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 34/154 (22%), Positives = 55/154 (35%), Gaps = 19/154 (12%)
Query: 128 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITS-LPSLRYLYLQHNNFSGKIPSSFS 186
L G +P G L L+L N +T +P+ + L HN IP+ F
Sbjct: 342 LEGKLP--AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397
Query: 187 ----PQLVVLDLSFNSFTG-------NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIP 233
+ +D S+N + + ++ ++L +N +S
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 234 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 267
L +NL N L IP + K N +F LL
Sbjct: 458 PLSSINLMGNMLTE-IPKNSLKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 26/143 (18%), Positives = 52/143 (36%), Gaps = 22/143 (15%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFSP-- 187
IP N G + +E LS N L +P+ + S+ + + +N +F P
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 188 -------QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---------D 231
+ ++LS N + + + L+ ++L N L+ N +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 232 IPKLRHLNLSYNGLKGSIPSSLQ 254
L ++L +N L + +
Sbjct: 487 TYLLTSIDLRFNKLT-KLSDDFR 508
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-24
Identities = 19/152 (12%), Positives = 49/152 (32%), Gaps = 33/152 (21%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGG-------------------LPSEITSLPSLRYLYL 172
+ + +L L + ++ + +L L + +
Sbjct: 198 VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 173 QHNNFSGKIPSSFS--PQLVVLDLSFNSFT--------GNIPQSIQNLTQLTGLSLQSNN 222
+ K+P+ P++ +++++ N ++ + + NN
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 223 L-SGSIPN--FDIPKLRHLNLSYNGLKGSIPS 251
L + + + KL L YN L+G +P+
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-21
Identities = 19/139 (13%), Positives = 36/139 (25%), Gaps = 11/139 (7%)
Query: 130 GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQ- 188
G P +L + LSL +G +P I L L L L +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 189 -----LVVLDLSFNSFTGNIPQSI--QNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLN 239
+ ++ + L + S+ SI K +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 240 LSYNGLKGSIPSSLQKFPN 258
N + + ++ +
Sbjct: 190 QLSNNI-TFVSKAVMRLTK 207
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 20/110 (18%), Positives = 32/110 (29%), Gaps = 9/110 (8%)
Query: 132 IPNNTLGKLDALEVLSLR------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF 185
P L+ +R N P IT PSL L + N+ +
Sbjct: 528 FPTQ-PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
Query: 186 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKL 235
+P + VLD+ N + + L + I D +
Sbjct: 586 TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-DIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 15/92 (16%), Positives = 30/92 (32%), Gaps = 6/92 (6%)
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP------KLRHLNLS 241
++ L L +G +P +I LT+L L+L S+ + F
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 242 YNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 273
+ + + S + + + P K
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 67/308 (21%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNV 443
LG+G++G + A ++ V VK LKE ++DF+++ E++ + QH ++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHI 105
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR----------GAGRTPLDWETRVKILL 493
V L+V++Y G L+ L + PL + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR- 552
A G+ ++ + F H ++ N L+ Q L I DFG++ + + YR
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY------STDYYRV 216
Query: 553 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 600
PE I RK + +SDV+SFGV+L E+ T GK P + + +D +
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC---I 273
Query: 601 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
EV+ +MR C + P R ++ +V ++
Sbjct: 274 TQGRELERPRACPPEVY--AIMR----------------GCWQREPQQRHSIKDVHARLQ 315
Query: 657 EVRQSDSE 664
+ Q+
Sbjct: 316 ALAQAPPV 323
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 49/291 (16%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 444
EV+G+G +G Y L + VK L + F + I+ HPNV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 153
Query: 445 PLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
L + L V Y G L + + + L A+G+ +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLA 209
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 555
S KF H ++ A N ++++ ++DFGL M + +++ + A E
Sbjct: 210 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA 610
++T+K + KSDV+SFGVLL E++T G P D+ + R E
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQPEYCPD 323
Query: 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
+++V ML+ C +MRP+ E+V I + +
Sbjct: 324 PLYEV--------------MLK----CWHPKAEMRPSFSELVSRISAIFST 356
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 69/303 (22%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 391 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 443
+V+G G +G YK +L ++ V +K LK + DF + I+G+ H N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 108
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ L +++ +Y +G+L L G V +L G A G+ ++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA 164
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGYR------APEV 556
+M + H ++ A N+L+N +L +SDFGL+ L + P ++G + APE
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 557 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAE 611
I RK + SDV+SFG+++ E++T G+ P + +++ + R + +
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---INDGFRLPTPMDCPSA 278
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSENRPSSE 670
++ + M+Q C + RP ++V ++++ +R DS +
Sbjct: 279 IYQL--------------MMQ----CWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320
Query: 671 ENK 673
+ +
Sbjct: 321 DPR 323
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 392 VLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 446
LGKG +G Y A ++S ++ +K L + + K E Q+ EI + +HPN++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRL 74
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
Y++ L+ +Y G++ L + + + T + A +++ HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTA-TYITELANALSYCHSKR 129
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETR 560
H +IK N+L+ + I+DFG + V A SR + Y PE+IE R
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 600
H K D++S GVL E L GK P ++ T + P +V
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 43/210 (20%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
+VLG G+ GT + ++ V VKR L E +++++++ +HPNV+
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCT 86
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ + + + + +L + + L+ + +L T G+AH+HS+
Sbjct: 87 EKDRQFQYIAIEL-CAATLQEYVE-QKDFAHLGLE---PITLLQQTTSGLAHLHSLN--- 138
Query: 510 FTHGNIKASNVLI-----NQDLDGCISDFGL-------TPLMNVPATPSRSAGYRAPEVI 557
H ++K N+LI + + ISDFGL + + + G+ APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 558 E---TRKHSHKSDVYSFGVLLLEMLTGKAP 584
++ D++S G + +++ +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 61/303 (20%), Positives = 116/303 (38%), Gaps = 57/303 (18%)
Query: 393 LGKGSYGTAYKAVL---EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
LG G++G+ + V ++ V +K LK+ + ++ +I+ ++ +P +V L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLI 76
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ +LV + G L L G R + ++L + G+ ++
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------------APE 555
F H ++ A NVL+ ISDFGL+ + + + Y APE
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKAL-----GADDSYYTARSAGKWPLKWYAPE 183
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA 610
I RK S +SDV+S+GV + E L+ G+ P + +++ ++ R E
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECPPECPP 240
Query: 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSE 670
E++ + M C + RP+ V + + S +
Sbjct: 241 ELYAL--------------MSD----CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282
Query: 671 ENK 673
+
Sbjct: 283 HHH 285
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 25/154 (16%), Positives = 58/154 (37%), Gaps = 9/154 (5%)
Query: 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN 176
+ + + PI ++ L + + +N +T + I L L+ +Y ++
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRITF-ISKAIQRLTKLQIIYFANSP 459
Query: 177 FSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPK 234
F+ + + + N S NL LT + L + +P+ +D+P+
Sbjct: 460 FTYDNIAVD---WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
Query: 235 LRHLNLSYNGLKG--SIPSSLQKFPNSSFVGNSL 266
L+ LN++ N + + + + G +
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 27/147 (18%), Positives = 48/147 (32%), Gaps = 18/147 (12%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG- 179
+ L L + L + LP + LP L+ L + N
Sbjct: 472 ANSDYAKQYENEEL-SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 180 --------KIPSSFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSI 227
++ P++ + + +N+ P S +Q + +L L N + +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HL 588
Query: 228 PNF-DIPKLRHLNLSYNGLKGSIPSSL 253
F KL L L YN ++ IP
Sbjct: 589 EAFGTNVKLTDLKLDYNQIE-EIPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-23
Identities = 31/154 (20%), Positives = 51/154 (33%), Gaps = 18/154 (11%)
Query: 134 NNTLGKLDALEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+ L + LR N LT L + T+LP L + + +N FS P+ QL
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL 778
Query: 190 VVLDLSF------NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 243
+ N P I L L + SN++ + P+L L+++ N
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADN 837
Query: 244 GLK-GSIPSSLQKFPNSSFV----GNSLLCGPPL 272
+ S +V + G
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 23/142 (16%), Positives = 49/142 (34%), Gaps = 22/142 (15%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFSP-- 187
IP + D +E L N L +P+ S+ + + +N + +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 188 -----QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN----------FDI 232
+ LS+N + + ++ + L +N ++ SIP +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNT 727
Query: 233 PKLRHLNLSYNGLKGSIPSSLQ 254
L ++L +N L S+ +
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFR 748
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 6e-21
Identities = 26/144 (18%), Positives = 46/144 (31%), Gaps = 15/144 (10%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS----PQLV 190
G L L L N + +P + + L HN IP+ F+ +
Sbjct: 590 AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMG 647
Query: 191 VLDLSFNSFTGNIPQ-----SIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYN 243
+D S+N + ++L N + + + LS N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 244 GLKGSIPSSLQKFPNSSFVGNSLL 267
+ SIP + K + ++ LL
Sbjct: 708 LM-TSIPENSLKPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 25/146 (17%), Positives = 47/146 (32%), Gaps = 21/146 (14%)
Query: 132 IPNNT-LGKLDALEVLSLRSNVLTGGLPSEITS------LPSLRYLYLQHNNFSGKIPSS 184
IPN + + + N + I+ + + L +N
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 185 FS--PQLVVLDLSFNSFT-------GNIPQSIQNLTQLTGLSLQSNNLSG---SIPNFDI 232
F+ + + LS N T + +N LT + L+ N L+ +
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTL 752
Query: 233 PKLRHLNLSYNGLKGSIPSSLQKFPN 258
P L ++++SYN S P+
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQ 777
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 23/136 (16%), Positives = 44/136 (32%), Gaps = 12/136 (8%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSE--ITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 190
+ +++ + N L P+ + + L L HN +F +L
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLT 598
Query: 191 VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYNGLK 246
L L +N IP+ Q+ GL N L F+ + ++ SYN +
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 247 GSIPSSLQKFPNSSFV 262
+ + +
Sbjct: 658 SEGRNISCSMDDYKGI 673
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 39/250 (15%), Positives = 69/250 (27%), Gaps = 69/250 (27%)
Query: 76 SDRQALLDFADAV-------------PHLRKLNWSSTNPICQ--SWVGINCTQDRTRVFG 120
D +AL +A+ + LNW+ + G++ + RV G
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL-DNNGRVTG 327
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS--------------------- 159
L L G G G +P+ +G+L L+VLS ++ T
Sbjct: 328 LSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386
Query: 160 ----EITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN------IPQSIQN 209
+ L L + + + + L I ++IQ
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQR 446
Query: 210 LTQLTGLSLQSNNLSGSIPNFDI---------------------PKLRHLNLSYNGLKGS 248
LT+L + ++ + D L + L
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 249 IPSSLQKFPN 258
+P L P
Sbjct: 507 LPDFLYDLPE 516
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 20/100 (20%), Positives = 36/100 (36%), Gaps = 10/100 (10%)
Query: 132 IPNNTLGKLDALEVLSLR------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF 185
P L+ +R N + P+ IT+ PSL L + N+ K+
Sbjct: 768 FPT-QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825
Query: 186 SPQLVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLS 224
+PQL +LD++ N ++ + L +
Sbjct: 826 TPQLYILDIADNPNISIDVTSVCPYIEAGM-YVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 12/95 (12%)
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH---------L 238
++ L L+ G +P +I LT+L LS +++ + S F +L +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 239 NLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 273
+ Y + L S + +++ P +K
Sbjct: 384 RMHYKKMFLDYDQRLNL---SDLLQDAINRNPEMK 415
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 62/297 (20%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVK--RLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
+ LG+G +G ++A + +K RL + + ++++ + ++ +HP +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIV--- 66
Query: 448 AYYYS------------KDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 492
Y+ + K+ +Y +L ++G + + I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIF 124
Query: 493 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNV 541
L A V +HS H ++K SN+ D + DFGL T L +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 542 PATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
PA + Y +PE I +SHK D++S G++L E+L P T+ + V
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS--TQMERVRT 236
Query: 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+ VR +F + + + ML P RP ++
Sbjct: 237 ----LTDVRNLKFPPLFTQKYPCEYVM---VQDMLS-------PSPMERPEAINIIE 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 36/266 (13%), Positives = 83/266 (31%), Gaps = 54/266 (20%)
Query: 391 EVLGKGSYGTAYKAV---------------LEESTTVVVKRLKEVVVGKRDFEQ------ 429
VLG+ +A E + +K++KE V+ R
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 430 --------QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY-FASGSLSTLLH--GNRGA 478
+ + Q ++ +R + Y +L T + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 479 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538
L R+++ L R +A +H G H ++ +++++Q ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 539 MNVPATPSRSAGYRAPEVIETR-----------KHSHKSDVYSFGVLLLEMLTGKAPLQS 587
S S G+ PE+ R + D ++ G+++ + P+
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 588 PTRDDMV--------DLPRWVQSVVR 605
++P+ V++++
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVRALLE 341
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 392 VLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 446
LGKG +G Y A +++ ++ +K L + + K E Q+ EI + +HPN++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRM 79
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
Y++ + L+ ++ G L L + GR + + + A + + H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFMEE-LADALHYCHERK 134
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 558
H +IK N+L+ + I+DFG + P+ T Y PE+IE
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLD----YLPPEMIE 185
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 605
+ H K D++ GVL E L G P SP+ + + P ++ +
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 61/275 (22%), Positives = 103/275 (37%), Gaps = 46/275 (16%)
Query: 336 GSNGVSKGKASSGGRSEKPKEEFGSGVQEP----------EKNKLVFFEGCSYNFDLEDL 385
GS VS G+A S K + +Q + + Y ++ +
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 386 LRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNV 443
+G+GS+G ++ + VK V F + E+ P +
Sbjct: 61 THQ--PRVGRGSFGEVHRMKDKQTGFQCAVK-----KVRLEVFRVE-ELVACAGLSSPRI 112
Query: 444 VPLRAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGV 499
VP Y + + ++ + GSL L+ + G P E R LG G+
Sbjct: 113 VP---LYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGL 163
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFG----LTPLMNVPATPSRSA--G-- 550
++H+ HG++KA NVL++ D + DFG L P + + G
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 551 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ APEV+ + K D++S ++L ML G P
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 67/303 (22%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 442
E LG+ +G YK L E++ V +K LK+ G + +F + + R QHPN
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR-LQHPN 73
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 491
VV L +++ Y + G L L ++ L+ V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY 551
+ A G+ ++ S H ++ NVL+ L+ ISD GL + + Y
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY------AADYY 184
Query: 552 R------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 598
+ APE I K S SD++S+GV+L E+ + G P + D+V++
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM-- 242
Query: 599 WVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
+++ ++ A V+ + M++ C + P RP ++
Sbjct: 243 -IRNRQVLPCPDDCPAWVYAL--------------MIE----CWNEFPSRRPRFKDIHSR 283
Query: 655 IEE 657
+
Sbjct: 284 LRA 286
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 65/300 (21%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNV 443
LG+G++G + A ++ V VK LK+ + ++DF+++ E++ + QH ++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHI 79
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKIL 492
V D ++V++Y G L+ L + +D + R + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 493 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGY 551
A G+ ++ S F H ++ N L+ +L I DFG++ + +
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 552 ---R--APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 605
R PE I RK + +SDV+SFGV+L E+ T GK P + ++++ +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---ITQGRV 253
Query: 606 ----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
EV+D +M C + P R N+ E+ +++ + ++
Sbjct: 254 LERPRVCPKEVYD--VML----------------GCWQREPQQRLNIKEIYKILHALGKA 295
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 35/298 (11%)
Query: 367 KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKR 425
KL ++F EDL +G+G+YG+ K V + S ++ VKR++ V ++
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEK 62
Query: 426 DFEQ-QME--IVGRVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAG 479
+ +Q M+ +V R P +V +Y ++ + + + S
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYIV---QFYGALFREGDCWICMELMS-TSFDKFYKYVYSVL 118
Query: 480 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539
+ E KI L T + + H+ K H +IK SN+L+++ + + DFG++ +
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 540 NVPATPSRSAG---YRAPEVIETRKH----SHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592
+R AG Y APE I+ +SDV+S G+ L E+ TG+ P P +
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNS 234
Query: 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 650
+ D + VV+ + ++ + E F V C+ K RP E
Sbjct: 235 VFDQ---LTQVVKGD-PPQLSNSEEREFSPSFINFVN------LCLTKDESKRPKYKE 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 39/317 (12%), Positives = 75/317 (23%), Gaps = 50/317 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-------------- 433
E L G + E +K R +++
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 434 -----------VGRVGQHPNVVPLRAYY--YSKDEKLLVYDYFASGSLSTLLH--GNRGA 478
V P L Y+ LL+ AS L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186
Query: 479 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TP 537
R + R A++ S G HG+ N+ I D + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 538 LMNVPATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+ S Y E + +H + + G+ + + P T
Sbjct: 244 VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM- 654
R V + + + + + ++ + R E +
Sbjct: 304 WKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAMETP 354
Query: 655 -IEEVRQSDSENRPSSE 670
+++ S + + +
Sbjct: 355 EFLQLQNEISSSLSTGQ 371
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKR--LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E +GKGS+G +K + + VV +K L+E D +Q++ ++ + P V
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVT--- 83
Query: 448 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
YY Y KD KL ++ +Y GS LL PLD IL +G+ ++HS
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS 137
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 554
H +IKA+NVL+++ + ++DFG V + + R AP
Sbjct: 138 EK---KIHRDIKAANVLLSEHGEVKLADFG------VAGQLTDTQIKRNTFVGTPFWMAP 188
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
EVI+ + K+D++S G+ +E+ G+ P
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPH 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 447
EV+G G+ A + V +KR+ + + ++ EI HPN+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIV--- 76
Query: 448 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRT---PLDWETRVKILLGTARGVAH 501
+YY + ++L LV + GS+ ++ G LD T IL G+ +
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRS--AG---YR 552
+H G H ++KA N+L+ +D I+DFG L ++ R G +
Sbjct: 137 LHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 553 APEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 585
APEV+E + + K+D++SFG+ +E+ TG AP
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 30/149 (20%), Positives = 46/149 (30%), Gaps = 9/149 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I N T +L L L L + S L L L N ++ S L
Sbjct: 48 IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG 247
L + + N L L L SN++S F KL+ L+ N +
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 248 SIPSSLQKFPNSSFV-----GNSLLCGPP 271
+ ++ + GN + P
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEP 196
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 36/155 (23%), Positives = 59/155 (38%), Gaps = 9/155 (5%)
Query: 128 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 186
L + L L+VL+L ++L LP+L++L LQ N+F +
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 187 ----PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIPKLRHLNLS 241
+L +L LSF + + +L + + L N L+ S K +LNL+
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLA 531
Query: 242 YNGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLK 273
N + +PS L + N L C
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 29/135 (21%), Positives = 51/135 (37%), Gaps = 8/135 (5%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSGKIPSSFS---- 186
+ + +L LS++ N L + + +L +LR L L H++ +
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYN 243
L L+LS+N ++ + QL L L L ++ L+ LNLS++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 244 GLKGSIPSSLQKFPN 258
L S P
Sbjct: 436 LLDISSEQLFDGLPA 450
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 21/120 (17%), Positives = 33/120 (27%), Gaps = 4/120 (3%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
E L NVL + + L +L +L L +F +L L L+ N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
++ L L +S + L L L N +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 30/136 (22%), Positives = 41/136 (30%), Gaps = 8/136 (5%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SP 187
N L L L+ L+L N P L L L K S
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSY 242
L VL+LS + + Q L L L+LQ N+ + +L L LS+
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 243 NGLKGSIPSSLQKFPN 258
L +
Sbjct: 486 CDLSSIDQHAFTSLKM 501
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 38/212 (17%), Positives = 65/212 (30%), Gaps = 21/212 (9%)
Query: 61 CVIVSLLPLAFADLNSDRQALLDF-----------ADAVPHLRKLNWSSTNPICQSWVGI 109
I L + L L+ A + LN+
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG-TQNLLVIFKG 221
Query: 110 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDA--LEVLSLRSNVLTGGLPSEITSLPSL 167
++ + I L +E ++L+ + + L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDED-ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280
Query: 168 RYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
+ L L + S ++PS L L LS N F S N LT LS++ N
Sbjct: 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
Query: 226 SIPNFDI---PKLRHLNLSYNGLKGSIPSSLQ 254
+ + LR L+LS++ ++ S +LQ
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-21
Identities = 30/141 (21%), Positives = 47/141 (33%), Gaps = 5/141 (3%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+ L AL+ L ++ + + +L LYL N+ S +L
Sbjct: 96 MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKL 155
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ-SNNLSGSIPN--FDIPKLRHLNLSYNGLK 246
VLD N+ + + +L Q T LSL + N I FD + LN
Sbjct: 156 KVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL 215
Query: 247 GSIPSSLQKFPNSSFVGNSLL 267
I L+ S +
Sbjct: 216 LVIFKGLKNSTIQSLWLGTFE 236
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 28/150 (18%), Positives = 48/150 (32%), Gaps = 12/150 (8%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I +T L+ L L +N L + ++ +L++L+ S L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-----LNLSYNG 244
L L N + +L L Q+N + + D+ L+ LNL+ N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGND 190
Query: 245 LKGSIPSSLQKFPNS---SFVGNSLLCGPP 271
+ I +F G L
Sbjct: 191 IA-GIEPGAFDSAVFQSLNFGGTQNLLVIF 219
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 25/137 (18%), Positives = 38/137 (27%), Gaps = 9/137 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---- 187
I L LE L L SN ++ + L+ L Q+N S
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP----NFDIPKLRHLNLSYN 243
+ L+L+ N G I + L+ I N I L
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 244 GLKGSIPSSLQKFPNSS 260
+ P+ + S
Sbjct: 239 DDEDISPAVFEGLCEMS 255
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-19
Identities = 21/131 (16%), Positives = 45/131 (34%), Gaps = 9/131 (6%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSSFSP----QL 189
+ L+ + + +++ SL + + P+ F +
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG 247
++L + F + + L L L + +LS +P+ + L+ L LS N +
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315
Query: 248 SIPSSLQKFPN 258
S FP+
Sbjct: 316 LCQISASNFPS 326
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 32/145 (22%), Positives = 56/145 (38%), Gaps = 12/145 (8%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QL 189
N+L L LE+L L L+ TSL + ++ L HN + + S +
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG-- 247
+ L+L+ N + +P + L+Q ++L+ N L + N I L + L+
Sbjct: 526 IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN--IYFLEWYKENMQKLEDTE 583
Query: 248 ----SIPSSLQKFPNSSFVGNSLLC 268
P L+ +L C
Sbjct: 584 DTLCENPPLLR---GVRLSDVTLSC 605
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 3/93 (3%)
Query: 168 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 227
+ ++ + +IP + L+ SFN + L LT L L +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 228 PNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ +L L L+ N L ++L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 31/213 (14%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPN 442
E LG GS+G + ++ +V VK LK V+ DF +++ + + H N
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 82
Query: 443 VVPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
++ L Y +V + GSL L ++G T + + A G+
Sbjct: 83 LIRL----YGVVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGM 134
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------- 552
++ S F H ++ A N+L+ I DFGL + +R
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
APE ++TR SH SD + FGV L EM T G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 32/265 (12%), Positives = 77/265 (29%), Gaps = 53/265 (20%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQME----------------- 432
VLG+ +A +E+ + V + +QM+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 433 -----------IVGRVGQHPNVVPLRAYYYSKDEKLLVYDY-FASGSLSTLLH--GNRGA 478
+ + Q ++ +R + Y +L T + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 479 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538
L R+++ L R +A +H G H ++ +++++Q ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 539 MNVPATPSRSAGYRAPEVI----------ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 588
A G+ PE + D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 589 TRDDMV--------DLPRWVQSVVR 605
++P+ V++++
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLE 345
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVL---EESTTVVVKRLKE---VVVGKRDFEQQMEIVGRV 437
LL + LG G++GT K + TV VK LK K + + ++ ++
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 497
+P +V + + +LV + G L+ L NR + + ++++ +
Sbjct: 76 -DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSM 128
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 552
G+ ++ F H ++ A NVL+ ISDFGL+ + + Y+
Sbjct: 129 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-----RADENYYKAQTHG 180
Query: 553 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
APE I K S KSDV+SFGVL+ E + G+ P
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK-RDFEQQMEIVGRVGQHPNVVPLRA 448
VLGKG+YG Y L + +K + E + +++ + + +H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIV---Q 83
Query: 449 YY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVA 500
Y +S++ + ++ + GSLS LL G + D E + IL G+
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK---DNEQTIGFYTKQIL----EGLK 136
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFG----LTPLMNVPATPSRSAGYRAP 554
++H H +IK NVLIN G + SDFG L + T + + Y AP
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
Query: 555 EVIE--TRKHSHKSDVYSFGVLLLEMLTGKAP 584
E+I+ R + +D++S G ++EM TGK P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 58/283 (20%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 446
LGKG + ++ ++ V K + + ++ K ++M EI + R H +VV
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
++ D +V + SL L + E R L G ++H
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEP-EAR-YYLRQIVLGCQYLHRNR 135
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 558
H ++K N+ +N+DL+ I DFGL + TP+ Y APEV+
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPEVLS 188
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTA 610
+ HS + DV+S G ++ +L GK P ++ + +P+ + V
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----- 243
Query: 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
L++ +MLQ P RP ++E++
Sbjct: 244 -----SLIQ---------KMLQ-------TDPTARPTINELLN 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 383 EDLLRASAEVLGKGSYGTAYKAVLE---ESTTVVVKRLKE--VVVGKRDFEQQMEIVGRV 437
D L + LG G++G+ + V + V +K LK+ + ++ +I+ ++
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 497
+P +V L + +LV + G L L G R + ++L +
Sbjct: 394 -DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSM 447
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAG----- 550
G+ ++ F H N+ A NVL+ ISDFGL+ + +RSAG
Sbjct: 448 GMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 584
+ APE I RK S +SDV+S+GV + E L+ G+ P
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 58/283 (20%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 446
LGKG + ++ ++ V K + + ++ K ++M EI + R H +VV
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
++ D +V + SL L + + E R L G ++H
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALT-EPEAR-YYLRQIVLGCQYLHRNR 161
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 558
H ++K N+ +N+DL+ I DFGL + TP+ Y APEV+
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPEVLS 214
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTA 610
+ HS + DV+S G ++ +L GK P ++ + +P+ + V
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----- 269
Query: 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
L++ +MLQ P RP ++E++
Sbjct: 270 -----SLIQ---------KMLQ-------TDPTARPTINELLN 291
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 47/245 (19%), Positives = 102/245 (41%), Gaps = 28/245 (11%)
Query: 359 GSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 418
GS ++ + G Y ++ DL +G G+ G +K ++ V+ +
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQM 58
Query: 419 EVVVGKRDFEQ-QME--IVGRVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLL 472
K + ++ M+ +V + P +V + + + + + + + +
Sbjct: 59 RRSGNKEENKRILMDLDVVLKSHDCPYIV---QCFGTFITNTDVFIAMELMGTCAEKLKK 115
Query: 473 HGNRGAGRTPLDWETRV-KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 531
R G P E + K+ + + + ++ H ++K SN+L+++ +
Sbjct: 116 ---RMQGPIP---ERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLC 167
Query: 532 DFGLTPLMNVPATPSRSAG---YRAPEVIETRK-----HSHKSDVYSFGVLLLEMLTGKA 583
DFG++ + RSAG Y APE I+ + ++DV+S G+ L+E+ TG+
Sbjct: 168 DFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
Query: 584 PLQSP 588
P ++
Sbjct: 228 PYKNC 232
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 59/282 (20%), Positives = 118/282 (41%), Gaps = 59/282 (20%)
Query: 393 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPLRA 448
LGKGS+ Y+A + V +K + + + K Q++ E+ + +HP+++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD-WETRVKILLGTARGVAHIHSMGG 507
Y+ + LV + +G ++ L P E R + G+ ++HS G
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEAR-HFMHQIITGMLYLHSHG- 132
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIET 559
H ++ SN+L+ ++++ I+DFGL + +P TP+ Y +PE+
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN----YISPEIATR 186
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTAE 611
H +SDV+S G + +L G+ P + T + ++P ++ +
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK------ 240
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+L+ Q+L+ + P R ++ V+
Sbjct: 241 ----DLIH---------QLLR-------RNPADRLSLSSVLD 262
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 69/313 (22%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 442
+ LG+G +G KA TTV VK LKE RD + ++ +V HP+
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPH 87
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 495
V+ L LL+ +Y GSL L +R G L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 496 ------------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543
++G+ ++ M K H ++ A N+L+ + ISDFGL+ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVY--- 201
Query: 544 TPSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR 590
Y A E + ++ +SDV+SFGVLL E++T G P
Sbjct: 202 ---EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 591 DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMD 649
+ + +L +++ R + R N EEM + MLQ C + PD RP
Sbjct: 259 ERLFNL---LKTGHR-----------MERPDNCSEEMYRLMLQ----CWKQEPDKRPVFA 300
Query: 650 EVVRMIEEVRQSD 662
++ + +E++
Sbjct: 301 DISKDLEKMMVKR 313
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 68/323 (21%), Positives = 127/323 (39%), Gaps = 83/323 (25%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPN 442
+G+G++G ++A E T V VK LKE + DF+++ ++ +PN
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 111
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-------------------GAGRTPL 483
+V L L+++Y A G L+ L G PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 484 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543
++ I A G+A++ KF H ++ N L+ +++ I+DFGL
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL-------- 220
Query: 544 TPSRSAG----YR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQ 586
SR+ Y+ PE I +++ +SDV+++GV+L E+ + G P
Sbjct: 221 --SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 587 SPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 642
++++ V+ E E+++ LMR C +K+P
Sbjct: 279 GMAHEEVIYY---VRDGNILACPENCPLELYN--LMR----------------LCWSKLP 317
Query: 643 DMRPNMDEVVRMIEEVRQSDSEN 665
RP+ + R+++ + +
Sbjct: 318 ADRPSFCSIHRILQRMCERAEGT 340
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 447
E +G+G+ GT Y A+ + V ++++ + + E EI V R ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIV--- 80
Query: 448 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
Y Y ++L +V +Y A GSL+ ++ T +D + + + +HS
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGY-RAPE 555
H +IK+ N+L+ D ++DFG +TP + + TP Y APE
Sbjct: 135 NQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-----YWMAPE 186
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
V+ + + K D++S G++ +EM+ G+ P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 65/288 (22%), Positives = 108/288 (37%), Gaps = 39/288 (13%)
Query: 377 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QME-- 432
S +DL LG+G+YG K S ++ VKR++ V ++ ++ M+
Sbjct: 1 SMEVKADDLEPI--MELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLD 57
Query: 433 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 492
I R P V + + + + + + P D KI
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG--KIA 115
Query: 493 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-- 550
+ + + H+HS H ++K SNVLIN + DFG++ + AG
Sbjct: 116 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCK 173
Query: 551 -YRAPEVIETRKH----SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 605
Y APE I + S KSD++S G+ ++E+ + P D + ++ VV
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY-----DSWGTPFQQLKQVVE 228
Query: 606 EE---WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 650
E A+ F E + F + C+ K RP E
Sbjct: 229 EPSPQLPADKFSAEFVDFTS-------------QCLKKNSKERPTYPE 263
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 7/134 (5%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SP 187
+ + +L+ L L N + + S L L +L QH+N S
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 244
L+ LD+S L+ L L + N+ + F + L L+LS
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 245 LKGSIPSSLQKFPN 258
L+ P++ +
Sbjct: 482 LEQLSPTAFNSLSS 495
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 32/130 (24%), Positives = 48/130 (36%), Gaps = 8/130 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF-SGKIPSSFS--PQ 188
+ L +L+ L L I L +L+ L + HN S K+P FS
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 189 LVVLDLSFNSFTGNIPQSIQNLTQLTG----LSLQSNNLSGSIPN-FDIPKLRHLNLSYN 243
L LDLS N ++ L Q+ L L N ++ P F +L L L N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 244 GLKGSIPSSL 253
++ +
Sbjct: 211 FDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 39/152 (25%), Positives = 60/152 (39%), Gaps = 14/152 (9%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEIT--SLPSLRYLYLQHNNFSGKIPSSFS--P 187
+ +N LG L+ LE L + + L + SL +L YL + H + F+
Sbjct: 388 MSSNFLG-LEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
L VL ++ NSF N I L LT L L L + F+ + L+ LN++ N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASN 504
Query: 244 GLKGSIPSSLQKFPNSSFV---GNSLLCGPPL 272
LK + + + N C P
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-18
Identities = 34/146 (23%), Positives = 49/146 (33%), Gaps = 21/146 (14%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
I + L L L L N + L + L SL+ L N +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 189 LVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-------LNL 240
L L+++ N +P+ NLT L L L SN + SI D+ L L+L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDL 184
Query: 241 SYNGLKGSIPSSLQKFPNSSFVGNSL 266
S N + +F L
Sbjct: 185 SLN--------PMNFIQPGAFKEIRL 202
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 24/121 (19%), Positives = 40/121 (33%), Gaps = 5/121 (4%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
+ L L N L S P L+ L L ++ L L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLK-GSIPSSLQKFP 257
+ L+ L L NL+ + L+ LN+++N ++ +P
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 258 N 258
N
Sbjct: 150 N 150
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 29/140 (20%), Positives = 47/140 (33%), Gaps = 12/140 (8%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTG---GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 187
+ L L L + R L + L ++ L S++
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 247
L+L F +++L +LT SN + D+P L L+LS NGL
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGNAFSEVDLPSLEFLDLSRNGL-- 359
Query: 248 SIPSSLQKFPNSSFVGNSLL 267
S + + S G + L
Sbjct: 360 ----SFKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 172 LQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 229
NF KIP + LDLSFN S + +L L L + +I +
Sbjct: 14 CMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA 71
Query: 230 FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ + L L L+ N ++ + +
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 25/156 (16%), Positives = 42/156 (26%), Gaps = 13/156 (8%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQ------HNNFSGKIPSS 184
I ++ L L+LR+N + + I L L L N S+
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 185 FS--PQLVVLDLSFNS---FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 239
L + + + +I LT ++ SL S + +HL
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 240 LSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKAC 275
L L+ +F N
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 38/225 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
++LG GS GT + V VKR L + +++++ HPNV+
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCS 77
Query: 450 YYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ + + + +L L+ + +L A GVAH+HS+
Sbjct: 78 ETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135
Query: 508 PKFTHGNIKASNVLINQDLDGC-------------ISDFGL--------TPLMNVPATPS 546
H ++K N+L++ ISDFGL + PS
Sbjct: 136 --IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 547 RSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAP 584
++G+RAPE++E R+ + D++S G + +L+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 28/207 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAY 449
E LG+GSYG+ YKA+ +E+ +V +K+V V E EI + + P+VV Y
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVA--IKQVPVESDLQEIIKEISIMQQCDSPHVV---KY 89
Query: 450 Y--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
Y Y K+ L +V +Y +GS+S ++ L + IL T +G+ ++H M
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMR 145
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGYRAPEVIE 558
H +IKA N+L+N + ++DFG LT M V TP + APEVI+
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF----WMAPEVIQ 198
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPL 585
++ +D++S G+ +EM GK P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 31/151 (20%), Positives = 52/151 (34%), Gaps = 9/151 (5%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 190
+ + G ++ L L+ N + S +L +L LQ+N +L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLK 194
Query: 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGS 248
LDLS N + Q+ +T +SL++N L I L H +L NG
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 249 IPSSLQKFPN--SSFVGNSL--LCGPPLKAC 275
+ ++ L G + C
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 19/127 (14%), Positives = 38/127 (29%), Gaps = 6/127 (4%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 191
+ ++ L L N L+ +++ L L L N + L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRT 84
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 251
LDL+ N + + L +NN+S + +++ L+ N +
Sbjct: 85 LDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDL 138
Query: 252 SLQKFPN 258
Sbjct: 139 DEGCRSR 145
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 24/144 (16%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLT-----GGLP------------SEITSLPSLRYLYLQH 174
I L LE+L+L SNVL L E+ PS+ L+ +
Sbjct: 49 ISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108
Query: 175 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 232
NN S ++ S + L+ N T +++ L L+ N + ++ ++
Sbjct: 109 NNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA 166
Query: 233 --PKLRHLNLSYNGLKGSIPSSLQ 254
L HLNL YN + + +
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 197
+ ++ + + L L S S +++ L L N S + + +L +L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253
+++L+ L L L +N + + P + L+ + N + + S
Sbjct: 69 VLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS-RVSCSR 118
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 7/105 (6%)
Query: 156 GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 213
+ + + + ++ + S + LDLS N + + T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 214 TGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP--SSLQK 255
L+L SN L + + LR L+L+ N ++ + S++
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET 103
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 3/104 (2%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFSPQLVVLDL 194
+ +SLR+N L + + +L + L+ N F G + FS V +
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 238
+ + + + + L +P +L L
Sbjct: 268 AKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 55/308 (17%), Positives = 111/308 (36%), Gaps = 55/308 (17%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--VVP 445
+ +G G ++ + E+ +K + + + ++ + ++ Q + ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 92
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L Y + +V + + L++ L + +D R V IH
Sbjct: 93 LYDYEITDQYIYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 506 GGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPEVI 557
G H ++K +N LI DG + DFG+ M T + Y PE I
Sbjct: 147 G---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 558 E-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 606
+ K S KSDV+S G +L M GK P Q + + L +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNHEI 259
Query: 607 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDS 663
E+ ++ + +L + L+ + P R ++ E++ + + +
Sbjct: 260 EF-PDIPEKDLQDV------LKCCLK-------RDPKQRISIPELLAHPYVQIQTHPVNQ 305
Query: 664 ENRPSSEE 671
+ ++EE
Sbjct: 306 MAKGTTEE 313
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP---- 445
E++G G+YG YK ++ + +K + + + +Q++ ++ + H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 446 -LRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
++ D++L LV ++ +GS++ L+ +G L E I RG++H+H
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLH 146
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 553
K H +IK NVL+ ++ + + DFG V A R+ G R A
Sbjct: 147 QH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMA 197
Query: 554 PEVIETRKHS-----HKSDVYSFGVLLLEMLTGKAPL 585
PEVI ++ KSD++S G+ +EM G PL
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 47/224 (20%), Positives = 90/224 (40%), Gaps = 41/224 (18%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
VLG+G++G KA +S +K+++ ++ ++ + H VV A
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAA 70
Query: 450 YYSKDEKL-------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 496
+ + + + +Y +G+L L+H + W +IL
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA-- 128
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------- 547
+++IHS G H ++K N+ I++ + I DFGL ++ +
Sbjct: 129 --LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 548 ---------SAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTG 581
+A Y A EV++ H + K D+YS G++ EM+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 63/309 (20%), Positives = 114/309 (36%), Gaps = 59/309 (19%)
Query: 391 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNV 443
+ LG G T Y A +L V +K + K + FE+++ ++ H N+
Sbjct: 17 DKLGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNI 73
Query: 444 VPLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
V + +++ LV +Y +LS + + PL +T + G+ H
Sbjct: 74 VSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKH 126
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSR----SAGYRAPEV 556
H M H +IK N+LI+ + I DFG+ L T + + Y +PE
Sbjct: 127 AHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT---------RDDMVDLPRWVQSVVREE 607
+ +D+YS G++L EML G+ P T +D + ++ V+ + +
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSENR 666
++ + K R + E+ + V + N
Sbjct: 244 L----------------SNVI------LRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281
Query: 667 PSSEENKSK 675
E +K K
Sbjct: 282 DVYELDKMK 290
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 3/114 (2%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L L L + +N +T S + +L +LR LYL +N S P + ++ L+L
Sbjct: 84 LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGA 141
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 250
N ++ + N+T L L++ + + P ++ L L+L+YN ++ P
Sbjct: 142 NHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 28/123 (22%), Positives = 56/123 (45%), Gaps = 6/123 (4%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L +L + N +T + + ++ L L + +N + P + QL L++
Sbjct: 195 LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGT 252
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 255
N + +I ++++LT+L L++ SN +S I + + +L L L+ N L +
Sbjct: 253 NQIS-DIN-AVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309
Query: 256 FPN 258
N
Sbjct: 310 LTN 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 24/114 (21%), Positives = 46/114 (40%), Gaps = 3/114 (2%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L + L+L +N S ++++ L YL + + P + L L L++
Sbjct: 128 LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNY 186
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 250
N P + +LT L + N ++ P ++ +L L + N + P
Sbjct: 187 NQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 30/124 (24%), Positives = 52/124 (41%), Gaps = 11/124 (8%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194
+ + L L + +N +T S + +L L +L + N S ++ +L +L++
Sbjct: 217 VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP-S 251
N + + NL+QL L L +N L + L L LS N + P +
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA 330
Query: 252 SLQK 255
SL K
Sbjct: 331 SLSK 334
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 6/112 (5%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194
L L L L + +N ++ + + L L+ L + N S S + QL L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 246
+ N + I LT LT L L N+++ P + K+ + + +K
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 24/116 (20%), Positives = 42/116 (36%), Gaps = 6/116 (5%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195
L L+ +T L S+ L + + + L L+L+
Sbjct: 17 PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLN 74
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIP 250
N T P + NL +LT L + +N ++ I + LR L L+ + + P
Sbjct: 75 GNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 4/100 (4%)
Query: 159 SEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL 218
L LQ + + + + L ++ +I I+ LT L L+L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 219 QSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
N ++ P ++ KL +L + N + + S+LQ N
Sbjct: 74 NGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTN 111
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLR 447
+G+GS G A + S V +K + + K+ + E+ + R QH NVV
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVA--VKMMDLRKQQRRELLFNEVVIMRDYQHFNVV--- 105
Query: 448 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
Y Y E+L ++ ++ G+L+ ++ + L+ E + + +A++H+
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA 159
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGY-RAPE 555
G H +IK+ ++L+ D +SDFG ++ + + TP Y APE
Sbjct: 160 QGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP-----YWMAPE 211
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
VI ++ + D++S G++++EM+ G+ P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 34/151 (22%), Positives = 54/151 (35%), Gaps = 9/151 (5%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 190
+ + G ++ L L+ N + S +L +L LQ+N +L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLK 194
Query: 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLK-G 247
LDLS N + Q+ +T +SL++N L I L H +L NG G
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 248 SIPSSLQKFPNSSFV---GNSLLCGPPLKAC 275
++ K V L G + C
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-20
Identities = 19/127 (14%), Positives = 38/127 (29%), Gaps = 6/127 (4%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 191
+ ++ L L N L+ +++ L L L N + L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRT 84
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 251
LDL+ N + + L +NN+S + +++ L+ N +
Sbjct: 85 LDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDL 138
Query: 252 SLQKFPN 258
Sbjct: 139 DEGCRSR 145
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 6e-19
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 24/144 (16%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLT-----GGLP------------SEITSLPSLRYLYLQH 174
I L LE+L+L SNVL L E+ PS+ L+ +
Sbjct: 49 ISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108
Query: 175 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 232
NN S ++ S + L+ N T +++ L L+ N + ++ ++
Sbjct: 109 NNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA 166
Query: 233 --PKLRHLNLSYNGLKGSIPSSLQ 254
L HLNL YN + + +
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-18
Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 197
+ ++ + + L L S S +++ L L N S + + +L +L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253
+++L+ L L L +N + + P + L+ + N + + S
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS-RVSCSR 118
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 7/105 (6%)
Query: 156 GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 213
+ + + + ++ + S + LDLS N + + T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 214 TGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP--SSLQK 255
L+L SN L + + LR L+L+ N ++ + S++
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET 103
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 21/132 (15%), Positives = 41/132 (31%), Gaps = 3/132 (2%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFSPQLVVLDL 194
+ +SLR+N L + + +L + L+ N F G + FS V +
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 254
+ + Q+ + T T + +P +L L + L S +
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETE 326
Query: 255 KFPNSSFVGNSL 266
+
Sbjct: 327 RLECERENQARQ 338
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 16/158 (10%), Positives = 37/158 (23%), Gaps = 33/158 (20%)
Query: 135 NTLGKLDALEVLSLRSNVL-TGGLPSEITSLPSLRYLYLQ-------------------- 173
L LE LR N G L + ++ + Q
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 174 -HNNFSGKIPSSFSPQLVVLDLSFNSFT-------GNIPQSIQNLTQLTGLSLQSNNLSG 225
+P+ F+ +L+ L ++ + +N + +
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR- 349
Query: 226 SIPN---FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 260
++ + L L + + +
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 13/130 (10%), Positives = 27/130 (20%), Gaps = 9/130 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----- 186
+ + + + L +L+ + G
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 187 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 245
+ +D + I Q L + L + N + H L
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN---GRRAHAELDGTLQ 391
Query: 246 KGSIPSSLQK 255
+ LQ
Sbjct: 392 QAVGQIELQH 401
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 54/322 (16%), Positives = 111/322 (34%), Gaps = 77/322 (23%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--VVP 445
+ +G G ++ + E+ +K + + + ++ + ++ Q + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 73
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L Y + +V + + L++ L + +D R V IH
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIHQH 127
Query: 506 GGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPEVI 557
G H ++K +N LI DG + DFG+ M T + Y PE I
Sbjct: 128 G---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 558 E-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-----------RDDMVD 595
+ K S KSDV+S G +L M GK P Q + ++
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241
Query: 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR-- 653
P + ++ ++++ L+ + P R ++ E++
Sbjct: 242 FPDIPEKDLQ----------DVLK---------CCLK-------RDPKQRISIPELLAHP 275
Query: 654 -MIEEVRQSDSENRPSSEENKS 674
+ + + + ++EE K
Sbjct: 276 YVQIQTHPVNQMAKGTTEEMKY 297
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 34/258 (13%)
Query: 341 SKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 400
++ G P +++P+ +L F + F +G GS+G
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDL-------REIGHGSFGA 69
Query: 401 AYKAVLEESTTVV-VKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLRAYY--YSKD 454
Y A ++ VV +K++ + Q E+ + +HPN + Y Y ++
Sbjct: 70 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---QYRGCYLRE 126
Query: 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 514
+ + GS S LL ++ PL + G +G+A++HS H +
Sbjct: 127 HTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 179
Query: 515 IKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHS---HKSD 567
+KA N+L+++ + DFG + P + TP + APEVI K D
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY----WMAPEVILAMDEGQYDGKVD 235
Query: 568 VYSFGVLLLEMLTGKAPL 585
V+S G+ +E+ K PL
Sbjct: 236 VWSLGITCIELAERKPPL 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 63/379 (16%), Positives = 131/379 (34%), Gaps = 67/379 (17%)
Query: 332 KKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEK---NKLVFFEGCSYNFDLEDLLRA 388
+G+ + A+ R + G+ + N+ + +G Y+
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL------- 61
Query: 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--V 443
+ +G G ++ + E+ +K + + + ++ + ++ Q + +
Sbjct: 62 --KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKI 118
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ L Y + +V + + L++ L + +D R V IH
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIH 172
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPE 555
G H ++K +N LI DG + DFG+ M T + Y PE
Sbjct: 173 QHG---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 556 VIE-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 604
I+ K S KSDV+S G +L M GK P Q + + L +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNH 285
Query: 605 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQS 661
E+ ++ + +L + L+ + P R ++ E++ + +
Sbjct: 286 EIEF-PDIPEKDLQDV------LKCCLK-------RDPKQRISIPELLAHPYVQIQTHPV 331
Query: 662 DSENRPSSEENKSKDSNVQ 680
+ + ++EE K +
Sbjct: 332 NQMAKGTTEEMKYVLGQLV 350
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 391 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQQME----IVGRVGQHPNV 443
++G+G G Y+A V E V +K + E + F +M+ GR+ Q P+V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHV 96
Query: 444 VPLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
VP+ + + + + + L+ +L + PL V I+ +
Sbjct: 97 VPI--HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDA 149
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFG---------LTPLMNVPATPSRSAGYR 552
H+ G TH ++K N+L++ D + DFG LT L N T Y
Sbjct: 150 AHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY----YM 202
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
APE ++++D+Y+ +L E LTG P
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-20
Identities = 24/125 (19%), Positives = 54/125 (43%), Gaps = 7/125 (5%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194
+ ++ L++ + T + I+ L +L L + + + + S L +LD+
Sbjct: 62 IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSL 253
S ++ +I I L ++ + L N I +P+L+ LN+ ++G+ +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-DY-RGI 177
Query: 254 QKFPN 258
+ FP
Sbjct: 178 EDFPK 182
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 3/109 (2%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194
+ L LE L + +T ++ L SL L + H+ I + + P++ +DL
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 243
S+N +I ++ L +L L++Q + + D PKL L
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 28/125 (22%), Positives = 55/125 (44%), Gaps = 5/125 (4%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195
T ++++L ++L + +T + I +++ L + + + + P S L L +
Sbjct: 39 TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIM 96
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSL 253
T + ++ LT LT L + + SI +PK+ ++LSYNG I L
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155
Query: 254 QKFPN 258
+ P
Sbjct: 156 KTLPE 160
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-14
Identities = 19/91 (20%), Positives = 40/91 (43%), Gaps = 5/91 (5%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194
L L +L +L + + + ++I +LP + + L +N I P+L L++
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
F+ + + I++ +L L S + G
Sbjct: 167 QFDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 23/121 (19%), Positives = 45/121 (37%), Gaps = 7/121 (5%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 199
A L + + SL Y+ L + N + ++ + L ++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHA 78
Query: 200 TGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNFD-IPKLRHLNLSYNGLKGSIPSSLQKFP 257
T N I L+ L L + +++ IPN + L L++S++ SI + + P
Sbjct: 79 T-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 258 N 258
Sbjct: 137 K 137
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 10/97 (10%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 162 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 221
++ + L ++ + + + L + L+ + T ++ I+ + L++ +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMN-SLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76
Query: 222 NLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ + P + L L + + +L +
Sbjct: 77 HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 39/216 (18%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 447
LG G++G YKA +E+ + K ++ + + E +EI + HP +V
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIV--- 79
Query: 448 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
Y D KL ++ ++ G++ ++ L + + +HS
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHS 135
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 554
H ++KA NVL+ + D ++DFG V A ++ R AP
Sbjct: 136 KR---IIHRDLKAGNVLMTLEGDIRLADFG------VSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 555 EVIETRKHS-----HKSDVYSFGVLLLEMLTGKAPL 585
EV+ +K+D++S G+ L+EM + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 41/120 (34%), Positives = 53/120 (44%), Gaps = 5/120 (4%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
LG L L+ LSL N L + SL +L L L +N S P S +L L L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 274
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP-SSLQK 255
N + P + LT LT L L N L P ++ L +L L +N + P SSL K
Sbjct: 275 NQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK 332
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 28/123 (22%), Positives = 50/123 (40%), Gaps = 6/123 (4%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195
+ LD + L + + L +L + +N + P +LV + ++
Sbjct: 41 SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMN 98
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 255
N P + NLT LTGL+L +N ++ P ++ L L LS N + S+L
Sbjct: 99 NNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSG 154
Query: 256 FPN 258
+
Sbjct: 155 LTS 157
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 38/124 (30%), Positives = 52/124 (41%), Gaps = 6/124 (4%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 194
TL L L L L +N ++ + ++ L L L L N S P + L L+L
Sbjct: 237 GTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLEL 294
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 254
+ N P I NL LT L+L NN+S P + KL+ L N + SSL
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLA 350
Query: 255 KFPN 258
N
Sbjct: 351 NLTN 354
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-18
Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 7/124 (5%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 194
+ L L L L L SN ++ S ++ L SL+ L N + P + L LD+
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLANLTTLERLDI 184
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 254
S N + + LT L L +N +S P + L L+L+ N LK +L
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLA 240
Query: 255 KFPN 258
N
Sbjct: 241 SLTN 244
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 9/123 (7%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L +L+ LS + V + +L +L L + N S + L L +
Sbjct: 152 LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATN 208
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQK 255
N + P + LT L LSL N L I + L L+L+ N + P L
Sbjct: 209 NQISDITP--LGILTNLDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISNLAP--LSG 263
Query: 256 FPN 258
Sbjct: 264 LTK 266
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-16
Identities = 23/115 (20%), Positives = 39/115 (33%), Gaps = 4/115 (3%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195
T L L +T T L + L + L ++ S
Sbjct: 19 TDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFS 76
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 250
N T P ++NLT+L + + +N ++ P ++ L L L N + P
Sbjct: 77 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 20/129 (15%), Positives = 45/129 (34%), Gaps = 3/129 (2%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
+ L L+ L +N ++ S + +L ++ +L HN S P + ++ L L+
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLND 384
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 256
++T N++ + + L D ++++N F
Sbjct: 385 QAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTF 443
Query: 257 PNSSFVGNS 265
+G
Sbjct: 444 SQPVTIGKG 452
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 159 SEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL 218
T+L L N + + + Q+ L ++ L LT ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75
Query: 219 QSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+N L+ P ++ KL + ++ N + P L N
Sbjct: 76 SNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTN 113
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 34/133 (25%), Positives = 57/133 (42%), Gaps = 10/133 (7%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLT-GGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQL 189
+ + L+ + V+ L +N L G+ + + L Y+ + N + IP P L
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 194
Query: 190 VVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGL 245
L L N T + S++ L L L L N++S ++ N + P LR L+L+ N L
Sbjct: 195 TELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL 252
Query: 246 KGSIPSSLQKFPN 258
+P L
Sbjct: 253 V-KVPGGLADHKY 264
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 18/146 (12%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--P 187
I N + L + + +T +P + PSL L+L N + K+ + S
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLN 216
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 245
L L LSFNS + S+ N L L L +N L +P D ++ + L N
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN-- 273
Query: 246 KGSIPSSLQKFPNSSFVGNSLLCGPP 271
++ ++ F
Sbjct: 274 ------NISAIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 25/125 (20%), Positives = 46/125 (36%), Gaps = 15/125 (12%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+ +L L+ L L L N ++ + + P LR L+L +N K+P + +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265
Query: 190 VVLDLSFNSFTGNIPQS-------IQNLTQLTGLSLQSNNLS-GSIPN---FDIPKLRHL 238
V+ L N+ + I + +G+SL SN + I + +
Sbjct: 266 QVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 239 NLSYN 243
L
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 37/154 (24%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+P +T +L L++N +T + +L +L L L +N S P +F+ +L
Sbjct: 50 LPPDT-------ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 190 VVLDLSFNSFT---GNIPQSIQ------------------NLTQLTGLSLQSNNL-SGSI 227
L LS N +P+++Q L Q+ + L +N L S I
Sbjct: 103 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 228 PN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
N F + KL ++ ++ + +IP L P+
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPS 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 28/96 (29%), Positives = 37/96 (38%), Gaps = 8/96 (8%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
LR + K+P P +LDL N T +NL L L L +N +S
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89
Query: 226 SIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 258
I F + KL L LS N LK +P +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKT 122
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 47/227 (20%), Positives = 71/227 (31%), Gaps = 24/227 (10%)
Query: 63 IVSLLPLAFADLNSDRQALLDFAD-------AVPHLRKLNWSSTNPICQSWVGINCTQDR 115
I + F L + LD D +P + + S + + +
Sbjct: 350 IAIIQDQTFKFLEKLQT--LDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANL-- 405
Query: 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQH 174
+ L L L ++ L++L L N + + + PSL L+L
Sbjct: 406 -----IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE 460
Query: 175 NNFSGKIPSSFS-------PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 227
N + L VL L+ N P +LT L GLSL SN L+
Sbjct: 461 NMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLS 520
Query: 228 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKA 274
N L L++S N L P N +C L
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELST 567
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 30/137 (21%), Positives = 41/137 (29%), Gaps = 9/137 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI--PSSFS--P 187
I L L +L L S+ + P L L L L S + F
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 188 QLVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLS----GSIPNFDIPKLRHLNLSY 242
L LDLS N + S L L + SN + + L +L+
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 243 NGLKGSIPSSLQKFPNS 259
N L + K N
Sbjct: 184 NSLYSRVSVDWGKCMNP 200
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 13/137 (9%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+ + L L+VL+L N + L +L+ L L +N S+F P++
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
+DL N Q+ + L +L L L+ N L+ +I P + + LS N
Sbjct: 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFI--PSIPDIFLSGN------ 391
Query: 250 PSSLQKFPNSSFVGNSL 266
L P + N +
Sbjct: 392 --KLVTLPKINLTANLI 406
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 32/127 (25%), Positives = 46/127 (36%), Gaps = 8/127 (6%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI-PSSFS--PQLVVLDLSF 196
L+ E L L N + S L L+ L L I +F P L +LDL
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKG-SIPS 251
+ P + Q L L L L LS ++ L L+LS N ++ +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 252 SLQKFPN 258
S K +
Sbjct: 143 SFGKLNS 149
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 32/160 (20%), Positives = 52/160 (32%), Gaps = 19/160 (11%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGL--PSEITSLPSLRYLYLQHNNFSG-KIPSSFS-- 186
+ + L L L L L+ + +L +L L L N + SF
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLTQ--LTGLSLQSNNLSGSIP--------NFDIPKLR 236
L +D S N ++ L L+ SL +N+L + F L
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 237 HLNLSYNGLKGSIPS----SLQKFPNSSFVGNSLLCGPPL 272
L++S NG I ++ K S + + G
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 34/150 (22%), Positives = 49/150 (32%), Gaps = 8/150 (5%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 191
+ + L L+VL L N L P + L +LR L L N + + L +
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEI 530
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSI- 249
LD+S N P +L+ L + N I L H N++ G I
Sbjct: 531 LDISRNQLLAPNPDVFVSLSVLD---ITHNKFICECELSTFINWLNHTNVTIAGPPADIY 587
Query: 250 ---PSSLQKFPNSSFVGNSLLCGPPLKACF 276
P S S LK+
Sbjct: 588 CVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 29/147 (19%), Positives = 54/147 (36%), Gaps = 16/147 (10%)
Query: 126 IGLVGPIPNNTLGKLD------ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 179
+ P N L LD +++ SN ++ + + +N
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 180 KIPSSFSP----QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN---FD 231
++F+ + LDLS ++ + + L L L+L N ++ I + +
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYG 312
Query: 232 IPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ L+ LNLSYN L S+ P
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPK 339
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 26/152 (17%), Positives = 55/152 (36%), Gaps = 26/152 (17%)
Query: 133 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSL--PSLRYLYLQHNNFSGKIPSSFS---- 186
+ + GKL++L+ + SN + E+ L +L + L N+ ++ +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 187 ----PQLVVLDLSFNSFTGNIP------------QSIQNLTQLTGLSLQSNNLS----GS 226
L +LD+S N +T +I S+ + G +N+ +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 227 IPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+RHL+LS+ + + +
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 25/105 (23%), Positives = 37/105 (35%), Gaps = 13/105 (12%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
R + + N + ++P L LSFN S L QL L L S
Sbjct: 5 DGRIAFYRFCNLT-QVPQVL-NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 226 SIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 267
+I F ++P LR L+L + + +F G L
Sbjct: 63 TIDKEAFRNLPNLRILDLGSS--------KIYFLHPDAFQGLFHL 99
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 34/218 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 447
++LG+G+ ++ +++ + +K + D ++ E++ ++ H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLF 73
Query: 448 AYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
A + L+ ++ GSL T+L A P E +L G+ H+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHLREN 131
Query: 506 GGPKFTHGNIKASNVLINQDLDGC----ISDFGL-------TPLMNVPATPSRSAGYRAP 554
G H NIK N++ DG ++DFG +++ T Y P
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE----EYLHP 184
Query: 555 EVIE--------TRKHSHKSDVYSFGVLLLEMLTGKAP 584
++ E +K+ D++S GV TG P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 27/130 (20%), Positives = 47/130 (36%), Gaps = 10/130 (7%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--P 187
+ + +L+ L L N + + S L L +L QH+N S F
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYN 243
L+ LD+S I L+ L L + N+ + ++ L L+LS
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 244 GLKGSIPSSL 253
L+ + +
Sbjct: 186 QLE-QLSPTA 194
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 35/153 (22%), Positives = 55/153 (35%), Gaps = 15/153 (9%)
Query: 133 PNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 188
+ L L L + + I L SL L + N+F F+
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNG 244
L LDLS + + +L+ L L++ NN S+ F + L+ L+ S N
Sbjct: 177 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNH 234
Query: 245 LKGSIPSSLQKFPNS----SFVGNSLLCGPPLK 273
+ S LQ FP+S + N C +
Sbjct: 235 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 267
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 32/119 (26%), Positives = 44/119 (36%), Gaps = 11/119 (9%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----PQLVVLDLSFNS 198
L L SN L L L L L N S K S S L LDLSFN
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 199 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKGSIPSSL 253
+ + L QL L Q +NL + F + L +L++S+ + + +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 30/119 (25%), Positives = 46/119 (38%), Gaps = 8/119 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
N L +LEVL + N +I T L +L +L L P++F+
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 189 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLSYN 243
L VL++S N+F + L L L N++ + L LNL+ N
Sbjct: 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 8/98 (8%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLS 224
S + + +P+ L+L N ++P + LTQLT LSL SN LS
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 225 -GSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ L++L+LS+NG+ ++ S+
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 102
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 28/128 (21%), Positives = 52/128 (40%), Gaps = 17/128 (13%)
Query: 139 KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 196
L LRS L P + L L+++ + ++P + L L L+
Sbjct: 79 TQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-----------FDIPKLRHLNLSYNGL 245
N +P SI +L +L LS+++ +P + L+ L L + G+
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 246 KGSIPSSL 253
+ S+P+S+
Sbjct: 196 R-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 16/137 (11%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-------- 186
+T+ + LE L+L N L LP+ I SL LR L ++ ++P +
Sbjct: 121 DTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 187 ---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLS 241
L L L + ++P SI NL L L ++++ LS ++ +PKL L+L
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237
Query: 242 YNGLKGSIPSSLQKFPN 258
+ P
Sbjct: 238 GCTALRNYPPIFGGRAP 254
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 24/137 (17%), Positives = 53/137 (38%), Gaps = 17/137 (12%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192
+ +L L+ +++ + L LP + L L L N +P+S + +L L
Sbjct: 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155
Query: 193 DLSFNSFTGNIPQSIQN---------LTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLS 241
+ +P+ + + L L L L+ + S+P ++ L+ L +
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214
Query: 242 YNGLKGSIPSSLQKFPN 258
+ L ++ ++ P
Sbjct: 215 NSPLS-ALGPAIHHLPK 230
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 28/128 (21%), Positives = 52/128 (40%), Gaps = 6/128 (4%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192
L L+ L L + LP+ I +L +L+ L ++++ S + + P+L L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250
DL + N P L L L+ + ++P + +L L+L +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 251 SSLQKFPN 258
S + + P
Sbjct: 295 SLIAQLPA 302
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 20/134 (14%), Positives = 40/134 (29%), Gaps = 10/134 (7%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSL--PSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192
+ ++ + L + P L L+ + P L +
Sbjct: 52 QANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250
+ +P ++Q L L+L N L ++P + +LR L++ +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 251 SSLQKFPNSSFVGN 264
L S
Sbjct: 168 EPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 2/97 (2%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192
+ L LE L LR P L+ L L+ + +P QL L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 229
DL +P I L + + + + +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 19/137 (13%), Positives = 41/137 (29%), Gaps = 28/137 (20%)
Query: 142 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS----------------- 184
E L + + ++ + + + +S
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATA 72
Query: 185 ------FSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR 236
P V L+L P L+ L +++ + L +P+ L
Sbjct: 73 DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130
Query: 237 HLNLSYNGLKGSIPSSL 253
L L+ N L+ ++P+S+
Sbjct: 131 TLTLARNPLR-ALPASI 146
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 19/120 (15%), Positives = 35/120 (29%), Gaps = 27/120 (22%)
Query: 164 LPSLRYLYLQHNNFSGKIPSSFS-------------------PQLVVLDLSFNSFTG--N 202
LY Q + S + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 203 IPQSIQNLTQ--LTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+++ TQ L L+S L P+ F + L+H+ + GL +P ++Q+F
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 57/312 (18%), Positives = 108/312 (34%), Gaps = 74/312 (23%)
Query: 391 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQ--QME--IVGRVGQHPNV 443
E+LG G + A V VK L+ + F + E + HP +
Sbjct: 18 EILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAI 74
Query: 444 V----------PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 493
V P Y +V +Y +L ++H P+ + ++++
Sbjct: 75 VAVYDTGEAETPAGPLPY------IVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIA 123
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------ 547
+ + H G H ++K +N++I+ + DFG+ +
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 548 -SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT---------RDDMVDLP 597
+A Y +PE +SDVYS G +L E+LTG+ P + R+D +
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240
Query: 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIE 656
+ + +A++ + +V + +AK P+ R E+ +
Sbjct: 241 ARHEGL-----SADL------------DAVV------LKALAKNPENRYQTAAEMRADLV 277
Query: 657 EVRQSDSENRPS 668
V + P
Sbjct: 278 RVHNGEPPEAPK 289
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-19
Identities = 30/146 (20%), Positives = 50/146 (34%), Gaps = 11/146 (7%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 190
L L L L + N +P +R+L L + + L
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLE 434
Query: 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-PKLRHLNLSYNGLKGSI 249
VLD+S N+ + L +L L + N L ++P+ + P L + +S N LK
Sbjct: 435 VLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVP 489
Query: 250 PSSLQKFPNSSFV---GNSLLCGPPL 272
+ + + N C P
Sbjct: 490 DGIFDRLTSLQKIWLHTNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 46/233 (19%), Positives = 81/233 (34%), Gaps = 33/233 (14%)
Query: 35 SSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFA--DAVPHLR 92
SS + + ++ S L L I+ L + F D + + + D V L
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 93 KLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNV 152
K+ + L +P L + L+ ++ +++ ++
Sbjct: 282 KVETVTIR-------------------RLHIPQFYL-FYDLSTVYSLLEKVKRITVENSK 321
Query: 153 LTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-----PQLVVLDLSFNSFT--GNIPQ 205
+ S L SL +L L N + + + P L L LS N +
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 206 SIQNLTQLTGLSLQSNNLSGSIPNFDIP-KLRHLNLSYNGLK---GSIPSSLQ 254
+ L LT L + N + P K+R LNLS G++ IP +L+
Sbjct: 382 ILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE 434
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 33/134 (24%), Positives = 52/134 (38%), Gaps = 8/134 (5%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
I + L L+VL L+S+ + + + SL SL +L L N+ S S F
Sbjct: 41 IGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99
Query: 189 LVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD---IPKLRHLNLSYNG 244
L L+L N + + NLT L L + + I D + L L +
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 245 LKGSIPSSLQKFPN 258
L+ SL+ +
Sbjct: 160 LRNYQSQSLKSIRD 173
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-17
Identities = 30/135 (22%), Positives = 48/135 (35%), Gaps = 10/135 (7%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSG-KIPSSFS--P 187
I + L +LE L L N L+ L S L SL+YL L N + + S F
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 188 QLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYN 243
L L + I LT L L +++ +L + + + + HL L +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLS 182
Query: 244 GLKGSIPSSLQKFPN 258
+ +
Sbjct: 183 ESAFLLEIFADILSS 197
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 22/116 (18%), Positives = 42/116 (36%), Gaps = 7/116 (6%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
++ L L N +T ++ + +L+ L L+ + + +F L LDLS N +
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKGSIPSS 252
L+ L L+L N ++ + L+ L + I
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 17/150 (11%), Positives = 42/150 (28%), Gaps = 14/150 (9%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I L +L L +++ L + S+ + +L L + + + +
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV 198
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG------------SIPNFDIPKLRH 237
L+L + + + + + S ++ ++
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258
Query: 238 LNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 267
+ + NGL PS V +
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTI 288
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 163 SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNN 222
S + + +F+ IPS + + LDLSFN T ++ L L L+S+
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 223 LSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 253
++ +I F + L HL+LS N L S+ SS
Sbjct: 62 IN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW 93
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 21/149 (14%), Positives = 49/149 (32%), Gaps = 22/149 (14%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 191
+ +L + + L+L + L L S+RYL L+ N + S V
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 192 LDLSFNSFTGN---------IPQSIQNLTQLTGLSLQSNNLSG-------------SIPN 229
+ +F G+ + + ++ + +L+ + L+G +
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282
Query: 230 FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ +R L++ L + +
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 17/144 (11%), Positives = 46/144 (31%), Gaps = 21/144 (14%)
Query: 133 PNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSG--------- 179
P ++ L+ R +VLT L + + L + +G
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274
Query: 180 ----KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-I 232
++ + + L + ++ L ++ ++++++ + +P +
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHL 333
Query: 233 PKLRHLNLSYNGLKGSIPSSLQKF 256
L L+LS N + +
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACK 357
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 60/213 (28%), Positives = 109/213 (51%), Gaps = 35/213 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+V+G GS+G ++A L ES V +K+ V+ KR ++++I+ R+ +HPNVV L+A++
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFKNRELQIM-RIVKHPNVVDLKAFF 101
Query: 451 YSKDEKL------LVYDYFASGSLSTLLH---GNRGAGRTPLDWETRVKILL-GTARGVA 500
YS +K LV +Y + ++ + + + +K+ + R +A
Sbjct: 102 YSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLA 155
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATP------SRSAGYRA 553
+IHS+G H +IK N+L++ + DFG + + P SR YRA
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA-KILIAGEPNVSYICSRY--YRA 209
Query: 554 PEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 585
PE+I + + D++S G ++ E++ G+ PL
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ-PL 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 1e-18
Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 23/219 (10%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRA 448
E LG G +G + + +++ V +K+ ++ + K +EI + + HPNVV R
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 449 YY------YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAH 501
D LL +Y G L L+ E ++ LL + + +
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK---EGPIRTLLSDISSALRY 136
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVPATPSRSA----GYRAP 554
+H H ++K N+++ I D G ++ Y AP
Sbjct: 137 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAP 192
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
E++E +K++ D +SFG L E +TG P +
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 28/152 (18%), Positives = 51/152 (33%), Gaps = 25/152 (16%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLV 190
+P L LS+ +N L + + + SL+ L L N + + S P L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLF 189
Query: 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 250
++S+N + ++ + L N+++ + +L L L +N L
Sbjct: 190 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT-DTA 242
Query: 251 S---------------SLQKFPNSSFVGNSLL 267
L+K FV L
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 11/128 (8%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192
+TL A+E L N + + + L L LQHNN + + P LV +
Sbjct: 199 STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEV 253
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250
DLS+N + + +L L + +N L ++ + IP L+ L+LS+N L +
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
Query: 251 SSLQKFPN 258
+ +F
Sbjct: 312 RNQPQFDR 319
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 32/146 (21%), Positives = 55/146 (37%), Gaps = 24/146 (16%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLT----GGLPS------------EITSLPSLRYLYLQHN 175
I ++T +L+ L L SN LT +PS + ++ L HN
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 215
Query: 176 NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DI 232
+ + + + +L +L L N+ T + + N L + L N L I +
Sbjct: 216 SIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKM 271
Query: 233 PKLRHLNLSYNGLKGSIPSSLQKFPN 258
+L L +S N L ++ Q P
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPT 296
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 30/121 (24%), Positives = 57/121 (47%), Gaps = 11/121 (9%)
Query: 140 LDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 196
L+ ++++ +++ + LP+ + S + L L +F+ + L + F
Sbjct: 44 LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 197 NSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSS 252
N+ +P + QN+ LT L L+ N+LS S+P + PKL L++S N L+ I
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159
Query: 253 L 253
Sbjct: 160 T 160
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 7/125 (5%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I + K+ LE L + +N L L +P+L+ L L HN+ + + +L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
L L NS + + L L+L N+ + + + I
Sbjct: 321 ENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377
Query: 250 PSSLQ 254
L+
Sbjct: 378 DYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 19/140 (13%), Positives = 41/140 (29%), Gaps = 16/140 (11%)
Query: 134 NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV 191
++ L + + E +L + + + +++ + Q+ +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73
Query: 192 LDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKG 247
L+L+ I + L + N + +P ++P L L L N
Sbjct: 74 LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN---- 127
Query: 248 SIPSSLQKFPNSSFVGNSLL 267
L P F L
Sbjct: 128 ----DLSSLPRGIFHNTPKL 143
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 44/297 (14%), Positives = 92/297 (30%), Gaps = 61/297 (20%)
Query: 391 EVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVGKRD------FEQQMEIVGRVGQHPN 442
+ G G Y A+ VV+K L D + + + V HP+
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 443 VVPLRAYYYSKDEKL-------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495
+V + + + + +V +Y SL L + LL
Sbjct: 141 IV--QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEI 191
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAGYRAP 554
++++HS+G + ++K N+++ ++ + D G +N + G++AP
Sbjct: 192 LPALSYLHSIG---LVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTPGFQAP 246
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614
E++ T + +D+Y+ G L + + T + +
Sbjct: 247 EIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG-------RYVDGLPEDDPVLKTYDSYG 298
Query: 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSENRPSSE 670
L R + P R +E+ + V +
Sbjct: 299 RLLRR-----------------AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 50/241 (20%), Positives = 99/241 (41%), Gaps = 44/241 (18%)
Query: 392 VLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 446
+LG+GS+ T A ++ +K L K ++ + +++ R+ HP V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKL 95
Query: 447 RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVA 500
+ + DEKL Y +G L + R G ET + I+ +
Sbjct: 96 Y-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFD---ETCTRFYTAEIVSA----LE 144
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRS------AGYR 552
++H G H ++K N+L+ + D I+DFG +++ + +R+ A Y
Sbjct: 145 YLHGKG---IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVV 604
+PE++ + SD+++ G ++ +++ G P ++ + D P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 605 R 605
R
Sbjct: 260 R 260
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 32/212 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+V+G GS+G Y+A L +S +V +K+V+ KR ++++I+ ++ H N+V LR ++
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFF 116
Query: 451 YSKDEKL------LVYDYFASGSLSTLLHG---NRGAGRTPLDWETRVKILL-GTARGVA 500
YS EK LV DY + ++ + + L VK+ + R +A
Sbjct: 117 YSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLA 170
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGL--TPLMNVPATP---SRSAGYRAP 554
+IHS G H +IK N+L++ D + DFG + P SR YRAP
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--YRAP 225
Query: 555 EVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 585
E+I + DV+S G +L E+L G+ P+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 38/231 (16%)
Query: 386 LRASAEVLGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKRDFEQQMEIVGRVGQ 439
L + LG+GS+ K V + + ++ KR++ + ++++ +
Sbjct: 12 LDLKDKPLGEGSFSICRKCV-HKKSNQAFAVKIISKRMEA------NTQKEITALKLCEG 64
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLST--LLHGN---RGAGRTPLDWETRVKILLG 494
HPN+V L ++ + LV + G L + A ++ L+
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-------MRKLVS 117
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC--ISDFGL----TPLMNVPATPSR 547
V+H+H +G H ++K N+L +++ + I DFG P TP
Sbjct: 118 ---AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 598
+ Y APE++ + D++S GV+L ML+G+ P QS R
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPL 446
+ LG G+YG + + +K +++ V +++ ++ + HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKL 101
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHSM 505
++ K LV + + G L + R + E +++ GV ++H
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELF-----DEIIHRMKFN-EVDAAVIIKQVLSGVTYLHKH 155
Query: 506 GGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVIET 559
H ++K N+L+ I DFGL+ + +A Y APEV+
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR- 211
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+K+ K DV+S GV+L +L G P T +++
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 46/225 (20%), Positives = 79/225 (35%), Gaps = 43/225 (19%)
Query: 449 YYYSKDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
K+ +Y +L + NR + + I + A V +HS
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGL-------------TPLMNVPATPSRSAG-- 550
G H ++K SN+ D + DFGL M AT + G
Sbjct: 184 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 551 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609
Y +PE I +SHK D++S G++L E+L T+ + V + + V ++
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF-----STQMERVRI---ITDVRNLKFP 292
Query: 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
F + M+Q ++ P RP +++
Sbjct: 293 LL--------FTQKYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 54/302 (17%), Positives = 110/302 (36%), Gaps = 39/302 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 447
++LG+G+ ++ +++ + +K + D ++ E++ ++ H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLF 73
Query: 448 AYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
A + L+ ++ GSL T+L A P E +L G+ H+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHLREN 131
Query: 506 GGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVPATPSRSA----GYRAPEVI 557
G H NIK N++ DG ++DFG + S Y P++
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMY 187
Query: 558 ET--------RKHSHKSDVYSFGVLLLEMLTGKAP---LQSPTRDDMV-------DLPRW 599
E +K+ D++S GV TG P + P R+ V
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 600 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKV-PDMRPNMDEVVRMIEEV 658
+ V + E + ++ ++ + +L +A + + + D+ ++
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 659 RQ 660
Sbjct: 308 LH 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 448
E +G GSY + + ++T + VK + + KRD +++EI+ R GQHPN++ L+
Sbjct: 28 EDIGVGSYSVCKRCI-HKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETRVKILLGTARG 498
Y +V + G L LD E +L +
Sbjct: 84 VYDDGKYVYVVTELMKGGEL--------------LDKILRQKFFSEREAS-AVLFTITKT 128
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVP----ATPSRSAG 550
V ++H+ G H ++K SN+L + I DFG + TP +A
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592
+ APEV+E + + D++S GVLL MLTG P + D
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFE---QQMEIVGRVGQHPNVVP 445
VLGKGS+G + + VK + K V K D E ++++++ ++ HPN++
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMK 90
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHS 504
L ++ K LV + + G L + R E ++ G+ ++H
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELF-----DEIISRKRFS-EVDAARIIRQVLSGITYMHK 144
Query: 505 MGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVIE 558
H ++K N+L+ I DFGL+ +A Y APEV+
Sbjct: 145 NK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+ K DV+S GV+L +L+G P D++
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 37/154 (24%), Positives = 60/154 (38%), Gaps = 17/154 (11%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--P 187
+ T L L L L L L + L +L+YLYLQ N +P +F
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG 153
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
L L L N + ++P+ + L L L L N ++ + F + +L L L N
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFAN 211
Query: 244 GLKGSIPSS-LQKFPNSSFV---GNSLLCGPPLK 273
L ++P+ L ++ N +C +
Sbjct: 212 NLS-ALPTEALAPLRALQYLRLNDNPWVCDCRAR 244
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 8/115 (6%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
+ + L N ++ + + +L L+L N + ++F+ L LDLS N+
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 201 GNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPS 251
++ + L +L L L L + F + L++L L N L+ ++P
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD 146
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 24/102 (23%), Positives = 38/102 (37%), Gaps = 8/102 (7%)
Query: 157 LPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 214
+P I + + ++L N S +SF L +L L N + L L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 215 GLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 253
L L N S+ F + +L L+L GL+ + L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 18/86 (20%), Positives = 27/86 (31%), Gaps = 5/86 (5%)
Query: 170 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 229
+P + L N + S + LT L L SN L+ I
Sbjct: 16 TSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA 73
Query: 230 ---FDIPKLRHLNLSYNGLKGSIPSS 252
+ L L+LS N S+ +
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPA 99
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 7e-18
Identities = 37/129 (28%), Positives = 57/129 (44%), Gaps = 8/129 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
I ++ L + N + LP + ++P L L L+ N+ S F P+
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 247
L L +S N+ I Q T L L L SN L+ + IP L H N+SYN L
Sbjct: 149 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLST 206
Query: 248 -SIPSSLQK 255
+IP ++++
Sbjct: 207 LAIPIAVEE 215
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 11/128 (8%)
Query: 135 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192
+TL A+E L N + + + L L LQHNN + + P LV +
Sbjct: 205 STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEV 259
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250
DLS+N + + +L L + +N L ++ + IP L+ L+LS+N L +
Sbjct: 260 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 317
Query: 251 SSLQKFPN 258
+ +F
Sbjct: 318 RNQPQFDR 325
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 2e-16
Identities = 33/146 (22%), Positives = 56/146 (38%), Gaps = 24/146 (16%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLT----GGLPS------------EITSLPSLRYLYLQHN 175
I ++T +L+ L L SN LT +PS + ++ L HN
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 221
Query: 176 NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-I 232
+ + + + +L +L L N+ T + + N L + L N L I F +
Sbjct: 222 SIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKM 277
Query: 233 PKLRHLNLSYNGLKGSIPSSLQKFPN 258
+L L +S N L ++ Q P
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPT 302
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 30/121 (24%), Positives = 57/121 (47%), Gaps = 11/121 (9%)
Query: 140 LDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 196
L+ ++++ +++ + LP+ + S + L L +F+ + L + F
Sbjct: 50 LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108
Query: 197 NSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSS 252
N+ +P + QN+ LT L L+ N+LS S+P + PKL L++S N L+ I
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 165
Query: 253 L 253
Sbjct: 166 T 166
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 9e-14
Identities = 26/126 (20%), Positives = 44/126 (34%), Gaps = 7/126 (5%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I + K+ LE L + +N L L +P+L+ L L HN+ + + +L
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
L L NS + S L L+L N+ + + + I
Sbjct: 327 ENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383
Query: 250 PSSLQK 255
L+
Sbjct: 384 DYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 21/142 (14%), Positives = 42/142 (29%), Gaps = 17/142 (11%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I +N L + + E +L + + + +++ + Q+
Sbjct: 19 IDSN-LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 190 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 245
+L+L+ I + L + N + +P ++P L L L N
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN-- 133
Query: 246 KGSIPSSLQKFPNSSFVGNSLL 267
L P F L
Sbjct: 134 ------DLSSLPRGIFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 28/129 (21%), Positives = 44/129 (34%), Gaps = 8/129 (6%)
Query: 134 NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLD 193
N + L+VL L N L + L LYL HN+ + S L L
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLT 351
Query: 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253
LS N + N +++ + ++ + I +L H K + L
Sbjct: 352 LSHNDWDCNSLRAL--FRNVARPAVDDADQHCKID----YQLEHGLCCKESDKPYLDRLL 405
Query: 254 QKFPNSSFV 262
Q +S V
Sbjct: 406 QYIALTSVV 414
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 30/132 (22%), Positives = 44/132 (33%), Gaps = 9/132 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 190
+P L + + + N L G L YL + + IP L
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLN 196
Query: 191 VLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLK 246
L L N I + ++L L L N + I N +P LR L+L N L
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254
Query: 247 GSIPSSLQKFPN 258
+P+ L
Sbjct: 255 -RVPAGLPDLKL 265
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 37/200 (18%), Positives = 61/200 (30%), Gaps = 43/200 (21%)
Query: 63 IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF-GL 121
I + F+ L ++ + NP+ S F GL
Sbjct: 135 IRKVPKGVFSGL--------------RNMNCIEMGG-NPLENSGF-------EPGAFDGL 172
Query: 122 RLPGIGLVG----PIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNN 176
+L + + IP + + L L L N + + E L L L HN
Sbjct: 173 KLNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 177 FSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--------GS 226
S S P L L L N + +P + +L L + L +NN++
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287
Query: 227 IPNFDIPKLRHLNLSYNGLK 246
++L N +
Sbjct: 288 GFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 24/126 (19%), Positives = 45/126 (35%), Gaps = 17/126 (13%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
I L + L L L N + + + + LP+LR L+L +N S ++P+
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
Query: 189 LVVLDLSFNSFTGNIPQSI-------QNLTQLTGLSLQSNNLS-GSIPN---FDIPKLRH 237
L V+ L N+ T + + G+SL +N + + +
Sbjct: 266 LQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324
Query: 238 LNLSYN 243
+
Sbjct: 325 IQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 44/213 (20%), Positives = 72/213 (33%), Gaps = 50/213 (23%)
Query: 77 DRQALLDFA-DAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF--GLRLPGIGLVGP-- 131
D +A +P L L + + +C C V L L + P
Sbjct: 1 DEEASGAETTSGIPDLDSLP-PTYSAMCPF----GCHCHLRVVQCSDLGLKAV----PKE 51
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I +T +L L++N ++ + L L L L +N S +FS +L
Sbjct: 52 ISPDT-------TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 190 VVLDLSFNSFT---GNIPQSIQ------------------NLTQLTGLSLQSNNL-SGSI 227
L +S N N+P S+ L + + + N L +
Sbjct: 105 QKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164
Query: 228 PN--FDIPKLRHLNLSYNGLKG---SIPSSLQK 255
FD KL +L +S L G +P +L +
Sbjct: 165 EPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE 197
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
LR + +P SP +LDL N + + L L L L +N +S
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91
Query: 226 SIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 258
I F + KL+ L +S N L IP +L +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSS 124
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 12/114 (10%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 199
+ VL++ + LT LP + + L + NN + +P+ P+L L++S N
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALP-PELRTLEVSGNQL 93
Query: 200 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253
T ++P L +L+ S +L L L + N L S+P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPSG-----LCKLWIFGNQLT-SLPVLP 140
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 17/126 (13%)
Query: 134 NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 189
N L L L+ LS+ N L LP+ L L+ +N + +P S L
Sbjct: 130 GNQLTSLPVLPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPMLPS-GL 183
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
L +S N ++P L +L + + +L L+ L +S N L S+
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG-----LKELIVSGNRLT-SL 236
Query: 250 PSSLQK 255
P +
Sbjct: 237 PVLPSE 242
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 31/119 (26%), Positives = 50/119 (42%), Gaps = 13/119 (10%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 199
L+ LS+ N L LP+ L L+ +N + +P+ S L L +S N
Sbjct: 180 PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPALPS-GLKELIVSGNRL 233
Query: 200 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
T ++P L +L + N L+ S+P L L++ N L +P SL +
Sbjct: 234 T-SLPVLPSELKEL---MVSGNRLT-SLPML-PSGLLSLSVYRNQLT-RLPESLIHLSS 285
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 6/87 (6%)
Query: 180 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 239
K+ + + VL++ + T +P + +T L + NNL+ S+P P+LR L
Sbjct: 33 KMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA-LPPELRTLE 87
Query: 240 LSYNGLKGSIPSSLQKFPNSSFVGNSL 266
+S N L S+P S N L
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPL 113
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 41/231 (17%)
Query: 391 EVLGKGSYGTAYKAVLEES---------------TTVVVKRLKEVVVGKRDFEQQMEIVG 435
LG G+YG + K + + ++ ++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 436 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGN---RGAGRTPLDWETRVK 490
+ HPN++ L + K LV +++ G L + A +K
Sbjct: 102 SLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-------MK 153
Query: 491 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCI--SDFGLTPLM---NVPAT 544
+L G+ ++H H +IK N+L+ N++ I DFGL+
Sbjct: 154 QILS---GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
+A Y APEV++ +K++ K DV+S GV++ +L G P D++
Sbjct: 208 RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 188
I + + +L L+VL + + +L L + H N + +P +
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY 249
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNG 244
L L+LS+N + I S+ L +L + L L+ + + + LR LN+S N
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ 307
Query: 245 LKGSIP----SSLQKFPNSSFVGNSLLC 268
L ++ S+ N L C
Sbjct: 308 LT-TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 33/142 (23%), Positives = 51/142 (35%), Gaps = 16/142 (11%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
+ L L L LRSN L +P + T L +L L + N + F
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 189 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGL 245
L L++ N ++ L L L+L+ NL+ SIP + L L L +
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHL-- 186
Query: 246 KGSIPSSLQKFPNSSFVGNSLL 267
++ + SF L
Sbjct: 187 ------NINAIRDYSFKRLYRL 202
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 16/131 (12%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
+L L N + E S P L L L N S P +F+ L L L N
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
Query: 201 GNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKF 256
IP + L+ LT L + N + + ++ D+ L+ L + N L
Sbjct: 94 -LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN--------DLVYI 143
Query: 257 PNSSFVGNSLL 267
+ +F G + L
Sbjct: 144 SHRAFSGLNSL 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 23/106 (21%), Positives = 34/106 (32%), Gaps = 13/106 (12%)
Query: 165 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 224
R + F +P + +LDL N + L L L N +S
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 225 GSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 267
++ ++ LR L L N L+ P F G S L
Sbjct: 70 -AVEPGAFNNLFNLRTLGLRSN--------RLKLIPLGVFTGLSNL 106
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-17
Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 14/152 (9%)
Query: 132 IPNNTLGKLDALEVLSL-RSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFSPQ 188
IP+ ++ +L L L L+ + L +LRYL L N +IP+ + +
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSY-ISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIK 208
Query: 189 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 245
L LDLS N + P S Q L L L + + + I ++ L +NL++N L
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL 267
Query: 246 KGSIP----SSLQKFPNSSFVGNSLLCGPPLK 273
+P + L N C +
Sbjct: 268 T-LLPHDLFTPLHHLERIHLHHNPWNCNCDIL 298
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 36/138 (26%), Positives = 53/138 (38%), Gaps = 22/138 (15%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
I NT +L+L N + + L L L L N+ +F+ L
Sbjct: 62 ISTNT-------RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 190 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 245
L+L N T IP L++L L L++N + SIP++ IP LR L+L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK- 171
Query: 246 KGSIPSSLQKFPNSSFVG 263
L +F G
Sbjct: 172 ------RLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 6/90 (6%)
Query: 165 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 224
+ N ++P S +L+L N S ++L L L L N++
Sbjct: 43 NQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 225 GSIPN---FDIPKLRHLNLSYNGLKGSIPS 251
+I + L L L N L +IP+
Sbjct: 102 -TIEIGAFNGLANLNTLELFDNRLT-TIPN 129
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 35/128 (27%), Positives = 49/128 (38%), Gaps = 15/128 (11%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSF 196
L+VLS+ ++ P+L L L N G+ + P L VL L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 197 NSFT---GNIPQSIQNLTQLTGLSLQSNNLSGSIP--NFDIP-KLRHLNLSYNGLK---G 247
G QL GL L N+L + + D P +L LNLS+ GLK
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK 270
Query: 248 SIPSSLQK 255
+P+ L
Sbjct: 271 GLPAKLSV 278
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 9/129 (6%)
Query: 126 IGLVGPIPNNTLGKLDALEVLSLRSNVLT---GGLPSEITSLPSLRYLYLQHNNFSGKIP 182
+G G I K L+VL+LR+ + G + + L+ L L HN+
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 183 SSF---SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 239
+ QL L+LSF +P+ + +L+ L L N L + ++P++ +L+
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLS 302
Query: 240 LSYNGLKGS 248
L N S
Sbjct: 303 LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 33/181 (18%), Positives = 60/181 (33%), Gaps = 22/181 (12%)
Query: 117 RVFGLRLPGIGLVGPIPNNTLGKLDA--LEVLSLRSNVLTGGLPSEITSL--PSLRYLYL 172
+ L + + I L L L+ L+L + +TG P + P L L L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 173 QHN------NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG- 225
++ + ++ P L VL ++ + ++ L+ L L N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 226 -----SIPNFDIPKLRHLNLSYNGLK---GSIPSSLQKFPNSSFV---GNSLLCGPPLKA 274
++ P L+ L L G++ G + + NSL +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 275 C 275
C
Sbjct: 249 C 249
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 25/113 (22%), Positives = 35/113 (30%), Gaps = 3/113 (2%)
Query: 89 PHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSL 148
P L+ L + S V R ++ GL L L + L L+L
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
Query: 149 RSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTG 201
L +P + L L L +N PQ+ L L N F
Sbjct: 261 SFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 24/227 (10%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVGRVG 438
+ D + S +VLG G G + T +K L + Q+++ +
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECF-HRRTGQKCALKLLYD----SPKARQEVDHHWQAS 79
Query: 439 QHPNVVPLRAYY----YSKDEKLLVYDYFASGSLSTLLHGNRGAGR-TPLDWETRVKILL 493
P++V + Y + K L++ + G L + + RG T + ++ +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIG 138
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLM--NVPATPSRS 548
+ +HS H ++K N+L +D ++DFG N TP +
Sbjct: 139 T---AIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192
Query: 549 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
Y APEV+ K+ D++S GV++ +L G P S T +
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 72/288 (25%), Positives = 113/288 (39%), Gaps = 77/288 (26%)
Query: 349 GRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEE 408
G E KE G GV + + FE +R VLGKGS+G A ++E
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFE----------FIR----VLGKGSFGKVMLARVKE 46
Query: 409 STTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463
+ + VK L K+V++ D E M I+ HP + L + + D V ++
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106
Query: 464 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 518
G L + + R E R + I+ + +H G + ++K
Sbjct: 107 NGGDLMFHIQK---SRRFD---EARARFYAAEIISA----LMFLHDKG---IIYRDLKLD 153
Query: 519 NVLINQDLDG--CISDFGL----------------TPLMNVPATPSRSAGYRAPEVIETR 560
NVL+ D +G ++DFG+ TP Y APE+++
Sbjct: 154 NVLL--DHEGHCKLADFGMCKEGICNGVTTATFCGTP------------DYIAPEILQEM 199
Query: 561 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 600
+ D ++ GVLL EML G AP ++ DD+ V P W+
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 16/153 (10%)
Query: 132 IPNNTLGKLDALEVLSL-RSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--P 187
IP+ ++ +L L L L + L +L+YL L N +P+ +
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEY-ISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLV 218
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNG 244
L L++S N F P S L+ L L + ++ +S I + L LNL++N
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNN 277
Query: 245 LKGSIPSS-LQKFPNSSFV---GNSLLCGPPLK 273
L S+P + N C +
Sbjct: 278 LS-SLPHDLFTPLRYLVELHLHHNPWNCDCDIL 309
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 13/126 (10%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
L+L N + L L L L N+ +F+ L L+L N T
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136
Query: 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFP 257
+ + L++L L L++N + SIP+ F +P L L+L L+
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK-------KLEYIS 188
Query: 258 NSSFVG 263
+F G
Sbjct: 189 EGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 19/90 (21%), Positives = 30/90 (33%), Gaps = 6/90 (6%)
Query: 165 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 224
+ S ++P L+L N+ + ++L L L L N++
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 225 GSIPN---FDIPKLRHLNLSYNGLKGSIPS 251
I + L L L N L IPS
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLT-VIPS 140
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 56/248 (22%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRL-------KEVVVGKRDFEQQME--IV 434
+LL+ VLG+GS+G + ++ + ++L K + + +ME I+
Sbjct: 27 ELLK----VLGQGSFGKVFLV--KKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 435 GRVGQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 490
V HP +V L +Y+ + KL L+ D+ G L T L E VK
Sbjct: 81 VEV-NHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLSK---EVMFT---EEDVKF 130
Query: 491 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPAT 544
+ L + H+HS+G + ++K N+L+ D +G ++DFGL+
Sbjct: 131 YLAELALA----LDHLHSLG---IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEK 181
Query: 545 PSRS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 593
+ S Y APEV+ R H+ +D +SFGVL+ EMLTG P Q R +
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
Query: 594 -VDLPRWV 600
+ +P+++
Sbjct: 242 KLGMPQFL 249
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 9e-17
Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 43/280 (15%)
Query: 343 GKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGT 400
+A G ++ P+E+ + + + + N G L D L VLGKGS+G
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNN------GNRDRMKLTDFNFLM----VLGKGSFGK 356
Query: 401 AYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDE 455
+ + + + VK L K+VV+ D E M ++ G+ P + L + + + D
Sbjct: 357 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416
Query: 456 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSMGGPKFTHGN 514
V +Y G L + GR E A G+ + S G + +
Sbjct: 417 LYFVMEYVNGGDLMYHIQQ---VGRFK---EPHAVFYAAEIAIGLFFLQSKG---IIYRD 467
Query: 515 IKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRKHSHKSDV 568
+K NV++ D +G I+DFG+ + T G Y APE+I + + D
Sbjct: 468 LKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 569 YSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 600
++FGVLL EML G+AP + D++ V P+ +
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 32/250 (12%)
Query: 351 SEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEEST 410
+ P +EF + + + E D R VLG+G +G + ++ +
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFR----VLGRGGFGEVFACQMKATG 210
Query: 411 TV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465
+ K+L K+ + ++ ++ M +I+ +V +V L + +K + LV
Sbjct: 211 KLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG 269
Query: 466 GSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKASNV 520
G + H P E R I+ G + H+H + ++K NV
Sbjct: 270 GDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENV 320
Query: 521 LINQDLDG--CISDFGLT-PLMNVPATPSRSAG---YRAPEVIETRKHSHKSDVYSFGVL 574
L+ D DG ISD GL L AG + APE++ ++ D ++ GV
Sbjct: 321 LL--DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 575 LLEMLTGKAP 584
L EM+ + P
Sbjct: 379 LYEMIAARGP 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 29/219 (13%)
Query: 392 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 446
VLGKG +G + + + K+L K+ + ++ + +I+ +V VV L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSL 249
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAH 501
Y +KD LV G L ++ G+ E R I G +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYH---MGQAGFP-EARAVFYAAEICCG----LED 301
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRSAG---YRAPEV 556
+H + ++K N+L+ D G ISD GL + T G Y APEV
Sbjct: 302 LHRER---IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
++ +++ D ++ G LL EM+ G++P Q + +
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 139 KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 197
++ +L+ L + N ++ + SL L + N + I P++ VLDL N
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431
Query: 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
+IP+ + L L L++ SN L S+P+ FD + L+ + L N
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 34/132 (25%), Positives = 54/132 (40%), Gaps = 6/132 (4%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS--GKIPSSFS--P 187
+ K+ L +N+LT + L L L LQ N KI +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 246
L LD+S NS + + + L L++ SN L+ +I P+++ L+L N +K
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434
Query: 247 GSIPSSLQKFPN 258
SIP + K
Sbjct: 435 -SIPKQVVKLEA 445
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 12/135 (8%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS-- 186
G L LE L L+ N L + T + SL+ L + N+ S S
Sbjct: 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNG 244
L+ L++S N T I + + ++ L L SN + SIP + L+ LN++ N
Sbjct: 399 KSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455
Query: 245 LKGSIP-SSLQKFPN 258
LK S+P + +
Sbjct: 456 LK-SVPDGIFDRLTS 469
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 33/129 (25%), Positives = 49/129 (37%), Gaps = 17/129 (13%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+ T +L++ N ++ S+I SL LR L + HN S F +L
Sbjct: 19 LSQKT-------TILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FD-IPKLRHLNLSYNGL 245
LDLS N I L L L N ++P F + +L+ L LS L
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
Query: 246 KGSIPSSLQ 254
+ S +
Sbjct: 128 EKSSVLPIA 136
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 41/258 (15%), Positives = 80/258 (31%), Gaps = 31/258 (12%)
Query: 3 PGSLVICRSDYFSTMLFVCGNIETLLGLHFCYSSHLLIPCIKQLL--MKFSSAAPLFFPL 60
P L ++ + +L + ++L + IK +L K S + L
Sbjct: 157 PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKL 216
Query: 61 CVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFG 120
L L ++ + + + V H +S +N
Sbjct: 217 QTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN-------------------- 256
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 180
++L G + + L AL + + S+V ++ +
Sbjct: 257 VKLQGQL-DFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 181 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN----FD-IP 233
S + LD S N T + ++ +LT+L L LQ N L + +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMK 374
Query: 234 KLRHLNLSYNGLKGSIPS 251
L+ L++S N +
Sbjct: 375 SLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 6/83 (7%)
Query: 172 LQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 229
N +P S + +L++S N + I +L++L L + N + +
Sbjct: 7 RSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISV 64
Query: 230 FD-IPKLRHLNLSYNGLKGSIPS 251
F +L +L+LS+N L I
Sbjct: 65 FKFNQELEYLDLSHNKLV-KISC 86
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 133 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 190
+L L++ SN+LT + + P ++ L L N IP L
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQ 447
Query: 191 VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNL 223
L+++ N ++P I LT L + L +N
Sbjct: 448 ELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 18/129 (13%), Positives = 36/129 (27%), Gaps = 8/129 (6%)
Query: 138 GKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SPQLVVLD 193
L+ L L N + E ++ L++L L + + V+L
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 194 LSFNSFTGNIPQSIQNLTQLT-GLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSI 249
L P+ +Q+ + + +N I + + L N+
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 250 PSSLQKFPN 258
L
Sbjct: 207 SYFLSILAK 215
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 21/135 (15%), Positives = 39/135 (28%), Gaps = 3/135 (2%)
Query: 133 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVL 192
G + L+ L L + L I L + L + + K
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 252
L T I +++ T +L+ +N+ + K + L+ + S
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKC---VLEDNKCSYFLSILAKLQTNPKLS 223
Query: 253 LQKFPNSSFVGNSLL 267
N NS +
Sbjct: 224 NLTLNNIETTWNSFI 238
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 30/220 (13%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 446
+LGKGS+G K + VK + + +D +++E++ ++ HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKL 86
Query: 447 RAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAH 501
+V + + G L + A R +K + G+ +
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVFS---GITY 136
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPE 555
+H H ++K N+L+ C I DFGL+ +A Y APE
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
V+ + K DV+S GV+L +L+G P D++
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 61/253 (24%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 438
+LR LG GS+G + + +K L KE+VV + E ++ V
Sbjct: 9 QILR----TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV- 63
Query: 439 QHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----IL 492
HP ++ + + +++ ++ DY G L +LL R + R P K +
Sbjct: 64 THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP---NPVAKFYAAEVC 116
Query: 493 LGTARGVAHIHSMGGPKFTHGNI-----KASNVLINQDLDG--CISDFGLTPLMNVPA-- 543
L + ++HS +I K N+L+ D +G I+DFG +
Sbjct: 117 LA----LEYLHSK--------DIIYRDLKPENILL--DKNGHIKITDFGFAKYVPDVTYT 162
Query: 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 593
TP Y APEV+ T+ ++ D +SFG+L+ EML G P
Sbjct: 163 LCGTPD----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218
Query: 594 -VDLPRWVQSVVR 605
+ P + V+
Sbjct: 219 ELRFPPFFNEDVK 231
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 36/130 (27%), Positives = 52/130 (40%), Gaps = 14/130 (10%)
Query: 138 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLDL 194
G L L L L N L LP +LP+L L + N + +P +L L L
Sbjct: 74 GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 195 SFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 250
N +P + +L LSL +NNL+ +P + + L L L N L +IP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 251 SSLQKFPNSS 260
F +
Sbjct: 189 KGF--FGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 34/125 (27%), Positives = 51/125 (40%), Gaps = 13/125 (10%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 191
+P +T +L L N+L + + L L L + P L
Sbjct: 29 LPKDT-------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGS 248
LDLS N ++P Q L LT L + N L+ S+P + +L+ L L N LK +
Sbjct: 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-T 138
Query: 249 IPSSL 253
+P L
Sbjct: 139 LPPGL 143
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 37/111 (33%), Positives = 48/111 (43%), Gaps = 9/111 (8%)
Query: 139 KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS 195
L AL VL + N LT LP L L+ LYL+ N P + P+L L L+
Sbjct: 98 TLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156
Query: 196 FNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 243
N+ T +P + L L L LQ N+L +IP F L L N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 4/96 (4%)
Query: 164 LPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 223
+ S + N + +P +L LS N ++ T+LT L+L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 224 SGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ + +P L L+LS+N L+ S+P Q P
Sbjct: 68 T-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 42/225 (18%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
EVLG G++ + + T +K + K E ++ ++ ++ +H N+V L
Sbjct: 15 EVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLE 72
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR--VKILLGT 495
Y S LV + G L D + ++ +L
Sbjct: 73 DIYESTTHYYLVMQLVSGGEL--------------FDRILERGVYTEKDASLVIQQVLS- 117
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM--NVPATPSRSAG 550
V ++H G H ++K N+L + I+DFGL+ + + +T + G
Sbjct: 118 --AVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPG 172
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
Y APEV+ + +S D +S GV+ +L G P T + +
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE 217
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 8/144 (5%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 191
I + L L N +T +++ L L NN + K+ + + QL
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTF 216
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 251
LD S N T I + LTQLT N L+ + + KL L+ L +
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLLEIDLT 272
Query: 252 SLQKFPNSSFVGNSLLCGPPLKAC 275
+ G + +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHN 296
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 31/140 (22%), Positives = 52/140 (37%), Gaps = 7/140 (5%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195
+ +L L L ++ +T + I L L L NN + + S + L L
Sbjct: 37 SEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLDLSQNTNLTYLACD 93
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 255
N T N+ + LT+LT L+ +N L+ + P L +LN + N L S +
Sbjct: 94 SNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLTEIDVSHNTQ 149
Query: 256 FPNSSFVGNSLLCGPPLKAC 275
N + +
Sbjct: 150 LTELDCHLNKKITKLDVTPQ 169
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
+ + L L+ N LT +++ L L N K+ + QL LD SF
Sbjct: 123 VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSF 179
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP-SSLQK 255
N T + + L L+ +NN++ + +L L+ S N L I + L +
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLT-EIDVTPLTQ 234
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 25/131 (19%), Positives = 44/131 (33%), Gaps = 6/131 (4%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L L ++T L L Q + ++ S +P+LV L L+
Sbjct: 271 LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYLNN 327
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 256
T + + + T+L LS + ++ IP L + + +L
Sbjct: 328 TELT-ELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLTNN 384
Query: 257 PNSSFVGNSLL 267
+ V LL
Sbjct: 385 SLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 4/136 (2%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 190
N D + + L +L L +++ + L
Sbjct: 8 TQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLT 67
Query: 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 250
L + N+ T + + T LT L+ SN L+ ++ + KL +LN N L
Sbjct: 68 KLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTNKLTKLDV 123
Query: 251 SSLQKFPNSSFVGNSL 266
S + N+L
Sbjct: 124 SQNPLLTYLNCARNTL 139
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 19/135 (14%), Positives = 39/135 (28%), Gaps = 10/135 (7%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L + L L L + LT L ++ L+ L + + P L +
Sbjct: 314 LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAE 370
Query: 197 NSFTGNIPQSIQNLTQLTG------LSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 250
+P+ LT L N ++ + + +++ L P
Sbjct: 371 GQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429
Query: 251 SSLQKFPNSSFVGNS 265
+ F + +
Sbjct: 430 AVTYTFTSENGAIVG 444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 32/216 (14%), Positives = 70/216 (32%), Gaps = 25/216 (11%)
Query: 392 VLGKGSYGTAYKA----------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR----- 436
L +G + E+S + + K + + +
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 437 -VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGN---RGAGRTPLDWETRVKIL 492
++ + + DE ++Y+Y + S+ + + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 493 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG 550
++IH+ H ++K SN+L++++ +SDFG + M +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYE 215
Query: 551 YRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAP 584
+ PE + K D++S G+ L M P
Sbjct: 216 FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 63/253 (24%), Positives = 102/253 (40%), Gaps = 67/253 (26%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 438
+ L VLGKGS+G + + + + VK L K+VV+ D E M ++ G
Sbjct: 23 NFLM----VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 493
+ P + L + + + D V +Y G L + GR E I +
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFK---EPHAVFYAAEIAI 132
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGL---------------- 535
G + + S G + ++K NV++ D +G I+DFG+
Sbjct: 133 G----LFFLQSKG---IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFCG 183
Query: 536 TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-- 593
TP Y APE+I + + D ++FGVLL EML G+AP + D++
Sbjct: 184 TP------------DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
Query: 594 ------VDLPRWV 600
V P+ +
Sbjct: 232 SIMEHNVAYPKSM 244
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 438
+ L+ +LGKG++G + + +K L KEV+V K + + ++
Sbjct: 151 EYLK----LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS- 205
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 493
+HP + L+ + + D V +Y G L L R + E R + I+
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS------RERVFSEDRARFYGAEIVS 259
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG 550
+ ++HS + ++K N+++ D DG I+DFGL + AT G
Sbjct: 260 A----LDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGATMKTFCG 311
Query: 551 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596
Y APEV+E + D + GV++ EM+ G+ P + + + +L
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 15/130 (11%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNF-SGKIPSSFS--P 187
+ L +L+ L L L + L +L+ L + HN S K+P FS
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTG----LSLQSNNLSGSIPN--FDIPKLRHLNL 240
L LDLS N +I + + L Q+ L L N ++ I F +L+ L L
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELAL 207
Query: 241 SYNGLKGSIP 250
N LK S+P
Sbjct: 208 DTNQLK-SVP 216
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 28/127 (22%), Positives = 45/127 (35%), Gaps = 18/127 (14%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 188
+P +T + L L N L S P L+ L L I +
Sbjct: 26 LPFST-------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRHLNLSYNG 244
L L L+ N ++ L+ L L NL+ S+ N L+ LN+++N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 245 LKGSIPS 251
++ S
Sbjct: 136 IQ-SFKL 141
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 16/124 (12%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEIT--SLPSLRYLYLQHNNFSGKIPS-SFS-- 186
+ N +G L L+ L++ N++ +L +L +L L N I
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172
Query: 187 PQLVV----LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDI-PKLRHLN 239
Q+ + LDLS N I +L L+L +N L S+P+ FD L+ +
Sbjct: 173 HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIW 230
Query: 240 LSYN 243
L N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 5/74 (6%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 237
IP + LDLSFN S + +L L L + +I + + + L
Sbjct: 22 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLST 80
Query: 238 LNLSYNGLKGSIPS 251
L L+ N ++ S+
Sbjct: 81 LILTGNPIQ-SLAL 93
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 62/267 (23%), Positives = 110/267 (41%), Gaps = 45/267 (16%)
Query: 356 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAE------VLGKGSYGTAYKAVLEES 409
+E + EKN L + E +R E V+G+G++G L+ +
Sbjct: 39 DECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA 98
Query: 410 TTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYF 463
V +K L K ++ + + E ++ + L Y + D L LV DY+
Sbjct: 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLH-YAFQDDNNLYLVMDYY 156
Query: 464 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 518
G L TLL ++ R P E + +++ + +H + + H +IK
Sbjct: 157 VGGDLLTLL--SKFEDRLP---EEMARFYLAEMVIA----IDSVHQLH---YVHRDIKPD 204
Query: 519 NVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---YRAPEVIETRKHSHKS----- 566
N+L+ D++G ++DFG LM S A G Y +PE+++ +
Sbjct: 205 NILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262
Query: 567 DVYSFGVLLLEMLTGKAPLQSPTRDDM 593
D +S GV + EML G+ P + + +
Sbjct: 263 DWWSLGVCMYEMLYGETPFYAESLVET 289
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 5e-16
Identities = 51/275 (18%), Positives = 114/275 (41%), Gaps = 29/275 (10%)
Query: 331 KKKDNGSNGVSKGKASSGGRSE-KPKEEFGSGVQEPEKNKLVFFEGCSYN--FDLEDLLR 387
+K+ G + +GK G + + + + + + V + +D+
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH---- 162
Query: 388 ASAEVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVV 444
E LG G++G ++ E +T K + K ++++ + + +HP +V
Sbjct: 163 ---EELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLV 217
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L + +E +++Y++ + G L + + + ++ + G+ H+H
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK---GLCHMHE 273
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAPEVIE 558
+ H ++K N++ + DFGLT ++ P + +A + APEV E
Sbjct: 274 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAE 329
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
+ + +D++S GVL +L+G +P D+
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E LG G++G ++ V E++T V K + + K + ++ I+ ++ HP ++ L
Sbjct: 57 EELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLH 114
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ K E +L+ ++ + G L + + + ++ G+ H+H
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACE---GLKHMHEHS- 169
Query: 508 PKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 561
H +IK N++ + DFGL +N P + +A + APE+++
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDREP 226
Query: 562 HSHKSDVYSFGVLLLEMLTGKAP 584
+D+++ GVL +L+G +P
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-16
Identities = 33/131 (25%), Positives = 53/131 (40%), Gaps = 21/131 (16%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 199
+LE + +N+L E+ +LP L +Y +N +P P L L++ N
Sbjct: 214 PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP-PSLEALNVRDNYL 269
Query: 200 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---------------FDIPKLRHLNLSYNG 244
T ++P+ Q+LT L + LS PN P L LN+S N
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 328
Query: 245 LKGSIPSSLQK 255
L +P+ +
Sbjct: 329 LI-ELPALPPR 338
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 33/116 (28%), Positives = 53/116 (45%), Gaps = 9/116 (7%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 199
+LE ++ +N L LP E+ +LP L +Y +N+ K+P L + N
Sbjct: 172 PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDLPL-SLESIVAGNNIL 227
Query: 200 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 255
+P +QNL LT + +N L ++P+ P L LN+ N L +P Q
Sbjct: 228 E-ELP-ELQNLPFLTTIYADNNLLK-TLPDL-PPSLEALNVRDNYLT-DLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 28/132 (21%), Positives = 50/132 (37%), Gaps = 13/132 (9%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 195
L L+++ + +N L LP PSL ++ +N ++P P L +
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE-ELPELQNLPFLTAIYAD 203
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQ 254
NS +P +L + +N L +P ++P L + N LK ++P
Sbjct: 204 NNSLK-KLPDLPLSLESIV---AGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPDLPP 257
Query: 255 KFPNSSFVGNSL 266
+ N L
Sbjct: 258 SLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 24/135 (17%), Positives = 49/135 (36%), Gaps = 14/135 (10%)
Query: 138 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 197
+LE L++ +N L LP+ P L L N+ + ++P L L + +N
Sbjct: 314 DLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELPQ-NLKQLHVEYN 367
Query: 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFP 257
P +++ L+ N+ +P L+ L++ N L+ P +
Sbjct: 368 PLR-EFPDIPESVE-----DLRMNSHLAEVPEL-PQNLKQLHVETNPLR-EFPDIPESVE 419
Query: 258 NSSFVGNSLLCGPPL 272
+ ++
Sbjct: 420 DLRMNSERVVDPYEF 434
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 25/154 (16%), Positives = 41/154 (26%), Gaps = 35/154 (22%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSL-------------PSLRYLYLQHNNFS 178
+P + + + P L L + S
Sbjct: 26 MPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 179 GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--------- 229
+P P L L S NS T +P+ Q+L L + LS P
Sbjct: 85 -SLPELP-PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNN 141
Query: 230 --------FDIPKLRHLNLSYNGLKGSIPSSLQK 255
+ L+ +++ N LK +P
Sbjct: 142 QLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 35/126 (27%), Positives = 50/126 (39%), Gaps = 17/126 (13%)
Query: 134 NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 189
NN L L LE L++R N LT LP SL L + S P L
Sbjct: 246 NNLLKTLPDLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS-----ELPPNL 299
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
L+ S N ++ +L +L ++ +N L +P P+L L S+N L +
Sbjct: 300 YYLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPA-LPPRLERLIASFNHLA-EV 352
Query: 250 PSSLQK 255
P Q
Sbjct: 353 PELPQN 358
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 23/133 (17%), Positives = 44/133 (33%), Gaps = 24/133 (18%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------------- 186
L+ S+ LT +P E ++ S Y + + P
Sbjct: 10 NTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 187 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSY 242
Q L+L+ + ++P+ +L L N+L+ +P + L N +
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 243 NGLKGSIPSSLQK 255
L +P L+
Sbjct: 124 KALS-DLPPLLEY 135
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 14/111 (12%), Positives = 34/111 (30%), Gaps = 23/111 (20%)
Query: 134 NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSL----------------PSLRYLYLQ 173
N L ++ L+ L + N L P S+ +L+ L+++
Sbjct: 346 FNHLAEVPELPQNLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVE 404
Query: 174 HNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 224
N + P + L ++ + + +L + ++
Sbjct: 405 TNPLR-EFPDIPE-SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 53/246 (21%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 438
L + +LGKGS+G + A +++ +K L K+VV+ D E M ++
Sbjct: 20 ILHK----MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 493
+HP + + + +K+ V +Y G L + + +R I+L
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFD---LSRATFYAAEIIL 129
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPA-------- 543
G + +HS G + ++K N+L+ D DG I+DFG+ N+
Sbjct: 130 G----LQFLHSKG---IVYRDLKLDNILL--DKDGHIKIADFGMCKE-NMLGDAKTNTFC 179
Query: 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------V 594
TP Y APE++ +K++H D +SFGVLL EML G++P +++
Sbjct: 180 GTPD----YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235
Query: 595 DLPRWV 600
PRW+
Sbjct: 236 FYPRWL 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 35/294 (11%), Positives = 76/294 (25%), Gaps = 75/294 (25%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQME----IVGRVGQHPNVV 444
G ++A+ + + V + + V D Q+ + R+ P V
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVA 94
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
+ +++ L+V ++ GSL + T ++ + A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAHR 147
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSH 564
G S V ++ D D ++ P A P
Sbjct: 148 AG---VALSIDHPSRVRVSIDGDVVLAYPATMP----DANP------------------- 181
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-----------PRWVQSVVREEWTAEVF 613
+ D+ G L +L + PL + P + + + +A
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA- 240
Query: 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP 667
V +R ++ ++++
Sbjct: 241 ---------------------ARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 67/283 (23%), Positives = 109/283 (38%), Gaps = 65/283 (22%)
Query: 352 EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTAYKAVLEES 409
K KE+F + P +N L+ ++ LG GS+G +ES
Sbjct: 20 AKAKEDFLKKWETPSQNTA----------QLDQFDRIK----TLGTGSFGRVMLVKHKES 65
Query: 410 TTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLL--VYDY 462
+K L K+ VV + E + I+ V P +V L + KD L V +Y
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKL--EFSFKDNSNLYMVMEY 122
Query: 463 FASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKA 517
A G + + L R GR E + I+L ++HS+ + ++K
Sbjct: 123 VAGGEMFSHL---RRIGRFS---EPHARFYAAQIVLT----FEYLHSLD---LIYRDLKP 169
Query: 518 SNVLINQDLDG--CISDFGLTPLMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYS 570
N+LI D G ++DFG + TP APE+I ++ ++ D ++
Sbjct: 170 ENLLI--DQQGYIQVTDFGFAKRVKGRTWTLCGTPE----ALAPEIILSKGYNKAVDWWA 223
Query: 571 FGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 605
GVL+ EM G P + + V P S ++
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 9e-16
Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 448
+G+GS+G AV + + K++ K V F+Q++EI+ + HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYE 73
Query: 449 YYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAHIH 503
+ + LV + G L + A R +K +L VA+ H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-------MKDVLS---AVAYCH 123
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVI 557
+ H ++K N L D + DFGL + T + Y +P+V+
Sbjct: 124 KLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 558 ETRKHSHKSDVYSFGVLLLEMLTGKAP 584
E + + D +S GV++ +L G P
Sbjct: 181 E-GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-16
Identities = 46/229 (20%), Positives = 93/229 (40%), Gaps = 45/229 (19%)
Query: 392 VLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPL 446
V+G+G++ ++++ V +K + K ++ + + E ++ + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQL 126
Query: 447 RAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARG 498
+++ + L LV +Y+ G L TLL ++ R P + I++
Sbjct: 127 ---HFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIP---AEMARFYLAEIVMA---- 174
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---Y 551
+ +H +G + H +IK N+L+ D G ++DFG L S A G Y
Sbjct: 175 IDSVHRLG---YVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 552 RAPEVIETRKHSHKSDVY-------SFGVLLLEMLTGKAPLQSPTRDDM 593
+PE+++ + Y + GV EM G+ P + + +
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 448
+ G+G++GT + + V +K+ +++ R+ Q M+ + + HPN+V L++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVL-HHPNIVQLQS 86
Query: 449 YYYSKDEK-------LLVYDYFASGSLSTLLH---GNRGAGRTPLDWETRVKILL-GTAR 497
Y+Y+ E+ +V +Y + LH N + +K+ L R
Sbjct: 87 YFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPIL-IKVFLFQLIR 140
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVPATP------SRS 548
+ +H H +IK NVL+N+ L C DFG + P+ P SR
Sbjct: 141 SIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLC--DFGSAKKL-SPSEPNVAYICSRY 196
Query: 549 AGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 585
YRAPE+I +H + D++S G + EM+ G+ P+
Sbjct: 197 --YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 56/264 (21%), Positives = 103/264 (39%), Gaps = 43/264 (16%)
Query: 377 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQMEIV 434
S++ ED+ + +VLG+G++ + ++ VK + K+ + +++E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 435 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRV 489
+ H NV+ L ++ +D LV++ GS+ + A V
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-------V 117
Query: 490 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGL----------T 536
+ + + +H+ G H ++K N+L NQ I DF L +
Sbjct: 118 QDVAS---ALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 537 PLMNVP-ATPSRSAGYRAPEVIETRKHSHKS-----DVYSFGVLLLEMLTGKAPLQSPTR 590
P+ TP SA Y APEV+E D++S GV+L +L+G P
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
Query: 591 DDMVDLPRWVQSVVREEWTAEVFD 614
D W + +F+
Sbjct: 232 SD----CGWDRGEACPACQNMLFE 251
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 35/129 (27%), Positives = 58/129 (44%), Gaps = 15/129 (11%)
Query: 132 IPNNTLGKLDA--LEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS- 186
N T L+A ++ L + + L + + L L L N + KI +F
Sbjct: 264 PDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWG 321
Query: 187 -PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLS 241
L+ L+LS N +I + +NL +L L L N++ ++ + F +P L+ L L
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALD 379
Query: 242 YNGLKGSIP 250
N LK S+P
Sbjct: 380 TNQLK-SVP 387
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 33/146 (22%), Positives = 58/146 (39%), Gaps = 10/146 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 187
+ + +L L+ L + + + L SL L L +N F ++ + F+
Sbjct: 45 LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLA 103
Query: 188 QLVVLDLSFNSFTG-NIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSY 242
L VL L+ + G + + + LT L L L+ NN+ P F + + L+L++
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 243 NGLKGSIPSSLQKFPNSSFVGNSLLC 268
N +K L F F L
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSS 189
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 30/147 (20%), Positives = 51/147 (34%), Gaps = 23/147 (15%)
Query: 129 VGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS- 186
V +P + + L N + + + L L++L ++ I + +F
Sbjct: 25 VPELPAHV-------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77
Query: 187 -PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNL-SGSIPN--FD-IPKLRHLNL 240
L++L L +N F + L L L+L NL + F + L L L
Sbjct: 78 LSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 241 SYNGLKGSIPSSLQKFPNSSFVGNSLL 267
N +K I P S F+
Sbjct: 137 RDNNIK-KIQ------PASFFLNMRRF 156
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 39/139 (28%), Positives = 50/139 (35%), Gaps = 17/139 (12%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGG-LPSEI-TSLPSLRYLYLQHNNFSGKIPSSF---S 186
+ L LEVL+L L G L L SL L L+ NN P+SF
Sbjct: 94 LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLT--QLTGLSLQSNNL---------SGSIPNFD-IPK 234
+ VLDL+FN + + N T L L S L N
Sbjct: 154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213
Query: 235 LRHLNLSYNGLKGSIPSSL 253
+ L+LS NG K S+
Sbjct: 214 ITTLDLSGNGFKESMAKRF 232
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 29/158 (18%), Positives = 47/158 (29%), Gaps = 48/158 (30%)
Query: 139 KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------------ 186
+L ++ + + L S+ L L N F + F
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 187 -----------------------------PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGL 216
+ DLS + + +S+ + T L L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 217 SLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPS 251
+L N ++ I + F + L LNLS N L SI S
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDS 340
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 13/47 (27%), Positives = 24/47 (51%), Gaps = 2/47 (4%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNF 177
+ + + L L+ L+L +N L +P I L SL+ ++L N +
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 54/227 (23%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVK----------RLKEVVVGKRDFEQQMEIVGRVG 438
E+LG+G + + + T VK +EV + ++++I+ +V
Sbjct: 23 EILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR 488
HPN++ L+ Y + LV+D G L D+ ETR
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGEL--------------FDYLTEKVTLSEKETR 127
Query: 489 --VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPA 543
++ LL + +H + H ++K N+L++ D++ ++DFG + +
Sbjct: 128 KIMRALLE---VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 544 TPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ Y APE+IE + + D++S GV++ +L G P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 50/227 (22%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVLEESTTVV--VKRL-KEVVVGKRDFEQQM---EIVGRV 437
+ R ++G+G +G Y + T + +K L K+ + K+ + ++ V
Sbjct: 192 SVHR----IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 438 --GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK----- 490
G P +V + +++ D+ + D G L L G E ++
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS---EADMRFYAAE 300
Query: 491 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSR- 547
I+LG + H+H+ + ++K +N+L+ D G ISD GL + +
Sbjct: 301 IILG----LEHMHNRF---VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASV 351
Query: 548 -SAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592
+ GY APEV++ + +D +S G +L ++L G +P + D
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 33/223 (14%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
LG G++G + S V+K + V E ++E++ + HPN++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIF 86
Query: 448 AYYYSKDEKLLVYDYFASGSL------STLLHGN---RGAGRTPLDWETRVKILLGTARG 498
+ +V + G L + +K ++
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-------MKQMMN---A 136
Query: 499 VAHIHSMGGPKFTHGNIKASNVL-INQDLDGCI--SDFGLTPLM---NVPATPSRSAGYR 552
+A+ HS H ++K N+L + I DFGL L + +A Y
Sbjct: 137 LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
APEV + R + K D++S GV++ +LTG P + +++
Sbjct: 194 APEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 73/289 (25%)
Query: 337 SNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKG 396
N +G SG EK + L F+ LLR V+G+G
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFD----------LLR----VIGRG 63
Query: 397 SYGTAYKAVLEESTTV----VVKRLKEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAY 449
SY L+++ + VVK KE+V D + + + HP +V L +
Sbjct: 64 SYAKVLLVRLKKTDRIYAMRVVK--KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHS 504
+ ++ V +Y G L + H R + P E + I L + ++H
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP---EEHARFYSAEISLA----LNYLHE 171
Query: 505 MGGPKFTHGNIKASNVLINQDLDG--CISDFGL----------------TPLMNVPATPS 546
G + ++K NVL+ D +G ++D+G+ TP
Sbjct: 172 RG---IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP--------- 217
Query: 547 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
Y APE++ + D ++ GVL+ EM+ G++P D D
Sbjct: 218 ---NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 46/215 (21%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 391 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 441
E LG G + K E+ST + ++ + V + + E+++ I+ +V H
Sbjct: 18 EELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHH 75
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVA 500
NV+ L Y ++ + +L+ + + G L + A + L E + GV
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLS-EEEATSFIKQILDGVN 129
Query: 501 HIHSMGGPKFTHGNIKASNVLI-NQDLDGC---ISDFGL-------TPLMNVPATPSRSA 549
++H+ H ++K N+++ ++++ + DFGL N+ TP
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP---- 182
Query: 550 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ APE++ ++D++S GV+ +L+G +P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 38/127 (29%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 187
+P +L LE L + N L LP + L +L L L N +P F
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT 133
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
+L L L +N ++P+ + LT L L L +N L +P FD + +L+ L L N
Sbjct: 134 KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNN 191
Query: 244 GLKGSIP 250
LK +P
Sbjct: 192 QLK-RVP 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 40/127 (31%), Positives = 56/127 (44%), Gaps = 18/127 (14%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 188
IP +T + L L+SN L+ L LR LYL N +P+ F
Sbjct: 35 IPADT-------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 244
L L ++ N +P + L L L L N L S+P FD + KL +L+L YN
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 245 LKGSIPS 251
L+ S+P
Sbjct: 145 LQ-SLPK 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 21/74 (28%), Positives = 34/74 (45%), Gaps = 5/74 (6%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 237
IPS+ LDL N + ++ LT+L L L N L ++P F + L
Sbjct: 31 IPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLET 89
Query: 238 LNLSYNGLKGSIPS 251
L ++ N L+ ++P
Sbjct: 90 LWVTDNKLQ-ALPI 102
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 28/94 (29%), Positives = 38/94 (40%), Gaps = 6/94 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
+P L L LSL N L LP + L SL+ L L +N +F +
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSN 221
L L L N +P+ +L +L L LQ N
Sbjct: 183 LKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 29/132 (21%), Positives = 49/132 (37%), Gaps = 13/132 (9%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSE--ITSLPSLRYLYLQHNNFSGKIPS-SF--- 185
I + L +L L+ L + + L P + S L + N + IP +F
Sbjct: 96 IDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154
Query: 186 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLS 241
+ + L L N FT ++ N T+L + L N I F L++S
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213
Query: 242 YNGLKGSIPSSL 253
+ ++PS
Sbjct: 214 QTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 23/130 (17%), Positives = 42/130 (32%), Gaps = 12/130 (9%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 187
IP++ L + + + +V L S +L + ++ +++ I P
Sbjct: 46 IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105
Query: 188 QLVVLDLSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLS 241
L L + P + + L + N SIP F + L L
Sbjct: 106 LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164
Query: 242 YNGLKGSIPS 251
NG S+
Sbjct: 165 NNGFT-SVQG 173
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 17/117 (14%)
Query: 159 SEITSLP-SLRYLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQL 213
I SLP S + L L + IPS +FS P + + +S + + NL+++
Sbjct: 24 QRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82
Query: 214 TGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 267
T + +++ I +P L+ L + G L+ FP+ + V ++ +
Sbjct: 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG--------LKMFPDLTKVYSTDI 131
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 132 IPNNTLGKLDA-LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSP-- 187
IP N L L L +N T + + L +YL N + I +F
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 188 -QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSL 218
+LD+S S T +P ++L +L +
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 56/225 (24%)
Query: 391 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 441
E LG G + K E+ST + ++ + V + + E+++ I+ +V HP
Sbjct: 18 EELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHP 75
Query: 442 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 491
N++ L Y ++ + +L+ + F SLS E
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS----------------EEEATS 119
Query: 492 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGL-------TPLM 539
+ GV ++H+ H ++K N++ +++++ + DFGL
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 540 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
N+ TP + APE++ ++D++S GV+ +L+G +P
Sbjct: 177 NIFGTP----EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 75/352 (21%), Positives = 122/352 (34%), Gaps = 98/352 (27%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 442
+ LG+G++G +A TV VK LKE R +++I+ +G H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 443 VVPLRAYYYSKDEKLLV-YDYFASGSLSTLLHGNRGA------------------GRTPL 483
VV L L+V ++ G+LST L R G P+
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 484 DWETRVKILLGT----------ARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGC- 529
D + R+ + + + ++ + P+ + + LI Q G
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 530 --------------------------ISDFGLTPLMNVPATPSRSAGYR------APEVI 557
I DFGL + R R APE I
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267
Query: 558 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEV 612
R ++ +SDV+SFGVLL E+ + G +P P + R ++ R + T E+
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325
Query: 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
+ ML C P RP E+V + + Q++++
Sbjct: 326 YQT--------------MLD----CWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVLEESTTV----VVKRLKEVVVGKRDFEQQM---EIVGR 436
DLLR V+G+GSY L+++ + VVK KE+V D + + +
Sbjct: 12 DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVK--KELVNDDEDIDWVQTEKHVFEQ 65
Query: 437 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 491
HP +V L + + ++ V +Y G L + H R + P E + I
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP---EEHARFYSAEI 119
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPA------ 543
L + ++H G + ++K NVL+ D +G ++D+G+ P
Sbjct: 120 SLA----LNYLHERG---IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTF 170
Query: 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
TP+ Y APE++ + D ++ GVL+ EM+ G++P D D
Sbjct: 171 CGTPN----YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 50/226 (22%), Positives = 77/226 (34%), Gaps = 51/226 (22%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQM-------EI-VGRVGQ 439
+ GSYG V E V +KR+ V R EI +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 440 HPNVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL- 493
HPN++ L + KL LV + + T L R + ++ +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVIS-PQHIQYFMY 141
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 550
G+ +H G H ++ N+L+ + D I DF L +R
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL----------AREDTADA 188
Query: 551 ----------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 585
YRAPE++ K K D++S G ++ EM K L
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-AL 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 46/218 (21%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 441
+ +G G+ G A V +K+L F+ Q E+V + H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 121
Query: 442 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
N++ L + + D Y + L + LD E +L G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIK 178
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 550
H+HS G H ++K SN+++ D I DFGL +R+AG
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL----------ARTAGTSFMMTPYVV 225
Query: 551 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
YRAPEVI + D++S G ++ EM+ K L
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK-IL 262
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 30/128 (23%), Positives = 47/128 (36%), Gaps = 11/128 (8%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS---P 187
I ++ L +LE L L N L+ L S L SL +L L N + +S
Sbjct: 91 IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
+L +L + I + LT L L + +++L S I + HL L
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK 208
Query: 244 GLKGSIPS 251
+
Sbjct: 209 QHI-LLLE 215
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 35/225 (15%), Positives = 65/225 (28%), Gaps = 32/225 (14%)
Query: 63 IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLR 122
+ +L F L L L NP ++ + T++ LR
Sbjct: 112 LSNLSSSWFKPL--------------SSLTFL-NLLGNPY-KTLGETSLFSHLTKLQILR 155
Query: 123 LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 182
+ + I L LE L + ++ L P + S+ ++ +L L +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215
Query: 183 SSFS--PQLVVLDLSFNSFTGNIPQSIQ--------NLTQLTGLSLQSNNLSGSIPNFD- 231
+ L+L + + + +L + +
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQ 275
Query: 232 IPKLRHLNLSYNGLKGSIPSS-LQKFPNSSFV---GNSLLCGPPL 272
I L L S N LK S+P + + + N C P
Sbjct: 276 ISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 31/115 (26%), Positives = 44/115 (38%), Gaps = 8/115 (6%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 202
+ + S S + + IPS + + LDLS N T
Sbjct: 9 WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTEAVKSLDLSNNRIT-Y 66
Query: 203 IPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 253
I S Q L L L SN ++ +I F + L HL+LSYN L ++ SS
Sbjct: 67 ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW 119
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 41/202 (20%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 448
E LG+G +G ++ V E S+ T + K +K + ++++ I+ H N++ L
Sbjct: 11 EDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHE 68
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 508
+ S +E ++++++ + + + + + V + + +HS
Sbjct: 69 SFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCE---ALQFLHSHN-- 122
Query: 509 KFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKH 562
H +I+ N++ I +FG + P R + Y APEV +
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 563 SHKSDVYSFGVLLLEMLTGKAP 584
S +D++S G L+ +L+G P
Sbjct: 181 STATDMWSLGTLVYVLLSGINP 202
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSSFSPQL 189
+ +LE L + N L + S+ L L N +G + P++
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV 452
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
VLDL N +IP+ + +L L L++ SN L S+P+ FD + L+++ L N
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 32/133 (24%), Positives = 50/133 (37%), Gaps = 8/133 (6%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---- 187
I + L+ NV T + ++L L+ L LQ N
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 188 -QLVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 245
L LD+S NS ++ + L+L SN L+GS+ PK++ L+L N +
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRI 462
Query: 246 KGSIPSSLQKFPN 258
SIP +
Sbjct: 463 M-SIPKDVTHLQA 474
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 33/121 (27%), Positives = 45/121 (37%), Gaps = 17/121 (14%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+P T + LSL N ++ +I+ L LR L L HN F L
Sbjct: 50 LPPRT-------KALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FD-IPKLRHLNLSYNGL 245
LD+S N NI + L L L N+ +P F + KL L LS
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 246 K 246
+
Sbjct: 159 R 159
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 11/126 (8%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---S 186
L L+ L L+ N L + ++ SL L + N+ + +
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNG 244
++VL+LS N TG++ + + ++ L L +N + SIP + L+ LN++ N
Sbjct: 428 ESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 245 LKGSIP 250
LK S+P
Sbjct: 485 LK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 37/251 (14%), Positives = 78/251 (31%), Gaps = 21/251 (8%)
Query: 28 LGLHFCYSSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLP-LAFADLNSDRQALLDFAD 86
+ + L IP L + F + + + V+ L L +++ + +
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 87 AV------PHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI----PNNT 136
+ P L + + V + V L + + + I +
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLD 193
L +L + +++ V + + + L ++ + I L+
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSSFTFLN 359
Query: 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIP----KLRHLNLSYNGLKGS 248
+ N FT ++ Q L +L L LQ N L + + L L++S N L
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSH 418
Query: 249 IPSSLQKFPNS 259
+ S
Sbjct: 419 AYDRTCAWAES 429
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 6/90 (6%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
+ + N + +P P+ L LS NS + I L++L L L N +
Sbjct: 32 LESMVDYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR- 89
Query: 226 SIPN--FD-IPKLRHLNLSYNGLKGSIPSS 252
S+ F L +L++S+N L+ +I
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC 118
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
+ VL+L SN+LTG + + P ++ L L +N IP + L L+++ N
Sbjct: 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486
Query: 201 GNIPQSI-QNLTQLTGLSLQSNN 222
++P + LT L + L N
Sbjct: 487 -SVPDGVFDRLTSLQYIWLHDNP 508
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 36/123 (29%), Positives = 48/123 (39%), Gaps = 8/123 (6%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L + L L N L S I L S++ L L + P + L VL L
Sbjct: 81 LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 255
N T NI + LT L LS+ + +S + + KL L N + I S L
Sbjct: 139 NQIT-NIS-PLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS-DI-SPLAS 193
Query: 256 FPN 258
PN
Sbjct: 194 LPN 196
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 24/123 (19%), Positives = 48/123 (39%), Gaps = 8/123 (6%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
+ L+ L L L+ N +T + + +L + L L N + + LDL+
Sbjct: 59 VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTS 116
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 255
T P + L+ L L L N ++ +I + L++L++ + + + L
Sbjct: 117 TQITDVTP--LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVS-DL-TPLAN 171
Query: 256 FPN 258
Sbjct: 172 LSK 174
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 6/123 (4%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195
T LD + LS +T + L +L L L+ N + P ++ L+LS
Sbjct: 36 TQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 255
N N+ +I L + L L S ++ P + L+ L L N + +I S L
Sbjct: 94 GNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NI-SPLAG 149
Query: 256 FPN 258
N
Sbjct: 150 LTN 152
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 29/123 (23%), Positives = 53/123 (43%), Gaps = 8/123 (6%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
+ L +++ L L S +T + + L +L+ LYL N + P + L L +
Sbjct: 103 IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQK 255
+ ++ + NL++LT L N +S I +P L ++L N + + S L
Sbjct: 161 AQVS-DLT-PLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQIS-DV-SPLAN 215
Query: 256 FPN 258
N
Sbjct: 216 TSN 218
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 28/128 (21%), Positives = 50/128 (39%), Gaps = 4/128 (3%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L L+VL L N +T S + L +L+YL + + S P + +L L
Sbjct: 125 LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 256
N + +I + +L L + L++N +S P + L + L+ +
Sbjct: 183 NKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 257 PNSSFVGN 264
+ V
Sbjct: 241 VVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 15/137 (10%)
Query: 130 GPIPNNT-------LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 182
G I T L ++ + +T L + L +
Sbjct: 1 GSITQPTAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG 58
Query: 183 SSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLS 241
+ L+ L+L N T ++ ++NLT++T L L N L ++ + ++ L+L+
Sbjct: 59 VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLT 115
Query: 242 YNGLKGSIPSSLQKFPN 258
+ P L N
Sbjct: 116 STQITDVTP--LAGLSN 130
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 24/107 (22%), Positives = 41/107 (38%), Gaps = 2/107 (1%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L L L N ++ S + SLP+L ++L++N S P + + L ++ L+
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 243
+ T NL + S D NL++N
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 18/94 (19%), Positives = 38/94 (40%), Gaps = 7/94 (7%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L L + L++N ++ S + + +L + L + + P ++ LVV ++
Sbjct: 191 LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVK 247
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF 230
I T + S NL+ ++ +F
Sbjct: 248 G----PSGAPIAPATISDNGTYASPNLTWNLTSF 277
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 72/293 (24%)
Query: 349 GRSEKPKEEFGSGVQEPE---KNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTAYK 403
G S+ + E + P ++ + + D L+ V+GKGS+G
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK----VIGKGSFGKVLL 56
Query: 404 AVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLL 458
A + VK L K+ ++ K++ + M ++ + +HP +V L + + D+
Sbjct: 57 ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116
Query: 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHG 513
V DY G L L E R + I + ++HS+ +
Sbjct: 117 VLDYINGGELFYHLQR---ERCFL---EPRARFYAAEIASA----LGYLHSLN---IVYR 163
Query: 514 NIKASNVLINQDLDG--CISDFGL----------------TPLMNVPATPSRSAGYRAPE 555
++K N+L+ D G ++DFGL TP Y APE
Sbjct: 164 DLKPENILL--DSQGHIVLTDFGLCKENIEHNSTTSTFCGTP------------EYLAPE 209
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 600
V+ + + D + G +L EML G P S +M + L +
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI 262
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 56/225 (24%)
Query: 391 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 441
E LG G + K E+ST + +R K V + D E+++ I+ + QHP
Sbjct: 17 EELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHP 74
Query: 442 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 491
NV+ L Y +K + +L+ + F SL+ E
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT----------------EEEATE 118
Query: 492 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGL-------TPLM 539
L GV ++HS+ H ++K N++ +++++ I DFGL
Sbjct: 119 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 540 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
N+ TP + APE++ ++D++S GV+ +L+G +P
Sbjct: 176 NIFGTP----EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 57/241 (23%), Positives = 102/241 (42%), Gaps = 44/241 (18%)
Query: 384 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 438
D L+ +LGKG++G + + +K L KEV++ K + + ++
Sbjct: 8 DYLK----LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 493
+HP + L+ + + D V +Y G L H +R E R + I+
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFT---EERARFYGAEIVS 116
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG 550
+ ++HS + +IK N+++ D DG I+DFGL ++ AT G
Sbjct: 117 A----LEYLHSRD---VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 551 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRW 599
Y APEV+E + D + GV++ EM+ G+ P + + + + PR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227
Query: 600 V 600
+
Sbjct: 228 L 228
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 42/222 (18%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 391 EVLGKGSYGTAYKAVLEEST-------TVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHP 441
E LG G + K ++ T + +RL V + + E+++ I+ + +HP
Sbjct: 11 EELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHP 68
Query: 442 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 491
N++ L + +K + +L+ + F SL+ E
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT----------------EDEATQ 112
Query: 492 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGLTPLMNVPATPS 546
L GV ++HS H ++K N++ +++++ + DFG+ +
Sbjct: 113 FLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF 168
Query: 547 R----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ + + APE++ ++D++S GV+ +L+G +P
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 26/211 (12%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQ---------MEIVGRVGQ 439
+LGKG +GT + L + V +K + + V+G + VG G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGS-LSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
HP V+ L ++ +++ +LV + L + G +R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEG-PSR-CFFGQVVAA 151
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLM--NVPATPSRSAGYRAP 554
+ H HS G H +IK N+LI+ GC + DFG L+ + Y P
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLR-RGCAKLIDFGSGALLHDEPYTDFDGTRVYSPP 207
Query: 555 EVIETRK-HSHKSDVYSFGVLLLEMLTGKAP 584
E I + H+ + V+S G+LL +M+ G P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGK--RDFEQQMEIVGRVGQHPNVVP 445
+LGKGS+G K + T VK + K K +++E++ ++ HPN++
Sbjct: 28 CMLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMK 85
Query: 446 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 500
L +V + + G L + A R +K + G+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVFS---GIT 135
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMN---VPATPSRSAGYRAP 554
++H H ++K N+L+ C I DFGL+ +A Y AP
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
EV+ + K DV+S GV+L +L+G P
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 33/137 (24%), Positives = 58/137 (42%), Gaps = 17/137 (12%)
Query: 134 NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 189
N L L LE L N L+ LP SL++L + +N + +P + L
Sbjct: 89 QNALISLPELPASLEYLDACDNRLST-LPELP---ASLKHLDVDNNQLT-MLPELPA-LL 142
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249
++ N T +P+ +L L S+++N L+ +P L L++S N L+ S+
Sbjct: 143 EYINADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPEL-PESLEALDVSTNLLE-SL 195
Query: 250 PSSLQKFPNSSFVGNSL 266
P+ + +S
Sbjct: 196 PAVPVRNHHSEETEIFF 212
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 33/166 (19%), Positives = 53/166 (31%), Gaps = 14/166 (8%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 202
LE ++ +N LT LP TSL L +++N + +P L LD+S N +
Sbjct: 142 LEYINADNNQLTM-LPELPTSL---EVLSVRNNQLT-FLPELPE-SLEALDVSTNLLE-S 194
Query: 203 IPQSIQNLTQLT----GLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKF 256
+P + N ++ IP + + L N L I SL +
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
Query: 257 PNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKL 302
+ P F KQS ++
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 22/123 (17%), Positives = 38/123 (30%), Gaps = 7/123 (5%)
Query: 133 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVL 192
P N L + S S N + Q L
Sbjct: 6 PINNNFSLSQNSFYNTISGTY-ADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 252
L+ + + ++P ++ Q+T L + N L S+P L +L+ N L ++P
Sbjct: 65 QLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPE-LPASLEYLDACDNRLS-TLPEL 118
Query: 253 LQK 255
Sbjct: 119 PAS 121
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 18/98 (18%), Positives = 29/98 (29%), Gaps = 5/98 (5%)
Query: 136 TLGKLDALE----VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 191
+ E R N +T +P I SL + L+ N S +I S S Q
Sbjct: 198 VPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 229
D ++ QN + + +
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 393 LGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQMEIVG-RVGQHPNVVPLR- 447
+G+G+YG YKA ++ +K+++ + EI R +HPNV+ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQK 85
Query: 448 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDW---ETRVK-ILLGTARGVAHI 502
+ D K+ L++DY A L ++ +R + VK +L G+ ++
Sbjct: 86 VFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 503 HSMGGPKFTHGNIKASNVLINQDLD--GC--ISDFGLTPLMNVPATPSRSAG-------Y 551
H+ H ++K +N+L+ + G I+D G L N P P Y
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 552 RAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
RAPE++ R ++ D+++ G + E+LT + P+
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 64/291 (21%)
Query: 331 KKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRA 388
G+ G S G + K E + K+ +E+ LL+
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKV----------GIENFELLK- 60
Query: 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRL-------KEVVVGK-RDFEQQM---EIVGRV 437
VLG G+YG + + + +L K +V K + E +++ +
Sbjct: 61 ---VLGTGAYGKVFLV--RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 438 GQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---- 490
Q P +V L +Y+ + KL L+ DY G L T L R E V+
Sbjct: 116 RQSPFLVTL---HYAFQTETKLHLILDYINGGELFTHL---SQRERFT---EHEVQIYVG 166
Query: 491 -ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLT-PLMNVPATPS 546
I+L + H+H +G + +IK N+L+ D +G ++DFGL+ + +
Sbjct: 167 EIVLA----LEHLHKLG---IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERA 217
Query: 547 RS----AGYRAPEVIETRKHSHKSDV--YSFGVLLLEMLTGKAPLQSPTRD 591
Y AP+++ H V +S GVL+ E+LTG +P
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 46/258 (17%), Positives = 83/258 (32%), Gaps = 60/258 (23%)
Query: 391 EVLGKGSYGTAYKAVLEEST-------TVVVKRLKEVVVGKR-DFEQQMEIVGRVGQHPN 442
+G+GSYG A+ E T + +++++ + ++ ++ ++ HPN
Sbjct: 32 GAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPN 89
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTAR--- 497
+ L Y + LV + G L L + G+ +D
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 498 ------------------------------GVAHIHSMGGPKFTHGNIKASNVLINQDLD 527
+ ++H+ G H +IK N L + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206
Query: 528 GC--ISDFGLTPLMNVPATPSR--------SAGYRAPEVIE--TRKHSHKSDVYSFGVLL 575
+ DFGL+ + + APEV+ + K D +S GVLL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 576 LEMLTGKAPLQSPTRDDM 593
+L G P D
Sbjct: 267 HLLLMGAVPFPGVNDADT 284
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 61/248 (24%), Positives = 99/248 (39%), Gaps = 54/248 (21%)
Query: 384 DLLRASAEVLGKGSYGT---AYKAVLEESTTVV-VKRL-KEVVVGK-RDFEQQM---EIV 434
+LLR VLGKG YG K + + +K L K ++V +D I+
Sbjct: 20 ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 435 GRVGQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 490
V +HP +V L Y+ KL L+ +Y + G L L G E
Sbjct: 76 EEV-KHPFIVDL---IYAFQTGGKLYLILEYLSGGELFMQLER---EGIFM---EDTACF 125
Query: 491 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPAT 544
I + + H+H G + ++K N+++ + G ++DFGL T
Sbjct: 126 YLAEISMA----LGHLHQKG---IIYRDLKPENIML--NHQGHVKLTDFGLCKESIHDGT 176
Query: 545 PSRS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 593
+ + Y APE++ H+ D +S G L+ +MLTG P R
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 594 -VDLPRWV 600
++LP ++
Sbjct: 237 KLNLPPYL 244
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 43/219 (19%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 381 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTV-----VVKRLKEVVVGKRDFEQQMEIVG 435
+ + +++ LG+G + + + +ST +K+ + + + ++ ++
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 436 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495
P V+ L Y + E +L+ +Y A G + +L + D +K +L
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE- 142
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGCI--SDFGL-------TPLMNVPATP 545
GV ++H H ++K N+L + G I DFG+ L + TP
Sbjct: 143 --GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 546 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
Y APE++ + +D+++ G++ +LT +P
Sbjct: 198 ----EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVK---------RLKEVVVGKRDFEQQMEIVGRVGQ 439
+ LG G+ G A E T V ++ + E ++EI+ ++
Sbjct: 141 KTLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-N 198
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
HP ++ ++ ++ ++D +V + G L ++ G L T V
Sbjct: 199 HPCIIKIKNFFDAED-YYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRA 553
++H G H ++K NVL++ + C I+DFG + ++ ++ T + Y A
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 554 PEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAP 584
PEV+ T ++ D +S GV+L L+G P
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 53/262 (20%), Positives = 101/262 (38%), Gaps = 40/262 (15%)
Query: 341 SKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 400
A ++ P Q K+ L + + D + +++VLG G G
Sbjct: 23 PPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKN-----AIIDDYKVTSQVLGLGINGK 77
Query: 401 AYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY----YSKDE 455
+ + + +K L++ +++E+ R Q P++V + Y +
Sbjct: 78 VLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 456 KLLVYDYFASGSL--STLLHGN-----RGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 508
L+V + G L G+ R A +K + + ++HS+
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------MKSIGEA---IQYLHSIN-- 181
Query: 509 KFTHGNIKASNVL-INQDLDGC--ISDFGL---TPLMNVPATPSRSAGYRAPEVIETRKH 562
H ++K N+L ++ + ++DFG T N TP + Y APEV+ K+
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 563 SHKSDVYSFGVLLLEMLTGKAP 584
D++S GV++ +L G P
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPP 262
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 53/286 (18%), Positives = 104/286 (36%), Gaps = 60/286 (20%)
Query: 331 KKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASA 390
+ + K + F S E E + +D +
Sbjct: 47 DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK------- 99
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRLK---------EVVVGKRDFEQQMEIVGRVGQ 439
+V+G+G + V +T VK ++ ++ + ++ I+ +V
Sbjct: 100 DVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR- 488
HP+++ L Y S LV+D G L D+ ETR
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGEL--------------FDYLTEKVALSEKETRS 204
Query: 489 -VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPAT 544
++ LL V+ +H+ H ++K N+L++ ++ +SDFG + +
Sbjct: 205 IMRSLLE---AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258
Query: 545 PSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAP 584
+ GY APE+++ + + D+++ GV+L +L G P
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 42/246 (17%)
Query: 371 VFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV--VKRL-KEVVVGKRDF 427
VF E NFD ++LR +GKGS+G V + T + +K + K+ V + +
Sbjct: 5 VFDENEDVNFDHFEILR----AIGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEV 59
Query: 428 EQQM---EIVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPL 483
+I+ + +HP +V L Y + +E + +V D G L L +
Sbjct: 60 RNVFKELQIMQGL-EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK- 113
Query: 484 DWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLT 536
E VK +++ + ++ + H ++K N+L+ D G I+DF +
Sbjct: 114 --EETVKLFICELVMA----LDYLQNQR---IIHRDMKPDNILL--DEHGHVHITDFNIA 162
Query: 537 PLMNVPATPSRSAG---YRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTR 590
++ + AG Y APE+ +RK +S D +S GV E+L G+ P +
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
Query: 591 DDMVDL 596
++
Sbjct: 223 TSSKEI 228
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 38/211 (18%), Positives = 78/211 (36%), Gaps = 25/211 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVV--------KRLKEVVVGKRDFEQQMEIVGRVGQHPN 442
EV+GKG + + + T K + D +++ I + HP+
Sbjct: 30 EVIGKGPFSVVRRCI-NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPH 87
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSL--STLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
+V L Y S +V+++ L + + G + ++ +L +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---ALR 144
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVPATPSR----SAGYRA 553
+ H H ++K VL+ + + FG+ + + + + A
Sbjct: 145 YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
PEV++ + DV+ GV+L +L+G P
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 46/218 (21%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 441
+ +G G+ G A V +K+L F+ Q E+V + H
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 84
Query: 442 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
N++ L + + D Y + L + LD E +L G+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIK 141
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 550
H+HS G H ++K SN+++ D I DFGL +R+AG
Sbjct: 142 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL----------ARTAGTSFMMTPYVV 188
Query: 551 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
YRAPEVI + D++S G ++ EM+ G L
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VL 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 38/217 (17%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQM--EI-VGRVGQHPNVVP 445
++LG+GSYG + + E VK L K+ + + E + EI + R +H NV+
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 446 LR--AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR------ 497
L Y K + +V +Y + +L D + + A
Sbjct: 71 LVDVLYNEEKQKMYMVMEY-CVCGMQEML-----------DSVPEKRFPVCQAHGYFCQL 118
Query: 498 --GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSA 549
G+ ++HS G H +IK N+L+ IS G+ ++ A T S
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 550 GYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAP 584
++ PE+ K D++S GV L + TG P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 29/126 (23%), Positives = 51/126 (40%), Gaps = 17/126 (13%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
IP T L L +N T + I LP LR + +N + +F
Sbjct: 30 IPQYT-------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 244
+ + L+ N N+ + + L L L L+SN ++ + N F + +R L+L N
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 245 LKGSIP 250
+ ++
Sbjct: 141 IT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 28/130 (21%), Positives = 43/130 (33%), Gaps = 10/130 (7%)
Query: 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG 179
LRL KL L ++ +N +T + + + L N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLEN 95
Query: 180 KIPSSFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IP 233
F L L L N T + L+ + LSL N ++ ++ FD +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153
Query: 234 KLRHLNLSYN 243
L LNL N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 17/77 (22%), Positives = 32/77 (41%), Gaps = 6/77 (7%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLR 236
IP L L+ N FT I + L QL ++ +N ++ I F+ +
Sbjct: 26 IPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVN 84
Query: 237 HLNLSYNGLKGSIPSSL 253
+ L+ N L+ ++ +
Sbjct: 85 EILLTSNRLE-NVQHKM 100
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 32/222 (14%)
Query: 391 EVLGKGSYGTAYKAVLEESTTV-----VVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP 445
E LGKG++ + V + ++ K + E++ I + +HPN+V
Sbjct: 17 EELGKGAFSVVRRCV-KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVR 74
Query: 446 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 500
L + L++D G L + A ++ +L V
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-------IQQILE---AVL 124
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSR----SAGYRA 553
H H MG H N+K N+L+ L G ++DFGL + + GY +
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
PEV+ + D+++ GV+L +L G P + +
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM------EI-VGRVGQHPNV 443
E LG G+Y T YK + + + V LKEV K D E+ EI + + +H N+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVA--LKEV---KLDSEEGTPSTAIREISLMKELKHENI 65
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLL-HGNRGAGRTPLDWETRVKILLGTARGVAHI 502
V L +++++ LV+++ + L + G L+ +G+A
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG-----YRAPE 555
H H ++K N+LIN+ G + DFGL +P + S+ YRAP+
Sbjct: 125 HENK---ILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIP-VNTFSSEVVTLWYRAPD 178
Query: 556 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
V+ +R +S D++S G +L EM+TGK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 47/208 (22%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG+G Y ++A+ + + VVVK LK V K+ +++++I+ + PN++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADI 99
Query: 450 YYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ LV+++ + L L + + + + HSMG
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 150
Query: 508 PKFTHGNIKASNVLINQDL-DGCISDFGL------TPLMNVPATPSRSAG--YRAPEVIE 558
H ++K NV+I+ + + D+GL NV R A ++ PE++
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-----RVASRYFKGPELLV 203
Query: 559 TRKHSHKS-DVYSFGVLLLEMLTGKAPL 585
+ S D++S G +L M+ K P
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 61/226 (26%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG------------RVG 438
E +G+G+YG YKA + V +KR++ + + E G +
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR--------LDAEDE--GIPSTAIREISLLKEL 76
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 497
HPN+V L +S+ LV+++ L +L N+ L ++++KI L R
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT----GLQ-DSQIKIYLYQLLR 130
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG----- 550
GVAH H H ++K N+LIN DG ++DFGL +R+ G
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINS--DGALKLADFGL----------ARAFGIPVRS 175
Query: 551 ---------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
YRAP+V+ ++K+S D++S G + EM+TGK
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 26/210 (12%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQM------EI-VGRVGQHP 441
LG G++G + AV E++ VVVK + KE V+ E EI + +H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGS-LSTLL--HGNRGAGRTPLDWETRVKILLGTARG 498
N++ + + ++ LV + SG L + H LD I
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-------LDEPLASYIFRQLVSA 142
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPE 555
V ++ H +IK N++I +D + DFG + G Y APE
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199
Query: 556 VIETRK-HSHKSDVYSFGVLLLEMLTGKAP 584
V+ + +++S GV L ++ + P
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 46/266 (17%)
Query: 356 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAE------VLGKGSYGTAYKAVLEES 409
+ KN F + LR AE V+G+G++G + +
Sbjct: 34 YDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST 93
Query: 410 TTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYF 463
V +K L K ++ + D E I+ P VV L Y + D L +V +Y
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLF-YAFQDDRYLYMVMEYM 151
Query: 464 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 518
G L L+ P E + ++L + IHSMG F H ++K
Sbjct: 152 PGGDLVNLMS----NYDVP---EKWARFYTAEVVLA----LDAIHSMG---FIHRDVKPD 197
Query: 519 NVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---YRAPEVIETR----KHSHKSD 567
N+L+ D G ++DFG + +A G Y +PEV++++ + + D
Sbjct: 198 NMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 568 VYSFGVLLLEMLTGKAPLQSPTRDDM 593
+S GV L EML G P + +
Sbjct: 256 WWSVGVFLYEMLVGDTPFYADSLVGT 281
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 40/124 (32%), Positives = 55/124 (44%), Gaps = 10/124 (8%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 195
L L L L L N + S + L L+ L L+HN S I PQL L L
Sbjct: 83 LTNLKNLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 139
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 254
N T +I + LT+L LSL+ N +S I + KL++L LS N + + +L
Sbjct: 140 NNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL-RALA 194
Query: 255 KFPN 258
N
Sbjct: 195 GLKN 198
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 10/124 (8%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 195
+L+ +T L S+ + +++ + + P + L L+
Sbjct: 17 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLN 73
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQ 254
N T +I + + NL L L L N + + + D+ KL+ L+L +NG+ I + L
Sbjct: 74 GNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGIS-DI-NGLV 128
Query: 255 KFPN 258
P
Sbjct: 129 HLPQ 132
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 2e-12
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 8/123 (6%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
+ L + L L N LT +T+L +L +L+L N +L L L
Sbjct: 61 IQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEH 118
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 255
N + +I + +L QL L L +N ++ I + KL L+L N + I L
Sbjct: 119 NGIS-DI-NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DI-VPLAG 173
Query: 256 FPN 258
Sbjct: 174 LTK 176
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 30/122 (24%), Positives = 46/122 (37%), Gaps = 4/122 (3%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L L+ LSL N ++ + + LP L LYL +N + S +L L L
Sbjct: 105 LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 162
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 256
N + +I + LT+L L L N++S + L L L +
Sbjct: 163 NQIS-DIV-PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 257 PN 258
Sbjct: 221 VV 222
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 2/130 (1%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L +L L+ LSL N ++ + L L+ LYL N+ S + L VL+L
Sbjct: 149 LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 206
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 256
NL + +L D N+ ++ + + S +
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 266
Query: 257 PNSSFVGNSL 266
+
Sbjct: 267 QPVTIGKAKA 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 53/221 (23%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVP 445
E LGKG++ + V ++T K + + RDF+ ++ I ++ QHPN+V
Sbjct: 12 EELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVR 69
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR--VKILL 493
L + LV+D G L + + ++ +L
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGEL--------------FEDIVAREFYSEADASHCIQQIL 115
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL-------TPLMNVPA 543
+A+ HS G H N+K N+L+ G ++DFGL
Sbjct: 116 E---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
TP GY +PEV++ +S D+++ GV+L +L G P
Sbjct: 170 TP----GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 46/152 (30%), Positives = 62/152 (40%), Gaps = 20/152 (13%)
Query: 133 PNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 188
T +L L L L N L + SE +P+LRYL L N+ + FS
Sbjct: 56 AEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQA 113
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD----IPKLRHLNLS 241
L VL L N + ++ +++ QL L L N +S P +PKL L+LS
Sbjct: 114 LEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLS 171
Query: 242 YNGLKGSIPSSLQKFPNSSFV-----GNSLLC 268
N LK + LQK P N L C
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 31/124 (25%), Positives = 46/124 (37%), Gaps = 15/124 (12%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--P 187
I + + L L L SN L L + + L +L L L +N+ + +F
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMA 136
Query: 188 QLVVLDLSFNSFTGNIP----QSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNL 240
QL L LS N + P + L +L L L SN L +P +P L
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGL 194
Query: 241 SYNG 244
+
Sbjct: 195 YLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 26/91 (28%), Positives = 37/91 (40%), Gaps = 13/91 (14%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLR 236
+P S +LDLS N+ + + LT L L L N+L+ I + F +P LR
Sbjct: 33 VPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLR 91
Query: 237 HLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 267
+L+LS N L F L
Sbjct: 92 YLDLSSN--------HLHTLDEFLFSDLQAL 114
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 28/100 (28%), Positives = 39/100 (39%), Gaps = 9/100 (9%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS---- 186
+ L ALEVL L +N + + + L+ LYL N S
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNK 161
Query: 187 -PQLVVLDLSFNSFTGNIPQSIQNLTQLT--GLSLQSNNL 223
P+L++LDLS N +Q L GL L +N L
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 48/223 (21%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLRAY 449
+GKG++ A + V +K + + + ++ E+ + ++ HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
++ L+ +Y + G + L + GR E R V + H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH---GRMKEK-EAR-SKFRQIVSAVQYCHQKR--- 134
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK-HSHK 565
H ++KA N+L++ D++ I+DFG + V G Y APE+ + +K +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 600
DV+S GV+L +++G P ++ +P ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E+LG G +G +K E +T + K + + K + + ++ ++ ++ H N++ L
Sbjct: 95 EILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLY 152
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ SK++ +LV +Y G L + + T LD +K + G+ H+H M
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRII-DESYNLTELDTILFMKQICE---GIRHMHQMY- 207
Query: 508 PKFTHGNIKASNVL-INQDLDGC-ISDFGL-------TPLMNVPATPSRSAGYRAPEVIE 558
H ++K N+L +N+D I DFGL L TP + APEV+
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP----EFLAPEVVN 261
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAP 584
S +D++S GV+ +L+G +P
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 29/123 (23%), Positives = 47/123 (38%), Gaps = 9/123 (7%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
+ L+ L L N ++ S + L L L + N + S L L L
Sbjct: 59 MQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDN 115
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 255
N + S+ +L L LS+++N L SI + KL L+L N + + L +
Sbjct: 116 NELR-DT-DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEIT-NT-GGLTR 170
Query: 256 FPN 258
Sbjct: 171 LKK 173
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 26/122 (21%), Positives = 42/122 (34%), Gaps = 7/122 (5%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L +L +T L ++ ++N F L L LS
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSH 72
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 256
N + ++ +++LT+L LS+ N L ++ L L L N L SL
Sbjct: 73 NQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNEL--RDTDSLIHL 127
Query: 257 PN 258
N
Sbjct: 128 KN 129
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 17/87 (19%), Positives = 29/87 (33%), Gaps = 2/87 (2%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L LE+LS+R+N L + L L L L N + + ++ +DL+
Sbjct: 124 LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTG 181
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNL 223
+ L +
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
LG+G+ Y+ + + ++ + V K+ ++ ++ R+ HPN++ L+ +
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIF 117
Query: 451 YSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAHIHSM 505
+ E LV + G L + G R A VK +L VA++H
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-------VKQILE---AVAYLHEN 167
Query: 506 GGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIET 559
G H ++K N+L D I+DFGL+ ++ + T + GY APE++
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 591
+ + D++S G++ +L G P D
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 49/223 (21%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVG------------- 435
+G+G+YG +KA ++ V +KR++ + E G
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR--------VQTGEE--GMPLSTIREVAVLR 66
Query: 436 --RVGQHPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETR 488
+HPNVV L ++ KL LV+++ L+T L G
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPT----ET 121
Query: 489 VKILLG-TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATP 545
+K ++ RG+ +HS H ++K N+L+ G ++DFGL + +
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMAL 176
Query: 546 SRSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
+ YRAPEV+ ++ D++S G + EM K PL
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PL 218
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 446
+ LG G++G V VK L ++ + + + EI ++ +HP+++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 503
+ + +V +Y + G L + + GR E R IL V + H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEM-EARRLFQQILSA----VDYCH 128
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 560
H ++K NVL++ ++ I+DFGL+ +M T S Y APEVI R
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185
Query: 561 K-HSHKSDVYSFGVLLLEMLTGKAP 584
+ D++S GV+L +L G P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 7e-13
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 43/217 (19%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG------------RVG 438
E +G+G+YG YKA T +K+++ E++ E G +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR--------LEKEDE--GIPSTTIREISILKEL 57
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 497
+H N+V L ++K +LV+++ L LL G L+ K L
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG----GLE-SVTAKSFLLQLLN 111
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG----- 550
G+A+ H H ++K N+LIN+ +G I+DFGL +P +
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINR--EGELKIADFGLARAFGIP-VRKYTHEIVTLW 165
Query: 551 YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
YRAP+V+ ++K+S D++S G + EM+ G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 16/125 (12%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
+P + L N + P + LR + L +N S P +F L
Sbjct: 30 LPETI-------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 190 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGL 245
L L N T +P+S+ + L L L L +N ++ + F + L L+L N L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
Query: 246 KGSIP 250
+ +I
Sbjct: 141 Q-TIA 144
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 17/76 (22%), Positives = 31/76 (40%), Gaps = 5/76 (6%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 237
IP++ + + L N+ P + +L + L +N +S + F + L
Sbjct: 26 IPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNS 84
Query: 238 LNLSYNGLKGSIPSSL 253
L L N + +P SL
Sbjct: 85 LVLYGNKIT-ELPKSL 99
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 4/93 (4%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
+ + L +L L L N +T LP + L SL+ L L N + +F
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 189 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 221
L +L L N + L + + L N
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 34/218 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI----VGRVGQ 439
+G G+YGT YKA S V LK V V E+ +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVA--LKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 440 HPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 494
HPNVV L ++ K+ LV+++ L T L G +K L+
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA----ETIKDLMR 127
Query: 495 -TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG- 550
RG+ +H+ H ++K N+L+ G ++DFGL + + +
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSG--GTVKLADFGLARIYSYQMALTPVVVT 182
Query: 551 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
YRAPEV+ ++ D++S G + EM K
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 27/130 (20%), Positives = 50/130 (38%), Gaps = 11/130 (8%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 187
I LE + + N + + +++ ++LP L + ++ N I F P
Sbjct: 45 IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLP 104
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLSY 242
L L +S ++P + Q L +Q N +I F + L L+
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 243 NGLKGSIPSS 252
NG++ I +S
Sbjct: 164 NGIQ-EIHNS 172
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 28/118 (23%), Positives = 48/118 (40%), Gaps = 11/118 (9%)
Query: 132 IPNNTLGKLDA-LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--P 187
I N+ L +L L N + + + + L L L NN ++P+ F
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYN 243
V+LD+S ++P +NL +L S NL +P + + L +L+Y
Sbjct: 203 GPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLK-KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 25/140 (17%), Positives = 46/140 (32%), Gaps = 24/140 (17%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 188
+P N L L + L + + N+ I + FS P+
Sbjct: 28 LPRNA-------IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 189 LVVLDLS-FNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYN 243
L + + N+ I QNL L L + + + +P+ + L++ N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 244 GLKGSIPSSLQKFPNSSFVG 263
++ +SFVG
Sbjct: 139 -------INIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 17/105 (16%), Positives = 32/105 (30%), Gaps = 11/105 (10%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
S R Q + + +IPS + L + L + + N++
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 226 SIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 267
I F +PKL + + ++L +F L
Sbjct: 69 VIEADVFSNLPKLHEIRIEKA-------NNLLYINPEAFQNLPNL 106
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM------EI-VGRVGQHPNV 443
+ LG+G+Y T YK + + +V LKE+ + + E+ E+ + + +H N+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVA--LKEI---RLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHI 502
V L +++ LV++Y L L ++ VK+ L RG+A+
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLD----DCGNIIN-MHNVKLFLFQLLRGLAYC 116
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG-----YRAPE 555
H K H ++K N+LIN+ G ++DFGL ++P T + YR P+
Sbjct: 117 HR---QKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIP-TKTYDNEVVTLWYRPPD 170
Query: 556 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
++ + +S + D++ G + EM TG+
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 46/229 (20%), Positives = 91/229 (39%), Gaps = 57/229 (24%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLK---EVVVGKRDF-E----QQMEIVGRVGQHP 441
+LG+G+YG A + + +V +K+++ + + R E + +H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-------KHE 69
Query: 442 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 491
N++ + R + ++ ++ + + L ++ L + ++
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ------MLS-DDHIQYFIYQT 121
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSR 547
L R V +H H ++K SN+LIN + D + DFGL + P+
Sbjct: 122 L----RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 548 SAG----------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 585
YRAPEV+ T ++ DV+S G +L E+ + P+
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PI 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 50/226 (22%), Positives = 97/226 (42%), Gaps = 60/226 (26%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------------MEIVGRV 437
+ LG+G + T YKA + + +V +K++ +G R + E+
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVA--IKKIKLGHRSEAKDGINRTALREIKLLQEL---- 69
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 496
HPN++ L + K LV+D+ + L ++ N L + +K + T
Sbjct: 70 -SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL----VLT-PSHIKAYMLMTL 122
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---- 550
+G+ ++H H ++K +N+L+++ +G ++DFGL ++S G
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDE--NGVLKLADFGL----------AKSFGSPNR 167
Query: 551 ----------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
YRAPE++ R + D+++ G +L E+L P
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PF 212
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 441
+G G+YG+ A+ + S V +K+L F+ ++ E+ + + QH
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHE 83
Query: 442 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
NV+ L + YD Y + T L E ++ +G+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQK---IMGLKFSEEKIQYLVYQMLKGLK 140
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP---SRSAGYRAPEVI 557
+IHS G H ++K N+ +N+D + I DFGL + T +R YRAPEVI
Sbjct: 141 YIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--YRAPEVI 195
Query: 558 ETRKHSHKS-DVYSFGVLLLEMLTGKAPL 585
+ H +++ D++S G ++ EMLTGK L
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK-TL 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 52/239 (21%), Positives = 88/239 (36%), Gaps = 54/239 (22%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ LG GS+G + ES LK+V+ R ++++I+ +V H N++ L Y+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFA--LKKVLQDPRYKNRELDIM-KVLDHVNIIKLVDYF 69
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR---------------------- 488
Y+ ++ N
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 489 -------------VKILL-GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDF 533
+ I + R V IHS+G H +IK N+L+N + + DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 534 GLTPLMNVPATP------SRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 585
G + +P+ P SR YRAPE++ + D++S G + E++ GK PL
Sbjct: 187 GSAKKL-IPSEPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PL 241
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG------------RV 437
LG+G+YG YKA+ + V +KR++ E + E G +
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEE--GVPGTAIREVSLLKE 89
Query: 438 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 496
QH N++ L++ + L+++Y A L + N + +K L
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKN-----PDVS-MRVIKSFLYQLI 142
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGC--ISDFGLTPLMNVPATPSRSAG- 550
GV HS + H ++K N+L++ I DFGL +P +
Sbjct: 143 NGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEI 198
Query: 551 ----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
YR PE++ +R +S D++S + EML
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 40/124 (32%), Positives = 55/124 (44%), Gaps = 10/124 (8%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 195
L L L L L N + S + L L+ L L+HN S I PQL L L
Sbjct: 86 LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 142
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 254
N T +I + LT+L LSL+ N +S I + KL++L LS N + + +L
Sbjct: 143 NNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL-RALA 197
Query: 255 KFPN 258
N
Sbjct: 198 GLKN 201
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 29/124 (23%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195
T +L++++ + ++ + I LP++ L+L N + P + L L L
Sbjct: 41 TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLD 98
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 254
N ++ S+++L +L LSL+ N +S I +P+L L L N + I + L
Sbjct: 99 ENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT-DI-TVLS 153
Query: 255 KFPN 258
+
Sbjct: 154 RLTK 157
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 26/124 (20%), Positives = 49/124 (39%), Gaps = 10/124 (8%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 195
+L+ +T L S+ + +++ + + P + L L+
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLN 76
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQ 254
N T +I + NL L L L N + + + D+ KL+ L+L +NG+ I + L
Sbjct: 77 GNKLT-DIK-PLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGIS-DI-NGLV 131
Query: 255 KFPN 258
P
Sbjct: 132 HLPQ 135
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 30/108 (27%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L L+ LSL N ++ + + LP L LYL +N + S +L L L
Sbjct: 108 LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 165
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYN 243
N + +I + LT+L L L N++S + + L L L
Sbjct: 166 NQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 2/107 (1%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L +L L+ LSL N ++ + L L+ LYL N+ S + L VL+L
Sbjct: 152 LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 209
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 243
NL + +L D N+ ++
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 2/88 (2%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L L+ L L N ++ + L +L L L K + S +V +
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLS 224
+ P+ I + +++ +
Sbjct: 232 TDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 2e-12
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 52/221 (23%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPN 442
E +G+G+YGT +KA E+ +V LK V + D + + EI + + +H N
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVA--LKRV---RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAH 501
+V L +S + LV+++ L G LD VK L +G+
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLD-PEIVKSFLFQLLKGLGF 116
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG--------- 550
HS H ++K N+LIN+ +G +++FGL +R+ G
Sbjct: 117 CHSRN---VLHRDLKPQNLLINR--NGELKLANFGL----------ARAFGIPVRCYSAE 161
Query: 551 -----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
YR P+V+ + +S D++S G + E+ PL
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVP 445
E LGKG++ + V ++T K + + RDF+ ++ I ++ QHPN+V
Sbjct: 35 EELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVR 92
Query: 446 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 500
L + LV+D G L + A ++ +L +A
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-------IQQILE---SIA 142
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL-------TPLMNVPATPSRSAG 550
+ HS G H N+K N+L+ G ++DFGL TP G
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP----G 195
Query: 551 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
Y +PEV++ +S D+++ GV+L +L G P
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 52/274 (18%), Positives = 91/274 (33%), Gaps = 39/274 (14%)
Query: 345 ASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 404
G P + + P K K + + +LG G +G+ Y
Sbjct: 14 LVPRGSHMAPCNDLHATKLAPGKEKEPLES----QYQVG-------PLLGSGGFGSVYSG 62
Query: 405 V-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR--------VGQHPNVVPLRAYYYSKDE 455
+ + ++ V +K +++ + V V+ L ++ D
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 456 KLLVYDYFA-SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 514
+L+ + L + G + R V H H+ G H +
Sbjct: 123 FVLILERPEPVQDLFDFITER---GALQEE-LAR-SFFWQVLEAVRHCHNCG---VLHRD 174
Query: 515 IKASNVLINQDLDGC---ISDFGLTPLM--NVPATPSRSAGYRAPEVIETRK-HSHKSDV 568
IK N+LI DL+ + DFG L+ V + Y PE I + H + V
Sbjct: 175 IKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 569 YSFGVLLLEMLTGKAPLQSPTR--DDMVDLPRWV 600
+S G+LL +M+ G P + V + V
Sbjct: 233 WSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 47/218 (21%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHPN 442
++G+GSYG K +++ +V +K+ + +M EI + + +H N
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVA--IKKF---LESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
+V L K LV+++ + + + LD++ K L G+
Sbjct: 86 LVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------ 550
HS H +IK N+L++Q + DFG +R+
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGF----------ARTLAAPGEVYDDEVAT 187
Query: 551 --YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
YRAPE++ K+ DV++ G L+ EM G+ PL
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PL 224
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 30/106 (28%), Positives = 43/106 (40%), Gaps = 12/106 (11%)
Query: 144 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG 201
VL L LT + + L + +L L HN +P + + L VL S N+
Sbjct: 444 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 202 NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 243
N+ + NL +L L L +N L P+L LNL N
Sbjct: 500 NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 26/128 (20%), Positives = 45/128 (35%), Gaps = 6/128 (4%)
Query: 135 NTLGKLDALEVL--SLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVL 192
+TL +D + + +R L+L H + + + L
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHL 468
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKG-SIP 250
DLS N +P ++ L L L N L ++ +P+L+ L L N L+ +
Sbjct: 469 DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAI 526
Query: 251 SSLQKFPN 258
L P
Sbjct: 527 QPLVSCPR 534
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.5 bits (138), Expect = 1e-08
Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 13/111 (11%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 195
L +L + L L N L LP + +L L L N + + P+L L L
Sbjct: 459 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLC 516
Query: 196 FNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPNFD------IPKLRHL 238
N Q + + +L L+LQ N+L +P + +
Sbjct: 517 NNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 12/91 (13%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN---NFSGKIPSSFSPQ 188
+P L L LEVL N L + + +LP L+ L L +N + P P+
Sbjct: 478 LPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 189 LVVLDLSFN------SFTGNIPQSIQNLTQL 213
LV+L+L N + + + +++ +
Sbjct: 535 LVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 56/230 (24%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG------------RV 437
+G+G++G +KA ++ V +K++ E + E G ++
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKE--GFPITALREIKILQL 72
Query: 438 GQHPNVVPLR-------AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 489
+H NVV L + Y + LV+D+ L+ LL + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLS----NVLVKFT-LSEI 126
Query: 490 K-ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPS 546
K ++ G+ +IH H ++KA+NVLI + DG ++DFGL ++ S
Sbjct: 127 KRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR--DGVLKLADFGLARAFSLAK-NS 180
Query: 547 RSAG---------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
+ YR PE++ R + D++ G ++ EM T +Q
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 44/218 (20%), Positives = 81/218 (37%), Gaps = 47/218 (21%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHPN 442
+G+GSYG +K ++ +V +K+ + + EI + + +HPN
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVA--IKKF---LESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
+V L + K LV++Y + + + I T + V
Sbjct: 64 LVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------ 550
H H ++K N+LI + + DFG +R
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGF----------ARLLTGPSDYYDDEVAT 165
Query: 551 --YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
YR+PE++ ++ DV++ G + E+L+G PL
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV-PL 202
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 53/220 (24%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 441
+G G+YG+ A ++ V VK+L F+ + E+ + + +H
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHE 88
Query: 442 NVVPLR-----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495
NV+ L A + + LV + L+ ++ L + ++
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ------KLTDDHVQFLIYQI 141
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----- 550
RG+ +IHS H ++K SN+ +N+D + I DFGL +R
Sbjct: 142 LRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL----------ARHTADEMTG 188
Query: 551 ------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKA 583
YRAPE++ H +++ D++S G ++ E+LTG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR------VGQHPNVVP 445
LG+G+YG AV V VK +V + E + + + H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHI 502
+ + + L +Y + G L + + P + + ++ GV ++
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP-DAQRFFHQLMA----GVVYL 121
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEV 556
H +G TH +IK N+L+++ + ISDFGL + + Y APE+
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 557 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 602
++ R+ H+ DV+S G++L ML G+ P P+ D + W +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEK 224
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 54/222 (24%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 441
+ +G G+YG AV + V +K+L F+ ++ E+ + +H
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHE 84
Query: 442 NVVPLRAYYYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495
NV+ L + + LV + + L L+ L + ++
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE------KLGEDRIQFLVYQM 137
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----- 550
+G+ +IH+ G H ++K N+ +N+D + I DFGL +R A
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL----------ARQADSEMTG 184
Query: 551 ------YRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 585
YRAPEVI + D++S G ++ EM+TGK L
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TL 225
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 65/238 (27%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIV--GRVGQH 440
+ LGKG+YG +K++ + VV VK++ + F+ EI+ + H
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGH 68
Query: 441 PNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 493
N+V L + +++ LV+DY + L ++ N L+ + ++
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILE-PVHKQYVVYQLI- 119
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSRSA 549
+ + ++HS G H ++K SN+L+N + ++DFGL + V S
Sbjct: 120 ---KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 550 G---------------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 585
YRAPE++ K D++S G +L E+L GK P+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 49/226 (21%), Positives = 91/226 (40%), Gaps = 55/226 (24%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGK--------RDFEQQMEIVGRVGQ 439
+ LG G+ G A E T V +K + K + E ++EI+ ++
Sbjct: 16 KTLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-N 73
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR- 488
HP ++ ++ ++ ++D +V + G L D +
Sbjct: 74 HPCIIKIKNFFDAED-YYIVLELMEGGEL--------------FDKVVGNKRLKEATCKL 118
Query: 489 -VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NV 541
+L V ++H G H ++K NVL++ + C I+DFG + ++ ++
Sbjct: 119 YFYQMLL---AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 542 PATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAP 584
T + Y APEV+ T ++ D +S GV+L L+G P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR------VGQHPNVVP 445
LG+G+YG AV V VK +V + E + + + H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHI 502
+ + + L +Y + G L + + P + + ++ GV ++
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP-DAQRFFHQLMA----GVVYL 121
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEV 556
H +G TH +IK N+L+++ + ISDFGL + + Y APE+
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 557 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 602
++ R+ H+ DV+S G++L ML G+ P P+ D + W +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEK 224
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 38/234 (16%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLRAY 449
+G G++G A V VK ++ G E Q EI R +HPN+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR--------GVAH 501
+ ++ +Y + G L + AGR D AR GV++
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI---CNAGRFSED----------EARFFFQQLLSGVSY 131
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---YRAPEV 556
HSM H ++K N L++ I DFG + + + P + G Y APEV
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 557 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609
+ ++ +DV+S GV L ML G P + P ++ D + +Q ++ +++
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPRDYRKTIQRILSVKYS 240
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLK---EVVVGKRDF-E----QQMEIVGRVGQHP 441
+G+G+YG A + V +K++ +R E + +H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHE 85
Query: 442 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 496
N++ + RA + + + +V D + L LL L + L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ------HLSNDHICYFLYQIL 138
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 550
RG+ +IHS H ++K SN+L+N D I DFGL V G
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA---RVADPDHDHTGFLTEYV 192
Query: 551 ----YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 585
YRAPE++ K KS D++S G +L EML+ + P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 446
E LG+GS+G A + V +K + ++++ + + EI ++ +HP+++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 503
+ + ++V +Y A G L + R D E R I+ + + H
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEK---KRMTED-EGRRFFQQII----CAIEYCH 125
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 560
H ++K N+L++ +L+ I+DFGL+ +M N T S Y APEVI +
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 561 K-HSHKSDVYSFGVLLLEMLTGKAP 584
+ DV+S G++L ML G+ P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 446
+ LG G++G V VK L ++ + + + EI ++ +HP+++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 503
+ + +V +Y + G L + N GR E+R IL G V + H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEK-ESRRLFQQILSG----VDYCH 133
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 560
H ++K NVL++ ++ I+DFGL+ +M T S Y APEVI R
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190
Query: 561 K-HSHKSDVYSFGVLLLEMLTGKAP 584
+ D++S GV+L +L G P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 16/115 (13%)
Query: 137 LGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIP--SSFSPQLVVL 192
L L A + L+L +N + L + + +LR L L N KI + + L L
Sbjct: 44 LSTLKACKHLALSTNNIEKISSL----SGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 243
+S+N ++ I+ L L L + +N ++ + D + KL L L+ N
Sbjct: 99 WISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 30/130 (23%), Positives = 52/130 (40%), Gaps = 12/130 (9%)
Query: 135 NTLGKLDALEV-LSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV 191
++ +A +V L + + + +++L + ++L L NN KI SS S L +
Sbjct: 18 KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLK--GS 248
L L N I L L + N ++ S+ + + LR L +S N + G
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGE 132
Query: 249 IPSSLQKFPN 258
I L
Sbjct: 133 I-DKLAALDK 141
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 40/209 (19%), Positives = 78/209 (37%), Gaps = 50/209 (23%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
+VLG G G + + + +K L++ +++E+ R Q P++V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 450 Y----YSKDEKLLVYDYFASGSL--STLLHGN-----RGAGRTPLDWETRVKILLGTARG 498
Y + L+V + G L G+ R A +K +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------MKSIGEA--- 129
Query: 499 VAHIHSMGGPKFTHGNIKASNVL-INQDLDGC--ISDFGLTPLMNVPATPSRSAGYRAPE 555
+ ++HS+ H ++K N+L ++ + ++DFG A E
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------AKE 169
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAP 584
K+ D++S GV++ +L G P
Sbjct: 170 TTG-EKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 50/228 (21%), Positives = 87/228 (38%), Gaps = 45/228 (19%)
Query: 393 LGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQ----------- 439
+GKGSYG A ++T +K L K+ ++ + F ++ G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 440 --------------HPNVVPLRAYYY--SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPL 483
HPNVV L ++D +V++ G + + PL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPL 134
Query: 484 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 542
+ +G+ ++H H +IK SN+L+ +D I+DFG++
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 543 ATPSRSAG---YRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAP 584
A S + G + APE + + DV++ GV L + G+ P
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 28/218 (12%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI--------VGRVGQH 440
+V+GKGS+G KA + V +K ++ KR Q EI +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500
NV+ + + ++ + ++ S +L L+ N+ G L R K + +
Sbjct: 160 -NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGF-SLP-LVR-KFAHSILQCLD 214
Query: 501 HIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATP---SRSAGYRAPE 555
+H + H ++K N+L+ Q I DFG + + SR YRAPE
Sbjct: 215 ALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--YRAPE 269
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 593
VI ++ D++S G +L E+LTG L D
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 51/247 (20%), Positives = 87/247 (35%), Gaps = 66/247 (26%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 441
++G+GSYG Y A + + V +K++ + FE + EI + +
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSD 85
Query: 442 NVVPLRAYYYSKDEKL-----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 491
++ L D +V + S L L L E +K +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI-----FLT-EEHIKTILYNL 138
Query: 492 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----------TPLMNV 541
L G IH G H ++K +N L+NQD + DFGL + ++
Sbjct: 139 L----LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 542 PATPSRSAG----------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAP 584
YRAPE+I +++ KS D++S G + E+L
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 585 LQSPTRD 591
+ +
Sbjct: 252 HINDPTN 258
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 6/93 (6%)
Query: 158 PSEITSLPSLRYLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 214
+ +L LY+++ + +L L + + P + +L+
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 215 GLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 245
L+L N L S+ L+ L LS N L
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 9/52 (17%), Positives = 22/52 (42%), Gaps = 4/52 (7%)
Query: 202 NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYNGLKGSIP 250
+ + LT L +++ + D+ +LR+L + +GL+ +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA 72
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 21/110 (19%), Positives = 31/110 (28%), Gaps = 12/110 (10%)
Query: 103 CQSWVGINCTQDR-----------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSN 151
G+ CT+D + L + + + L L L L++ +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 152 VLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QLVVLDLSFNSFT 200
L P P L L L N + L L LS N
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 39/126 (30%), Positives = 57/126 (45%), Gaps = 18/126 (14%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV- 190
IP +T E L L+S L + L L +L L +N + + L
Sbjct: 33 IPADT-------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 191 --VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 244
L L+ N ++P + +LTQL L L N L S+P+ FD + KL+ L L+ N
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
Query: 245 LKGSIP 250
L+ SIP
Sbjct: 143 LQ-SIP 147
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 39/120 (32%), Positives = 52/120 (43%), Gaps = 12/120 (10%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 187
+ L L L L +N L LP + L L LYL N +PS F
Sbjct: 74 LSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
+L L L+ N +IP LT L LSL +N L S+P+ FD + KL+ + L N
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 22/74 (29%), Positives = 32/74 (43%), Gaps = 5/74 (6%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRH 237
+PS LDL + + LT+LT L+L N L ++ FD +L
Sbjct: 29 VPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGT 87
Query: 238 LNLSYNGLKGSIPS 251
L L+ N L S+P
Sbjct: 88 LGLANNQLA-SLPL 100
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 49/226 (21%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRL--KEVVVGKRDF-E----QQMEIVGRVGQHPN 442
+ LG G G + AV + V +K++ + K E +++ H N
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-------DHDN 69
Query: 443 VVPLRAYYYSKDEKL--------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETR 488
+V + +L +V +Y + L+ +L PL E
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG------PLLEEHA 122
Query: 489 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNVPATPSR 547
+ RG+ +IHS H ++K +N+ IN +DL I DFGL +M+ +
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 548 SAG-------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 585
YR+P ++ ++ D+++ G + EMLTGK L
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TL 224
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 54/247 (21%), Positives = 89/247 (36%), Gaps = 61/247 (24%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 441
++G GSYG +A E V +K++ V FE + EI + H
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHD 112
Query: 442 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 496
+VV + K ++L +V + S L L +L
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPV-----YLTELHIKTLLYNLL 166
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 550
GV ++HS G H ++K +N L+NQD + DFGL ++ P +
Sbjct: 167 VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 551 -------------------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAP 584
YRAPE+I +++ ++ DV+S G + E+L
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 585 LQSPTRD 591
+ D
Sbjct: 284 NVAYHAD 290
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 50/225 (22%), Positives = 87/225 (38%), Gaps = 50/225 (22%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-------------VG 435
LG G + T + A + +T V +K ++ K E + EI
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 436 RVGQHPNVVPLRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 490
+G + +++ L ++ K +V++ +L L+ G PL VK
Sbjct: 82 SMGAN-HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLI---YVKQ 135
Query: 491 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC------ISDFGLTPLMN 540
+LL G+ ++H G H +IK NVL+ I+D G +
Sbjct: 136 ISKQLLL----GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 541 VPATP---SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 582
T +R YR+PEV+ +D++S L+ E++TG
Sbjct: 190 EHYTNSIQTRE--YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 39/120 (32%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 139 KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLV---VLDL 194
+L L L L N L LP+ + L +L+ L L N +P +L L+L
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140
Query: 195 SFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 250
+ N ++P+ + LT LT L L N L S+P FD + +L+ L L N LK S+P
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 42/120 (35%), Positives = 58/120 (48%), Gaps = 12/120 (10%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 187
+PN KL L+ L L N L LP + L +L YL L HN +P F
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLT 157
Query: 188 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
L LDLS+N ++P+ + LTQL L L N L S+P+ FD + L+++ L N
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 15/114 (13%)
Query: 144 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNI 203
+L+ +T ++ L S+ + +++ + P + L L N
Sbjct: 22 IKANLKKKSVTD-AVTQN-ELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL---- 75
Query: 204 PQSI---QNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRHLNLSYNGLKGSIPS 251
I + LT LT L L N L S+PN FD L+ L L N L+ S+P
Sbjct: 76 -HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPD 126
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 34/99 (34%), Positives = 45/99 (45%), Gaps = 13/99 (13%)
Query: 162 TSLPS-----LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 214
LP + LYL N F+ +P S L ++DLS N + QS N+TQL
Sbjct: 23 KVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 215 GLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 250
L L N L IP FD + LR L+L N + +P
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 36/118 (30%), Positives = 51/118 (43%), Gaps = 16/118 (13%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QL 189
IP + L L N T +P E+++ L + L +N S SFS QL
Sbjct: 29 IPRDV-------TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 190 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
+ L LS+N IP L L LSL N++S +P F+ + L HL + N
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 41/126 (32%), Positives = 57/126 (45%), Gaps = 18/126 (14%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV- 190
IP T L L +N L L SL LYL N +P+ +L
Sbjct: 26 IPAQT-------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 191 --VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 244
L+LS N ++P + LTQL L+L +N L S+P+ FD + +L+ L L N
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135
Query: 245 LKGSIP 250
LK S+P
Sbjct: 136 LK-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 28/74 (37%), Positives = 36/74 (48%), Gaps = 5/74 (6%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRH 237
+P+ Q LDL NS LT LT L L N L S+PN F+ L +
Sbjct: 22 VPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTY 80
Query: 238 LNLSYNGLKGSIPS 251
LNLS N L+ S+P+
Sbjct: 81 LNLSTNQLQ-SLPN 93
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 3e-09
Identities = 37/244 (15%), Positives = 70/244 (28%), Gaps = 34/244 (13%)
Query: 41 PCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSST- 99
L+ K L + + D + +++ + H L W
Sbjct: 91 EEGVNLMDKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDID 150
Query: 100 -NPICQSWVGINCTQDRTRVFG--LRLPGIGL-VGPIPNNTLGKLDALEVLSLRSNVLTG 155
SW+ D + V L + + + L+ L + S L
Sbjct: 151 FEEQEISWI---EQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPD 207
Query: 156 GLPSEITS--LPSLRYL--YLQHNNFSGK---------IPSSFSPQLVVLDLSFNSFTGN 202
+ +I LP+L L Y+ ++ P L L +
Sbjct: 208 SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNV 267
Query: 203 IPQSI---QNLTQLTGLSLQSNNLS--------GSIPNFDIPKLRHLNLSYNGLKGSIPS 251
+ + L QL + + + L+ + L+ +N+ YN L +
Sbjct: 268 VVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKI--KHLKFINMKYNYLSDEMKK 325
Query: 252 SLQK 255
LQK
Sbjct: 326 ELQK 329
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 21/112 (18%), Positives = 34/112 (30%), Gaps = 8/112 (7%)
Query: 137 LGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 194
L LR + L + +L + N +L L +
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGA---TLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 71
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--GSIPNF-DIPKLRHLNLSYN 243
+ N Q L LT L L +N+L G + + L +L + N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 14/108 (12%)
Query: 159 SEITSLPSLRYLYLQHNNFSGKIP--SSFSPQLVVLDLSFNSFT--GNIPQSIQNLTQLT 214
++ T+ R L L+ I + Q +D S N P L +L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLK 67
Query: 215 GLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLK--GSIPSSLQKFPN 258
L + +N + D +P L L L+ N L G + L +
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKS 114
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 28/109 (25%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L L+ L + +N + +LP L L L +N+
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----------------EL 103
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN------FDIPKLRHLN 239
+ +L LT L + N ++ + + + +P++R L+
Sbjct: 104 GDL-----DPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 26/102 (25%), Positives = 39/102 (38%), Gaps = 17/102 (16%)
Query: 162 TSLPS-----LRYLYLQHNNFSGKIPSS--FS--PQLVVLDLSFNSFTGNIPQSI-QNLT 211
+P L L N +I S F P LV L+L N T I + + +
Sbjct: 21 KEIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 212 QLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 250
+ L L N + I N F + +L+ LNL N + +
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 33/119 (27%), Positives = 47/119 (39%), Gaps = 16/119 (13%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188
IP +T L L N L + LP L L L+ N +G P++F
Sbjct: 27 IPLHT-------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 189 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
+ L L N I + L QL L+L N +S + F+ + L LNL+ N
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 3e-08
Identities = 50/385 (12%), Positives = 112/385 (29%), Gaps = 100/385 (25%)
Query: 357 EFGSGVQEPEKNKL--VFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA---------- 404
+F +G + + + VF + NFD +D+ +L K +
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 405 --VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL----- 457
L +V++ E V+ + +++ M + + P+ + Y + ++L
Sbjct: 68 FWTLLSKQEEMVQKFVEEVL-RINYKFLMSPIKTEQRQPS--MMTRMYIEQRDRLYNDNQ 124
Query: 458 LVYDYFAS---------GSLSTL-------LHGNRGAGRTPLDWETRVKILLGTARGVAH 501
+ Y S +L L + G G+G+T + L
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV--------ALDVCLSYKV 176
Query: 502 IHSMGGPKF--THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP-EVIE 558
M F N + ++ + + P N + S+ + I+
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLL---YQIDP--NWTSRSDHSSNIKLRIHSIQ 231
Query: 559 TRK------HSHKS------DVYSFGVLLLEMLTGKAPLQSPTRDDMV--DLPRWVQSVV 604
+++ +V + + TR V L + +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKA--WNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 605 REEWTAEVFD----VEL------MRFQNIEEEMVQM--LQIGMACVAKVPDM-------- 644
+ + L R Q++ E++ ++ + + D
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI-IAESIRDGLATWDNWK 348
Query: 645 RPNMDEVVRMIE---------EVRQ 660
N D++ +IE E R+
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRK 373
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 57/345 (16%), Positives = 105/345 (30%), Gaps = 106/345 (30%)
Query: 1 MFPGS----LVI--CRSDYFSTMLFVCGNIETL-LGLHFCYSSHLLIPCIKQLLMKFSSA 53
+ GS + + C S + I L L C S ++ +++LL +
Sbjct: 158 V-LGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLKN--CNSPETVLEMLQKLLYQID-- 210
Query: 54 APLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKL----NWSSTNPICQSWV-- 107
P + S + L ++S + L + P+ L N + +
Sbjct: 211 -PNWTSRSDHSSNIKL---RIHSIQAELRRLLKSKPYENCLLVLLN------VQNAKAWN 260
Query: 108 --GINC-----TQDRT---RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL 157
++C T+ + + I L + TL + +L + L
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH--SMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 158 PSEITSL-P--------SLR--------YLYLQHNNFSGKIPSSF---SP--------QL 189
P E+ + P S+R + ++ + + I SS P +L
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378
Query: 190 VVLDLSFNSFTGNIPQSI--------------QNLTQLTGLSL---QSNNLSGSIPN--F 230
V S +IP + + +L SL Q + SIP+
Sbjct: 379 SVFPPSA-----HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 231 DI-PKLR-----HLNL--SYNGLKGSIPSSLQKFPNS----SFVG 263
++ KL H ++ YN K L S +G
Sbjct: 434 ELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-08
Identities = 21/111 (18%), Positives = 41/111 (36%), Gaps = 8/111 (7%)
Query: 139 KLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLSF 196
++ L L ++ G L L +L + + I + +L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73
Query: 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 243
N +G + + LT L+L N + + + + L+ L+L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-06
Identities = 32/108 (29%), Positives = 43/108 (39%), Gaps = 16/108 (14%)
Query: 158 PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT--GNIPQSIQNLTQL 213
PS++ L L +N GK+ +L L T N+P L +L
Sbjct: 16 PSDVKEL----VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKL 66
Query: 214 TGLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLKG-SIPSSLQKFPN 258
L L N +SG + P L HLNLS N +K S L+K N
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN 114
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 25/86 (29%), Positives = 34/86 (39%), Gaps = 9/86 (10%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN---FSGKIPSSFSPQLVVLD 193
L KL+ L+ L L N ++GGL P+L +L L N S P L LD
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
Query: 194 LSFNSFTGN------IPQSIQNLTQL 213
L T + + + LT L
Sbjct: 120 LFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 26/110 (23%), Positives = 43/110 (39%), Gaps = 8/110 (7%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITS-LPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLSFN 197
A+ L L + G +T+ +L +L L + + + P+L L+LS N
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSEN 81
Query: 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYN 243
G + + L LT L+L N L I + L+ L+L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 32/125 (25%), Positives = 45/125 (36%), Gaps = 16/125 (12%)
Query: 141 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS 198
+++ L P+ + L L +N GKI + L L L
Sbjct: 6 SGMDMKRRIHLELRNRTPAAVREL----VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVG 60
Query: 199 FT--GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLKG-SIPSSL 253
N+P L +L L L N + G + +P L HLNLS N LK S L
Sbjct: 61 LISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116
Query: 254 QKFPN 258
+K
Sbjct: 117 KKLEC 121
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 28/86 (32%), Positives = 33/86 (38%), Gaps = 6/86 (6%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN---FSGKIPSSFSPQLVVLD 193
L KL L+ L L N + GGL LP+L +L L N S P L LD
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126
Query: 194 LSFNSFT---GNIPQSIQNLTQLTGL 216
L T + L QLT L
Sbjct: 127 LFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 38/287 (13%), Positives = 90/287 (31%), Gaps = 93/287 (32%)
Query: 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHSMGGPKFTHGNIK 516
+V++ L + + PL VK I+ +G+ ++H+ H +IK
Sbjct: 122 MVFE-VLGHHLLKWIIKSNY-QGLPLPC---VKKIIQQVLQGLDYLHTKCR--IIHTDIK 174
Query: 517 ASNVLIN-------------------------------------------------QDLD 527
N+L++ + L
Sbjct: 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234
Query: 528 GCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586
I+D G + ++ YR+ EV+ ++ +D++S + E+ TG +
Sbjct: 235 VKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
Query: 587 -----SPTRDD-----MVDL-----PRWVQSVVREEWTAEVFD-------VELMRFQNIE 624
TRD+ +++L + + +++ E F + ++ +
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIV---AGKYSKEFFTKKGDLKHITKLKPWGLF 351
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 671
E +V+ + + + + + E R ++ E
Sbjct: 352 EVLVEKYEWS----------QEEAAGFTDFLLPMLELIPEKRATAAE 388
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 23/142 (16%)
Query: 127 GLVGPIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGK-- 180
L N L + N L G S L + + N +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 181 ---IPSSFS--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNN--------L 223
+ + +L VLDL N+FT + ++++ L L L +
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 224 SGSIPNFDIPKLRHLNLSYNGL 245
+ + L+ L L YN +
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEI 286
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 25/105 (23%), Positives = 35/105 (33%), Gaps = 17/105 (16%)
Query: 137 LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGK--------IPSS 184
L L+VL L+ N T L + S P+LR L L S +
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 185 FSPQLVVLDLSFNSFTGN----IPQSIQ-NLTQLTGLSLQSNNLS 224
+ L L L +N + + I + L L L N S
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 22/142 (15%), Positives = 39/142 (27%), Gaps = 36/142 (25%)
Query: 137 LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFS-------------- 178
L K L + L N L ++ L +LYL +N
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 179 -GKIPSSFSPQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNL---------- 223
+ +P L + N ++ Q+ L + + N +
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 224 SGSIPNFDIPKLRHLNLSYNGL 245
G +L+ L+L N
Sbjct: 210 EGLAYC---QELKVLDLQDNTF 228
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 29/154 (18%), Positives = 51/154 (33%), Gaps = 38/154 (24%)
Query: 143 LEVLSLRSNVLT--GG-----------LPSEITSLPSLRYLYLQHNNFSGK----IPSSF 185
LE L L +N L G + + + P LR + N +F
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 186 S--PQLVVLDLSFNSFT-----GNIPQSIQNLTQLTGLSLQSNN--------LSGSIPNF 230
L + + N + + + +L L LQ N L+ ++ ++
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 231 DIPKLRHLNLSYNGL--KG--SIPSSLQKFPNSS 260
P LR L L+ L +G ++ + K N
Sbjct: 244 --PNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 24/132 (18%), Positives = 46/132 (34%), Gaps = 32/132 (24%)
Query: 143 LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGK----IPSSFS--PQLVVL 192
+E SL+ + +T + + + S++ + L N + + + + L +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 193 DLSFNSFTGNIP-----------QSIQNLTQLTGLSLQSNN--------LSGSIPNFDIP 233
+ S FTG + Q++ +L + L N L +
Sbjct: 66 EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH--T 122
Query: 234 KLRHLNLSYNGL 245
L HL L NGL
Sbjct: 123 PLEHLYLHNNGL 134
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 41/119 (34%), Positives = 54/119 (45%), Gaps = 11/119 (9%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 187
+ L L+ L L SN L LP + SL L L L N + +PS+ F
Sbjct: 55 LEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLV 112
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
L L + N T +P+ I+ LT LT L+L N L SIP+ FD + L H L N
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 23/74 (31%), Positives = 33/74 (44%), Gaps = 5/74 (6%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 237
+P+ +L L N T P +L L L L SN L ++P FD + +L
Sbjct: 34 VPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTV 92
Query: 238 LNLSYNGLKGSIPS 251
L+L N L +PS
Sbjct: 93 LDLGTNQLT-VLPS 105
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 28/220 (12%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ--MEI--------VGRVGQ 439
++GKGS+G KA E V +K ++ K+ F Q +E+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
+ +V L+ ++ ++ LV++ S +L LL + K +
Sbjct: 116 Y-YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNT---NFRGVSLNLTRKFAQQMCTAL 170
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATP---SRSAGYRAP 554
+ + H ++K N+L+ I DFG + + SR YR+P
Sbjct: 171 LFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--YRSP 227
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 594
EV+ + D++S G +L+EM TG+ D +
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 33/118 (27%), Positives = 47/118 (39%), Gaps = 15/118 (12%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189
IP++ L L SN L L L L L N F +L
Sbjct: 26 IPSSA-------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 190 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
+L L N ++P + LTQL L+L +N L S+P+ FD + L+ + L N
Sbjct: 79 TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 25/74 (33%), Positives = 35/74 (47%), Gaps = 5/74 (6%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 237
+P+ L+L N LTQLT LSL N + S+P+ FD + KL
Sbjct: 22 VPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTI 80
Query: 238 LNLSYNGLKGSIPS 251
L L N L+ S+P+
Sbjct: 81 LYLHENKLQ-SLPN 93
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 7e-06
Identities = 31/211 (14%), Positives = 60/211 (28%), Gaps = 49/211 (23%)
Query: 373 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK-------RLKEVVVGKR 425
F C L+ E +G+G +G ++ + + T V +K L K
Sbjct: 13 FSHCLPTEKLQRC-----EKIGEGVFGEVFQTIADH-TPVAIKIIAIEGPDLVNGSHQKT 66
Query: 426 DFEQQMEIV----------GRVGQHPNVVPLRAYYYSKDEK----LLVYDYFAS--GSLS 469
E EI+ + + L + + + L +D++ S GS +
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 470 TLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 511
+ T IL +A + +F
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFE 184
Query: 512 HGNIKASNVLINQDLDGCISDFGLTPLMNVP 542
H ++ NVL+ + + +P
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 29/118 (24%)
Query: 142 ALEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLV 190
L L + +T G L + + SL+ L L N + QL
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 316
Query: 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 248
L + SFT + + + L N L L +S N L+ +
Sbjct: 317 SLWVKSCSFT---AACCSHFSSV----LAQN-----------RFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 23/117 (19%), Positives = 36/117 (30%), Gaps = 29/117 (24%)
Query: 143 LEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLVV 191
LE L L L+ L S + + P + L + +N+ + + QL
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 248
L L T + ++L + S LR L L N L
Sbjct: 204 LKLESCGVT---SDNCRDL----CGIVASK-----------ASLRELALGSNKLGDV 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 24/127 (18%), Positives = 44/127 (34%), Gaps = 24/127 (18%)
Query: 143 LEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGK----IPSSFS--PQLVVLDLS 195
++ L ++ L+ + L + + L + I S+ P L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 196 FNSFTGNIPQSI-----QNLTQLTGLSLQSNNLSGS---------IPNFDIPKLRHLNLS 241
N + ++ LSLQ+ L+G+ P L+ L+LS
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL---PTLQELHLS 121
Query: 242 YNGLKGS 248
N L +
Sbjct: 122 DNLLGDA 128
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 25/114 (21%), Positives = 44/114 (38%), Gaps = 29/114 (25%)
Query: 143 LEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLVV 191
++ LSL++ LT G L S + +LP+L+ L+L N + +L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 245
L L + S + S + L L++ P + L +S N +
Sbjct: 147 LQLEYCSLS---AASCEPL----ASVLRAK-----------PDFKELTVSNNDI 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 24/115 (20%), Positives = 36/115 (31%), Gaps = 29/115 (25%)
Query: 142 ALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLV 190
LE L ++S T S + L L + +N + L
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373
Query: 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 245
VL L+ + S +L +L +N LR L+LS N L
Sbjct: 374 VLWLADCDVS---DSSCSSLAA----TLLAN-----------HSLRELDLSNNCL 410
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 34/227 (14%), Positives = 69/227 (30%), Gaps = 48/227 (21%)
Query: 391 EVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVGKRDFEQQ--MEI--------VGRVG 438
LG+G++G + + + V +K ++ + + +EI +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK----IIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 498
+ V + ++ + ++ + L N PL R +
Sbjct: 81 KF-LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP-YPLP-HVR-HMAYQLCHA 135
Query: 499 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------------- 545
+ +H + TH ++K N+L + + +
Sbjct: 136 LRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 546 ---------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 583
+R YR PEVI + DV+S G +L E G
Sbjct: 193 HEHHTTIVATRH--YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 27/109 (24%), Positives = 38/109 (34%), Gaps = 27/109 (24%)
Query: 497 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP----------- 545
+ V +HS K TH ++K N+L Q + + P
Sbjct: 129 KSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 546 -----------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 583
+R YRAPEVI S DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVSTRH--YRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 41/234 (17%), Positives = 71/234 (30%), Gaps = 58/234 (24%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ----MEIVGRVGQHP---- 441
+G G++G ++ VK VV + + + +I+ ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 442 NVVPLRAYYYSKD------EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 495
N+V + D E L SL ++ N E +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPL-------GPSLYEIITRN---NYNGFHIEDIKLYCIEI 146
Query: 496 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------- 547
+ + ++ M TH ++K N+L++ R
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 548 ----SAG--------------YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 583
A YRAPEVI SD++SFG +L E+ TG
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 22/128 (17%), Positives = 41/128 (32%), Gaps = 25/128 (19%)
Query: 143 LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---------PQL 189
+ L+L N L G L SL L+ +YL ++ ++
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
Query: 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-----------SIPNFDIPK-LRH 237
+++D + + I NL + +L +I + +IP LR
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRE 346
Query: 238 LNLSYNGL 245
+ L
Sbjct: 347 SIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 26/130 (20%), Positives = 43/130 (33%), Gaps = 29/130 (22%)
Query: 143 LEVLSLRSN--------VLTGGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSP 187
+ L+LR N L L + ++ L L+ NN + K +S
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANV---NSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 188 QLVVLDLSFNSFTGNIPQSI-----QNLTQLTGLSLQSNNLSGSIPNF------DIPKLR 236
+ LDLS N + + L+L N L G + L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 237 HLNLSYNGLK 246
+ L Y+ +K
Sbjct: 257 TVYLDYDIVK 266
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 35/93 (37%), Positives = 43/93 (46%), Gaps = 13/93 (13%)
Query: 162 TSLPS-----LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQL 213
S+P+ + LYL N + P F QL LDL N T +P + LTQL
Sbjct: 22 ASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 214 TGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 243
T LSL N L SIP FD + L H+ L N
Sbjct: 81 TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 16/114 (14%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH----NNFSGKIPSSFSPQLVVLDLSFNS 198
L+ LSL L+ + + + +L L L + F+ + S +L L+LS+
Sbjct: 120 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 179
Query: 199 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----------IPKLRHLNLSY 242
+ +Q ++ NLSG N P L HL+LS
Sbjct: 180 DFTE--KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 231
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 682 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.85 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.79 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.77 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.74 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.74 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.73 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.73 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.72 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.72 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.69 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.69 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.69 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.69 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.69 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.68 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.67 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.67 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.67 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.67 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.67 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.66 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.66 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.66 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.66 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.65 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.65 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.65 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.65 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.65 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.64 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.64 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.64 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.62 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.62 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.62 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.62 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.61 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.61 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.61 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.61 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.6 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.6 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.6 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.59 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.59 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.59 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.59 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.59 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.58 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.58 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.57 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.56 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.56 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.56 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.55 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.54 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.54 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.54 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.53 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.53 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.52 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.51 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.51 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.5 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.5 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.49 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.49 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.48 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.44 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.43 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.43 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.42 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.42 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.41 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.41 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.38 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.37 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.37 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.37 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.35 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.31 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.29 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.23 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.23 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.22 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.21 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.04 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.81 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.8 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.75 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.71 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.56 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.42 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.41 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.17 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.14 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.05 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.03 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.01 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.83 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.77 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.11 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.83 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.75 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.28 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.12 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.08 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.05 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.87 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.65 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.62 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.58 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.94 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.63 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 89.31 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.28 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.06 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.83 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 81.09 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=428.85 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=202.1
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|++. +++.||||+++.... ..++|.+|+++++++ +|||||+++|+|.+++..++||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence 578999999999999874 367899999976432 346799999999999 999999999999999999999999
Q ss_pred ccCCchhHhhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEee
Q 005693 463 FASGSLSTLLHGNRGA----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 532 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 532 (682)
|++|+|.++++..... ...+++|.+++.|+.|||+||+|||+.+ ||||||||+|||+++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcc
Confidence 9999999999764321 2346999999999999999999999987 99999999999999999999999
Q ss_pred cCCCCCCCCC------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 533 FGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 533 fGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
||+|+..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... .....+..
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~i~~ 275 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAIDCITQ 275 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHHHHHHH
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHHHHHHc
Confidence 9999865432 23457899999999999999999999999999999999 89999864322 11222221
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.. .. .....+...+.+++.+||+.||++|||++||+++|+.+.+..
T Consensus 276 g~-~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 276 GR-EL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp TC-CC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred CC-CC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 11 10 111223445778888999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=422.20 Aligned_cols=252 Identities=28% Similarity=0.430 Sum_probs=199.6
Q ss_pred hhccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
..+.||+|+||+||+|+++ ..||||+++..... .++|.+|+++++++ +|||||+++|++. ++..++|||||++
T Consensus 40 l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~-~~~~~iVmEy~~g 115 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMT-KDNLAIVTQWCEG 115 (307)
T ss_dssp EEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCSS
T ss_pred EeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE-CCeEEEEEEcCCC
Confidence 3578999999999999865 36999998754433 35689999999999 9999999999885 4578999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.++++... ..+++.+++.|+.|||.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 116 GsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 116 SSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999997533 34999999999999999999999987 999999999999999999999999999875432
Q ss_pred ---CCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 543 ---ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
....||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.... ......+...... +.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~----p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYAS----PD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCC----CC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----CC
Confidence 23468999999999964 45899999999999999999999999754321 1122222222111 11
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
+. ....++...+.+++.+||+.||++||||+||++.|+.++...+
T Consensus 259 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 259 LS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred cc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 10 0112234567778889999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=423.70 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=203.3
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+.++.++ +|||||+++|+|.+++..++|||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEEEEEE
Confidence 467999999999999863 467899999976533 357899999999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEE
Q 005693 462 YFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 530 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 530 (682)
||++|+|.++|+..... ....++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEE
Confidence 99999999999654311 1235899999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCC------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 005693 531 SDFGLTPLMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 603 (682)
Q Consensus 531 ~DfGla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~ 603 (682)
+|||+|+.... .....||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+ ....
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------~~~~- 259 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VVEM- 259 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH------HHHH-
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH------HHHH-
Confidence 99999976532 223457889999999999999999999999999999999 899998654221 1222
Q ss_pred hhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 604 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
+...... ...+++...+.+++.+||+.||++||||+||+++|+.+
T Consensus 260 i~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2221111 11123445677888899999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=425.82 Aligned_cols=252 Identities=24% Similarity=0.440 Sum_probs=204.3
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|++. ++..||||+++.... ..++|.+|+++++++ +|||||+++|+|.+++..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEc
Confidence 578999999999999864 367899999976432 356799999999999 999999999999999999999999
Q ss_pred ccCCchhHhhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 463 FASGSLSTLLHGNR--------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 463 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
|++|+|.++++... ......++|.+++.++.|||+||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcc
Confidence 99999999997542 122346999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhc
Q 005693 535 LTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 607 (682)
Q Consensus 535 la~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~ 607 (682)
+|+..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... .....+....
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~i~~~~ 247 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECITQGR 247 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHHTC
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCC
Confidence 99754332 12347889999999999999999999999999999999 89999865422 1122222111
Q ss_pred cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 608 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.. .....+...+.+++.+||+.||++|||++|+.+.|+++.+..
T Consensus 248 -~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 248 -VL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp -CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -CC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11 111223446778888999999999999999999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=422.05 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=197.1
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecC----ceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----EKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|+++ |+.||||+++........++.|+..+.++ +|||||++++++.+++ ..++||||+++
T Consensus 8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 578999999999999985 88999999976432222333444444566 8999999999998764 57999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
|+|.++++.. .++|+.+.+++.|++.||+|||+++ .++|+||||||+|||+++++.+||+|||+|+...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999743 3899999999999999999999861 2459999999999999999999999999997653
Q ss_pred CC--------CCCCCCCcccCccccccC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC--------ChhH
Q 005693 541 VP--------ATPSRSAGYRAPEVIETR------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--------DLPR 598 (682)
Q Consensus 541 ~~--------~~~~~~~~y~aPE~~~~~------~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~--------~l~~ 598 (682)
.. ....||+.|||||++.+. .++.++|||||||++|||+||+.||......+.. ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 32 124589999999999764 3678999999999999999999887643322110 0111
Q ss_pred HHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 599 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 599 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.......+. ..++.+.......+....+.+++.+||+.||++||||+||++.|+++.+..
T Consensus 240 ~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 240 EMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 122222111 112222111222356677889999999999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=417.28 Aligned_cols=240 Identities=20% Similarity=0.331 Sum_probs=199.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|+
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 157 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA 157 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 357999999999999976 578999999975533 456789999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++... .+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..... .
T Consensus 158 L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 158 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 99999742 3899999999999999999999998 999999999999999999999999999866432 3
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
+..||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+. +... +.+...
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~-~~~~-----~~~~~~--- 293 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIR-DNLP-----PRLKNL--- 293 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSSC-----CCCSCG---
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH-cCCC-----CCCCcc---
Confidence 457999999999999999999999999999999999999999764321 1122221 1111 111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.||++|||++|++++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1223455677779999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=415.31 Aligned_cols=245 Identities=21% Similarity=0.244 Sum_probs=200.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.++||+|+||+||+|+.. +++.||||+++.... ..+|+.+++++ +|||||++++++.+++..|+||||++||+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999975 478999999975432 34689999998 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCCC-----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP----- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~----- 542 (682)
.++++.. ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+.....
T Consensus 138 ~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 138 GQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999743 24999999999999999999999998 99999999999999988 6999999999865432
Q ss_pred ----CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+.. ..+..+..... .
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~~~~------~ 277 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPPPIR------E 277 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCCGGG------G
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCCCch------h
Confidence 2246899999999999999999999999999999999999999876544321 11111111000 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.... ....+.+++.+||+.||++|||++|++++|....+..
T Consensus 278 ~~~~---~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 278 IPPS---CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp SCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cCcc---CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 1112 2344566777999999999999999999998877544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=419.25 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=206.9
Q ss_pred hhccccccCeEEEEEEEEcC------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec-CceEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLV 459 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV 459 (682)
..+.||+|+||+||+|.+.. ++.||||+++.... ..++|.+|++++.++.+|||||+++|+|.++ +..++|
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 36789999999999999653 25799999976533 2457899999999997779999999999764 568999
Q ss_pred EeeccCCchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCe
Q 005693 460 YDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 528 (682)
||||++|+|.++|+.... .....+++.+++.++.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~v 224 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVV 224 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCE
Confidence 999999999999975432 11345899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005693 529 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 529 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~ 601 (682)
||+|||+|+...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ .+.
T Consensus 225 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------~~~ 298 (353)
T 4ase_A 225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFC 298 (353)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHH
T ss_pred EECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 999999998764432 2246888999999999999999999999999999998 899998654221 222
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
..+.+...... .+.....+.+++.+||+.||++|||++|++++|+.+.+...+
T Consensus 299 ~~i~~g~~~~~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 299 RRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp HHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred HHHHcCCCCCC----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 22222221111 112334567788899999999999999999999999876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=405.40 Aligned_cols=241 Identities=24% Similarity=0.391 Sum_probs=192.3
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEee
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDY 462 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~ 462 (682)
+.||+|+||+||+|.+.. +..||+|++...... .+.|.+|+++++++ +|||||++++++.+ ++..|+||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 569999999999999764 678999999765433 35688999999999 99999999999875 3457999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNV 541 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~ 541 (682)
|++|+|.++++.. ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 111 ~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 111 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999743 34899999999999999999999985 56999999999999984 79999999999986543
Q ss_pred C--CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 542 P--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 542 ~--~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
. .+..||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... .......+ ........++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i-~~~~~~~~~~----- 252 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRV-TSGVKPASFD----- 252 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHH-TTTCCCGGGG-----
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHH-HcCCCCCCCC-----
Confidence 3 24569999999999865 699999999999999999999999975321 11112222 1111111111
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... ...+.+++.+||+.||++|||++|++++
T Consensus 253 -~~~---~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 -KVA---IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GCC---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 2246677889999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=412.74 Aligned_cols=241 Identities=18% Similarity=0.377 Sum_probs=194.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|+.. +++.||||++...... .+.+.+|+++++++ +|||||++++++.+++..|+||||++|
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVmEy~~g 107 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVMDYCEG 107 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999975 5789999999765433 35688999999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
|+|.+++...+ ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 108 g~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 108 GDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999997543 234789999999999999999999998 9999999999999999999999999998775432
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
+..||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+ .......+....... ...
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~~~--------~~~ 247 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSFPP--------VSL 247 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCCCC--------CCT
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCCCC--------CCc
Confidence 3458999999999999999999999999999999999999998643 222233333322110 011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+ ...+.+++.+||+.||++|||++|++++
T Consensus 248 ~~---s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 248 HY---SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12 2346677779999999999999999873
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=417.97 Aligned_cols=240 Identities=20% Similarity=0.341 Sum_probs=199.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..|+|||||++|+
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 467999999999999976 478999999975533 456789999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.++++.. .+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..... .
T Consensus 235 L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 235 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred HHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 99999742 3899999999999999999999998 999999999999999999999999999866433 3
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
+..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... .....+. +... +.+.....+
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~-~~~~-----~~~~~~~~~ 373 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIR-DNLP-----PRLKNLHKV 373 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCC-----CCCSCTTSS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH-cCCC-----CCCcccccC
Confidence 456899999999999999999999999999999999999999754321 1122211 1111 111112222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+ ..+.+++.+||+.||++|||++|++++
T Consensus 374 s---~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 374 S---PSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp C---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3 345667779999999999999999884
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=402.35 Aligned_cols=238 Identities=18% Similarity=0.293 Sum_probs=198.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.||+|++.+.. ...+.+.+|+++++++ +|||||++++++++++..|+||||++
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 578999999999999975 57889999997542 2346789999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 116 gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 116 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999743 24999999999999999999999998 999999999999999999999999999876422
Q ss_pred ----CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
.+.+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+. ......+......
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~~--------- 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLEYD--------- 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC---------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC---------
Confidence 245799999999999999999999999999999999999999976432 2222333322211
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....++ ..+.+++.+|++.||++|||++|+..+
T Consensus 253 ~p~~~s---~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 FPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CCTTCC---HHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred CCcccC---HHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 111222 345677779999999999999997543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=390.76 Aligned_cols=237 Identities=23% Similarity=0.364 Sum_probs=185.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 478999999999999964 578999999975432 245689999999999 8999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 96 GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 68999999743 34999999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.+..||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.+ .......+...... ..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~~---------~p 232 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVYT---------LP 232 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC---------CC
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCC---------CC
Confidence 34579999999999998876 579999999999999999999997543 22222222222111 11
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+ ..+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~s---~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 233 KFLS---PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TTSC---HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1222 345677779999999999999999984
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=397.99 Aligned_cols=237 Identities=26% Similarity=0.393 Sum_probs=188.7
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|+.. .++.||+|+++.... ....+.+|++++.++ +|||||++++++.+++..|+||||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEEc
Confidence 578999999999999863 357899999975432 234688899999998 999999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 541 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 541 (682)
++||+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 108 LRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999743 24999999999999999999999998 99999999999999999999999999986532
Q ss_pred ---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 542 ---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 542 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
..+..||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.. .....+......
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~~~--------- 244 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILKAKLG--------- 244 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---------
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHcCCCC---------
Confidence 23457999999999999999999999999999999999999999865322 222222222110
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR 653 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 653 (682)
....++ ..+.+++.+||+.||++|||+ +|+++
T Consensus 245 ~p~~~s---~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQFLS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTTSC---HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcCC---HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111222 345677779999999999984 56665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=386.23 Aligned_cols=240 Identities=21% Similarity=0.354 Sum_probs=182.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCc-----------
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE----------- 455 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----------- 455 (682)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+++++++ +|||||++++++.+.+.
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----------CE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccccCCCc
Confidence 478999999999999975 578999999975432 245688999999999 99999999999976543
Q ss_pred -eEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 456 -KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 456 -~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
.|+||||+++|+|.+++..... ....++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence 6899999999999999975432 233567778999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCC----------------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 005693 535 LTPLMNVPA----------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 598 (682)
Q Consensus 535 la~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~ 598 (682)
+|+...... +..||+.|||||++.+..|+.++|||||||++|||++ ||.... +...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~ 235 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVR 235 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHH
Confidence 998764321 2358999999999999999999999999999999996 775321 0001
Q ss_pred HHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 599 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 599 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... ..... ............+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~-~~~~~----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTDV-RNLKF----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHH-HTTCC----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHH-hcCCC----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 11000 01112333445678889999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=379.12 Aligned_cols=188 Identities=23% Similarity=0.459 Sum_probs=164.1
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|+.+ .++.||+|++... .....+.+|++++..+.+|||||++++++.+++..|+||||+++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 468999999999999864 3568999998654 33566889999999997899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~-- 542 (682)
|+|.++++ .+++.++..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999984 2889999999999999999999998 9999999999999877 79999999999654321
Q ss_pred ------------------------------CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 543 ------------------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 543 ------------------------------~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
.+..||+.|+|||++.+. .|+.++||||+||++|||+||+.||....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 123589999999999775 48999999999999999999999996543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=378.10 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=191.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec------CceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 459 (682)
.+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|+++++.+ +|||||++++++... +..|+|
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~~~iv 137 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVV 137 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCEEEEE
Confidence 478999999999999975 5789999999765432 34678899999999 999999999998643 578999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||++ |+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 138 mE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 138 LDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 99996 6899999743 35999999999999999999999998 999999999999999999999999999865
Q ss_pred CC--------CCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc-
Q 005693 540 NV--------PATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT- 609 (682)
Q Consensus 540 ~~--------~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~- 609 (682)
.. ..+..||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+. ...+......
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~------l~~I~~~~g~p 282 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ------LQLIMMVLGTP 282 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH------HHHHHHHHCCC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH------HHHHHHhcCCC
Confidence 32 2245789999999998875 468999999999999999999999986543221 1111110000
Q ss_pred -cccc--------h---hhhc--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 -AEVF--------D---VELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 -~~~~--------d---~~l~--~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.... . ..+. ..... ......+.+|+.+||+.||++|||++|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0 0000 00000 0112356678889999999999999999884
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=360.78 Aligned_cols=267 Identities=27% Similarity=0.520 Sum_probs=224.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|..++++.||+|++..... ..+.+.+|++++..+ +||||+++++++..++..++||||+++|+|
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 467999999999999988899999999876533 346788999999988 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 543 (682)
.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 123 ~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 123 KRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999975432 2345899999999999999999999998 9999999999999999999999999987543221
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...+++.|+|||++.+..++.++||||||+++|||++|+.||......+......|..............++.... ..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-cc
Confidence 2236788999999998899999999999999999999999999877777777777766555444444444443322 23
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
..+....+.+++.+||+.||++|||++|++++|+.+.+..
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 3567788999999999999999999999999999988654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=388.41 Aligned_cols=242 Identities=18% Similarity=0.260 Sum_probs=191.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhc--CCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|+.. +++.||+|++++... ......+|..++..+. +|||||++++++++++..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 478999999999999976 478899999975432 2333445544444332 799999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
++||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 274 ~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 274 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999743 24999999999999999999999998 999999999999999999999999999876443
Q ss_pred --CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 --ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
.+.+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+....+ ............. ..
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~~---------~~ 413 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAV---------EL 413 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCCC---------CC
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCCC---------CC
Confidence 35679999999999975 579999999999999999999999997644322 1111222111110 11
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
...++. .+.+++.+||+.||++|++ ++|+.++
T Consensus 414 p~~~S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 414 PDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CTTSCH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CccCCH---HHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 122233 4556777999999999998 7888774
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=388.03 Aligned_cols=243 Identities=20% Similarity=0.387 Sum_probs=199.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|..+ +++.||+|++..... ..+.+.+|+++++.+ +|||||++++++.+++..|+|||||++|+
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 578999999999999975 478899999876533 356788999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC--CCeEEeecCCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~--~~~kl~DfGla~~~~~~~-- 543 (682)
|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+......
T Consensus 241 L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 241 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp HHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred HHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999996432 34899999999999999999999998 9999999999999854 899999999998775443
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+....+.. . ......
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~~---~--~~~~~~ 382 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWNM---D--DSAFSG 382 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCCC---C--SGGGTT
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCCC---C--cccccC
Confidence 346899999999999999999999999999999999999999865422 1122222221110 0 011122
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
++ ..+.+++.+||+.||++|||++|++++
T Consensus 383 ~s---~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 383 IS---EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23 345567779999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=362.01 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=202.9
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCc----eEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE----KLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|+.. ++.||||++.........+++|+.++.++ +||||+++++++..... .++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 478999999999999876 78999999976544445566788888888 89999999999987554 6999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM----------GGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~----------~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
|+|.++++.. .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999743 389999999999999999999998 7 99999999999999999999999999
Q ss_pred CCCCCCC------CCCCCCCcccCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH------
Q 005693 536 TPLMNVP------ATPSRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR------ 598 (682)
Q Consensus 536 a~~~~~~------~~~~~~~~y~aPE~~~~~-----~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~------ 598 (682)
++..... ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||.+...........
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9654332 224578999999999863 45678899999999999999999998765443332211
Q ss_pred ----HHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 599 ----WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 599 ----~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
+......... .+.+............+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 258 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 258 SLEDMQEVVVHKKK-----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CHHHHHHHHTTSCC-----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chhhhhhhhhcccC-----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111111 1111111112245566888999999999999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=360.37 Aligned_cols=278 Identities=38% Similarity=0.681 Sum_probs=224.1
Q ss_pred CCCHHHHHHHh-----hccccccCeEEEEEEEEcCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEE
Q 005693 379 NFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY 451 (682)
Q Consensus 379 ~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 451 (682)
.|+..++.... .+.||+|+||.||+|...+++.||+|++..... ....+.+|++++..+ +||||+++++++.
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 97 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 97 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEEC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEe
Confidence 35555554443 468999999999999988899999999976532 234689999999998 8999999999999
Q ss_pred ecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEe
Q 005693 452 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 531 (682)
Q Consensus 452 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 531 (682)
..+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+...++|+||||||+||++++++.+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999986543 34459999999999999999999999822239999999999999999999999
Q ss_pred ecCCCCCCCCCC-----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--CCCCCChhHHHHHHh
Q 005693 532 DFGLTPLMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT--RDDMVDLPRWVQSVV 604 (682)
Q Consensus 532 DfGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~--~~~~~~l~~~~~~~~ 604 (682)
|||+++...... ...+|+.|+|||++.+..++.++||||||+++|||++|+.||.... .........|.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999997654322 2347899999999998889999999999999999999999996321 122334555665555
Q ss_pred hhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 605 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 605 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
.........+.... .....+....+.+++.+||+.||++|||++|++++|+...
T Consensus 257 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 55544444444432 2334677888999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=351.70 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=196.3
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+. +++.||+|++...... .+++.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 57899999999999987 4788999999765433 24688899999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 196 (309)
T 3p86_A 120 SLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196 (309)
T ss_dssp BHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred cHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccccc
Confidence 99999975321 223899999999999999999999985 45999999999999999999999999999765433
Q ss_pred CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||...... ............. ..
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~----------~~ 260 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRL----------EI 260 (309)
T ss_dssp -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCC----------CC
T ss_pred ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCC----------CC
Confidence 2345789999999999999999999999999999999999999754321 1111111111000 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.......+.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 11223456778889999999999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.52 Aligned_cols=248 Identities=25% Similarity=0.436 Sum_probs=203.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 578999999999999975 47889999885532 2346788999999999 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC----
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 543 (682)
|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 94 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 94 LRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999997532 34899999999999999999999998 9999999999999999999999999997653321
Q ss_pred --------------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC---ChhHHHHHHhhh
Q 005693 544 --------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---DLPRWVQSVVRE 606 (682)
Q Consensus 544 --------------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~---~l~~~~~~~~~~ 606 (682)
...||+.|+|||++.+..++.++||||||+++|||++|..||......... ..........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC-- 244 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC--
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC--
Confidence 335788999999999999999999999999999999999998754332221 1111111000
Q ss_pred ccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 607 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 607 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.......+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 245 ----------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 245 ----------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ----------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 01122346678889999999999999999999999986644
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.51 Aligned_cols=247 Identities=25% Similarity=0.437 Sum_probs=206.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|...+++.||+|++.......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 478999999999999998889999999988777778899999999999 8999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-----CC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~~ 544 (682)
+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 94 ~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 94 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9997533 34899999999999999999999998 999999999999999999999999999765432 23
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... ......... ... . ..
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~-~~~--~-----~~--- 229 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG-FRL--Y-----KP--- 229 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-CCC--C-----CC---
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcC-ccC--C-----CC---
Confidence 345678999999998999999999999999999999 99999754321 111111111 000 0 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
......+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11234567788899999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=358.55 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=204.3
Q ss_pred hccccccCeEEEEEEEEc--------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.||+|+||.||+|+.. ++..||+|+++.... ..+++.+|++++.++.+||||+++++++.+++..++|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 578999999999999863 245699999976432 2356889999999997899999999999999999999
Q ss_pred EeeccCCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCe
Q 005693 460 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 528 (682)
|||+++|+|.+++...... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCE
Confidence 9999999999999764321 1234899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005693 529 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 529 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~ 601 (682)
||+|||+++...... ...+++.|+|||++.+..++.++|||||||++|||+| |+.||.+....+. ..
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~------~~ 316 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------FK 316 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------HH
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence 999999997654322 2234678999999999999999999999999999999 9999986543221 11
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
. +....... ........+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 317 ~-~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 317 L-LKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp H-HHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H-HhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 11111100 111233456778889999999999999999999999986544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.11 Aligned_cols=240 Identities=22% Similarity=0.344 Sum_probs=197.0
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|.. .+++.||+|++..... ..+.+.+|+.++..+ +||||+++++++..++..++||||+++|+
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 46799999999999996 4578899999875543 456788999999998 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 104 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 99999743 3899999999999999999999998 999999999999999999999999998765432 2
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .....
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~---------~~~~~ 239 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP---------ELQNP 239 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC---------CCSCG
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---------CCCCc
Confidence 345789999999999999999999999999999999999999754311 111111111110 01111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2233456778889999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.35 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=205.1
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|..+++..||+|+++......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 468999999999999999888999999987777778899999999999 8999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 92 NYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp HHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9997532 24899999999999999999999998 9999999999999999999999999997654332 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........... .. ...
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~---~~-----~~~-- 228 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHR---LY-----RPH-- 228 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCC---CC-----CCT--
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCCC---CC-----CCC--
Confidence 335667999999998889999999999999999999 99999754321 11111111110 00 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.....+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 229 -~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 229 -LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp -TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred -cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 11235677888999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.13 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=201.8
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|.+. .+..||||+++.... ..+.+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEEEECC
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEEeeCC
Confidence 578999999999999975 344699999976432 245788999999999 8999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 133 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 133 ENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999998764332
Q ss_pred C-------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 544 T-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 544 ~-------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ..+++.|+|||++.+..++.++||||||+++|||++ |..||...... ......... ..
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~-~~------ 272 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISSVEEG-YR------ 272 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTT-CC------
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHcC-CC------
Confidence 1 224567999999998899999999999999999999 99999754321 111111111 10
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENR 666 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 666 (682)
..........+.+++.+||+.||++|||++|+++.|+.+.+.....+
T Consensus 273 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~ 319 (325)
T 3kul_A 273 ----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR 319 (325)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence 00111233456778889999999999999999999999997766543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=339.37 Aligned_cols=248 Identities=22% Similarity=0.357 Sum_probs=204.0
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||++...++..||+|+++......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 478999999999999999888999999988777778899999999999 8999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-----CC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~~ 544 (682)
+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 108 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 108 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp HHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 9997532 24899999999999999999999998 999999999999999999999999999765432 23
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+++.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+.... .. . ..
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~~-~~--~-----~~--- 243 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGL-RL--Y-----RP--- 243 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC-CC--C-----CC---
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhccc-CC--C-----CC---
Confidence 345678999999998899999999999999999998 99999754321 1111111110 00 0 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
......+.+++.+||+.+|++|||++|++++|+++...+
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 111245677888999999999999999999999988654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=345.41 Aligned_cols=253 Identities=15% Similarity=0.176 Sum_probs=204.0
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|++++.++.+||||+++++++..++..++||||+ +|+|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 47899999999999996 457889999987543 34578999999999989999999999999999999999999 9999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC-----eEEeecCCCCCCCCC-
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGLTPLMNVP- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DfGla~~~~~~- 542 (682)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 92 EDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99997542 34999999999999999999999998 999999999999999887 999999999765322
Q ss_pred ----------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 543 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 543 ----------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. ......+........
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---KERYQKIGDTKRATP- 240 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---HHHHHHHHHHHHHSC-
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---HHHHHHHHhhhccCC-
Confidence 234578999999999999999999999999999999999999987643332 222222211111000
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.+ . ..... . .+.+++.+||+.||++||+++++.+.|+++.+..
T Consensus 241 ~~-~--~~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 IE-V--LCENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HH-H--HTTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH-H--HhccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00 0 00011 1 6778888999999999999999999999887654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.76 Aligned_cols=271 Identities=29% Similarity=0.528 Sum_probs=214.2
Q ss_pred CCCCHHHHHHHh-----------hccccccCeEEEEEEEEcCCceEEEEEeecccc-----ChhhHHHHHHHHHHhcCCC
Q 005693 378 YNFDLEDLLRAS-----------AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHP 441 (682)
Q Consensus 378 ~~~~~~~l~~~~-----------~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~ 441 (682)
..|+.+++...+ .+.||+|+||.||+|.. +++.||+|++..... ..+.+.+|++++.++ +||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 90 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHE 90 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCC
Confidence 346677776665 26799999999999986 578999999875421 245688999999999 899
Q ss_pred ceeceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeE
Q 005693 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVL 521 (682)
Q Consensus 442 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NIL 521 (682)
||+++++++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999999999999999999999999999999975332 345899999999999999999999998 999999999999
Q ss_pred ecCCCCeEEeecCCCCCCCCC------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005693 522 INQDLDGCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595 (682)
Q Consensus 522 l~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~ 595 (682)
+++++.+||+|||++...... ....+++.|+|||.+.+ .++.++||||||+++|||++|..||......+..
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 243 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL- 243 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence 999999999999998765432 23357889999998865 5889999999999999999999999865543322
Q ss_pred hhHHHHHHhhhc-cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 596 LPRWVQSVVREE-WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 596 l~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
..+........ ...+.++..+ ..........+.+++.+||+.+|++|||++|++++|+++.+
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 -LDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp -THHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred -HHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22222221111 1111122111 12235566788899999999999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.45 Aligned_cols=251 Identities=23% Similarity=0.402 Sum_probs=194.0
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHh-cCCCceeceEEEEEec----CceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSK----DEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+. +++.||||++... ....+.+|.+++... .+||||+++++++... ...++||||++
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 47899999999999998 5889999998653 245566777777763 2899999999997653 35789999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--------SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
+|+|.++++. ..+++..+..++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 90 MGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp TCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 9999999963 24899999999999999999999 766 999999999999999999999999998
Q ss_pred CCCCCC--------CCCCCCCcccCccccccC------CCCCcchHHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 005693 537 PLMNVP--------ATPSRSAGYRAPEVIETR------KHSHKSDVYSFGVLLLEMLTG----------KAPLQSPTRDD 592 (682)
Q Consensus 537 ~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~sDvwS~Gvvl~elltg----------~~Pf~~~~~~~ 592 (682)
+..... ....+|+.|+|||++.+. .++.++|||||||++|||+|| +.||......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 654332 223688999999999876 455789999999999999999 78886543322
Q ss_pred CCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 593 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
. ... ............ +..............+.+++.+||+.||++|||++|+++.|+++
T Consensus 241 ~-~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 P-SFE-DMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp C-CHH-HHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred c-chh-hhhHHHhccCCC----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2 111 111111111111 11111111234567788899999999999999999999999976
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.92 Aligned_cols=239 Identities=21% Similarity=0.303 Sum_probs=196.2
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++.++ +||||+++++++...+..++||||+++|+|
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 47999999999999986 688999999975543 356788999999999 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----CC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 544 (682)
.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 130 ~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 130 TDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 999863 23899999999999999999999998 999999999999999999999999998765432 23
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ......... ..... ... ..
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~~~~-~~~~~-----~~~---~~ 265 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLRD-SPPPK-----LKN---SH 265 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SSCCC-----CTT---GG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCCCC-----cCc---cc
Confidence 4688999999999999999999999999999999999999975431 111111111 11100 001 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++.+||+.||++|||++|++++
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122346677889999999999999999885
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.32 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=207.5
Q ss_pred hccccccCeEEEEEEEEc--------CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.||+|+||+||+|+.. .+..||+|+++..... .+.+.+|++++.++.+||||+++++++..++..++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 578999999999999863 2356999999765332 356889999999998899999999999999999999
Q ss_pred EeeccCCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCe
Q 005693 460 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 528 (682)
|||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcE
Confidence 9999999999999764321 1235899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005693 529 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 529 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~ 601 (682)
||+|||+++...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... ....
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~------~~~~ 304 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ELFK 304 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHH
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH
Confidence 999999998664322 2235678999999999999999999999999999999 99999754321 1122
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCC
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 669 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~ 669 (682)
.+ ....... .. ......+.+++.+||+.||++|||++|+++.|+++.+....++...
T Consensus 305 ~~-~~~~~~~-------~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 305 LL-KEGHRMD-------KP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp HH-HTTCCCC-------CC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred HH-HcCCCCC-------CC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 11 1111110 01 1223456778889999999999999999999999998776655443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=362.46 Aligned_cols=248 Identities=24% Similarity=0.437 Sum_probs=205.2
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||+||+|.++++..||||+++......+++.+|+++++++ +||||+++++++. .+..++||||+++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 578999999999999998889999999987666778899999999999 9999999999986 66789999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-----CC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~~ 544 (682)
++++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 271 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 271 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp HHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred HHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 9997432 124789999999999999999999998 999999999999999999999999999876432 22
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++....++.++|||||||++|||+| |+.||.+.... .....+. ..... ...
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~-~~~~~----------~~~ 407 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALE-RGYRM----------PRP 407 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHH-HTCCC----------CCC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-cCCCC----------CCC
Confidence 335678999999998999999999999999999999 99999754321 1111111 11110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
......+.+++.+||+.||++|||++++++.|+++....
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 223346778888999999999999999999999887543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=344.82 Aligned_cols=238 Identities=20% Similarity=0.326 Sum_probs=196.4
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|.. .+++.||+|++...... .+.+.+|+++++.+ +||||+++++++...+..++||||+++
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 47899999999999997 46889999999765443 34577899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 99 GEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp CBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 9999999643 23899999999999999999999998 999999999999999999999999999765433
Q ss_pred CCCCCCCcccCccccccCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 ATPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....+|+.|+|||++.+..++ .++||||+||++|||++|+.||.+.. .......+...... ...
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---------~p~ 235 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGKYR---------IPF 235 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CCT
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---------CCC
Confidence 245689999999999888775 78999999999999999999997643 22222222222111 011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. ....+.+++.+||+.||++|||++|++++
T Consensus 236 ~---~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 Y---MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp T---SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C---CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 22345677789999999999999999885
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.17 Aligned_cols=255 Identities=16% Similarity=0.184 Sum_probs=204.4
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|++++..+.+|+|++++++++......++||||+ +++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 46899999999999996 467889999986543 34578899999999988999999999999999999999999 9999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC-----eEEeecCCCCCCCCC-
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGLTPLMNVP- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DfGla~~~~~~- 542 (682)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++.....
T Consensus 93 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 93 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99997532 24899999999999999999999998 999999999999988776 999999999765432
Q ss_pred ----------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 543 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 543 ----------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||.+....... ...............
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK---QKYERIGEKKQSTPL 242 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH---HHHHHHHHHHHHSCH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH---HHHHHHHhhccCccH
Confidence 2335788999999999999999999999999999999999999865432221 111111111100000
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.. ... .....+.+++.+||+.||++||+++++++.|+++.+...
T Consensus 243 --~~--~~~---~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 --RE--LCA---GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp --HH--HTT---TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HH--HHh---hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 00 001 123456778889999999999999999999999987654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.91 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=197.0
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHh-cCCCceeceEEEEEec----CceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSK----DEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.. ++.||+|++.... ...+.+|.+++... .+||||+++++++... ...++||||++
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 118 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence 578999999999999986 8899999986543 34445555555443 2899999999999887 67899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|||++...
T Consensus 119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 99999999643 3899999999999999999999880 112999999999999999999999999999655
Q ss_pred CCCC--------CCCCCCcccCccccccCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 005693 540 NVPA--------TPSRSAGYRAPEVIETRKHSHK------SDVYSFGVLLLEMLTG----------KAPLQSPTRDDMVD 595 (682)
Q Consensus 540 ~~~~--------~~~~~~~y~aPE~~~~~~~~~~------sDvwS~Gvvl~elltg----------~~Pf~~~~~~~~~~ 595 (682)
.... ...+|+.|+|||++.+..++.+ +|||||||++|||+|| ..||......+. .
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~ 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP-S 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-C
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC-c
Confidence 3322 3357899999999988776665 9999999999999999 555554332221 1
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
. ............. +.........++...+.+++.+||+.||++|||++|++++|+++.+...
T Consensus 272 ~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 272 Y-EDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp H-HHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred h-hhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 1 1111111111111 1111111123566778899999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=334.93 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=201.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 468999999999999975 5788999998654322 34678899999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 95 g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 95 GPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999743 24899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 544 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
...+|+.|+|||.+.+..++.++||||||+++|||+||+.||.+.... ........+... ......
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~----~~~~~~ 236 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVP----NVTTDV 236 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCC----CHHHHS
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCC----Ccchhc
Confidence 234789999999999999999999999999999999999999754321 111111111110 000000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCCCCC
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSENR 666 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~i~~~~~~~~ 666 (682)
.. .....+.+++.+|++.||++|| +++++.+.|+.+.......+
T Consensus 237 ~~---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 237 RK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp CT---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred cc---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 11 1234566778899999999999 89999999998876665443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=357.13 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=202.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecC-ceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++.++ +||||+++++++.+.+ ..++||||+++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 578999999999999986 6799999997654 457899999999999 9999999999988765 78999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-CCCC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR 547 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 547 (682)
.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ...+
T Consensus 275 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 348 (450)
T 1k9a_A 275 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348 (450)
T ss_dssp HHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------CC
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCC
Confidence 99997532 234789999999999999999999998 9999999999999999999999999997654322 2346
Q ss_pred CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHH
Q 005693 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 626 (682)
Q Consensus 548 ~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 626 (682)
++.|+|||++.+..++.++|||||||++|||+| |+.||......+ +. .. +...... .....+
T Consensus 349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~---~~-i~~~~~~----------~~p~~~ 411 (450)
T 1k9a_A 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PR-VEKGYKM----------DAPDGC 411 (450)
T ss_dssp CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH---HH-HHTTCCC----------CCCTTC
T ss_pred CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH-HHcCCCC----------CCCCcC
Confidence 778999999999999999999999999999998 999998654332 11 11 1111110 111223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 627 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 627 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
...+.+++.+||+.||++|||++|+++.|+++....
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 456677888999999999999999999999988643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.58 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=189.2
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc-----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... ++.||+|+++.... ..+.+.+|++++..+ +||||+++++++.+++..++||||++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEEEEcCC
Confidence 468999999999999976 78899999875432 235788999999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC--------CCCeEEeecCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--------DLDGCISDFGLT 536 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~--------~~~~kl~DfGla 536 (682)
+++|.+++.. ..+++..+..++.|++.||+|||+.+..+|+||||||+||+++. ++.+||+|||++
T Consensus 90 ~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 90 GGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp TEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 9999999953 24899999999999999999999987556999999999999986 678999999999
Q ss_pred CCCCCCC--CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 537 PLMNVPA--TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 537 ~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
....... ...+++.|+|||.+.+..++.++||||||+++|||++|+.||.+.... ..............
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~--- 234 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKLALP--- 234 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSCCCCC---
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCCCCCC---
Confidence 7654432 345788999999999989999999999999999999999999754311 11111111111100
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
........+.+++.+||+.||++|||++|++++|+++
T Consensus 235 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 -------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1112234567788899999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.71 Aligned_cols=241 Identities=21% Similarity=0.346 Sum_probs=196.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCEEEEEEE
Confidence 478999999999999976 478899999976532 235789999999999 89999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC----CeEEeecCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 537 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 537 (682)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++ .+||+|||++.
T Consensus 96 ~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999642 34899999999999999999999998 99999999999998877 79999999997
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 538 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 538 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
..... ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.... .....+...... ++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~~~~~---~~ 238 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITAVSYD---FD 238 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCC---CC
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCC---CC
Confidence 76543 2446899999999999989999999999999999999999999764321 112222211110 01
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.. ..... ...+.+++.+||..||++|||++|+++
T Consensus 239 ~~--~~~~~---s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EE--FFSQT---SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HH--HHTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ch--hccCC---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 01112 234567777999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=354.32 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=200.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+++.+|++++.++ +||||+++++++..++..++||||+++|
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 578999999999999986 678899999875432 234688999999999 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999997432 24899999999999999999999998 9999999999999999999999999987644321
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
...+++.|+|||++.+..++.++|||||||++|||+| |..||......+ ....+......
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 334 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRL--------- 334 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCC---------
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------
Confidence 1123557999999998899999999999999999999 999997543211 11111111110
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.........+.+++.+||+.||++|||++++++.|+++...
T Consensus 335 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 -PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 01112234567788899999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.87 Aligned_cols=238 Identities=21% Similarity=0.284 Sum_probs=195.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+ +++.||+|+++... .....+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 478999999999999976 47889999997642 2345688899999998 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 89 GGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999743 24899999999999999999999998 999999999999999999999999999764322
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+...... ..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---------~p 225 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEIR---------FP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC---------CC
Confidence 234578999999999999999999999999999999999999975431 1222222221110 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
... ...+.+++.+||+.||++|| +++|++++
T Consensus 226 ~~~---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCC---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112 23456677799999999999 89999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=346.12 Aligned_cols=245 Identities=19% Similarity=0.296 Sum_probs=194.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+. ++.||+|++++.... .+.+.+|..++.++.+||||+++++++.+++..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 5789999999999999765 678999999865332 24578899999888789999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 137 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 137 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999976322
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC--CChhHHHHHHhhhccccccchhhhc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--VDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..........+..... .
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~ 280 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------R 280 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--------C
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--------C
Confidence 2345689999999999999999999999999999999999999975432221 1111112211111110 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR 653 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~ 653 (682)
.... ....+.+++.+||+.||++||++ +|+++
T Consensus 281 ~p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 281 IPRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CCTT---SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred CCCc---CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 1111 22345677789999999999985 66666
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.20 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=198.6
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.... ++.+|+|.++........+.+|++++..+ +||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 4679999999999999764 67899999876544556788999999998 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC--CCCeEEeecCCCCCCCCCCC--
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPAT-- 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~~~~~~~-- 544 (682)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.......
T Consensus 89 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 99996432 34899999999999999999999998 999999999999997 78999999999987654332
Q ss_pred -CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 -~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+++.|+|||++.+..++.++|||||||++|||++|..||.+.... .....+....... +. ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~---~~--~~~~-- 228 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTF---DE--EAFK-- 228 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC---CH--HHHT--
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCCC---Ch--hhhc--
Confidence 34788999999999888999999999999999999999999764321 2222222221110 00 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.....+.+++.+|++.||++|||++|++++-
T Consensus 229 -~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 229 -EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1234566778899999999999999999843
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.07 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=206.0
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|...+++.||+|++.......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 468999999999999998888999999988766778899999999999 8999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-----CC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~~ 544 (682)
+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 92 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9997543 34899999999999999999999998 999999999999999999999999998765432 23
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... .... ..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~-~~~~-------~~--- 227 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG-FRLY-------KP--- 227 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT-CCCC-------CC---
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcC-CcCC-------CC---
Confidence 345678999999998899999999999999999999 8999975431 1111211111 1000 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
......+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11234566788899999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.69 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=193.7
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+..+++.||+|++...... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~- 103 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEK- 103 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence 4689999999999999988999999999754332 35688999999999 899999999999999999999999985
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 104 DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 8888886533 34899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc---cchh---
Q 005693 543 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE---VFDV--- 615 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~---~~d~--- 615 (682)
....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. ............... ..+.
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccchh
Confidence 23457889999999876 5689999999999999999999999986554332 111111111100000 0000
Q ss_pred ---hhc--cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 616 ---ELM--RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 616 ---~l~--~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... .... .+.....+.+++.+||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 0000 01122456788889999999999999999873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.06 Aligned_cols=248 Identities=26% Similarity=0.497 Sum_probs=192.8
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|+.. ++..||+|+++.... ..+++.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEeCC
Confidence 478999999999999865 467799999975432 245788999999999 8999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.++++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 129 ENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999997532 34899999999999999999999998 9999999999999999999999999998764332
Q ss_pred C-------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 544 T-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 544 ~-------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ..+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ..... +.....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~~-i~~~~~------ 268 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIKA-VDEGYR------ 268 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHHH-HHTTEE------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCCC------
Confidence 1 123567999999999999999999999999999998 99999754321 11111 111110
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
..........+.+++.+||+.||++||+++|+++.|+++.+..
T Consensus 269 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 ----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0111123456778888999999999999999999999997643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.09 Aligned_cols=246 Identities=22% Similarity=0.376 Sum_probs=194.5
Q ss_pred hccccccCeEEEEEEEEcC-Cc----eEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|++.. ++ .||+|.+.... ...+++.+|++++.++ +||||+++++++..+ ..++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-SEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-CeEEEEEe
Confidence 4789999999999999643 33 35888876443 2456799999999999 899999999999875 47899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999997543 34899999999999999999999998 999999999999999999999999998765432
Q ss_pred C------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ...+++.|+|||++.+..++.++|||||||++|||+| |+.||.+....+. .........
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~~------ 237 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGER------ 237 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCC------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------HHHHHcCCC------
Confidence 2 2234678999999999999999999999999999999 9999986543221 111111110
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
..........+.+++.+||+.+|++||+++|++++|+.+.+.
T Consensus 238 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 011112334577788899999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.79 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=206.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.+.. +..||||+++......+++.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 5789999999999999875 77899999987766778899999999999 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 543 (682)
.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 99997543 234899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...++..|+|||++.+..++.++|||||||++|||+| |..||.+....+ +.. .+...... ..
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~----------~~ 440 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRM----------ER 440 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC----------CC
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC----------CC
Confidence 2234568999999999899999999999999999999 999998654322 111 11111110 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.......+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 112334567788899999999999999999999988643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=357.95 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=201.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|.++++..||||+++......+++.+|+++++++ +||||+++++++.+ +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 578999999999999999888899999987666678899999999999 99999999999865 6789999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 267 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 267 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 9997432 124899999999999999999999998 9999999999999999999999999998764322 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.+.... .....+ ...... ...
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i-~~~~~~----------~~~ 403 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQV-ERGYRM----------PCP 403 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHH-HTTCCC----------CCC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-HcCCCC----------CCC
Confidence 234678999999999999999999999999999999 99999754321 111111 111110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
......+.+++.+||+.||++|||++++++.|+++.....
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 1234467788889999999999999999999998875543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.60 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=196.8
Q ss_pred hccccccCeEEEEEEEEc-----CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e 461 (682)
.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCceEEEEE
Confidence 478999999999999852 578899999875432 235788999999999 899999999998653 56899999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999997543 24899999999999999999999998 99999999999999999999999999987643
Q ss_pred CC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-------CCCC--hhHHHHHHhh
Q 005693 542 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-------DMVD--LPRWVQSVVR 605 (682)
Q Consensus 542 ~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~-------~~~~--l~~~~~~~~~ 605 (682)
.. ...++..|+|||++.+..++.++||||||+++|||+||..|+...... .... ..........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 32 223456699999999999999999999999999999999998643110 0000 0000111111
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
... ...........+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 247 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 247 NNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 110 11111223456777888999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.19 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=179.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|... +++.||+|++... ....+.+|+.++..+.+||||+++++++.++...++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 467999999999999986 4788999999653 2467788999999996699999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC---CeEEeecCCCCCCCCC---
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla~~~~~~--- 542 (682)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 94 FERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999753 34899999999999999999999998 99999999999998766 7999999999765433
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHHhhhccccccchhhhccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ........+....... ..
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~---~~----- 237 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF---EG----- 237 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC---CS-----
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC---Cc-----
Confidence 2345688999999999999999999999999999999999999865433221 2222222222221110 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0001223456778889999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=350.11 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=202.1
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCc-eEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-KLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lV~ 460 (682)
.+.||+|+||.||+|++. +++.||||+++.... ..+.+.+|++++.++.+||||+++++++.+.+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 578999999999999843 346899999976432 235689999999999889999999999987654 89999
Q ss_pred eeccCCchhHhhccCCCCC-------------------------------------------------------------
Q 005693 461 DYFASGSLSTLLHGNRGAG------------------------------------------------------------- 479 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~------------------------------------------------------------- 479 (682)
||+++|+|.++++......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999997653210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC------CCCCCCcccC
Q 005693 480 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRA 553 (682)
Q Consensus 480 ~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~a 553 (682)
...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...... ...+|+.|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 122899999999999999999999998 9999999999999999999999999998654322 2335778999
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHH
Q 005693 554 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQ 632 (682)
Q Consensus 554 PE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ 632 (682)
||++.+..++.++||||||+++|||+| |+.||.+....+ .............. .......+.+
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~----------~~~~~~~l~~ 327 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA----------PDYTTPEMYQ 327 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC----------CTTCCHHHHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC----------CCCCCHHHHH
Confidence 999999999999999999999999998 999997654321 11111111111110 0112235677
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 633 IGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 633 l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
++.+||+.||++|||++|++++|+++.+..
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 888999999999999999999999988654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.23 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=194.8
Q ss_pred hccccccCeEEEEEEEEcC-Cce----EEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STT----VVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~----vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|.+.. ++. ||+|.+..... ..+.+.+|+.++.++ +||||+++++++. ++..++||||
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCccEEEEEe
Confidence 4789999999999999754 333 77777754422 235678899999998 9999999999885 5678999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 96 LPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp CTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred CCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999997542 34889999999999999999999998 999999999999999999999999999876433
Q ss_pred C------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ...++..|+|||++.+..++.++||||||+++|||+| |+.||.+....+. ... ........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~-~~~~~~~~---- 237 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV------PDL-LEKGERLA---- 237 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH------HHH-HHTTCBCC----
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH------HHH-HHcCCCCC----
Confidence 2 2235678999999999999999999999999999999 9999986543221 111 11111000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
........+.+++.+||+.||++|||++|++++|+.+...
T Consensus 238 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 238 ------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011122456788899999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=333.46 Aligned_cols=263 Identities=17% Similarity=0.253 Sum_probs=205.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecC--ceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|.... ++.||+|+++... ...+.+.+|++++.++ +||||+++++++.... ..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEEEeCCC
Confidence 4689999999999999865 7889999997543 2356788999999999 8999999999998765 6799999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe----cCCCCeEEeecCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla~~~~ 540 (682)
+|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 93 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp TCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999975432 233899999999999999999999998 9999999999999 788889999999997765
Q ss_pred CCC---CCCCCCcccCccccc--------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 541 VPA---TPSRSAGYRAPEVIE--------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 541 ~~~---~~~~~~~y~aPE~~~--------~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
... ...+++.|+|||++. +..++.++|||||||++|||++|+.||........ ..............
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHHHCCT
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhcCCCc
Confidence 433 345788999999986 56789999999999999999999999975432221 12222222222111
Q ss_pred c---cc---------chhhhc-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 610 A---EV---------FDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 610 ~---~~---------~d~~l~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
. .. +...+. ...........+.+++.+||+.||++|||++|++++..+-..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 0 00 000111 112234566677889999999999999999999999886553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.84 Aligned_cols=238 Identities=24% Similarity=0.327 Sum_probs=193.6
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+. ++.||+|+++... ...+.+.+|.+++..+.+||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 4789999999999999764 7889999997642 2345677899999988789999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 108 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 108 GGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence 99999999753 24899999999999999999999998 99999999999999999999999999986432
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+...... ..
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~~---------~p 244 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEVV---------YP 244 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---------CC
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCC---------CC
Confidence 22446899999999999989999999999999999999999999765322 222222222110 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~ 653 (682)
.. ....+.+++.+|++.||++||++ +|+++
T Consensus 245 ~~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 TW---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11 22345677789999999999998 77776
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.90 Aligned_cols=241 Identities=22% Similarity=0.337 Sum_probs=193.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|... +++.||+|++..... ..+.+.+|+.++..+ +||||+++++++.+++..++||||+++|
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 478999999999999976 578899999865432 246788999999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 541 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 541 (682)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999743 34899999999999999999999998 99999999999999999999999999975432
Q ss_pred -CCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 542 -PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ . ..........
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~----~~~~~~~~~~---------- 227 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----YSDWKEKKTY---------- 227 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-H----HHHHHTTCTT----------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-H----HHHHhccccc----------
Confidence 124568899999999987775 7789999999999999999999976442211 0 1111111000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..........+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00011223445678889999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.02 Aligned_cols=246 Identities=19% Similarity=0.286 Sum_probs=190.4
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~~ 465 (682)
+.||+|+||+||++... +++.||+|+++. ...+.+|++++.++.+||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999976 477899999864 35678889988777799999999999876 5678999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~ 542 (682)
|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999997532 234899999999999999999999998 999999999999998 789999999999765432
Q ss_pred ---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ....+....... ....
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~i~~~~~~~-----~~~~ 290 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEF-----PNPE 290 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HHHHHHHTCCCC-----CTTT
T ss_pred CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HHHHHHcCcccC-----CCcc
Confidence 244578999999999999999999999999999999999999986543332110 111111111100 0001
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.. .....+.+++.+||+.||++|||++|++++-.
T Consensus 291 ~~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 291 WS---EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp TT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cc---cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 11 22345667788999999999999999998543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.30 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=200.7
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|.+. ++..||||+++.... ...++.+|+.++.++ +||||+++++++.+....++|||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEEEE
Confidence 478999999999999953 356799999975432 244688899999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC---CeEEeecCCC
Q 005693 462 YFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT 536 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla 536 (682)
|+++|+|.+++..... .....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 9999999999975432 12245899999999999999999999998 99999999999999555 5999999998
Q ss_pred CCC------CCCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLM------NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
+.. .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .....+......
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~i~~~~~~ 305 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRM 305 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCCC
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC
Confidence 643 12223346788999999999999999999999999999998 99999754321 111111111100
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.........+.+++.+||+.||++|||++|++++|+.+.+..
T Consensus 306 -----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 306 -----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 001122345677888999999999999999999999988654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.51 Aligned_cols=246 Identities=19% Similarity=0.293 Sum_probs=194.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+. ++.||+|+++..... .+.+.+|..++.++.+||||+++++++.+++..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 4789999999999999864 678999999865432 23477888999888789999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 94 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999976432
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC--ChhHHHHHHhhhccccccchhhhc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--DLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .........+..... .
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~ 237 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------R 237 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--------C
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--------C
Confidence 23456899999999999999999999999999999999999999754322111 111111111111110 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 654 (682)
.... ....+.+++.+||+.||++||++ +|++++
T Consensus 238 ~p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 IPRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCTT---SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCC---CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111 22346677789999999999995 677663
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=342.35 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=201.3
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|+..+ ++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceEEEEe
Confidence 5789999999999999753 37899999975432 245688999999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe
Q 005693 462 YFASGSLSTLLHGNRGA-------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 522 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 522 (682)
|+++|+|.+++...... ....+++.+++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEE
Confidence 99999999999764311 1246899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCC------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005693 523 NQDLDGCISDFGLTPLMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 595 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~ 595 (682)
+.++.+||+|||+++.... .....+++.|+|||++.+..++.++||||||+++|||+| |..||.+....
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---- 283 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 283 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH----
Confidence 9999999999999865422 223446788999999998899999999999999999999 99999754321
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.....+.... ... ........+.+++.+||+.||++|||++|++++|+++.+...
T Consensus 284 --~~~~~~~~~~-~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 284 --EVIYYVRDGN-ILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp --HHHHHHHTTC-CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred --HHHHHHhCCC-cCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 1111111111 100 011223456778889999999999999999999999886554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.08 Aligned_cols=242 Identities=23% Similarity=0.377 Sum_probs=196.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEE
Confidence 578999999999999976 478899999975432 246789999999999 89999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC----CeEEeecCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 537 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 537 (682)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++
T Consensus 95 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 95 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp CCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999642 34899999999999999999999998 99999999999999887 79999999997
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 538 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 538 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ............ +.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~---~~ 237 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNYE---FE 237 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHTCCC---CC
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhcCCC---cC
Confidence 66432 2345889999999999999999999999999999999999999754321 111111111100 00
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ... .....+.+++.+||+.||++|||++|++++
T Consensus 238 ~~--~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DE--YFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HH--HHT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cc--ccc---cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 001 122346677889999999999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=338.20 Aligned_cols=238 Identities=21% Similarity=0.322 Sum_probs=194.7
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+++++.+ +||||+++++++...+..++||||+
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 47899999999999997 457889999987542 2245788999999998 8999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 92 ~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 92 GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 78999988643 24899999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+....+.... +........
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~~~~~~p 228 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNSCVYVMP 228 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCSSCCCCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHcCCCCCc
Confidence 34568999999999988776 7899999999999999999999986543332110 000000011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.. ....+.+++.+||+.||++|||++|++++-
T Consensus 229 ~~---~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 229 DF---LSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp TT---SCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred cc---CCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 11 223456778899999999999999999853
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=343.26 Aligned_cols=256 Identities=18% Similarity=0.216 Sum_probs=193.0
Q ss_pred hccccccCeEEEEEEEEcCC------ceEEEEEeeccccChhhHHHHHHHHHHhc--------------CCCceeceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------------QHPNVVPLRAY 449 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~~~~~~~~~e~~~l~~l~--------------~h~niv~l~~~ 449 (682)
.+.||+|+||.||+|.+..+ +.||+|++.... ..+.+|++++.++. +|+||++++++
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 47899999999999998653 679999986542 23444444444332 59999999999
Q ss_pred EEec----CceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec--
Q 005693 450 YYSK----DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-- 523 (682)
Q Consensus 450 ~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-- 523 (682)
+... ...++||||+ +|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 9775 3479999999 999999997532 34999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCCCCCCCC-----------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005693 524 QDLDGCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592 (682)
Q Consensus 524 ~~~~~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~ 592 (682)
.++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999654321 22348899999999999999999999999999999999999998543221
Q ss_pred CCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 593 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
............ ......+..+.. . .....+.+++..||+.+|++||+++++++.|+++.+...
T Consensus 269 --~~~~~~~~~~~~-~~~~~~~~~~~~-~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 269 --KYVRDSKIRYRE-NIASLMDKCFPA-A---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp --HHHHHHHHHHHH-CHHHHHHHHSCT-T---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHHHHHHHHhhh-hHHHHHHHhccc-c---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 111111111111 111111211100 1 123456777889999999999999999999999886543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.36 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=200.6
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... ++..||+|+++... ...+.+.+|+.++.++.+||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 578999999999999962 34579999997543 2346789999999999889999999999999999999999
Q ss_pred eccCCchhHhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec
Q 005693 462 YFASGSLSTLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 523 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~ 523 (682)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT 206 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEc
Confidence 99999999999764321 0134799999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCCCCCCCCCC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCCh
Q 005693 524 QDLDGCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 596 (682)
Q Consensus 524 ~~~~~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l 596 (682)
.++.+||+|||++........ ..+++.|+|||++.+..++.++||||||+++|||+| |..||.+....+
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 282 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 282 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH----
Confidence 999999999999976543322 234678999999999999999999999999999998 999997654221
Q ss_pred hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 597 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
............. ........+.+++.+||+.||++|||++|++++|+.+.+...+.
T Consensus 283 --~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 283 --NFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp --HHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred --HHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 1112222211110 01112345677888999999999999999999999998776654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.26 Aligned_cols=238 Identities=19% Similarity=0.285 Sum_probs=196.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 478999999999999976 57889999997642 2345677899999988 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-C
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 543 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 90 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 90 GGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp SCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 99999999753 24899999999999999999999998 999999999999999999999999999765443 3
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+..... ......
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~---------~~p~~~ 226 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL---------RFPPFF 226 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC---------CCCTTS
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC---------CCCCCC
Confidence 45689999999999999999999999999999999999999975431 122222222211 011112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
...+.+++.+|++.||++|| +++|++++
T Consensus 227 ---~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 227 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 23456777799999999999 89999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=341.64 Aligned_cols=245 Identities=20% Similarity=0.301 Sum_probs=190.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||+||+++.. +++.||+|++.......+.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 468999999999999986 578899999987666667889999999999 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC--eEEeecCCCCCCCC---CC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLTPLMNV---PA 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DfGla~~~~~---~~ 543 (682)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++.... ..
T Consensus 104 ~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 104 YERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 9999643 24899999999999999999999998 999999999999987765 99999999875432 23
Q ss_pred CCCCCCcccCccccccCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 TPSRSAGYRAPEVIETRKHSHK-SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...+|+.|+|||++.+..++.+ +|||||||++|||++|+.||.+..... ................ .....
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~-------~~~~~ 246 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYSI-------PDDIR 246 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCCC-------CTTSC
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCCC-------CCcCC
Confidence 4468999999999988887665 899999999999999999998654322 2222233222221110 00111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
....+.+++.+||+.||++|||++|++++-
T Consensus 247 ---~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 247 ---ISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp ---CCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 123456778899999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.45 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=194.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||+||+|+.. ++.||+|++... ...+.+.+|++++.++ +||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRV-NHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHC-CCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcC-CCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 478999999999999986 788999998643 2356789999999999 9999999999876 4589999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC-eEEeecCCCCCCCCC-CCCCC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-GCISDFGLTPLMNVP-ATPSR 547 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-~kl~DfGla~~~~~~-~~~~~ 547 (682)
+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++...... ....+
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~g 165 (307)
T 2eva_A 88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKG 165 (307)
T ss_dssp HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------C
T ss_pred HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCC
Confidence 99975431 234788999999999999999999932223999999999999998887 799999999765433 23457
Q ss_pred CCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHH
Q 005693 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 627 (682)
Q Consensus 548 ~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 627 (682)
++.|+|||++.+..++.++||||||+++|||++|+.||....... ......... ..... ......
T Consensus 166 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~----------~~~~~~ 230 (307)
T 2eva_A 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GTRPP----------LIKNLP 230 (307)
T ss_dssp CTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TCCCC----------CBTTCC
T ss_pred CCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CCCCC----------cccccC
Confidence 899999999999999999999999999999999999997543211 111111111 10000 011223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 628 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 628 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
..+.+++.+||+.||++|||++|+++.|+.+.+....
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 4567788899999999999999999999999876544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.58 Aligned_cols=242 Identities=20% Similarity=0.323 Sum_probs=194.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.+|+|++..... ..+.+.+|+++++.+ +||||+++++++.+++..++||||+++
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 578999999999999875 578899999876543 235688999999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec---CCCCeEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DfGla~~~~~~ 542 (682)
|+|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||++......
T Consensus 95 g~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 95 GELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999998753 34899999999999999999999998 99999999999998 4678999999999776543
Q ss_pred C----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 A----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 ~----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
. ...||+.|+|||++.+..++.++||||+||++|+|++|..||.+.... .....+...... ....
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~-----~~~~ 235 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQIKAGAYD-----FPSP 235 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC-----CCTT
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhCCCC-----CCcc
Confidence 2 346899999999999999999999999999999999999999754321 122222221111 0001
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... ...+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~---s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 EWDTV---TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccC---CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11122 3346677779999999999999999984
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=340.57 Aligned_cols=244 Identities=16% Similarity=0.294 Sum_probs=195.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc------cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+++..++||||
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEeC
Confidence 578999999999999975 57889999986432 1356789999999999 899999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC---eEEeecCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPLM 539 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~~~ 539 (682)
+++|+|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 108 ~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 108 MDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp CSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999888764321 1234899999999999999999999998 999999999999987655 999999999776
Q ss_pred CCCC----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 540 NVPA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 540 ~~~~----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.... ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ......+...... ...
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~~~---~~~ 253 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGKYK---MNP 253 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTCCC---CCH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCCCC---CCc
Confidence 5432 3458999999999999999999999999999999999999997532 1111222211111 000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
..... ....+.+++.+||+.||++|||+.|+++
T Consensus 254 --~~~~~---~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 254 --RQWSH---ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --HHHTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --ccccc---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00111 2345667788999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.42 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=205.2
Q ss_pred hccccccCeEEEEEEEE------cCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|++++.++.+||||+++++++..++..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 57899999999999985 2356899999975432 246788999999999889999999999999999999999
Q ss_pred eccCCchhHhhccCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCe
Q 005693 462 YFASGSLSTLLHGNRGA-------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 528 (682)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCE
Confidence 99999999999764321 1234899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005693 529 CISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 529 kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~ 601 (682)
||+|||++........ ..+++.|+|||++.+..++.++||||||+++|||+| |+.||.+....+ ...
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 258 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFY 258 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHH
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh------HHH
Confidence 9999999987654332 224667999999999999999999999999999999 999997654221 111
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
....+..... ........+.+++.+||+.||++|||++|++++|+++.....
T Consensus 259 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 259 KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHhccCCCCC----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1222111100 011223456778889999999999999999999999887543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.20 Aligned_cols=242 Identities=21% Similarity=0.327 Sum_probs=196.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999975 4788999999765433 34678899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC---CeEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla~~~~~~ 542 (682)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++......
T Consensus 113 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 113 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999998643 34899999999999999999999998 99999999999998654 5999999999876543
Q ss_pred C---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
. ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+....... ....
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~~-----~~~~ 253 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDY-----PSPE 253 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-----CTTG
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCC-----Cccc
Confidence 3 34689999999999998999999999999999999999999975432 12222222211110 0001
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. ......+.+++.+||+.||++|||++|++++
T Consensus 254 ~---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 W---DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp G---GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c---cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 1123456677789999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.50 Aligned_cols=239 Identities=21% Similarity=0.328 Sum_probs=187.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---------------------------ChhhHHHHHHHHHHhcCCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------------------------GKRDFEQQMEIVGRVGQHP 441 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~e~~~l~~l~~h~ 441 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++ +||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 96 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL-DHP 96 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC-CCT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC-CCC
Confidence 468999999999999975 477899999865431 124688999999999 899
Q ss_pred ceeceEEEEEe--cCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 005693 442 NVVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN 519 (682)
Q Consensus 442 niv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~N 519 (682)
||+++++++.+ .+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 167 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSN 167 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 99999999986 567899999999999988764 234899999999999999999999998 9999999999
Q ss_pred eEecCCCCeEEeecCCCCCCCCC----CCCCCCCcccCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005693 520 VLINQDLDGCISDFGLTPLMNVP----ATPSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 592 (682)
Q Consensus 520 ILl~~~~~~kl~DfGla~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~ 592 (682)
|+++.++.+||+|||+++..... ....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--- 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--- 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc---
Confidence 99999999999999999765433 2346889999999997765 3778999999999999999999997532
Q ss_pred CCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 593 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.............. ...... ....+.+++.+||+.||++|||++|++++
T Consensus 245 ---~~~~~~~~~~~~~~-------~~~~~~---~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 ---IMCLHSKIKSQALE-------FPDQPD---IAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ---HHHHHHHHHHCCCC-------CCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ---HHHHHHHHhcccCC-------CCCccc---cCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 11112221111110 001111 22356677789999999999999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=341.09 Aligned_cols=238 Identities=22% Similarity=0.353 Sum_probs=194.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+ +++.||+|+++... ...+.+..|.+++..+.+||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999986 47789999997642 2345677888898887799999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 102 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999976432
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+...... ..
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~~---------~p 238 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDNPF---------YP 238 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---------CC
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCCC---------CC
Confidence 23456899999999999999999999999999999999999999754321 112222211100 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 653 (682)
... ...+.+++.+||+.||++||++. |+.+
T Consensus 239 ~~~---s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccc---CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 112 23456777899999999999997 6654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.25 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=203.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|...++..||+|+++......+.+.+|++++.++ +||||+++++++. ++..++||||+++|+|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 478999999999999998888999999987666778899999999999 9999999999986 45689999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... .
T Consensus 96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 9996432 124899999999999999999999998 9999999999999999999999999997654322 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.+.... ....... ...... ..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~-~~~~~~-------~~--- 232 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLE-RGYRMV-------RP--- 232 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHH-TTCCCC-------CC---
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHHh-cccCCC-------Cc---
Confidence 335678999999998889999999999999999999 99999754321 1111111 111000 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
......+.+++.+|++.||++|||++++++.|+++......
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 12234567788899999999999999999999999866543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.23 Aligned_cols=240 Identities=19% Similarity=0.331 Sum_probs=190.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCc-----------
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE----------- 455 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----------- 455 (682)
.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+...
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 578999999999999986 688999999975432 346789999999999 89999999999866542
Q ss_pred ----------------------------------------------eEEEEeeccCCchhHhhccCCCCCCCCCCHHHHH
Q 005693 456 ----------------------------------------------KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 489 (682)
Q Consensus 456 ----------------------------------------------~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~ 489 (682)
.++||||+++|+|.+++..... ....++..++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHH
Confidence 7899999999999999986442 3346777899
Q ss_pred HHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----------------CCCCCCCcccC
Q 005693 490 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----------------ATPSRSAGYRA 553 (682)
Q Consensus 490 ~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----------------~~~~~~~~y~a 553 (682)
.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ....+|+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 99999999999999998 999999999999999999999999999765433 22357889999
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHH
Q 005693 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI 633 (682)
Q Consensus 554 PE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l 633 (682)
||++.+..++.++|||||||++|||++|..|+... ...... ..... ...........+.++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~-~~~~~----------~~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITD-VRNLK----------FPLLFTQKYPQEHMM 305 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHH-HHTTC----------CCHHHHHHCHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHH-hhccC----------CCcccccCChhHHHH
Confidence 99999999999999999999999999987765310 000010 00000 001112334556788
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 005693 634 GMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 634 ~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+.+||+.||++|||++|++++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCCCcCCCHHHHhhc
Confidence 889999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.85 Aligned_cols=193 Identities=21% Similarity=0.337 Sum_probs=169.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhc----CCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----QHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.||+|+++......+.+..|++++..+. +||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~- 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL- 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence 478999999999999974 5788999999765444567788999999884 4999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC--------------------
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-------------------- 524 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-------------------- 524 (682)
+++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 119 ~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 119 GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 899999997543 234899999999999999999999998 999999999999975
Q ss_pred -----CCCeEEeecCCCCCCCCC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 525 -----DLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 525 -----~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999765543 34568899999999999999999999999999999999999997644
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=324.39 Aligned_cols=255 Identities=17% Similarity=0.171 Sum_probs=198.8
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCc-eeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|+. .+++.||+|++.... ..+++.+|++++..+ +|++ +..+..+....+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHh-hcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 46899999999999997 567889999986543 345789999999999 5555 445444446677789999999 899
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe---cCCCCeEEeecCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~-- 542 (682)
|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||++ ++++.+||+|||++......
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999997432 24899999999999999999999998 9999999999999 48899999999998765432
Q ss_pred ---------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 ---------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 ---------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+.................
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch----
Confidence 2345788999999999999999999999999999999999999876544333322221111100000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
. .. .. .....+.+++.+||+.||++|||++|+++.|+++......
T Consensus 240 ~-~~--~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 240 E-VL--CK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp H-HH--TT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred H-HH--Hh---hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 00 01 1224567788899999999999999999999999876644
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=346.70 Aligned_cols=241 Identities=22% Similarity=0.311 Sum_probs=195.0
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+... ++.||+|+++... ...+.+.+|+.++..+ +||||+++++++.+++..++||||++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 4689999999999999864 6789999997532 2345688899999988 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.++++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 153 gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 153 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp TEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99999999743 3899999999999999999999998 999999999999999999999999999766543
Q ss_pred ---CCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.+..||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+... ......+.......
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~----- 292 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSL----- 292 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHHC-----
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHHhccccc-----
Confidence 2557899999999997665 78999999999999999999999975432 12222222211000
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 654 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 654 (682)
........+ ..+.+++.+|++.+|++ ||+++|++++
T Consensus 293 ~~p~~~~~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPDDNDIS---KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCTTCCCC---HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCCccccc---HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000111222 34556677999999998 9999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=360.17 Aligned_cols=248 Identities=25% Similarity=0.427 Sum_probs=205.0
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||.||+|.++++..||||+++......++|.+|+++++++ +|+||+++++++.+ +..++||||+++|+|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 578999999999999999888999999987666678899999999999 89999999999865 6789999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-----CC
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~~ 544 (682)
++++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 350 ~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 350 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 9997432 124899999999999999999999998 999999999999999999999999999876432 22
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..++..|+|||++....++.++|||||||++|||++ |+.||.+.... .....+ ...... ...
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~i-~~~~~~----------~~~ 486 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQV-ERGYRM----------PCP 486 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHHH-HTTCCC----------CCC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-HcCCCC----------CCC
Confidence 345678999999999999999999999999999999 99999754321 111111 111110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
..+...+.+++.+||+.||++|||++++++.|+++....
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 123345677888999999999999999999999887544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.83 Aligned_cols=247 Identities=22% Similarity=0.434 Sum_probs=194.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC--------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+. .++||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~lv~ 100 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNP--PRMVM 100 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTT--TEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCC--CeEEE
Confidence 467999999999999975 5788999998654321 15788999999999 899999999998544 37999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC-----eEEeecCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGL 535 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DfGl 535 (682)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++. +||+|||+
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp ECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 9999999999886432 35899999999999999999999985 45999999999999988776 99999999
Q ss_pred CCCCCCCC-CCCCCCcccCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 536 TPLMNVPA-TPSRSAGYRAPEVIE--TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 536 a~~~~~~~-~~~~~~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
++...... ...+++.|+|||++. ...++.++||||||+++|||++|+.||......+ ................
T Consensus 176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRPTI 251 (287)
T ss_dssp CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHHSCCCCCC
T ss_pred cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhccCCCCCC
Confidence 97654432 356889999999984 4557899999999999999999999997544221 1111221111111111
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.......+.+++.+||+.||++|||++|+++.|+++
T Consensus 252 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 252 ----------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 112234567788899999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=332.53 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=195.8
Q ss_pred hccccccCeEEEEEEEEcC-C-------ceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-S-------TTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.||+|.... + ..||+|++.... ...+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCCCCEEEE
Confidence 4689999999999998654 2 469999986553 3356789999999999 8999999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC--------eEEee
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--------GCISD 532 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--------~kl~D 532 (682)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|
T Consensus 92 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp ECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred ECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999997532 23899999999999999999999998 999999999999998887 99999
Q ss_pred cCCCCCCCCCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 005693 533 FGLTPLMNVPATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611 (682)
Q Consensus 533 fGla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 611 (682)
||++..........+++.|+|||++.+ ..++.++||||||+++|||++|..|+.... +...............
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~~~~~~~~~~- 238 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DSQRKLQFYEDRHQLP- 238 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHHTTCCCC-
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----chHHHHHHhhccCCCC-
Confidence 999977655444457888999999987 678999999999999999999655443221 1111111111100000
Q ss_pred cchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 612 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.. ....+.+++.+||+.||++|||++|++++|+++.....
T Consensus 239 ---------~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 239 ---------AP---KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp ---------CC---SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ---------CC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 00 12245678889999999999999999999999886543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.56 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=193.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHH-hcCCCceeceEEEEEec-----CceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR-VGQHPNVVPLRAYYYSK-----DEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~-l~~h~niv~l~~~~~~~-----~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|+. +++.||+|++.... ...+..|.++... ..+|+||+++++.+... ...++||||+
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 47899999999999987 47899999997543 3444455544332 23899999999876532 2568999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM---------GGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~---------~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
++|+|.+++.... .++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 95 ~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 95 PNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp TTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeecc
Confidence 9999999997432 68899999999999999999998 6 9999999999999999999999999
Q ss_pred CCCCCCCC------------CCCCCCCcccCcccccc-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCC-CCCC
Q 005693 535 LTPLMNVP------------ATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR-DDMV 594 (682)
Q Consensus 535 la~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~-~~~~ 594 (682)
+++..... ....+|+.|+|||++.+ ..++.++|||||||++|||++|..||..... .+..
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 99765321 12357889999999976 4567789999999999999999777643322 2211
Q ss_pred Ch----------hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 595 DL----------PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 595 ~l----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
.. ................+.. ...........+.+++.+||+.||++|||++|+++.|+++......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 11 0111111111111111111 1112234556788899999999999999999999999999988777
Q ss_pred CCCCC
Q 005693 665 NRPSS 669 (682)
Q Consensus 665 ~~~~~ 669 (682)
+...+
T Consensus 323 ~~~~~ 327 (336)
T 3g2f_A 323 NKSVS 327 (336)
T ss_dssp -----
T ss_pred cccCC
Confidence 65443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.21 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=203.4
Q ss_pred hccccccCeEEEEEEEEc--------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|++++.++.+||||+++++++..++..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 578999999999999873 456799999975432 2356889999999998899999999999999999999
Q ss_pred EeeccCCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCe
Q 005693 460 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 528 (682)
|||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCE
Confidence 9999999999999864421 1234899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005693 529 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 529 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~ 601 (682)
||+|||+++...... ...+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.... ....
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~ 270 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------ELFK 270 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH------HHHH
Confidence 999999997654321 2335678999999998889999999999999999999 99999754321 1111
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
.. ....... ........+.+++.+||+.+|++|||++|+++.|+++.......
T Consensus 271 ~~-~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 271 LL-KEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp HH-HHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HH-hcCCCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 11 1111100 01122345677888999999999999999999999998766543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=337.47 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=201.8
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCceEEEEe
Confidence 578999999999999862 347899999975432 235688899999999 89999999999999999999999
Q ss_pred eccCCchhHhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe
Q 005693 462 YFASGSLSTLLHGNRGA-------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 522 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 522 (682)
|+++|+|.+++...... ....+++.++..++.|++.||+|||+++ |+||||||+||++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli 183 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILV 183 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEE
Confidence 99999999999764321 1234889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005693 523 NQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 595 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~ 595 (682)
++++.+||+|||+++...... ...+++.|+|||++.+..++.++||||||+++|||++ |+.||.+....+.
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 261 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-- 261 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999997654322 2335678999999999889999999999999999999 9999976543221
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
. . ......... ........+.+++.+||+.||++||+++|++++|+++.+.
T Consensus 262 -~---~-~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 262 -F---N-LLKTGHRME----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp -H---H-HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -H---H-HhhcCCcCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1 1 111111000 0112234567788899999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=325.14 Aligned_cols=255 Identities=16% Similarity=0.166 Sum_probs=197.5
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|++++..+.+|+++..+..++...+..++||||+ +|+|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence 57899999999999997 457889999875543 23568899999999944444545555556777889999999 9999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe---cCCCCeEEeecCCCCCCCCC---
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~--- 542 (682)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++.....
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 92 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 99997432 24899999999999999999999998 9999999999999 78899999999999765432
Q ss_pred --------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 543 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 543 --------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.+...................... .
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~ 240 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI----E 240 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----H
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh----h
Confidence 2345788999999999999999999999999999999999999876554443332211111100000 0
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
. .... ....+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 241 -~--~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 -V--LCKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -H--HTTT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -h--hhcc---CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 0011 12456778889999999999999999999999987654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=324.58 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=198.9
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+ ++.||+|+++..... .+.+.+|+.++.++ +||||+++++++.+. ...++||||++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEeeecccC
Confidence 478999999999999986 788999999765433 34688899999988 899999999999877 67899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||||+||++++++.++|+|||++..... ..
T Consensus 93 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-~~ 167 (271)
T 3kmu_A 93 YGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PG 167 (271)
T ss_dssp TCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-TT
T ss_pred CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-cC
Confidence 999999998543 235899999999999999999999875 5599999999999999999999999988765433 33
Q ss_pred CCCCCcccCccccccCCCCC---cchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 PSRSAGYRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~---~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..+|+.|+|||++.+..++. ++||||||+++|||++|+.||..... ................ .
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-------~- 233 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPTI-------P- 233 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCCC-------C-
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCCC-------C-
Confidence 45789999999998765544 79999999999999999999975432 1111222211111110 1
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 234 --~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 234 --PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1123456778889999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=338.05 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=190.3
Q ss_pred hccccccCeEEEEEEEEcCCc----eEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCce------
Q 005693 390 AEVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK------ 456 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~----~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------ 456 (682)
.+.||+|+||.||+|....+. .||+|+++.... ..+.+.+|+++++++ +||||+++++++...+..
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-------CE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccCCCcc
Confidence 578999999999999865433 799999976432 245788999999999 999999999999877655
Q ss_pred EEEEeeccCCchhHhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 457 LLVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccc
Confidence 999999999999999964321 12235899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 536 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 536 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
++...... ...+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+. .........
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------~~~~~~~~~ 257 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------YNYLIGGNR 257 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHHTTCC
T ss_pred cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH------HHHHhcCCC
Confidence 97654322 2235668999999999999999999999999999999 9999986543221 111111111
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
. .........+.+++.+||+.||++|||+.|+++.|+++.+.....
T Consensus 258 ~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 258 L-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp C-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred C-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 0 011122345678888999999999999999999999999776543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=333.84 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=192.2
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+..+++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 467999999999999998899999999965432 235688999999999 899999999999999999999999986
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 85 DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9999987532 34899999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----cccc----ccc
Q 005693 543 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EWTA----EVF 613 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~----~~~~----~~~ 613 (682)
....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+. +.... ..... .|.. ..+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIF-RILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH-HHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHHCCCChhhchhhhccccc
Confidence 233578899999999764 589999999999999999999999976432111 11111 11000 0000 001
Q ss_pred hhhhccc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
++..... .........+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111000 0001123456678889999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.64 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=195.1
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+. ++.||+|+++... ...+.+..|..++..+.+||||+++++++.+.+..++||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 4789999999999999875 6789999997642 2345677888888887789999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 105 GGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 99999999743 23899999999999999999999998 99999999999999999999999999976432
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+...... ..
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---------~p 241 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA---------YP 241 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CC
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC---------CC
Confidence 2345689999999999999999999999999999999999999975432 1222222222110 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
.. ....+.+++.+||+.||++||+ ++|++++
T Consensus 242 ~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 KS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TT---SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 2235667777999999999995 5777764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=329.92 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=189.5
Q ss_pred hccccccCeEEEEEEEEcC----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|.... +..||+|+++.... ..+.+.+|+.++.++ +||||+++++++ .++..++||||+
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~ 97 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-TENPVWIIMELC 97 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEE-ccCccEEEEecC
Confidence 5789999999999999753 34689998865432 245688999999999 899999999998 456789999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 98 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 98 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999997532 34899999999999999999999998 9999999999999999999999999998765432
Q ss_pred -----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 -----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
...+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+. ...+......
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~------~~~i~~~~~~-------- 236 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERL-------- 236 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHHTTCCC--------
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH------HHHHHcCCCC--------
Confidence 2234678999999998899999999999999999997 9999986543221 1111111100
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.........+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00112234567788899999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.87 Aligned_cols=240 Identities=20% Similarity=0.299 Sum_probs=194.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++.... ++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 5789999999999999764 6789999987542 2345788999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 99 GGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp TEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999999743 34899999999999999999999998 999999999999999999999999999765433
Q ss_pred -CCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 -ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ............. .
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~---------~ 238 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEIVHTFETTVV---------T 238 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHHHHHHHHCCC---------C
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhhccc---------C
Confidence 34568999999999974 458999999999999999999999997544322 1111111111110 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVR 653 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~ 653 (682)
.. ......+.+++.+||+.||++||+ ++++.+
T Consensus 239 ~p---~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 YP---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CC---TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CC---CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01 112345677788999999999998 777765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.92 Aligned_cols=249 Identities=25% Similarity=0.471 Sum_probs=195.7
Q ss_pred hccccccCeEEEEEEEEcCC-----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|....+ ..||+|+++.... ...++.+|++++.++ +||||+++++++...+..++||||
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcEEEEeC
Confidence 47899999999999986532 3599999875432 234688999999999 899999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 128 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 128 MENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp CTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999997532 34899999999999999999999998 999999999999999999999999999776432
Q ss_pred C-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 543 A-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 543 ~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
. ...+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+. +....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~-~~~~~---- 269 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAIN-DGFRL---- 269 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-TTCCC----
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHH-CCCcC----
Confidence 2 1124667999999998899999999999999999999 99999754321 1111111 11100
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.........+.+++.+||+.+|++||+++|+++.|+++.+...
T Consensus 270 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 270 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0011223456778889999999999999999999999886543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.93 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=205.4
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.... +..||+|++.......+.+.+|++++.++ +||||+++++++.+++..++||||+++|+|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 4689999999999999875 67899999987655567899999999999 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 544 (682)
.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 97 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp HHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred HHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 99997543 345899999999999999999999998 99999999999999999999999999987654321
Q ss_pred -CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 545 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 545 -~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
..+++.|+|||++.+..++.++||||||+++|+|++ |..||......+ +. .. ....... ..
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~---~~-~~~~~~~----------~~ 233 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY---EL-LEKDYRM----------ER 233 (288)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH---HH-HHTTCCC----------CC
T ss_pred CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH-HhccCCC----------CC
Confidence 224667999999998999999999999999999999 999997654222 11 11 1111100 01
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.......+.+++.+|++.||++|||++|+++.|+++.+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1122345677888999999999999999999999887653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=335.45 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=201.7
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHh-cCCCceeceEEEEEecC----ceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSKD----EKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~~----~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.. ++.||+|++... ..+.+.+|.+++..+ .+||||+++++++.... ..++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~ 123 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123 (342)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred EeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence 578999999999999985 889999998653 245678888888873 38999999999998876 7899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--------SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
+|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||++
T Consensus 124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999743 3899999999999999999999 666 999999999999999999999999998
Q ss_pred CCCCCC--------CCCCCCCcccCccccccCC------CCCcchHHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 005693 537 PLMNVP--------ATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTG----------KAPLQSPTRDD 592 (682)
Q Consensus 537 ~~~~~~--------~~~~~~~~y~aPE~~~~~~------~~~~sDvwS~Gvvl~elltg----------~~Pf~~~~~~~ 592 (682)
...... ....+++.|+|||++.+.. ++.++||||||+++|||+|| ..||......+
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 655432 2345788999999997653 34689999999999999999 67776543222
Q ss_pred CCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 593 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 593 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.....+............ +.......+....+.+++.+||+.||++|||++|++++|+++.+...
T Consensus 275 -~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 275 -PSVEEMRKVVCEQKLRPN-----IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp -CCHHHHHHHHTTSCCCCC-----CCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred -ccHHHHHHHHHHHHhCCC-----CcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 122222222222211111 11111123566778889999999999999999999999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=331.04 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=191.9
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++.+||||+++++++.+++..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999954 578999999976533 3567899999999976899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC---eEEeecCCCCCCCCC---
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPLMNVP--- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~~~~~~--- 542 (682)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 99 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 99 LSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 9999753 24899999999999999999999998 999999999999998776 999999998765321
Q ss_pred --------CCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC-----hh---HHHH
Q 005693 543 --------ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-----LP---RWVQ 601 (682)
Q Consensus 543 --------~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~-----l~---~~~~ 601 (682)
....+++.|+|||++.. ..++.++|||||||++|||++|+.||.+....+... .. ....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 12347889999999875 558899999999999999999999998765432110 00 0001
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+..... ...+. ... .....+.+++.+||+.||++|||++|++++
T Consensus 251 ~~i~~~~~-~~~~~---~~~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKY-EFPDK---DWA---HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCC-CCCHH---HHT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCc-ccCch---hcc---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111100 00000 001 123456778889999999999999999884
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.18 Aligned_cols=237 Identities=22% Similarity=0.321 Sum_probs=187.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccCh---hhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|... +++.||||++....... ..+..|+..+.++.+|+||+++++++.+++..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 568999999999999986 68899999986544332 345556666667768999999999999999999999999 6
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 79998886532 34999999999999999999999998 999999999999999999999999998766433
Q ss_pred CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+ ... .... ..... .
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~-~~~-~~~~----~~~~~--~-- 274 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GW-QQL-RQGY----LPPEF--T-- 274 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HH-HHH-TTTC----CCHHH--H--
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HH-HHH-hccC----CCccc--c--
Confidence 23457899999999876 78999999999999999999977765321 01 111 1111 11111 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.||++|||++|++++
T Consensus 275 -~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 -AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1123456778889999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=326.63 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=200.7
Q ss_pred ccccccCeEEEEEEEEc---CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++.++ +||||+++++++ ..+..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 47999999999999864 567899999976432 345688999999999 899999999999 55678999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 94 GPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999643 234899999999999999999999998 9999999999999999999999999997654322
Q ss_pred -----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 -----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+.... ..
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~i~~~~-~~------- 232 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGK-RM------- 232 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTC-CC-------
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHhcCC-cC-------
Confidence 2235678999999998889999999999999999999 999997543221 111111111 00
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
.........+.+++.+||+.+|++||+++|++++|+++......
T Consensus 233 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 233 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 00112234567788899999999999999999999999876544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=337.90 Aligned_cols=256 Identities=22% Similarity=0.339 Sum_probs=201.0
Q ss_pred hccccccCeEEEEEEEEc-----CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 460 (682)
.+.||+|+||+||++.+. +++.||+|+++.... ..+.+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEEEEE
Confidence 478999999999998753 577899999976532 245688999999999 899999999999874 5678999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999743 2899999999999999999999998 9999999999999999999999999997765
Q ss_pred CCC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC-----CCC-hh--HHHHHHhh
Q 005693 541 VPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD-----MVD-LP--RWVQSVVR 605 (682)
Q Consensus 541 ~~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~-----~~~-l~--~~~~~~~~ 605 (682)
... ...+++.|+|||++.+..++.++||||||+++|||+||+.||....... ... .. ........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 432 2346777999999999889999999999999999999999986432100 000 00 00000011
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
... ...........+.+++.+||+.||++|||++|+++.|+++.+.....
T Consensus 266 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 266 RGE----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccc----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 000 01111223456778888999999999999999999999998766543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=360.48 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=199.6
Q ss_pred cccccCeEEEEEEEEc---CCceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 392 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.||+|+||.||+|.+. ++..||||+++... ...+++.+|++++.++ +|||||++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999874 45679999997653 2457899999999999 99999999999976 5789999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-- 544 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 544 (682)
+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 421 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 421 PLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp BHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred cHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999999743 234899999999999999999999998 99999999999999999999999999987643321
Q ss_pred -----CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 545 -----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 545 -----~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ....+ ......
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i-~~~~~~-------- 558 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFI-EQGKRM-------- 558 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHHHH-HTTCCC--------
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHH-HcCCCC--------
Confidence 123578999999999999999999999999999998 999998654322 11111 111110
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
.....+...+.+++.+||+.+|++||+++++++.|+.+......
T Consensus 559 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 559 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 11112345677888899999999999999999999998766543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.06 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=196.0
Q ss_pred hccccccCeEEEEEEEE-----cCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 460 (682)
.+.||+|+||.||+|++ .+++.||+|+++.... ..+.+.+|++++.++ +||||+++++++... ...++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCceEEEEE
Confidence 47899999999999984 3578899999975432 346789999999999 899999999999876 6689999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999996432 34899999999999999999999998 9999999999999999999999999997664
Q ss_pred CCC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC--------CCCCChhHHHHHHhh
Q 005693 541 VPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--------DDMVDLPRWVQSVVR 605 (682)
Q Consensus 541 ~~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~--------~~~~~l~~~~~~~~~ 605 (682)
... ...++..|+|||++.+..++.++||||||+++|||++|+.|+..... ...............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 332 33467779999999998999999999999999999999998653210 000000000011111
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
... ...........+.+++.+||+.||++|||++|+++.|+++.
T Consensus 258 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 100 00111123345778888999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.44 Aligned_cols=256 Identities=16% Similarity=0.225 Sum_probs=188.8
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeecccc------------ChhhHHHHHHHHHHhcCCCceeceEEEEEe-
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV------------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS- 452 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~- 452 (682)
.+.||+|+||.||+|... .+..+|+|+...... ....+.+|+..+..+ +||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEEEEEEE
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeecccccc
Confidence 478999999999999986 467899999875421 122355666677777 89999999999988
Q ss_pred ---cCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC--C
Q 005693 453 ---KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL--D 527 (682)
Q Consensus 453 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~--~ 527 (682)
....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence 67889999999 999999997532 5899999999999999999999998 99999999999999887 9
Q ss_pred eEEeecCCCCCCCCC-----------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 005693 528 GCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596 (682)
Q Consensus 528 ~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l 596 (682)
+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~ 269 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--A 269 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--H
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--H
Confidence 999999999755321 233578899999999998999999999999999999999999964321110 0
Q ss_pred hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 597 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
........... . ................+.+++.+||+.||++||+++++++.|+++....
T Consensus 270 ~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 270 VQTAKTNLLDE----L-PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHHT----T-THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHHHhhccc----c-cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 01111111110 0 0000000000022345777888999999999999999999999876533
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.71 Aligned_cols=242 Identities=22% Similarity=0.358 Sum_probs=192.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|++++.++ +||||+++++++...+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357999999999999975 57889999997653 2356789999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe--cCCCCeEEeecCCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI--NQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl--~~~~~~kl~DfGla~~~~~~~-- 543 (682)
|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++......
T Consensus 173 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 173 LFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp EHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 999886432 34899999999999999999999998 9999999999999 567889999999998765432
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+....+... . .....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~~~--~---~~~~~ 314 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWDLE--D---EEFQD 314 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCSC--S---GGGTT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCCCC--h---hhhcc
Confidence 34588999999999998999999999999999999999999975432 122223322222110 0 01112
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
. ...+.+++.+||+.||++|||++|+++
T Consensus 315 ~---~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 I---SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp S---CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2 245667778999999999999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.98 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=197.8
Q ss_pred hccccccCeEEEEEEEEcCC----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCce-EEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK-LLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~-~lV~e~ 462 (682)
.+.||+|+||+||+|.+.++ ..+|+|++..... ..+.+.+|++++.++ +||||+++++++.+.+.. ++||||
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEECC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEEEEec
Confidence 47899999999999986432 2689999875432 235688999999999 899999999999876665 999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 105 ~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 105 MCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999753 234899999999999999999999998 999999999999999999999999999754321
Q ss_pred --------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC-CCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ-SPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 --------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~-~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....+++.|+|||.+.+..++.++||||||+++|||++|..|+. ..... .+. .... .....
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~---~~~~-~~~~~--- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLT---HFLA-QGRRL--- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHH---HHHH-TTCCC---
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHH---HHhh-cCCCC---
Confidence 22345778999999999999999999999999999999665543 32211 111 1111 11000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
.........+.+++.+||+.||++|||++|+++.|+++.......
T Consensus 248 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 248 -------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred -------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 001112245677888999999999999999999999998776544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=343.09 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=192.6
Q ss_pred hccccccCeEEEEEEEEcC--C--ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEe-cCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|...+ + ..||+|.++.... ..+++.+|+.++.++ +||||+++++++.. ++..++||||
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEEEEC
Confidence 4689999999999998642 2 3588998865432 245788999999999 89999999998754 4578999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 173 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 173 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999997532 34789999999999999999999998 999999999999999999999999999765322
Q ss_pred C--------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 A--------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 ~--------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
. ...+++.|+|||++.+..++.++||||||+++|||+| |.+||......+ +... ....... .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~~~~~~~---~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGRRL---L 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---HHTTCCC---C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---HHcCCCC---C
Confidence 1 2235678999999999999999999999999999999 677887544322 1111 1111100 0
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENR 666 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 666 (682)
.. ......+.+++.+||+.||++|||++|+++.|+++......+.
T Consensus 317 -----~p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 317 -----QP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp -----CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred -----CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 01 1223456778889999999999999999999999997766543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=334.15 Aligned_cols=242 Identities=24% Similarity=0.375 Sum_probs=196.5
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+. .+++.||+|++...... .+++.+|++++.++ +||||+++++++..++..++||||++
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEEecCC
Confidence 46799999999999997 46788999999754322 24688999999999 89999999999999999999999997
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 68888875322 34899999999999999999999998 99999999999999999999999999988877777
Q ss_pred CCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..+|+.|+|||++. ...++.++|||||||++|||++|+.||..... ............. .. ...
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~~-~~------~~~ 276 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-AL------QSG 276 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CC------CCT
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-CC------CCC
Confidence 78999999999984 56789999999999999999999999975431 1122222211110 00 011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
. ....+.+++.+||+.||++|||++|++++..
T Consensus 277 ~---~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 277 H---WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp T---SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred C---CCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 1 1234567778999999999999999987644
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=338.61 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=196.7
Q ss_pred hcccccc--CeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+| +||.||+|+.. +++.||+|+++..... .+.+.+|+++++++ +||||+++++++.+++..++||||+
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEEEEEcc
Confidence 4789999 99999999986 5789999999765433 24577899999999 8999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC---
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--- 540 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~--- 540 (682)
++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 109 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 109 AYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp TTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred CCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999997543 234899999999999999999999998 9999999999999999999999999874321
Q ss_pred --------CCCCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-----
Q 005693 541 --------VPATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----- 605 (682)
Q Consensus 541 --------~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~----- 605 (682)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. .........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDT 260 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-----------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccccc
Confidence 1223357888999999987 57899999999999999999999999865433211 000000000
Q ss_pred -----hc------------cccccch--------hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 005693 606 -----EE------------WTAEVFD--------VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEV 658 (682)
Q Consensus 606 -----~~------------~~~~~~d--------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i 658 (682)
+. ...+... ...............+.+++.+||+.||++|||++|++++ ++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 00 0000000 0000000111223457788889999999999999999975 5444
Q ss_pred h
Q 005693 659 R 659 (682)
Q Consensus 659 ~ 659 (682)
.
T Consensus 341 ~ 341 (389)
T 3gni_B 341 K 341 (389)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.88 Aligned_cols=238 Identities=18% Similarity=0.202 Sum_probs=196.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 468999999999999976 57889999997542 2345688899999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-C
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 543 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 125 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 125 GGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp TCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 99999999743 23899999999999999999999998 999999999999999999999999999766443 3
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+...... ....
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---------~p~~- 260 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKVR---------FPSH- 260 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CCTT-
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCCC---------CCCC-
Confidence 45689999999999999999999999999999999999999975432 1222222221110 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
....+.+++.+||+.||++||+ ++|++++
T Consensus 261 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 2234667778999999999998 8888873
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=332.61 Aligned_cols=238 Identities=22% Similarity=0.343 Sum_probs=187.5
Q ss_pred hccccccCeEEEEEEEE----cCCceEEEEEeecccc-----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.||+++. .+++.||+|+++.... ....+.+|++++..+ +||||+++++++..++..++||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCEEEEEE
Confidence 47899999999999997 4688999999976431 234577899999999 8999999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 101 EYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred eCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999743 24889999999999999999999998 9999999999999999999999999987643
Q ss_pred CC----CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 541 VP----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 541 ~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
.. ....||+.|+|||++.+..++.++||||||+++|||++|+.||.+.... .....+......
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~------- 239 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCKLN------- 239 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC-------
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC-------
Confidence 22 2345889999999999999999999999999999999999999754321 122222221110
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
.... ....+.+++.+||+.||++|| +++|++++
T Consensus 240 --~p~~---~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 240 --LPPY---LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --CCTT---SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CCCC---CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0111 223566777899999999999 78888873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.37 Aligned_cols=244 Identities=24% Similarity=0.370 Sum_probs=193.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|..+ +++.||+|+++... ....+|++++.++.+||||+++++++.+++..++||||+++|+|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L 103 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTT---CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc---CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence 578999999999999976 47789999997643 34567888898887899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC----CCeEEeecCCCCCCCCC--
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~----~~~kl~DfGla~~~~~~-- 542 (682)
.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.....
T Consensus 104 ~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 104 LDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp HHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 9999743 34899999999999999999999998 9999999999998543 34999999999765432
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+....... .....
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~i~~~~~~~-----~~~~~ 247 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPEEILARIGSGKFSL-----SGGYW 247 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---CHHHHHHHHHHCCCCC-----CSTTT
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---CHHHHHHHHccCCccc-----Ccccc
Confidence 2456789999999998888999999999999999999999999754322 2222222222221110 00001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
... ...+.+++.+||+.||++|||++|++++-
T Consensus 248 ~~~---s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 248 NSV---SDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp TTS---CHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ccC---CHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 122 23456777799999999999999999853
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=330.84 Aligned_cols=255 Identities=23% Similarity=0.401 Sum_probs=201.4
Q ss_pred hccccccCeEEEEEEEEcC-Cce--EEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STT--VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~--vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+... +.. +++|.++... ...+.+.+|++++.++.+||||+++++++.+.+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 5789999999999999654 443 4899887532 2345788999999999889999999999999999999999999
Q ss_pred CCchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeec
Q 005693 465 SGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 533 (682)
Q Consensus 465 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 533 (682)
+|+|.+++..... .....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEccc
Confidence 9999999975430 12345899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 534 GLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 534 Gla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
|+++..... ....+++.|+|||++.+..++.++||||||+++|||+| |+.||.+... ........ ....
T Consensus 187 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~-~~~~ 259 (327)
T 1fvr_A 187 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLP-QGYR 259 (327)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHGG-GTCC
T ss_pred CcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHHHhh-cCCC
Confidence 998754322 22345778999999998889999999999999999998 9999975432 11122211 1110
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
.. .. ......+.+++.+||+.||++|||++|+++.|+++.+....
T Consensus 260 ~~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 260 LE-------KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp CC-------CC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CC-------CC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 00 11 11224567788899999999999999999999999876654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.71 Aligned_cols=256 Identities=22% Similarity=0.295 Sum_probs=192.7
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc------ChhhHHHHHHHHHHhc--CCCceeceEEEEEecC-----c
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKD-----E 455 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~-----~ 455 (682)
.+.||+|+||+||+|+. .+++.||+|++..... ....+.+|++++.++. +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 46899999999999996 4578899999874432 1346778888887774 4999999999998765 4
Q ss_pred eEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 456 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 456 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
.++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred EEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 789999997 59999997543 233899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCC---CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccc
Q 005693 536 TPLMNVPAT---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWT 609 (682)
Q Consensus 536 a~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~~ 609 (682)
++....... ..+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. +........ .+.|.
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSC
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChhhcc
Confidence 987654332 3578899999999999999999999999999999999999976442211 001111000 01111
Q ss_pred cccc--hhhhc--cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 AEVF--DVELM--RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 ~~~~--d~~l~--~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.... ..... .... ..+....+.+++.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000 00000 0000 01123456778889999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.20 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=182.1
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|+... ++.||+|+++... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 4689999999999999874 6789999997643 356788899999999 899999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCCCCCCCC---
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~--- 542 (682)
.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 136 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 207 (349)
T 2w4o_A 136 FDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207 (349)
T ss_dssp HHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence 9999743 34899999999999999999999998 999999999999975 889999999999866443
Q ss_pred CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....+...... ...+ ..
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~~--~~~~---~~-- 275 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEYY--FISP---WW-- 275 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCCC--CCTT---TT--
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCCc--cCCc---hh--
Confidence 23457899999999999999999999999999999999999997543211 111222211110 0000 01
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.||++|||++|++++
T Consensus 276 -~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 -DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223456678889999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=343.10 Aligned_cols=244 Identities=17% Similarity=0.293 Sum_probs=194.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.+. ++.||+|+++... .....+.+|..++..+ +||||+++++++.+++..++||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 4689999999999999875 6789999997532 2234588999999988 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 158 gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 158 GGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 999999997532 34899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ----CCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 544 ----TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...||+.|+|||++. ...++.++|||||||++|||++|+.||.+.... .....+......... .
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~-p 303 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQF-P 303 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCCC-C
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHHhhhhccccccC-C
Confidence 346899999999997 556899999999999999999999999864322 122222211100000 0
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 654 (682)
. .....+ ..+.+++.+|+..+|++ ||+++|++++
T Consensus 304 ~---~~~~~s---~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 T---QVTDVS---ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp S---SCCCSC---HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred c---ccccCC---HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0 001122 34556677999888888 9999999884
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=336.59 Aligned_cols=248 Identities=14% Similarity=0.208 Sum_probs=198.5
Q ss_pred hccccccCeEEEEEEE------EcCCceEEEEEeeccccChhhHHHHHHHHHHhcC--CCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAV------LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~--h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||+||+|. ...++.||+|+++.. ...++.+|++++.++.. |+||+++++++..++..++|||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 4689999999999994 456788999998753 35678888888888732 8999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-----------CCCeEE
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----------DLDGCI 530 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-----------~~~~kl 530 (682)
|+++|+|.++++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEE
Confidence 999999999997543323445999999999999999999999998 999999999999998 899999
Q ss_pred eecCCCCCCC---C---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 005693 531 SDFGLTPLMN---V---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 604 (682)
Q Consensus 531 ~DfGla~~~~---~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~ 604 (682)
+|||+|+... . .....||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----------- 293 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----------- 293 (365)
T ss_dssp CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----------
T ss_pred eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----------
Confidence 9999996432 1 1234589999999999999999999999999999999999999964322110
Q ss_pred hhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHhhhcCCC
Q 005693 605 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR-PNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 605 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~evl~~L~~i~~~~~~ 664 (682)
. .+..+... ...+ .+.+++..|++.+|.+| |+++++.+.|+++.+....
T Consensus 294 ----~---~~~~~~~~-~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 294 ----K---PEGLFRRL-PHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp ----E---ECSCCTTC-SSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred ----e---echhcccc-CcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 0 00111111 1123 34456669999999998 6789999999988876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=326.25 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=188.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+.. ..+|+|+++..... .+.+.+|++++.++ +|+||+++++++ .....++||||++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 478999999999999864 35999998755433 35688999999998 899999999965 566789999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 105 SLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999996432 34899999999999999999999998 999999999999999999999999998765421
Q ss_pred --CCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 543 --ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
....+++.|+|||++. +..++.++||||||+++|||++|+.||......+ ............. ..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~----~~ 247 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSP----DL 247 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCC----CT
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCc----ch
Confidence 1235788999999986 5668889999999999999999999997543211 1111111111110 00
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
.. ........+.+++.+||+.+|++|||++|+++.|+++.+
T Consensus 248 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 011233567788889999999999999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.14 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=202.4
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecC-ceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~ 460 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++.++.+||||+++++++...+ ..++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 578999999999999852 357899999976433 23468899999999988999999999988755 489999
Q ss_pred eeccCCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeE
Q 005693 461 DYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 529 (682)
||+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEE
Confidence 999999999999764321 0223789999999999999999999998 99999999999999999999
Q ss_pred EeecCCCCCCCCCCC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 005693 530 ISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS 602 (682)
Q Consensus 530 l~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~ 602 (682)
|+|||+++....... ..+++.|+|||++.+..++.++||||||+++|||+| |..||.+....+ ....
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~ 262 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR 262 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHH
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHH
Confidence 999999986644322 235678999999999999999999999999999998 999997644221 1111
Q ss_pred HhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 603 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 603 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.......... . ......+.+++.+||+.||++|||++|++++|+.+.+...
T Consensus 263 ~~~~~~~~~~-------~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 263 RLKEGTRMRA-------P---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHTCCCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HhccCccCCC-------C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1111111000 0 1123356778889999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.98 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=195.5
Q ss_pred hccccccCeEEEEEEEEcCC----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEE-ecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY-SKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~-~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|...++ ..+|+|.+..... ..+.+.+|+++++++ +||||+++++++. .++..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceEEEEeC
Confidence 47899999999999986432 2578888865332 235688999999999 8999999999865 45578999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 109 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 109 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999997532 34889999999999999999999998 999999999999999999999999999765432
Q ss_pred --------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 --------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....+++.|+|||.+.+..++.++||||||+++|||++ |.+||......+ .. ......... .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~---~~~~~~~~~---~ 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT---VYLLQGRRL---L 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH---HHHHTTCCC---C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH---HHHhcCCCC---C
Confidence 12335678999999999999999999999999999999 556665443222 11 111111100 0
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
.. ......+.+++.+||+.||++|||++|+++.|+++......
T Consensus 253 -----~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 253 -----QP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp -----CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred -----CC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 01 11223567788899999999999999999999999876554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.88 Aligned_cols=190 Identities=26% Similarity=0.433 Sum_probs=154.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC--ceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~ 463 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++..+.+||||+++++++..++ ..++||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 468999999999999975 5788999998654332 3457789999999966999999999998654 689999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC--
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-- 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-- 541 (682)
+ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 7 5999999742 3899999999999999999999998 99999999999999999999999999975432
Q ss_pred -----------------------CCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 542 -----------------------PATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 542 -----------------------~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
.....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112357889999999976 678999999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=324.51 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=190.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|... +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 468999999999999976 4788999999755432 35678899999999 899999999999999999999999986
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
++.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 -~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 86 -DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp -EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred -CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 6666554322 34899999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------cccc--c
Q 005693 543 -ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE-------EWTA--E 611 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~-------~~~~--~ 611 (682)
....+|+.|+|||++.+.. ++.++|||||||++|||++|..||..... .......+... .|.. .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHHhCCCChhhhhhhcc
Confidence 2345788999999997766 79999999999999999999888643221 11111111110 0000 0
Q ss_pred cch--------hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFD--------VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d--------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+ ...............+.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000000111223456678889999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=339.42 Aligned_cols=265 Identities=16% Similarity=0.248 Sum_probs=206.8
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecC--ceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|.... ++.||+|+++... ...+.+.+|++++.++ +||||+++++++...+ ..++||||++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 4689999999999999865 7889999997543 2356788999999999 8999999999998765 6799999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe----cCCCCeEEeecCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla~~~~ 540 (682)
+|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 93 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp TEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999975432 233899999999999999999999998 9999999999999 778889999999997765
Q ss_pred CCC---CCCCCCcccCcccccc--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 541 VPA---TPSRSAGYRAPEVIET--------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 541 ~~~---~~~~~~~y~aPE~~~~--------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..............
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHSCCT
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcCCCc
Confidence 432 3457899999999865 5678899999999999999999999975432221 12222222222111
Q ss_pred ccc------------chhhhc-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 610 AEV------------FDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 610 ~~~------------~d~~l~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
... +..... ...........+.+++.+||+.||++||+++|+++.++++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000 000011 11122456667788999999999999999999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.92 Aligned_cols=279 Identities=18% Similarity=0.300 Sum_probs=199.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|... +++.||+|++...... ...+.+|++++.++ +||||+++++++..++..++||||++ |
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 468999999999999976 5788999998654322 22456789999998 89999999999999999999999997 5
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 85 DLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 9999887542 34899999999999999999999998 9999999999999999999999999987654332
Q ss_pred -CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccccccchhhh
Q 005693 544 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVEL 617 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~~~~d~~l 617 (682)
...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ......... +.+.........
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcchhh
Confidence 2356889999999876 5689999999999999999999999986542221 111111111 000000000000
Q ss_pred c-----c--ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhcCCCCCCCCcccCCCCCCCC
Q 005693 618 M-----R--FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQSDSENRPSSEENKSKDSNVQ 680 (682)
Q Consensus 618 ~-----~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i~~~~~~~~~~~~~~~~~~~~~~ 680 (682)
. . ... .......+.+++.+|++.||++|||++|+++ .+..+.+..............++.+.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~q 310 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQ 310 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCCCC
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHHhh
Confidence 0 0 000 0112235667888999999999999999998 555555444433333333333444444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.36 Aligned_cols=241 Identities=20% Similarity=0.306 Sum_probs=190.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcC-CCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||++...+++.||||++...... .+.+.+|++++.++.+ |+||+++++++..++..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 4789999999999999888899999999765433 3568899999999954 7999999999999999999999 568
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 89999997532 4889999999999999999999998 99999999999995 589999999999876432
Q ss_pred ---CCCCCCCcccCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 543 ---ATPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~-----------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... +.............
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH 285 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTS
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCccc
Confidence 23458999999999865 368899999999999999999999997432 11122222221111
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
... ..... ...+.+++.+||+.||++|||++|++++-
T Consensus 286 ~~~-------~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 286 EIE-------FPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CCC-------CCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCC-------CCccc---hHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 100 00111 23566788899999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=338.47 Aligned_cols=243 Identities=21% Similarity=0.373 Sum_probs=196.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|... +++.+|+|++..... ....+.+|++++..+ +||||+++++++.+.+..++||||+++|+
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 468999999999999976 477899999875432 345788999999999 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC--CCCeEEeecCCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~~~~~~-- 543 (682)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 135 L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 135 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 99999743 234899999999999999999999998 999999999999974 4779999999998765432
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+....+.. +. ..
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~~---~~-----~~ 273 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWEF---DE-----DA 273 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCCC---CS-----ST
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---Cc-----cc
Confidence 23578999999999999999999999999999999999999975431 11222222211110 00 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.+++.+||+.||++|||++|++++
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11223456677789999999999999999885
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.81 Aligned_cols=244 Identities=22% Similarity=0.384 Sum_probs=196.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe----------------
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS---------------- 452 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~---------------- 452 (682)
.+.||+|+||.||+|... +++.||+|+++.. .+.+.+|++++.++ +||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECC---SGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccccccC
Confidence 578999999999999986 6889999998753 35678899999999 89999999999864
Q ss_pred cCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEee
Q 005693 453 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 532 (682)
Q Consensus 453 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 532 (682)
....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred cceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECc
Confidence 345789999999999999997532 234899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 533 FGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 533 fGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
||++...... ....+++.|+|||++.+..++.++||||||+++|||++|..|+... ....... .....
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~~-~~~~~ 236 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTDL-RDGII 236 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHHH-HTTCC
T ss_pred chhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHHh-hcccc
Confidence 9998765443 2345788999999999999999999999999999999999887421 1111111 11111
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
. .. ....+.+++.+||+.||++|||++|++++|+.+......+
T Consensus 237 ~----------~~---~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 237 S----------DI---FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp C----------TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred c----------cc---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 1 11 1234567788999999999999999999999998765543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.02 Aligned_cols=246 Identities=22% Similarity=0.368 Sum_probs=192.1
Q ss_pred hccccccCeEEEEEEEEcC-Cce----EEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STT----VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|.... ++. |++|.+.... ...+.+.+|+.++.++ +||||+++++++..+ ..++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-~~~~v~~~ 97 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS-SEEEEECC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC-CceEEEEe
Confidence 4789999999999999653 343 5777765432 2456789999999999 899999999999865 47899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+.+|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999997543 34899999999999999999999998 999999999999999999999999999876433
Q ss_pred C------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+. . .........
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~----~~~~~~~~~----- 238 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGERL----- 238 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCCC-----
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcCCCC-----
Confidence 2 1234667999999999999999999999999999999 9999986543321 1 111111100
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.........+.+++.+||+.||++||+++|+++.|+++.+.
T Consensus 239 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 -----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 01112233567788899999999999999999999998743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=350.71 Aligned_cols=244 Identities=23% Similarity=0.284 Sum_probs=198.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 468999999999999976 57899999997542 2345688899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 268 gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 268 GGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp SCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 999999997543 234899999999999999999999998 9999999999999999999999999998765432
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ +..... . ...
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~-i~~~~~-~-------~p~ 410 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERL-VKEVPE-E-------YSE 410 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHH-HHHCCC-C-------CCT
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHH-hhcccc-c-------CCc
Confidence 3568999999999999899999999999999999999999998654322 11111111 111100 0 011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
. ....+.+++.+||+.||++|| +++|++++
T Consensus 411 ~---~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 411 R---FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp T---SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred c---CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1 223556777799999999999 78999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.93 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=191.8
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|.... ++.||+|++...... .+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEEEeCCC
Confidence 4689999999999999864 788999998665433 34577899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 87 TVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred chHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999988643 24899999999999999999999998 9999999999999999999999999997665332
Q ss_pred --CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh---------hHHHHHHhhhccccc
Q 005693 544 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL---------PRWVQSVVREEWTAE 611 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l---------~~~~~~~~~~~~~~~ 611 (682)
...+++.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+.... ..+........+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 3357888999999976 5679999999999999999999999976543221100 000000000000000
Q ss_pred cchhhhccccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+....... .......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 01223456788889999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=329.64 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=191.5
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCce----EEEE
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK----LLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~----~lV~ 460 (682)
.+.||+|+||.||+|+. .+++.||+|+++..... ...+.+|++++.++ +||||+++++++...... ++||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCcccEEEE
Confidence 47899999999999997 45788999999765332 23577888888888 899999999999876544 9999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.++++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 96 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 96 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999999999743 24899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
... ...+++.|+|||++.+..++.++||||||+++|||++|+.||.+.... .............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~--- 238 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP--- 238 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC---
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC---
Confidence 321 234789999999999999999999999999999999999999754321 1111212111110
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHHHHhhhcCCCC
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVRMIEEVRQSDSEN 665 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~~L~~i~~~~~~~ 665 (682)
.. ..... ....+.+++.+||+.||++||++. ++.+.+..+.......
T Consensus 239 -~~-~~~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~ 286 (311)
T 3ork_A 239 -PS-ARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286 (311)
T ss_dssp -HH-HHSTT---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCS
T ss_pred -cc-cccCC---CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCC
Confidence 00 00111 234566778899999999999655 4555666666554443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=360.26 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=196.8
Q ss_pred ccccccCeEEEEEEEEc---CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||.||+|.+. .++.||||+++..... .+++.+|++++.++ +|||||++++++. .+..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 57999999999999763 3568999999865432 46799999999999 8999999999986 456899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 453 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 453 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999743 34899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 544 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 544 ------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ....+.......
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~----- 592 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG----- 592 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC-----
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence 1234677999999999999999999999999999998 999997654221 111111111110
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
........+.+++.+||+.||++||+++++++.|+++...
T Consensus 593 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1112335677888899999999999999999999988653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=337.14 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=197.8
Q ss_pred hccccccCeEEEEEEEE-----cCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e 461 (682)
.+.||+|+||.||+|++ .+++.||+|++..... ..+.+.+|++++.++ +||||+++++++.. ....++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEEEEEe
Confidence 47899999999999985 3577899999876532 245689999999999 99999999999874 456889999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 107 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred ecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999997532 24899999999999999999999998 99999999999999999999999999976543
Q ss_pred CC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--------CCCChhHHHHHHhhh
Q 005693 542 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD--------DMVDLPRWVQSVVRE 606 (682)
Q Consensus 542 ~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~--------~~~~l~~~~~~~~~~ 606 (682)
.. ...+++.|+|||++.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 22 234677799999999988999999999999999999999998643211 000000111111111
Q ss_pred ccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 607 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 607 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
.. ...........+.+++.+||+.||++|||++|++++|+.+.......
T Consensus 260 ~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 260 GQ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred cc----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 10 01111223345777888999999999999999999999998665543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.77 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=183.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEe--------cCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--------KDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~lV 459 (682)
.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.++.++.+||||+++++++.. ....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 478999999999999975 578899999865432 345688999999999669999999999953 2347899
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||++ |+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 188 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188 (337)
T ss_dssp EECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred EEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceec
Confidence 99996 799998864221 234899999999999999999999975 45999999999999999999999999999776
Q ss_pred CCCC----------------CCCCCCcccCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 005693 540 NVPA----------------TPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 600 (682)
Q Consensus 540 ~~~~----------------~~~~~~~y~aPE~~---~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~ 600 (682)
.... ...+++.|+|||++ .+..++.++||||||+++|||++|+.||.........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------ 262 (337)
T 3ll6_A 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------ 262 (337)
T ss_dssp SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh------
Confidence 4322 23378889999998 5667889999999999999999999999754322110
Q ss_pred HHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 601 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 601 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
....... ... .....+.+++.+||+.||++|||++|++++|+++.+....+
T Consensus 263 ----~~~~~~~-------~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 263 ----NGKYSIP-------PHD---TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp -------CCCC-------TTC---CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred ----cCcccCC-------ccc---ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 0000000 000 11123567788999999999999999999999998766544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.92 Aligned_cols=239 Identities=25% Similarity=0.374 Sum_probs=193.0
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|.... +..||+|++.... .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEEEEecCC
Confidence 4789999999999999765 5689999986542 2345688899999998 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 93 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 99999999743 23899999999999999999999998 999999999999999999999999998665433
Q ss_pred CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............ ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---------~~-- 227 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFT---------FP-- 227 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC---------CC--
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHhCCCC---------CC--
Confidence 2345788999999999999999999999999999999999999754311 111111111100 01
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
......+.+++.+||+.||++|||++|++++-
T Consensus 228 -~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 228 -DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp -TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred -CcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 11223456778899999999999999999953
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.62 Aligned_cols=242 Identities=21% Similarity=0.343 Sum_probs=196.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEE
Confidence 578999999999999976 478899999976432 246789999999999 89999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC----CeEEeecCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 537 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 537 (682)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++ .+||+|||++.
T Consensus 96 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999743 34899999999999999999999998 99999999999999888 79999999997
Q ss_pred CCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 538 LMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 538 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...... ...+++.|+|||++.+..++.++||||||+++|||++|+.||.+.... .....+...... .+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~---~~ 238 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITSVSYD---FD 238 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCC---CC
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcccc---cC
Confidence 665432 345788999999999999999999999999999999999999754321 111111111100 01
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... .. .....+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~--~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEF--FS---HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHH--HT---TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhh--hc---ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 100 01 122346678889999999999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.70 Aligned_cols=245 Identities=17% Similarity=0.291 Sum_probs=196.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+.++..+.+||||+++++++.+.+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 378999999999999976 478999999976533 3467889999999997889999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~ 542 (682)
|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 114 ~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 114 GEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999986432 235899999999999999999999998 999999999999998 789999999999876543
Q ss_pred C---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
. ...+++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..... +..
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~-----~~~--- 253 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQVNV-----DYS--- 253 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC-----CCC---
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhccc-----ccC---
Confidence 2 3458899999999999999999999999999999999999997543211 1111111100 000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..........+.+++.+||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00111223456677889999999999999999885
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.87 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=196.3
Q ss_pred hccccccCeEEEEEEEEcCC----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|...++ ..||+|.+..... ..+.+.+|++++.++ +||||+++++++.+ +..++||||+
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCCEEEEecC
Confidence 47899999999999986532 3599999876422 346788999999999 89999999999764 5678999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999997532 34899999999999999999999998 9999999999999999999999999997664432
Q ss_pred -----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 -----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .. ....... ...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~---~~~~~~~-~~~------ 234 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VI---GVLEKGD-RLP------ 234 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HH---HHHHHTC-CCC------
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HH---HHHhcCC-CCC------
Confidence 2345678999999998899999999999999999998 999997543322 11 1111111 000
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.. ......+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 235 -~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 235 -KP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp -CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 01 112345677888999999999999999999999987643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.40 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=192.3
Q ss_pred hccccccCeEEEEEEEEcC----CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCc-----eE
Q 005693 390 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~ 457 (682)
.+.||+|+||.||+|.... +..||+|+++..... .+.+.+|+.++.++ +||||+++++++...+. .+
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-------CEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccCCcccE
Confidence 5789999999999998653 347999998755333 34688899999999 89999999999987553 49
Q ss_pred EEEeeccCCchhHhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
+||||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcc
Confidence 99999999999999854321 22345999999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
....... ...+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~~~~- 267 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM------YDYLLHGHR- 267 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------HHHHHTTCC-
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHHcCCC-
Confidence 7654322 2335678999999999999999999999999999999 8899976543221 111111110
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
. .........+.+++.+||+.||++|||++|++++|+++.+..+
T Consensus 268 ~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 268 L----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp C----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred C----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 0111223457778889999999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.62 Aligned_cols=242 Identities=21% Similarity=0.311 Sum_probs=189.3
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCC-CceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||++...+++.||+|++...... .+.+.+|++++.++.+| +||+++++++..++..++||| +.+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 4789999999999999888899999999765433 25688999999999433 999999999999999999999 568
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 93 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 93 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 8999999753 34899999999999999999999998 99999999999997 5789999999998764332
Q ss_pred ----CCCCCCcccCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 544 ----TPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~-----------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... +.............
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH 238 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTS
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCCc
Confidence 3458999999999865 678899999999999999999999997432 11111222221111
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
... .... ....+.+++.+||+.||++|||++|++++-.
T Consensus 239 ~~~-------~~~~---~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 239 EIE-------FPDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp CCC-------CCCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccC-------Cccc---CCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 100 0111 1235667888999999999999999998643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.21 Aligned_cols=243 Identities=16% Similarity=0.262 Sum_probs=192.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+++.+ +++.||+|++++... ..+.+.+|.+++..+ +||||+++++++.+++..|+||||++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 468999999999999985 578999999975321 234588899999988 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 145 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 145 GGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp SCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999997432 24899999999999999999999998 9999999999999999999999999997664432
Q ss_pred ----CCCCCCcccCccccc-------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 544 ----TPSRSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~-------~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
...||+.|+|||++. ...++.++|||||||++|||++|+.||.+.... .....+.........
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYGKIVHYKEHLSL 291 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCCC
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhcccCcCC
Confidence 346899999999997 356899999999999999999999999764322 112222211100000
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR---PNMDEVVRM 654 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~evl~~ 654 (682)
+. .... ....+.+++.+|+. +|++| |+++|++++
T Consensus 292 --p~--~~~~---~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 --PL--VDEG---VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --C------C---CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --Cc--cccC---CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00 0011 22345667779999 99998 689999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.70 Aligned_cols=257 Identities=21% Similarity=0.362 Sum_probs=186.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++..++..++||||++ |
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 467999999999999865 478899999975432 346788999999999 89999999999999999999999998 5
Q ss_pred chhHhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 467 SLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 467 ~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence 99998864321 12235899999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----cccc----cc
Q 005693 543 -ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EWTA----EV 612 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~----~~~~----~~ 612 (682)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. .......... .|.. ..
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhhhhhhh
Confidence 23457889999999976 4589999999999999999999999986542211 1111111000 0000 00
Q ss_pred chhhhc--cccCh---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 FDVELM--RFQNI---------EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 ~d~~l~--~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+..... ..... ......+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 00000 0122357788889999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=321.77 Aligned_cols=239 Identities=22% Similarity=0.414 Sum_probs=176.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEEecCC
Confidence 468999999999999974 688999999975422 236788999999998 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 95 NGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp TEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999997532 34899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||......+... ..... + ....
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-------~--~~~~ 232 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVLA-------D--YEMP 232 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSS-------C--CCCC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhhc-------c--cCCc
Confidence 3457889999999998889999999999999999999999998654332211 00000 0 0001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 233 ~~---~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 233 SF---LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp TT---SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc---cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11 22356678889999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.18 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=201.7
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.. .+++.||||++.... ...++.+|++++..+.+|+++..+..++...+..++||||+ +++|
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL 89 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence 47899999999999997 457889999876543 34568899999999966688888888888888999999999 9999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe---cCCCCeEEeecCCCCCCCCCC--
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~~-- 543 (682)
.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 90 ~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 90 EDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99997432 24999999999999999999999998 9999999999999 688999999999997654322
Q ss_pred ---------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 544 ---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 544 ---------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+........ ....+...... ....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~~~i~~~~~~-~~~~ 238 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ---KYEKISEKKVA-TSIE 238 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH---HHHHHHHHHHH-SCHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH---HHHHHhhcccc-ccHH
Confidence 3457889999999999999999999999999999999999998754432211 11111111110 0000
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.. .. .....+.+++.+||+.+|++||+++++++.|+++....
T Consensus 239 ~l---~~---~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 AL---CR---GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HH---HT---TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH---hc---CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00 01 11345778888999999999999999999999987644
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=345.41 Aligned_cols=238 Identities=23% Similarity=0.368 Sum_probs=196.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++...+..++||||++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 478999999999999976 68899999997542 1245688999999998 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 100 gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 100 GGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp SEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999743 34899999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+... ......+...... ..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p 236 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGIFY---------TP 236 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTCCC---------CC
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCcC---------CC
Confidence 24568999999999988776 6899999999999999999999975432 1222222221110 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... ...+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~---s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 QYL---NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TTC---CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ccC---CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 111 2346677889999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.74 Aligned_cols=256 Identities=20% Similarity=0.366 Sum_probs=194.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+++.+|++++.++ +||||+++++++..++..++||||++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 478999999999999974 678999999975322 235688899999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 9999999864321 1334899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...+++.|+|||++.+..++.++||||||+++|||++|+.||.+... ............... .. ..
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~-~~------~~ 260 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDYP-PL------PS 260 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTTCSC-CC------CT
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcccCC-CC------cc
Confidence 23578899999999999999999999999999999999999975421 222222222111111 00 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
......+.+++.+||+.||++|||++|+++.|+++.+....
T Consensus 261 ---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 261 ---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 11233566778899999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.50 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=195.7
Q ss_pred ccccccCeEEEEEEEEc---CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||.||+|.+. .++.||+|+++..... .+++.+|++++..+ +||||+++++++ ..+..++||||++
T Consensus 23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~ 100 (291)
T 1xbb_A 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWMLVMEMAE 100 (291)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEEEEEECCT
T ss_pred CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcEEEEEeCC
Confidence 38999999999999653 3578999999765332 45788999999999 899999999999 5678899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 101 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999999753 23899999999999999999999998 99999999999999999999999999976643321
Q ss_pred -------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 545 -------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 545 -------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+.......
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~----- 240 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG----- 240 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC-----
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence 234678999999998889999999999999999999 999997543211 111111111000
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
........+.+++.+||+.||++||+++|+++.|+++....
T Consensus 241 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 241 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 01122345677888999999999999999999999988654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=328.42 Aligned_cols=252 Identities=20% Similarity=0.310 Sum_probs=192.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 478999999999999976 5778999998765332 25688899999998 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 118 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 118 GVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999743 24899999999999999999999998 9999999999999999999999999987654332
Q ss_pred ----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 544 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
...+++.|+|||++.+..++.++||||||+++|||++|+.||..... ............ ... ..
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~----~~~-~~ 257 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIP----RPS-TV 257 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCC----CGG-GT
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCC----Ccc-cc
Confidence 33578899999999999999999999999999999999999975321 111111111110 000 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCCCC
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~i~~~~~~~ 665 (682)
.. .....+.+++.+||+.||++|| +++++++.|+++.+.....
T Consensus 258 ~~---~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 258 RP---GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp ST---TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CC---CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 11 1223466777899999999999 9999999999887666543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=316.89 Aligned_cols=251 Identities=20% Similarity=0.368 Sum_probs=200.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeEEEEEe
Confidence 578999999999999986 578999999875432 256789999999999 89999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC----CeEEeecCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 537 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 537 (682)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 89 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 89 LVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred ecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999642 24899999999999999999999998 99999999999999877 89999999997
Q ss_pred CCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 538 LMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 538 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
...... ...+++.|+|||++.+..++.++||||||+++|||++|+.||...... ............ .+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---~~ 231 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVNYD---FD 231 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC---CC
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcccC---Cc
Confidence 654332 335788999999999999999999999999999999999999754321 111111111100 00
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhcCC
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQSDS 663 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i~~~~~ 663 (682)
.. ... .....+.+++.+||+.||++|||++|+++ .++.+.....
T Consensus 232 ~~--~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 232 EE--YFS---NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HH--HHT---TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred ch--hcc---cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 00 001 12235677888999999999999999998 5677765543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.68 Aligned_cols=242 Identities=21% Similarity=0.328 Sum_probs=195.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 468999999999999976 4788999999765443 24577899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC---eEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~~~~~~ 542 (682)
|+|.+.+... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 90 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 90 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999888643 34899999999999999999999998 999999999999987665 999999999766543
Q ss_pred C---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
. ...+++.|+|||++.+..++.++||||||+++|+|++|+.||...... ............. ....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~-----~~~~ 230 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYDY-----PSPE 230 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCC-----CTTT
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhccccC-----Cchh
Confidence 3 345788999999999999999999999999999999999999754321 1122221111110 0001
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. .....+.+++.+||+.||++|||++|++++
T Consensus 231 ~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 WD---TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TT---TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hc---ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 122346677789999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=338.46 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=202.0
Q ss_pred hccccccCeEEEEEEEEcCC------ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|..... ..||+|.++.... ..+.+.+|++++.++.+||||+++++++..++..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 57899999999999997532 3699999976532 245688999999999789999999999999999999999
Q ss_pred eccCCchhHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEee
Q 005693 462 YFASGSLSTLLHGNRG---------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 532 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 532 (682)
|+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECc
Confidence 9999999999964321 01234799999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 533 FGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 533 fGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
||++....... ...+++.|+|||++.+..++.++||||||+++|||+| |..||.+....+ .......
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~ 281 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFYKLVK 281 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------HHHHHHH
T ss_pred cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------HHHHHHh
Confidence 99997654322 2234668999999999899999999999999999999 999997643221 1112222
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
...... .. ......+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 282 ~~~~~~-------~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 282 DGYQMA-------QP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HTCCCC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCC-------CC---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 211110 00 112345677888999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.26 Aligned_cols=244 Identities=22% Similarity=0.325 Sum_probs=190.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||++... ++..+|+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 578999999999999975 477899999876543 357789999999999 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe---cCCCCeEEeecCCCCCCCCC-
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~- 542 (682)
+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99998854321 1234899999999999999999999998 9999999999999 45678999999999765433
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....+++.|+|||++. ..++.++||||||+++|||++|+.||.+.... ............... ..
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~------~~ 248 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAV------EC 248 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC--------
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccc------cc
Confidence 2345788999999986 56889999999999999999999999754311 111111111100000 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 249 ~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 249 RP---LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred Cc---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 12356678889999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.53 Aligned_cols=256 Identities=14% Similarity=0.166 Sum_probs=198.9
Q ss_pred hccccccCeEEEEEEEEcC---------CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceec---------------
Q 005693 390 AEVLGKGSYGTAYKAVLEE---------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP--------------- 445 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~--------------- 445 (682)
.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++.++ +||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-cccchhhhhhhhccCCccCccc
Confidence 4789999999999999764 688999998753 5788999999999 8999887
Q ss_pred eEEEEEe-cCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC
Q 005693 446 LRAYYYS-KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 524 (682)
Q Consensus 446 l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 524 (682)
+++++.. +...++||||+ +|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDP 194 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEET
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcC
Confidence 6778776 67889999999 999999998542 234999999999999999999999998 999999999999999
Q ss_pred CC--CeEEeecCCCCCCCCC-----------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 005693 525 DL--DGCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 591 (682)
Q Consensus 525 ~~--~~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~ 591 (682)
++ .+||+|||+++..... ....+++.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999765422 2235788999999999999999999999999999999999999854321
Q ss_pred CCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 592 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 592 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
. ..+........ .. .....+.. ...... ...+.+++.+||+.||++|||++|+++.|+++.+....
T Consensus 275 ~-~~~~~~~~~~~-~~-~~~~~~~~-~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 275 T-EDIMKQKQKFV-DK-PGPFVGPC-GHWIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp H-HHHHHHHHHHH-HS-CCCEECTT-SCEECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred H-HHHHHHHHhcc-CC-hhhhhhhc-cccCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 1 11111111111 10 01111100 001111 24566777899999999999999999999999877643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.11 Aligned_cols=241 Identities=22% Similarity=0.339 Sum_probs=194.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++..+ +||||+++++++.+++..++||||+++|
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 578999999999999976 578899999875433 246788999999998 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 541 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 541 (682)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+.....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999643 34899999999999999999999998 99999999999999999999999999875432
Q ss_pred -CCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 542 -PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
.....+++.|+|||++.+..+ +.++||||||+++|||++|+.||........ .. ......... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~~~---~------ 228 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY----SDWKEKKTY---L------ 228 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH----HHHHTTCTT---S------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH----HHhhhcccc---c------
Confidence 223457889999999987765 7789999999999999999999976543211 11 111111000 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||+.||++|||++|++++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011123356678889999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.00 Aligned_cols=241 Identities=21% Similarity=0.318 Sum_probs=194.6
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|.... +..+|+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 5789999999999999765 5679999987653 3467899999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe---cCCCCeEEeecCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~-- 542 (682)
|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 93 L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 93 LFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp HHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99998743 23899999999999999999999998 9999999999999 78899999999999765433
Q ss_pred -CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 543 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
....+++.|+|||++.+. ++.++||||||+++|||++|+.||...... ............. ... ...
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~--~~~---~~~ 232 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTF--PEK---DWL 232 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC--CHH---HHT
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC--Cch---hhh
Confidence 234578899999998654 899999999999999999999999754321 1111111111100 000 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++.+|++.||++|||+.|++++
T Consensus 233 ---~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 233 ---NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123456778889999999999999999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.99 Aligned_cols=247 Identities=13% Similarity=0.033 Sum_probs=177.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhc-CCCceeceE-------EEEEecC--
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG-QHPNVVPLR-------AYYYSKD-- 454 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-~h~niv~l~-------~~~~~~~-- 454 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++..+. +||||++++ +++..+.
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 478999999999999975 578899999987543 2345677877777664 599988755 5554432
Q ss_pred ---------------ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCcEec
Q 005693 455 ---------------EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR------VKILLGTARGVAHIHSMGGPKFTHG 513 (682)
Q Consensus 455 ---------------~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gl~~LH~~~~~~ivHr 513 (682)
..++||||++ |+|.+++..... .+++..+ ..++.||+.||+|||+++ |+||
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr 218 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG 218 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence 3799999999 899999975321 2444555 778899999999999998 9999
Q ss_pred CCCCCCeEecCCCCeEEeecCCCCCCCCCC-CCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 005693 514 NIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 590 (682)
Q Consensus 514 DLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~ 590 (682)
||||+|||++.++.+||+|||+++...... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998776544 4456789999999987 6799999999999999999999999986643
Q ss_pred CCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 591 DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 591 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
....... ............ ...........+.+++.+||+.||++|||++|+++
T Consensus 299 ~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 299 GIKGSWK--------RPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCTTCCC--------BCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccchh--------hhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2211100 000000000000 00101122345667778999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.61 Aligned_cols=258 Identities=17% Similarity=0.255 Sum_probs=197.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcC-------CCceeceEEEEE----ecCceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ-------HPNVVPLRAYYY----SKDEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~-------h~niv~l~~~~~----~~~~~~ 457 (682)
.+.||+|+||+||+|+.. +++.||+|+++......+.+.+|++++..+.+ |+||+++++++. +....+
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 121 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence 468999999999999965 46789999997654445678899999998842 888999999998 456789
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCC----------
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDL---------- 526 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~---------- 526 (682)
+||||+ +|+|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 122 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 999999 566766665432 23489999999999999999999998 7 99999999999999775
Q ss_pred ---------------------------------------CeEEeecCCCCCCCCC-CCCCCCCcccCccccccCCCCCcc
Q 005693 527 ---------------------------------------DGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKS 566 (682)
Q Consensus 527 ---------------------------------------~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~s 566 (682)
.+||+|||++...... ....+|+.|+|||++.+..++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 7999999999766543 334689999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---h---------ccccccch------------------hh
Q 005693 567 DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---E---------EWTAEVFD------------------VE 616 (682)
Q Consensus 567 DvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~---~---------~~~~~~~d------------------~~ 616 (682)
|||||||++|||++|+.||......+...-......+.. . .+....+. ..
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 999999999999999999987654443211111111110 0 00000000 00
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+....+.+++.+||+.||++|||++|++++
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 01112235666788999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.98 Aligned_cols=232 Identities=22% Similarity=0.314 Sum_probs=192.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEEEE
Confidence 578999999999999964 577899999976532 234677899999999 999999999999999999999
Q ss_pred EeeccCC-chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 460 YDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 460 ~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
|||+.+| +|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 9999777 999999743 24899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCC---CCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 539 MNVPA---TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 539 ~~~~~---~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
..... ...+|+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------------~ 238 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------------E 238 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------------T
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------------h
Confidence 65433 2357899999999988876 789999999999999999999997422100 0
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........ ....+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001111 12346677789999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=336.98 Aligned_cols=234 Identities=21% Similarity=0.275 Sum_probs=182.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+. ++.||+|+++..... ...+.+|..++.+..+||||+++++++.+.+..|+||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 4789999999999999864 678999999765432 23445565554333389999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 123 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 123 GGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 99999999743 24889999999999999999999998 99999999999999999999999999975322
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+..... ...
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~---------~~~ 259 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL---------QLK 259 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCC---------CCC
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhccc---------CCC
Confidence 2345689999999999999999999999999999999999999975432 122222222111 011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMD 649 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 649 (682)
...+ ..+.+++.+||+.||++||++.
T Consensus 260 ~~~~---~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 260 PNIT---NSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SSSC---HHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCC---HHHHHHHHHHcccCHHhCCCCC
Confidence 1222 3456677799999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.10 Aligned_cols=244 Identities=19% Similarity=0.299 Sum_probs=197.1
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 57999999999999986 57899999997543 2345688899999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
|+|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 270 g~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp CBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 999999975432 2345899999999999999999999998 9999999999999999999999999997654332
Q ss_pred --CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ........+..... ....
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~~---------~~p~ 414 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQAV---------TYPD 414 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCCC---------CCCT
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhccc---------CCCc
Confidence 3468999999999999999999999999999999999999998653221 22222222222111 0111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR 653 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 653 (682)
.. ...+.+++.+||+.||++||++ +|+++
T Consensus 415 ~~---s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 KF---SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp TS---CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cc---CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 12 2345667779999999999965 66765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=323.34 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=193.3
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEec-CceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||++... ++.||+|+++... ..+.+.+|++++.++ +||||+++++++.+. +..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 578999999999999875 7899999987543 456788999999999 899999999997654 478999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-CCCC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR 547 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 547 (682)
.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...+
T Consensus 103 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 176 (278)
T 1byg_A 103 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 176 (278)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred HHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCc
Confidence 99997432 123788999999999999999999998 9999999999999999999999999987654432 3346
Q ss_pred CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHH
Q 005693 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 626 (682)
Q Consensus 548 ~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 626 (682)
++.|+|||++.+..++.++||||||+++|||+| |+.||......+ ...... ..... ......
T Consensus 177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~-~~~~~----------~~~~~~ 239 (278)
T 1byg_A 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVE-KGYKM----------DAPDGC 239 (278)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHHHT-TTCCC----------CCCTTC
T ss_pred cccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHh-cCCCC----------CCcccC
Confidence 788999999998899999999999999999998 999997543221 111111 11100 011122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 627 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 627 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
...+.+++.+||+.||++|||++|+++.|++++...
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 345677888999999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=342.89 Aligned_cols=193 Identities=23% Similarity=0.319 Sum_probs=168.7
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhc-----CCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||+||+|.... ++.||||+++......+.+.+|++++..+. +|+||+++++++...+..++||||+
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 181 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence 4789999999999998764 788999999765444567788888888774 5779999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC--eEEeecCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLTPLMNV 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DfGla~~~~~ 541 (682)
. |+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++.....
T Consensus 182 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 182 S-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp C-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 6 69999987543 234899999999999999999999998 999999999999999987 99999999976554
Q ss_pred C-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 542 P-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 542 ~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 3 34568899999999999999999999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=344.85 Aligned_cols=237 Identities=20% Similarity=0.277 Sum_probs=187.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|+++.... ....+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 578999999999999975 478899999975421 234567788888888 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 542 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 232 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 232 GGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp SCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999743 248999999999999999999998 77 999999999999999999999999999764322
Q ss_pred ---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+...... .
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---------~ 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEIR---------F 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------C
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC---------C
Confidence 244689999999999999999999999999999999999999975432 1122222211110 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 653 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 653 (682)
... ....+.+++.+||+.||++|| +++|+++
T Consensus 369 p~~---~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRT---LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTT---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred Ccc---CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111 223566777899999999999 9999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=328.93 Aligned_cols=255 Identities=20% Similarity=0.364 Sum_probs=196.2
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~ 463 (682)
.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++..+ +||||+++++++.. ....++||||+
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 47899999999999997 467899999986542 2346788999999999 99999999999873 34678999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999975322 2345899999999999999999999998 9999999999999999999999999987654211
Q ss_pred -------------CCCCCCcccCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 005693 544 -------------TPSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 607 (682)
Q Consensus 544 -------------~~~~~~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 607 (682)
...+++.|+|||++.+.. ++.++||||||+++|||++|+.||........ .... .....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~~~ 263 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----AVQNQ 263 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----HHHCC
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----Hhhcc
Confidence 123588899999987654 68899999999999999999999963211110 1110 00000
Q ss_pred cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 608 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 608 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
. ...........+.+++.+||+.||++|||++|++++|+++......
T Consensus 264 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 264 L----------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred C----------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 0 0000112234567788899999999999999999999998765544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=322.07 Aligned_cols=241 Identities=21% Similarity=0.322 Sum_probs=193.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|... +++.||+|+++.... ...++.+|+..+..+.+||||+++++++.+++..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 578999999999999986 688999999976432 2456778888888887899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-------------------C
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-------------------L 526 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-------------------~ 526 (682)
|+|.+++..... ....+++..+..++.|++.||+|||+++ |+||||||+||+++.+ .
T Consensus 96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CC
T ss_pred CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999975321 1234899999999999999999999998 9999999999999844 4
Q ss_pred CeEEeecCCCCCCCCCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 005693 527 DGCISDFGLTPLMNVPATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 605 (682)
Q Consensus 527 ~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~ 605 (682)
.+||+|||.+..........+++.|+|||++.+. .++.++||||||+++|||++|..|+.... . .....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~-~~~~~- 241 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------Q-WHEIR- 241 (289)
T ss_dssp CEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--------H-HHHHH-
T ss_pred EEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--------H-HHHHH-
Confidence 7999999999888777777799999999999876 56689999999999999999998764321 0 11111
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....... ... ....+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~-------~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 242 QGRLPRI-------PQV---LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TTCCCCC-------SSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cCCCCCC-------Ccc---cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111100 111 22356677789999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.38 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=200.0
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|... .++.||+|++..... ....+.+|++++..+ +||||+++++++.+.+..++|||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccCCccEEEEE
Confidence 578999999999999865 357799999975432 234688899999999 89999999999999999999999
Q ss_pred eccCCchhHhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCC
Q 005693 462 YFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 536 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 536 (682)
|+++|+|.+++..... .....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccc
Confidence 9999999999974321 11234789999999999999999999998 999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
+...... ...+++.|+|||++.+..++.++||||||+++|||++ |..||..... .............
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVMEGGLL 259 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHHTTCCC
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------HHHHHHHHcCCcC
Confidence 7653321 2234678999999999899999999999999999999 8999975432 1112221111110
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
. .. ......+.+++.+||+.||++|||++|++++|+++...
T Consensus 260 -~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 260 -D-------KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -C-------CC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 0 01 12234567788899999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=317.26 Aligned_cols=238 Identities=22% Similarity=0.323 Sum_probs=195.1
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|.... +..||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 5789999999999999764 6689999986542 2346788999999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 98 RGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999997432 4899999999999999999999998 999999999999999999999999998655432
Q ss_pred CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....+++.|+|||++.+..++.++||||||+++|||++|+.||...... ........... .....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~---------~~~~~ 234 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNVDL---------KFPPF 234 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCC---------CCCTT
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhcccc---------CCCCc
Confidence 3445788999999999999999999999999999999999999754311 11111111110 01111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....+.+++.+|++.||++|||++|++++
T Consensus 235 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 235 ---LSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ---CCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 22345677889999999999999999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.08 Aligned_cols=244 Identities=21% Similarity=0.341 Sum_probs=194.7
Q ss_pred hccccccCeEEEEEEEE----cCCceEEEEEeeccc-----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.||+++. .+++.||+|+++... ...+.+.+|++++..+.+||||+++++++..++..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 57899999999999997 367899999987532 234567789999999978999999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 139 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 139 DYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp CCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 999999999999743 24899999999999999999999998 9999999999999999999999999987653
Q ss_pred CC-----CCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VP-----ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~-----~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..............
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~----- 283 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP----- 283 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCCC-----
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccCC-----
Confidence 22 22358899999999985 347899999999999999999999997554322 22222222221110
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRMI 655 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L 655 (682)
....+....+.+++.+||+.||++|| +++|++++.
T Consensus 284 -------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00111223466788899999999999 999998854
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.08 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=191.7
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|.. .+++.||+|+++.. ..+.+.+|++++.++.+||||+++++++.+ ....++||||++++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 47899999999999986 45788999998743 357889999999999669999999999987 56789999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~~-- 543 (682)
+|.+++.. +++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 119 ~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 119 DFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp CHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred hHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 99999852 889999999999999999999998 99999999999999777 89999999997654332
Q ss_pred -CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc-------ch
Q 005693 544 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV-------FD 614 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~d 614 (682)
...+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+........... ..+. .+
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~-~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTED-LYDYIDKYNIELD 265 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHH-HHHHHHHTTCCCC
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCch-hhhHHHHhccccc
Confidence 3457888999999977 668999999999999999999999996432210 00111000000000 0000 00
Q ss_pred hh---------------hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VE---------------LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~---------------l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
+. .............+.+++.+||+.||++|||++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00001111134567788889999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=329.15 Aligned_cols=247 Identities=20% Similarity=0.255 Sum_probs=190.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc------cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEEEEEeC
Confidence 678999999999999975 46789999987542 2235788999999999 899999999999999999999999
Q ss_pred ccCCchhHhhccCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005693 463 FASGSLSTLLHGNRGA-----------------------------------GRTPLDWETRVKILLGTARGVAHIHSMGG 507 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 507 (682)
+++|+|.+++...... ....+++..+..++.|++.||+|||+.+
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~- 188 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG- 188 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999998521110 0112467788899999999999999998
Q ss_pred CCcEecCCCCCCeEecCCC--CeEEeecCCCCCCCC--------CCCCCCCCcccCcccccc--CCCCCcchHHHHHHHH
Q 005693 508 PKFTHGNIKASNVLINQDL--DGCISDFGLTPLMNV--------PATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLL 575 (682)
Q Consensus 508 ~~ivHrDLk~~NILl~~~~--~~kl~DfGla~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl 575 (682)
|+||||||+||+++.++ .+||+|||+++.... .....+++.|+|||++.+ ..++.++||||||+++
T Consensus 189 --ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp --EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred --ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 99999999999998776 899999999975422 123457889999999975 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 576 LEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 576 ~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
|||++|+.||.+.... .............. .+ ........+.+++.+||+.||++|||++|++++
T Consensus 267 ~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 267 HLLLMGAVPFPGVNDA------DTISQVLNKKLCFE--NP------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT--SG------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHCCCCCCCCChH------HHHHHHHhcccccC--Cc------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999999999754321 11222222111100 00 011123456678889999999999999999983
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=327.52 Aligned_cols=243 Identities=19% Similarity=0.358 Sum_probs=194.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++.++.+||||+++++++......++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 378999999999999986 6889999998754321 245778999999997899999999999999999999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 179 ~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp ECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999742 34899999999999999999999998 999999999999999999999999998765
Q ss_pred CCC---CCCCCCCcccCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 005693 540 NVP---ATPSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610 (682)
Q Consensus 540 ~~~---~~~~~~~~y~aPE~~~~------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 610 (682)
... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILMLRMIMEGQYQF 324 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCC
Confidence 443 23468899999999863 3578899999999999999999999975321 11111111111100
Q ss_pred ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 611 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+ ... .....+.+++.+||+.||++|||++|++++
T Consensus 325 --~~~---~~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 325 --SSP---EWD---DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp --CHH---HHS---SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCc---ccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 001 122346778889999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.75 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=184.7
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc---------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.||+|+||+||+|.... ++.||+|++..... ....+.+|++++.++ +||||+++++++. .+..++|
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE-SSEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCceEEE
Confidence 5789999999999999754 68899999975421 123588999999999 9999999999975 4568999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC---CeEEeecCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT 536 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla 536 (682)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 218 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 218 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 9999999999998643 34899999999999999999999998 99999999999997554 5999999999
Q ss_pred CCCCCCC---CCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 005693 537 PLMNVPA---TPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610 (682)
Q Consensus 537 ~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 610 (682)
+...... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+... +......
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----i~~~~~~ 363 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----ITSGKYN 363 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----HHTTCCC
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----HhcCCCC
Confidence 8765432 3457899999999853 567889999999999999999999997543222 11111 1111000
Q ss_pred ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 611 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. . +. .. ......+.+++.+||+.||++|||++|++++
T Consensus 364 ~-~-~~--~~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 364 F-I-PE--VW---AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp C-C-HH--HH---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-C-ch--hh---cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0 00 00 1123456778889999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.20 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=186.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||+||+|... +++.||+|++...... .+.+.+|+.+++.+ +||||+++++++...+ ..++|
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCeEEEE
Confidence 478999999999999975 4788999999765332 45678899999999 9999999999996553 46999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 999976 56666642 2889999999999999999999998 999999999999999999999999999876
Q ss_pred CCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH---------------
Q 005693 540 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ--------------- 601 (682)
Q Consensus 540 ~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~--------------- 601 (682)
... ....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. +.....
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHTTSCH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHcch
Confidence 543 234689999999999999999999999999999999999999986532111 000000
Q ss_pred ---HHhhhccc-ccc-----chhhhcccc--ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 602 ---SVVREEWT-AEV-----FDVELMRFQ--NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 602 ---~~~~~~~~-~~~-----~d~~l~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........ ... +........ ........+.+++.+||+.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000 000000000 011124567889999999999999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=346.32 Aligned_cols=243 Identities=13% Similarity=0.167 Sum_probs=185.2
Q ss_pred hccccccCeEEEEEEEE-cCCceEEEEEeecccc----ChhhHHHHHHHHHHhc--CCCceeceE-------EEEEecCc
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG--QHPNVVPLR-------AYYYSKDE 455 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~-------~~~~~~~~ 455 (682)
.+.||+|+||+||+|.. .+++.||||++..... ..+.+.+|++++..+. +||||++++ +++..++.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 47899999999999995 4588999999974322 2356888996555443 799999998 77765542
Q ss_pred -----------------eEEEEeeccCCchhHhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 005693 456 -----------------KLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 516 (682)
Q Consensus 456 -----------------~~lV~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk 516 (682)
.++||||+ +|+|.+++...... ....+++..+..++.||+.||+|||+++ |+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 78999999 68999999753211 1123456888899999999999999998 9999999
Q ss_pred CCCeEecCCCCeEEeecCCCCCCCCCC-CCCCCCcccCccccccC-----------CCCCcchHHHHHHHHHHHHhCCCC
Q 005693 517 ASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETR-----------KHSHKSDVYSFGVLLLEMLTGKAP 584 (682)
Q Consensus 517 ~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~~~~sDvwS~Gvvl~elltg~~P 584 (682)
|+|||++.++.+||+|||+++...... ...| +.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred HHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998654432 3446 899999999887 899999999999999999999999
Q ss_pred CCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 005693 585 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR 659 (682)
Q Consensus 585 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i~ 659 (682)
|.+....+.... + ....... ...+.+++.+||+.||++|||+.|+++ .++++.
T Consensus 313 f~~~~~~~~~~~---------------~----~~~~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 313 ITKDAALGGSEW---------------I----FRSCKNI---PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp C------CCSGG---------------G----GSSCCCC---CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred Ccccccccchhh---------------h----hhhccCC---CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 976543322110 0 0011122 234667778999999999999999997 455544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.95 Aligned_cols=254 Identities=19% Similarity=0.293 Sum_probs=196.7
Q ss_pred hccccccCeEEEEEEEE-c-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCC------ceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVL-E-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP------NVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~------niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|.. . +++.||+|+++......+.+.+|++++..+ +|+ +++++++++...+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 46799999999999987 3 578899999976544456788899998887 444 59999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-----------------
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ----------------- 524 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~----------------- 524 (682)
|+ +++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99 889999997543 235889999999999999999999998 999999999999987
Q ss_pred --CCCeEEeecCCCCCCCCC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 005693 525 --DLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 525 --~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~ 601 (682)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL---AMME 247 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH---HHHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHH
Confidence 678999999999765543 3446889999999999999999999999999999999999999865432211 1111
Q ss_pred HHhh---hcc-----cccc---------------------chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 005693 602 SVVR---EEW-----TAEV---------------------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652 (682)
Q Consensus 602 ~~~~---~~~-----~~~~---------------------~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 652 (682)
.... ... .... .................+.+++.+||+.||++|||++|++
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 1100 000 0000 0000000111234556788999999999999999999998
Q ss_pred HH
Q 005693 653 RM 654 (682)
Q Consensus 653 ~~ 654 (682)
++
T Consensus 328 ~h 329 (339)
T 1z57_A 328 KH 329 (339)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=325.31 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=192.0
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|+... ++.||+|++...... .+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 4689999999999999865 788999998765433 34577899999999 899999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 109 TILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred chHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9999887643 23899999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC-h--------hHHHHHHhhhccccc
Q 005693 543 -ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-L--------PRWVQSVVREEWTAE 611 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~-l--------~~~~~~~~~~~~~~~ 611 (682)
....+++.|+|||++.+. .++.++|||||||++|||++|+.||......+... + +.+............
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 234578899999999775 68999999999999999999999997654221100 0 000000000000000
Q ss_pred cchhhhccccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~~l~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+........ ......+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000 1223457788889999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=318.78 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=190.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e 461 (682)
.+.||+|+||.||+|... ++..||+|++...... .+.+.+|+.++.++ +||||+++++++.. ....++|||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEE
Confidence 457999999999999975 4677999998765433 34688899999999 89999999999875 345799999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec-CCCCeEEeecCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMN 540 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~ 540 (682)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++ +++.+||+|||++....
T Consensus 110 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 110 LMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred ecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999743 34899999999999999999999975 4599999999999998 78999999999997654
Q ss_pred CCC--CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 541 VPA--TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 541 ~~~--~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
... ...+++.|+|||++.+ .++.++||||||+++|+|++|+.||..... ........... ......+
T Consensus 184 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~-~~~~~~~---- 252 (290)
T 1t4h_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSG-VKPASFD---- 252 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTT-CCCGGGG----
T ss_pred ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhcc-CCccccC----
Confidence 432 3457899999998864 589999999999999999999999975331 11112211111 1111111
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.||++|||++|++++
T Consensus 253 -----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 -----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0112356778889999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.09 Aligned_cols=242 Identities=20% Similarity=0.337 Sum_probs=194.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+++.. +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 578999999999999976 578899999976532 345688999999999 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe---cCCCCeEEeecCCCCCCCCCC-
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~~- 543 (682)
|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||++.......
T Consensus 93 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 93 LFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp HHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 99998643 24899999999999999999999998 9999999999999 788999999999987654332
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...+++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+....... .. ...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~~---~~--~~~-- 231 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYYEF---ES--PFW-- 231 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCCCC---CT--TTT--
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCC---Cc--ccc--
Confidence 123788999999999999999999999999999999999999754321 1122221111100 00 001
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+|++.||++|||++|++++
T Consensus 232 -~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 232 -DDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1223456778889999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.14 Aligned_cols=202 Identities=23% Similarity=0.413 Sum_probs=155.8
Q ss_pred HHHHHHhhccccccCeEEEEEEEEc---CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceE
Q 005693 383 EDLLRASAEVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKL 457 (682)
Q Consensus 383 ~~l~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~ 457 (682)
++.....+++||+|+||+||+|+.. +++.||+|++..... ...+.+|++++.++ +||||+++++++.. +...+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEE
Confidence 3333333668999999999999976 467899999975433 45688999999999 89999999999965 56789
Q ss_pred EEEeeccCCchhHhhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe----cCCCCeE
Q 005693 458 LVYDYFASGSLSTLLHGNR----GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGC 529 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~k 529 (682)
+||||+.+ +|.+++.... ......+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999974 8888775321 112234899999999999999999999998 9999999999999 7789999
Q ss_pred EeecCCCCCCCCC-------CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 005693 530 ISDFGLTPLMNVP-------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 590 (682)
Q Consensus 530 l~DfGla~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~ 590 (682)
|+|||+++..... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999876432 234578999999999874 589999999999999999999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.64 Aligned_cols=251 Identities=21% Similarity=0.350 Sum_probs=188.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++..+ +||||+++++++.... ..++|
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccCceEEEE
Confidence 467999999999999975 5788999999654332 35678899999999 8999999999997653 45999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 109 ~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 9999 88999999742 3899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC-CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------ccccc
Q 005693 540 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------EWTAE 611 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~------~~~~~ 611 (682)
.... ...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ ....+... .....
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD------QLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCHHHHHT
T ss_pred ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCCHHHHHH
Confidence 5433 3467899999999877 678999999999999999999999998653211 11111100 00000
Q ss_pred c---------------chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005693 612 V---------------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 659 (682)
Q Consensus 612 ~---------------~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~ 659 (682)
+ ....+. .........+.+++.+|++.||++|||++|++++ ++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 000000 0011223456778889999999999999999984 44443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.63 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=197.9
Q ss_pred hccccccCeEEEEEEEE-----cCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecC--ceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e 461 (682)
.+.||+|+||.||++++ .+++.||+|++..... ..+.+.+|++++.++ +||||+++++++...+ ..++|||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCceEEEEE
Confidence 57899999999999985 3578899999876432 245788999999999 8999999999987644 6799999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999997543 34899999999999999999999998 99999999999999999999999999976644
Q ss_pred CC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC--------CCCCC-hhHHHHHHhh
Q 005693 542 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--------DDMVD-LPRWVQSVVR 605 (682)
Q Consensus 542 ~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~--------~~~~~-l~~~~~~~~~ 605 (682)
.. ...++..|+|||.+.+..++.++||||||+++|||+||..||..... ..... ..........
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32 22356679999999988899999999999999999999999863210 00000 0000111111
Q ss_pred hccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 606 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
... ...........+.+++.+||+.||++|||++|+++.|+++++.
T Consensus 278 ~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 278 NNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 110 0011122334577788899999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=327.94 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=194.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhc----------CCCceeceEEEEEecC----
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QHPNVVPLRAYYYSKD---- 454 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~~---- 454 (682)
.+.||+|+||+||+|+.. +++.||+|++.......+.+.+|++++.++. .|+||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 103 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence 478999999999999974 5788999999765445567888999988873 2899999999998654
Q ss_pred ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEec------CCCC
Q 005693 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLIN------QDLD 527 (682)
Q Consensus 455 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~------~~~~ 527 (682)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++ ..+.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred eEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcce
Confidence 678999999 889999997543 23489999999999999999999998 8 99999999999994 4457
Q ss_pred eEEeecCCCCCCCCC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 005693 528 GCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 606 (682)
Q Consensus 528 ~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 606 (682)
+||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.................+...
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence 999999999766543 3446889999999999999999999999999999999999999865433222111111111100
Q ss_pred ------------ccc----------cccc--------hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 607 ------------EWT----------AEVF--------DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 607 ------------~~~----------~~~~--------d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.+. ..+. +...............+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 000 0000 00001112234567788899999999999999999999984
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.71 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=190.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEec--------CceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~ 457 (682)
.+.||+|+||.||+|+.. +++.||+|++..... ....+.+|++++..+ +||||+++++++... +..+
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccccCCceEE
Confidence 478999999999999984 578999999865432 235678999999999 899999999999874 4679
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 101 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 99999975 7877776432 34899999999999999999999998 9999999999999999999999999997
Q ss_pred CCCCC--------CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh--
Q 005693 538 LMNVP--------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE-- 606 (682)
Q Consensus 538 ~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~-- 606 (682)
..... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. .........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCC
Confidence 65321 22346888999999876 45799999999999999999999999865422111 111111100
Q ss_pred -ccccccchhh--------hccccChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 607 -EWTAEVFDVE--------LMRFQNIEEE------MVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 607 -~~~~~~~d~~--------l~~~~~~~~~------~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......+.. ........+. ...+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000 0001111121 2346788899999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=355.75 Aligned_cols=238 Identities=24% Similarity=0.306 Sum_probs=195.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+... ++.||||+++... ...+.+..|.+++..+.+|+||+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 4689999999999999764 6779999997542 2345677888898888789999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC---
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 541 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 426 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 426 GGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 99999999753 24899999999999999999999998 99999999999999999999999999975322
Q ss_pred -CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 542 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+..... ...
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~---------~~p 562 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV---------AYP 562 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCC---------CCC
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC---------CCC
Confidence 2345689999999999999999999999999999999999999986432 122222222211 011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 653 (682)
.. ....+.+++.+||+.||++||++ +||++
T Consensus 563 ~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 KS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TT---SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred cc---CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 12 22346677779999999999997 77765
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.23 Aligned_cols=241 Identities=21% Similarity=0.340 Sum_probs=194.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|... +++.||+|++.... .....+.+|++++.++ +||||+++++++.+....++||||+++
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 578999999999999976 57889999996542 2456789999999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec---CCCCeEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DfGla~~~~~~ 542 (682)
|+|.+.+... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999988643 24899999999999999999999998 99999999999995 4567999999999876543
Q ss_pred C---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
. ...+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.... .....+........ ...
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~-----~~~ 245 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAFD-----LPQ 245 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCSC-----SGG
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCC-----Ccc
Confidence 2 3458899999999876 5899999999999999999999999764321 12222222211110 011
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. .....+.+++.+||+.||++|||++|++++
T Consensus 246 ~~---~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 WR---TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG---GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cC---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 122345677789999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.94 Aligned_cols=243 Identities=23% Similarity=0.396 Sum_probs=190.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe------cCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|... +++.||+|++.......+.+.+|+.++.++.+||||+++++++.. .+..++||||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 108 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence 478999999999999974 578899999987666677899999999999889999999999987 4578999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 109 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp CTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred CCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999997543 234899999999999999999999998 999999999999999999999999998765432
Q ss_pred ----CCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 ----ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....+++.|+|||++. +..++.++||||||+++|||++|+.||...... .......... ....
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~- 254 (326)
T 2x7f_A 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRNP-APRL- 254 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCC-
T ss_pred ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcCc-cccC-
Confidence 2345788999999987 566899999999999999999999999754311 1111111111 0000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... ...+.+++.+||+.||++||+++|++++
T Consensus 255 -----~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 255 -----KSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -----SCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -----Ccccc---CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111 2356677789999999999999999883
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=339.99 Aligned_cols=181 Identities=28% Similarity=0.440 Sum_probs=146.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec-----CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 460 (682)
.+.||+|+||+||+|... +++.||||++...... .+.+.+|++++.++ +||||+++++++... ...|+||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEEEE
Confidence 478999999999999965 5788999999764332 35688999999999 999999999999543 4689999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+ +|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 137 EIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred ecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 998 56999999743 34899999999999999999999998 9999999999999999999999999998754
Q ss_pred CC-------------------------------CCCCCCCcccCcccc-ccCCCCCcchHHHHHHHHHHHHh
Q 005693 541 VP-------------------------------ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLT 580 (682)
Q Consensus 541 ~~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~ellt 580 (682)
.. ....+|+.|+|||++ ....++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 22 123468889999986 55679999999999999999999
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.94 Aligned_cols=191 Identities=21% Similarity=0.381 Sum_probs=166.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|... ++..||+|++..... ..+.+.+|+.++..+ +||||+++++++..++..++||||+++|
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 468999999999999976 577899999875432 235688999999998 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC--CCC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--VPA 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~--~~~ 543 (682)
+|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++.... ...
T Consensus 117 ~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 117 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999997532 489999999999999999999985 7 9999999999999999999999999986432 223
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
...+++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4468899999999999999999999999999999999999997543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.31 Aligned_cols=241 Identities=22% Similarity=0.358 Sum_probs=191.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc--------------cChhhHHHHHHHHHHhcCCCceeceEEEEEecC
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--------------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 454 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 454 (682)
.+.||+|+||+||+|.... ++.||+|+++... ...+.+.+|+.++.++ +||||+++++++.+..
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCC
Confidence 4789999999999999764 6789999997543 1245688999999999 8999999999999999
Q ss_pred ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC---CeEEe
Q 005693 455 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCIS 531 (682)
Q Consensus 455 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~ 531 (682)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999998643 24899999999999999999999998 99999999999999776 69999
Q ss_pred ecCCCCCCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 532 DFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 532 DfGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
|||++...... ....+|+.|+|||++. ..++.++||||+||++|+|++|..||.+.... .....+.....
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~ 264 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DIIKKVEKGKY 264 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC
Confidence 99999776543 2446899999999987 46899999999999999999999999864321 12222222111
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. + ....... ...+.+++.+|++.||++|||++|++++
T Consensus 265 ~~---~--~~~~~~~---s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 YF---D--FNDWKNI---SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CC---C--HHHHTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC---C--ccccCCC---CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 10 0 0011112 2346677789999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.27 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=188.3
Q ss_pred hccccccCeEEEEEEEEcC--Cc--eEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE--ST--TVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~--~~--~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||+||+|.+.. ++ .||+|+++.... ..+.+.+|++++.++ +||||+++++++..+. .++|||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-ceeeEe
Confidence 4689999999999998642 22 589999875422 235688999999999 8999999999997654 889999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999997532 34899999999999999999999998 99999999999999999999999999876643
Q ss_pred CC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 542 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 542 ~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. ...++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..............
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~--- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL--- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC---
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCC---
Confidence 32 2235668999999998889999999999999999999 9999975432 11222222111110
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 664 (682)
.........+.+++.+||+.||++|||++++++.|+++......
T Consensus 245 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 245 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred -------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 01112334577788899999999999999999999998765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.76 Aligned_cols=239 Identities=21% Similarity=0.345 Sum_probs=194.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++...+ ++.+|+|++..... ..+.+.+|+.+++.+ +||||+++++++.+++..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecCC
Confidence 4789999999999999864 67789999875532 235678899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 99 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999998643 24899999999999999999999998 999999999999999999999999998765422
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............ ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---------~~ 235 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEYS---------IP 235 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC---------CC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhccCC---------Cc
Confidence 2345788999999999988999999999999999999999999754311 111111111100 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.. ....+.+++.+||+.||++|||++|++++-
T Consensus 236 ~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 236 KH---INPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cc---cCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11 123466778899999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=319.97 Aligned_cols=240 Identities=25% Similarity=0.406 Sum_probs=191.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|.... ++.||+|.+.... ..+++.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 4689999999999999764 7889999987643 356788999999999 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----CC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 544 (682)
.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... ..
T Consensus 112 ~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 112 SDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp HHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 9998632 234899999999999999999999998 999999999999999999999999998665432 23
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..+++.|+|||++.+..++.++||||||+++|||++|+.||...... ....... ....... ....
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~--------~~~~ 249 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIP-TNPPPTF--------RKPE 249 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCCC--------SSGG
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHh-cCCCccc--------CCcc
Confidence 45788999999999989999999999999999999999999753211 1111111 1110000 0111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.....+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 12345677888999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.12 Aligned_cols=243 Identities=24% Similarity=0.300 Sum_probs=191.5
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
..||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++..+ +||||+++++++...+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 47999999999999975 467899999876533 346788999999999 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCCCCCC----C
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~~----~ 543 (682)
.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++...... .
T Consensus 107 ~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 107 SALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 99997543 2234678999999999999999999998 999999999999987 899999999999765432 2
Q ss_pred CCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 544 TPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
...+++.|+|||++.+.. ++.++||||||+++|||++|+.||......+ ............. .
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~-----~----- 246 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFKVHP-----E----- 246 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHCCCC-----C-----
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhccccccc-----c-----
Confidence 345788999999997653 7899999999999999999999996432111 0000000000000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
........+.+++.+||+.||++||+++|++++
T Consensus 247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011223456677889999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.83 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=196.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++..+ +||||+++++++.++...++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 468999999999999975 578899999975532 346789999999999 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 106 ~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 106 SALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99999963 24899999999999999999999998 999999999999999999999999998665432
Q ss_pred CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 543 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
....+++.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ........ . ..
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~-~------~~- 241 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFL-IPKNNPPT-L------EG- 241 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCC-C------CS-
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHH-hhcCCCCC-C------cc-
Confidence 2345788899999999999999999999999999999999999754211 11111 11111100 0 01
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
.....+.+++.+||+.||++|||++|++++..
T Consensus 242 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 242 --NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp --SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred --ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 12234677888999999999999999998654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.49 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=196.6
Q ss_pred hccccccCeEEEEEEEE------cCCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|+. .++..||+|++..... ...++.+|+.++.++ +||||+++++++......++|||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcEEEEe
Confidence 47899999999999984 2466899999964422 345688899999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCC
Q 005693 462 YFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLT 536 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla 536 (682)
|+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++. +..+||+|||++
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccc
Confidence 99999999999765321 1245899999999999999999999998 999999999999994 446999999988
Q ss_pred CCCCC------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 537 PLMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 537 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
..... .....+++.|+|||++.+..++.++||||||+++|||+| |..||...... ...........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~- 263 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGR- 263 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCC-
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHHHHHhcCCC-
Confidence 64322 122345778999999998899999999999999999998 99999754311 11111111110
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.. ........+.+++.+||+.||++||+++|++++|+.+.+..
T Consensus 264 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 264 MD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00 01122345677888999999999999999999999887644
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=342.23 Aligned_cols=241 Identities=23% Similarity=0.379 Sum_probs=195.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+.
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 578999999999999976 57899999986542 2356789999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe---cCCCCeEEeecCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~ 541 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 110 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 110 GGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp SCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999743 34899999999999999999999998 9999999999999 5678999999999876654
Q ss_pred CC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 542 PA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 542 ~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
.. ...+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.... .....+........ ..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~-----~~ 249 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEKGKYTFE-----LP 249 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCC-----SG
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCCC-----Cc
Confidence 43 2357899999999876 6899999999999999999999999864321 11222222211111 11
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... .....+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~---~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 250 QWK---KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGG---GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111 123446677789999999999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.15 Aligned_cols=245 Identities=21% Similarity=0.355 Sum_probs=191.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc---cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|+.. ++..||+|++.... .....+.+|+.+++.+ +||||+++++++.+....++||||+++
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999976 57789999997653 2356788999999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC---CCeEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~~~~~~ 542 (682)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++......
T Consensus 121 g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 121 GELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999988643 34899999999999999999999998 9999999999999764 45999999999765433
Q ss_pred ---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
....+|+.|+|||++. ..++.++||||+||++|+|++|..||.+.... .....+........ ...
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~-----~~~ 260 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKYTFD-----SPE 260 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCC-----SGG
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCC-----chh
Confidence 2346899999999986 46999999999999999999999999864321 22222222211100 001
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEV 658 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i 658 (682)
.... ...+.+++.+||+.||++|||++|++++ +.+.
T Consensus 261 ~~~~---s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 261 WKNV---SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp GTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred cccC---CHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 1122 2345677789999999999999999974 4443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.88 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=187.4
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc---------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.||+|+||.||+|.... ++.||+|++..... ....+.+|++++.++ +||||+++++++..++ .++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEEE
Confidence 5789999999999999764 67899999865321 124588999999999 9999999999987654 8999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC---eEEeecCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLT 536 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla 536 (682)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++
T Consensus 93 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 93 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 9999999999998643 34899999999999999999999998 999999999999987665 999999999
Q ss_pred CCCCCCC---CCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 005693 537 PLMNVPA---TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610 (682)
Q Consensus 537 ~~~~~~~---~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 610 (682)
....... ...+++.|+|||++. ...++.++|||||||++|||++|..||....... .+..... .....
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~----~~~~~ 238 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT----SGKYN 238 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH----HTCCC
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH----hCccc
Confidence 8765432 224788999999974 5668899999999999999999999997544322 1211111 11000
Q ss_pred ccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 611 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
..+.. . ......+.+++.+||+.||++|||++|+++
T Consensus 239 --~~~~~--~---~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 --FIPEV--W---AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCHHH--H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCchh--h---hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0 112345677888999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.62 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=191.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++..+ +||||+++++++.+.+..++||||
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEEEEEc
Confidence 578999999999999975 4788999998753221 24678999999999 899999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 986 8988886432 34888999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccccc--c
Q 005693 543 ----ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAE--V 612 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~~~~--~ 612 (682)
....+|+.|+|||++.+. .++.++|||||||++|||++|..||.+....+. +........ .+.|... .
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTTSS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhhhhhhccC
Confidence 234578899999999764 478999999999999999999999976432111 111111100 0011000 0
Q ss_pred chh-hhccccC------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 613 FDV-ELMRFQN------IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 613 ~d~-~l~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
.+. ....... .......+.+++.+||+.||++|||++|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 0000000 012234677888899999999999999999853
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.07 Aligned_cols=238 Identities=21% Similarity=0.349 Sum_probs=194.5
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||++...+ ++.+|+|++..... ..+.+.+|+.++..+ +|+||+++++++.+.+..++||||++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEecCC
Confidence 4789999999999999865 67789999875532 235678899999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 125 ~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 125 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999998643 24899999999999999999999998 999999999999999999999999999765422
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ............. ..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~---------~~ 261 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEYS---------IP 261 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC---------CC
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCCCC---------CC
Confidence 234578899999999998899999999999999999999999975431 1111111111110 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 262 ~~---~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 KH---INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cc---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 12345677889999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=329.33 Aligned_cols=195 Identities=22% Similarity=0.302 Sum_probs=165.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCc-----eeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-----VVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-----iv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||+||+|... +++.||||+++.......++..|++++..+.+|++ |+++++++...+..++||||+
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 138 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence 468999999999999976 46789999997654445667888889888865664 999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec--CCCCeEEeecCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DfGla~~~~~ 541 (682)
+ |+|.+++.... ...+++..+..++.|++.||.|||.+. .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 139 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 139 S-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp C-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 6 59999997543 234899999999999999999999521 2399999999999995 478899999999977654
Q ss_pred C-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 542 P-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 542 ~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
. ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 214 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3 34568899999999999999999999999999999999999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.93 Aligned_cols=238 Identities=21% Similarity=0.333 Sum_probs=188.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEEEEeccC
Confidence 478999999999999986 68899999987542 2345788999999998 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 95 GGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999999743 23899999999999999999999998 9999999999999999999999999997765432
Q ss_pred --CCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 --TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
...+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.... .......+...... ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~---------~~ 231 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKKIRGGVFY---------IP 231 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CC
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCccc---------Cc
Confidence 3357888999999988765 689999999999999999999997532 11112211111100 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. .....+.+++.+||+.||++|||++|++++
T Consensus 232 ~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 E---YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h---hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 112346678889999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=323.30 Aligned_cols=245 Identities=19% Similarity=0.279 Sum_probs=168.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|... +++.||+|++... ....+|+....+..+||||+++++++.. +...++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 457999999999999986 5789999998653 3344455554455599999999999976 445799999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC---CCeEEeecCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNV 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~~~~~ 541 (682)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||+++....
T Consensus 110 gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 110 GGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp TEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 999999998543 235899999999999999999999998 9999999999999864 5599999999976543
Q ss_pred C--CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 542 P--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 542 ~--~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
. ....+++.|+|||++.+..++.++||||||+++|||++|+.||........... ......... .......
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~ 256 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLGQ-----YGFPNPE 256 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTTT
T ss_pred cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhccc-----cccCchh
Confidence 3 234578899999999888899999999999999999999999976543321100 000000000 0000000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. ......+.+++.+||+.||++|||++|++++
T Consensus 257 ~---~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 W---SEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp S---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred h---ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 1223456677889999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.14 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=184.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|... +++.||+|+++..... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEecCCC
Confidence 478999999999999965 5788999999754322 34577899999999 999999999999999999999999985
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec-----CCCCeEEeecCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-----QDLDGCISDFGLTPLMN 540 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-----~~~~~kl~DfGla~~~~ 540 (682)
+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+||+|||+++...
T Consensus 118 -~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 118 -DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp -EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred -CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999997543 3899999999999999999999998 99999999999994 45569999999987554
Q ss_pred CC----CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc------c
Q 005693 541 VP----ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW------T 609 (682)
Q Consensus 541 ~~----~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~------~ 609 (682)
.. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ ....+..... .
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID------QLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCTTTS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH------HHHHHHHHhCCCchhhh
Confidence 22 233568899999999875 48999999999999999999999997643211 1111111000 0
Q ss_pred ccc-----chhhhc--cccChHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 AEV-----FDVELM--RFQNIEE-----EMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 ~~~-----~d~~l~--~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... +..... ....... ....+.+++.+||+.||++|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 000000 0000011 22456788889999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.82 Aligned_cols=244 Identities=22% Similarity=0.330 Sum_probs=176.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|... +++.||+|+++..... ..+...|...+.+..+||||+++++++.+++..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~- 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT- 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-
Confidence 468999999999999974 5788999999764332 223334444434444899999999999999999999999974
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+|.+++..... ....+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 91 SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 88877754211 133589999999999999999999998 8 9999999999999999999999999997664432
Q ss_pred -CCCCCCcccCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 544 -TPSRSAGYRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 544 -~~~~~~~y~aPE~~----~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
...+++.|+|||++ .+..++.++||||||+++|||++|+.||..... ............... .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-~------ 234 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSPQ-L------ 234 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCCC-C------
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCCC-c------
Confidence 23578899999996 556789999999999999999999999974321 111111111111110 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
........+.+++.+||+.||++|||++|+++
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 ---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00112345677888999999999999999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=315.52 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=193.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~ 463 (682)
.+.||+|+||.||++... +++.||+|++...... .+.+.+|++++.++ +||||+++++++.. ....++||||+
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~ 89 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYC 89 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEEEeCC
Confidence 468999999999999976 5788999999754332 35688899999999 89999999998864 56789999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~ 168 (279)
T 2w5a_A 90 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168 (279)
T ss_dssp TTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred CCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence 99999999975332 2344899999999999999999999976 23499999999999999999999999999876544
Q ss_pred CC----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 542 PA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 542 ~~----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
.. ...+++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+. .......
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~-~~~~~~~----- 236 (279)
T 2w5a_A 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIR-EGKFRRI----- 236 (279)
T ss_dssp -CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HTCCCCC-----
T ss_pred ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHHh-hcccccC-----
Confidence 32 124788899999999989999999999999999999999999754311 1111111 1111100
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
. ......+.+++.+||+.||++||+++|+++++..
T Consensus 237 --~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 --P---YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --C---cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0 1123456777889999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=330.37 Aligned_cols=187 Identities=26% Similarity=0.400 Sum_probs=158.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec-----CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 460 (682)
.+.||+|+||.||+|.... ++.||||+++..... .+.+.+|++++.++ +||||+++++++... ...|+||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 4789999999999999764 678999999764332 35688999999999 899999999999766 5689999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||++ |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 110 EIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp ECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred ecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9986 5999999743 34899999999999999999999998 9999999999999999999999999997654
Q ss_pred CC--------------------------CCCCCCCcccCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 005693 541 VP--------------------------ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586 (682)
Q Consensus 541 ~~--------------------------~~~~~~~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~elltg~~Pf~ 586 (682)
.. ....+|+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 32 234578999999986 55669999999999999999998655554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=319.51 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=189.2
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||.||+|.... ++.||+|++.... ...+.+.+|++++..+ +||||+++++++..++..++||||+++++
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 4679999999999999864 7789999986543 3456788999999999 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC----CCCC
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPA 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~----~~~~ 543 (682)
|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++... ....
T Consensus 103 l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 103 VDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999986432 34899999999999999999999998 999999999999999999999999987432 1223
Q ss_pred CCCCCCcccCcccc-----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 544 TPSRSAGYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 544 ~~~~~~~y~aPE~~-----~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
...+++.|+|||++ ....++.++||||||+++|||++|+.||..... .............. .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-~------ 242 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPPT-L------ 242 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCC-C------
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCcc-c------
Confidence 44678899999998 366789999999999999999999999975431 11122221111110 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.........+.+++.+||+.||++|||++|++++
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011123456778889999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.71 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=184.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.+++.+ +||||+++++++...+ ..++|
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccceEEE
Confidence 468999999999999975 4778999999764332 34677899999998 8999999999997665 67999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 109 ~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 109 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 999975 78888852 2889999999999999999999998 999999999999999999999999999876
Q ss_pred CCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHH-------H
Q 005693 540 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---------DLPRW-------V 600 (682)
Q Consensus 540 ~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~---------~l~~~-------~ 600 (682)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. ..+.+ .
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 543 2345788999999999999999999999999999999999999865321100 00000 0
Q ss_pred HHHhhhccc--cccchhhhc---ccc---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 601 QSVVREEWT--AEVFDVELM---RFQ---NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 601 ~~~~~~~~~--~~~~d~~l~---~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......... ...+..... ... ........+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 000000000 000 012235567889999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=323.82 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=185.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC------------hhhHHHHHHHHHHhcCCCceeceEEEEEecC---
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG------------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--- 454 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--- 454 (682)
.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++.++ +||||+++++++...+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEEECCTTT
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEEeccCCC
Confidence 4789999999999999888999999998654321 15688999999999 8999999999986533
Q ss_pred --ceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEee
Q 005693 455 --EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 532 (682)
Q Consensus 455 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 532 (682)
..++||||++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred cceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEe
Confidence 5799999998 6888888743 235899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCCC---CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 533 FGLTPLMNVPA---TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 533 fGla~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
||+++...... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ ....+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN------QLNKIVEVVG 251 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHcC
Confidence 99997544332 3457888999999877 678999999999999999999999998643211 1111110000
Q ss_pred c---c-----------ccchhhhccc--c----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 609 T---A-----------EVFDVELMRF--Q----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 609 ~---~-----------~~~d~~l~~~--~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. . +......... . ........+.+++.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 0 0000000000 0 001123456788889999999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.77 Aligned_cols=242 Identities=19% Similarity=0.354 Sum_probs=193.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 458 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 458 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++.+||||+++++++..++..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 468999999999999986 478899999875421 134577899999999669999999999999999999
Q ss_pred EEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999743 34899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCC---CCCCCCcccCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 539 MNVPA---TPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 539 ~~~~~---~~~~~~~y~aPE~~~------~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
..... ...+++.|+|||++. ...++.++||||||+++|||++|+.||..... .............
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~ 247 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQ 247 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHHHhcCCcc
Confidence 54332 345788999999985 45678999999999999999999999975431 1111222211111
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.. . .........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~--~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 248 FG--S------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC--T------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cC--c------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00 0 011123345677888999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.62 Aligned_cols=254 Identities=17% Similarity=0.278 Sum_probs=193.5
Q ss_pred hccccccCeEEEEEEEEcC-C-ceEEEEEeeccccChhhHHHHHHHHHHhcCCCc------eeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEE-S-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN------VVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n------iv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|.... + +.||+|+++......+.+.+|++++.++ +|++ ++.+++++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 4689999999999999753 3 5799999976544456788899999888 5544 9999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe-------------------
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI------------------- 522 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl------------------- 522 (682)
|+ ++++.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 103 ~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 103 LL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred cc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccc
Confidence 99 667777776432 234899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCCC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 005693 523 NQDLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~ 601 (682)
+.++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL---VMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 66789999999999765443 3446889999999999999999999999999999999999999864422111 1111
Q ss_pred HHhhh---ccc-----ccc-------ch--------------hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 005693 602 SVVRE---EWT-----AEV-------FD--------------VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 652 (682)
Q Consensus 602 ~~~~~---~~~-----~~~-------~d--------------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 652 (682)
..... .+. ... ++ ...........+...+.+++.+||+.||++|||++|++
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 11000 000 000 00 00000011123455788899999999999999999998
Q ss_pred HH
Q 005693 653 RM 654 (682)
Q Consensus 653 ~~ 654 (682)
++
T Consensus 333 ~h 334 (355)
T 2eu9_A 333 LH 334 (355)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.87 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=192.7
Q ss_pred hccccccCeEEEEEEEEc--CCceEEEEEeecccc---ChhhHHHHHHHHHHhc--CCCceeceEEEEE-----ecCceE
Q 005693 390 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYY-----SKDEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~-----~~~~~~ 457 (682)
.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+.++..+. +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 468999999999999983 577899999875432 2346778888887764 7999999999987 456789
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+||||++ |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 96 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 9999998 69999997543 234899999999999999999999998 9999999999999999999999999997
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-------hc
Q 005693 538 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR-------EE 607 (682)
Q Consensus 538 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~-------~~ 607 (682)
..... ....+++.|+|||++.+..++.++||||||+++|||++|+.||.+....+ ....+.. ..
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCGGG
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHHcCCCCccc
Confidence 76532 23457889999999999999999999999999999999999998653211 1111111 11
Q ss_pred cccccchh--hhc------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 608 WTAEVFDV--ELM------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 608 ~~~~~~d~--~l~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
|......+ ... ...........+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11100000 000 000011223456677889999999999999999963
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.22 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=188.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCc------eEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lV~e~~ 463 (682)
.+.||+|+||.||+|+..++..+|+|++.... ....+|+++++.+ +||||+++++++..... .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCT---TSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---chHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 47899999999999999888889999986532 2334689999998 99999999999976543 78999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec-CCCCeEEeecCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~~~ 542 (682)
+++.+........ ....+++..+..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 8754433332111 1234899999999999999999999998 99999999999999 7999999999999765432
Q ss_pred ---CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH----------hhhcc
Q 005693 543 ---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV----------VREEW 608 (682)
Q Consensus 543 ---~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~----------~~~~~ 608 (682)
....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+. +....... ....+
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhh
Confidence 234578899999998765 589999999999999999999999986542211 11111100 00000
Q ss_pred ccccchhhhccccChH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005693 609 TAEVFDVELMRFQNIE-----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 659 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~ 659 (682)
....+. .. ...... .....+.+++.+||+.||++|||+.|++++ ++++.
T Consensus 274 ~~~~~~-~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 274 MEHKFP-QI-RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp SSSCCC-CC-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhhccc-cc-cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000000 00 000001 123467788889999999999999999984 55544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.77 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=190.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec-----CceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~e 461 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceEEEEEc
Confidence 468999999999999976 467899999975332 235688999999999 899999999999765 36799999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 997 5999998642 3899999999999999999999998 99999999999999999999999999976542
Q ss_pred C-------CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc---cc
Q 005693 542 P-------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW---TA 610 (682)
Q Consensus 542 ~-------~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~---~~ 610 (682)
. ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. ........... ..
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHhCCCCHHHHH
Confidence 2 23467899999998754 45899999999999999999999999865433221 11111100000 00
Q ss_pred ccch-------hhhc--cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 611 EVFD-------VELM--RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 611 ~~~d-------~~l~--~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+ .... .... .......+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000 0000 01123456788889999999999999999984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.09 Aligned_cols=252 Identities=16% Similarity=0.253 Sum_probs=195.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccCh------------------hhHHHHHHHHHHhcCCCceeceEEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK------------------RDFEQQMEIVGRVGQHPNVVPLRAYYY 451 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------~~~~~e~~~l~~l~~h~niv~l~~~~~ 451 (682)
.+.||+|+||.||+|.. +++.||+|++....... +.+.+|++++.++ +||||+++++++.
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 113 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCCCSEEEE
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcceEEEEEe
Confidence 46899999999999999 78999999997543221 7789999999999 8999999999999
Q ss_pred ecCceEEEEeeccCCchhHh------hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecC
Q 005693 452 SKDEKLLVYDYFASGSLSTL------LHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQ 524 (682)
Q Consensus 452 ~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~ 524 (682)
+.+..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ .+ |+||||||+||+++.
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK 187 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence 99999999999999999999 5432 13459999999999999999999999 87 999999999999999
Q ss_pred CCCeEEeecCCCCCCCCC--CCCCCCCcccCccccccC-CCCC-cchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 005693 525 DLDGCISDFGLTPLMNVP--ATPSRSAGYRAPEVIETR-KHSH-KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 600 (682)
Q Consensus 525 ~~~~kl~DfGla~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~ 600 (682)
++.+||+|||.+...... ....+++.|+|||++.+. .++. ++||||||+++|||++|+.||...... ....
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----VELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----HHHH
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHH
Confidence 999999999999765332 344578899999999887 5666 999999999999999999999864421 1112
Q ss_pred HHHhhhcccccc----chhhhcc---ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 601 QSVVREEWTAEV----FDVELMR---FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 601 ~~~~~~~~~~~~----~d~~l~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+......... ....... ..........+.+++.+||+.||++|||++|++++
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222111110000 0000000 00001223456778889999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.54 Aligned_cols=245 Identities=23% Similarity=0.363 Sum_probs=184.2
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||+||.+...+++.||||++.... .+.+.+|++++.++.+||||+++++++.+++..++||||++ |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 46799999999987777779999999986532 35678899999887789999999999999999999999996 6999
Q ss_pred HhhccCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-------------CCeEEeecC
Q 005693 470 TLLHGNRGAGR--TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-------------LDGCISDFG 534 (682)
Q Consensus 470 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-------------~~~kl~DfG 534 (682)
+++........ ...++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 99975432111 11233456789999999999999998 9999999999999754 489999999
Q ss_pred CCCCCCCCC--------CCCCCCcccCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhH
Q 005693 535 LTPLMNVPA--------TPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 598 (682)
Q Consensus 535 la~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~ 598 (682)
+++...... ...||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......+
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------ 247 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------ 247 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence 998765432 2357899999999975 568999999999999999999 999997432111
Q ss_pred HHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 599 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 599 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
..+.......... ...........+.+++.+||+.||++|||++|+++
T Consensus 248 --~~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111110000 11112344567788889999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=324.11 Aligned_cols=246 Identities=20% Similarity=0.325 Sum_probs=189.1
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|...+ .+|+|+++.... ..+.+.+|+.++.++ +|+||+++++++.+.+..++||||++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEeecccCC
Confidence 5789999999999998764 599999875432 235677899999998 8999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ ++.+||+|||+++.....
T Consensus 115 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 115 TLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp EHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 9999997532 34889999999999999999999998 99999999999998 679999999998654321
Q ss_pred -----CCCCCCCcccCcccccc---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 543 -----ATPSRSAGYRAPEVIET---------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 543 -----~~~~~~~~y~aPE~~~~---------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
....+++.|+|||++.. ..++.++||||||+++|||++|+.||...... ........ ..
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-~~ 259 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQMGT-GM 259 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHHHHT-TC
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHhcc-CC
Confidence 12236788999999864 34788999999999999999999999754321 11111111 11
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
...... .. ....+.+++.+||+.||++|||++|+++.|+++....
T Consensus 260 ~~~~~~------~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 KPNLSQ------IG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCC------SS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCc------CC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111100 01 1234667888999999999999999999999988654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.08 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=178.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.||+|++.... ...+++.+|++++.++ +||||+++++++..++..++||||+++|
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 478999999999999854 57889999986542 2345678888888888 8999999999999999999999999999
Q ss_pred chhHhhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-
Q 005693 467 SLSTLLHGNR---GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 467 ~L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 542 (682)
+|.+++.... ......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 9999986421 112345899999999999999999999998 999999999999999999999999988654322
Q ss_pred --------CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 --------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 --------~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+. .......... ..
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~-~~- 247 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQNDPP-SL- 247 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHTSSCC-CT-
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhccCCC-cc-
Confidence 22357889999999876 5689999999999999999999999976432211 1111111100 00
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
................+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000000011122356778889999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=346.55 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=196.7
Q ss_pred hccccccCeEEEEEEEEcC----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||.||+|.+.. +..||+|+++.... ..+.+.+|+.++.++ +||||+++++++. ++..++||||+
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cCceEEEEEcC
Confidence 5789999999999999753 35689998865432 235788999999999 9999999999984 56789999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 473 ~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 473 TLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp TTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999998765432
Q ss_pred C-----CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 T-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 ~-----~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
. ..+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+..... ..
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i~~~~~-~~------ 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGER-LP------ 612 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHHTCC-CC------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcCCC-CC------
Confidence 2 234678999999998899999999999999999997 99999754321 11111111110 00
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
........+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 613 ----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 613 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0112234567788899999999999999999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.68 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=187.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV~e~ 462 (682)
.+.||+|+||.||+|+.. +++.||||++... .....+|+++++++ +||||+++++++.... ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC---TTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---chhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 478999999999999986 4789999998653 23345799999999 9999999999986432 25789999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC-CCeEEeecCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNV 541 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~ 541 (682)
+++ ++.+.+..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 986 66666543211 1345899999999999999999999998 9999999999999965 5689999999976543
Q ss_pred C---CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hcc---ccc
Q 005693 542 P---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEW---TAE 611 (682)
Q Consensus 542 ~---~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~---~~~---~~~ 611 (682)
. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+......... +.+ ...
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCSC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChh
Confidence 2 234678999999999765 68999999999999999999999998653211 11111111000 000 000
Q ss_pred cchhhhcc--ccCh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 005693 612 VFDVELMR--FQNI-----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR 659 (682)
Q Consensus 612 ~~d~~l~~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i~ 659 (682)
..+..+.. .... ......+.+++.+||+.||++|||+.|+++ .++++.
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00000000 0000 112345778888999999999999999997 344443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=319.56 Aligned_cols=263 Identities=21% Similarity=0.295 Sum_probs=182.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCc-------eEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-------KLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-------~~lV~e 461 (682)
.+.||+|+||.||+|... +++.||||++...........++++.+..+ +||||+++++++..... .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEEEEee
Confidence 467999999999999985 578899999876555555677788888888 99999999999976544 789999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--SMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPL 538 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~ 538 (682)
|+++ +|.+.+..... ....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 107 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp CCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred cccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 9986 55444432111 2334889999999999999999999 877 999999999999997 89999999999987
Q ss_pred CCCCC---CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-----------HH
Q 005693 539 MNVPA---TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ-----------SV 603 (682)
Q Consensus 539 ~~~~~---~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~-----------~~ 603 (682)
..... ...+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+. +..... ..
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHH
T ss_pred cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHHcCCCCHHHHHhc
Confidence 65433 345788999999986654 89999999999999999999999986532211 111111 00
Q ss_pred hhhccccccchhhh-----ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 005693 604 VREEWTAEVFDVEL-----MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ 660 (682)
Q Consensus 604 ~~~~~~~~~~d~~l-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~~ 660 (682)
..........+... ............+.+++.+||+.||++|||++|++++ ++++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00000000000000 0000001134567788889999999999999999984 555543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=327.29 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=174.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec------CceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 459 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+++++.+ +||||+++++++... ...++|
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccCCeEEEE
Confidence 468999999999999965 5788999999754332 35677899999999 899999999999754 567999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
+||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 113 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 9999 6899998863 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC-CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ccccccch
Q 005693 540 NVP-ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTAEVFD 614 (682)
Q Consensus 540 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d 614 (682)
... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. .......... .....+..
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHTTCCC
T ss_pred cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHhhh
Confidence 543 23467899999999877 6789999999999999999999999986532111 1111111000 00000000
Q ss_pred h-------hhcc--ccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 V-------ELMR--FQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~-------~l~~--~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. .+.. ..... .....+.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000 00011 112456788889999999999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.82 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=188.8
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcC-CCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||++...+++.||+|++...... .+.+.+|++++.++.+ |+||+++++++..++..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 4689999999999999888999999999754333 3568899999999954 7999999999999999999999 668
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++ +.+||+|||+++......
T Consensus 112 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 112 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 8999999753 24899999999999999999999998 999999999999965 899999999998764332
Q ss_pred ----CCCCCCcccCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 544 ----TPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~-----------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
...+++.|+|||++.+ ..++.++||||||+++|||++|+.||..... .............
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~ 257 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNH 257 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTS
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhccc
Confidence 2357889999999875 4678899999999999999999999974321 1111222221111
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 656 (682)
... ..... ...+.+++.+||+.||++||+++|++++-.
T Consensus 258 ~~~-------~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 258 EIE-------FPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp CCC-------CCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccC-------Ccccc---hHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 100 01111 235667788999999999999999998543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.50 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=188.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEec---------------
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------------- 453 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------------- 453 (682)
.+.||+|+||.||+|... +++.||+|++.... ....+|+++++.+ +||||+++++++...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTC-CCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccc
Confidence 478999999999999974 57899999986542 3345789999998 999999999998543
Q ss_pred -----------------------CceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005693 454 -----------------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510 (682)
Q Consensus 454 -----------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 510 (682)
...++||||++ |+|.+.+..... ....+++..+..++.|++.||+|||+.+ |
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i 162 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG---I 162 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 23789999998 488777753211 1235899999999999999999999998 9
Q ss_pred EecCCCCCCeEec-CCCCeEEeecCCCCCCCCC---CCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCC
Q 005693 511 THGNIKASNVLIN-QDLDGCISDFGLTPLMNVP---ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 585 (682)
Q Consensus 511 vHrDLk~~NILl~-~~~~~kl~DfGla~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf 585 (682)
+||||||+||+++ .++.+||+|||+++..... ....+++.|+|||++.+.. ++.++||||+||++|||++|+.||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 9999999999998 6889999999999765433 2345788999999987654 899999999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHHhhhcccccc-------chhhhc--cccC-----hHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 005693 586 QSPTRDDMVDLPRWVQSVVREEWTAEV-------FDVELM--RFQN-----IEEEMVQMLQIGMACVAKVPDMRPNMDEV 651 (682)
Q Consensus 586 ~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~d~~l~--~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 651 (682)
.+....+. +...... ........+ .+.... .... .......+.+++.+||+.||++|||++|+
T Consensus 243 ~~~~~~~~--~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 243 SGETSIDQ--LVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CCSSHHHH--HHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCChHHH--HHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 86532211 1111110 000000000 000000 0000 01123456788889999999999999999
Q ss_pred HH--HHHHhhh
Q 005693 652 VR--MIEEVRQ 660 (682)
Q Consensus 652 l~--~L~~i~~ 660 (682)
++ .++++..
T Consensus 320 l~hp~f~~~~~ 330 (383)
T 3eb0_A 320 MAHPFFDHLRN 330 (383)
T ss_dssp HTSGGGHHHHH
T ss_pred hcCHHHHHHHh
Confidence 97 4555544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.64 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=187.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCce------EEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK------LLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------~lV 459 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++..+ +||||+++++++...+.. ++|
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccceeEEEE
Confidence 468999999999999975 4788999999765433 35678899999999 899999999999877655 999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+. |+|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99997 589888742 2899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC-CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------ccccc
Q 005693 540 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------EWTAE 611 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~------~~~~~ 611 (682)
.... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ ....+... .+...
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD------QLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCHHHHTT
T ss_pred ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCcHHHHHH
Confidence 5433 3467899999999987 678999999999999999999999998643211 11111110 00000
Q ss_pred cch-------hhhc--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFD-------VELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d-------~~l~--~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+ .... ..... ......+.+++.+||+.||++|||++|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 0000 00000 1123467788889999999999999999984
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.96 Aligned_cols=239 Identities=21% Similarity=0.342 Sum_probs=187.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc-----cChhhHHHHHHHHHHhcCCCceeceEEEEE--ecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYY--SKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~--~~~~~~lV~e 461 (682)
.+.||+|+||.||++... +++.+|+|+++... ...+.+.+|++++.++ +||||+++++++. +....++|||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CEEEEEE
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 468999999999999975 57789999997542 2246788999999999 8999999999985 4457899999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|++++ |.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99876 777776433 234899999999999999999999998 99999999999999999999999999876542
Q ss_pred C------CCCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 542 P------ATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 542 ~------~~~~~~~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
. ....+++.|+|||++.+.. ++.++||||||+++|||++|+.||.... .......+......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~~~---- 231 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKGSYA---- 231 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCC----
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcCCCC----
Confidence 2 2345788999999997644 3779999999999999999999997542 11222222111110
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... .....+.+++.+||+.||++|||++|++++
T Consensus 232 -----~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 -----IPG---DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCS---SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCC---ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011 123356677889999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=317.89 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=188.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec-----CceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~e 461 (682)
.+.||+|+||.||+|... +++.||+|++..... ....+.+|++++.++ +||||+++++++... ...++|||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceEEEEEe
Confidence 468999999999999976 578899999964322 234677899999999 899999999998754 57899999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+. |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 997 5999998742 3899999999999999999999998 99999999999999999999999999976542
Q ss_pred C--------------CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 005693 542 P--------------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 606 (682)
Q Consensus 542 ~--------------~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 606 (682)
. ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCC
Confidence 1 12356888999998764 6789999999999999999999999986532110 0000000000
Q ss_pred cc----ccccchh-------hhcc--ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 607 EW----TAEVFDV-------ELMR--FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 607 ~~----~~~~~d~-------~l~~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ....... .+.. ... .......+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0000000 0000 000 01223456778889999999999999999983
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.90 Aligned_cols=241 Identities=21% Similarity=0.334 Sum_probs=192.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 578999999999999986 578899999975533 356788999999999 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC---CCeEEeecCCCCCCCCC
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVP 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~~~~~~ 542 (682)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||++......
T Consensus 106 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999988643 24899999999999999999999998 9999999999999764 46999999998776543
Q ss_pred CCC---CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 ATP---SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 ~~~---~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
... .+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+.... .....+........ ...
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~-----~~~ 245 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAFD-----LPQ 245 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCC-----SGG
T ss_pred CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCCC-----chh
Confidence 322 25677999999875 4899999999999999999999999754321 11222221111100 011
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
... ....+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~---~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 WRT---ISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp GTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhh---cCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 111 23456677889999999999999999983
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.26 Aligned_cols=241 Identities=21% Similarity=0.357 Sum_probs=184.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe-------------cCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-------------KDE 455 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-------------~~~ 455 (682)
.+.||+|+||.||+|+.. +++.||+|++.......+.+.+|++++.++ +||||+++++++.+ ...
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 478999999999999975 678999999976544456788999999999 89999999999865 346
Q ss_pred eEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 456 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 456 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcc
Confidence 789999999999999997432 34788999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCC------------------CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 005693 536 TPLMNVP------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 596 (682)
Q Consensus 536 a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l 596 (682)
+...... ....+++.|+|||++.+. .++.++||||||+++|||++ ||.... +.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~ 234 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ER 234 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hH
Confidence 9765421 123467889999999764 68999999999999999998 553211 00
Q ss_pred hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 597 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
............ .+... ........+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKKLRSVSI---EFPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHSTTC---CCCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcccccc---ccCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111000 00000 111223456778889999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.84 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=187.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCc------eEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lV 459 (682)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++..+ +||||+++++++..... .++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccceeEEEE
Confidence 467999999999999975 5788999999764333 34678899999999 89999999999987654 4999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+. |+|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp EECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred ecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 99997 588888742 3899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC-CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------ccccc
Q 005693 540 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------EWTAE 611 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~------~~~~~ 611 (682)
.... ...+++.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+ ....+... .+...
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD------QLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH------HHHHHHHHHCBCCHHHHTT
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCCHHHHHH
Confidence 5432 3457889999999877 678999999999999999999999998643211 11111110 00000
Q ss_pred cchh-------hh-----cc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDV-------EL-----MR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~-------~l-----~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+. .+ .. ..........+.+++.+|++.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00 00 00111234566778889999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.32 Aligned_cols=233 Identities=21% Similarity=0.379 Sum_probs=189.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-------ChhhHHHHHHHHHHhcC-CCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++.++.+ |+||+++++++..++..++||
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 478999999999999864 578899999976532 22567789999999953 799999999999999999999
Q ss_pred eeccC-CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec-CCCCeEEeecCCCCC
Q 005693 461 DYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPL 538 (682)
Q Consensus 461 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~ 538 (682)
||+.+ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+||+|||+++.
T Consensus 128 e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 128 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 99986 8999999742 24899999999999999999999998 99999999999999 789999999999976
Q ss_pred CCCCC--CCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 539 MNVPA--TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 539 ~~~~~--~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
..... ...+++.|+|||++.+..+ +.++||||||+++|||++|+.||.... .......
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~------- 260 (320)
T 3a99_A 200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV------- 260 (320)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC-------
T ss_pred cccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcccc-------
Confidence 65432 3457889999999987766 678999999999999999999996421 0011100
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...... ...+.+++.+||+.||++|||++|++++
T Consensus 261 --~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 --FFRQRV---SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CCSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cccccC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111 2346677789999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=313.74 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=171.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||.||+|... +++.||+|+++.... ...++..|+..+.+..+||||+++++++..++..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 468999999999999985 578899999976432 2334556666455544999999999999999999999999985
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+|.+++..........+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 182 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence 888777532111234589999999999999999999998 8 9999999999999999999999999997764432
Q ss_pred -CCCCCCcccCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 544 -TPSRSAGYRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 544 -~~~~~~~y~aPE~~----~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
...+++.|+|||++ .+..++.++||||||+++|||++|+.||........ ......... . +.+.
T Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-~-----~~~~ 251 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVKGD-P-----PQLS 251 (327)
T ss_dssp -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSC-C-----CCCC
T ss_pred ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhcCC-C-----CCCC
Confidence 23578889999998 456689999999999999999999999975431100 000000000 0 0000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..........+.+++.+||+.||++|||++|++++
T Consensus 252 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 252 -NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00001123456778889999999999999999883
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.69 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=181.7
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEE--------------ec
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYY--------------SK 453 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~--------------~~ 453 (682)
.+.||+|+||.||+|.... ++.||+|++..... ..+.+.+|++++.++ +||||+++++++. +.
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccccccccc
Confidence 4689999999999999875 78899999875432 245688999999999 9999999999874 34
Q ss_pred CceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec-CCCCeEEee
Q 005693 454 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISD 532 (682)
Q Consensus 454 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~D 532 (682)
...++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+||+|
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECC
T ss_pred CceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEcc
Confidence 57799999998 699999963 24899999999999999999999998 99999999999997 567999999
Q ss_pred cCCCCCCCCCC-------CCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 005693 533 FGLTPLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 604 (682)
Q Consensus 533 fGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~ 604 (682)
||+++...... ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+ ....+.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~~ 238 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE------QMQLIL 238 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 99998764321 1235778999998865 678999999999999999999999998653211 111111
Q ss_pred hhccc-------------cccchhhhccc-cCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 605 REEWT-------------AEVFDVELMRF-QNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 605 ~~~~~-------------~~~~d~~l~~~-~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... ........... ... ......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 10000 00000000000 000 1123456778889999999999999999884
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=326.06 Aligned_cols=239 Identities=21% Similarity=0.350 Sum_probs=180.9
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||+||.....+++.||||++.... ...+.+|++++..+.+||||+++++++.+.+..++||||+. |+|.
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 46899999999776666778999999986532 23467899999998789999999999999999999999996 5999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-----CCCeEEeecCCCCCCCCC--
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----DLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-----~~~~kl~DfGla~~~~~~-- 542 (682)
+++..... ...+..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred HHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 99975432 2444556789999999999999998 999999999999953 336789999999766432
Q ss_pred -----CCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 543 -----ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 -----~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
....||+.|+|||++. ...++.++|||||||++|||++ |..||...... ........ .....
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~-~~~~~- 249 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGA-CSLDC- 249 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTC-CCCTT-
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhcc-CCccc-
Confidence 2345899999999997 4567889999999999999999 99999643211 11111111 00000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
..........+.+++.+||+.||++|||++|+++
T Consensus 250 ------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 ------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111123344677888999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.93 Aligned_cols=241 Identities=18% Similarity=0.302 Sum_probs=170.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccCh--hhHHHHHH-HHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK--RDFEQQME-IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~e~~-~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||.||+|... +++.||+|++....... .++..|.. ++..+ +||||+++++++.+++..++||||+ +
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecc-C
Confidence 468999999999999986 57899999997653322 23333443 44455 9999999999999999999999999 4
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+.+..+.... ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++.......
T Consensus 108 ~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 108 TCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 5555555422 23489999999999999999999995 7 9999999999999999999999999987654332
Q ss_pred --CCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 544 --TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
...+++.|+|||++. ...++.++||||||+++|||++|+.||..... .............. .
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~------~ 249 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEEPP------L 249 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSCCC------C
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccCCC------C
Confidence 335788999999994 45688999999999999999999999975321 11122222221110 0
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
...... ....+.+++.+||+.||++||+++|+++
T Consensus 250 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPGHMG---FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccCC---CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 001111 2234667778999999999999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=301.55 Aligned_cols=230 Identities=13% Similarity=0.099 Sum_probs=177.9
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccCh----hhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|.... ++.||+|++....... +.+.+|+.++.++ +||||+++++++..++..|+||||++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 114 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIR 114 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEEEEecC
Confidence 4689999999999999865 7889999997654332 5688899999988 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
+++|.+++... ....++.+++.|++.||+|||+++ |+||||||+|||+++++.+||+++|
T Consensus 115 g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 115 GGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred CCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999531 355678899999999999999998 9999999999999999999998554
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
|++ .++.++|||||||++|||+||+.||.+....+..... .................
T Consensus 175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-- 231 (286)
T 3uqc_A 175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQPIEPADIDRD-- 231 (286)
T ss_dssp ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSCBCCHHHHCTT--
T ss_pred ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccCCCChhhcccC--
Confidence 333 3688999999999999999999999876543321000 00000000000000111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 665 (682)
....+.+++.+||+.||++| |++|+++.|+++.......
T Consensus 232 -~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 232 -IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp -SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred -CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 22346677889999999999 9999999999998766543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.85 Aligned_cols=233 Identities=23% Similarity=0.387 Sum_probs=184.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-------ChhhHHHHHHHHHHhc---CCCceeceEEEEEecCceEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVG---QHPNVVPLRAYYYSKDEKLL 458 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~---~h~niv~l~~~~~~~~~~~l 458 (682)
.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.++.++. +|+||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 578999999999999864 578899999965432 2234667888888875 79999999999999999999
Q ss_pred EEee-ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec-CCCCeEEeecCCC
Q 005693 459 VYDY-FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLT 536 (682)
Q Consensus 459 V~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla 536 (682)
|||| +.+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+||+|||++
T Consensus 116 v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 9999 7899999999743 24899999999999999999999998 99999999999999 8899999999998
Q ss_pred CCCCCC--CCCCCCCcccCccccccCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 537 PLMNVP--ATPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 537 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
...... ....++..|+|||++.+..+. .++||||||+++|||++|+.||.... ......
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~------ 249 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAE------ 249 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTC------
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhc------
Confidence 766543 234578899999999877664 58999999999999999999996421 001000
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... .....+.+++.+||+.||++|||++|++++
T Consensus 250 ---~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 ---LHFPA---HVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---CCCCT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---cCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011 122346677889999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.95 Aligned_cols=228 Identities=18% Similarity=0.284 Sum_probs=175.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|... +++.||+|+++. ...+.+|++++.+..+||||+++++++.. +...++||||++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 367999999999999974 578899999864 35678899988777799999999999987 667899999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNV 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~ 541 (682)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 99 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp SCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999997643 235899999999999999999999998 999999999999998 7889999999986432
Q ss_pred CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 542 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 542 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
+..++.++|||||||++|||++|+.||......+.... .................
T Consensus 172 -----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~- 226 (299)
T 3m2w_A 172 -----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIRMGQYEFPNPEW- 226 (299)
T ss_dssp -----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------SCCSSCTTCCSSCHHHH-
T ss_pred -----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------HHHHHhhccccCCchhc-
Confidence 24577899999999999999999999975432221000 00000000000000000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
......+.+++.+||+.||++|||++|++++-
T Consensus 227 --~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 227 --SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --ccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 11234567788899999999999999999843
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=336.03 Aligned_cols=233 Identities=18% Similarity=0.266 Sum_probs=188.7
Q ss_pred hccccccCeEEEEEEEEc--CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCc-----eEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lV~ 460 (682)
.+.||+|+||.||+|.+. +++.||||++..... ....+.+|++++.++ +||||+++++++...+. .|+||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 468999999999999986 578899999865322 234678899999999 89999999999988766 69999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++...
T Consensus 164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999987752 4899999999999999999999998 9999999999999986 89999999998877
Q ss_pred CCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 541 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 541 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
......||++|+|||++.+. ++.++|||||||++|||++|..||.+........ .
T Consensus 233 ~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~------------------------~ 287 (681)
T 2pzi_A 233 SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE------------------------D 287 (681)
T ss_dssp CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT------------------------T
T ss_pred cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccc------------------------c
Confidence 76677799999999998765 4889999999999999999999887532211100 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHHhh
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVRMIEEVR 659 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~L~~i~ 659 (682)
.........+.+++.+||+.||++||+ ++++.+.|..+.
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 001122345678888999999999995 666777666554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=330.04 Aligned_cols=262 Identities=19% Similarity=0.272 Sum_probs=196.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEe------cCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lV~ 460 (682)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.. ++..++||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeEEEEE
Confidence 578999999999999974 578899999875422 245688999999999 99999999999765 66779999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCC---eEEeecCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTP 537 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~ 537 (682)
||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 99999999999986432 234888999999999999999999998 999999999999997765 8999999998
Q ss_pred CCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH--------hhh
Q 005693 538 LMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV--------VRE 606 (682)
Q Consensus 538 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 606 (682)
...... ...+++.|+|||++.+..++.++||||||+++|||++|..||.+.... ..|.... ...
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------CCSC
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchhhhhh
Confidence 765433 345788999999999999999999999999999999999999753110 0000000 000
Q ss_pred ccccc--cchhhhccc-cChHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHHhhhcC
Q 005693 607 EWTAE--VFDVELMRF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDE-----VVRMIEEVRQSD 662 (682)
Q Consensus 607 ~~~~~--~~d~~l~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e-----vl~~L~~i~~~~ 662 (682)
..... .+....... .........+.+++.+||+.||++|||++| ..+.++.+....
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000 000000000 111234556778888999999999999988 556677766544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=311.28 Aligned_cols=236 Identities=13% Similarity=0.132 Sum_probs=172.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc----ChhhHHHHHHHHHHhcCC-Cceec------------------
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQH-PNVVP------------------ 445 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h-~niv~------------------ 445 (682)
.+.||+|+||+||+|.+. +++.||||++..... ..+.+++|+.++..+ +| +|...
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhhcccCC
Confidence 468999999999999965 578999999873322 246788899888877 44 32111
Q ss_pred ---eEEEEEe-----cCceEEEEeeccCCchhHhhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 005693 446 ---LRAYYYS-----KDEKLLVYDYFASGSLSTLLHGNR--GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI 515 (682)
Q Consensus 446 ---l~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDL 515 (682)
+..++.. ....+++|+++ +|+|.+++.... ......+++..++.++.|+++||+|||+++ |+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 1111111 12346666655 679999884211 012334788899999999999999999998 999999
Q ss_pred CCCCeEecCCCCeEEeecCCCCCCCCCC-CCCCCCcccCcccc----------ccCCCCCcchHHHHHHHHHHHHhCCCC
Q 005693 516 KASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVI----------ETRKHSHKSDVYSFGVLLLEMLTGKAP 584 (682)
Q Consensus 516 k~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~----------~~~~~~~~sDvwS~Gvvl~elltg~~P 584 (682)
||+|||++.++.+||+|||+++...... ...| +.|+|||++ ....++.++|||||||++|||++|+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999987665432 3456 899999999 555688999999999999999999999
Q ss_pred CCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 585 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 585 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
|......+... ..+......+ ..+.+++.+||+.||++||++.|+++
T Consensus 317 f~~~~~~~~~~-------------------~~~~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 317 NTDDAALGGSE-------------------WIFRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCTTGGGSCSG-------------------GGGSSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchhhhHH-------------------HHHhhcccCC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 97654332211 1111111222 45677778999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=293.89 Aligned_cols=238 Identities=13% Similarity=0.168 Sum_probs=180.8
Q ss_pred HhhccccccCeEEEEEEEEcCCceEEEEEeecccc---------ChhhHHHHHHHHHHhc--------CCCceeceEEEE
Q 005693 388 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVG--------QHPNVVPLRAYY 450 (682)
Q Consensus 388 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~--------~h~niv~l~~~~ 450 (682)
...+.||+|+||+||+|+. +++.||+|+++.... ..+.+.+|+++++.+. +||||+++.+.+
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 3468899999999999998 579999999976532 1267899999999885 488888888775
Q ss_pred E------------------------------ecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 005693 451 Y------------------------------SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 500 (682)
Q Consensus 451 ~------------------------------~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~ 500 (682)
. .++..++||||+++|++.+.+.+ ..+++..++.++.||+.||+
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence 3 26788999999999987777642 23899999999999999999
Q ss_pred HHH-hcCCCCcEecCCCCCCeEecCCC--------------------CeEEeecCCCCCCCCCCCCCCCCcccCcccccc
Q 005693 501 HIH-SMGGPKFTHGNIKASNVLINQDL--------------------DGCISDFGLTPLMNVPATPSRSAGYRAPEVIET 559 (682)
Q Consensus 501 ~LH-~~~~~~ivHrDLk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~ 559 (682)
||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++.+
T Consensus 176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCC
T ss_pred HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcC
Confidence 999 888 99999999999999887 8999999999876543 3468999999999987
Q ss_pred CCCCCcchHHHHHHH-HHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcc
Q 005693 560 RKHSHKSDVYSFGVL-LLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACV 638 (682)
Q Consensus 560 ~~~~~~sDvwS~Gvv-l~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl 638 (682)
.. +.++||||+|++ .+++++|..||.. ..|.......-........ .............+.+++.+||
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKT-KCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSS-CCCSHHHHHHHHHHHHHHHHGG
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCc-ccchhhhhhcCHHHHHHHHHHh
Confidence 66 889999998777 7889999999852 1121111111000000000 0001112345667888889999
Q ss_pred cCCCCCCCCHHHHH
Q 005693 639 AKVPDMRPNMDEVV 652 (682)
Q Consensus 639 ~~dP~~RPt~~evl 652 (682)
+.| |++|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 976 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-28 Score=278.55 Aligned_cols=181 Identities=17% Similarity=0.104 Sum_probs=127.6
Q ss_pred cccccCeEEEEEEE-EcCCceEEEEEeeccc-----------cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 392 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVV-----------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-----------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
..+.|++|.+..++ .--|..+++|++.... ...++|.+|++++.++.+|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666654 3347889999996542 12356899999999998999999999999999999999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||++||+|.+++... .+++.. +|+.||+.||+|+|++| ||||||||+|||+++++.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999743 236554 58899999999999999 999999999999999999999999999876
Q ss_pred CCCCC----CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 005693 540 NVPAT----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584 (682)
Q Consensus 540 ~~~~~----~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~P 584 (682)
..... ..||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 54432 247889999999975 467789999999998887665444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=247.20 Aligned_cols=189 Identities=36% Similarity=0.672 Sum_probs=169.6
Q ss_pred cCChhHHHHHHHHHHhCCCCC-CcCCCCCCCCCCC--cceEEecCCC--CeEEEEEeCCCcccc--cCCccccCCCCCCc
Q 005693 72 ADLNSDRQALLDFADAVPHLR-KLNWSSTNPICQS--WVGINCTQDR--TRVFGLRLPGIGLVG--PIPNNTLGKLDALE 144 (682)
Q Consensus 72 ~~~~~~~~al~~~~~~~~~~~-~~~w~~~~~~c~~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~lp~~~~~~l~~L~ 144 (682)
.|.++|+.||++||+++.+.. ..+|+.+.++| . |.||.|+... ++|+.|+|+++++.| .+|+ .++++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C-~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCC-cCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence 466789999999999996543 34898776777 5 9999998654 799999999999999 8998 799999999
Q ss_pred EEEccC-CCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCC
Q 005693 145 VLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 221 (682)
Q Consensus 145 ~L~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N 221 (682)
+|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..+. ++|++|+|++|+|++.+|..|+++++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 999999999999999999999999999999999887 89999999999999999999999999999999999
Q ss_pred cccCCCCCC--CCC-CCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 222 NLSGSIPNF--DIP-KLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 222 ~l~g~~p~~--~l~-~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+++|.+|.. .++ +|+.|+|++|++++.+|..+..++ |+.++
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~ 203 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVD 203 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEE
Confidence 999988874 776 999999999999999999888765 55443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-25 Score=249.77 Aligned_cols=177 Identities=16% Similarity=0.210 Sum_probs=144.2
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||+||+|.. .++.+++|+....... .+.+.+|++++.++ +||||+++..++...+..++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEEEE
Confidence 56899999999999954 4678888886543221 23478999999999 9999997777777888889999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++.. +..++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+++...
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999963 4579999999999999998 999999999999999 99999999998876
Q ss_pred CCC-----------CCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 005693 541 VPA-----------TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQ 586 (682)
Q Consensus 541 ~~~-----------~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltg~~Pf~ 586 (682)
... ...||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 532 2347899999999986 568888999999999999888887774
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=256.01 Aligned_cols=190 Identities=24% Similarity=0.349 Sum_probs=155.7
Q ss_pred cccCChhHHHHHHHHHHhCCCC-CCcCCCCCCCCCCCcceEEecCCCCeEEEEEeCCCccccc---CCc-----------
Q 005693 70 AFADLNSDRQALLDFADAVPHL-RKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP---IPN----------- 134 (682)
Q Consensus 70 ~~~~~~~~~~al~~~~~~~~~~-~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~---lp~----------- 134 (682)
+..+.++|++||++||+++.+. ...+|+.+.+|| +|.||+|+ .++|+.|+|+++++.|. +|+
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 3445678999999999998543 344898666666 89999998 58999999999999987 543
Q ss_pred -----------cccCCCCCCcEEEccCCCCCCCCCC--cCCCCCCCcEEeecccccCCcCCCCcc---cccceeeccccc
Q 005693 135 -----------NTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLDLSFNS 198 (682)
Q Consensus 135 -----------~~~~~l~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~L~~L~ls~N~ 198 (682)
..++++++|++|||++|.++|.+|. .++++++|++|+|++|.+++.+|..+. ++|++|+|++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 3688999999999999999999998 899999999999999999999998762 789999999999
Q ss_pred CcccCCcc---hhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 199 FTGNIPQS---IQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 199 l~g~~p~~---~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+++..|.. ++++++|+.|+|++|++++.+|...+++|++|+|++|++++.+|. ++++++|+.++
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~ 229 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLD 229 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEE
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEE
Confidence 99888877 778888888888888888777766777777777777777776666 66666665543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-24 Score=250.33 Aligned_cols=184 Identities=26% Similarity=0.458 Sum_probs=162.3
Q ss_pred hhHHHHHHHHHHhCCCCCC----------cCCCCCCCCCCCc---ceEEecCCCCeEEEEEeCCCcccccCCccccCCCC
Q 005693 75 NSDRQALLDFADAVPHLRK----------LNWSSTNPICQSW---VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLD 141 (682)
Q Consensus 75 ~~~~~al~~~~~~~~~~~~----------~~w~~~~~~c~~w---~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~ 141 (682)
..|+.||.++++++..... .+|+.+.++| .| .||+|+.. ++|+.|+|+++++.|.+|+ .+++|+
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~-~l~~L~ 105 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPD-AIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT-CCEEEEECTTSCCEEEECG-GGGGCT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC-CCEEEEEecCcccCCcCCh-HHhcCc
Confidence 4699999999999854321 2698776766 89 99999865 8999999999999999998 899999
Q ss_pred CCcEEEccCCC---------------------------------------------------------------------
Q 005693 142 ALEVLSLRSNV--------------------------------------------------------------------- 152 (682)
Q Consensus 142 ~L~~L~L~~N~--------------------------------------------------------------------- 152 (682)
+|++|+|++|.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 99999999884
Q ss_pred ---------CCCCCCCcCCCCCCCcEEeecccccCCc-----------------CCCCcc----cccceeecccccCccc
Q 005693 153 ---------LTGGLPSEITSLPSLRYLYLQHNNFSGK-----------------IPSSFS----PQLVVLDLSFNSFTGN 202 (682)
Q Consensus 153 ---------l~g~~p~~~~~l~~L~~L~L~~N~l~g~-----------------~p~~~~----~~L~~L~ls~N~l~g~ 202 (682)
|+| +|+.|+++++|++|+|++|+|+|. +|..++ ++|++|+|++|+++|.
T Consensus 186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 445 899999999999999999999996 898876 7899999999999999
Q ss_pred CCcchhhhccccceeccCCc-ccC-CCCCC--CC------CCCCeEEecccCCCCCCCc--cccCCCCCCCCC
Q 005693 203 IPQSIQNLTQLTGLSLQSNN-LSG-SIPNF--DI------PKLRHLNLSYNGLKGSIPS--SLQKFPNSSFVG 263 (682)
Q Consensus 203 ~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~--~l------~~L~~l~ls~N~l~g~~p~--~~~~l~~l~~~~ 263 (682)
+|..|+++++|+.|+|++|+ ++| .+|.. .+ ++|+.|+|++|+++ .+|. .++++++|+.++
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~ 336 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLE 336 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEE
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEe
Confidence 99999999999999999998 998 78763 44 89999999999999 8998 888888887665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=254.25 Aligned_cols=184 Identities=27% Similarity=0.467 Sum_probs=161.3
Q ss_pred ChhHHHHHHHHHHhCCCCCCcCCCCCC-----CC-CCCc------------ceEEecCCCCeEEEEEeCCCcccccCCcc
Q 005693 74 LNSDRQALLDFADAVPHLRKLNWSSTN-----PI-CQSW------------VGINCTQDRTRVFGLRLPGIGLVGPIPNN 135 (682)
Q Consensus 74 ~~~~~~al~~~~~~~~~~~~~~w~~~~-----~~-c~~w------------~gv~C~~~~~~v~~l~l~~~~l~g~lp~~ 135 (682)
...|+.||++||+++... +|+.+. ++ +|+| .||.|+. .++|+.|+|+++++.|.+|+
T Consensus 267 ~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~- 341 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD- 341 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG-
T ss_pred chHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch-
Confidence 356999999999999654 686554 34 2599 9999986 58999999999999999998
Q ss_pred ccCCCCCCcEEEc-cCCCCCCC----------------------------------------------------------
Q 005693 136 TLGKLDALEVLSL-RSNVLTGG---------------------------------------------------------- 156 (682)
Q Consensus 136 ~~~~l~~L~~L~L-~~N~l~g~---------------------------------------------------------- 156 (682)
.|++|++|++|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 7999999999999 77766554
Q ss_pred ------------------CCCcCCCCCCCcEEeecccccCC-----------------cCCCCcc----cccceeecccc
Q 005693 157 ------------------LPSEITSLPSLRYLYLQHNNFSG-----------------KIPSSFS----PQLVVLDLSFN 197 (682)
Q Consensus 157 ------------------~p~~~~~l~~L~~L~L~~N~l~g-----------------~~p~~~~----~~L~~L~ls~N 197 (682)
+|..|++|++|++|+|++|+|+| .+|..++ ++|++|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 88899999999999999999998 4898875 79999999999
Q ss_pred cCcccCCcchhhhccccceeccCCc-ccC-CCCCC---------CCCCCCeEEecccCCCCCCCc--cccCCCCCCCCC
Q 005693 198 SFTGNIPQSIQNLTQLTGLSLQSNN-LSG-SIPNF---------DIPKLRHLNLSYNGLKGSIPS--SLQKFPNSSFVG 263 (682)
Q Consensus 198 ~l~g~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~---------~l~~L~~l~ls~N~l~g~~p~--~~~~l~~l~~~~ 263 (682)
+++|.+|..|++|++|+.|+|++|+ ++| .+|.. .+++|+.|+|++|+++ .+|. .++++++|..++
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~ 579 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLD 579 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEE
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEE
Confidence 9999999999999999999999998 998 77742 4569999999999999 8998 888888877664
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-22 Score=210.90 Aligned_cols=186 Identities=18% Similarity=0.316 Sum_probs=150.3
Q ss_pred ccCChhHHHHHHHHHHhCC-CCC--CcCCC----CCCCCCCCcceEEecC--------CCCeEEEEEeCCCcccccCCcc
Q 005693 71 FADLNSDRQALLDFADAVP-HLR--KLNWS----STNPICQSWVGINCTQ--------DRTRVFGLRLPGIGLVGPIPNN 135 (682)
Q Consensus 71 ~~~~~~~~~al~~~~~~~~-~~~--~~~w~----~~~~~c~~w~gv~C~~--------~~~~v~~l~l~~~~l~g~lp~~ 135 (682)
..+..+++.||++||.++. +.. ..+|. ...++| .|.|+.|.. ...+|+.|+|++|++. .+|+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~- 98 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD- 98 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS-
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh-
Confidence 3456789999999999772 222 23783 344555 899999952 3468999999999998 8888
Q ss_pred ccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhh----
Q 005693 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQN---- 209 (682)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~---- 209 (682)
.++++++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..+. ++|++|+|++|++.+.+|..++.
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~ 176 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence 6888999999999999999 89999999999999999999998 7888776 78999999999888888887765
Q ss_pred -----hccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 210 -----LTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 210 -----l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+++|+.|+|++|+|+ .+|.. .+++|+.|+|++|++++ +|+.++++++|+.++
T Consensus 177 ~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235 (328)
T ss_dssp CCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred hhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence 888999999999888 66653 78888999999998884 666777777776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=200.73 Aligned_cols=151 Identities=19% Similarity=0.240 Sum_probs=118.7
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc-------------------ChhhHHHHHHHHHHhcCCCceeceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-------------------GKRDFEQQMEIVGRVGQHPNVVPLRAYY 450 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~~h~niv~l~~~~ 450 (682)
.+.||+|+||.||+|...+++.||+|.++.... ....+.+|++++.++. | +++.+++
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~v~~~~ 170 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LAVPKVY 170 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SSSCCEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CCcCeEE
Confidence 378999999999999997789999999964321 1345889999999994 4 5555554
Q ss_pred EecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEE
Q 005693 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 530 (682)
Q Consensus 451 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 530 (682)
.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+.+ |+||||||+|||++ ++.+||
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEE
T ss_pred ec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEE
Confidence 43 56799999999999998 531 124469999999999999998 99999999999999 999999
Q ss_pred eecCCCCCCCCCCCCCCCCcccCcccccc----------CCCCCcchHHH
Q 005693 531 SDFGLTPLMNVPATPSRSAGYRAPEVIET----------RKHSHKSDVYS 570 (682)
Q Consensus 531 ~DfGla~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~sDvwS 570 (682)
+|||+|+.. ..++|||++.. ..+...+|+|.
T Consensus 234 ~DFG~a~~~---------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 234 IDFPQSVEV---------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCCTTCEET---------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EECCCCeEC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999998643 34789998754 34455566654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.4e-22 Score=231.66 Aligned_cols=160 Identities=36% Similarity=0.638 Sum_probs=119.8
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcC-----------------------------------
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI----------------------------------- 161 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~----------------------------------- 161 (682)
++..|+|++|.++|.+|. .++++++|+.|+|++|.++|.+|..+
T Consensus 515 ~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (768)
T 3rgz_A 515 NLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593 (768)
T ss_dssp TCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred CCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence 455666666666666665 56666777777777766666655432
Q ss_pred -----------------------------------CCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCC
Q 005693 162 -----------------------------------TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP 204 (682)
Q Consensus 162 -----------------------------------~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p 204 (682)
.++++|+.|||++|+++|.+|..++ ++|+.|+|++|+|+|.+|
T Consensus 594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip 673 (768)
T 3rgz_A 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 673 (768)
T ss_dssp EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC
Confidence 2345677777777777777777776 678888888888888888
Q ss_pred cchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCcc--ccCCCCCCCCCCCCCCCCCCCCCCC
Q 005693 205 QSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKACFP 277 (682)
Q Consensus 205 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~--~~~l~~l~~~~n~~~~~~~l~~c~~ 277 (682)
..|++|++|+.|+|++|+++|.+|.. .+++|+.|||++|+|+|.+|.. +..++.+.|.+|+++||.|+..|..
T Consensus 674 ~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 88888888888888888888888864 7888888888888888888864 5677778899999999988877743
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.82 E-value=7.6e-20 Score=184.83 Aligned_cols=151 Identities=25% Similarity=0.252 Sum_probs=126.0
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.+..|+|++|++++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|. ++|++|+|
T Consensus 36 ~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDA-TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCCCCTT-TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCccCHh-HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 477899999999865544 799999999999999999988888899999999999999999976666665 78999999
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCC---CCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF---VGNSLLC 268 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~---~~n~~~~ 268 (682)
++|+|++..+..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..+..+.++++|+. .+|+..|
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 999999777777899999999999999999777743 7899999999999999777777777666554 4555544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-19 Score=177.31 Aligned_cols=148 Identities=27% Similarity=0.272 Sum_probs=69.5
Q ss_pred CCCCCCCCCCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCC
Q 005693 96 WSSTNPICQSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPS 166 (682)
Q Consensus 96 w~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 166 (682)
|......| +|.+|.|+... .+++.|+|++|++++..|. .|.++++|++|+|++|+|++..+..|.++++
T Consensus 12 ~~~~~~~C-s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 89 (229)
T 3e6j_A 12 ACPSQCSC-SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPG-VFDSLINLKELYLGSNQLGALPVGVFDSLTQ 89 (229)
T ss_dssp CCCTTCEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred cCCCCCEE-eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHH-HhhCccCCcEEECCCCCCCCcChhhcccCCC
Confidence 44445556 89999997532 1234444444444433232 3444444444444444444333333444444
Q ss_pred CcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecc
Q 005693 167 LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY 242 (682)
Q Consensus 167 L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~ 242 (682)
|++|+|++|+|++..+..|. ++|++|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+.. .+++|+.|+|++
T Consensus 90 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 168 (229)
T 3e6j_A 90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168 (229)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence 44444444444433333332 34444444444444 44444444444444444444444333321 344444444444
Q ss_pred cCCC
Q 005693 243 NGLK 246 (682)
Q Consensus 243 N~l~ 246 (682)
|.++
T Consensus 169 N~~~ 172 (229)
T 3e6j_A 169 NPWD 172 (229)
T ss_dssp SCBC
T ss_pred CCcc
Confidence 4444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-20 Score=193.46 Aligned_cols=143 Identities=22% Similarity=0.371 Sum_probs=74.3
Q ss_pred EEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCC-CCcEEeecccccCCcCCCCcc-cccceeecc
Q 005693 118 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSSFS-PQLVVLDLS 195 (682)
Q Consensus 118 v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~L~~N~l~g~~p~~~~-~~L~~L~ls 195 (682)
+..|+|++|.+++.+|. .++.+++|++|+|++|+++|.+|..+++++ +|++|+|++|+++|.+|..+. .+|++|+|+
T Consensus 127 L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls 205 (313)
T 1ogq_A 127 LVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS 205 (313)
T ss_dssp CCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECC
T ss_pred CCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECc
Confidence 44444444444444444 344444444444444444444444444444 444444444444444444443 225555555
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 261 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~ 261 (682)
+|++++.+|..|+++++|+.|+|++|++++.+|.. .+++|++|+|++|+++|.+|..+.++++|+.
T Consensus 206 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 272 (313)
T 1ogq_A 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272 (313)
T ss_dssp SSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCE
T ss_pred CCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCE
Confidence 55555555555555666666666666665555543 4556666666666666666665555554443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=169.65 Aligned_cols=146 Identities=26% Similarity=0.282 Sum_probs=114.2
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 174 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 174 (682)
|.|.+|.|+... .+++.|+|++|+++ .+++..++++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 389999998632 25788888888888 45555688888888888888888866666678888888888888
Q ss_pred cccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCC
Q 005693 175 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250 (682)
Q Consensus 175 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p 250 (682)
|++++..+..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|.+.+..|
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 888865555554 68888888888888777777888888888888888888766653 67888888888887775443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=177.80 Aligned_cols=146 Identities=25% Similarity=0.286 Sum_probs=102.5
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.++.|+|++|+++ .+++..|+++++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|. ++|++|+|
T Consensus 38 ~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 3566777777776 34444677777788888877777754445567777788888888777755544444 67778888
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
++|++++..|..|+++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..+..|.++++|+.++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 187 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEE
Confidence 888777777777777777888888888777655542 677777888887777765555666666665543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.1e-19 Score=174.01 Aligned_cols=146 Identities=20% Similarity=0.258 Sum_probs=98.9
Q ss_pred EEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCC-CcCCCCCCCcEEeecccccCCcCCCCcc--cccceeeccc
Q 005693 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 196 (682)
Q Consensus 120 ~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~ 196 (682)
.+++++|+++ .+|. .+. ..+++|+|++|+|++..| ..|.++++|++|+|++|+|++..|..|. ++|++|+|++
T Consensus 15 ~l~~s~n~l~-~iP~-~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPE-HIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCcc-CCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4666666666 4665 232 345677777777776544 3467777777777777777766665665 6777777777
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC---CCCCCCCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLCG 269 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~---~~~n~~~~~ 269 (682)
|+|++..|..|.++++|++|+|++|+|++..|.. .+++|+.|+|++|++++..|..|..+++|. +.+|+..|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 7777766667777777777777777777766653 677777777777777776677766665554 335555443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=170.89 Aligned_cols=144 Identities=24% Similarity=0.304 Sum_probs=87.2
Q ss_pred EEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeeccccc
Q 005693 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS 198 (682)
Q Consensus 121 l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~ 198 (682)
+++++++++ .+|. .+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|. ++|++|+|++|+
T Consensus 16 v~c~~~~l~-~iP~-~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 16 VDCRGKGLT-EIPT-NLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EECTTSCCS-SCCS-SCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEcCCCCcC-cCCC-ccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 334445555 4554 232 5666666666666655555666666666666666666666666665 566666666666
Q ss_pred CcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC---CCCCCCCC
Q 005693 199 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLC 268 (682)
Q Consensus 199 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~---~~~n~~~~ 268 (682)
|++..+..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|+|++..+..|..+++|+ +.+|++.|
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 66554455666666666777776666655543 566666677777766655555555544443 33455544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.3e-18 Score=172.66 Aligned_cols=132 Identities=14% Similarity=0.160 Sum_probs=102.5
Q ss_pred hccccccCeEEEEEEEE-cCCce--EEEEEeeccccC-------------------------hhhHHHHHHHHHHhcCCC
Q 005693 390 AEVLGKGSYGTAYKAVL-EESTT--VVVKRLKEVVVG-------------------------KRDFEQQMEIVGRVGQHP 441 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~~h~ 441 (682)
.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+.++.++ +|+
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 130 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA-KEA 130 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-HHT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-HhC
Confidence 46799999999999997 67888 999987543111 12578899999998 666
Q ss_pred ce--eceEEEEEecCceEEEEeeccC-C----chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEec
Q 005693 442 NV--VPLRAYYYSKDEKLLVYDYFAS-G----SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHG 513 (682)
Q Consensus 442 ni--v~l~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivHr 513 (682)
++ +..++. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 53 444432 367899999942 4 66666432 224467789999999999999 887 9999
Q ss_pred CCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 514 NIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 514 DLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
||||+|||+++ .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.7e-18 Score=166.16 Aligned_cols=147 Identities=20% Similarity=0.193 Sum_probs=131.9
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 174 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 174 (682)
|.|..+.|++.. ..++.|+|++|++++..|.+.|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 379999997632 24678999999999776766799999999999999999988888999999999999999
Q ss_pred cccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCC
Q 005693 175 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250 (682)
Q Consensus 175 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p 250 (682)
|+|++..|..|. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|.+++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999988777776 89999999999999999999999999999999999999987864 89999999999999987544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.8e-17 Score=169.39 Aligned_cols=151 Identities=26% Similarity=0.307 Sum_probs=131.9
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|++++ ++ .++.+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 468899999999986 44 699999999999999999988888899999999999999999987776665 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCC---CCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLC 268 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~---~n~~~~ 268 (682)
|++|+|++..|..|+++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..|..+.++++|+.+ +|+..|
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9999999888888999999999999999999877754 78999999999999998888777777776654 555544
Q ss_pred C
Q 005693 269 G 269 (682)
Q Consensus 269 ~ 269 (682)
.
T Consensus 220 ~ 220 (272)
T 3rfs_A 220 T 220 (272)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-17 Score=165.63 Aligned_cols=143 Identities=22% Similarity=0.229 Sum_probs=127.4
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 174 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 174 (682)
|.|..|.|++.. ..++.|+|++|++++ +++..|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 479999998632 368999999999995 5555899999999999999999988899999999999999999
Q ss_pred cccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCC
Q 005693 175 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 175 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g 247 (682)
|+|++..+..|. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|.+..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 999955444454 89999999999999999999999999999999999999887763 78999999999999974
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-18 Score=179.48 Aligned_cols=144 Identities=26% Similarity=0.393 Sum_probs=126.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCc----------
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---------- 185 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~---------- 185 (682)
.++..|+|++|+++ .+|. .++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+
T Consensus 104 ~~L~~L~L~~n~l~-~lp~-~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPD-TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp TTCSEEEEESSCCC-CCCS-CGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCEEECCCCCcc-chhH-HHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 36888999999998 8887 7899999999999999999 889899999999999999999999999877
Q ss_pred -ccccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 186 -SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 186 -~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
.++|++|+|++|+|+ .+|..++++++|+.|+|++|++++.++.. .+++|+.|+|++|++.+.+|..++++++|+.++
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 368999999999999 88888999999999999999999755554 788999999999999999999888888877664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.1e-17 Score=167.52 Aligned_cols=153 Identities=24% Similarity=0.287 Sum_probs=132.6
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|+++ .+|+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|. ++|++|+
T Consensus 61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 46889999999998 67776789999999999999999977777889999999999999999987777765 8999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC---CCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLC 268 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~---~~~n~~~~ 268 (682)
|++|+|++..+..|..+++|+.|+|++|++++..+.. .+++|+.|+|++|++++..+..+..+++|+ +.+|++.|
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 9999999877778999999999999999999877653 789999999999999976666677666654 55666655
Q ss_pred C
Q 005693 269 G 269 (682)
Q Consensus 269 ~ 269 (682)
.
T Consensus 220 ~ 220 (270)
T 2o6q_A 220 T 220 (270)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.3e-18 Score=182.39 Aligned_cols=166 Identities=28% Similarity=0.275 Sum_probs=140.2
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccC-CCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeec
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLG-KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQ 173 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 173 (682)
|.|..|.|+... ..++.|+|++|++++ +++..+. ++++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 378889997532 247789999999995 5554777 99999999999999998888889999999999999
Q ss_pred ccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC-----CCCCCCeEEecccCCC
Q 005693 174 HNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 174 ~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~l~~L~~l~ls~N~l~ 246 (682)
+|+|++..+..|. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 9999977666666 89999999999999999999999999999999999999755442 5899999999999999
Q ss_pred CCCCccccCCC-----CCCCCCCCCCCCC
Q 005693 247 GSIPSSLQKFP-----NSSFVGNSLLCGP 270 (682)
Q Consensus 247 g~~p~~~~~l~-----~l~~~~n~~~~~~ 270 (682)
+..+..+..++ .|.+.+|++.|.+
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 65556666664 4677788888764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-17 Score=162.51 Aligned_cols=153 Identities=25% Similarity=0.340 Sum_probs=128.3
Q ss_pred cceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCc
Q 005693 106 WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF 185 (682)
Q Consensus 106 w~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 185 (682)
|..-.|+. +.++.+++++. .+|.+ + .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|
T Consensus 14 ~~~~~Cs~-----~~v~c~~~~l~-~ip~~-~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 84 (229)
T 3e6j_A 14 PSQCSCSG-----TTVDCRSKRHA-SVPAG-I--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF 84 (229)
T ss_dssp CTTCEEET-----TEEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CCCCEEeC-----CEeEccCCCcC-ccCCC-C--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc
Confidence 45556764 45899999987 78873 3 3899999999999999999999999999999999999985555555
Q ss_pred c--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCC
Q 005693 186 S--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 261 (682)
Q Consensus 186 ~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~ 261 (682)
. ++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|.. .+++|+.|+|++|+|++..+..|.++++|+.
T Consensus 85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 163 (229)
T 3e6j_A 85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163 (229)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence 5 89999999999999888888999999999999999999 55653 8999999999999999776677777776654
Q ss_pred ---CCCCCCC
Q 005693 262 ---VGNSLLC 268 (682)
Q Consensus 262 ---~~n~~~~ 268 (682)
.+|+..|
T Consensus 164 L~l~~N~~~c 173 (229)
T 3e6j_A 164 AYLFGNPWDC 173 (229)
T ss_dssp EECTTSCBCT
T ss_pred EEeeCCCccC
Confidence 4566554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.1e-17 Score=168.73 Aligned_cols=145 Identities=23% Similarity=0.200 Sum_probs=78.4
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCC-CCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
+++.|+|++|.+++..|. .|+++++|++|+|++|. ++...|..+.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 57 ~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 57 NLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCccceeCHh-hcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 455555555555543333 45555556666666554 4444455555555566666665555554454443 4555555
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
|++|++++..+..|+++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..|..+.++++|+.+
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 206 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEe
Confidence 5555555444445555555555555555555444331 45555555555555555555555555444433
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=7.6e-18 Score=162.85 Aligned_cols=127 Identities=27% Similarity=0.318 Sum_probs=111.4
Q ss_pred EEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCC-cCCCCCCCcEEeecccccCCcCCCCcc--cccceeeccc
Q 005693 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 196 (682)
Q Consensus 120 ~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~ 196 (682)
.++++++++. .+|. .+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|. ++|++|+|++
T Consensus 12 ~l~~s~~~l~-~ip~-~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPR-DIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCS-CCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEcCCCCcC-cCcc-CCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 5677778885 7887 3433 899999999999976664 489999999999999999998898887 7999999999
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p 250 (682)
|+|++..|..|.++++|+.|+|++|+|++.+|.. .+++|++|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 9999999999999999999999999999988864 88999999999999998665
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=191.06 Aligned_cols=153 Identities=20% Similarity=0.218 Sum_probs=131.3
Q ss_pred ceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccccc
Q 005693 107 VGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 177 (682)
Q Consensus 107 ~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 177 (682)
..|.|+..+ ..++.|+|++|+|+ .+|+..|+++++|++|||++|+|++..|..|.+|++|++|+|++|+|
T Consensus 34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 112 (635)
T ss_dssp TEEECTTSCCSSCCSSSCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CEEECCCCCcCccCCCCCcCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence 357787532 36899999999999 56666899999999999999999977788899999999999999999
Q ss_pred CCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCC-CCCC--CCCCCCeEEecccCCCCCCCcc
Q 005693 178 SGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF--DIPKLRHLNLSYNGLKGSIPSS 252 (682)
Q Consensus 178 ~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~--~l~~L~~l~ls~N~l~g~~p~~ 252 (682)
++..|..|. ++|++|+|++|+|++..+..|++|++|+.|+|++|++++. +|.. .+++|++|+|++|++++..|..
T Consensus 113 ~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 192 (635)
T 4g8a_A 113 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 192 (635)
T ss_dssp CEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence 976666666 7999999999999988888899999999999999999864 4553 7899999999999999888888
Q ss_pred ccCCCCCC
Q 005693 253 LQKFPNSS 260 (682)
Q Consensus 253 ~~~l~~l~ 260 (682)
+..+.++.
T Consensus 193 l~~L~~l~ 200 (635)
T 4g8a_A 193 LRVLHQMP 200 (635)
T ss_dssp GHHHHTCT
T ss_pred ccchhhhh
Confidence 77665544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-17 Score=171.85 Aligned_cols=155 Identities=23% Similarity=0.285 Sum_probs=92.5
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCC--CCCCcCCCCCCCcEEee
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYL 172 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~L 172 (682)
|.|.+|.|+... .+++.|+|++|+++ .+|+..|+++++|++|+|++|+++. .+|..+.++++|++|+|
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 489999998632 36899999999998 7887678999999999999999873 22444555566666666
Q ss_pred cccccCCcCCCCcc--cccceeecccccCcccCC-cchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCC
Q 005693 173 QHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 173 ~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g 247 (682)
++|.++ .+|..+. ++|++|+|++|++++..+ ..+.++++|+.|+|++|++++..|.. .+++|+.|+|++|.+++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 666555 2333332 445555555555543333 34444555555555555554444432 44445555555554443
Q ss_pred -CCCccccCCCCCC
Q 005693 248 -SIPSSLQKFPNSS 260 (682)
Q Consensus 248 -~~p~~~~~l~~l~ 260 (682)
.+|..+.++++|+
T Consensus 165 ~~~~~~~~~l~~L~ 178 (306)
T 2z66_A 165 NFLPDIFTELRNLT 178 (306)
T ss_dssp GEECSCCTTCTTCC
T ss_pred ccchhHHhhCcCCC
Confidence 2344444444433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.9e-17 Score=166.16 Aligned_cols=147 Identities=24% Similarity=0.233 Sum_probs=126.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccc-cCCcCCCCcc--ccccee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN-FSGKIPSSFS--PQLVVL 192 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~--~~L~~L 192 (682)
.+++.|+|++|++++ +++..|+++++|++|+|++|.+++..|..|.++++|++|+|++|+ +++..|..+. ++|++|
T Consensus 32 ~~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 368899999999985 554479999999999999999998889999999999999999997 7766677776 799999
Q ss_pred ecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 193 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+|++|++++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..+..+.++++|+.++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 99999999888999999999999999999999777653 789999999999999976666688777776554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=8.4e-17 Score=155.48 Aligned_cols=154 Identities=25% Similarity=0.254 Sum_probs=122.9
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 174 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 174 (682)
|.|..+.|+... .+++.|+|++|++++..+.+.++.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 379999998632 36889999999998655544589999999999999999999999999999999999999
Q ss_pred cccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCCCC-CCCCeEEecccCCCCCCCc
Q 005693 175 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-PKLRHLNLSYNGLKGSIPS 251 (682)
Q Consensus 175 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l-~~L~~l~ls~N~l~g~~p~ 251 (682)
|+|++..|..|. ++|++|+|++|+|++.+|..|..+++|+.|+|++|.+++..+...+ ..|+...+..+......|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 999988887776 8999999999999999999999999999999999999986653211 1122223344445445555
Q ss_pred cccCCC
Q 005693 252 SLQKFP 257 (682)
Q Consensus 252 ~~~~l~ 257 (682)
.+....
T Consensus 168 ~l~~~~ 173 (192)
T 1w8a_A 168 KVRDVQ 173 (192)
T ss_dssp TTTTSB
T ss_pred HHcCCC
Confidence 554443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-16 Score=160.15 Aligned_cols=154 Identities=24% Similarity=0.316 Sum_probs=135.6
Q ss_pred CCCcceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCC
Q 005693 103 CQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 182 (682)
Q Consensus 103 c~~w~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p 182 (682)
|..|.|+.|.. ....+++++++++ .+|. .+. ++|+.|+|++|++++..|..|.++++|++|+|++|+|++..|
T Consensus 4 Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~-~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 4 CETVTGCTCNE---GKKEVDCQGKSLD-SVPS-GIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp CHHHHSSEEEG---GGTEEECTTCCCS-SCCS-CCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred CCCCCceEcCC---CCeEEecCCCCcc-ccCC-CCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 55899999964 2346899999998 7887 344 689999999999999889899999999999999999998888
Q ss_pred CCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCC
Q 005693 183 SSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258 (682)
Q Consensus 183 ~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~ 258 (682)
..|. ++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..+..|+++++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 7776 89999999999999888889999999999999999999777753 7999999999999999777778888888
Q ss_pred CCCCC
Q 005693 259 SSFVG 263 (682)
Q Consensus 259 l~~~~ 263 (682)
|+.++
T Consensus 157 L~~L~ 161 (251)
T 3m19_A 157 LQTLS 161 (251)
T ss_dssp CCEEE
T ss_pred CCEEE
Confidence 77664
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=188.19 Aligned_cols=157 Identities=24% Similarity=0.261 Sum_probs=137.0
Q ss_pred CCCcceEEecCCC-----------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEe
Q 005693 103 CQSWVGINCTQDR-----------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLY 171 (682)
Q Consensus 103 c~~w~gv~C~~~~-----------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 171 (682)
| .|.|+ |+... .+++.|+|++|++++..|. .|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 4 C-~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 4 C-DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHG-DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp E-CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSS-TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred C-CCCce-EECCCCccccccccCCCCccEEECcCCccCccChh-hhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 5 79998 87431 3689999999999976665 799999999999999999988889999999999999
Q ss_pred ecccccCCcCCCCcc--cccceeecccccCcc-cCCcchhhhccccceeccCCcccCCCCC--C-CCCCCCeEEecccCC
Q 005693 172 LQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGL 245 (682)
Q Consensus 172 L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~-~l~~L~~l~ls~N~l 245 (682)
|++|++++..|..|. ++|++|+|++|++++ .+|..++++++|+.|+|++|++.+.+|. + .+++|++|++++|++
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 999999987776676 799999999999997 4678999999999999999996666663 2 889999999999999
Q ss_pred CCCCCccccCCCCCCCC
Q 005693 246 KGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 246 ~g~~p~~~~~l~~l~~~ 262 (682)
++.+|..++++++|+.+
T Consensus 161 ~~~~~~~l~~l~~L~~L 177 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHL 177 (549)
T ss_dssp CEECTTTTTTCSEEEEE
T ss_pred cccChhhhhccccCceE
Confidence 99999998888776554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-16 Score=164.75 Aligned_cols=142 Identities=30% Similarity=0.312 Sum_probs=101.0
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.++.|+|++|++++..+. .|.++++|++|+|++|+|++. |.. +.+++|++|+|++|+|+ .+|..+. ++|++|+|
T Consensus 32 ~l~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLA-TLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TCCEEECTTSCCSEEEGG-GGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCEEEcCCCcCCccCHH-HhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 577788888888754444 688888888888888888743 332 67777888888888777 5666554 67778888
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
++|+|++..|..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|+|++..+..|.++++|..+
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 177 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEE
Confidence 888887666677777778888888888777655543 67777788888877775444455656655544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=176.11 Aligned_cols=165 Identities=25% Similarity=0.243 Sum_probs=130.6
Q ss_pred CCCCCCCCCCcceEEecCC-----------CCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCC
Q 005693 96 WSSTNPICQSWVGINCTQD-----------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSL 164 (682)
Q Consensus 96 w~~~~~~c~~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 164 (682)
|......| .|.|+ |+.. ..+++.|+|++|++++ +|+..++++++|++|+|++|++++..|..|.++
T Consensus 23 ~~~~~~~C-~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 99 (353)
T 2z80_A 23 SNQASLSC-DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL 99 (353)
T ss_dssp ----CCEE-CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred CCccCCCC-CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCC
Confidence 44344445 79887 6532 1368899999999985 555579999999999999999998888889999
Q ss_pred CCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCC-cchhhhccccceeccCCc-ccCCCCCC--CCCCCCeE
Q 005693 165 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNN-LSGSIPNF--DIPKLRHL 238 (682)
Q Consensus 165 ~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~-l~g~~p~~--~l~~L~~l 238 (682)
++|++|+|++|++++..+..+. ++|++|+|++|++++..+ ..+.++++|+.|++++|+ +.+..|.. .+++|+.|
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L 179 (353)
T 2z80_A 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179 (353)
T ss_dssp TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence 9999999999999964444354 789999999999995444 488999999999999995 66554543 78899999
Q ss_pred EecccCCCCCCCccccCCCCCCCCC
Q 005693 239 NLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 239 ~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
++++|++++..|..+.++++|+.++
T Consensus 180 ~l~~n~l~~~~~~~l~~l~~L~~L~ 204 (353)
T 2z80_A 180 EIDASDLQSYEPKSLKSIQNVSHLI 204 (353)
T ss_dssp EEEETTCCEECTTTTTTCSEEEEEE
T ss_pred ECCCCCcCccCHHHHhccccCCeec
Confidence 9999999988898888888776654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.4e-16 Score=151.65 Aligned_cols=146 Identities=24% Similarity=0.292 Sum_probs=123.1
Q ss_pred EEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeeccc
Q 005693 119 FGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 196 (682)
Q Consensus 119 ~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~ 196 (682)
+.++.++++++ .+|.. ..++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|. ++|++|+|++
T Consensus 10 ~~v~c~~~~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTG---IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCS-SCCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCcc-CCCCC---CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 46888999988 67763 356899999999999977777789999999999999999966665555 8999999999
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCC---CCCCCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF---VGNSLLC 268 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~---~~n~~~~ 268 (682)
|+|++..+..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..+..+.++++|+. .+|+..|
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 9999877778999999999999999999877753 7999999999999999776666777776654 4565554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.67 E-value=6.5e-17 Score=184.21 Aligned_cols=170 Identities=19% Similarity=0.164 Sum_probs=138.1
Q ss_pred cCCCCCCCCCCC---cceEEecCC----------------CCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCC
Q 005693 94 LNWSSTNPICQS---WVGINCTQD----------------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 154 (682)
Q Consensus 94 ~~w~~~~~~c~~---w~gv~C~~~----------------~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~ 154 (682)
.+|.+..+||.. |.++.|+.. -..+..++++++.+. .+|+..++++++|++|+|++|.|+
T Consensus 10 ~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~ 88 (597)
T 3oja_B 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 88 (597)
T ss_dssp -CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCC
T ss_pred cCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCC
Confidence 368877676654 665555410 024567888888887 678777899999999999999999
Q ss_pred CCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--
Q 005693 155 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-- 230 (682)
Q Consensus 155 g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-- 230 (682)
+..|..|+++++|++|+|++|.+++..|..|. ++|++|+|++|+|++..+..|+++++|+.|+|++|.+++.+|..
T Consensus 89 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 168 (597)
T 3oja_B 89 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 168 (597)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTT
T ss_pred CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhh
Confidence 88888999999999999999999988887776 89999999999999766667899999999999999999988863
Q ss_pred CCCCCCeEEecccCCCCCCCccccCCCCCCCCCC
Q 005693 231 DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN 264 (682)
Q Consensus 231 ~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~n 264 (682)
.+++|+.|+|++|.+++..+..+.++..|.+.+|
T Consensus 169 ~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 169 ATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp TCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred cCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 8999999999999999765555555555544444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.67 E-value=6.5e-17 Score=174.19 Aligned_cols=169 Identities=20% Similarity=0.187 Sum_probs=131.9
Q ss_pred CCCCCCCCCCCcceEEecCCC-------------------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCC
Q 005693 95 NWSSTNPICQSWVGINCTQDR-------------------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG 155 (682)
Q Consensus 95 ~w~~~~~~c~~w~gv~C~~~~-------------------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g 155 (682)
+|....+||+.|.+..|.... ..+..++++++.+. .+|+..+..+++|++|+|++|++++
T Consensus 5 ~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~ 83 (390)
T 3o6n_A 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE 83 (390)
T ss_dssp --CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCE
T ss_pred CCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccc
Confidence 688777777665555553110 35677899999887 6888678999999999999999998
Q ss_pred CCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--C
Q 005693 156 GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--D 231 (682)
Q Consensus 156 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~ 231 (682)
..|..|.++++|++|+|++|++++..|..+. ++|++|+|++|+++...+..|+++++|+.|+|++|++++..|.. .
T Consensus 84 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 163 (390)
T 3o6n_A 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163 (390)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSS
T ss_pred cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccC
Confidence 7788999999999999999999988787776 79999999999999655556799999999999999999887763 8
Q ss_pred CCCCCeEEecccCCCCCCCccccCCCCCCCCCC
Q 005693 232 IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN 264 (682)
Q Consensus 232 l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~n 264 (682)
+++|+.|++++|++++.-...+.++..+.+.+|
T Consensus 164 l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 164 TTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp CTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCCCCEEECCCCcCCccccccccccceeecccc
Confidence 899999999999999754444445544444443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=177.06 Aligned_cols=158 Identities=22% Similarity=0.207 Sum_probs=137.0
Q ss_pred CcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccc
Q 005693 105 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 175 (682)
Q Consensus 105 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 175 (682)
.|..|.|.... ..+..|+|++|++++..|. .|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQD-EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHh-HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 57889997532 3678999999999965554 8999999999999999999888999999999999999999
Q ss_pred ccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCc
Q 005693 176 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS 251 (682)
Q Consensus 176 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~ 251 (682)
++++..+..|. ++|++|+|++|++++..|..|.++++|+.|+|++|++++..|.. .+++|+.|+|++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 99965555565 89999999999999999999999999999999999999877754 889999999999999976666
Q ss_pred cccCCCCCCCCC
Q 005693 252 SLQKFPNSSFVG 263 (682)
Q Consensus 252 ~~~~l~~l~~~~ 263 (682)
.+.++++|..++
T Consensus 171 ~l~~l~~L~~L~ 182 (477)
T 2id5_A 171 ALSHLHGLIVLR 182 (477)
T ss_dssp HHTTCTTCCEEE
T ss_pred HhcccCCCcEEe
Confidence 677777776553
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=7.8e-17 Score=177.09 Aligned_cols=151 Identities=23% Similarity=0.314 Sum_probs=133.0
Q ss_pred Ccce--EEecCCC--------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCC-CcCCCCCCCcEEeec
Q 005693 105 SWVG--INCTQDR--------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQ 173 (682)
Q Consensus 105 ~w~g--v~C~~~~--------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~ 173 (682)
.|.+ |.|+... .+++.|+|++|++++..|. .|+++++|++|+|++|.+.+.+| ..|.++++|++|+|+
T Consensus 9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNET-SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTT-TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChh-HhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 4554 8887643 4689999999999976665 79999999999999999987774 679999999999999
Q ss_pred ccccCCcCCCCcc--cccceeecccccCcccCCcc--hhhhccccceeccCCcccCCCCCC---CCCCCCeEEecccCCC
Q 005693 174 HNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 174 ~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~~---~l~~L~~l~ls~N~l~ 246 (682)
+|++++..|..|. ++|++|+|++|++++.+|.. |+++++|+.|+|++|++++..|.. .+++|+.|+|++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 9999988898887 89999999999999876665 999999999999999999988862 8999999999999999
Q ss_pred CCCCccccCC
Q 005693 247 GSIPSSLQKF 256 (682)
Q Consensus 247 g~~p~~~~~l 256 (682)
+..|..+.++
T Consensus 168 ~~~~~~l~~l 177 (455)
T 3v47_A 168 SICEEDLLNF 177 (455)
T ss_dssp CCCTTTSGGG
T ss_pred ccChhhhhcc
Confidence 9888888765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-16 Score=160.51 Aligned_cols=134 Identities=30% Similarity=0.353 Sum_probs=120.6
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|++++ +++..++++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 85 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 578999999999995 5554789999999999999999988888899999999999999999977776665 8999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p 250 (682)
|++|+|++..|..|+++++|+.|+|++|++++.+|.. .+++|+.|+|++|.+.+..|
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9999999888888999999999999999999988764 89999999999999987655
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-16 Score=163.58 Aligned_cols=149 Identities=28% Similarity=0.308 Sum_probs=106.2
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|++++ ++. .+.+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|. ++|++|+
T Consensus 55 ~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 55 TRLTQLNLDRAELTK-LQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp TTCCEEECTTSCCCE-EEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCc-ccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 467778888887774 443 367778888888888887 6777777788888888888888766556665 6788888
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCC---CCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS---SFVGNSLLC 268 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l---~~~~n~~~~ 268 (682)
|++|+|++..+..|..+++|+.|+|++|+|++..+.. .+++|+.|+|++|+|+ .+|..+..+.+| .+.+|++.|
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 8888888766667777888888888888887555443 5778888888888887 566665554443 344566655
Q ss_pred C
Q 005693 269 G 269 (682)
Q Consensus 269 ~ 269 (682)
.
T Consensus 210 ~ 210 (290)
T 1p9a_G 210 N 210 (290)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=9.5e-17 Score=166.85 Aligned_cols=140 Identities=23% Similarity=0.227 Sum_probs=69.4
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCC-cCCCCcc--cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~~p~~~~--~~L~~L~ 193 (682)
++..|++++|++++..+...+..+++|++|+|++|.+++..|..+.++++|++|+|++|++++ .+|..+. ++|++|+
T Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 181 (306)
T 2z66_A 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181 (306)
T ss_dssp TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEE
Confidence 344455555555432221245555555555555555554445555555555555555555544 3444443 4555555
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKF 256 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l 256 (682)
|++|++++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..|..+..+
T Consensus 182 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred CCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 5555555544555555555555555555555433321 44555555555555555555444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=174.13 Aligned_cols=157 Identities=21% Similarity=0.167 Sum_probs=114.0
Q ss_pred CcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccc
Q 005693 105 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 175 (682)
Q Consensus 105 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 175 (682)
.|..|.|.+.. .+++.|+|++|++++..|. .|+++++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQAD-TFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHH-HcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 46788887532 3688999999999965555 8999999999999999999888899999999999999999
Q ss_pred ccCCcCCCCcc--cccceeecccccCcccCCcchhhhccc-------------------------cceeccCCcccCCCC
Q 005693 176 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL-------------------------TGLSLQSNNLSGSIP 228 (682)
Q Consensus 176 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L-------------------------~~L~l~~N~l~g~~p 228 (682)
+|++..+..|. ++|++|+|++|+|++..+..|.++++| +.|+|++|++++...
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 213 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPN 213 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccccc
Confidence 99966666565 789999999999886655555555444 444555555543221
Q ss_pred CCCCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 229 NFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 229 ~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
-..+++|+.|+|++|++++..|..|.++++|+.+
T Consensus 214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 247 (452)
T 3zyi_A 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247 (452)
T ss_dssp CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEE
T ss_pred ccccccccEEECcCCcCcccCcccccCccCCCEE
Confidence 1255566666666666665556666555555443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-16 Score=149.28 Aligned_cols=130 Identities=26% Similarity=0.303 Sum_probs=109.6
Q ss_pred CcceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCC
Q 005693 105 SWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS 184 (682)
Q Consensus 105 ~w~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 184 (682)
+|.++.|+. ++++ .+|.. ..++|++|+|++|++++..+..|.++++|++|+|++|++++..+..
T Consensus 8 ~~~~l~~~~------------~~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (177)
T 2o6r_A 8 SGTEIRCNS------------KGLT-SVPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71 (177)
T ss_dssp ETTEEECCS------------SCCS-SCCTT---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred CCCEEEecC------------CCCc-cCCCC---CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence 677777654 4555 56652 2478999999999999777777899999999999999999766665
Q ss_pred cc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCC
Q 005693 185 FS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 250 (682)
Q Consensus 185 ~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p 250 (682)
|. ++|++|+|++|+|++..+..+.++++|+.|+|++|+|++.++.. .+++|+.|+|++|.+++..|
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 55 79999999999999888888999999999999999999766653 68999999999999997665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-16 Score=162.70 Aligned_cols=143 Identities=21% Similarity=0.200 Sum_probs=123.5
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.++.|+|++|++++. ++..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+. ++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHL-GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEE-CTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCccccc-CHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 588999999999854 444799999999999999999977777899999999999999999987777776 79999999
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCC-CCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 260 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~ 260 (682)
++|++++..+..++++++|+.|+|++|++++. +|.. .+++|+.|+|++|++++..+..+..+.++.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 176 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc
Confidence 99999988777899999999999999999873 4653 889999999999999987777776555444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.6e-16 Score=159.95 Aligned_cols=152 Identities=24% Similarity=0.262 Sum_probs=89.7
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCC-cCCCCcc--cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~~p~~~~--~~L~~L~ 193 (682)
++..|+|++|.+++..+. .+.++++|++|+|++|++++..+..+.++++|++|+|++|++++ .+|..+. ++|++|+
T Consensus 77 ~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~ 155 (276)
T 2z62_A 77 HLSTLILTGNPIQSLALG-AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (276)
T ss_dssp TCCEEECTTCCCCEECTT-TTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred CCCEEECCCCccCccChh-hhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEE
Confidence 455566666665543332 45666666666666666665444456666666666666666654 2455554 5566666
Q ss_pred cccccCcccCCcchhhhcccc----ceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCC---CCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLT----GLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNS 265 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~----~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~---~~~n~ 265 (682)
|++|++++..+..+..+++|+ .|++++|++++..+.. ...+|+.|+|++|++++..+..+.++++|+ +.+|+
T Consensus 156 Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 235 (276)
T 2z62_A 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235 (276)
T ss_dssp CCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSC
T ss_pred CCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCc
Confidence 666666655555666665555 5566666666544443 445788888888888865555556555544 44566
Q ss_pred CCCC
Q 005693 266 LLCG 269 (682)
Q Consensus 266 ~~~~ 269 (682)
..|.
T Consensus 236 ~~c~ 239 (276)
T 2z62_A 236 WDCS 239 (276)
T ss_dssp BCCC
T ss_pred cccc
Confidence 5554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=181.89 Aligned_cols=152 Identities=20% Similarity=0.229 Sum_probs=133.1
Q ss_pred ceEEecCC---------CCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccccc
Q 005693 107 VGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 177 (682)
Q Consensus 107 ~gv~C~~~---------~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 177 (682)
..|.|++. ..+++.|+|++|++++..+. .|+++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l 92 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSY-SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChh-hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence 36777652 24689999999999965554 799999999999999999988899999999999999999999
Q ss_pred CCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccC-CCCCC--CCCCCCeEEecccCCCCCCCcc
Q 005693 178 SGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF--DIPKLRHLNLSYNGLKGSIPSS 252 (682)
Q Consensus 178 ~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~--~l~~L~~l~ls~N~l~g~~p~~ 252 (682)
++..|..|. ++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|.. .+++|++|+|++|++++..|..
T Consensus 93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~ 172 (606)
T 3vq2_A 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172 (606)
T ss_dssp CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence 988899887 899999999999998888999999999999999999986 56764 8999999999999999888887
Q ss_pred ccCCCCC
Q 005693 253 LQKFPNS 259 (682)
Q Consensus 253 ~~~l~~l 259 (682)
++.+.+|
T Consensus 173 ~~~l~~L 179 (606)
T 3vq2_A 173 LQFLREN 179 (606)
T ss_dssp THHHHHC
T ss_pred hhhhhcc
Confidence 7665543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.2e-16 Score=163.99 Aligned_cols=157 Identities=21% Similarity=0.267 Sum_probs=127.7
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 174 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 174 (682)
|.|..+.|+... .+++.|+|++|++.+..| ..|+++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRK-DDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCH-hHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 479999997532 368899999999985444 4799999999999999999988899999999999999999
Q ss_pred cccCCcCCCCcccccceeecccccCcccCCcchhhhccccceeccCCcccC--CCCCC--CCCCCCeEEecccCCCCCCC
Q 005693 175 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG--SIPNF--DIPKLRHLNLSYNGLKGSIP 250 (682)
Q Consensus 175 N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~--~l~~L~~l~ls~N~l~g~~p 250 (682)
|+++ .+|..+.++|++|+|++|++++..+..|.++++|+.|+|++|+++. ..|.. .+ +|+.|++++|++++ +|
T Consensus 112 n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~ 188 (332)
T 2ft3_A 112 NHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IP 188 (332)
T ss_dssp SCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CC
T ss_pred CcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cC
Confidence 9999 7888877999999999999998777789999999999999999963 44443 34 77777777777774 44
Q ss_pred ccc-cCCCCCCCCCC
Q 005693 251 SSL-QKFPNSSFVGN 264 (682)
Q Consensus 251 ~~~-~~l~~l~~~~n 264 (682)
..+ .++..|.+.+|
T Consensus 189 ~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 189 KDLPETLNELHLDHN 203 (332)
T ss_dssp SSSCSSCSCCBCCSS
T ss_pred ccccCCCCEEECCCC
Confidence 433 34445544444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.2e-17 Score=187.09 Aligned_cols=133 Identities=17% Similarity=0.313 Sum_probs=118.5
Q ss_pred cccccCCccccCCCCCCcEEEccCCCCCCC-----------------CCCcCC--CCCCCcEEeecccccCCcCCCCcc-
Q 005693 127 GLVGPIPNNTLGKLDALEVLSLRSNVLTGG-----------------LPSEIT--SLPSLRYLYLQHNNFSGKIPSSFS- 186 (682)
Q Consensus 127 ~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~L~~N~l~g~~p~~~~- 186 (682)
+++| ||+ .++++++|++|+|++|+|+|. +|+.++ ++++|++|+|++|++.|.+|..+.
T Consensus 194 ~l~~-ip~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 271 (636)
T 4eco_A 194 NITF-VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271 (636)
T ss_dssp EEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred CCcc-CCH-HHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence 4556 887 699999999999999999986 999999 999999999999999999999887
Q ss_pred -cccceeeccccc-Ccc-cCCcchhhh------ccccceeccCCcccCCCCC--C--CCCCCCeEEecccCCCCCCCccc
Q 005693 187 -PQLVVLDLSFNS-FTG-NIPQSIQNL------TQLTGLSLQSNNLSGSIPN--F--DIPKLRHLNLSYNGLKGSIPSSL 253 (682)
Q Consensus 187 -~~L~~L~ls~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~g~~p~--~--~l~~L~~l~ls~N~l~g~~p~~~ 253 (682)
++|++|+|++|+ |+| .+|..++++ ++|+.|+|++|+++ .+|. . .+++|+.|+|++|+++|.+| .+
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~ 349 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF 349 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence 799999999998 999 899999987 99999999999999 7776 3 89999999999999999999 77
Q ss_pred cCCCCCCCCC
Q 005693 254 QKFPNSSFVG 263 (682)
Q Consensus 254 ~~l~~l~~~~ 263 (682)
+++++|+.++
T Consensus 350 ~~l~~L~~L~ 359 (636)
T 4eco_A 350 GSEIKLASLN 359 (636)
T ss_dssp EEEEEESEEE
T ss_pred CCCCCCCEEE
Confidence 7776665543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=174.17 Aligned_cols=130 Identities=22% Similarity=0.254 Sum_probs=114.7
Q ss_pred CCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceec
Q 005693 141 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL 218 (682)
Q Consensus 141 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l 218 (682)
++|+.|+|++|++++.+|..|.++++|++|+|++|++++..|..|. ++|++|+|++|++++..|..|+++++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 6899999999999999999999999999999999999988888886 79999999999999988999999999999999
Q ss_pred cCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC---CCCCCCCCCC
Q 005693 219 QSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLCGP 270 (682)
Q Consensus 219 ~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~---~~~n~~~~~~ 270 (682)
++|++++..|.. .+++|++|+|++|++++..+..+..+++|+ +.+|+..|.+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 999999887864 899999999999999976666667666655 4566665543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=180.32 Aligned_cols=154 Identities=19% Similarity=0.108 Sum_probs=137.5
Q ss_pred cceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccc
Q 005693 106 WVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN 176 (682)
Q Consensus 106 w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~ 176 (682)
+..|.|.+.. ..++.|+|++|++++..|. .|+++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNT-TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTT-TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChh-HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 5678887532 4689999999999965555 89999999999999999999889999999999999999999
Q ss_pred cCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCC-CCCC-CCCCCCeEEecccCCCCCCCcc
Q 005693 177 FSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF-DIPKLRHLNLSYNGLKGSIPSS 252 (682)
Q Consensus 177 l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~-~l~~L~~l~ls~N~l~g~~p~~ 252 (682)
+++..|..|. ++|++|+|++|++++..|..++++++|++|+|++|++++. +|.. .+++|+.|+|++|++++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 9998898887 8999999999999988789999999999999999999984 4554 8999999999999999888888
Q ss_pred ccCCCCCC
Q 005693 253 LQKFPNSS 260 (682)
Q Consensus 253 ~~~l~~l~ 260 (682)
++.+++|.
T Consensus 173 ~~~l~~L~ 180 (606)
T 3t6q_A 173 MSSLQQAT 180 (606)
T ss_dssp HHTTTTCC
T ss_pred hhhhcccc
Confidence 88888776
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.64 E-value=8.3e-17 Score=186.79 Aligned_cols=178 Identities=20% Similarity=0.281 Sum_probs=113.3
Q ss_pred CChhHHHHHHHHHHhCCC---CCCcCCCCCCCCCCCcceEEecCCCCeEEEEEeC------------------CCcccc-
Q 005693 73 DLNSDRQALLDFADAVPH---LRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLP------------------GIGLVG- 130 (682)
Q Consensus 73 ~~~~~~~al~~~~~~~~~---~~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~------------------~~~l~g- 130 (682)
..+.++.+|.++..+... .....|......+.+|.++.++. .+++.|+|. ++.+.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCc
Confidence 345678899999877621 22235755555555898887765 344444443 333322
Q ss_pred -------cCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcc
Q 005693 131 -------PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG 201 (682)
Q Consensus 131 -------~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g 201 (682)
.++++.+..+..|+.|+|++|.+. .+|..+.++++|++|+|++|+|+ .+|..|. ++|++|+|++|+|+
T Consensus 207 ~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 207 DDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 234457888999999999999998 88888889999999999999999 8888876 78999999999999
Q ss_pred cCCcchhhhccccceeccCCcccCCCCC-C-CCCCCCeEEecccCCCCCCCccccCC
Q 005693 202 NIPQSIQNLTQLTGLSLQSNNLSGSIPN-F-DIPKLRHLNLSYNGLKGSIPSSLQKF 256 (682)
Q Consensus 202 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~-~l~~L~~l~ls~N~l~g~~p~~~~~l 256 (682)
.+|..|++|++|++|+|++|.|+ .+|. + .+++|+.|+|++|.|+|.+|..+..+
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 339 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEK 339 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence 78999999999999999999998 5565 3 88999999999999999888777543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.1e-16 Score=162.62 Aligned_cols=141 Identities=20% Similarity=0.253 Sum_probs=116.5
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 174 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 174 (682)
|.|..+.|+... ..++.|+|++|++++ +++..|+++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 479999998522 367889999999995 5554799999999999999999988899999999999999999
Q ss_pred cccCCcCCCCcccccceeecccccCcccCCcchhhhccccceeccCCcccC--CCCCC--CCCCCCeEEecccCCC
Q 005693 175 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG--SIPNF--DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 175 N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~--~l~~L~~l~ls~N~l~ 246 (682)
|+++ .+|..+.++|++|++++|++++..+..|.++++|+.|+|++|+++. ..+.. .+++|+.|++++|+++
T Consensus 110 n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 110 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 9999 7888877889999999999987777778888888888888888853 33432 5666777777776666
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.1e-16 Score=149.07 Aligned_cols=132 Identities=25% Similarity=0.229 Sum_probs=106.2
Q ss_pred CeEEEEEeCCCccc-ccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--ccccee
Q 005693 116 TRVFGLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192 (682)
Q Consensus 116 ~~v~~l~l~~~~l~-g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L 192 (682)
.+++.|+|++|+++ |.+|. .+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+. ++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 46788888888887 78887 578888999999999988865 6788888999999999998877776654 788899
Q ss_pred ecccccCcccC-CcchhhhccccceeccCCcccCCCC----C-CCCCCCCeEEecccCCCCCCCc
Q 005693 193 DLSFNSFTGNI-PQSIQNLTQLTGLSLQSNNLSGSIP----N-FDIPKLRHLNLSYNGLKGSIPS 251 (682)
Q Consensus 193 ~ls~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p----~-~~l~~L~~l~ls~N~l~g~~p~ 251 (682)
+|++|+|++.. +..+..+++|+.|+|++|++++..+ . ..+++|+.|++++|.+. .+|+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999888642 2788888889999999998887665 2 27888888998888887 4443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.6e-16 Score=185.23 Aligned_cols=86 Identities=30% Similarity=0.334 Sum_probs=63.6
Q ss_pred cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCCCCC
Q 005693 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSL 266 (682)
Q Consensus 187 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~n~~ 266 (682)
++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+|....++|+.|+|++|+|++..|..+.++..+.+.+|++
T Consensus 480 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~ 559 (844)
T 3j0a_A 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKF 559 (844)
T ss_dssp CCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECC
T ss_pred ccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCc
Confidence 35566666666666666666777777777777777777665554447788888888888888888888888888889999
Q ss_pred CCCCCC
Q 005693 267 LCGPPL 272 (682)
Q Consensus 267 ~~~~~l 272 (682)
.|.++.
T Consensus 560 ~C~c~~ 565 (844)
T 3j0a_A 560 ICECEL 565 (844)
T ss_dssp CCSSSC
T ss_pred cccccc
Confidence 986653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-16 Score=179.92 Aligned_cols=142 Identities=25% Similarity=0.214 Sum_probs=72.1
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCC-CcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
++..|+|++|.+++ +|. .++.+++|+.|+|++|++++..| ..+.++++|++|+|++|++++.+|..+. ++|++|+
T Consensus 377 ~L~~L~L~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 454 (606)
T 3vq2_A 377 SLRHLDLSFNGAII-MSA-NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454 (606)
T ss_dssp CCCEEECCSCSEEE-ECC-CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred cccEeECCCCcccc-chh-hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEE
Confidence 34555555555553 443 45555555555555555554444 3455555555555555555554554443 4555555
Q ss_pred cccccCcc-cCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC
Q 005693 194 LSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 260 (682)
Q Consensus 194 ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~ 260 (682)
|++|++++ .+|..|+++++|+.|+|++|++++.+|.. .+++|+.|+|++|++++.+|..+.++++|+
T Consensus 455 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 524 (606)
T 3vq2_A 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524 (606)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCC
T ss_pred CCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCC
Confidence 55555554 24445555555555555555555444432 445555555555555544454444444443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-16 Score=158.09 Aligned_cols=141 Identities=16% Similarity=0.196 Sum_probs=112.8
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCC-CCCCCCCcCCCCCCCcEEeecc-cccCCcCCCCcc--cccce
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVV 191 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~--~~L~~ 191 (682)
..++.|+|++|+++ .+|+..|+++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|. ++|++
T Consensus 31 ~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 36889999999998 4555579999999999999997 8866666899999999999998 999966666665 78999
Q ss_pred eecccccCcccCCcchhhhcccc---ceeccCC-cccCCCCCC--CCCCCC-eEEecccCCCCCCCccccCCCCCC
Q 005693 192 LDLSFNSFTGNIPQSIQNLTQLT---GLSLQSN-NLSGSIPNF--DIPKLR-HLNLSYNGLKGSIPSSLQKFPNSS 260 (682)
Q Consensus 192 L~ls~N~l~g~~p~~~~~l~~L~---~L~l~~N-~l~g~~p~~--~l~~L~-~l~ls~N~l~g~~p~~~~~l~~l~ 260 (682)
|+|++|++++ +|. |..+++|+ .|++++| ++++..+.. .+++|+ .|++++|+++ .+|......++|+
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~ 182 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD 182 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEE
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCC
Confidence 9999999996 666 88888888 9999999 888766643 788899 9999999988 5655432224443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=146.89 Aligned_cols=123 Identities=30% Similarity=0.379 Sum_probs=109.4
Q ss_pred EEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccc
Q 005693 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 197 (682)
Q Consensus 120 ~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N 197 (682)
.+++++++++ .+|.+ + .++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|. ++|++|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4677788887 78873 3 368999999999999 8889999999999999999999988777776 89999999999
Q ss_pred cCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCC
Q 005693 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 198 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g 247 (682)
+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999988899999999999999999999766653 78999999999999874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=8.8e-16 Score=175.57 Aligned_cols=152 Identities=20% Similarity=0.201 Sum_probs=125.9
Q ss_pred CcceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCC
Q 005693 105 SWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS 184 (682)
Q Consensus 105 ~w~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 184 (682)
.|....|..... ..+=++.+|+ .+|.+ + -+++++|||++|+|++..|..|.++++|++|+|++|+|++..|..
T Consensus 23 ~~~~c~~~~~~~---~~~c~~~~l~-~vP~~-l--p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~ 95 (635)
T 4g8a_A 23 SWEPCVEVVPNI---TYQCMELNFY-KIPDN-L--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 95 (635)
T ss_dssp --CCSEEEETTT---EEECTTSCCS-SCCSS-S--CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred CCCCccccCCCC---EEECCCCCcC-ccCCC-C--CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhH
Confidence 366555554322 3467788888 78873 3 257999999999999777789999999999999999999877777
Q ss_pred cc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCC-CCCccccCCCCC
Q 005693 185 FS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG-SIPSSLQKFPNS 259 (682)
Q Consensus 185 ~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g-~~p~~~~~l~~l 259 (682)
|. ++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..+.. .+++|++|+|++|.+++ .+|..++++++|
T Consensus 96 f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L 175 (635)
T 4g8a_A 96 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 175 (635)
T ss_dssp TTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTC
T ss_pred hcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhh
Confidence 86 89999999999999887889999999999999999999877653 89999999999999986 467888888777
Q ss_pred CCCC
Q 005693 260 SFVG 263 (682)
Q Consensus 260 ~~~~ 263 (682)
+.++
T Consensus 176 ~~L~ 179 (635)
T 4g8a_A 176 EHLD 179 (635)
T ss_dssp CEEE
T ss_pred hhhc
Confidence 6654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.3e-16 Score=174.00 Aligned_cols=151 Identities=25% Similarity=0.363 Sum_probs=123.6
Q ss_pred CCCCCCCCCC----CcceE-EecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcE
Q 005693 95 NWSSTNPICQ----SWVGI-NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY 169 (682)
Q Consensus 95 ~w~~~~~~c~----~w~gv-~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 169 (682)
+|..+.++|. .|.|+ .|.. .+++.|+|++|++++ +|.. + +++|++|+|++|+|+ .+| ..+++|++
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 4665556663 49999 7864 479999999999996 8874 4 388999999999999 788 56899999
Q ss_pred EeecccccCCcCCCCcccccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCC
Q 005693 170 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 249 (682)
Q Consensus 170 L~L~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~ 249 (682)
|+|++|+|++ +|. +..+|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +
T Consensus 105 L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp EECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-C
T ss_pred EEccCCCCCC-cch-hhcCCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-c
Confidence 9999999997 888 77899999999999997 776 68999999999999997 565 78899999999999997 7
Q ss_pred Ccccc-CCCCCCCCCCC
Q 005693 250 PSSLQ-KFPNSSFVGNS 265 (682)
Q Consensus 250 p~~~~-~l~~l~~~~n~ 265 (682)
|. |. ++..|.+.+|.
T Consensus 176 p~-l~~~L~~L~Ls~N~ 191 (571)
T 3cvr_A 176 PE-LPESLEALDVSTNL 191 (571)
T ss_dssp CC-CCTTCCEEECCSSC
T ss_pred ch-hhCCCCEEECcCCC
Confidence 77 54 34444444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=166.17 Aligned_cols=135 Identities=27% Similarity=0.316 Sum_probs=70.6
Q ss_pred eEEEEEeCCCcccccCCccccCCC-----CCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCc--CCCCc--c-
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKL-----DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK--IPSSF--S- 186 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~--~p~~~--~- 186 (682)
+++.|+|++|++++. |. .++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.|. +|..+ .
T Consensus 122 ~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 122 DLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 455556666655544 43 44444 5566666666666555555556666666666666655543 12111 1
Q ss_pred -cccceeecccccCcc--cCC-cchhhhccccceeccCCcccCCCCC--C-CCCCCCeEEecccCCCCCCCcccc
Q 005693 187 -PQLVVLDLSFNSFTG--NIP-QSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQ 254 (682)
Q Consensus 187 -~~L~~L~ls~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~g~~p~--~-~l~~L~~l~ls~N~l~g~~p~~~~ 254 (682)
++|++|+|++|+|++ .++ ..+.++++|+.|+|++|++++.+|. . .+++|+.|+|++|+|+ .+|..+.
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 456666666666552 112 2233455666666666666554432 1 3455666666666665 4554443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=166.65 Aligned_cols=154 Identities=27% Similarity=0.271 Sum_probs=114.8
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCc-------------------------CCCCCCCcEE
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE-------------------------ITSLPSLRYL 170 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~-------------------------~~~l~~L~~L 170 (682)
.++..|+|++|+++ .+|+..|..+++|++|+|++|+|++..+.. |.++++|++|
T Consensus 112 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 190 (440)
T 3zyj_A 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190 (440)
T ss_dssp SSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred ccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence 46778888888887 556556888888888888888777444434 4455555555
Q ss_pred eecccccCCcCCCCcc-cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCC
Q 005693 171 YLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 171 ~L~~N~l~g~~p~~~~-~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g 247 (682)
+|++|+++ .+|.... ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|+|++
T Consensus 191 ~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 191 NLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp ECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred cCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 56666655 3343111 67889999999999888999999999999999999999877764 88999999999999997
Q ss_pred CCCccccCCCCC---CCCCCCCCCCCC
Q 005693 248 SIPSSLQKFPNS---SFVGNSLLCGPP 271 (682)
Q Consensus 248 ~~p~~~~~l~~l---~~~~n~~~~~~~ 271 (682)
..+..|..+++| .+.+|++.|.+.
T Consensus 270 ~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 270 LPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred cChhHhccccCCCEEEcCCCCccCCCC
Confidence 777666666654 566788877654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.6e-16 Score=183.01 Aligned_cols=149 Identities=21% Similarity=0.235 Sum_probs=125.9
Q ss_pred CcceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCC-CCcCCCCCCCcEEeecccccCCcCCC
Q 005693 105 SWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL-PSEITSLPSLRYLYLQHNNFSGKIPS 183 (682)
Q Consensus 105 ~w~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~L~~N~l~g~~p~ 183 (682)
+|..|.+ ...+++.|+|++|.+++..|. .|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|.
T Consensus 15 ~L~~vP~--lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 15 NLTQVPQ--VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CSSCCCS--SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCC--CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 5666665 335788999999999866565 7999999999999999777777 67899999999999999999988888
Q ss_pred Ccc--cccceeecccccCcccCCcc--hhhhccccceeccCCcccCCCCC--C-CCCCCCeEEecccCCCCCCCccccCC
Q 005693 184 SFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKF 256 (682)
Q Consensus 184 ~~~--~~L~~L~ls~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~--~-~l~~L~~l~ls~N~l~g~~p~~~~~l 256 (682)
.|. ++|++|+|++|++++.+|.. |++|++|+.|+|++|++++..+. + .+++|+.|+|++|.+++..|..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 887 78999999999999877765 89999999999999999887654 2 88999999999999998888777544
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-16 Score=185.57 Aligned_cols=144 Identities=22% Similarity=0.355 Sum_probs=131.0
Q ss_pred CeEEEEEeCCCcccc-----------------cCCccccC--CCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccc
Q 005693 116 TRVFGLRLPGIGLVG-----------------PIPNNTLG--KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN 176 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g-----------------~lp~~~~~--~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~ 176 (682)
.++..|+|++|.++| .+|+ .++ +|++|++|+|++|++.|.+|..|++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 478899999999998 4998 677 99999999999999999999999999999999999998
Q ss_pred -cCC-cCCCCcc--c-------ccceeecccccCcccCCc--chhhhccccceeccCCcccCCCCCC-CCCCCCeEEecc
Q 005693 177 -FSG-KIPSSFS--P-------QLVVLDLSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSY 242 (682)
Q Consensus 177 -l~g-~~p~~~~--~-------~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~ 242 (682)
++| .+|..+. + +|++|+|++|+|+ .+|. .|+++++|+.|+|++|+++ .+|.+ .+++|+.|+|++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 998 8888765 3 8999999999999 8999 9999999999999999999 77755 889999999999
Q ss_pred cCCCCCCCccccCCCC-CCCCC
Q 005693 243 NGLKGSIPSSLQKFPN-SSFVG 263 (682)
Q Consensus 243 N~l~g~~p~~~~~l~~-l~~~~ 263 (682)
|+++ .+|..+.++++ |+.++
T Consensus 605 N~l~-~lp~~l~~l~~~L~~L~ 625 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTDQVEGLG 625 (876)
T ss_dssp SCCS-CCCTTSCEECTTCCEEE
T ss_pred Cccc-cchHHHhhccccCCEEE
Confidence 9999 89988887777 66553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-16 Score=174.79 Aligned_cols=145 Identities=20% Similarity=0.174 Sum_probs=83.8
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc---cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~L~~L~ 193 (682)
.+..|+|++|.+++..+ ..+++|+.|+|++|.|++..|..++++++|++|+|++|+|++.+|..+. ++|++|+
T Consensus 100 ~L~~L~L~~N~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 100 SIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TCCEEECCSSCCCCEEE----CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECcCCcCCCCCc----cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 45556666666654322 2345666666666666666666666666666666666666665555553 5666666
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCC---CCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLC 268 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~---~~~n~~~~ 268 (682)
|++|+|++..+ +..+++|+.|+|++|+|++.+|.+ .+++|+.|+|++|+|++ +|..+..+++|. +.+|+..|
T Consensus 176 Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred cCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 66666665422 234666666666666666655543 55666666666666663 555554444433 33444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=166.21 Aligned_cols=154 Identities=25% Similarity=0.235 Sum_probs=117.9
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCc-------------------------CCCCCCCcEE
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE-------------------------ITSLPSLRYL 170 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~-------------------------~~~l~~L~~L 170 (682)
.++..|+|++|+++ .+|+..|+++++|++|+|++|+|++..+.. |.++++|++|
T Consensus 123 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 201 (452)
T 3zyi_A 123 ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201 (452)
T ss_dssp TTCCEEECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred ccCCEEECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence 46788888888888 556557888888888888888887444333 4555666666
Q ss_pred eecccccCCcCCCCcc-cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCC
Q 005693 171 YLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 171 ~L~~N~l~g~~p~~~~-~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g 247 (682)
+|++|++++ +|.... ++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|.. .+++|+.|+|++|+|++
T Consensus 202 ~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 280 (452)
T 3zyi_A 202 NLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280 (452)
T ss_dssp ECTTSCCSS-CCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred ECCCCcccc-cccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence 666666664 332111 68999999999999888999999999999999999999887764 88999999999999997
Q ss_pred CCCccccCCCCC---CCCCCCCCCCCC
Q 005693 248 SIPSSLQKFPNS---SFVGNSLLCGPP 271 (682)
Q Consensus 248 ~~p~~~~~l~~l---~~~~n~~~~~~~ 271 (682)
..+..+..+++| .+.+|++.|.+.
T Consensus 281 ~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 281 LPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred cChHHhccccCCCEEEccCCCcCCCCC
Confidence 776666666654 566788777654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.7e-16 Score=144.25 Aligned_cols=122 Identities=26% Similarity=0.281 Sum_probs=75.4
Q ss_pred eEEEEEeCCCccc-ccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 117 RVFGLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~-g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
+++.|++++|+++ +.+|. .++.+++|++|+|++|.+++. ..++++++|++|+|++|++++.+|..+. ++|++|+
T Consensus 18 ~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred cCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 4566666666666 56665 566666666666666666654 5566666666666666666655555443 5666666
Q ss_pred cccccCccc-CCcchhhhccccceeccCCcccCCCC---C-C-CCCCCCeEEec
Q 005693 194 LSFNSFTGN-IPQSIQNLTQLTGLSLQSNNLSGSIP---N-F-DIPKLRHLNLS 241 (682)
Q Consensus 194 ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p---~-~-~l~~L~~l~ls 241 (682)
|++|++++. .|..++++++|+.|++++|++++..+ . . .+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666652 33566666666666666666665544 1 1 55666666654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=9.7e-16 Score=148.59 Aligned_cols=140 Identities=19% Similarity=0.330 Sum_probs=118.5
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
+++.|++++|++. .+| .+..+++|++|+|++|.++ .++.+..+++|++|+|++|++++..|..+. ++|++|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 5788999999998 677 4899999999999999775 334799999999999999999987888877 79999999
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
++|++++..|..++++++|+.|+|++|++.+.+|.. .+++|+.|++++|++++ ++ .+..+++|+.++
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~ 187 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLY 187 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEE
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEE
Confidence 999999989999999999999999999833345544 88999999999999996 44 566666665543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.3e-16 Score=161.65 Aligned_cols=148 Identities=22% Similarity=0.214 Sum_probs=104.2
Q ss_pred CeEEEEEeCCCcccccCCc---cccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCc--CC-CCc-c--
Q 005693 116 TRVFGLRLPGIGLVGPIPN---NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK--IP-SSF-S-- 186 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~---~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~--~p-~~~-~-- 186 (682)
.++..|+|++|.+++..+. ..+..+++|++|+|++|++++..|..|+++++|++|+|++|++.+. ++ ..+ .
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 4677788888888876551 2355788888888888888877778888888888888888887652 22 221 2
Q ss_pred cccceeecccccCcccCCc----chhhhccccceeccCCcccCCCCCC--C---CCCCCeEEecccCCCCCCCcccc-CC
Q 005693 187 PQLVVLDLSFNSFTGNIPQ----SIQNLTQLTGLSLQSNNLSGSIPNF--D---IPKLRHLNLSYNGLKGSIPSSLQ-KF 256 (682)
Q Consensus 187 ~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~~p~~--~---l~~L~~l~ls~N~l~g~~p~~~~-~l 256 (682)
++|++|+|++|+|+ .+|. .++++++|+.|+|++|+|++..|.. . +++|++|+|++|+|+ .+|..+. ++
T Consensus 197 ~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L 274 (310)
T 4glp_A 197 PAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKL 274 (310)
T ss_dssp CCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCC
T ss_pred CCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCC
Confidence 67888888888887 3333 2567788888888888888775532 3 368888888888888 6666553 44
Q ss_pred CCCCCCCCC
Q 005693 257 PNSSFVGNS 265 (682)
Q Consensus 257 ~~l~~~~n~ 265 (682)
..|.+.+|.
T Consensus 275 ~~L~Ls~N~ 283 (310)
T 4glp_A 275 RVLDLSSNR 283 (310)
T ss_dssp SCEECCSCC
T ss_pred CEEECCCCc
Confidence 444444443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=176.51 Aligned_cols=149 Identities=26% Similarity=0.289 Sum_probs=127.8
Q ss_pred CcceEEecCC---------CCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccc
Q 005693 105 SWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 175 (682)
Q Consensus 105 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 175 (682)
.+..|.|+.. ..+++.|+|++|++++ +|+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 5 ~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 5 SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred ECCeeECCCCCccccccccCCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4566777642 2478999999999995 55557999999999999999999999999999999999999999
Q ss_pred ccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCc
Q 005693 176 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS 251 (682)
Q Consensus 176 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~ 251 (682)
++++..+..|. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|.. .+++|++|+|++|++++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99965555666 79999999999999888889999999999999999999887764 899999999999999987776
Q ss_pred ccc
Q 005693 252 SLQ 254 (682)
Q Consensus 252 ~~~ 254 (682)
.+.
T Consensus 164 ~~~ 166 (680)
T 1ziw_A 164 ELD 166 (680)
T ss_dssp HHG
T ss_pred Hhh
Confidence 543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=8e-16 Score=175.46 Aligned_cols=143 Identities=24% Similarity=0.229 Sum_probs=109.3
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCc-CCCCCCCcEEeecccccCCcCCCCcc--ccccee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L 192 (682)
.++..|++++|.+.+..|. .++.+++|+.|+|++|++++..|.. +.++++|+.|+|++|.+++..|..+. ++|++|
T Consensus 376 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 454 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454 (606)
T ss_dssp TTCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence 4677888888888866555 6888888888888888888776654 77888888888888888877777665 678888
Q ss_pred ecccccCccc---CCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCC
Q 005693 193 DLSFNSFTGN---IPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS 259 (682)
Q Consensus 193 ~ls~N~l~g~---~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l 259 (682)
+|++|++++. .+..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|++++..|..+.+++.|
T Consensus 455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 526 (606)
T 3t6q_A 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526 (606)
T ss_dssp ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence 8888888762 3356778888888888888888776653 77788888888888887777777777766
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=6.9e-16 Score=171.08 Aligned_cols=97 Identities=21% Similarity=0.216 Sum_probs=53.2
Q ss_pred CCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchh-hhccccceeccCCcccCCCCCCCCCCCCeEEec
Q 005693 165 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS 241 (682)
Q Consensus 165 ~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls 241 (682)
++|+.|+|++|++++..|..+. ++|++|+|++|+|++.+|..+. ++++|+.|+|++|.|++..+...+++|+.|+|+
T Consensus 120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls 199 (487)
T 3oja_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLS 199 (487)
T ss_dssp SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECC
T ss_pred CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECC
Confidence 3444444444444444444443 4566666666666655555554 556666666666666655444456666666666
Q ss_pred ccCCCCCCCccccCCCCCCCC
Q 005693 242 YNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 242 ~N~l~g~~p~~~~~l~~l~~~ 262 (682)
+|++++ +|+.+..+++|..+
T Consensus 200 ~N~l~~-~~~~~~~l~~L~~L 219 (487)
T 3oja_A 200 SNKLAF-MGPEFQSAAGVTWI 219 (487)
T ss_dssp SSCCCE-ECGGGGGGTTCSEE
T ss_pred CCCCCC-CCHhHcCCCCccEE
Confidence 666664 33335555555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.2e-15 Score=163.72 Aligned_cols=141 Identities=22% Similarity=0.203 Sum_probs=97.3
Q ss_pred CcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccc
Q 005693 105 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 175 (682)
Q Consensus 105 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 175 (682)
.|..|.|.... ..++.|+|++|++.+..+ ..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKV-NSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECT-TTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCH-HHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 46788887532 356788999999885444 47888999999999999888777788888888999999888
Q ss_pred ccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC---CCCCCCeEEecccCCC
Q 005693 176 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 176 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~l~~L~~l~ls~N~l~ 246 (682)
+|++..+..|. ++|++|+|++|+|++..+..|.++++|+.|+|++|+..+.++.. .+++|+.|+|++|+++
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 88865555555 67888888888887665556666666666666554333333321 4444444444444444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.7e-15 Score=157.85 Aligned_cols=143 Identities=23% Similarity=0.359 Sum_probs=112.6
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCC--CCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~--g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~l 194 (682)
++..|++++|.+. .+|+..++++++|++|+|++|.++ +..|..+..+ +|+.|++++|++++ +|..+.++|++|+|
T Consensus 124 ~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~~~L~~L~l 200 (332)
T 2ft3_A 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPETLNELHL 200 (332)
T ss_dssp TCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSCSSCSCCBC
T ss_pred cCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccccCCCCEEEC
Confidence 4666667777666 445445777777777777777774 3566667777 77777777777774 67666688999999
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
++|++++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+++ .+|..+.++++|+.++
T Consensus 201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 270 (332)
T 2ft3_A 201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270 (332)
T ss_dssp CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEE
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEE
Confidence 999999888889999999999999999999877753 7899999999999999 7888888887776654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-15 Score=167.91 Aligned_cols=147 Identities=20% Similarity=0.155 Sum_probs=130.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|.+++..|. .|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|. ++|++|+
T Consensus 56 ~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPG-AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp TTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCEeChh-hhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 4789999999999976666 899999999999999999966666789999999999999999988888877 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCC--CCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|++|++++..|..|.++++|+.|+|++|++++..+. ..+++|+.|+|++|++++..+..|.++++|+.++
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 206 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEE
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceee
Confidence 999999999999999999999999999999976554 2889999999999999988777888888777654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.4e-15 Score=158.09 Aligned_cols=144 Identities=25% Similarity=0.357 Sum_probs=124.6
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCC--CCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~--g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~l 194 (682)
.+..|++++|.+.+ +++..++++++|++|+|++|.++ +..|..+.++++|++|+|++|+++ .+|..+.++|++|+|
T Consensus 122 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~L~~L~l 199 (330)
T 1xku_A 122 TLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHL 199 (330)
T ss_dssp TCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEEC
T ss_pred cccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccccccCCEEEC
Confidence 56777777777774 44446889999999999999996 377888999999999999999998 578777799999999
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
++|++++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+++ .+|..+..+++|+.++
T Consensus 200 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 269 (330)
T 1xku_A 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269 (330)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEE
Confidence 999999998999999999999999999999877753 8899999999999999 8898888888777654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.5e-15 Score=171.06 Aligned_cols=108 Identities=24% Similarity=0.264 Sum_probs=68.9
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
++..|+|++|.+++..|. .|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|. ++|++|+|
T Consensus 76 ~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTY-AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCSEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCCCChH-HhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 456666666666644333 566666677777776666666666666666677777776666643333333 56666666
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 225 (682)
++|+|++..|..|+++++|+.|+|++|+|++
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 6666666666666666666666666666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.4e-15 Score=168.75 Aligned_cols=150 Identities=23% Similarity=0.333 Sum_probs=124.2
Q ss_pred CCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCC--CCCCcCCCCCCCcEEeecccccCCcCCCCc-c--ccc
Q 005693 115 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQHNNFSGKIPSSF-S--PQL 189 (682)
Q Consensus 115 ~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-~--~~L 189 (682)
-.+++.|+|++|.+++.+|. .++++++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|... . ++|
T Consensus 352 l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 35788999999999988887 79999999999999999996 345678999999999999999998777653 3 789
Q ss_pred ceeecccccCcccCCcchhhhccccceeccCCcccCCCCC-C-CCCCCCeEEecccCCCCCCCcc-ccCCCCCC---CCC
Q 005693 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-F-DIPKLRHLNLSYNGLKGSIPSS-LQKFPNSS---FVG 263 (682)
Q Consensus 190 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~-~l~~L~~l~ls~N~l~g~~p~~-~~~l~~l~---~~~ 263 (682)
++|+|++|+|++.+|..+. ++|+.|+|++|+|+ .+|. . .+++|+.|+|++|+++ .+|.. +..+++|+ +.+
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~ 506 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHD 506 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCS
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecC
Confidence 9999999999988887765 78999999999999 4554 3 8899999999999999 56665 77666655 456
Q ss_pred CCCCCC
Q 005693 264 NSLLCG 269 (682)
Q Consensus 264 n~~~~~ 269 (682)
|+..|.
T Consensus 507 N~~~c~ 512 (562)
T 3a79_B 507 NPWDCT 512 (562)
T ss_dssp CCBCCC
T ss_pred CCcCCC
Confidence 666654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=9.4e-16 Score=141.47 Aligned_cols=123 Identities=17% Similarity=0.258 Sum_probs=108.2
Q ss_pred CCCCCcEEEccCCCCC-CCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccc
Q 005693 139 KLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTG 215 (682)
Q Consensus 139 ~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 215 (682)
..++|+.|+|++|+++ +.+|..+..+++|++|+|++|++++. ..+. ++|++|+|++|++++.+|..+.++++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 4578999999999998 89999999999999999999999976 4554 79999999999999889999999999999
Q ss_pred eeccCCcccCCC--CCC-CCCCCCeEEecccCCCCCCC---ccccCCCCCCCCC
Q 005693 216 LSLQSNNLSGSI--PNF-DIPKLRHLNLSYNGLKGSIP---SSLQKFPNSSFVG 263 (682)
Q Consensus 216 L~l~~N~l~g~~--p~~-~l~~L~~l~ls~N~l~g~~p---~~~~~l~~l~~~~ 263 (682)
|+|++|++++.. +.. .+++|+.|++++|++++..+ ..+..+++|+.++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 146 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEET
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccccc
Confidence 999999999742 333 89999999999999997665 4688888887765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.7e-15 Score=141.39 Aligned_cols=125 Identities=22% Similarity=0.285 Sum_probs=109.0
Q ss_pred CCCCCCcEEEccCCCCC-CCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhcccc
Q 005693 138 GKLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 214 (682)
Q Consensus 138 ~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 214 (682)
...++|+.|+|++|+++ +.+|..+..+++|++|+|++|++++. ..+. ++|++|+|++|++++.+|..+.++++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34578999999999998 89999999999999999999999976 4554 7999999999999988999999999999
Q ss_pred ceeccCCcccCCC--CCC-CCCCCCeEEecccCCCCCCC---ccccCCCCCCCCCC
Q 005693 215 GLSLQSNNLSGSI--PNF-DIPKLRHLNLSYNGLKGSIP---SSLQKFPNSSFVGN 264 (682)
Q Consensus 215 ~L~l~~N~l~g~~--p~~-~l~~L~~l~ls~N~l~g~~p---~~~~~l~~l~~~~n 264 (682)
.|+|++|++++.. +.. .+++|+.|++++|.+++..+ ..+..+++|+.++-
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 154 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDG 154 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETT
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecC
Confidence 9999999999754 233 89999999999999996555 47888888887763
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.3e-16 Score=161.81 Aligned_cols=146 Identities=21% Similarity=0.252 Sum_probs=118.2
Q ss_pred CeEEEEEeCCCcccccCCcccc-CCCCCCcEEEccCCCCCCCCCCcCCCC-----CCCcEEeecccccCCcCCCCcc--c
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTL-GKLDALEVLSLRSNVLTGGLPSEITSL-----PSLRYLYLQHNNFSGKIPSSFS--P 187 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~-~~l~~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~--~ 187 (682)
.++..|+|++|+++|.+|...+ +.+++|++|+|++|++++. |..++++ ++|++|+|++|++++..|..+. +
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 4688899999999999988432 8999999999999999977 8888887 8999999999999988778876 7
Q ss_pred ccceeecccccCccc--CCcch--hhhccccceeccCCcccCC--CCCC---CCCCCCeEEecccCCCCCCC-ccccCCC
Q 005693 188 QLVVLDLSFNSFTGN--IPQSI--QNLTQLTGLSLQSNNLSGS--IPNF---DIPKLRHLNLSYNGLKGSIP-SSLQKFP 257 (682)
Q Consensus 188 ~L~~L~ls~N~l~g~--~p~~~--~~l~~L~~L~l~~N~l~g~--~p~~---~l~~L~~l~ls~N~l~g~~p-~~~~~l~ 257 (682)
+|++|+|++|+++|. +|..+ +++++|+.|+|++|+|++. ++.. .+++|+.|+|++|++++.+| ..+..++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 899999999998876 34444 8899999999999999842 2221 67899999999999998775 4455555
Q ss_pred CCCCC
Q 005693 258 NSSFV 262 (682)
Q Consensus 258 ~l~~~ 262 (682)
+|+.+
T Consensus 254 ~L~~L 258 (312)
T 1wwl_A 254 QLNSL 258 (312)
T ss_dssp TCCEE
T ss_pred CCCEE
Confidence 55544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.2e-15 Score=158.01 Aligned_cols=132 Identities=11% Similarity=0.124 Sum_probs=95.3
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---------------hhh--------HHHHHHHHHHhcCCCceece
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------------KRD--------FEQQMEIVGRVGQHPNVVPL 446 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------~~~--------~~~e~~~l~~l~~h~niv~l 446 (682)
.+.||+|+||.||+|...+|+.||||+++..... ... ..+|...+.++ .+.++...
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~gv~vp 178 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEGFPVP 178 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTTCSCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcCCCCC
Confidence 5689999999999999988999999987532110 001 23455666666 33333221
Q ss_pred EEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC
Q 005693 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL 526 (682)
Q Consensus 447 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~ 526 (682)
.-+.. ...++||||++++.|.++.. . .....++.|++.+|.+||+.| ||||||||.|||+++++
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK 242 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred eeeec--cCceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence 11111 23579999999988876542 1 124568899999999999998 99999999999999877
Q ss_pred C----------eEEeecCCCCC
Q 005693 527 D----------GCISDFGLTPL 538 (682)
Q Consensus 527 ~----------~kl~DfGla~~ 538 (682)
. +.|+||+-+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 3 88999996644
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.1e-15 Score=157.70 Aligned_cols=148 Identities=25% Similarity=0.244 Sum_probs=123.1
Q ss_pred ceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCC-CCCCCcEEeecccccCCcCCCCc
Q 005693 107 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPSSF 185 (682)
Q Consensus 107 ~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~ 185 (682)
....|.. ..+++++++|+ .+|. .+. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|
T Consensus 14 ~~C~C~~-----~~l~c~~~~l~-~iP~-~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~ 84 (361)
T 2xot_A 14 ANCLCAS-----NILSCSKQQLP-NVPQ-SLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF 84 (361)
T ss_dssp TTCEEET-----TEEECCSSCCS-SCCS-SCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTT
T ss_pred CCCEECC-----CEEEeCCCCcC-ccCc-cCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhc
Confidence 5667764 25899999998 6887 343 4689999999999987777787 99999999999999998777777
Q ss_pred c--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccc---cCCCC
Q 005693 186 S--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSL---QKFPN 258 (682)
Q Consensus 186 ~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~---~~l~~ 258 (682)
. ++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|+|++..+..| .++++
T Consensus 85 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~ 164 (361)
T 2xot_A 85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPK 164 (361)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTT
T ss_pred cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCc
Confidence 6 79999999999999888889999999999999999999877764 89999999999999996444444 45666
Q ss_pred CCCCC
Q 005693 259 SSFVG 263 (682)
Q Consensus 259 l~~~~ 263 (682)
|..++
T Consensus 165 L~~L~ 169 (361)
T 2xot_A 165 LMLLD 169 (361)
T ss_dssp CCEEE
T ss_pred CCEEE
Confidence 65544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.8e-15 Score=150.59 Aligned_cols=138 Identities=20% Similarity=0.247 Sum_probs=114.6
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.++..|++++|+++ .+| .++.+++|++|+|++|+|++..| +.++++|++|+|++|++++ +|....++|++|+|+
T Consensus 41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~~~L~~L~L~ 114 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPSACLSRLFLD 114 (263)
T ss_dssp TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCCSSCCEEECC
T ss_pred CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccccCcccEEEcc
Confidence 36788999999988 576 48999999999999999996554 9999999999999999996 443333899999999
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+|+|++. +.+.++++|+.|+|++|+|++..+-..+++|+.|+|++|++++. ..+.++++|..++
T Consensus 115 ~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~ 178 (263)
T 1xeu_A 115 NNELRDT--DSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWID 178 (263)
T ss_dssp SSCCSBS--GGGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEE
T ss_pred CCccCCC--hhhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEe
Confidence 9999964 36999999999999999999764334889999999999999976 5677777766543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.2e-15 Score=168.94 Aligned_cols=151 Identities=25% Similarity=0.305 Sum_probs=104.9
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCC-CcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
++..|++++|.+.+ +|+ .++.+++|++|+|++|.+++..| ..+.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 374 ~L~~L~l~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 451 (570)
T 2z63_A 374 SLKYLDLSFNGVIT-MSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451 (570)
T ss_dssp CCCEEECCSCSEEE-EEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred ccCEEECCCCcccc-ccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence 45566666666663 444 27777777777777777776655 4577777777777777777777776665 6777788
Q ss_pred cccccCc-ccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC---CCCCCCC
Q 005693 194 LSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLL 267 (682)
Q Consensus 194 ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~---~~~n~~~ 267 (682)
|++|+++ +.+|..+..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..|..+.++++|+ +.+|+..
T Consensus 452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 531 (570)
T 2z63_A 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531 (570)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCccc
Confidence 8877776 567777777778888888888777766653 677788888888877776666666666554 3345544
Q ss_pred CC
Q 005693 268 CG 269 (682)
Q Consensus 268 ~~ 269 (682)
|.
T Consensus 532 ~~ 533 (570)
T 2z63_A 532 CS 533 (570)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.9e-15 Score=142.56 Aligned_cols=120 Identities=21% Similarity=0.268 Sum_probs=108.5
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 174 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 174 (682)
|.|..+.|++.. ..++.|+|++|+++ .+|. .|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~-~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPK-ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCG-GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHH-HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 478889997532 36889999999998 8886 899999999999999999988888999999999999999
Q ss_pred cccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccC
Q 005693 175 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225 (682)
Q Consensus 175 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 225 (682)
|+|++..|..|. ++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999988887786 899999999999997777789999999999999999974
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.4e-15 Score=167.04 Aligned_cols=148 Identities=27% Similarity=0.378 Sum_probs=105.2
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCC--CCCCcCCCCCCCcEEeecccccCCcCCCC-cc--cccc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLV 190 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~--~~L~ 190 (682)
..++.|++++|.+++.+|. .++++++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +. ++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4577788888888776776 67788888888888888875 55666778888888888888887756654 32 6788
Q ss_pred eeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCcc-ccCCCCCC---CCCC
Q 005693 191 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS-LQKFPNSS---FVGN 264 (682)
Q Consensus 191 ~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~-~~~l~~l~---~~~n 264 (682)
+|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|.. .+++|+.|+|++|+++ .+|.. +.++++|+ +.+|
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N 478 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCC
Confidence 888888888777776654 67888888888887 55542 7778888888888887 45554 65555544 4455
Q ss_pred CCCC
Q 005693 265 SLLC 268 (682)
Q Consensus 265 ~~~~ 268 (682)
+..|
T Consensus 479 ~~~c 482 (520)
T 2z7x_B 479 PWDC 482 (520)
T ss_dssp CBCC
T ss_pred CCcc
Confidence 5544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-15 Score=158.30 Aligned_cols=146 Identities=21% Similarity=0.227 Sum_probs=121.3
Q ss_pred eEEEEEeCCCcccccCCcccc--CCCCCCcEEEccCCCCCCCCC----CcCCCCCCCcEEeecccccCCcCCCCcc--cc
Q 005693 117 RVFGLRLPGIGLVGPIPNNTL--GKLDALEVLSLRSNVLTGGLP----SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQ 188 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~--~~l~~L~~L~L~~N~l~g~~p----~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~ 188 (682)
++..|+|++|++++.+|. .+ +.+++|++|+|++|++++..| ..+..+++|++|+|++|++++..|..+. ++
T Consensus 92 ~L~~L~l~~n~l~~~~~~-~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPP-LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCC-CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchhh-hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 488999999999999988 56 999999999999999998766 3456899999999999999988888876 79
Q ss_pred cceeecccccCccc--C--CcchhhhccccceeccCCcccCCCCC-----CCCCCCCeEEecccCCCCCCCccccCC---
Q 005693 189 LVVLDLSFNSFTGN--I--PQSIQNLTQLTGLSLQSNNLSGSIPN-----FDIPKLRHLNLSYNGLKGSIPSSLQKF--- 256 (682)
Q Consensus 189 L~~L~ls~N~l~g~--~--p~~~~~l~~L~~L~l~~N~l~g~~p~-----~~l~~L~~l~ls~N~l~g~~p~~~~~l--- 256 (682)
|++|+|++|++++. + +..++++++|++|+|++|+++...+. ..+++|++|+|++|++++..|+.+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 99999999998863 2 23457899999999999999743221 167999999999999999888877665
Q ss_pred CCCCCCC
Q 005693 257 PNSSFVG 263 (682)
Q Consensus 257 ~~l~~~~ 263 (682)
++|+.++
T Consensus 251 ~~L~~L~ 257 (310)
T 4glp_A 251 SALNSLN 257 (310)
T ss_dssp TTCCCEE
T ss_pred CcCCEEE
Confidence 4555544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=3.5e-15 Score=168.64 Aligned_cols=143 Identities=21% Similarity=0.193 Sum_probs=126.0
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.+++.|+|++|++++..+ ..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|. ++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEECT-TTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCccCh-hHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 468899999999996444 4799999999999999999988888899999999999999999987778776 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccC-CCCCC--CCCCCCeEEecccCCCCCCCccccCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS 259 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l 259 (682)
|++|++++..+..|+++++|++|+|++|++++ .+|.. .+++|+.|++++|++++..|..++.+.+|
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 175 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTC
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhcc
Confidence 99999997766689999999999999999997 45764 79999999999999998878777766665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=9e-15 Score=169.13 Aligned_cols=140 Identities=23% Similarity=0.267 Sum_probs=99.0
Q ss_pred cCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCC--------Ccc--cccceeecccccCc
Q 005693 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS--------SFS--PQLVVLDLSFNSFT 200 (682)
Q Consensus 131 ~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~--------~~~--~~L~~L~ls~N~l~ 200 (682)
.+|. .++++++|++|+|++|++++..|..|.++++|++|+|++|++++..+. .+. ++|++|+|++|+|+
T Consensus 471 ~~p~-~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 549 (680)
T 1ziw_A 471 SSPS-PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549 (680)
T ss_dssp CSSC-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC
T ss_pred cCCc-ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC
Confidence 4454 577777777777777777766666677777888888888877753221 122 67888888888888
Q ss_pred ccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCcc----ccCCCCCCCCCCCCCCCCC
Q 005693 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS----LQKFPNSSFVGNSLLCGPP 271 (682)
Q Consensus 201 g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~----~~~l~~l~~~~n~~~~~~~ 271 (682)
...+..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|++++..|.. +.++..+.+.+|++.|.++
T Consensus 550 ~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 444456888888888888888888655543 6788888888888888766653 3456666677788877654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.6e-15 Score=150.11 Aligned_cols=144 Identities=19% Similarity=0.235 Sum_probs=121.9
Q ss_pred CeEEEEEeCCCc-ccccCCccccCCCCCCcEEEccC-CCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccc-
Q 005693 116 TRVFGLRLPGIG-LVGPIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV- 190 (682)
Q Consensus 116 ~~v~~l~l~~~~-l~g~lp~~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~- 190 (682)
.++..|++++|+ ++ .+++..|+++++|++|+|++ |++++..+..|.++++|++|+|++|++++ +|. +. ++|+
T Consensus 55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 468899999998 66 67766899999999999999 99997777789999999999999999996 776 54 6677
Q ss_pred --eeecccc-cCcccCCcchhhhcccc-ceeccCCcccCCCCCC--CCCCCCeEEecccC-CCCCCCccccCC-CCCCCC
Q 005693 191 --VLDLSFN-SFTGNIPQSIQNLTQLT-GLSLQSNNLSGSIPNF--DIPKLRHLNLSYNG-LKGSIPSSLQKF-PNSSFV 262 (682)
Q Consensus 191 --~L~ls~N-~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~-l~g~~p~~~~~l-~~l~~~ 262 (682)
+|+|++| ++++..+..|.++++|+ .|+|++|+++ .+|.. ..++|+.|+|++|+ +++..+..|..+ ++|+.+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L 210 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence 9999999 99988778899999999 9999999999 55543 45789999999995 986666778777 777665
Q ss_pred C
Q 005693 263 G 263 (682)
Q Consensus 263 ~ 263 (682)
+
T Consensus 211 ~ 211 (239)
T 2xwt_C 211 D 211 (239)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.4e-15 Score=144.69 Aligned_cols=128 Identities=23% Similarity=0.339 Sum_probs=109.0
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|++++|.++ .+ + .++.+++|++|+|++|++++..|..++++++|++|+|++|++++..|..+. ++|++|+
T Consensus 66 ~~L~~L~l~~n~~~-~~-~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT-NY-N-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS-CC-G-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC-cc-h-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 46889999999765 33 3 699999999999999999988899999999999999999999987777776 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g 247 (682)
|++|++.+.+| .+.++++|+.|+|++|++++..+-..+++|+.|++++|++.+
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99999433666 799999999999999999975533489999999999999874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=6.2e-15 Score=165.96 Aligned_cols=146 Identities=22% Similarity=0.296 Sum_probs=112.1
Q ss_pred CeEEEEEeCCCcccccCCc--cccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPN--NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~--~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ 193 (682)
.+++.|+|++|++++ ++. ..++.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+++ .+|..+.++|++|+
T Consensus 361 ~~L~~L~Ls~N~l~~-~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~ 437 (549)
T 2z81_A 361 PSLQTLVLSQNHLRS-MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLD 437 (549)
T ss_dssp TTCCEEECTTSCCCC-HHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEE
T ss_pred ccCcEEEccCCcccc-cccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEE
Confidence 356677777777763 221 24777888888888888888 67778888888888888888887 56666667888888
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCC---CCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLCG 269 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~---~~~n~~~~~ 269 (682)
|++|+|++.+ .++++|+.|+|++|+|+ .+|.. .+++|+.|+|++|++++.+|..+.++++|+ +.+|+..|.
T Consensus 438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 438 VSNNNLDSFS----LFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred CCCCChhhhc----ccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 8888888653 47889999999999998 56654 789999999999999988887777666654 556666554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=156.54 Aligned_cols=107 Identities=26% Similarity=0.352 Sum_probs=66.4
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCC-cc--cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~--~~L~~L~ 193 (682)
++..|+|++|++.+ +++..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|.. |. ++|++|+
T Consensus 70 ~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 70 QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred cCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 45666666666663 33335666666666666666666655666666666666666666666 33333 32 5666666
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 225 (682)
|++|++++..|..|+++++|+.|+|++|++++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 66666666666666666666666666666653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=8.5e-15 Score=165.47 Aligned_cols=125 Identities=26% Similarity=0.326 Sum_probs=106.4
Q ss_pred CCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCC--cCCCCcc--cccceeecccccCcccCCc-chhhhcc
Q 005693 138 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG--KIPSSFS--PQLVVLDLSFNSFTGNIPQ-SIQNLTQ 212 (682)
Q Consensus 138 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~--~~L~~L~ls~N~l~g~~p~-~~~~l~~ 212 (682)
+.+++|++|+|++|++++.+|..+.++++|++|+|++|++++ .+|..+. ++|++|+|++|++++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 788999999999999999899999999999999999999996 3344554 7899999999999985665 5889999
Q ss_pred ccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 213 LTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 213 L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|+.|+|++|++++.+|..-.++|+.|+|++|+++ .+|..+.++++|+.++
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~ 479 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEE
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEE
Confidence 9999999999998777653379999999999999 7888777777776654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=4.2e-15 Score=166.22 Aligned_cols=125 Identities=27% Similarity=0.314 Sum_probs=102.9
Q ss_pred CCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCC--cCCCCcc--cccceeecccccCcccCCc-chhhhcc
Q 005693 138 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG--KIPSSFS--PQLVVLDLSFNSFTGNIPQ-SIQNLTQ 212 (682)
Q Consensus 138 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~--~~L~~L~ls~N~l~g~~p~-~~~~l~~ 212 (682)
+.+++|++|+|++|++++.+|..++++++|++|+|++|++++ .+|..+. ++|++|+|++|++++.+|. .+..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 678889999999999998888889999999999999999986 5555554 7899999999999986665 4888889
Q ss_pred ccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 213 LTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 213 L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|+.|+|++|++++.+|..-.++|+.|+|++|+++ .+|..+.++++|+.++
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~ 450 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEE
T ss_pred CCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEE
Confidence 9999999999988777654478999999999998 7888777777776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=153.86 Aligned_cols=95 Identities=21% Similarity=0.241 Sum_probs=61.1
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCC-cCCCCCCCcE-Eee
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRY-LYL 172 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~-L~L 172 (682)
|+|..|.|++.. ..++.|+|++|+|+ .||++.|++|++|++|+|++|++.+.+|. .|.++++|+. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 489999998532 35889999999998 78887899999999999999998765553 3444444332 333
Q ss_pred cccccCCcCCCCcc--cccceeecccccC
Q 005693 173 QHNNFSGKIPSSFS--PQLVVLDLSFNSF 199 (682)
Q Consensus 173 ~~N~l~g~~p~~~~--~~L~~L~ls~N~l 199 (682)
+.|++++..|..|. ++|++|++++|+|
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l 116 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGI 116 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECC
T ss_pred cCCcccccCchhhhhcccccccccccccc
Confidence 34444433333332 3333333333333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.9e-15 Score=156.56 Aligned_cols=143 Identities=22% Similarity=0.208 Sum_probs=85.1
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCC-c---------------CCCCCCCcEEeecccccCC
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-E---------------ITSLPSLRYLYLQHNNFSG 179 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~-~---------------~~~l~~L~~L~L~~N~l~g 179 (682)
.++..|+|++|.+++..+ ++.+++|++|+|++|++++..+. . ...+++|+.|+|++|++++
T Consensus 58 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (317)
T ss_dssp TTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred CcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence 467888888888875442 77888888888888877642211 0 0123445555555555554
Q ss_pred cCCCCcc--cccceeecccccCcccCCcchh-hhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCC
Q 005693 180 KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 256 (682)
Q Consensus 180 ~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l 256 (682)
..|..+. ++|++|+|++|++++..|..+. .+++|+.|+|++|++++..+...+++|+.|+|++|++++ +|+.+..+
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l 213 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSA 213 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE-ECGGGGGG
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc-chhhhccc
Confidence 4444443 5566666666666665555553 566666666666666654333456667777777777763 44445555
Q ss_pred CCCCCC
Q 005693 257 PNSSFV 262 (682)
Q Consensus 257 ~~l~~~ 262 (682)
++|+.+
T Consensus 214 ~~L~~L 219 (317)
T 3o53_A 214 AGVTWI 219 (317)
T ss_dssp TTCSEE
T ss_pred CcccEE
Confidence 555544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-15 Score=158.33 Aligned_cols=137 Identities=19% Similarity=0.144 Sum_probs=79.7
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc---cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~L~~L~ 193 (682)
.+..|++++|++++..+ ..+++|++|+|++|++++..|..+..+++|++|+|++|++++..|..+. ++|++|+
T Consensus 100 ~L~~L~l~~n~l~~~~~----~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 100 SIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TCCEEECCSSCCSEEEE----CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECCCCccCCcCc----cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 34455555555553222 2345666666666666665555666666666666666666665555543 5666666
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 260 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~ 260 (682)
|++|+|++. | ....+++|+.|+|++|+|++.++.+ .+++|+.|+|++|+++ .+|..+..+++|+
T Consensus 176 L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~ 240 (317)
T 3o53_A 176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240 (317)
T ss_dssp CTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCC
T ss_pred CCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCC
Confidence 666666644 2 2223666666666666666544443 5566666666666666 4555555444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-14 Score=147.13 Aligned_cols=137 Identities=32% Similarity=0.395 Sum_probs=105.1
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.+++.|+|++|++++ +++ ++++++|++|+|++|++++ +| .+.++++|++|+|++|++++. + .+. ++|++|+
T Consensus 68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~-~l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-N-GLVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-G-GGGGCTTCCEEE
T ss_pred CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-h-hhcCCCCCCEEE
Confidence 467788888888875 443 7888888888888888885 44 488888888888888888863 3 333 7888888
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|++|++++. ..++++++|+.|+|++|++++..|-..+++|+.|+|++|++++ +| .+.++++|..++
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~ 206 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLE 206 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEE
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEE
Confidence 888888865 5788888888888888888877664578888888888888885 44 366666666553
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-15 Score=176.14 Aligned_cols=137 Identities=27% Similarity=0.308 Sum_probs=119.1
Q ss_pred CCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--ccccee
Q 005693 115 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192 (682)
Q Consensus 115 ~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L 192 (682)
...+..|+|++|++. .+|. .+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|. ++|++|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred CCCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 357889999999998 8998 5779999999999999999 99999999999999999999999 8899987 799999
Q ss_pred ecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CC-CCCCeEEecccCCCCCCCccccCC
Q 005693 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DI-PKLRHLNLSYNGLKGSIPSSLQKF 256 (682)
Q Consensus 193 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l-~~L~~l~ls~N~l~g~~p~~~~~l 256 (682)
+|++|.|+ .+|..|++|++|+.|+|++|+|+|.+|.. .+ ..+..|+|++|.++|.+|..+..+
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l 364 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFI 364 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccccee
Confidence 99999998 88999999999999999999999988864 11 123357899999999999876544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.3e-14 Score=161.33 Aligned_cols=117 Identities=25% Similarity=0.263 Sum_probs=97.9
Q ss_pred EEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecc
Q 005693 118 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS 195 (682)
Q Consensus 118 v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls 195 (682)
+..|+|++|++++ +|. +++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .+. ++|++|+|+
T Consensus 443 L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp CSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred ceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 5668899998885 774 888999999999999998 888889999999999999999986 66 555 789999999
Q ss_pred cccCcccC-CcchhhhccccceeccCCcccCCCCCC-----CCCCCCeEEe
Q 005693 196 FNSFTGNI-PQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNL 240 (682)
Q Consensus 196 ~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~l~~L~~l~l 240 (682)
+|+|++.. |..|++|++|+.|+|++|+|++.+|.. .+++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99998876 888999999999999999998877753 4788888864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-16 Score=155.39 Aligned_cols=143 Identities=25% Similarity=0.331 Sum_probs=119.6
Q ss_pred eEEEEEeCCCcccccCCc-----cccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--ccc
Q 005693 117 RVFGLRLPGIGLVGPIPN-----NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 189 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~-----~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L 189 (682)
+++.++++.+++.|.+|. ..++.+++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+. ++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455566666666666664 258999999999999999996 77 8999999999999999999 6787655 799
Q ss_pred ceeecccccCcccCCcchhhhccccceeccCCcccCCCC--C-CCCCCCCeEEecccCCCCCCCcc----------ccCC
Q 005693 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPSS----------LQKF 256 (682)
Q Consensus 190 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~-~~l~~L~~l~ls~N~l~g~~p~~----------~~~l 256 (682)
++|+|++|+|++ +| .+.++++|+.|+|++|++++..+ . ..+++|+.|++++|.+++.+|.. +.++
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 999999999996 55 79999999999999999996433 2 38999999999999998876653 7788
Q ss_pred CCCCCCCC
Q 005693 257 PNSSFVGN 264 (682)
Q Consensus 257 ~~l~~~~n 264 (682)
++|+.++.
T Consensus 174 ~~L~~Ld~ 181 (198)
T 1ds9_A 174 PNLKKLDG 181 (198)
T ss_dssp SSCSEECC
T ss_pred CCcEEECC
Confidence 88888763
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.50 E-value=4e-14 Score=145.99 Aligned_cols=136 Identities=22% Similarity=0.321 Sum_probs=116.5
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.+++.|++++|++. .++ .++.+++|++|+|++|++++..| +.++++|++|+|++|++++ +|. +. ++|++|+
T Consensus 46 ~~L~~L~l~~~~i~-~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 118 (291)
T 1h6t_A 46 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLS 118 (291)
T ss_dssp HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEE
T ss_pred CcccEEEccCCCcc-cCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEE
Confidence 35888999999998 455 48999999999999999996555 9999999999999999996 343 44 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|++|++++. ..+..+++|+.|+|++|++++. +.. .+++|+.|+|++|++++..| +..+++|+.++
T Consensus 119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 184 (291)
T 1h6t_A 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184 (291)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEE
Confidence 999999974 5799999999999999999976 443 89999999999999997555 77787777654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-14 Score=146.69 Aligned_cols=137 Identities=27% Similarity=0.374 Sum_probs=102.3
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|++++ +++ +..+++|++|+|++|++++ +| .+.++++|++|+|++|++++. |. +. ++|++|+
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEE
Confidence 467888888888874 544 7888888888888888885 34 688888888888888888864 32 33 7888888
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|++|++++..+ ++++++|+.|+|++|++++..+-..+++|+.|+|++|++++..+ +..+++|+.++
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~ 201 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEEE
Confidence 88888886544 88888888888888888875554478888888888888885433 55566555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=3.7e-14 Score=147.51 Aligned_cols=139 Identities=26% Similarity=0.389 Sum_probs=117.5
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.++..|+|++|.+++ ++ .++.+++|++|+|++|++++ +| .+.++++|++|+|++|++++..+-.-.++|++|+|+
T Consensus 85 ~~L~~L~L~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~ 159 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS--AIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIG 159 (308)
T ss_dssp CSCCEEECCSCCCSC-CG--GGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECC
T ss_pred CCCCEEEccCCcCCC-ch--hhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCccccCCCCccEEEcc
Confidence 578999999999985 54 59999999999999999996 44 399999999999999999976552222799999999
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+|++++..+ +.++++|+.|+|++|++++..+-..+++|+.|+|++|++++..| +.++++|..++
T Consensus 160 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 223 (308)
T 1h6u_A 160 NAQVSDLTP--LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223 (308)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEE
T ss_pred CCcCCCChh--hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEEE
Confidence 999996544 99999999999999999987665589999999999999996543 77777776553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=4.5e-14 Score=149.79 Aligned_cols=149 Identities=23% Similarity=0.250 Sum_probs=124.2
Q ss_pred ceEEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc
Q 005693 107 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS 186 (682)
Q Consensus 107 ~gv~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 186 (682)
..+.|... .+ .++++++++ .+|. .+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.
T Consensus 26 ~~~~C~~~--~~--c~~~~~~l~-~iP~-~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (353)
T 2z80_A 26 ASLSCDRN--GI--CKGSSGSLN-SIPS-GLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS 97 (353)
T ss_dssp -CCEECTT--SE--EECCSTTCS-SCCT-TCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred cCCCCCCC--eE--eeCCCCCcc-cccc-ccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcC
Confidence 45677653 23 789999998 7887 343 5899999999999976667899999999999999999988888787
Q ss_pred --cccceeecccccCcccCCcchhhhccccceeccCCcccCCCC-C-C-CCCCCCeEEecccC-CCCCCCccccCCCCCC
Q 005693 187 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-N-F-DIPKLRHLNLSYNG-LKGSIPSSLQKFPNSS 260 (682)
Q Consensus 187 --~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~-~-~l~~L~~l~ls~N~-l~g~~p~~~~~l~~l~ 260 (682)
++|++|+|++|+|++..+..|+++++|++|+|++|++++..+ . . .+++|+.|++++|+ +++..|..+.++++|+
T Consensus 98 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~ 177 (353)
T 2z80_A 98 SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE 177 (353)
T ss_dssp TCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred CCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC
Confidence 799999999999997666669999999999999999996554 2 2 89999999999995 7766677888888877
Q ss_pred CCC
Q 005693 261 FVG 263 (682)
Q Consensus 261 ~~~ 263 (682)
.++
T Consensus 178 ~L~ 180 (353)
T 2z80_A 178 ELE 180 (353)
T ss_dssp EEE
T ss_pred EEE
Confidence 654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.1e-14 Score=133.29 Aligned_cols=112 Identities=27% Similarity=0.313 Sum_probs=99.6
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.+++.|++++|++++ +|+..++.+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+. ++|++|+
T Consensus 28 ~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp TTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 468899999999984 6655789999999999999999977777789999999999999999977766665 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 228 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 228 (682)
|++|+|++..+..+.++++|+.|+|++|.+++..|
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99999997777778999999999999999998665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=130.55 Aligned_cols=105 Identities=25% Similarity=0.263 Sum_probs=81.8
Q ss_pred EEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeeccc
Q 005693 119 FGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 196 (682)
Q Consensus 119 ~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~ 196 (682)
+.+++++|+++ .+|. .+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|. ++|++|+|++
T Consensus 12 ~~l~~s~n~l~-~ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TEEECTTSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 35777788887 5886 34 38899999999999988888899999999999999999866555554 6788888888
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 227 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~ 227 (682)
|+|++..|..|.++++|+.|+|++|.++...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 8888666667777777777777777776543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.47 E-value=7.5e-14 Score=158.15 Aligned_cols=137 Identities=32% Similarity=0.382 Sum_probs=116.8
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|.+.+ +++ ++.|++|+.|+|++|.|++ +| .+..|++|+.|+|++|+|++. | .+. ++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI-N-GLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC-G-GGGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC-c-cccCCCccCEEE
Confidence 468899999999985 444 8999999999999999985 44 799999999999999999963 3 343 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|++|+|++. ..+..|++|+.|+|++|+|++.+|-..+++|+.|+|++|+|++. | .+..+++|..++
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~ 203 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLE 203 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEE
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEE
Confidence 999999975 68999999999999999999988855899999999999999964 3 577777776554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.4e-13 Score=130.07 Aligned_cols=104 Identities=29% Similarity=0.334 Sum_probs=93.1
Q ss_pred CcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccC
Q 005693 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 220 (682)
Q Consensus 143 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~ 220 (682)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|. ++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 6887774 8999999999999988888886 7999999999999988888899999999999999
Q ss_pred CcccCCCCCC--CCCCCCeEEecccCCCCCC
Q 005693 221 NNLSGSIPNF--DIPKLRHLNLSYNGLKGSI 249 (682)
Q Consensus 221 N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~ 249 (682)
|+|++..+.. .+++|+.|+|++|.+++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9999877753 8999999999999998543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-13 Score=155.42 Aligned_cols=117 Identities=28% Similarity=0.427 Sum_probs=76.5
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeeccc
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~ 196 (682)
+++.|+|++|+++ .+| +.+++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. ..++|++|+|++
T Consensus 81 ~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~ 149 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADN 149 (571)
T ss_dssp TCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCS
T ss_pred CCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCC
Confidence 4677777777777 566 345777777777777775 665 554 77777777777775 555 446677777777
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCc
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 251 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~ 251 (682)
|+|++ +|. .+++|+.|+|++|+|++ +|.+. ++|+.|+|++|+|+ .+|.
T Consensus 150 N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~-~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 150 NQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELP-ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCS-SCCC
T ss_pred CccCc-CCC---cCCCcCEEECCCCCCCC-cchhh-CCCCEEECcCCCCC-chhh
Confidence 77765 554 45666777777777665 44333 66666666666666 4555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=5.8e-14 Score=133.34 Aligned_cols=124 Identities=23% Similarity=0.286 Sum_probs=82.9
Q ss_pred eEEEEEeCCCcccccCCccccCCCC-CCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLD-ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++.|++++|+++ .+|. +..+. +|++|+|++|.|++. +.|.++++|++|+|++|+|++..|..+. ++|++|+
T Consensus 20 ~L~~L~l~~n~l~-~i~~--~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 20 RDRELDLRGYKIP-VIEN--LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp SCEEEECTTSCCC-SCCC--GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CceEEEeeCCCCc-hhHH--hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 5677777777777 4543 44444 777777777777754 5677777777777777777744333223 6777777
Q ss_pred cccccCcccCCc--chhhhccccceeccCCcccCCCCC----C-CCCCCCeEEecccCCC
Q 005693 194 LSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPN----F-DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 194 ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~----~-~l~~L~~l~ls~N~l~ 246 (682)
|++|+|+ .+|. .+..+++|+.|+|++|.++...+. . .+++|+.||+++|.+.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777775 4554 677777777777777777743331 2 6677777777777654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.2e-13 Score=129.18 Aligned_cols=104 Identities=25% Similarity=0.284 Sum_probs=81.2
Q ss_pred EEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeeccc
Q 005693 119 FGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 196 (682)
Q Consensus 119 ~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~ 196 (682)
+.++++++++. .+|. .+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|. ++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 46888999886 7887 343 8899999999999988888899999999999999999865444443 6788888888
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGS 226 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ 226 (682)
|+|++..+..|.++++|+.|+|++|.+...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 888865555677777777777777777643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.8e-13 Score=128.38 Aligned_cols=104 Identities=25% Similarity=0.319 Sum_probs=92.1
Q ss_pred cEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCC
Q 005693 144 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 221 (682)
Q Consensus 144 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N 221 (682)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|. ++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 78999999997 8888775 8999999999999988888886 79999999999999877777899999999999999
Q ss_pred cccCCCCC-C-CCCCCCeEEecccCCCCCCCc
Q 005693 222 NLSGSIPN-F-DIPKLRHLNLSYNGLKGSIPS 251 (682)
Q Consensus 222 ~l~g~~p~-~-~l~~L~~l~ls~N~l~g~~p~ 251 (682)
+|++.++. + .+++|+.|+|++|.+.. .+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c-~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC-ECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT-TBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc-ccc
Confidence 99987775 3 79999999999999984 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.9e-14 Score=158.01 Aligned_cols=134 Identities=22% Similarity=0.232 Sum_probs=68.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCC-------------cEEeecccccCCcCC
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL-------------RYLYLQHNNFSGKIP 182 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L-------------~~L~L~~N~l~g~~p 182 (682)
.++..|++++|++ |.+|+ .+++|++|++|+|++|+++|.+|..++++++| ++|++++|++++ +|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 4677888888888 78887 68889999999998888888888888887764 777888777775 34
Q ss_pred CCcccccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCC
Q 005693 183 SSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 261 (682)
Q Consensus 183 ~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~ 261 (682)
. +.++|++|+|++|++++ +|..+ ++|+.|++++|++++. |.. .++|++|++++|++++ +| .++++++|+.
T Consensus 88 ~-~~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~l-~~~-~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~ 157 (454)
T 1jl5_A 88 E-LPPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKAL-SDL-PPLLEYLGVSNNQLEK-LP-ELQNSSFLKI 157 (454)
T ss_dssp S-CCTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSCC-CSC-CTTCCEEECCSSCCSS-CC-CCTTCTTCCE
T ss_pred C-CcCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCcc-cCC-CCCCCEEECcCCCCCC-Cc-ccCCCCCCCE
Confidence 3 33567777777777775 55432 4555555555555531 111 1345555555555553 44 3444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-13 Score=155.61 Aligned_cols=136 Identities=23% Similarity=0.327 Sum_probs=116.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|++. .+| .++.|++|+.|+|++|+|++..| +.+|++|+.|+|++|+|++ +| .+. ++|++|+
T Consensus 43 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 115 (605)
T 1m9s_A 43 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS 115 (605)
T ss_dssp TTCCCCBCTTCCCC-CCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred CCCCEEECcCCCCC-CCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence 35777899999987 565 48999999999999999997655 9999999999999999996 34 444 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|++|+|++. +.+..|++|+.|+|++|+|++. +.. .+++|+.|+|++|+|++..| +..+++|..++
T Consensus 116 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 181 (605)
T 1m9s_A 116 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181 (605)
T ss_dssp CTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred ecCCCCCCC--ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence 999999963 5699999999999999999986 443 89999999999999997766 77777776654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.1e-13 Score=150.39 Aligned_cols=139 Identities=32% Similarity=0.354 Sum_probs=99.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.++..|++++|++++ ++ .+..+++|+.|+|++|.+++..| +.++++|+.|+|++|++++..|-.-.++|++|+|+
T Consensus 221 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~ 295 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 295 (466)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcC
Confidence 357778888888774 33 47788888888888888876554 77888888888888888765442222678888888
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+|++++..| ++.+++|+.|+|++|++++..|...+++|+.|++++|++++. +.+.++++|+.++
T Consensus 296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 359 (466)
T 1o6v_A 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLS 359 (466)
T ss_dssp SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred CCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCCCCEEe
Confidence 888876544 777788888888888887776655777788888888877764 3566666665543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-13 Score=131.17 Aligned_cols=123 Identities=17% Similarity=0.149 Sum_probs=103.3
Q ss_pred ccCCCCCCcEEEccCCCCCCCCCCcCCCCC-CCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhcc
Q 005693 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQ 212 (682)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~ 212 (682)
.+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|+|++. ..+. ++|++|+|++|+|++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4778999999999999999 5564 66655 999999999999975 4554 79999999999999765566699999
Q ss_pred ccceeccCCcccCCCCC---C-CCCCCCeEEecccCCCCCCCcc----ccCCCCCCCCCC
Q 005693 213 LTGLSLQSNNLSGSIPN---F-DIPKLRHLNLSYNGLKGSIPSS----LQKFPNSSFVGN 264 (682)
Q Consensus 213 L~~L~l~~N~l~g~~p~---~-~l~~L~~l~ls~N~l~g~~p~~----~~~l~~l~~~~n 264 (682)
|+.|+|++|+|+. +|. . .+++|+.|++++|.++ .+|.. +..+++|..++-
T Consensus 90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~ 147 (176)
T 1a9n_A 90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 147 (176)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCC
Confidence 9999999999974 443 2 8899999999999998 56764 788888887763
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.3e-13 Score=155.26 Aligned_cols=116 Identities=29% Similarity=0.323 Sum_probs=90.0
Q ss_pred CCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceecc
Q 005693 142 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 219 (682)
Q Consensus 142 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~ 219 (682)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..++ ++|++|+|++|+|++ +| .|++|++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 46788888888885 675 888888888888888888 7787776 788888888888886 66 78888888888888
Q ss_pred CCcccCCC-CCC--CCCCCCeEEecccCCCCCCCcc---ccCCCCCCCC
Q 005693 220 SNNLSGSI-PNF--DIPKLRHLNLSYNGLKGSIPSS---LQKFPNSSFV 262 (682)
Q Consensus 220 ~N~l~g~~-p~~--~l~~L~~l~ls~N~l~g~~p~~---~~~l~~l~~~ 262 (682)
+|+|++.+ |.. .+++|+.|+|++|+|++.+|.. +..+++|..+
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L 565 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCcc
Confidence 88888875 553 7888888888888888665432 2235555544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.7e-13 Score=146.98 Aligned_cols=124 Identities=23% Similarity=0.163 Sum_probs=80.8
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.++..|++++|+..+.++ ++.+++|++|+|++|++++ +| ++.+++|+.|+|++|++++. +-.-.++|++|+|+
T Consensus 148 ~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls 220 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCS 220 (457)
T ss_dssp TTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECC
T ss_pred CcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECc
Confidence 356777777776666662 6677777778887777775 44 67777777777777777754 31112677777777
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCCCCC----------CCCeEEecccCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP----------KLRHLNLSYNGLKGSIP 250 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~----------~L~~l~ls~N~l~g~~p 250 (682)
+|+|++ +| ++.+++|+.|+|++|++++..+. .++ +|+.|++++|.+.|.+|
T Consensus 221 ~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~-~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 221 SNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS-TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp SSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT-TCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred CCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH-HCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 777776 45 67777777777777777764432 222 34455555555555554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.41 E-value=8e-13 Score=145.01 Aligned_cols=133 Identities=25% Similarity=0.378 Sum_probs=104.3
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.+++.|++++|++++ +|. + .++|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|+|+
T Consensus 111 ~~L~~L~l~~n~l~~-l~~--~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-~~L~~L~L~ 181 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKA-LSD--L--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-PSLEFIAAG 181 (454)
T ss_dssp TTCCEEECCSSCCSC-CCS--C--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC-TTCCEEECC
T ss_pred CCCcEEECCCCccCc-ccC--C--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-ccccEEECc
Confidence 356667777776663 332 1 2689999999999986 77 59999999999999999986 66544 589999999
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+|++++ +| .++++++|+.|++++|++++ +|.. .++|+.|++++|+++ .+|. ++++++|+.++
T Consensus 182 ~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~-~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~ 243 (454)
T 1jl5_A 182 NNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL-PLSLESIVAGNNILE-ELPE-LQNLPFLTTIY 243 (454)
T ss_dssp SSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-cCcccEEECcCCcCC-cccc-cCCCCCCCEEE
Confidence 999997 66 68999999999999999987 4432 368999999999998 6774 77777776654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-13 Score=154.25 Aligned_cols=152 Identities=26% Similarity=0.351 Sum_probs=103.7
Q ss_pred CCCCCCCCCCCcceEEec------CCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCc
Q 005693 95 NWSSTNPICQSWVGINCT------QDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLR 168 (682)
Q Consensus 95 ~w~~~~~~c~~w~gv~C~------~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 168 (682)
.|....++| .|.|..|. .....++.|++++|+++ .+|. .+. ++|+.|+|++|+|+ .+|. .+++|+
T Consensus 14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~-~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~ 84 (622)
T 3g06_A 14 AWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPD-CLP--AHITTLVIPDNNLT-SLPA---LPPELR 84 (622)
T ss_dssp HHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCS-CCC--TTCSEEEECSCCCS-CCCC---CCTTCC
T ss_pred HHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccCh-hhC--CCCcEEEecCCCCC-CCCC---cCCCCC
Confidence 576655655 78664321 11235788899999888 7887 344 78888888888888 5665 578888
Q ss_pred EEeecccccCCcCCCCcccccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCC
Q 005693 169 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 248 (682)
Q Consensus 169 ~L~L~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~ 248 (682)
+|+|++|+|+ .+|. ..++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|++++
T Consensus 85 ~L~Ls~N~l~-~lp~-~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~-~l~~L~~L~Ls~N~l~~- 155 (622)
T 3g06_A 85 TLEVSGNQLT-SLPV-LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV-LPPGLQELSVSDNQLAS- 155 (622)
T ss_dssp EEEECSCCCS-CCCC-CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-
T ss_pred EEEcCCCcCC-cCCC-CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC-CCCCCCEEECcCCcCCC-
Confidence 8888888888 4666 44788888888888885 444 56777777788887775 333 24677777777777774
Q ss_pred CCccccCCCCCCCCCC
Q 005693 249 IPSSLQKFPNSSFVGN 264 (682)
Q Consensus 249 ~p~~~~~l~~l~~~~n 264 (682)
+|..+.++..|.+.+|
T Consensus 156 l~~~~~~L~~L~L~~N 171 (622)
T 3g06_A 156 LPALPSELCKLWAYNN 171 (622)
T ss_dssp CCCCCTTCCEEECCSS
T ss_pred cCCccCCCCEEECCCC
Confidence 4544445544444333
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.38 E-value=6.7e-13 Score=146.29 Aligned_cols=138 Identities=29% Similarity=0.345 Sum_probs=104.6
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.++..|++++|.+.+..| ++.+++|+.|+|++|++++. +.+..+++|+.|+|++|++++..|-.-.++|++|+|+
T Consensus 199 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~ 273 (466)
T 1o6v_A 199 TNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG 273 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEEecCCccccccc---ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchhhhcCCCCCEEECC
Confidence 467788888888885433 67788888888888888853 3678888888888888888876652223788888888
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
+|++++..| +..+++|+.|+|++|++++..|-..+++|+.|+|++|++++..| +..+++|+.+
T Consensus 274 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 274 ANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred CCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 888886544 88888888888888888876665578888888888888887655 4555555433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.38 E-value=7.9e-13 Score=134.16 Aligned_cols=123 Identities=24% Similarity=0.292 Sum_probs=105.5
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|++++ +++ ++++++|++|+|++|++++ +|. +.. ++|+.|+|++|++++. | .+. ++|++|+
T Consensus 63 ~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEE
Confidence 478999999999985 554 9999999999999999995 554 333 9999999999999964 4 344 8999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 248 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~ 248 (682)
|++|+|++. | .++.+++|+.|+|++|++++...-..+++|+.|++++|.+++.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence 999999975 4 7999999999999999999872233899999999999999865
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.37 E-value=6.4e-13 Score=140.32 Aligned_cols=139 Identities=22% Similarity=0.298 Sum_probs=89.9
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.++..|++++|.+.+ +++ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++..+-.-.++|++|+|+
T Consensus 177 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~ 251 (347)
T 4fmz_A 177 TDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIG 251 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECC
Confidence 357778888887763 443 6677777777777777775444 66777777777777777654431112667777777
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
+|++++. +.+..+++|+.|++++|++++. +.. .+++|+.|++++|++++..|..+.++++|+.+
T Consensus 252 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 252 TNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp SSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred CCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 7777653 3566777777777777777654 332 66677777777777766666666666555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=6.8e-13 Score=140.24 Aligned_cols=106 Identities=26% Similarity=0.360 Sum_probs=84.4
Q ss_pred CCcceEEecCCCCeEEEEEeCCC-cccccCCccccCCCCCCcEEEccC-CCCCCCCCCcCCCCCCCcEEeecccccCCcC
Q 005693 104 QSWVGINCTQDRTRVFGLRLPGI-GLVGPIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKI 181 (682)
Q Consensus 104 ~~w~gv~C~~~~~~v~~l~l~~~-~l~g~lp~~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~ 181 (682)
|+|.+|.|++ + +|+ .||. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..
T Consensus 8 C~~~~v~~~~------------~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 72 (347)
T 2ifg_A 8 HGSSGLRCTR------------DGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72 (347)
T ss_dssp SSSSCEECCS------------SCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred ccCCEEEcCC------------CCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeC
Confidence 3677777753 4 566 5886 89999999999996 9999877788999999999999999999877
Q ss_pred CCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccC
Q 005693 182 PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225 (682)
Q Consensus 182 p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 225 (682)
|..|. ++|++|+|++|+|++..|..|..++ |+.|+|++|.|..
T Consensus 73 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp TTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 77766 6888888888888866555665555 8888888887763
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.5e-12 Score=141.24 Aligned_cols=133 Identities=23% Similarity=0.202 Sum_probs=96.0
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.++..|++++|++++ +| ++.+++|++|+|++|++++. | ++++++|++|++++|+..+.++-.-.++|++|+|+
T Consensus 106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls 178 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCS 178 (457)
T ss_dssp TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECC
T ss_pred CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccccccCCcCCEEECC
Confidence 467888999998886 43 78888999999999988863 3 77888888888888866666643333678888888
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
+|+|++ +| ++.+++|+.|++++|++++. +-..+++|+.|+|++|++++ +| ++.+++|+.+
T Consensus 179 ~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L 238 (457)
T 3bz5_A 179 FNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYF 238 (457)
T ss_dssp SSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEE
T ss_pred CCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cC--ccccCCCCEE
Confidence 888776 44 67777777777777777764 44467777777777777776 44 5555555443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-14 Score=151.64 Aligned_cols=147 Identities=23% Similarity=0.295 Sum_probs=100.4
Q ss_pred CeEEEEEeCCCccccc-CCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccc-ccCCc-CCCCcc--cccc
Q 005693 116 TRVFGLRLPGIGLVGP-IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN-NFSGK-IPSSFS--PQLV 190 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~-lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N-~l~g~-~p~~~~--~~L~ 190 (682)
.++..|+|++|.+++. +|. .+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. +|..+. ++|+
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHG-ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp BCCCEEECTTCEECHHHHHH-HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCEEEccCCCcCHHHHHH-HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 4567777777777654 554 5777777777777777777777777777777777777777 56642 343333 6777
Q ss_pred eeecccc-cCccc-CCcchhhhc-cccceeccCC--ccc-CCCCCC--CCCCCCeEEecccC-CCCCCCccccCCCCCCC
Q 005693 191 VLDLSFN-SFTGN-IPQSIQNLT-QLTGLSLQSN--NLS-GSIPNF--DIPKLRHLNLSYNG-LKGSIPSSLQKFPNSSF 261 (682)
Q Consensus 191 ~L~ls~N-~l~g~-~p~~~~~l~-~L~~L~l~~N--~l~-g~~p~~--~l~~L~~l~ls~N~-l~g~~p~~~~~l~~l~~ 261 (682)
+|+|++| ++++. ++..+.+++ +|+.|+|++| .++ +.+|.. .+++|+.|+|++|. +++..+..+.++++|+.
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~ 251 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence 7777777 77754 566677777 7778887777 344 333432 67778888888887 66666667776666665
Q ss_pred CC
Q 005693 262 VG 263 (682)
Q Consensus 262 ~~ 263 (682)
++
T Consensus 252 L~ 253 (336)
T 2ast_B 252 LS 253 (336)
T ss_dssp EE
T ss_pred ee
Confidence 54
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.35 E-value=6.9e-13 Score=140.07 Aligned_cols=137 Identities=22% Similarity=0.287 Sum_probs=114.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..+++++|++.+ +++ ++.+++|+.|+|++|++++..+ +..+++|++|+|++|++++. + .+. ++|++|+
T Consensus 199 ~~L~~L~l~~n~l~~-~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~ 271 (347)
T 4fmz_A 199 TSLHYFTAYVNQITD-ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-N-AVKDLTKLKMLN 271 (347)
T ss_dssp TTCCEEECCSSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred CccceeecccCCCCC-Cch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-h-hHhcCCCcCEEE
Confidence 467889999999985 333 8899999999999999995544 99999999999999999964 3 333 7999999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
|++|++++. +.+..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..| +..+++|+.++
T Consensus 272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 339 (347)
T 4fmz_A 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339 (347)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEES
T ss_pred ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceee
Confidence 999999975 46899999999999999999887764 89999999999999997766 55666655543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.31 E-value=4.2e-14 Score=148.64 Aligned_cols=146 Identities=19% Similarity=0.267 Sum_probs=117.8
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCC-CCCcCCCCCCCcEEeecccccCCcCCCCcc--ccccee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 192 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L 192 (682)
.++..+++++|.+.+..+. +..+++|++|+|++|.+++. +|..+.++++|++|+|++|++++..|..+. ++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 4678889999999877664 67899999999999999876 888889999999999999999877776665 789999
Q ss_pred ecccc-cCccc-CCcchhhhccccceeccCC-cccCC-CCCC--CCC-CCCeEEeccc--CCC-CCCCccccCCCCCCCC
Q 005693 193 DLSFN-SFTGN-IPQSIQNLTQLTGLSLQSN-NLSGS-IPNF--DIP-KLRHLNLSYN--GLK-GSIPSSLQKFPNSSFV 262 (682)
Q Consensus 193 ~ls~N-~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~--~l~-~L~~l~ls~N--~l~-g~~p~~~~~l~~l~~~ 262 (682)
+|++| .+++. +|..+.++++|+.|+|++| ++++. ++.. .++ +|++|+|++| .++ +.+|..+.++++|+.+
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 99999 78863 7778899999999999999 88864 4442 778 9999999999 565 4566666666666554
Q ss_pred C
Q 005693 263 G 263 (682)
Q Consensus 263 ~ 263 (682)
+
T Consensus 228 ~ 228 (336)
T 2ast_B 228 D 228 (336)
T ss_dssp E
T ss_pred e
Confidence 3
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.29 E-value=7.2e-14 Score=150.12 Aligned_cols=148 Identities=20% Similarity=0.300 Sum_probs=92.9
Q ss_pred CeEEEEEeCCC---cccccCCccc------cCCCCCCcEEEccCCCCCC----CCCCcCCCCCCCcEEeecccccCCcCC
Q 005693 116 TRVFGLRLPGI---GLVGPIPNNT------LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIP 182 (682)
Q Consensus 116 ~~v~~l~l~~~---~l~g~lp~~~------~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~L~~N~l~g~~p 182 (682)
.++..|+|++| .++|.+|.+. +..+++|++|+|++|.+++ .+|..+.++++|++|+|++|.+++..+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 35666777664 4555555421 3667777777777777776 366667777777777777777764333
Q ss_pred CCcc---------------cccceeecccccCc-ccCC---cchhhhccccceeccCCccc--C---CCC-CC-CCCCCC
Q 005693 183 SSFS---------------PQLVVLDLSFNSFT-GNIP---QSIQNLTQLTGLSLQSNNLS--G---SIP-NF-DIPKLR 236 (682)
Q Consensus 183 ~~~~---------------~~L~~L~ls~N~l~-g~~p---~~~~~l~~L~~L~l~~N~l~--g---~~p-~~-~l~~L~ 236 (682)
..+. ++|++|+|++|+|+ +.+| ..+..+++|+.|+|++|+|+ | .+| .. .+++|+
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence 3332 46777777777776 4444 45666777777777777776 2 233 22 566777
Q ss_pred eEEecccCCC----CCCCccccCCCCCCCCC
Q 005693 237 HLNLSYNGLK----GSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 237 ~l~ls~N~l~----g~~p~~~~~l~~l~~~~ 263 (682)
.|+|++|.++ +.+|..+.++++|..++
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 7777777775 45666666666555443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.28 E-value=7.8e-12 Score=141.85 Aligned_cols=132 Identities=27% Similarity=0.344 Sum_probs=70.4
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCc---CCCC--------------CCCcEEeecccccCC
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE---ITSL--------------PSLRYLYLQHNNFSG 179 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~---~~~l--------------~~L~~L~L~~N~l~g 179 (682)
.+..|++++|+++ .+|. .+++|++|+|++|++++ +|.. +..| ++|+.|+|++|+|++
T Consensus 122 ~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 122 GLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp TCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC
T ss_pred CcCEEECCCCCCC-cCCC----CCCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC
Confidence 4556666666666 3554 13666666776666664 2322 2222 667777777777774
Q ss_pred cCCCCc-------------------ccccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEe
Q 005693 180 KIPSSF-------------------SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNL 240 (682)
Q Consensus 180 ~~p~~~-------------------~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~l 240 (682)
+|..+ .++|++|+|++|+|++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 196 -l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~-~~~~L~~L~L 268 (622)
T 3g06_A 196 -LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM-LPSGLLSLSV 268 (622)
T ss_dssp -CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEEC
T ss_pred -CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc-ccccCcEEeC
Confidence 34322 1345555555555553 33 233455555555555552 333 4455666666
Q ss_pred cccCCCCCCCccccCCCCCCCC
Q 005693 241 SYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 241 s~N~l~g~~p~~~~~l~~l~~~ 262 (682)
++|+|+ .+|..+.++++|..+
T Consensus 269 s~N~L~-~lp~~l~~l~~L~~L 289 (622)
T 3g06_A 269 YRNQLT-RLPESLIHLSSETTV 289 (622)
T ss_dssp CSSCCC-SCCGGGGGSCTTCEE
T ss_pred CCCCCC-cCCHHHhhccccCEE
Confidence 666655 455555555554443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=5.3e-12 Score=133.38 Aligned_cols=102 Identities=20% Similarity=0.168 Sum_probs=90.7
Q ss_pred cEEEccCC-CCCCCCCCcCCCCCCCcEEeecc-cccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceecc
Q 005693 144 EVLSLRSN-VLTGGLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 219 (682)
Q Consensus 144 ~~L~L~~N-~l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~ 219 (682)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|. ++|++|+|++|+|++..|..|++|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35799998 899 6898 99999999999996 999988777776 899999999999999999999999999999999
Q ss_pred CCcccCCCCCC-CCCCCCeEEecccCCCC
Q 005693 220 SNNLSGSIPNF-DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 220 ~N~l~g~~p~~-~l~~L~~l~ls~N~l~g 247 (682)
+|+|++.++.. ...+|+.|+|++|.|..
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccC
Confidence 99999776654 43449999999999984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=3.5e-11 Score=121.75 Aligned_cols=136 Identities=17% Similarity=0.113 Sum_probs=107.2
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
..++.|+++.||++... ++.+++|+..... ....++.+|++++..+.++..+.++++++...+..|+||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677788999999754 6789999987532 234579999999999966888999999999888999999999999998
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------------------------------------------- 506 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------------- 506 (682)
+.+.. ......++.+++++++.||+..
T Consensus 99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 76421 1223467889999999999811
Q ss_pred -------------CCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 507 -------------GPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 507 -------------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876666799998753
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.23 E-value=4e-13 Score=143.00 Aligned_cols=135 Identities=24% Similarity=0.283 Sum_probs=76.8
Q ss_pred eEEEEEeCCCcccccCCc---cccCCCC-CCcEEEccCCCCCCCCCCcCCCC-----CCCcEEeecccccCCcCCCCcc-
Q 005693 117 RVFGLRLPGIGLVGPIPN---NTLGKLD-ALEVLSLRSNVLTGGLPSEITSL-----PSLRYLYLQHNNFSGKIPSSFS- 186 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~---~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~- 186 (682)
+++.|+|++|++++.-+. ..+..++ +|++|+|++|+|++..+..+..+ ++|++|+|++|++++..+..+.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 366666666666533220 2455666 66666666666665555555554 6666666666666654444322
Q ss_pred ------cccceeecccccCcccCCcchhhh-----ccccceeccCCcccCCCCC----C--CCC-CCCeEEecccCCCCC
Q 005693 187 ------PQLVVLDLSFNSFTGNIPQSIQNL-----TQLTGLSLQSNNLSGSIPN----F--DIP-KLRHLNLSYNGLKGS 248 (682)
Q Consensus 187 ------~~L~~L~ls~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~----~--~l~-~L~~l~ls~N~l~g~ 248 (682)
++|++|+|++|+|++..+..+... ++|+.|+|++|++++..+. . .++ +|+.|+|++|++++.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~ 182 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchh
Confidence 356666666666665555444432 4666666666666642221 1 233 666666666666655
Q ss_pred CCc
Q 005693 249 IPS 251 (682)
Q Consensus 249 ~p~ 251 (682)
.+.
T Consensus 183 ~~~ 185 (362)
T 3goz_A 183 NCA 185 (362)
T ss_dssp CHH
T ss_pred hHH
Confidence 443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.23 E-value=3.5e-13 Score=144.72 Aligned_cols=148 Identities=20% Similarity=0.271 Sum_probs=116.0
Q ss_pred CeEEEEEeCCCcccccCCc---cccCCCCCCcEEEccCC---CCCCCCCCcC-------CCCCCCcEEeecccccCC---
Q 005693 116 TRVFGLRLPGIGLVGPIPN---NTLGKLDALEVLSLRSN---VLTGGLPSEI-------TSLPSLRYLYLQHNNFSG--- 179 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~---~~~~~l~~L~~L~L~~N---~l~g~~p~~~-------~~l~~L~~L~L~~N~l~g--- 179 (682)
.+++.|+|++|++.+..+. ..+..+++|++|+|++| ++++.+|..+ .++++|++|+|++|++++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 4688999999999865332 14778999999999995 5666777666 789999999999999997
Q ss_pred -cCCCCcc--cccceeecccccCcccCCcchh----hh---------ccccceeccCCccc-CCCCC----C-CCCCCCe
Q 005693 180 -KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ----NL---------TQLTGLSLQSNNLS-GSIPN----F-DIPKLRH 237 (682)
Q Consensus 180 -~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~----~l---------~~L~~L~l~~N~l~-g~~p~----~-~l~~L~~ 237 (682)
.+|..+. ++|++|+|++|+|++..+..+. .+ ++|+.|+|++|+++ +.+|. . .+++|+.
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 4665555 7999999999999865554444 44 89999999999998 45553 1 6789999
Q ss_pred EEecccCCC--C---CCCccccCCCCCCCCC
Q 005693 238 LNLSYNGLK--G---SIPSSLQKFPNSSFVG 263 (682)
Q Consensus 238 l~ls~N~l~--g---~~p~~~~~l~~l~~~~ 263 (682)
|+|++|+++ | .+|..+.++++|+.++
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~ 222 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 222 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEE
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEE
Confidence 999999998 3 3444677777776654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.22 E-value=9.2e-14 Score=134.67 Aligned_cols=123 Identities=20% Similarity=0.231 Sum_probs=105.8
Q ss_pred cCCCCCCcEEEccCCCCCCCCCC------cCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchh
Q 005693 137 LGKLDALEVLSLRSNVLTGGLPS------EITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ 208 (682)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~g~~p~------~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~ 208 (682)
+.....++.++|+.|.++|.+|. .+..+++|++|+|++|++++ +| .+. ++|++|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 55677889999999999999887 89999999999999999997 77 665 89999999999999 7899999
Q ss_pred hhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCC-ccccCCCCCCCCC
Q 005693 209 NLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP-SSLQKFPNSSFVG 263 (682)
Q Consensus 209 ~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p-~~~~~l~~l~~~~ 263 (682)
.+++|+.|+|++|++++ +|.. .+++|+.|+|++|++++..+ ..+.++++|+.++
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~ 146 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred cCCcCCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEE
Confidence 99999999999999997 4443 78899999999999995332 4677777776654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-12 Score=138.56 Aligned_cols=129 Identities=20% Similarity=0.145 Sum_probs=109.2
Q ss_pred EEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCC----CcCCCCC-CCcEEeecccccCCcCCCCcc-------cc
Q 005693 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP----SEITSLP-SLRYLYLQHNNFSGKIPSSFS-------PQ 188 (682)
Q Consensus 121 l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p----~~~~~l~-~L~~L~L~~N~l~g~~p~~~~-------~~ 188 (682)
.+|+.++++|.+|. .+...++|++|||++|.+++..+ ..+.+++ +|++|+|++|++++..+..+. ++
T Consensus 3 ~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999998887 67777779999999999997766 6788898 999999999999987666553 58
Q ss_pred cceeecccccCcccCCcchhhh-----ccccceeccCCcccCCCCCC------C-CCCCCeEEecccCCCCCCC
Q 005693 189 LVVLDLSFNSFTGNIPQSIQNL-----TQLTGLSLQSNNLSGSIPNF------D-IPKLRHLNLSYNGLKGSIP 250 (682)
Q Consensus 189 L~~L~ls~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~------~-l~~L~~l~ls~N~l~g~~p 250 (682)
|++|+|++|+|++..+..+... ++|+.|+|++|+|++..+.. . .++|++|+|++|++++.-+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence 9999999999998888876665 89999999999998766532 3 3699999999999996443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.15 E-value=6.2e-11 Score=125.38 Aligned_cols=139 Identities=15% Similarity=0.114 Sum_probs=107.1
Q ss_pred EEecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCc-c-
Q 005693 109 INCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-S- 186 (682)
Q Consensus 109 v~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-~- 186 (682)
..|+. ..++-++++|+ .||.+ + .++|++|+|++|+|+..-+..|.+|++|++|+|++|++.+.+|... .
T Consensus 7 C~C~~-----~~v~C~~~~Lt-~iP~~-l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~ 77 (350)
T 4ay9_X 7 CHCSN-----RVFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 77 (350)
T ss_dssp SEEET-----TEEEEESTTCC-SCCTT-C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCS
T ss_pred cEeeC-----CEEEecCCCCC-ccCcC-c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhc
Confidence 46764 24678899998 78873 4 4689999999999995444679999999999999999988888654 3
Q ss_pred -ccc-ceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecc-cCCCCCCCccccCC
Q 005693 187 -PQL-VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY-NGLKGSIPSSLQKF 256 (682)
Q Consensus 187 -~~L-~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~-N~l~g~~p~~~~~l 256 (682)
++| +.+++++|+|++..|..|.++++|+.|++++|+|++..+.. ...++..|++++ |++....+..|..+
T Consensus 78 L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~ 152 (350)
T 4ay9_X 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152 (350)
T ss_dssp CTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred chhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhc
Confidence 444 45788889999888999999999999999999999766643 555677777765 45553333445444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.06 E-value=1.7e-12 Score=142.57 Aligned_cols=148 Identities=20% Similarity=0.092 Sum_probs=114.6
Q ss_pred CeEEEEEeCCCccccc----CCccccCCCCCCcEEEccCCCCCCC----CCCcCCCCCCCcEEeecccccCCcCCCCcc-
Q 005693 116 TRVFGLRLPGIGLVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 186 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~----lp~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~- 186 (682)
.++..|+|++|.+.+. +.+..+..+++|++|+|++|++++. ++..+.++++|++|+|++|++++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 4688999999988753 2222344689999999999999864 677788899999999999999754443332
Q ss_pred ------cccceeecccccCccc----CCcchhhhccccceeccCCcccCCCCCC-------CCCCCCeEEecccCCCC--
Q 005693 187 ------PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPNF-------DIPKLRHLNLSYNGLKG-- 247 (682)
Q Consensus 187 ------~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~-------~l~~L~~l~ls~N~l~g-- 247 (682)
++|++|+|++|++++. +|..+..+++|+.|+|++|++++..+.. ..++|+.|+|++|++++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 4899999999999976 5677888899999999999998654321 26799999999999986
Q ss_pred --CCCccccCCCCCCCCC
Q 005693 248 --SIPSSLQKFPNSSFVG 263 (682)
Q Consensus 248 --~~p~~~~~l~~l~~~~ 263 (682)
.+|..+.++++|+.++
T Consensus 387 ~~~l~~~l~~~~~L~~L~ 404 (461)
T 1z7x_W 387 CSSLAATLLANHSLRELD 404 (461)
T ss_dssp HHHHHHHHHHCCCCCEEE
T ss_pred HHHHHHHHHhCCCccEEE
Confidence 7777776666666553
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=5.5e-10 Score=112.33 Aligned_cols=131 Identities=11% Similarity=0.085 Sum_probs=98.3
Q ss_pred ccc-ccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCc-eeceEEEEEecCceEEEEeeccCCchh
Q 005693 392 VLG-KGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 392 ~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.++ .|..+.||++...++..+++|..... ....+.+|++++..+.++.- +.+++++...++..++||||++|.++.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 45569999998777788999997653 33568899999999855522 566888888777889999999998884
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------------------------------------------- 506 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------------- 506 (682)
... .+ ...++.++++.++.||+..
T Consensus 104 --~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 104 --SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp --TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred --cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 211 11 2356777888888888643
Q ss_pred ------------CCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 507 ------------GPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 507 ------------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
.+.++|+|++|.||++++++.+.|+|||.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999864
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.04 E-value=1.7e-12 Score=142.49 Aligned_cols=137 Identities=20% Similarity=0.222 Sum_probs=106.7
Q ss_pred CeEEEEEeCCCccccc----CCccccCCCCCCcEEEccCCCCCCCC-----CCcCCCCCCCcEEeecccccCCc----CC
Q 005693 116 TRVFGLRLPGIGLVGP----IPNNTLGKLDALEVLSLRSNVLTGGL-----PSEITSLPSLRYLYLQHNNFSGK----IP 182 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~----lp~~~~~~l~~L~~L~L~~N~l~g~~-----p~~~~~l~~L~~L~L~~N~l~g~----~p 182 (682)
.++..|+|++|++++. ++. .+..+++|++|+|++|.+++.- +..+..+++|++|+|++|++++. ++
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 277 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCG-IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHH-HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHHHH-HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence 3788999999998863 455 6788999999999999987532 33344689999999999999864 45
Q ss_pred CCcc--cccceeecccccCcccCCcchhhh-----ccccceeccCCcccCC----CCCC--CCCCCCeEEecccCCCCCC
Q 005693 183 SSFS--PQLVVLDLSFNSFTGNIPQSIQNL-----TQLTGLSLQSNNLSGS----IPNF--DIPKLRHLNLSYNGLKGSI 249 (682)
Q Consensus 183 ~~~~--~~L~~L~ls~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~----~p~~--~l~~L~~l~ls~N~l~g~~ 249 (682)
..+. ++|++|+|++|++++..+..+... ++|+.|+|++|.+++. ++.. .+++|+.|+|++|++++..
T Consensus 278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 5544 789999999999987766666654 6999999999999865 2332 6789999999999998654
Q ss_pred Cccc
Q 005693 250 PSSL 253 (682)
Q Consensus 250 p~~~ 253 (682)
+..+
T Consensus 358 ~~~l 361 (461)
T 1z7x_W 358 VREL 361 (461)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1.3e-12 Score=131.49 Aligned_cols=159 Identities=19% Similarity=0.188 Sum_probs=117.5
Q ss_pred CcceEEecCCCCeEEEEEeCC---CcccccCCccccCCCCCCcEEEccCCCCCCCCCC-cCCCCCCCcE--EeecccccC
Q 005693 105 SWVGINCTQDRTRVFGLRLPG---IGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRY--LYLQHNNFS 178 (682)
Q Consensus 105 ~w~gv~C~~~~~~v~~l~l~~---~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~--L~L~~N~l~ 178 (682)
+|.|+.|+.++.+|+.+...+ ..+.|.++++.+..|+. .|...+|..++.++- .+...+.|.. ++++.|+..
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 799999998766777666655 46667777656555554 566667777766663 3667777776 788888644
Q ss_pred CcCCCCc------ccccceeecccccCcc--cCCcchhhhccccceeccCCcccCCCCCCCCC--CCCeEEecccCCCCC
Q 005693 179 GKIPSSF------SPQLVVLDLSFNSFTG--NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP--KLRHLNLSYNGLKGS 248 (682)
Q Consensus 179 g~~p~~~------~~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~--~L~~l~ls~N~l~g~ 248 (682)
.++..+ .++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.-.-..+. +|+.|+|++|.+++.
T Consensus 157 -~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~ 235 (267)
T 3rw6_A 157 -CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDT 235 (267)
T ss_dssp -HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGG
T ss_pred -HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccc
Confidence 333322 1689999999999998 56788899999999999999999752212233 999999999999988
Q ss_pred CCc-------cccCCCCCCCCCCCC
Q 005693 249 IPS-------SLQKFPNSSFVGNSL 266 (682)
Q Consensus 249 ~p~-------~~~~l~~l~~~~n~~ 266 (682)
+|. .+..+++|..++...
T Consensus 236 ~~~~~~y~~~il~~~P~L~~LDg~~ 260 (267)
T 3rw6_A 236 FRDQSTYISAIRERFPKLLRLDGHE 260 (267)
T ss_dssp CSSHHHHHHHHHHHCTTCCEESSCB
T ss_pred cCcchhHHHHHHHHCcccCeECCcC
Confidence 773 367889998888543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.2e-09 Score=113.79 Aligned_cols=140 Identities=15% Similarity=0.226 Sum_probs=104.9
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEee--ccc--cChhhHHHHHHHHHHhcC-CCceeceEEEEEec---CceEEEEee
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLK--EVV--VGKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSK---DEKLLVYDY 462 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~---~~~~lV~e~ 462 (682)
+.++.|.++.||+.... +..+++|+.. ... .....+.+|..++..+.+ +..++++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 46888999999998865 4678888775 322 234578899999999954 45688899888766 347999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------------------------------------ 506 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------ 506 (682)
++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9997774321 122678888999999999999999731
Q ss_pred -------------------CCCcEecCCCCCCeEecCCCC--eEEeecCCCCC
Q 005693 507 -------------------GPKFTHGNIKASNVLINQDLD--GCISDFGLTPL 538 (682)
Q Consensus 507 -------------------~~~ivHrDLk~~NILl~~~~~--~kl~DfGla~~ 538 (682)
.+.++|+|+++.||++++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245899999999999997753 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.4e-09 Score=112.45 Aligned_cols=183 Identities=16% Similarity=0.199 Sum_probs=120.9
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCc--eeceEEEEEecC---ceEEEEeeccC
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN--VVPLRAYYYSKD---EKLLVYDYFAS 465 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n--iv~l~~~~~~~~---~~~lV~e~~~~ 465 (682)
+.++.|.+..||+.. ..+++|+.... .....+.+|.+++..+..+.. +.+++......+ ..|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458899999999863 56888886432 234578899999998855433 344554443333 34789999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--------------------------------------- 506 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--------------------------------------- 506 (682)
..+.+... ..++.+++..++.+++..++.||+..
T Consensus 101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 88865432 12677788888899999898888621
Q ss_pred ----------------CCCcEecCCCCCCeEecC--CCCeEEeecCCCCCCCCCCCCCCCCcc---cCcccccc-----C
Q 005693 507 ----------------GPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPATPSRSAGY---RAPEVIET-----R 560 (682)
Q Consensus 507 ----------------~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~y---~aPE~~~~-----~ 560 (682)
.+.++|+|+++.||++++ ...+.|+||+.+..............+ ..|+.... +
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 134799999999999998 456789999987653221100000000 11221100 0
Q ss_pred C---------CCCcchHHHHHHHHHHHHhCCCCC
Q 005693 561 K---------HSHKSDVYSFGVLLLEMLTGKAPL 585 (682)
Q Consensus 561 ~---------~~~~sDvwS~Gvvl~elltg~~Pf 585 (682)
. .....+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 112358999999999999998776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.81 E-value=8e-11 Score=125.43 Aligned_cols=133 Identities=17% Similarity=0.183 Sum_probs=92.5
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcC-----CCCCCCcEEeecccccCCc----CCCCcc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-----TSLPSLRYLYLQHNNFSGK----IPSSFS 186 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~-----~~l~~L~~L~L~~N~l~g~----~p~~~~ 186 (682)
.++..|+|++|+++..-.......+.+|+.|+|++|+|+..-...+ ...++|+.|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 4788899999987643222223456778999999998874433333 3467899999999988742 222222
Q ss_pred --cccceeecccccCccc----CCcchhhhccccceeccCCcccCCCC----CC--CCCCCCeEEecccCCCCC
Q 005693 187 --PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIP----NF--DIPKLRHLNLSYNGLKGS 248 (682)
Q Consensus 187 --~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p----~~--~l~~L~~l~ls~N~l~g~ 248 (682)
++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+..-. .. ..++|+.|+|++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 6789999999998753 35567778889999999998874221 11 457889999999988753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.80 E-value=6.2e-09 Score=108.91 Aligned_cols=141 Identities=18% Similarity=0.191 Sum_probs=86.5
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccccc----CCcCCCCc-------
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF----SGKIPSSF------- 185 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l----~g~~p~~~------- 185 (682)
+++.|+|++ +++ .|++.+|.++++|+.|+|++|.+...-+..|.++.+|..|.+..+.. ...-+..|
T Consensus 102 ~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 102 TLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 467788887 666 67777888888888888888887644445566655555555444211 00000000
Q ss_pred ---------------------------------------------ccccceeecccccCcccCCcchhhhccccceeccC
Q 005693 186 ---------------------------------------------SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 220 (682)
Q Consensus 186 ---------------------------------------------~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~ 220 (682)
.++|+.|+|++|+++...+.+|.+|++|+.|+|.+
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 24677777777777755556677777777777777
Q ss_pred CcccCCCCCC---CCCCCC-eEEecccCCCCCCCccccCCCCCCCC
Q 005693 221 NNLSGSIPNF---DIPKLR-HLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 221 N~l~g~~p~~---~l~~L~-~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
| ++. ++.. ++++|+ .+++.+ +++..-+..|.++++|+.+
T Consensus 260 n-i~~-I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 260 N-LKT-IGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp T-CCE-ECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred c-cce-ehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 6 543 3331 666777 777766 5554444566666666544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.75 E-value=5.4e-09 Score=109.37 Aligned_cols=131 Identities=13% Similarity=0.170 Sum_probs=93.8
Q ss_pred cCCccccCC--------CCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCccc--ccceeecccccC-
Q 005693 131 PIPNNTLGK--------LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSF- 199 (682)
Q Consensus 131 ~lp~~~~~~--------l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~--~L~~L~ls~N~l- 199 (682)
.||+..|.+ +++|+.|+|.+ +++..-+..|.+|++|+.|+|++|.++...+..|.. ++..+.++.+..
T Consensus 83 ~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~ 161 (329)
T 3sb4_A 83 FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY 161 (329)
T ss_dssp EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH
T ss_pred ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh
Confidence 567778888 99999999999 888555677999999999999999998555566653 444554444211
Q ss_pred ---c----------------------ccCCcc---------------------------h-hhhccccceeccCCcccCC
Q 005693 200 ---T----------------------GNIPQS---------------------------I-QNLTQLTGLSLQSNNLSGS 226 (682)
Q Consensus 200 ---~----------------------g~~p~~---------------------------~-~~l~~L~~L~l~~N~l~g~ 226 (682)
. +.++.. + ..+++|+.|+|++|+++..
T Consensus 162 ~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I 241 (329)
T 3sb4_A 162 RFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTI 241 (329)
T ss_dssp HTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEE
T ss_pred hccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCccee
Confidence 0 000000 0 1378999999999999844
Q ss_pred CCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC-CCC
Q 005693 227 IPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS-FVG 263 (682)
Q Consensus 227 ~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~-~~~ 263 (682)
.+.. .+++|+.|+|++| ++..-+..|.++++|+ .+.
T Consensus 242 ~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~ 280 (329)
T 3sb4_A 242 PDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLE 280 (329)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEE
Confidence 3332 8999999999998 7755556788888887 443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.71 E-value=5.9e-11 Score=126.44 Aligned_cols=146 Identities=22% Similarity=0.246 Sum_probs=103.7
Q ss_pred eEEEEEeCCCcccccCCccccC-----CCCCCcEEEccCCCCCCCCCCcC-CCCCCCcEEeecccccCCcCCCCcc----
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLG-----KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS---- 186 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~-----~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~L~~N~l~g~~p~~~~---- 186 (682)
.+..|+|++|+++..-.. .+. +..+|+.|+|++|.|+..-...+ ..+++|+.|+|++|+|+......+.
T Consensus 73 ~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCT-VVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TCCEEECTTSCCCHHHHH-HHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hCCEEEecCCCCCHHHHH-HHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 577899999998742221 232 33799999999999975433333 3578999999999999854333331
Q ss_pred ---cccceeecccccCccc----CCcchhhhccccceeccCCcccCCC----CC--CCCCCCCeEEecccCCCCC----C
Q 005693 187 ---PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSI----PN--FDIPKLRHLNLSYNGLKGS----I 249 (682)
Q Consensus 187 ---~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~----p~--~~l~~L~~l~ls~N~l~g~----~ 249 (682)
++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+..- +. ...++|+.|+|++|.++.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 5799999999999853 5556678999999999999998422 21 1567899999999999752 3
Q ss_pred CccccCCCCCCCCC
Q 005693 250 PSSLQKFPNSSFVG 263 (682)
Q Consensus 250 p~~~~~l~~l~~~~ 263 (682)
+..+...++|..++
T Consensus 232 ~~~L~~~~~L~~L~ 245 (372)
T 3un9_A 232 ARAAREHPSLELLH 245 (372)
T ss_dssp HHHHHHCSSCCEEE
T ss_pred HHHHHhCCCCCEEe
Confidence 33343344444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.56 E-value=1.5e-09 Score=122.99 Aligned_cols=131 Identities=15% Similarity=0.110 Sum_probs=68.3
Q ss_pred eEEEEEeCCCcccccCCccccCC-CCCCcEEEcc----CCCCCCC-----CCCcCCCCCCCcEEeeccc--ccCCcCCCC
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGK-LDALEVLSLR----SNVLTGG-----LPSEITSLPSLRYLYLQHN--NFSGKIPSS 184 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~-l~~L~~L~L~----~N~l~g~-----~p~~~~~l~~L~~L~L~~N--~l~g~~p~~ 184 (682)
++..|++..+++++..+. .++. +++|+.|+|+ .|++++. ++..+.++++|+.|+|++| .+++..+..
T Consensus 379 ~L~~L~l~~~~l~~~~~~-~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLE-SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TCSEEEEEESCCCHHHHH-HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred cCeEEEeecCCccHHHHH-HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 344555555555544333 2332 5556666664 4555532 2223445566666666532 244333322
Q ss_pred cc---cccceeecccccCcc-cCCcchhhhccccceeccCCcccCC-CCCC--CCCCCCeEEecccCCCCC
Q 005693 185 FS---PQLVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGS-IPNF--DIPKLRHLNLSYNGLKGS 248 (682)
Q Consensus 185 ~~---~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~--~l~~L~~l~ls~N~l~g~ 248 (682)
+. ++|++|+|++|++++ .++..+.++++|+.|+|++|.+++. ++.. .+++|+.|+|++|++++.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 22 456666666666665 3344445666666666666666533 2221 456666666666666643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.48 E-value=4.8e-09 Score=105.44 Aligned_cols=76 Identities=28% Similarity=0.461 Sum_probs=45.3
Q ss_pred CCCCCCcEEeecccccCC--cCCCCcc--cccceeecccccCcccCCcchhhhc--cccceeccCCcccCCCCCC-----
Q 005693 162 TSLPSLRYLYLQHNNFSG--KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLT--QLTGLSLQSNNLSGSIPNF----- 230 (682)
Q Consensus 162 ~~l~~L~~L~L~~N~l~g--~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~~p~~----- 230 (682)
.++++|+.|+|++|+|++ .+|..+. ++|+.|+|++|+|++. ..+..++ +|+.|+|++|.+++.+|..
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 345666666666666665 3333332 5666666666666654 3344444 6777777777777666531
Q ss_pred ----CCCCCCeEE
Q 005693 231 ----DIPKLRHLN 239 (682)
Q Consensus 231 ----~l~~L~~l~ 239 (682)
.+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 566676665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=9.5e-07 Score=89.23 Aligned_cols=135 Identities=16% Similarity=0.166 Sum_probs=97.7
Q ss_pred cccccCeE-EEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 392 VLGKGSYG-TAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 392 ~lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+..|..| .||+.... ++..+++|+-... ...++.+|...+..+..+--|.++++++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445554 68987754 4567888886543 24568889999999876666888999999999999999999998887
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-------------------------------------------- 505 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-------------------------------------------- 505 (682)
+..... ......++.+++..++.||..
T Consensus 109 ~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 665321 122334556666666666642
Q ss_pred -----------CCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 506 -----------GGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 506 -----------~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
..+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01127899999999999988777899998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=6.8e-09 Score=99.04 Aligned_cols=111 Identities=14% Similarity=0.193 Sum_probs=78.8
Q ss_pred ccCCCCCCcEEEccCC-CCCCC----CCCcCCCCCCCcEEeecccccCCcCCCCcc------cccceeecccccCccc--
Q 005693 136 TLGKLDALEVLSLRSN-VLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN-- 202 (682)
Q Consensus 136 ~~~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~------~~L~~L~ls~N~l~g~-- 202 (682)
.+...+.|++|+|++| .|... +...+...++|++|+|++|+|+..--..+. ++|++|+|++|+|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4677788888888888 77632 344566678888899998888642211221 5788999999988854
Q ss_pred --CCcchhhhccccceec--cCCcccCCCC----CC--CCCCCCeEEecccCCC
Q 005693 203 --IPQSIQNLTQLTGLSL--QSNNLSGSIP----NF--DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 203 --~p~~~~~l~~L~~L~l--~~N~l~g~~p----~~--~l~~L~~l~ls~N~l~ 246 (682)
+...+...++|+.|+| ++|.|...-. .. ..++|++|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4566777788999999 7788874211 11 4578899999988874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.1e-08 Score=115.86 Aligned_cols=141 Identities=16% Similarity=0.105 Sum_probs=87.9
Q ss_pred eEEEEEeCCCc-ccc-cCCccccCCCCCCcEEEccCCCCCCC----CCCcCCCCCCCcEEeecccccCCcCCCCcc----
Q 005693 117 RVFGLRLPGIG-LVG-PIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS---- 186 (682)
Q Consensus 117 ~v~~l~l~~~~-l~g-~lp~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~---- 186 (682)
++..|+|+++. ++. .++. ...++++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++.-+..+.
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLS-IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHH-HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHH-HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 37888888775 221 1221 234778888888888888765 444456778888888888888743222221
Q ss_pred --cccceeecccccCcccCCcchhhhccccceeccCCcccCC---CCC--CCCCCCCeEEecccCCCCCCCccccCCCCC
Q 005693 187 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS---IPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNS 259 (682)
Q Consensus 187 --~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~---~p~--~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l 259 (682)
++|++|+|++|.+++ +|..+.++++|+.|+++++..... .+. ..+++|+.|+++++.. +.+|..+..+++|
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L 295 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQI 295 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGC
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCC
Confidence 678888888888885 677888888888888875332211 111 1455666666665432 2445444444444
Q ss_pred C
Q 005693 260 S 260 (682)
Q Consensus 260 ~ 260 (682)
+
T Consensus 296 ~ 296 (592)
T 3ogk_B 296 R 296 (592)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.7e-06 Score=85.95 Aligned_cols=136 Identities=18% Similarity=0.197 Sum_probs=95.2
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCC--ceeceEEEEE-ecCceEEEEeeccCCc
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP--NVVPLRAYYY-SKDEKLLVYDYFASGS 467 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~--niv~l~~~~~-~~~~~~lV~e~~~~g~ 467 (682)
+.++.|....||+. +..+++|+-.. ......+.+|.+++..+.+|- .|.+.+.+.. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888899988 56788888532 122457889999999995542 3566777764 3456789999999988
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG----------------------------------------- 506 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~----------------------------------------- 506 (682)
+.+.... .++..+...++.++++.|+.||+..
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8763221 1455556666666666666666432
Q ss_pred ----------------CCCcEecCCCCCCeEecC---CCCe-EEeecCCCCC
Q 005693 507 ----------------GPKFTHGNIKASNVLINQ---DLDG-CISDFGLTPL 538 (682)
Q Consensus 507 ----------------~~~ivHrDLk~~NILl~~---~~~~-kl~DfGla~~ 538 (682)
.+.++|+|+++.||++++ ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999997 4554 7999987643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=2.4e-06 Score=90.11 Aligned_cols=80 Identities=14% Similarity=0.139 Sum_probs=57.2
Q ss_pred ccc-cccCeEEEEEEEEc-------CCceEEEEEeeccc---c-ChhhHHHHHHHHHHhcCC--CceeceEEEEEec---
Q 005693 391 EVL-GKGSYGTAYKAVLE-------ESTTVVVKRLKEVV---V-GKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSK--- 453 (682)
Q Consensus 391 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~--- 453 (682)
+.| +.|....+|+.... ++..+++|+..... . ....+.+|..++..+..+ -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78889999998754 25678888765432 1 235688999999988655 3577788887654
Q ss_pred CceEEEEeeccCCchhH
Q 005693 454 DEKLLVYDYFASGSLST 470 (682)
Q Consensus 454 ~~~~lV~e~~~~g~L~~ 470 (682)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999876653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.17 E-value=4.2e-08 Score=110.95 Aligned_cols=122 Identities=18% Similarity=0.239 Sum_probs=55.0
Q ss_pred eEEEEEeCCCcccccCCccccC-CCCCCcEEEccCC-CCCCC-CCCcCCCCCCCcEEeecccccCCcCCCCcc------c
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLG-KLDALEVLSLRSN-VLTGG-LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------P 187 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~-~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~------~ 187 (682)
+++.|+|+++.+++..+. .+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. +
T Consensus 106 ~L~~L~L~~~~~~~~~~~-~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLE-LIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TCCEEEEESCBCCHHHHH-HHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCeEEeeCcEEcHHHHH-HHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 455555555555544333 232 4555555555555 33321 222233555555555555555543332221 3
Q ss_pred ccceeeccccc--Cccc-CCcchhhhccccceeccCC-cccCCCCCC--CCCCCCeEEe
Q 005693 188 QLVVLDLSFNS--FTGN-IPQSIQNLTQLTGLSLQSN-NLSGSIPNF--DIPKLRHLNL 240 (682)
Q Consensus 188 ~L~~L~ls~N~--l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~~p~~--~l~~L~~l~l 240 (682)
+|++|+|++|. ++.. ++..+.++++|+.|+|++| .+.+ +|.. .+++|+.|++
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l 242 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGT 242 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEEC
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccc
Confidence 55555555554 1110 1111233455555555555 2322 2221 4455555553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.16 E-value=2.4e-08 Score=112.91 Aligned_cols=105 Identities=18% Similarity=0.105 Sum_probs=51.2
Q ss_pred CCCCcEEEccCCCCCCCCCCcCC-CCCCCcEEeec--c----cccCCcCCC--C----cc--cccceeecccccCcccCC
Q 005693 140 LDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQ--H----NNFSGKIPS--S----FS--PQLVVLDLSFNSFTGNIP 204 (682)
Q Consensus 140 l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~L~--~----N~l~g~~p~--~----~~--~~L~~L~ls~N~l~g~~p 204 (682)
+++|+.|+++.|++++..+..+. ++++|+.|+|+ + |++++ .|. . +. ++|+.|+|++ ++++..+
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence 55566666655666544443443 35566666665 2 33431 111 0 10 4555555544 4544444
Q ss_pred cchhh-hccccceeccCCcccCCCCC---CCCCCCCeEEecccCCC
Q 005693 205 QSIQN-LTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGLK 246 (682)
Q Consensus 205 ~~~~~-l~~L~~L~l~~N~l~g~~p~---~~l~~L~~l~ls~N~l~ 246 (682)
..++. +++|+.|+|++|.+++.... ..+++|+.|+|++|.++
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 44444 55555555555555432221 13455555555555553
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.05 E-value=1.7e-07 Score=89.24 Aligned_cols=108 Identities=16% Similarity=0.209 Sum_probs=81.5
Q ss_pred CeEEEEEeCCC-ccccc----CCccccCCCCCCcEEEccCCCCCCC----CCCcCCCCCCCcEEeecccccCCc----CC
Q 005693 116 TRVFGLRLPGI-GLVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGK----IP 182 (682)
Q Consensus 116 ~~v~~l~l~~~-~l~g~----lp~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p 182 (682)
..++.|+|++| ++... +.. .+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~-~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHH-HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 56888999998 76531 222 467789999999999999732 344455668999999999999853 22
Q ss_pred CCcc--cccceeec--ccccCccc----CCcchhhhccccceeccCCccc
Q 005693 183 SSFS--PQLVVLDL--SFNSFTGN----IPQSIQNLTQLTGLSLQSNNLS 224 (682)
Q Consensus 183 ~~~~--~~L~~L~l--s~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 224 (682)
..+. ++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3333 67999999 88999865 3445666689999999999986
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.03 E-value=8.5e-06 Score=87.34 Aligned_cols=96 Identities=16% Similarity=0.198 Sum_probs=51.3
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.++.+.|++ ++. .|+...|.++.+|+.++|++|+++ .+|......++|+.+.|..| ++..-...|. ++|+.++|
T Consensus 158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 366666665 444 566667777777777777777776 44433223466666666533 4423233333 45555555
Q ss_pred ccccCcccCCcchhhhccccceec
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSL 218 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l 218 (682)
.+| ++..-..+|.+ .+|+.+.|
T Consensus 234 ~~~-l~~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 234 PEN-VSTIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp CTT-CCEECTTTTTT-CCCSEEEE
T ss_pred CCC-ccCcccccccc-CCccEEEe
Confidence 543 33233334444 44444444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=1.2e-06 Score=92.53 Aligned_cols=60 Identities=22% Similarity=0.322 Sum_probs=29.8
Q ss_pred cccceeecccccCcccCCcchh---hhccccceeccCCcccCC----CCCC--CCCCCCeEEecccCCC
Q 005693 187 PQLVVLDLSFNSFTGNIPQSIQ---NLTQLTGLSLQSNNLSGS----IPNF--DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 187 ~~L~~L~ls~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~g~----~p~~--~l~~L~~l~ls~N~l~ 246 (682)
++|++|+|++|.+++..+..+. .+++|+.|+|+.|.|++. ++.. .+++|+.|+|++|.++
T Consensus 252 p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 4555555555555543333332 355555555555555532 1111 3455555555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.00 E-value=1.6e-05 Score=85.17 Aligned_cols=138 Identities=16% Similarity=0.145 Sum_probs=95.4
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc-cccceeecc
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLS 195 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~~L~~L~ls 195 (682)
+++.+.|+++ ++ .|+..+|.+ .+|+.++|.+ +++..-+..|.++++|+.++|++|+++..-...|. .+|+.+.|.
T Consensus 136 ~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECC
T ss_pred CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeC
Confidence 4677777766 54 677777888 4699999885 67745567788999999999999988844444444 788999988
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCC--CCCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
+| ++..-..+|.++++|+.|+|.+| ++ .++. +.-.+|+.++| .|+++..-+..|.++++|..+
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l 276 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRESGITTVKL-PNGVTNIASRAFYYCPELAEV 276 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCCEE
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-cc-CccccccccCCccEEEe-CCCccEEChhHhhCCCCCCEE
Confidence 44 77667778889999999998875 43 2332 22256777777 444553334556666665543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=3.1e-05 Score=82.82 Aligned_cols=74 Identities=12% Similarity=0.194 Sum_probs=49.7
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccc--------cChhhHHHHHHHHHHhcCC-Cc-eeceEEEEEecCceEEE
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--------VGKRDFEQQMEIVGRVGQH-PN-VVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~~h-~n-iv~l~~~~~~~~~~~lV 459 (682)
+.||.|.++.||++... +++.+++|...... .....+..|.+++..+..+ +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999754 46789999764321 1234567888898887543 33 4455543 45567899
Q ss_pred EeeccCC
Q 005693 460 YDYFASG 466 (682)
Q Consensus 460 ~e~~~~g 466 (682)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.78 E-value=7e-05 Score=77.96 Aligned_cols=143 Identities=15% Similarity=0.226 Sum_probs=79.5
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCC-CceeceEE------EEEecCceEEEEeec
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRA------YYYSKDEKLLVYDYF 463 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~------~~~~~~~~~lV~e~~ 463 (682)
+.|+.|..+.||+....++ .+++|+... ...+...|.+++..+.++ -.+++++. +....+..++||||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3466677889999987654 588888865 234455566666655321 12334432 123456778999999
Q ss_pred cCCchh--------------HhhccC-CC---C-CC----CCCCHHHH-------------------------------H
Q 005693 464 ASGSLS--------------TLLHGN-RG---A-GR----TPLDWETR-------------------------------V 489 (682)
Q Consensus 464 ~~g~L~--------------~~l~~~-~~---~-~~----~~l~~~~~-------------------------------~ 489 (682)
+|..+. ..+|.. .. . .. ..-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986442 111110 00 0 00 01123211 0
Q ss_pred HHHHHHHHHHHHHHh--------c--CCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 490 KILLGTARGVAHIHS--------M--GGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 490 ~i~~~ia~gl~~LH~--------~--~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
.+..++..++.+|+. . ..+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666653 1 23459999999999999888899999998653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00011 Score=75.71 Aligned_cols=140 Identities=17% Similarity=0.151 Sum_probs=91.4
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCC--CceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
+.|+.|.+..+|+... ++..+++|+.... ....+..|.+.+..+..+ ..+++++++....+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4578899999999875 4678888887543 256788999999888543 6788899988888889999999998754
Q ss_pred hH-----------hhccCCC-CC----------------CCCCCHHHHH---HHHH----------------HHHHH-HH
Q 005693 469 ST-----------LLHGNRG-AG----------------RTPLDWETRV---KILL----------------GTARG-VA 500 (682)
Q Consensus 469 ~~-----------~l~~~~~-~~----------------~~~l~~~~~~---~i~~----------------~ia~g-l~ 500 (682)
.. .++.... .. .-.-+|.+.. ++.. .+... ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 2222211 00 0012454321 1111 11111 12
Q ss_pred HHHh-cCCCCcEecCCCCCCeEecCCCCeEEeecC
Q 005693 501 HIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFG 534 (682)
Q Consensus 501 ~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 534 (682)
.|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3322 2246699999999999999887 8899974
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.66 E-value=5.4e-06 Score=87.43 Aligned_cols=126 Identities=19% Similarity=0.288 Sum_probs=82.3
Q ss_pred eEEEEEeCCCcccccCCcccc--CCCCCCcEEEccC--CCCCCC-----CCCcC--CCCCCCcEEeecccccCCcCCCCc
Q 005693 117 RVFGLRLPGIGLVGPIPNNTL--GKLDALEVLSLRS--NVLTGG-----LPSEI--TSLPSLRYLYLQHNNFSGKIPSSF 185 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~--~~l~~L~~L~L~~--N~l~g~-----~p~~~--~~l~~L~~L~L~~N~l~g~~p~~~ 185 (682)
++..|+|..+++....-. .+ ..+++|++|+|+. |...|. +...+ ..+++|++|+|++|.+++..+..+
T Consensus 194 ~L~~L~L~~~~l~~~~l~-~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 194 NLKSLEIISGGLPDSVVE-DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TCSEEEEECSBCCHHHHH-HHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCcEEEEecCCCChHHHH-HHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 466666666655432111 23 3789999999863 222221 11122 357999999999999875332222
Q ss_pred -----ccccceeecccccCccc----CCcchhhhccccceeccCCcccCCCCCCCCCC--CCeEEecccC
Q 005693 186 -----SPQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPK--LRHLNLSYNG 244 (682)
Q Consensus 186 -----~~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~--L~~l~ls~N~ 244 (682)
.++|++|+|+.|.|++. ++..+.++++|+.|+|++|.|+...-. .+.. ...+++++|+
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~-~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKK-ELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHH-HHHHHCCSEEECCSBC
T ss_pred HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHH-HHHHHcCCEEEecCCc
Confidence 37899999999999874 556667899999999999998742111 1111 3568888887
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00039 Score=70.66 Aligned_cols=73 Identities=16% Similarity=0.217 Sum_probs=54.4
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCC--ceeceEEEEEecCceEEEEeeccCCc
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHP--NVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~--niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
+.+|.|..+.||+....+|+.+++|+-..... ....|+.|.+.++.+.+.. .+++++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 46899999999999999999999998754432 2356889999999885442 34555554 23578999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=9.5e-05 Score=65.61 Aligned_cols=57 Identities=19% Similarity=0.251 Sum_probs=45.2
Q ss_pred cEEeecccccC-CcCCCCcccccceeecccccCcccCCcchhhhccccceeccCCccc
Q 005693 168 RYLYLQHNNFS-GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 224 (682)
Q Consensus 168 ~~L~L~~N~l~-g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 224 (682)
+.++.+++.++ ..+|..+.++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777776 4677777788899999999998666677888888888888888765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00069 Score=72.86 Aligned_cols=73 Identities=12% Similarity=0.097 Sum_probs=45.3
Q ss_pred CCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCCCC-----CCcccCccccccCC---CCCcchHHHHHHHHHHHH
Q 005693 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRK---HSHKSDVYSFGVLLLEML 579 (682)
Q Consensus 508 ~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~-----~~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~ell 579 (682)
+.++|+|+++.|||+++++ ++|+||+.+..-........ ...|.+|+...... .....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4599999999999999876 99999998764321110000 11255555543211 112345557788888877
Q ss_pred hC
Q 005693 580 TG 581 (682)
Q Consensus 580 tg 581 (682)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00083 Score=68.67 Aligned_cols=71 Identities=6% Similarity=-0.011 Sum_probs=45.4
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec-cCCch
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF-ASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~-~~g~L 468 (682)
+.|+.|....+|+. ..+++|+.........+.++|..++..+..+.-..+++++ +.+.-++|+||+ ++-++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56888999999998 5688888754322222346788888777544333556554 444567899999 55444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0014 Score=67.67 Aligned_cols=75 Identities=12% Similarity=0.064 Sum_probs=50.2
Q ss_pred cccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCC-ceeceEEE-----EEecCceEEEEeeccC
Q 005693 392 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAY-----YYSKDEKLLVYDYFAS 465 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~-----~~~~~~~~lV~e~~~~ 465 (682)
.++ |....||+....+|+.+++|...........+..|..++..+..+. .+++++.. ....+..++||||++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 355 7778899887766778999998644345567778888888775432 24444433 1224456789999987
Q ss_pred Cc
Q 005693 466 GS 467 (682)
Q Consensus 466 g~ 467 (682)
..
T Consensus 112 ~~ 113 (328)
T 1zyl_A 112 RQ 113 (328)
T ss_dssp EE
T ss_pred CC
Confidence 54
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.18 E-value=7.8e-05 Score=69.49 Aligned_cols=81 Identities=7% Similarity=0.063 Sum_probs=48.3
Q ss_pred CCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccc-cCCcCCCCc------ccccceeeccccc-CcccCCcchhhhccc
Q 005693 142 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN-FSGKIPSSF------SPQLVVLDLSFNS-FTGNIPQSIQNLTQL 213 (682)
Q Consensus 142 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~------~~~L~~L~ls~N~-l~g~~p~~~~~l~~L 213 (682)
+|+.|||+++.++..--..+.++++|+.|+|+++. ++..--..+ .++|++|+|+++. +|..-=..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 57777777777764333456778888888888874 553111111 1357777777763 664333345566666
Q ss_pred cceeccCCc
Q 005693 214 TGLSLQSNN 222 (682)
Q Consensus 214 ~~L~l~~N~ 222 (682)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0022 Score=69.61 Aligned_cols=74 Identities=7% Similarity=0.050 Sum_probs=48.4
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
+.|+.|-...+|+....+ +..+++|+........-+..+|..++..+..+.-..++++.+. + .+||||++|-.|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 457778889999998765 4678888764322112234688999999865554567777762 2 359999987544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0032 Score=64.78 Aligned_cols=145 Identities=10% Similarity=0.097 Sum_probs=79.3
Q ss_pred ccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCC-ceeceEEE------EEecCceEEEEeec
Q 005693 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAY------YYSKDEKLLVYDYF 463 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~------~~~~~~~~lV~e~~ 463 (682)
+.|+.|....+|+....++ .+++|..... ....++..|..++..+..+. .+.+++.. ....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3567788889999987655 6888887652 23456677888887775432 13333321 12235678999999
Q ss_pred cCCchhH--------------hhccC-CC--CCC-CC---CCHHHHHH------------HHHHHHHHHHHHHhc----C
Q 005693 464 ASGSLST--------------LLHGN-RG--AGR-TP---LDWETRVK------------ILLGTARGVAHIHSM----G 506 (682)
Q Consensus 464 ~~g~L~~--------------~l~~~-~~--~~~-~~---l~~~~~~~------------i~~~ia~gl~~LH~~----~ 506 (682)
+|..+.. .++.. .. ... .. ..|..... +...+...+++++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8754321 11110 00 000 00 11222110 001133445555532 1
Q ss_pred CCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 507 ~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
.+.++|+|+.+.||+++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2348999999999999987666899998653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0015 Score=67.78 Aligned_cols=143 Identities=15% Similarity=0.108 Sum_probs=73.3
Q ss_pred cccccCeEE-EEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCC-ceeceEEEEEecCceEEEEeeccCCchh
Q 005693 392 VLGKGSYGT-AYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 392 ~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.|+.|.... +|+....++..+++|...... ..++..|+.++..+..+. .+.+++.+. .+.-++|||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcchH
Confidence 455554444 667654436667776543321 145566777777775442 355666663 23337899999776665
Q ss_pred HhhccCC---------------------CCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHHh---c
Q 005693 470 TLLHGNR---------------------GAGRTPLDWETRV-------K-------------ILLGTARGVAHIHS---M 505 (682)
Q Consensus 470 ~~l~~~~---------------------~~~~~~l~~~~~~-------~-------------i~~~ia~gl~~LH~---~ 505 (682)
+++.... ......++..... . ....+...++.+.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 4443211 0001112211100 0 00011122222311 1
Q ss_pred CCCCcEecCCCCCCeEecCC----CCeEEeecCCCCC
Q 005693 506 GGPKFTHGNIKASNVLINQD----LDGCISDFGLTPL 538 (682)
Q Consensus 506 ~~~~ivHrDLk~~NILl~~~----~~~kl~DfGla~~ 538 (682)
..+.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23459999999999999875 6789999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.001 Score=71.75 Aligned_cols=73 Identities=12% Similarity=0.104 Sum_probs=50.2
Q ss_pred ccccccCeEEEEEEEEcC--------CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 391 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
+.|+.|....||+....+ +..+++|+.... .....+.+|..++..+..+.-.+++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457778889999998753 467888887432 1125566888888888655545677776532 389999
Q ss_pred ccCCch
Q 005693 463 FASGSL 468 (682)
Q Consensus 463 ~~~g~L 468 (682)
++|-++
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0018 Score=68.34 Aligned_cols=143 Identities=15% Similarity=0.206 Sum_probs=83.3
Q ss_pred ccccccCeEEEEEEEEcC--------CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 391 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
+.+..|-...+|+....+ ++.+++|+.-..........+|.++++.+..+.-..++++++.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 346667778899988642 46788888643233455677899999888666555677776543 399999
Q ss_pred ccCCchhHh-----------------hccCCC-CCCCCC-CHHHHHHHHHHHHH-------------------HHHHH--
Q 005693 463 FASGSLSTL-----------------LHGNRG-AGRTPL-DWETRVKILLGTAR-------------------GVAHI-- 502 (682)
Q Consensus 463 ~~~g~L~~~-----------------l~~~~~-~~~~~l-~~~~~~~i~~~ia~-------------------gl~~L-- 502 (682)
++|..|..- +|...- ....+. -+.+..++..++.. .+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 988554311 111110 011111 23444444443321 23333
Q ss_pred --HhcC-CCCcEecCCCCCCeEecCC----CCeEEeecCCCC
Q 005693 503 --HSMG-GPKFTHGNIKASNVLINQD----LDGCISDFGLTP 537 (682)
Q Consensus 503 --H~~~-~~~ivHrDLk~~NILl~~~----~~~kl~DfGla~ 537 (682)
.... ...++|+|+.+.||+++++ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2222 2348999999999999876 789999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0021 Score=67.69 Aligned_cols=74 Identities=12% Similarity=0.112 Sum_probs=44.9
Q ss_pred ccccccCeEEEEEEEEcC---------CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 391 EVLGKGSYGTAYKAVLEE---------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
+.++.|....+|+....+ +..+++|+.........+...|.+++..+..+.-+.++++.. .-++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 457778888999998754 257788776442211123467888888885554355676553 2378999
Q ss_pred eccCCch
Q 005693 462 YFASGSL 468 (682)
Q Consensus 462 ~~~~g~L 468 (682)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.00014 Score=68.96 Aligned_cols=85 Identities=13% Similarity=0.140 Sum_probs=53.1
Q ss_pred cCCCCCCcEEEccCC-CCCC----CCCCcCCCCCCCcEEeecccccCCcCCCCcc------cccceeecccccCccc---
Q 005693 137 LGKLDALEVLSLRSN-VLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN--- 202 (682)
Q Consensus 137 ~~~l~~L~~L~L~~N-~l~g----~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~------~~L~~L~ls~N~l~g~--- 202 (682)
+.+-+.|++|+|++| +|.. .+-+.+..=+.|+.|+|++|+|...--..+. +.|+.|+|++|+|+..
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 455577888888875 6652 1223445556788888888888743333333 5688888888888743
Q ss_pred -CCcchhhhccccceeccCC
Q 005693 203 -IPQSIQNLTQLTGLSLQSN 221 (682)
Q Consensus 203 -~p~~~~~l~~L~~L~l~~N 221 (682)
+-..+..-+.|+.|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 2233444456777777654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.41 E-value=0.00086 Score=62.39 Aligned_cols=80 Identities=10% Similarity=0.035 Sum_probs=56.3
Q ss_pred CCCcEEeecccccCCcCCCCcc--cccceeeccccc-CcccCCcchhhh----ccccceeccCCc-ccC--CCCCCCCCC
Q 005693 165 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS-FTGNIPQSIQNL----TQLTGLSLQSNN-LSG--SIPNFDIPK 234 (682)
Q Consensus 165 ~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g--~~p~~~l~~ 234 (682)
-+|+.|||+++.++..--..+. ++|+.|+|+++. |+..-=..++.+ ++|+.|+|+++. ++. ...-..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 4799999999998743222222 789999999985 775433445543 479999999975 662 111126899
Q ss_pred CCeEEecccC
Q 005693 235 LRHLNLSYNG 244 (682)
Q Consensus 235 L~~l~ls~N~ 244 (682)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.01 Score=61.73 Aligned_cols=69 Identities=16% Similarity=0.140 Sum_probs=43.4
Q ss_pred cccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCC--CceeceEEE------EEecCceEEEEeeccC
Q 005693 394 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH--PNVVPLRAY------YYSKDEKLLVYDYFAS 465 (682)
Q Consensus 394 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~------~~~~~~~~lV~e~~~~ 465 (682)
|.|....||+....++ .+++|+...... ..|..++..+.++ +.+++.+.. ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444678999987666 889998765431 3455666555332 224454432 2334667899999998
Q ss_pred Cch
Q 005693 466 GSL 468 (682)
Q Consensus 466 g~L 468 (682)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 755
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0058 Score=53.90 Aligned_cols=56 Identities=27% Similarity=0.291 Sum_probs=41.2
Q ss_pred EEEeCCCccc-ccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccC
Q 005693 120 GLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS 178 (682)
Q Consensus 120 ~l~l~~~~l~-g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 178 (682)
.++.++++|+ ..+|.+ + -.+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5777788886 456652 2 246889999999998555566788888888888888775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.28 E-value=0.041 Score=52.50 Aligned_cols=102 Identities=12% Similarity=0.066 Sum_probs=66.5
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCCCC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 546 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 546 (682)
+|.+.|... ..++++++++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.|.+.+ +.+. .
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------~ 98 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------A 98 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------c
Confidence 788888753 3569999999999999998877632111 1 1233446899999999998764 1111 1
Q ss_pred CCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 005693 547 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 584 (682)
Q Consensus 547 ~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~P 584 (682)
....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 223467888764 3456788999999999998875444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0076 Score=63.99 Aligned_cols=110 Identities=15% Similarity=0.226 Sum_probs=77.9
Q ss_pred cCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchh
Q 005693 131 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ 208 (682)
Q Consensus 131 ~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~ 208 (682)
.+...+|.++..|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|. .+|+.++|..| ++..-..+|.
T Consensus 255 ~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~ 331 (394)
T 4gt6_A 255 RIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFA 331 (394)
T ss_dssp EECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred EcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhh
Confidence 344457888899999988766543 445678888999999886 445533334454 68899988765 6655567888
Q ss_pred hhccccceeccCCcccCCCCCC---CCCCCCeEEecccCC
Q 005693 209 NLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 245 (682)
Q Consensus 209 ~l~~L~~L~l~~N~l~g~~p~~---~l~~L~~l~ls~N~l 245 (682)
+|++|+.+.|.+| ++ .+... ++++|+.+++.+|..
T Consensus 332 ~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 332 GCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 9999999988655 54 34432 788899999887754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0073 Score=64.66 Aligned_cols=74 Identities=7% Similarity=0.075 Sum_probs=49.1
Q ss_pred ccccccCeEEEEEEEEcC--------CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 391 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
+.+..|-...+|+....+ +..+++++........-+.++|..++..+..+.-..++++.+ .-++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence 346667778899988753 567888876433222234578888888886555556677543 23789999
Q ss_pred ccCCch
Q 005693 463 FASGSL 468 (682)
Q Consensus 463 ~~~g~L 468 (682)
++|..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.05 E-value=0.00056 Score=64.91 Aligned_cols=109 Identities=14% Similarity=0.209 Sum_probs=70.5
Q ss_pred CCeEEEEEeCCC-cccc----cCCccccCCCCCCcEEEccCCCCCCC----CCCcCCCCCCCcEEeecccccCCcCCCCc
Q 005693 115 RTRVFGLRLPGI-GLVG----PIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSF 185 (682)
Q Consensus 115 ~~~v~~l~l~~~-~l~g----~lp~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 185 (682)
...++.|+|+++ ++.. .+-. .+..=+.|+.|+|++|+|... +-+.+..=+.|+.|+|++|+|+..--..+
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~-aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHH-HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 356788888875 4431 1222 466678899999999999732 22333345789999999999984322222
Q ss_pred c------cccceeecccc---cCccc----CCcchhhhccccceeccCCccc
Q 005693 186 S------PQLVVLDLSFN---SFTGN----IPQSIQNLTQLTGLSLQSNNLS 224 (682)
Q Consensus 186 ~------~~L~~L~ls~N---~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 224 (682)
. ..|++|+|++| .+... +-..+..-+.|+.|+|+.|.+.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 1 56999999876 33422 3345555677888888776643
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.87 E-value=0.015 Score=61.72 Aligned_cols=134 Identities=16% Similarity=0.133 Sum_probs=62.5
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.+..+.++..- + .+....+.+...|+.+.+..|..+ .-...|.++.+|+.+.+..+.+.. ..|. .+|+.+.+
T Consensus 231 ~l~~i~ip~~~-~-~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~---~~F~~~~~L~~i~l 304 (394)
T 4fs7_A 231 GVKNIIIPDSF-T-ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE---KTFYGCSSLTEVKL 304 (394)
T ss_dssp CCCEEEECTTC-C-EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT---TTTTTCTTCCEEEE
T ss_pred CCceEEECCCc-e-ecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc---cccccccccccccc
Confidence 34555555432 2 344456777777777777666443 333445555555555554443211 1111 44555555
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCC--C-CCCCCCeEEecccCCCCCCCccccCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 260 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~ 260 (682)
.+| ++..-..+|.++++|+.++|.++ ++ .+.. + ++.+|+.+++..| ++..-...|.++.+|+
T Consensus 305 ~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~ 369 (394)
T 4fs7_A 305 LDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLK 369 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCC
T ss_pred ccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCC
Confidence 433 44333445555555555555432 32 2222 1 4455555555443 3322223444444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.021 Score=60.07 Aligned_cols=123 Identities=14% Similarity=0.095 Sum_probs=77.2
Q ss_pred ccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccc
Q 005693 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 213 (682)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L 213 (682)
.+.....|+.+.+..+ +...-...+.++.+|+.+.+..+ ++..-...|. .+|+.+.+..+ ++..-...|.++++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 5667777888887655 33244456778888888888765 4423233333 56777777544 554555677888888
Q ss_pred cceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 214 TGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 214 ~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
+.+.+.+|.++..-... ++.+|+.++|..| ++..-...|.++.+|+-+
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 338 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI 338 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence 88888877776322222 6778888888654 542223456666666544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.029 Score=59.44 Aligned_cols=37 Identities=22% Similarity=0.233 Sum_probs=19.6
Q ss_pred cchhhhccccceeccCCcccCCCCCC---CCCCCCeEEeccc
Q 005693 205 QSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYN 243 (682)
Q Consensus 205 ~~~~~l~~L~~L~l~~N~l~g~~p~~---~l~~L~~l~ls~N 243 (682)
.+|.++++|+.+.+.++..+ ++.. .+.+|+.+++..|
T Consensus 156 ~aF~~c~~L~~i~l~~~~~~--I~~~~F~~c~~L~~i~l~~~ 195 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSMET--LHNGLFSGCGKLKSIKLPRN 195 (394)
T ss_dssp TTTTTCTTCCEEECCTTCCE--ECTTTTTTCTTCCBCCCCTT
T ss_pred hhhcccCCCcEEecCCccce--eccccccCCCCceEEEcCCC
Confidence 45666666666666544322 2221 4556666666544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.58 E-value=0.026 Score=59.74 Aligned_cols=100 Identities=13% Similarity=0.183 Sum_probs=59.7
Q ss_pred CCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCC--C-CC
Q 005693 158 PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--F-DI 232 (682)
Q Consensus 158 p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~-~l 232 (682)
...|.++++|+.+.+.++..+ .-...|. .+|+.+.+. +.++..-..+|.++.+|+.+.|.+| ++ .+.. + ++
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C 333 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGC 333 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTC
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCC
Confidence 456777777777777655433 2223333 567777775 4555455567777778888777654 33 2332 2 66
Q ss_pred CCCCeEEecccCCCCCCCccccCCCCCCCC
Q 005693 233 PKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 233 ~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~ 262 (682)
.+|+.+.|..+ ++..-...|.++++|+-+
T Consensus 334 ~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i 362 (394)
T 4gt6_A 334 EQLERIAIPSS-VTKIPESAFSNCTALNNI 362 (394)
T ss_dssp TTCCEEEECTT-CCBCCGGGGTTCTTCCEE
T ss_pred CCCCEEEECcc-cCEEhHhHhhCCCCCCEE
Confidence 77777777544 552223456666666543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.94 E-value=0.098 Score=54.80 Aligned_cols=104 Identities=13% Similarity=0.175 Sum_probs=53.7
Q ss_pred ccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhc
Q 005693 134 NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLT 211 (682)
Q Consensus 134 ~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~ 211 (682)
...+.+...|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|. .+|+.+++.+|.++..-..+|.++.
T Consensus 233 ~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~ 310 (379)
T 4h09_A 233 DGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCV 310 (379)
T ss_dssp TTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCT
T ss_pred cccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCC
Confidence 334556666666666544 44233345566666666666443 3312122232 4566666666666644455666666
Q ss_pred cccceeccCCcccCCCCCC---CCCCCCeEEec
Q 005693 212 QLTGLSLQSNNLSGSIPNF---DIPKLRHLNLS 241 (682)
Q Consensus 212 ~L~~L~l~~N~l~g~~p~~---~l~~L~~l~ls 241 (682)
+|+.+.|.+| ++ .+... ++.+|+.+.+.
T Consensus 311 ~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 311 KLSSVTLPTA-LK-TIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp TCCEEECCTT-CC-EECTTTTTTCTTCCCCCCC
T ss_pred CCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEEC
Confidence 6666666543 33 22221 45555555543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.63 E-value=0.46 Score=50.26 Aligned_cols=28 Identities=21% Similarity=0.478 Sum_probs=23.8
Q ss_pred cEecCCCCCCeEe------cCCCCeEEeecCCCC
Q 005693 510 FTHGNIKASNVLI------NQDLDGCISDFGLTP 537 (682)
Q Consensus 510 ivHrDLk~~NILl------~~~~~~kl~DfGla~ 537 (682)
++|+|+.+.||++ +++..++++||-+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999998764
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=89.31 E-value=0.068 Score=35.56 Aligned_cols=31 Identities=19% Similarity=0.163 Sum_probs=20.5
Q ss_pred ccccceeeeeeehhhHHHHHHHHhhhhhhcc
Q 005693 301 KLGLGAIIAIAVGGSAVLLLVALVILCYCLK 331 (682)
Q Consensus 301 ~~~~~~Ii~ivv~~~~~~l~~~~li~~~~~r 331 (682)
..+.++|.+++++.++.+++++.+++++++|
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 3456778888888877766666555555444
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.28 E-value=0.12 Score=35.54 Aligned_cols=31 Identities=29% Similarity=0.254 Sum_probs=17.4
Q ss_pred ceeeeeeehhhHHHHHHHHhhhhhhccccCC
Q 005693 305 GAIIAIAVGGSAVLLLVALVILCYCLKKKDN 335 (682)
Q Consensus 305 ~~Ii~ivv~~~~~~l~~~~li~~~~~rrk~~ 335 (682)
..|++.++++++++++++++++++.+||+++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 4456666666666555555555555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.06 E-value=0.1 Score=35.74 Aligned_cols=31 Identities=29% Similarity=0.413 Sum_probs=18.3
Q ss_pred ceeeeeeehhhHHHHHHHHhhhhhhccccCC
Q 005693 305 GAIIAIAVGGSAVLLLVALVILCYCLKKKDN 335 (682)
Q Consensus 305 ~~Ii~ivv~~~~~~l~~~~li~~~~~rrk~~ 335 (682)
+.|++.++++++++++++++++++.+||+++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 4466666776666666555555555555443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.83 E-value=3.5 Score=39.07 Aligned_cols=116 Identities=11% Similarity=0.095 Sum_probs=77.3
Q ss_pred CCCceeceEEEEEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 005693 439 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 518 (682)
Q Consensus 439 ~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~ 518 (682)
.||+.+.. .+-.+++...+.|+.-+.+-=...++ .++...+++++.+|+....+++. =+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 68988876 45556666666666443222222232 27889999999999887755554 478889999
Q ss_pred CeEecCCCCeEEeecCCCCCCCCCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 005693 519 NVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 586 (682)
Q Consensus 519 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~ 586 (682)
|++++.++.+++.=.|+-..+ +|. ..++..=.-.+=+++..+++++..|.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l-------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV-------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB-------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC-------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999876653322 222 11222223356778888999988885
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=81.09 E-value=0.32 Score=33.25 Aligned_cols=29 Identities=17% Similarity=0.370 Sum_probs=14.1
Q ss_pred eeeeeeehhhHHHHHHHHhhhhhhccccCC
Q 005693 306 AIIAIAVGGSAVLLLVALVILCYCLKKKDN 335 (682)
Q Consensus 306 ~Ii~ivv~~~~~~l~~~~li~~~~~rrk~~ 335 (682)
.|+++++| +++++++++.+++|.+||+.+
T Consensus 13 ~Ia~~vVG-vll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 13 SIISAVVG-ILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHH-HHHHHHHHHHHHHHHHHHCSC
T ss_pred chHHHHHH-HHHHHHHHHHHHhheehhhhh
Confidence 35555665 444444444444455554443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 682 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 7e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-54
Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
E LG G +G + T V VK LK+ + F + ++ ++ QH +V L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYA-V 76
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+++ ++ +Y +GSL L G L + + A G+A I +
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---Y 130
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVIETRKHSHK 565
H +++A+N+L++ L I+DFGL L+ +R + APE I + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 625
SDV+SFG+LL E++T + P +Q++ R ++R N E
Sbjct: 191 SDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLER--------GYRMVRPDNCPE 237
Query: 626 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
E+ Q++ C + P+ RP D + ++E+ +
Sbjct: 238 ELYQLM---RLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 64/283 (22%), Positives = 127/283 (44%), Gaps = 35/283 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLR 447
+ +G GS+GT YK V VK L + F+ ++ ++ + +H N++
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 70
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
Y + + +V + SL LH + + I TA+G+ ++H+
Sbjct: 71 GYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 561
H ++K++N+ +++DL I DFGL + + + + S + APEVI +
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 562 ---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618
+S +SDVY+FG++L E++TG+ P + ++ + +V + +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMVGRGYLSPDLS---K 233
Query: 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
N + M +++ C+ K D RP +++ IE + +S
Sbjct: 234 VRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLARS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 7e-53
Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 31/277 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ +G G +G + V +K ++E + + DF ++ E++ ++ HP +V L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 69
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+ LV+++ G LS L R ET + + L G+A++
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSHK 565
H ++ A N L+ ++ +SDFG+T + S + +PEV ++S K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 566 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
SDV+SFGVL+ E+ + GK P ++ + ++V+ + + +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------------- 229
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
+ QI C + P+ RP ++R + E+ +S
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 58/300 (19%), Positives = 109/300 (36%), Gaps = 35/300 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
E +GKG +G ++ V VK E ++ + +H N++ A
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAAD 66
Query: 451 YSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-- 504
+ LV DY GSL L+ R + E +K+ L TA G+AH+H
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 505 ---MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA--------GYRA 553
G P H ++K+ N+L+ ++ CI+D GL + A Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 554 PEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM----VDLPRWVQSV 603
PEV++ + ++D+Y+ G++ E+ + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
+R+ + + E + M +I C R + + + ++ Q +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 5e-51
Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 27/272 (9%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ +GKG +G V VK +K + F + ++ ++ +H N+V L
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 69
Query: 451 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ L +V +Y A GSL L GR+ L + +K L + ++
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 123
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMN-VPATPSRSAGYRAPEVIETRKHSHKSDV 568
F H ++ A NVL+++D +SDFGLT + T + APE + +K S KSDV
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 569 YSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV 628
+SFG+LL E+ + R + D+ V+ + + +
Sbjct: 184 WSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKGYKMD-----------APDGCPPAVY 230
Query: 629 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660
+++ C MRP+ ++ +E ++
Sbjct: 231 EVM---KNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 7e-51
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 31/274 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
+ LG G +G V +K +KE + + +F ++ +++ + H +V L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 68
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
+ ++ +Y A+G L L R + +++ + ++ S F
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSHK 565
H ++ A N L+N +SDFGL+ + S + PEV+ K S K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 566 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
SD+++FGVL+ E+ + GK P + T + + + R +E
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE------------- 228
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
++ I +C + D RP ++ I +V
Sbjct: 229 ----KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-50
Identities = 64/302 (21%), Positives = 117/302 (38%), Gaps = 46/302 (15%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPN 442
+ LG G++G +A + + TV VK LK + + +++++ +G H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA-------------GRTPLDWETRV 489
+V L L++ +Y G L L R + LD E +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 490 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS- 548
A+G+A + S H ++ A N+L+ I DFGL + +
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 549 -----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 603
+ APE I ++ +SDV+S+G+ L E+ + + + + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKM 260
Query: 604 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
++E + R + E +M I C P RP ++V++IE+ S+S
Sbjct: 261 IKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI-SES 309
Query: 664 EN 665
N
Sbjct: 310 TN 311
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-48
Identities = 48/291 (16%), Positives = 114/291 (39%), Gaps = 18/291 (6%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 447
LG G+ G +K + S + K + + + ++++++ P +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFY 70
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+YS E + ++ GSL +L + + K+ + +G+ ++
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIETRKHSHK 565
H ++K SN+L+N + + DFG++ + ++ + + Y +PE ++ +S +
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV--FDVELMRFQNI 623
SD++S G+ L+EM G+ P+ P ++ + E L +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 624 EEEMVQMLQIGMACVAKVPDMRPNM---DEVVRMIEEVRQSDSENRPSSEE 671
+ + ++ V + P P+ E + + + R ++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 59/310 (19%), Positives = 127/310 (40%), Gaps = 38/310 (12%)
Query: 391 EVLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 445
+V+G+G++G KA +++ +KR+KE RDF ++E++ ++G HPN++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGN-----------RGAGRTPLDWETRVKILLG 494
L + L +Y G+L L + + + L + +
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 495 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---Y 551
ARG+ ++ F H ++ A N+L+ ++ I+DFGL+ V + +
Sbjct: 136 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192
Query: 552 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611
A E + ++ SDV+S+GVLL E+++ P + + +
Sbjct: 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGM--TCAELYEKLPQ------ 241
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 671
L + N ++E+ ++ C + P RP+ +++ + + + ++
Sbjct: 242 --GYRLEKPLNCDDEVYDLM---RQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296
Query: 672 NKSKDSNVQT 681
K + +
Sbjct: 297 EKFTYAGIDC 306
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 66/286 (23%), Positives = 122/286 (42%), Gaps = 30/286 (10%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 450
LG+G +G + +T V +K LK + F Q+ +++ ++ +H +V L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYA-V 80
Query: 451 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 510
S++ +V +Y + GSL L G G L V + A G+A++ M +
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---Y 134
Query: 511 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVIETRKHSHK 565
H +++A+N+L+ ++L ++DFGL L+ +R + APE + + K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 625
SDV+SFG+LL E+ T ++ V+ R E +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGYRMPCPPECPE----------- 241
Query: 626 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-DSENRPSSE 670
+ + C K P+ RP + + +E+ S + + +P
Sbjct: 242 ---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 6e-48
Identities = 65/290 (22%), Positives = 129/290 (44%), Gaps = 41/290 (14%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVV 444
+V+G G +G L + V +K LK +RDF + I+G+ HPNV+
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVI 90
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L +++ ++ +GSL + L N G V +L G A G+ ++
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLAD 146
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---------SAGYRAPE 555
M + H ++ A N+L+N +L +SDFGL+ + + + APE
Sbjct: 147 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614
I+ RK + SDV+S+G+++ E+++ G+ P T D+++ + +++
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-------IEQDY------ 250
Query: 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 664
R + + Q+ + C K + RP ++V ++++ ++ +
Sbjct: 251 ----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (418), Expect = 8e-47
Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 29/279 (10%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG G YG Y+ V ++ TV VK LKE + +F ++ ++ + +HPN+V L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 81
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ ++ ++ G+L L R + + + + + ++
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN--- 135
Query: 510 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-----AGYRAPEVIETRKHSH 564
F H ++ A N L+ ++ ++DFGL+ LM + + + APE + K S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
KSDV++FGVLL E+ T +DL + + + ++ R + E
Sbjct: 196 KSDVWAFGVLLWEIATYGMSP-----YPGIDLSQVYELLEKD-----------YRMERPE 239
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
++ ++ AC P RP+ E+ + E + Q S
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-46
Identities = 65/329 (19%), Positives = 116/329 (35%), Gaps = 56/329 (17%)
Query: 365 PEKNKLVFFEGCSYNFDLEDLLRAS----AEVLGKGSYGTAYKAVLEES------TTVVV 414
N+ + + Y +DL+ +VLG G++G A V V
Sbjct: 13 SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72
Query: 415 KRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL 472
K LKE + +++++ ++G H N+V L L+++Y G L L
Sbjct: 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132
Query: 473 HGNRG------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 514
R L +E + A+G+ + H +
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189
Query: 515 IKASNVLINQDLDGCISDFGLTPLMN------VPATPSRSAGYRAPEVIETRKHSHKSDV 568
+ A NVL+ I DFGL + V + APE + ++ KSDV
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 569 YSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 627
+S+G+LL E+ + G P P + + +Q+ + + EE+
Sbjct: 250 WSYGILLWEIFSLGVNPY--PGIPVDANFYKLIQNGFKMDQP-----------FYATEEI 296
Query: 628 VQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
++Q +C A RP+ + +
Sbjct: 297 YIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 2e-46
Identities = 61/304 (20%), Positives = 124/304 (40%), Gaps = 55/304 (18%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 442
+G+G++G ++A E T V VK LKE + DF+++ ++ +PN
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 77
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG-------------------AGRTPL 483
+V L L+++Y A G L+ L G PL
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 484 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--- 540
++ I A G+A++ F H ++ N L+ +++ I+DFGL+ +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 541 ---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 596
+ + PE I +++ +SDV+++GV+L E+ + G P ++++
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254
Query: 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 656
V D ++ E +++ + C +K+P RP+ + R+++
Sbjct: 255 ---------------VRDGNILAC--PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 657 EVRQ 660
+ +
Sbjct: 298 RMCE 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 39/286 (13%)
Query: 391 EVLGKGSYGTAYKAVLEESTT----VVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNVV 444
EV+G+G +G Y L ++ VK L + + F + I+ HPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 91
Query: 445 PLRAYYYSKDEK-LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
L + L+V Y G L + + + L A+G+ +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLA 147
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAGYRAPE 555
S F H ++ A N ++++ ++DFGL M S + A E
Sbjct: 148 SKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615
++T+K + KSDV+SFGVLL E++T AP P D + +++
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDV--NTFDITVYLLQGR-------- 251
Query: 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
L++ + + + ++ + C +MRP+ E+V I + +
Sbjct: 252 RLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 62/294 (21%), Positives = 126/294 (42%), Gaps = 38/294 (12%)
Query: 391 EVLGKGSYGTAYKAVLEEST-----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNV 443
+V+G G +G YK +L+ S+ V +K LK + DF + I+G+ H N+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 71
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ L +++ +Y +G+L L G V +L G A G+ ++
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA 127
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-------GYRAPEV 556
+M + H ++ A N+L+N +L +SDFGL+ ++ + + + APE
Sbjct: 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616
I RK + SDV+SFG+++ E++T ++ + + R
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVMKAINDGFRLPT-------- 234
Query: 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSE 670
+ + Q+ M C + RP ++V +++++ ++ + ++
Sbjct: 235 ------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 61/300 (20%), Positives = 119/300 (39%), Gaps = 45/300 (15%)
Query: 379 NFDLEDLLRASAEVLGKGSYGTAYKAVL---EESTTVVVKRLKEVV--VGKRDFEQQMEI 433
N + D+ LG G++G+ + V ++ V +K LK+ + ++ +I
Sbjct: 9 NLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 434 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 493
+ ++ +P +V L + + +LV + G L L G R + ++L
Sbjct: 63 MHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLH 116
Query: 494 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------ 547
+ G+ ++ F H ++ A NVL+ ISDFGL+ + +
Sbjct: 117 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 548 -SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 605
+ APE I RK S +SDV+S+GV + E L+ G+ P + +++ +++ R
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKR 230
Query: 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 665
E E ++ + C + RP+ V + + S +
Sbjct: 231 MECPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-45
Identities = 51/276 (18%), Positives = 114/276 (41%), Gaps = 33/276 (11%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPL 446
+G GSYG K + +V K L + K+ ++ ++ + +HPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRY 68
Query: 447 RAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
+ L V +Y G L++++ R LD E ++++ + H
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHR 127
Query: 505 MG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIE 558
G H ++K +NV ++ + + DFGL ++N + +++ Y +PE +
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618
++ KSD++S G LL E+ P + ++ ++ ++ + +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------------KIREGKFR 232
Query: 619 RF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
R +E+ +++ + RP+++E++
Sbjct: 233 RIPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 5e-45
Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 40/298 (13%)
Query: 364 EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVV 422
+P+ +L F + F +G GS+G Y A + S V +K++
Sbjct: 1 DPDVAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53
Query: 423 GK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA 478
+D +++ + ++ +HPN + R Y + LV +Y + L +
Sbjct: 54 QSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-- 110
Query: 479 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538
PL + G +G+A++HS H ++KA N+L+++ + DFG +
Sbjct: 111 ---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 539 MNVPATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 595
M + + + APEVI ++ K DV+S G+ +E+ K PL +
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-- 222
Query: 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+ + + E A ++ + E + +C+ K+P RP + +++
Sbjct: 223 ----LYHIAQNESPA-------LQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-44
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 32/269 (11%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 446
LGKG +G Y A ++S + +K L + + K E Q+ E+ + +HPN++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
Y++ L+ +Y G++ L D + + A +++ HS
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR 126
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--SAGYRAPEVIETRKHSH 564
H +IK N+L+ + I+DFG + + + Y PE+IE R H
Sbjct: 127 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
K D++S GVL E L GK P ++ T + V+ + T D+
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL--------- 234
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+ ++L+ P RP + EV+
Sbjct: 235 --ISRLLK-------HNPSQRPMLREVLE 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (406), Expect = 2e-44
Identities = 55/297 (18%), Positives = 121/297 (40%), Gaps = 32/297 (10%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 448
E LG G++G ++ + K + K ++++ + + +HP +V L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHD 90
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 508
+ +E +++Y++ + G L + + + V+ + +G+ H+H
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 509 KFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHS 563
+ H ++K N++ + DFGLT ++ + +A + APEV E +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623
+ +D++S GVL +L+G +P D+ +++V +W ++ F I
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWN-----MDDSAFSGI 252
Query: 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDSENRPSSEENKSKDS 677
E+ ++ + P+ R + + + + PSS K +DS
Sbjct: 253 SEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 8e-44
Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 34/274 (12%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPL 446
+G+GS+ T YK + E+T V L++ + K + F+++ E++ + QHPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF 73
Query: 447 RAYYYS----KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
+ S K +LV + SG+L T L + + + +G+ +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFL 128
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR--SAGYRAPEVIET 559
H+ P H ++K N+ I I D GL L + + + APE+ E
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619
K+ DVY+FG+ +LEM T + P + + R V S V+ +V E+
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
C+ + D R ++ +++
Sbjct: 245 I-------------IEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-43
Identities = 58/292 (19%), Positives = 119/292 (40%), Gaps = 35/292 (11%)
Query: 373 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQ 430
+E + + + ED LG G++G YKA +E++ + K + + D+ +
Sbjct: 1 YEHVTRDLNPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 431 MEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 490
++I+ HPN+V L +Y ++ ++ ++ A G++ ++ PL
Sbjct: 60 IDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQV 114
Query: 491 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-- 548
+ T + ++H H ++KA N+L D D ++DFG++ S
Sbjct: 115 VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
Query: 549 --AGYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 601
+ APEV+ + R + +K+DV+S G+ L+EM + P + +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LL 225
Query: 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+ + E L + L+ C+ K D R ++++
Sbjct: 226 KIAKSEP------PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 41/280 (14%)
Query: 392 VLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVP 445
LG G++GT K + V VK LK K + + ++ ++ +P +V
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR 72
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
+ + +LV + G L+ L NR + + ++++ + G+ ++
Sbjct: 73 MIGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES 126
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAPEVIE 558
F H ++ A NVL+ ISDFGL+ + + + APE I
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 559 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617
K S KSDV+SFGVL+ E + G+ P + ++ + ++ R
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEKGERMGCP-------- 232
Query: 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657
EM ++ C + RP V +
Sbjct: 233 ---AGCPREMYDLM---NLCWTYDVENRPGFAAVELRLRN 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-43
Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 41/285 (14%)
Query: 391 EVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPN 442
E LG GS+G + + + +V VK LK V+ + DF +++ + + H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 72
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
++ L + K+ V + GSL L ++G T + + A G+ ++
Sbjct: 73 LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYL 127
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAPE 555
S F H ++ A N+L+ I DFGL + + APE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614
++TR SH SD + FGV L EM T G+ P ++ + +E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------IDKEGE------ 232
Query: 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659
R E+ + + + C A P+ RP + + E +
Sbjct: 233 ----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 6e-43
Identities = 67/296 (22%), Positives = 121/296 (40%), Gaps = 48/296 (16%)
Query: 391 EVLGKGSYGTAYKAVLEES--------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQH 440
+ LG+G++G A T V VK LK K D +ME++ +G+H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 441 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRV 489
N++ L ++ +Y + G+L L R G L + V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 490 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS- 548
ARG+ ++ S H ++ A NVL+ +D I+DFGL ++ ++
Sbjct: 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 549 -----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS 602
+ APE + R ++H+SDV+SFGVLL E+ T G +P +++ + ++
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---KLLKE 252
Query: 603 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
R + + + ++ + C VP RP ++V ++ +
Sbjct: 253 GHRMDKPSNCTN--------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 6e-42
Identities = 70/299 (23%), Positives = 117/299 (39%), Gaps = 44/299 (14%)
Query: 391 EVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 442
+ LG+G++G +A TV VK LKE R +++I+ +G H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 443 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVK 490
VV L L ++ ++ G+LST L R + L E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 491 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA- 549
A+G+ + S H ++ A N+L+++ I DFGL + R
Sbjct: 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 550 -----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 604
+ APE I R ++ +SDV+SFGVLL E+ + A V + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCRRL 250
Query: 605 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663
+E R + + +M Q + C P RP E+V + + Q+++
Sbjct: 251 KEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 152 bits (386), Expect = 1e-41
Identities = 57/296 (19%), Positives = 119/296 (40%), Gaps = 31/296 (10%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 448
E LG G++G ++ V + + V K + + K + ++ I+ ++ HP ++ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHD 93
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 508
+ K E +L+ ++ + G L + + + + G+ H+H
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHS-- 147
Query: 509 KFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHS 563
H +IK N++ I DFGL +N + + APE+++
Sbjct: 148 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 564 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623
+D+++ GVL +L+G +P + +Q+V R +W FD + F ++
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE---FDEDA--FSSV 255
Query: 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSENRPSSEENKSKDS 677
E ++ + K P R + + + ++ + + PSS NK +
Sbjct: 256 SPEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 53/269 (19%), Positives = 111/269 (41%), Gaps = 31/269 (11%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 448
E +G+G+ GT Y A+ + V ++++ + K ++ ++ ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLD 84
Query: 449 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 508
Y DE +V +Y A GSL+ ++ T +D + + + +HS
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 509 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKHSH 564
H +IK+ N+L+ D ++DFG + + + + APEV+ + +
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
K D++S G++ +EM+ G+ P + + L + EL + +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT------PELQNPEKLS 243
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
L C+ + R + E+++
Sbjct: 244 AIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 444
+G+G +G ++ + + V +K K + F Q+ + + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 71
Query: 445 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 504
L +++ ++ + G L + L + LD + + + +A++ S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES 126
Query: 505 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 559
F H +I A NVL++ + + DFGL+ M S G + APE I
Sbjct: 127 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 560 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618
R+ + SDV+ FGV + E+L G P Q +D++ +++ R
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERLPM---------- 230
Query: 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662
N + ++ C A P RP E+ + + + +
Sbjct: 231 -PPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 60/273 (21%), Positives = 114/273 (41%), Gaps = 34/273 (12%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
+ LG+G+YG AV + V VK + K V + ++++ I + H NVV
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFY 69
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ + + L +Y + G L + + G + + GV ++H +G
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 561
TH +IK N+L+++ + ISDFGL + + Y APE+++ R+
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 562 -HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620
H+ DV+S G++L ML G+ P P+ D + W + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKTYLN-----------PW 229
Query: 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+ I+ + +L + + P R + ++ +
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 51/301 (16%), Positives = 124/301 (41%), Gaps = 31/301 (10%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
E LG+G +G ++ V S T + K +K + ++++ I+ +H N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHES 69
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+ S +E ++++++ + + ++ + L+ V + + +HS
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHN--- 122
Query: 510 FTHGNIKASNVLINQDLDG--CISDFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSH 564
H +I+ N++ I +FG + + Y APEV + S
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
+D++S G L+ +L+G P + T + +++++ E+T FD E F+ I
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYT---FDEEA--FKEIS 231
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDSENRPSSEENKSKDSNVQT 681
E + + + K R E ++ + +++ + ++ + + + + ++
Sbjct: 232 IEAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 682 P 682
Sbjct: 289 D 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 8e-40
Identities = 57/298 (19%), Positives = 113/298 (37%), Gaps = 41/298 (13%)
Query: 391 EVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 443
+VLG G++GT YK + V +K L+E K ++ + ++ V +P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 73
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
L L+ G L + ++ + + + + A+G+ ++
Sbjct: 74 CRLL-GICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLE 128
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVI 557
H ++ A NVL+ I+DFGL L+ + G + A E I
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 558 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616
R ++H+SDV+S+GV + E++T G P ++ + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------------- 230
Query: 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKS 674
R + + I + C D RP E++ ++ + D + + ++
Sbjct: 231 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR-DPQRYLVIQGDER 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 2e-39
Identities = 63/303 (20%), Positives = 113/303 (37%), Gaps = 41/303 (13%)
Query: 391 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 442
LG+GS+G Y+ V E T V +K + E + +F + ++ +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 84
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----RTPLDWETRVKILLGTAR 497
VV L L++ + G L + L R A P +++ A
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 498 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGY 551
G+A++++ F H ++ A N ++ +D I DFG+T + + +
Sbjct: 145 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 552 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 611
+PE ++ + SDV+SFGV+L E+ T + R+V +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVMEGGLLDKPDN 259
Query: 612 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS--S 669
D + ++ C P MRP+ E++ I+E + S
Sbjct: 260 CPD--------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305
Query: 670 EEN 672
EEN
Sbjct: 306 EEN 308
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-39
Identities = 57/306 (18%), Positives = 120/306 (39%), Gaps = 36/306 (11%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
+VLG G G + + + +K L++ +++E+ R Q P++V +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDV 73
Query: 450 YYSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
Y + L+V + G L + + G +I+ + ++HS+
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 506 GGPKFTHGNIKASNVLINQDLDG---CISDFG---LTPLMNVPATPSRSAGYRAPEVIET 559
H ++K N+L ++DFG T N TP + Y APEV+
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619
K+ D++S GV++ +L G P S + + + +++ +R ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGMKTRIRMGQ----YEFPNPE 240
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV-----VRMIEEVRQSDSENRPSSEENKS 674
+ + EE+ +++ + P R + E + +V Q+ +E+K
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 675 KDSNVQ 680
+ +V+
Sbjct: 298 RWEDVK 303
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (360), Expect = 8e-39
Identities = 51/281 (18%), Positives = 107/281 (38%), Gaps = 42/281 (14%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLK----------EVVVGKRDFEQQMEIVGRVGQ 439
E+LG+G + + + + VK + EV + ++++I+ +V
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
HPN++ L+ Y + LV+D G L L L + KI+ +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVI 123
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV 556
+H + H ++K N+L++ D++ ++DFG + ++ G Y APE+
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 557 IET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 610
IE + + D++S GV++ +L G P + M+ +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----------RMIMS 229
Query: 611 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 651
+ + + + + ++ + P R +E
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 44/272 (16%), Positives = 106/272 (38%), Gaps = 38/272 (13%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 445
++LG+GS+ T A L S +K L++ + K + ++ +++ R+ HP V
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVK 72
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L + ++ Y +G L + D + ++H
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG- 126
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS------AGYRAPEVIET 559
H ++K N+L+N+D+ I+DFG +++ + +R+ A Y +PE++
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619
+ SD+++ G ++ +++ G P ++ + ++ +E
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---------------KIIKLEYDF 229
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 651
+ + +++ + R +E+
Sbjct: 230 PEKFFPKARDLVE---KLLVLDATKRLGCEEM 258
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 445
++LGKGS+G + A +++ +K LK+ VV D + ++ +HP +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
+ + +K+ V +Y G L + D G+ +HS
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK 122
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 561
G + ++K N+L+++D I+DFG+ + + + Y APE++ +K
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621
++H D +SFGVLL EML G++P +++ R E D+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL------ 233
Query: 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+V++ + P+ R + +R
Sbjct: 234 -----LVKLFV-------REPEKRLGVRGDIR 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (345), Expect = 1e-36
Identities = 51/269 (18%), Positives = 110/269 (40%), Gaps = 26/269 (9%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 447
+VLG G++ A + + V +K + K+ + GK E ++ ++ ++ +HPN+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALD 73
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
Y S L+ + G L + +++ V ++H +G
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 564
+++D ISDFGL+ + + + S + G Y APEV+ + +S
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624
D +S GV+ +L G P + + +++ E ++ + + +I
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAE-----YEFDSPYWDDIS 237
Query: 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+ ++ + K P+ R ++ ++
Sbjct: 238 DSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (333), Expect = 3e-35
Identities = 54/286 (18%), Positives = 108/286 (37%), Gaps = 40/286 (13%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVP 445
E+LG G + A L V VK L+ + F ++ + + HP +V
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVA 71
Query: 446 LRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
+ ++ +V +Y +L ++H P+ + ++++ + +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNF 126
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAP 554
H G H ++K +N++I+ + DFG+ + +A Y +P
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 555 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614
E +SDVYS G +L E+LTG+ P + + VRE+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP---- 233
Query: 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVR 659
R + + ++ ++ + +AK P+ R E+ + V
Sbjct: 234 -PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (332), Expect = 6e-35
Identities = 43/288 (14%), Positives = 80/288 (27%), Gaps = 36/288 (12%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
+G+GS+G ++ L + V +K + + + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
+LV D L R +T V IH
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 510 FTHGNIKASNVLINQDLDG-----CISDFGLTPLMNVPATPSR-----------SAGYRA 553
+ +IK N LI + + DFG+ P T +A Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 554 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613
R+ S + D+ + G + + L G P Q + + E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
EE + + D P+ D + + +V +
Sbjct: 242 A-------GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-35
Identities = 66/287 (22%), Positives = 111/287 (38%), Gaps = 38/287 (13%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
+V+G GS+G Y+A L +S V +K++ + KR ++++I+ ++ H N+V LR +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKL-DHCNIVRLRYF 81
Query: 450 YYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+YS EK LV DY H +R + L + R +A+IH
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLM---NVPATPSRSAGYRAP-EVIE 558
S G H +IK N+L++ D + DFG + + S YRAP +
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 559 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV------ 612
++ DV+S G +L E+L G+ + D + V E E+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 613 --------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 651
+ E + + + P R E
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-34
Identities = 45/283 (15%), Positives = 86/283 (30%), Gaps = 34/283 (12%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
+G GS+G Y + V +K V + +I + Q +P +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMM-QGGVGIPTIRW 70
Query: 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 509
++ + ++ SL L + +T + + + +IHS
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN--- 123
Query: 510 FTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSR-----------SAGYRAPE 555
F H ++K N L+ G I DFGL T +A Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615
+ S + D+ S G +L+ G P Q ++
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-------YERISEKKMSTP 236
Query: 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658
+ + E L C + D +P+ + ++ +
Sbjct: 237 IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 131 bits (329), Expect = 8e-34
Identities = 50/281 (17%), Positives = 106/281 (37%), Gaps = 37/281 (13%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQ-------MEIVGRVGQHPN 442
++G+G +G Y ++ +K L + + + E + +V G P
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-STGDCPF 68
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
+V + +++ D+ + D G L L + G+ H+
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHM 123
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIET- 559
H+ + ++K +N+L+++ ISD GL P + GY APEV++
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619
+ +D +S G +L ++L G +P + D ++ R ++ E
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----------- 229
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660
+ E+ +L+ + + + R R +EV++
Sbjct: 230 -DSFSPELRSLLE---GLLQRDVNRRLGCLG--RGAQEVKE 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 58/278 (20%), Positives = 109/278 (39%), Gaps = 38/278 (13%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLK-------EVVVGKRDFEQQMEIVGRVGQHPN 442
E LG G + K + + K +K V + D E+++ I+ + QHPN
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPN 74
Query: 443 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 502
V+ L Y +K + +L+ + A G L L L E + L GV ++
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYL 129
Query: 503 HSMGGPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG---YRAPE 555
HS+ + H ++K N+++ I DFGL ++ G + APE
Sbjct: 130 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 556 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615
++ ++D++S GV+ +L+G +P T+ + + V +E+
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------- 239
Query: 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
F N ++ + K P R + + ++
Sbjct: 240 ----FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (321), Expect = 2e-33
Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 34/285 (11%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRL---KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 447
E +G+G+YG YKA T +K++ KE +++ I+ + +H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLY 66
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
++K +LV+++ L L+ T LL G+A+ H
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIE-TRKH 562
H ++K N+LIN++ + I+DFGL +P YRAP+V+ ++K+
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 563 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR--- 619
S D++S G + EM+ G + D + + + V ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 620 -----------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
+ ++E + +L + P+ R + +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 9e-33
Identities = 58/300 (19%), Positives = 111/300 (37%), Gaps = 32/300 (10%)
Query: 391 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVG-----RVGQHPNV 443
+G+G+YG +KA ++ V +KR++ + + V +HPNV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 444 VPLRAYYYS----KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
V L ++ KL + L+T L G + ET ++ RG+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQLLRGL 129
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV 556
+HS H ++K N+L+ ++DFGL + + + YRAPEV
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 557 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616
+ ++ D++S G + EM K + + D + V + EE +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 617 LMRFQNIEEEMVQMLQIGMA---------CVAKVPDMRPNMDEVVRM--IEEVRQSDSEN 665
F + + ++ + C+ P R + + +++ + EN
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC-KEN 305
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-32
Identities = 54/321 (16%), Positives = 116/321 (36%), Gaps = 46/321 (14%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 447
+G+G+YG A + V +K++ + ++++I+ R +H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGIN 72
Query: 448 AYYYSKD----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ + + + + L LL L + L RG+ +IH
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIH 126
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGL-------TPLMNVPATPSRSAGYRAPEV 556
S H ++K SN+L+N D I DFGL + YRAPE+
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 557 IET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615
+ + ++ D++S G +L EML+ + D ++ + +E + ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 616 ELMR----------------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEE 657
+ F N + + + +L + P R +++ + +E+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 658 VRQSDSENRPSSEENKSKDSN 678
E + + +
Sbjct: 301 YYDPSDEPIAEAPFKFDMELD 321
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-31
Identities = 52/276 (18%), Positives = 99/276 (35%), Gaps = 44/276 (15%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLK-------EVVVGKRDFEQQMEIVGRV-GQHP 441
+LG G +G+ Y + + ++ V +K ++ + ++ ++ +V
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
V+ L ++ D +L+ + RG L E V H
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR--SAGYRAPEVIE 558
H+ G H +IK N+LI+ + + DFG L+ + Y PE I
Sbjct: 126 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 559 TRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617
+ H + V+S G+LL +M+ G P + E+ ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQV 221
Query: 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653
Q + E +++ C+A P RP +E+
Sbjct: 222 FFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 51/289 (17%), Positives = 113/289 (39%), Gaps = 37/289 (12%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK------RDFEQQMEIVGRVGQHPNV 443
+ LG+G + T YKA + + V +K++K + R ++++++ + HPN+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62
Query: 444 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+ L + K LV+D+ + + + L +L T +G+ ++H
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH 117
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIET 559
H ++K +N+L++++ ++DFGL P + YRAPE++
Sbjct: 118 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 560 RK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-------------DLPRWVQSVVR 605
+ + D+++ G +L E+L L + D + P
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 606 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654
+ + F ++++ ++Q P R + ++M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 1e-30
Identities = 51/275 (18%), Positives = 106/275 (38%), Gaps = 33/275 (12%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQME---IVGRVGQHPNVVPL 446
LG GS+G + + +K LK+ +V + + ++ + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+ + ++ DY G L +LL ++ + ++HS
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHK 565
+ ++K N+L++++ I+DFG + +V T + Y APEV+ T+ ++
Sbjct: 125 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 566 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 625
D +SFG+L+ EML G P + ++ + EL E
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYE---------------KILNAELRFPPFFNE 226
Query: 626 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660
++ +L + + R + E+V+
Sbjct: 227 DVKDLLS---RLITRDLSQRLGNLQ--NGTEDVKN 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 54/284 (19%), Positives = 110/284 (38%), Gaps = 34/284 (11%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 446
E +G+G+YG YKA + + V +K+++ + +++ ++ + HPN+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKL 66
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+++++ LV+++ + + L +G+A HS
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVI-ETRK 561
+ H ++K N+LIN + ++DFGL VP YRAPE++ +
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR-- 619
+S D++S G + EM+T +A + D + E V + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 620 ------------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 651
++E+ +L + P+ R +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-30
Identities = 62/316 (19%), Positives = 120/316 (37%), Gaps = 35/316 (11%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 446
+ +G G+YG AV + V +K+L + + +++ ++ + +H NV+ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGL 82
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+ + D++ G L + ++ +G+ +IH+ G
Sbjct: 83 LDVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPEVI-ETRKHSH 564
H ++K N+ +N+D + I DFGL + T YRAPEVI +++
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR----- 619
D++S G ++ EM+TGK + D + V E+ + E
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 620 -----------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSENR 666
N V +L+ + + R E + E + D+E+
Sbjct: 259 PELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAHPYFESLH--DTEDE 313
Query: 667 PSSEE-NKSKDSNVQT 681
P ++ + S D +T
Sbjct: 314 PQVQKYDDSFDDVDRT 329
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (290), Expect = 8e-29
Identities = 53/278 (19%), Positives = 104/278 (37%), Gaps = 19/278 (6%)
Query: 344 KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYK 403
A+ G ++ +EF + +E K + D D ++ LG GS+G
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGRVML 59
Query: 404 AVLEES-TTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 458
+ES +K L + V K + I+ V P +V L + +
Sbjct: 60 VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118
Query: 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 518
V +Y A G + + L ++HS+ + ++K
Sbjct: 119 VMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 519 NVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 577
N+LI+Q ++DFG + T + APE+I ++ ++ D ++ GVL+ E
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 578 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615
M G P + + + + +++++ D+
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (288), Expect = 9e-29
Identities = 50/289 (17%), Positives = 117/289 (40%), Gaps = 22/289 (7%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 449
LG+G Y ++A+ + + VVVK LK V K+ +++++I+ + PN++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADI 98
Query: 450 YYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ LV+++ + L L + + + + HSMG
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 149
Query: 508 PKFTHGNIKASNVLI-NQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV-IETRKH 562
H ++K NV+I ++ + D+GL + + ++ PE+ ++ + +
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 563 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622
+ D++S G +L M+ K P D+ L R + + E+ + +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 671
+ + + + + E + ++++ + D ++R ++ E
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 52/279 (18%), Positives = 104/279 (37%), Gaps = 38/279 (13%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 445
++LGKG++G + + +K L++ V+ +D + ++ +HP +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTA 69
Query: 446 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 505
L+ + + D V +Y G L L R E + ++HS
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR 124
Query: 506 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 561
+ +IK N+++++D I+DFGL + + Y APEV+E
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621
+ D + GV++ EM+ G+ P + + + +L + + E +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL------ 235
Query: 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660
+ +L+ K P R +EV +
Sbjct: 236 -----LAGLLK-------KDPKQRLGGGP--SDAKEVME 260
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 56/284 (19%), Positives = 112/284 (39%), Gaps = 30/284 (10%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 446
E +G+G+YGT +KA E+ V +KR++ + +++ ++ + +H N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRL 66
Query: 447 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 506
+S + LV+++ N LD E L +G+ HS
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 507 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----RSAGYRAPEVIETRK- 561
H ++K N+LIN++ + +++FGL +P + YR P+V+ K
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 562 HSHKSDVYSFGVLLLEMLTGKAPL-QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620
+S D++S G + E+ PL DD + + EE + + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 621 QNIEEEMVQMLQIG-----------MACVAKVPDMRPNMDEVVR 653
+ ++ + + P R + +E ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 56/286 (19%), Positives = 108/286 (37%), Gaps = 40/286 (13%)
Query: 391 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGKRD-----FEQQMEIVGRVGQHP 441
+VLG G+YG + + +K LK+ + ++ + +++ + Q P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 442 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
+V L + ++ + L+ DY G L T L R + + H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-----AGYRAPEV 556
+H +G + +IK N+L++ + ++DFGL+ T Y AP++
Sbjct: 145 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 557 IET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614
+ H D +S GVL+ E+LTG +P + + E + +
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----------SQAEISRRILK 250
Query: 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660
E Q + ++Q + K P R R +E+++
Sbjct: 251 SEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGP--RDADEIKE 291
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 5e-26
Identities = 54/297 (18%), Positives = 112/297 (37%), Gaps = 27/297 (9%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLK---EVVVGKRDFEQQMEIVGRVGQHPNVVPL 446
+G+G++G +KA ++ V +K++ E ++++I+ + +H NVV L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNL 74
Query: 447 RAYYYSKDEKLLVYD---YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 503
+K Y L G +++ G+ +IH
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 504 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAGYRAPE 555
H ++KA+NVLI +D ++DFGL ++ + YR PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 556 VIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614
++ + + D++ G ++ EM T +Q T + L + + E V +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 671
EL + + + ++ + + P D + +++ D R S++
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYAL---DLIDKLL----VLDPAQRIDSDD 301
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 53/293 (18%), Positives = 119/293 (40%), Gaps = 31/293 (10%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLK---EVVVGKRDFEQQMEIVGRVGQHPNVVPL 446
+G G+YG+ A + V VK+L + ++ + +++ ++ + +H NV+ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGL 82
Query: 447 RAYYYSKD-----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 501
+ + + + L+ ++ + L + ++ RG+ +
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKY 136
Query: 502 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVI-ET 559
IHS H ++K SN+ +N+D + I DFGL + + YRAPE++
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 560 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619
++ D++S G ++ E+LTG+ D + L + EL++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG---------TPGAELLK 244
Query: 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVRMIEEVRQSDSENRPSSEE 671
+ E + + ++ + V ++E++ DS+ R ++ +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 2e-23
Identities = 55/323 (17%), Positives = 108/323 (33%), Gaps = 44/323 (13%)
Query: 391 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 447
+ +G G+ G A V +K+L + ++ E+ + + H N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 448 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 507
+ + D + L + + LD E +L G+ H+HS
Sbjct: 83 NVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-- 138
Query: 508 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 564
H ++K SN+++ D I DFGL + YRAPEVI +
Sbjct: 139 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 565 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------------------------LP 597
D++S G ++ EM+ K D + P
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257
Query: 598 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---M 654
++ + + +F + + + +L + P R ++D+ ++ +
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDDALQHPYI 314
Query: 655 IEEVRQSDSENRPSSEENKSKDS 677
++ E P +K D
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDE 337
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.3 bits (246), Expect = 5e-23
Identities = 51/310 (16%), Positives = 98/310 (31%), Gaps = 33/310 (10%)
Query: 391 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ---------- 439
LG G + T + A + +T V +K ++ V E +++++ RV
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
+++ L ++ K + LL + + +I G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVPATPSRSA------GYR 552
++H G H +IK NVL+ D + + L N YR
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 553 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-----------LPRWVQ 601
+PEV+ +D++S L+ E++TG + L
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661
++R F +NI + L+ + K E+ + + Q
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA--KEISDFLSPMLQL 314
Query: 662 DSENRPSSEE 671
D R +
Sbjct: 315 DPRKRADAGG 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.5 bits (205), Expect = 1e-17
Identities = 41/180 (22%), Positives = 62/180 (34%), Gaps = 25/180 (13%)
Query: 84 FADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDAL 143
+D P N + I T + L L + P L L L
Sbjct: 209 ISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP---LSGLTKL 265
Query: 144 EVLSLRSNVLTGGLP--------------------SEITSLPSLRYLYLQHNNFSGKIPS 183
L L +N ++ P S I++L +L YL L NN S P
Sbjct: 266 TELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV 325
Query: 184 SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 243
S +L L + N + S+ NLT + LS N +S P ++ ++ L L+
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.6 bits (187), Expect = 1e-15
Identities = 42/156 (26%), Positives = 58/156 (37%), Gaps = 27/156 (17%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 202
L+ LSL N L + SL +L L L +N S P S +L L L N +
Sbjct: 221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNI 278
Query: 203 IP--------------------QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSY 242
P I NL LT L+L NN+S P + KL+ L +
Sbjct: 279 SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFAN 338
Query: 243 NGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLKAC 275
N + SSL N +++ N + PL
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTPLANL 372
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.3 bits (150), Expect = 6e-11
Identities = 25/88 (28%), Positives = 35/88 (39%), Gaps = 2/88 (2%)
Query: 163 SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNN 222
L +L L +N S P L L L+ N ++ +LT LT L L +N
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 223 LSGSIPNFDIPKLRHLNLSYNGLKGSIP 250
+S P + KL L L N + P
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 2/82 (2%)
Query: 162 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 221
T+L L N + + + Q+ L +I ++ L LT ++ +N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 76
Query: 222 NLSGSIPNFDIPKLRHLNLSYN 243
L+ P ++ KL + ++ N
Sbjct: 77 QLTDITPLKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 24/111 (21%), Positives = 38/111 (34%), Gaps = 2/111 (1%)
Query: 161 ITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 220
+ +L +L L + N S + L L + N + P I T L LSL
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNG 228
Query: 221 NNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 271
N L + L L+L+ N + P S +G + +
Sbjct: 229 NQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNIS 279
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 5/70 (7%)
Query: 209 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNS 265
L + L N++ ++ D+ ++ L G+K SI ++ N + + N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77
Query: 266 LLCGPPLKAC 275
L PLK
Sbjct: 78 LTDITPLKNL 87
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.7 bits (187), Expect = 8e-16
Identities = 27/83 (32%), Positives = 35/83 (42%), Gaps = 20/83 (24%)
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 252
DL N G +PQ + L L L++ NNL G IP +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG--------------------GN 289
Query: 253 LQKFPNSSFVGNSLLCGPPLKAC 275
LQ+F S++ N LCG PL AC
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.0 bits (167), Expect = 3e-13
Identities = 59/162 (36%), Positives = 82/162 (50%), Gaps = 8/162 (4%)
Query: 76 SDRQALLDFADAVPHLRKL-NWSSTNPICQ-SWVGINCTQD--RTRVFGLRLPGIGLVGP 131
D+QALL + + L +W T C +W+G+ C D RV L L G+ L P
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 132 IP-NNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQHNNFSGKIP--SSFSP 187
P ++L L L L + L G +P I L L YLY+ H N SG IP S
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 229
LV LD S+N+ +G +P SI +L L G++ N +SG+IP+
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 18/58 (31%), Positives = 26/58 (44%), Gaps = 1/58 (1%)
Query: 148 LRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGNIP 204
LR+N + G LP +T L L L + NN G+IP + + V + N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.0 bits (115), Expect = 8e-07
Identities = 16/88 (18%), Positives = 27/88 (30%), Gaps = 2/88 (2%)
Query: 95 NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 154
+ + GL L + G +P L +L L L++ N L
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ-GLTQLKFLHSLNVSFNNLC 281
Query: 155 GGLPSEITSLPSLRYLYLQHNNFSGKIP 182
G +P + +L +N P
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.3 bits (148), Expect = 2e-11
Identities = 34/203 (16%), Positives = 62/203 (30%), Gaps = 33/203 (16%)
Query: 391 EVLGKGSYGTAYKAVLEESTTVVVKRLK-----------EVVVGKRDFEQQMEIVGRVGQ 439
+++G+G + E+ VVK K + G F R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN-E 64
Query: 440 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 499
+ L+ K Y + + L L+ + + ++L V
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD---EVLDMILEEV 116
Query: 500 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY--RAPEVI 557
A + HG++ NVL+ + I DF + V R I
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQS----VEVGEEGWREILERDVRNI 168
Query: 558 ET---RKHSHKSDVYSFGVLLLE 577
T R + + D+ S +L+
Sbjct: 169 ITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 63.7 bits (153), Expect = 2e-11
Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 8/94 (8%)
Query: 148 LRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSI 207
N + + S PSL L + +N ++P+ P+L L SFN +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP-PRLERLIASFNHLA-EVPELP 323
Query: 208 QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS 241
QNL Q L ++ N L P+ + L ++
Sbjct: 324 QNLKQ---LHVEYNPLR-EFPDI-PESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 2e-09
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 169 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 228
YL ++ + P L L++S N +P L + L N+L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320
Query: 229 NFDIPKLRHLNLSYNGLKG--SIPSSLQK 255
L+ L++ YN L+ IP S++
Sbjct: 321 EL-PQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 1e-08
Identities = 19/73 (26%), Positives = 35/73 (47%), Gaps = 8/73 (10%)
Query: 140 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 199
+LE L++ +N L LP+ P L L N+ + ++P L L + +N
Sbjct: 283 PPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPELP-QNLKQLHVEYNPL 336
Query: 200 TG--NIPQSIQNL 210
+IP+S+++L
Sbjct: 337 REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 5e-06
Identities = 18/79 (22%), Positives = 28/79 (35%), Gaps = 3/79 (3%)
Query: 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253
N+ + I L L++ +N L +P P+L L S+N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL-PPRLERLIASFNHLA-EVPELP 323
Query: 254 QKFPNSSFVGNSLLCGPPL 272
Q N L P +
Sbjct: 324 QNLKQLHVEYNPLREFPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 14/60 (23%), Positives = 26/60 (43%), Gaps = 6/60 (10%)
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 247
Q L+L+ + ++P+ +L L N+L+ +P L+ L + N LK
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPEL-PQSLKSLLVDNNNLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 17/56 (30%), Positives = 22/56 (39%), Gaps = 3/56 (5%)
Query: 211 TQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSL 266
Q L L + LS S+P P L L S N L +P Q + N+L
Sbjct: 38 RQAHELELNNLGLS-SLPEL-PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 13/59 (22%), Positives = 21/59 (35%), Gaps = 6/59 (10%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTG 201
L L + L+ LP P L L N+ + ++P L L + N+
Sbjct: 40 AHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQ-SLKSLLVDNNNLKA 92
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 2e-11
Identities = 35/168 (20%), Positives = 60/168 (35%), Gaps = 4/168 (2%)
Query: 90 HLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLR 149
L +L+ + +G + + L L L +P++T L L L L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLH 161
Query: 150 SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSFTGNIPQSI 207
N ++ L SL L L N + P +F +L+ L L N+ + +++
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 208 QNLTQLTGLSLQSNNLSGSIPNFDIPK-LRHLNLSYNGLKGSIPSSLQ 254
L L L L N + L+ S + + S+P L
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (131), Expect = 8e-09
Identities = 43/220 (19%), Positives = 67/220 (30%), Gaps = 36/220 (16%)
Query: 85 ADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALE 144
A + R L + + + + L L + + T L L
Sbjct: 49 AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108
Query: 145 VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLSFNSFTGN 202
L L L P L +L+YLYLQ N +F L L L N +
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 203 IPQSIQNLTQLTGLSLQSNNLSGSIPNF--------------------------DIPKLR 236
++ + L L L L N ++ P+ + L+
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 237 HLNLSYNGLKGSIP-----SSLQKFPNSSFVGNSLLCGPP 271
+L L+ N + LQKF SS + + C P
Sbjct: 229 YLRLNDNPWVCDCRARPLWAWLQKFRGSS---SEVPCSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 6e-04
Identities = 27/156 (17%), Positives = 47/156 (30%), Gaps = 36/156 (23%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI---------- 181
IP + + + L N ++ + + +L L+L N +
Sbjct: 30 IPAAS-------QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 182 ---------------PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 224
P++F +L L L P + L L L LQ N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 225 GSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ D+ L HL L N + + + +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (87), Expect = 0.002
Identities = 6/34 (17%), Positives = 10/34 (29%)
Query: 181 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 214
+P + L N + S + LT
Sbjct: 26 VPVGIPAASQRIFLHGNRISHVPAASFRACRNLT 59
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 7e-11
Identities = 29/106 (27%), Positives = 40/106 (37%), Gaps = 4/106 (3%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
LR + K+P P +LDL N T +NL L L L +N +S
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 226 SIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG 269
P + KL L LS N LK +P + K V + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 49/239 (20%), Positives = 83/239 (34%), Gaps = 19/239 (7%)
Query: 56 LFFPLCVIVSLLPLAFADLNS------DRQALLDFADAVPHLRKLNWSSTNPICQSWVGI 109
L I + P AFA L + L + + +P + N I + +
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
Query: 110 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY 169
++ V L + G + L + + +T +P + PSL
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENG-AFQGMKKLSYIRIADTNITT-IPQGL--PPSLTE 175
Query: 170 LYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 227
L+L N + +S L L LSFNS + S+ N L L L +N L
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235
Query: 228 PN-FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSL----LCGPPLKACFPVAPS 281
D ++ + L N + +I S+ P + S L P++ + + PS
Sbjct: 236 GGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ-YWEIQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 24/119 (20%), Positives = 45/119 (37%), Gaps = 3/119 (2%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 200
+L L++N +T + +L +L L L +N S P +F+ +L L LS N
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 201 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ + L +L + + S+ N + + L + G + Q
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.0 bits (143), Expect = 4e-10
Identities = 14/108 (12%), Positives = 28/108 (25%), Gaps = 7/108 (6%)
Query: 143 LEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLS 195
++ L ++ L+ + L + + L + S P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 243
N + Q +Q +L + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 111
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 5e-08
Identities = 21/93 (22%), Positives = 29/93 (31%), Gaps = 15/93 (16%)
Query: 165 PSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGNIPQSI-----QNLTQL 213
LR L+L + S SS + L LDLS N + Q L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 214 TGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 246
L L S + + L+ L L+
Sbjct: 429 EQLVLYDIYWSEEMEDR----LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 7e-08
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 14/93 (15%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSP---QLVVLDLSFNSFTG----NIPQSIQNLTQLTGLSL 218
++ L +Q S + P Q V+ L T +I +++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 219 QSNNLSGSIPNF-------DIPKLRHLNLSYNG 244
+SN L + K++ L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 8e-08
Identities = 18/90 (20%), Positives = 29/90 (32%), Gaps = 15/90 (16%)
Query: 143 LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-------PQLVV 191
L VL L ++ L + + + SLR L L +N L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 192 LDLSFNSFTGNIPQSIQNL----TQLTGLS 217
L L ++ + +Q L L +S
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 8e-07
Identities = 15/77 (19%), Positives = 25/77 (32%), Gaps = 7/77 (9%)
Query: 186 SPQLVVLDLSFNSFTGN-IPQSIQNLTQLTGLSLQSNNLSG----SIPNF--DIPKLRHL 238
S + LD+ + + + L Q + L L+ I + P L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 239 NLSYNGLKGSIPSSLQK 255
NL N L + +
Sbjct: 61 NLRSNELGDVGVHCVLQ 77
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.7 bits (131), Expect = 1e-09
Identities = 28/120 (23%), Positives = 43/120 (35%), Gaps = 9/120 (7%)
Query: 145 VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIP 204
VL L LT + L + +L L HN P+ + + L +
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 205 QSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYN---GLKGSIPSSLQKFPN 258
+ NL +L L L +N L S + P+L LNL N +G + P+
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 3e-08
Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 9/109 (8%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196
L +L + L L N L P+ + +L L L N + P+L L L
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELLLCN 74
Query: 197 NSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD------IPKLRHL 238
N Q + + +L L+LQ N+L +P + +
Sbjct: 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 6e-07
Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 6/94 (6%)
Query: 168 RYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
R L+L H + + + + LDLS N P ++ L L L N L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 226 SIPNFDIPKLRHLNLSYNGLKG-SIPSSLQKFPN 258
++P+L+ L L N L+ + L P
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 91
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 19/126 (15%), Positives = 37/126 (29%), Gaps = 13/126 (10%)
Query: 73 DLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI 132
L +L + + + L+ S N + + + + + G
Sbjct: 4 HLAHKDLTVLCHLEQLLLVTHLDLSH-NRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 133 PNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIP-----SSFS 186
L +L L +N L + S P L L LQ N+ + +
Sbjct: 63 NLPRLQELL------LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 187 PQLVVL 192
P + +
Sbjct: 117 PSVSSI 122
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 3e-08
Identities = 16/78 (20%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 160 EITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 219
E++ + S + N + +P +L LS N ++ T+LT L+L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 220 SNNLSGSIPNFDIPKLRH 237
L+ + +P L
Sbjct: 64 RAELTKLQVDGTLPVLGT 81
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 12/54 (22%), Positives = 24/54 (44%), Gaps = 3/54 (5%)
Query: 206 SIQNLTQLTGLSLQSNNLSGSIPNFDIPK-LRHLNLSYNGLKGSIPSSLQKFPN 258
+ + ++ NL+ ++P D+PK L+LS N L ++L +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTR 56
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 15/51 (29%), Positives = 20/51 (39%), Gaps = 3/51 (5%)
Query: 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 243
+ N+ T + L L L LQ N+L +IP F L L N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 12/46 (26%), Positives = 20/46 (43%), Gaps = 1/46 (2%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 177
+P L L+ L+ L L+ N L +P L + +L N +
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 9e-08
Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 5/98 (5%)
Query: 146 LSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QLVVLDLSFNSFTGN-I 203
L L L + + S + + + FSP ++ +DLS + + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 204 PQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLN 239
+ ++L LSL+ LS I N L LN
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 8/69 (11%), Positives = 30/69 (43%), Gaps = 3/69 (4%)
Query: 192 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-NFDIPKLRHLNLSYNGLKG-SI 249
LDL+ + ++ + + + + + + +F +++H++LS + ++ ++
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 250 PSSLQKFPN 258
L +
Sbjct: 64 HGILSQCSK 72
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 6e-07
Identities = 28/116 (24%), Positives = 42/116 (36%), Gaps = 14/116 (12%)
Query: 137 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----PQLVVL 192
L + VL+ RS++ L ++P L L L +N S P L +L
Sbjct: 38 LVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD---------IPKLRHLN 239
+LS N +L L L N+LS + + PKL L+
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 2/64 (3%)
Query: 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 191
L L L L N ++ S + SLP+L ++L++N S P + + L +
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFI 221
Query: 192 LDLS 195
+ L+
Sbjct: 222 VTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 4e-06
Identities = 16/73 (21%), Positives = 30/73 (41%), Gaps = 2/73 (2%)
Query: 169 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 228
YL + + S P + +L L N + P + +L L + L++N +S P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
Query: 229 NFDIPKLRHLNLS 241
+ L + L+
Sbjct: 213 LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 2e-05
Identities = 15/64 (23%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 158 PSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLS 217
+ + +L L L N S P + P L+ + L N + P + N + L ++
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 218 LQSN 221
L +N
Sbjct: 224 L-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 11/59 (18%), Positives = 24/59 (40%), Gaps = 4/59 (6%)
Query: 188 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGL 245
+ + ++ T + Q+ +L +T LS ++ +I + L L L N +
Sbjct: 20 NAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 8/50 (16%), Positives = 21/50 (42%), Gaps = 2/50 (4%)
Query: 209 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
L ++ +N++ ++ D+ + L+ G+ +I +Q N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TI-EGVQYLNN 64
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 15/52 (28%), Positives = 23/52 (44%), Gaps = 2/52 (3%)
Query: 207 IQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
+ NL++LT L N +S P +P L ++L N + P L N
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSN 218
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 1e-05
Identities = 17/98 (17%), Positives = 37/98 (37%), Gaps = 11/98 (11%)
Query: 155 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 214
G L SE ++P+ + F+ + + +L S T + Q+ L +
Sbjct: 1 GPLGSETITVPTPIKQIFSDDAFA---------ETIKDNLKKKSVTDAVTQN--ELNSID 49
Query: 215 GLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 252
+ ++++ +P + L L+ N L P +
Sbjct: 50 QIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLA 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 14/79 (17%), Positives = 27/79 (34%), Gaps = 5/79 (6%)
Query: 131 PIPNNTLGKLDALE---VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 187
P P + DA +L+ +T L S+ + +++ + P
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQYLP 68
Query: 188 QLVVLDLSFNSFTGNIPQS 206
+ L L+ N T P +
Sbjct: 69 NVTKLFLNGNKLTDIKPLA 87
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 13/83 (15%), Positives = 27/83 (32%), Gaps = 15/83 (18%)
Query: 169 YLYLQHNNFSGKIPSSFS--------PQLVVLDLSFNSFTGNIPQSI-----QNLTQLTG 215
L L S + ++ L L L +N + +++ + + L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 216 LSLQSNNLSGSIPNFDIPKLRHL 238
L L N S + ++R +
Sbjct: 307 LELNGNRFSEEDDV--VDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 8e-05
Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 9/64 (14%)
Query: 163 SLPSLRYLYLQHNNFSGKIPSSFS-------PQLVVLDLSFNSFT--GNIPQSIQNLTQL 213
L+ L LQ+N + P L+ L+L+ N F+ ++ I+ +
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFST 330
Query: 214 TGLS 217
G
Sbjct: 331 RGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 13/89 (14%), Positives = 26/89 (29%), Gaps = 5/89 (5%)
Query: 95 NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 154
+ + + L G + + + L+ L L+ N +
Sbjct: 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286
Query: 155 GGLPSEITS-----LPSLRYLYLQHNNFS 178
+ + +P L +L L N FS
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 10/91 (10%)
Query: 143 LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVL 192
+E SL+ + +T + + + S++ + L N + S L +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 193 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 223
+ S + + L L L+ L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 8e-05
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 3/106 (2%)
Query: 169 YLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS 226
L L N F QL L+L N + +P S ++L LT L+L SN + +
Sbjct: 82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141
Query: 227 IPNFDIPKL-RHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 271
+ R +L+ + PS ++ + C
Sbjct: 142 CHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 8e-05
Identities = 21/122 (17%), Positives = 33/122 (27%), Gaps = 7/122 (5%)
Query: 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 202
L LR + + + +L + N +L L ++ N
Sbjct: 20 DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRI 78
Query: 203 IPQSIQNLTQLTGLSL---QSNNLSGSIPNFDIPKLRHLNLS---YNGLKGSIPSSLQKF 256
Q L LT L L L P + L +L + K + K
Sbjct: 79 GEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKV 138
Query: 257 PN 258
P
Sbjct: 139 PQ 140
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 2e-04
Identities = 17/115 (14%), Positives = 31/115 (26%), Gaps = 5/115 (4%)
Query: 159 SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGL 216
++ T+ R L L+ I + + Q +D S N L +L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 217 SLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 271
+ +N + D L L + + + P
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 1e-04
Identities = 10/65 (15%), Positives = 19/65 (29%), Gaps = 1/65 (1%)
Query: 166 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 225
S R Q + + +IPS + L + L + + N++
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 226 SIPNF 230
I
Sbjct: 68 VIEAD 72
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 4e-04
Identities = 11/45 (24%), Positives = 18/45 (40%), Gaps = 3/45 (6%)
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD 231
V+LD+S ++NL +L S NL +P +
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 8/54 (14%), Positives = 18/54 (33%), Gaps = 3/54 (5%)
Query: 130 GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 183
+PN+ +L + + + +L LR + K+P+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 11/84 (13%), Positives = 26/84 (30%), Gaps = 3/84 (3%)
Query: 169 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 228
+L + + + N+ + L + + S+P
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP 217
Query: 229 NFDIPKLRHLN-LSYNGLKGSIPS 251
++ + L+ L S LK +P+
Sbjct: 218 SYGLENLKKLRARSTYNLK-KLPT 240
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 10/50 (20%), Positives = 21/50 (42%), Gaps = 2/50 (4%)
Query: 209 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 258
L + L N++ ++ D+ ++ L G+K SI ++ N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNN 63
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 6e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 4/62 (6%)
Query: 187 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGL 245
+ + L + T + Q+ +L Q+T L + SI + + L +N S N L
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQL 74
Query: 246 KG 247
Sbjct: 75 TD 76
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 7e-04
Identities = 32/164 (19%), Positives = 52/164 (31%), Gaps = 21/164 (12%)
Query: 103 CQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT 162
G+ CT+D ++ L + L L + + L
Sbjct: 7 PHGSSGLRCTRDGAL-------------DSLHH-LPGAENLTELYIENQQHLQHLELRDL 52
Query: 163 S-LPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 219
L LR L + + P +F P+L L+LSFN+ ++ L L L
Sbjct: 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS 111
Query: 220 SNNLSGSIPNFDIPKL---RHLNLSYNGLKGSIPSSLQKFPNSS 260
N L S + + + L+ L PN+S
Sbjct: 112 GNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.3 bits (82), Expect = 0.004
Identities = 16/88 (18%), Positives = 33/88 (37%), Gaps = 5/88 (5%)
Query: 182 PSSFSPQ-LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRH 237
P + P L + + + + LT L +++ + D+ +LR+
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 238 LNLSYNGLKGSIPSSLQKFPNSSFVGNS 265
L + +GL+ P + P S + S
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 682 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.66 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.65 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.62 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.58 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.42 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.39 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.38 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.34 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.33 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.27 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.19 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.14 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.03 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.78 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.31 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.2 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.13 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.86 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.39 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.64 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.3 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.62 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=401.44 Aligned_cols=247 Identities=24% Similarity=0.421 Sum_probs=198.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||+||+|.+.+++.||||+++......++|.+|++++.++ +|||||+++|++..++..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 467999999999999998888999999987777788999999999999 9999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ..+++..+..++.|||.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 89 ~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 89 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred HHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9987532 34899999999999999999999998 9999999999999999999999999998764332 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+|+.|+|||++.+..++.++|||||||++|||+|+ .+||.... .......+.. .... . ..
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~-~~~~--~--------~p 224 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDIST-GFRL--Y--------KP 224 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHH-TCCC--C--------CC
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHh-cCCC--C--------Cc
Confidence 3468889999999999999999999999999999995 55554322 1122222111 1110 0 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
..+...+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 12234567888899999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=397.67 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=197.6
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+++ ..||||+++..... .+.|.+|++++.++ +|||||++++++. ++..++||||+++|
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAIVTQWCEGS 88 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence 478999999999999864 46999999754332 35788999999999 9999999999875 45789999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
+|.++++..+ ..+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 89 SLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999997533 34999999999999999999999988 999999999999999999999999999776432
Q ss_pred --CCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 543 --ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
....||+.|||||++.+ ..++.++|||||||++|||+||+.||.+....+ ............. ..
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p----~~ 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSP----DL 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCC----CG
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCC----cc
Confidence 23457899999999864 347899999999999999999999997543211 1222222221111 11
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.. ........+.+++.+||+.||++|||++|++++|+.+.+..+
T Consensus 232 ~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 SK--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp GG--SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hh--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 00 011223456778889999999999999999999999987643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=395.28 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=201.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||+||+|.+++++.||||+++......++|.+|++++.++ +|||||++++++. ++..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence 578999999999999999888999999987777778899999999999 9999999999875 46779999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ...+++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+...... .
T Consensus 96 ~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 9886432 234899999999999999999999988 9999999999999999999999999998764332 3
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChH
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 624 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 624 (682)
..+++.|+|||++.+..++.++|||||||++|||+||..|+.... ........+. ...... .. .
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~-~~~~~~-------~p---~ 233 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE-RGYRMV-------RP---D 233 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHH-TTCCCC-------CC---T
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH-hcCCCC-------Cc---c
Confidence 457888999999999999999999999999999999665553221 1111122211 111100 11 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 625 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 625 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
.....+.+++.+||+.||++|||++|+++.|+.+-.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 223456778889999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=388.32 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=205.2
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchh
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+.||+|+||+||+|++++++.||||+++.....+++|.+|+.++.++ +||||++++|++.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 468999999999999998888999999988777788999999999999 9999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----C
Q 005693 470 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 544 (682)
Q Consensus 470 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 544 (682)
+++.... ..+++..+.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 88 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred Hhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9986543 34889999999999999999999998 9999999999999999999999999997654322 2
Q ss_pred CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ .... +.+..... ..
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~-i~~~~~~~-------~p--- 223 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEH-IAQGLRLY-------RP--- 223 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHH-HHTTCCCC-------CC---
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHHH-HHhCCCCC-------Cc---
Confidence 346788999999999999999999999999999998 899997654222 1222 22211110 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
......+.+++.+||+.||++|||++|++++|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12234567888899999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-48 Score=397.68 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=205.3
Q ss_pred hccccccCeEEEEEEEEcC-CceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||+||+|.+.+ ++.||||+++......++|.+|+++++++ +|||||++++++.+++..++||||+++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 5789999999999999864 77899999987766778899999999999 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 544 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 544 (682)
.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 101 ~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 101 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred HHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 99997543 345899999999999999999999998 99999999999999999999999999987654332
Q ss_pred -CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 545 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 545 -~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
..+++.|+|||++.+..++.++|||||||++|||++|+.||.... +... ....+....... ..
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~-~~~~i~~~~~~~-------~~--- 238 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ-VYELLEKDYRME-------RP--- 238 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHH-HHHHHHTTCCCC-------CC---
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHHH-HHHHHhcCCCCC-------CC---
Confidence 225778999999999999999999999999999999877764322 1111 112222221111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
......+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12234567788899999999999999999999988654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-48 Score=399.25 Aligned_cols=247 Identities=25% Similarity=0.481 Sum_probs=193.9
Q ss_pred hccccccCeEEEEEEEEcCC----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||+||+|.++.. ..||||++..... ..++|.+|+++++++ +|||||+++|++.+++..++||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEec
Confidence 46899999999999997532 2588888865432 245799999999999 9999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 110 ~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 110 ENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp TTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999987533 34899999999999999999999998 9999999999999999999999999998764322
Q ss_pred C---------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 544 T---------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 544 ~---------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
. ..+|+.|+|||++.++.++.++|||||||++|||+| |+.||.+.... .....+.. ...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i~~-~~~---- 251 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAIEQ-DYR---- 251 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHT-TCC----
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHHHc-CCC----
Confidence 1 235778999999999999999999999999999998 89999765322 11222211 111
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
.....+....+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 252 ------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 ------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 011122345577788899999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=390.99 Aligned_cols=240 Identities=22% Similarity=0.333 Sum_probs=192.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 478999999999999975 578899999875432 345789999999999 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 541 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 541 (682)
+|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 89 ~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 89 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999743 34999999999999999999999998 99999999999999999999999999986532
Q ss_pred -CCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 542 -PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 542 -~~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
.....||+.|+|||++.+..+ +.++||||+||++|||+||+.||........ ............ ..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~~~~~~~~~~-------~~ 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYL-------NP 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-----HHHHHHTTCTTS-------TT
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCCCCC-------Cc
Confidence 234568999999999988776 5789999999999999999999975432211 111111111000 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.. .....+.+++.+||+.||++|||++|+++
T Consensus 229 ~~---~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WK---KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 12234567778999999999999999876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=393.72 Aligned_cols=240 Identities=22% Similarity=0.340 Sum_probs=197.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|... +++.||+|+++... ...+.+.+|+++++++ +|||||++++++.+++..|+||||+++|+
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 367999999999999964 58899999997554 3456799999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----C
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 543 (682)
|.+++... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 104 L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 99988642 3899999999999999999999998 999999999999999999999999999865432 2
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... ............. ....
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~---------~~~~ 239 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE---------LQNP 239 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC---------CSSG
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC---------CCCc
Confidence 445899999999999999999999999999999999999999754321 1122222221110 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223456677789999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=387.59 Aligned_cols=238 Identities=26% Similarity=0.384 Sum_probs=198.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.+ +++.||+|++.... ...+.+.+|+++++++ +|||||++++++.+++..++||||++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEeecC
Confidence 578999999999999986 47789999987432 2356788999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 90 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred CCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 99999999743 24899999999999999999999998 9999999999999999999999999998765433
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. .....+...... ....
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~---------~p~~ 226 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFT---------FPDF 226 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC---------CCTT
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC---------CCcc
Confidence 346899999999999999999999999999999999999999754321 112222221110 1111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
. ...+.+++.+||+.||++|||++|++++
T Consensus 227 ~---s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 227 V---TEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C---CHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 2 2345667779999999999999999873
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=387.94 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=198.8
Q ss_pred cccccCeEEEEEEEEc---CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 392 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 392 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.||+|+||+||+|.++ ++..||||+++.... ..++|.+|++++.++ +|||||+++|++.. +..++||||+++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence 4999999999999864 345799999975432 245789999999999 99999999999864 5689999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 543 (682)
+|.+++...+ ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 94 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred cHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999986432 35999999999999999999999998 9999999999999999999999999997664322
Q ss_pred ----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 544 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ .... +.+....+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~-i~~~~~~~------- 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAF-IEQGKRME------- 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHH-HHTTCCCC-------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcCCCCC-------
Confidence 2346788999999999999999999999999999998 899998654221 1111 22211111
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
..+.....+.+++.+||+.||++|||+.+|.+.|+.+....
T Consensus 233 ---~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 233 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11123345678888999999999999999999999887543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=388.99 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=200.5
Q ss_pred hhccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
..+.||+|+||+||+|.+++++.||||+++......+.|.+|+.+++++ +|||||++++++. ++..++||||+++|+|
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 3678999999999999999888999999987777788899999999999 9999999999984 5678999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-----
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 543 (682)
.+++.... ...++|.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 99 ~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 99 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred hhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 99986432 234899999999999999999999998 9999999999999999999999999998664322
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+|+.|+|||++.++.++.++|||||||++|||++|+.|+..... .......+.. ..... ..
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~~~i~~-~~~~~-------~~--- 236 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVER-GYRMP-------CP--- 236 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHT-TCCCC-------CC---
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHh-cCCCC-------CC---
Confidence 23478899999999999999999999999999999997666543221 1112222211 11111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
......+.+++.+||+.||++||++++|+++|+......
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 122345677888999999999999999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=392.03 Aligned_cols=242 Identities=21% Similarity=0.329 Sum_probs=197.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|+.. +++.||+|+++.... ..+.+.+|+++++++ +|||||++++++.+++..++||||+++|+
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 467999999999999975 477899999976432 346789999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC----CC
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PA 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----~~ 543 (682)
|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.... ..
T Consensus 96 L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 96 VDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 999986432 34999999999999999999999998 99999999999999999999999999976532 23
Q ss_pred CCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 544 TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
...||+.|+|||++. ...|+.++|||||||++|||+||+.||.+....+. ...+......
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~~~--------- 233 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSEPP--------- 233 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSCCC---------
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCC---------
Confidence 567899999999984 45688999999999999999999999986543221 1222221111
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...........+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111223456677889999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=386.69 Aligned_cols=242 Identities=24% Similarity=0.351 Sum_probs=194.1
Q ss_pred ccccccCeEEEEEEEEcC---CceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 391 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
+.||+|+||+||+|.+++ ++.||||+++....+ .+++.+|+++++++ +|||||++++++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcCC
Confidence 469999999999998653 357999999754332 35789999999999 99999999999864 56789999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 543 (682)
+|+|.++++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 91 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999753 34999999999999999999999998 9999999999999999999999999997654322
Q ss_pred ------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 005693 544 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 616 (682)
Q Consensus 544 ------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 616 (682)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ +...+.......
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~----- 230 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG----- 230 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC-----
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence 2347889999999999999999999999999999998 899998643211 111122211111
Q ss_pred hccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005693 617 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 659 (682)
Q Consensus 617 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~ 659 (682)
.. ......+.+++.+||+.||++|||++||++.|+...
T Consensus 231 --~p---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 --CP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CC---cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11 122345677888999999999999999999888764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=386.98 Aligned_cols=248 Identities=24% Similarity=0.432 Sum_probs=195.2
Q ss_pred hccccccCeEEEEEEEEcCC-----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.++||+|+||+||+|.++.+ ..||||+++.... ...+|.+|++++.++ +|||||+++|++.+.+..++||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEEEEEe
Confidence 47899999999999997643 3699999865432 234688999999999 899999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+.+|++.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 91 MENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp CTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999886533 34999999999999999999999998 999999999999999999999999999876432
Q ss_pred C-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 A-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ...+|+.|+|||++.+..++.++|||||||++|||++|..|+..... ...... .+.+....
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----~~~~~~-~i~~~~~~----- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMK-AINDGFRL----- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHH-HHHTTCCC-----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-----HHHHHH-HHhccCCC-----
Confidence 1 23467889999999999999999999999999999997666543221 111111 12221111
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
....+....+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 233 -----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11122335577888899999999999999999999998865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=384.56 Aligned_cols=241 Identities=24% Similarity=0.386 Sum_probs=191.4
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEee
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDY 462 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~ 462 (682)
+.||+|+||+||+|... +++.||+|++...... .+.+.+|+++++++ +|||||++++++.+ +...++||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 56999999999999976 4678999999765433 34688999999999 89999999999875 3457899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec-CCCCeEEeecCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~~ 541 (682)
+++|+|.+++... ..+++..+..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 94 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 94 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999743 34899999999999999999999975 5699999999999996 578999999999986544
Q ss_pred CC--CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 542 PA--TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 542 ~~--~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
.. ...||+.|+|||++.+ .++.++|||||||++|||++|+.||.+... .......+. .......++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~i~-~~~~~~~~~----- 235 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVT-SGVKPASFD----- 235 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHT-TTCCCGGGG-----
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHHHH-cCCCCcccC-----
Confidence 32 4568999999999865 599999999999999999999999974321 111112221 111111111
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 236 -~~---~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 -KV---AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -GC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cc---CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 12346677889999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=397.22 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=199.6
Q ss_pred hhccccccCeEEEEEEEEcCC------ceEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLEES------TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
..+.||+|+||+||+|+.... ..||+|++.... .....+.+|+.++.++.+|||||++++++.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 367899999999999997532 258999886543 234578899999999988999999999999999999999
Q ss_pred eeccCCchhHhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe
Q 005693 461 DYFASGSLSTLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 522 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 522 (682)
||+++|+|.++++..+.. ....+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill 197 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLV 197 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhcccc
Confidence 999999999999764321 1235899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005693 523 NQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 595 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~ 595 (682)
+.++.+||+|||+|+...... +..+|+.|||||++.+..++.++|||||||++|||+| |+.||.+....+
T Consensus 198 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~--- 274 (325)
T d1rjba_ 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA--- 274 (325)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---
T ss_pred ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999998765433 2235889999999999999999999999999999998 899998654322
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 657 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 657 (682)
.....+......+ .. ......+.+++.+||+.||++|||++||+++|..
T Consensus 275 ---~~~~~~~~~~~~~-------~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 ---NFYKLIQNGFKMD-------QP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp ---HHHHHHHTTCCCC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCC-------CC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1222222221111 11 1223456778889999999999999999999963
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=395.62 Aligned_cols=191 Identities=21% Similarity=0.378 Sum_probs=168.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+.. +++.||+|+++..... .+.+.+|+.+++++ +|||||+++++|.++++.++||||+++|
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 467999999999999975 5788999998754322 45788999999999 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC--CC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PA 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--~~ 543 (682)
+|.+++.+. ..+++..+..++.|++.||+|||++ + |+||||||+|||+++++.+||+|||+|+.... ..
T Consensus 90 ~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 161 (322)
T d1s9ja_ 90 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161 (322)
T ss_dssp EHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence 999999743 2489999999999999999999974 7 99999999999999999999999999976532 33
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 589 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~ 589 (682)
+..||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5679999999999999999999999999999999999999998654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=385.01 Aligned_cols=246 Identities=20% Similarity=0.321 Sum_probs=186.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEe--cCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~ 463 (682)
.+.||+|+||+||+|+.. +++.||+|++...... .+.+.+|+++++++ +|||||++++++.+ ++..|+||||+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEEEECC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 468999999999999975 5788999999765443 34588899999999 99999999999865 45679999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
++|+|.+++..... ....+++..++.++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 88 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp TTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 99999999864321 1345999999999999999999999875 23599999999999999999999999999976643
Q ss_pred C----CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 542 P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 542 ~----~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
. ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.... .....+.... ...+
T Consensus 167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~~-~~~~----- 234 (269)
T d2java1 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREGK-FRRI----- 234 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC-CCCC-----
T ss_pred CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcCC-CCCC-----
Confidence 3 2346899999999999999999999999999999999999999754321 1122222111 1111
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.... ...+.+++.+||+.||++|||++|++++
T Consensus 235 --~~~~---s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 --PYRY---SDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --Cccc---CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1112 2346677789999999999999999763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-46 Score=388.53 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=196.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.||||++...... .+.+.+|+++++++ +|||||++++++.+++..|+||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEEEecC
Confidence 467999999999999975 5778999999765432 24588999999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 544 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 544 (682)
+|+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 99 ~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 99 GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 99998776532 34999999999999999999999998 99999999999999999999999999998887778
Q ss_pred CCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcccc
Q 005693 545 PSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 621 (682)
Q Consensus 545 ~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 621 (682)
..||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.... ........... .... ..
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~-~~~~------~~ 237 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-PALQ------SG 237 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CCCS------CT
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC-CCCC------CC
Confidence 889999999999864 45899999999999999999999999754321 11222222111 0110 11
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 622 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.. ...+.+++.+||+.||++|||++|+++
T Consensus 238 ~~---s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC---CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 12 235667778999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-46 Score=383.72 Aligned_cols=242 Identities=21% Similarity=0.383 Sum_probs=183.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 478999999999999976 478899999975532 245678999999999 9999999999999999999999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec---CCCCeEEeecCCCCCCCCCC
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DfGla~~~~~~~ 543 (682)
+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+......
T Consensus 93 ~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 93 ELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp BHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999743 34999999999999999999999998 99999999999995 57899999999998765432
Q ss_pred ---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 544 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 544 ---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
+..||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... .....+........ ....
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-----~~~~ 233 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEYEFD-----SPYW 233 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCCCCC-----TTTT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCCCC-----Cccc
Confidence 346899999999999999999999999999999999999999754321 11222222211100 0011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..+ ...+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~---s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 234 DDI---SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCC---CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 122 2346677789999999999999999884
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=382.35 Aligned_cols=239 Identities=18% Similarity=0.296 Sum_probs=196.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+++++++ +||||+++++++.+++..|+||||++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEEccC
Confidence 578999999999999975 57889999997542 2345789999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 92 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999998743 34999999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 543 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 543 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+.. .....+......
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~--------- 228 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKIIKLEYD--------- 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCCC---------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHHcCCCC---------
Confidence 2346899999999999999999999999999999999999999854321 112222222110
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 655 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 655 (682)
..... ...+.+++.+||+.||++|||++|++++-
T Consensus 229 ~p~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 229 FPEKF---FPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp CCTTC---CHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred CCccC---CHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 11112 23456777899999999999999986643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=378.53 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=193.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe-cCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||.||+|+++ ++.||||+++.. ...+++.+|+++++++ +||||++++|++.+ ++..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 578999999999999986 778999999754 3457799999999999 99999999999864 4568999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC-CCCC
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR 547 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 547 (682)
.+++.... ...+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+|++|||+++...... ...+
T Consensus 89 ~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~ 162 (262)
T d1byga_ 89 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162 (262)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCccccc
Confidence 99996432 234899999999999999999999987 9999999999999999999999999998765433 3456
Q ss_pred CCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccChHHH
Q 005693 548 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 626 (682)
Q Consensus 548 ~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 626 (682)
+..|+|||++.+..++.++|||||||++|||+| |+.||......+ +..++ ......+ .....
T Consensus 163 ~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~~~~~----------~~~~~ 225 (262)
T d1byga_ 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGYKMD----------APDGC 225 (262)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTTCCCC----------CCTTC
T ss_pred cccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCCC----------CCccC
Confidence 788999999999999999999999999999998 688876543222 22111 1111111 11122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 627 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 627 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
...+.+++.+||+.||++|||++|++++|++++..
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 34567788899999999999999999999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=385.19 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=196.4
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHH--HHhcCCCceeceEEEEEecC----ceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIV--GRVGQHPNVVPLRAYYYSKD----EKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l--~~l~~h~niv~l~~~~~~~~----~~~lV~e~~ 463 (682)
.+.||+|+||+||+|+++ |+.||||+++... .+++.+|.+++ ..+ +|||||++++++.+++ ..++||||+
T Consensus 8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 467999999999999974 7899999986543 33444444444 455 8999999999998764 578999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----GPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
++|+|.++++.. .++|..+.+++.|+|.||+|+|+.. .++|+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 84 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999753 3899999999999999999999741 23499999999999999999999999999976
Q ss_pred CCCC--------CCCCCCCcccCccccccCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCC--------Ch
Q 005693 539 MNVP--------ATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--------DL 596 (682)
Q Consensus 539 ~~~~--------~~~~~~~~y~aPE~~~~~~------~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~--------~l 596 (682)
.... ....||+.|+|||++.+.. ++.++|||||||++|||+||..||......+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 5322 2345899999999987543 577899999999999999999888643322110 11
Q ss_pred hHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 597 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 597 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.........+.. .++.+.......+....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 238 ~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 122222221111 11111111222346677888999999999999999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=380.03 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=193.5
Q ss_pred hccccccCeEEEEEEEEcC------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecC-ceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~ 460 (682)
.+.||+|+||.||+|.+.. ++.||||+++.... ..+.+.+|+.++.++.+|+||+.+++++..++ ..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 5789999999999999643 35799999875432 24567888889999888999999999987654 679999
Q ss_pred eeccCCchhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeE
Q 005693 461 DYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 529 (682)
||+++|+|.++++.... .....+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence 99999999999975432 11335899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHH
Q 005693 530 ISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQS 602 (682)
Q Consensus 530 l~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~-~Pf~~~~~~~~~~l~~~~~~ 602 (682)
|+|||+|+...... ...||+.|+|||++.+..++.++|||||||++|||+||. .||.+.... .....
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~------~~~~~ 248 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCR 248 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS------HHHHH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 99999997654322 235788999999999999999999999999999999974 577654322 12222
Q ss_pred HhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 603 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 603 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.+.+...... .......+.+++.+||+.||++|||++|++++|+++.+..
T Consensus 249 ~~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 249 RLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2332222111 1122345678888999999999999999999999987653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.7e-45 Score=384.77 Aligned_cols=243 Identities=19% Similarity=0.368 Sum_probs=198.5
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.+++++ +|||||++++++.+++..++||||+++|+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 578999999999999975 578899999975533 345688999999999 89999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC--CCCeEEeecCCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~~~~~~-- 543 (682)
|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+......
T Consensus 110 L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 110 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp HHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999996432 34999999999999999999999998 999999999999964 5789999999998765443
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ......+....+... .. ...
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~---~~--~~~- 250 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNMD---DS--AFS- 250 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSC---CG--GGG-
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCC---cc--ccc-
Confidence 34689999999999999999999999999999999999999975432 222233222221110 00 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....+.+++.+||+.||++|||++|++++
T Consensus 251 --~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 --GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122345677789999999999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-45 Score=374.39 Aligned_cols=242 Identities=23% Similarity=0.380 Sum_probs=196.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-------ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+++++++ +|||||++++++.+++..++|||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999975 578999999975422 246789999999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC----CeEEeecCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 537 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 537 (682)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|++|||+|+
T Consensus 94 ~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 94 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999743 24999999999999999999999998 99999999999999876 49999999997
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 538 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 538 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
..... ....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+ ....+...... +.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~---~~ 236 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVNYE---FE 236 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTCCC---CC
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcCCC---CC
Confidence 76433 24467889999999999999999999999999999999999998643221 11222111110 00
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. ... .....+.+++.+||+.||++|||++|++++
T Consensus 237 ~~--~~~---~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DE--YFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HH--HHT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ch--hcC---CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 011 122356677889999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=377.95 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=201.6
Q ss_pred hccccccCeEEEEEEEEcCC-c--eEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLEES-T--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~-~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|.++++ . .||||+++.... ..+++.+|++++.++.+|||||++++++.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 57899999999999997643 3 477888764422 346799999999998789999999999999999999999999
Q ss_pred CCchhHhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeec
Q 005693 465 SGSLSTLLHGNR-----------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 533 (682)
Q Consensus 465 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 533 (682)
+|+|.++++... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccc
Confidence 999999997542 122345999999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 534 GLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 534 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~-~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
|+++...... ...+|..|+|||.+.+..++.++|||||||++|||++|. +||.+.. .......+. +...
T Consensus 172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~i~-~~~~ 244 (309)
T d1fvra_ 172 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLP-QGYR 244 (309)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHGG-GTCC
T ss_pred cccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHHHH-hcCC
Confidence 9997655332 335788999999999999999999999999999999976 4675433 222222222 1111
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.. ... .....+.+++.+||+.||++||||+||+++|+++.+...
T Consensus 245 ~~-------~~~---~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 245 LE-------KPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp CC-------CCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CC-------CCc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 11 111 223456677789999999999999999999999987554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=374.77 Aligned_cols=246 Identities=22% Similarity=0.359 Sum_probs=190.9
Q ss_pred hccccccCeEEEEEEEEcC----CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 390 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
.+.||+|+||+||+|.+.. +..||||+++.... ..+.+.+|+++++++ +|||||++++++. ++..++||||+
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeEEEEEEec
Confidence 5789999999999998753 34588888865432 245688999999999 9999999999985 56789999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
++|+|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+|+......
T Consensus 90 ~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 90 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred cCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999876433 34899999999999999999999998 9999999999999999999999999998764322
Q ss_pred -----CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 005693 544 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 617 (682)
Q Consensus 544 -----~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 617 (682)
...+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+....+. ...+. ......
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~------~~~i~-~~~~~~------ 229 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIE-NGERLP------ 229 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHH-TTCCCC------
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH------HHHHH-cCCCCC------
Confidence 2346788999999999999999999999999999998 8999986553321 11111 111111
Q ss_pred ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 618 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 618 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
... .....+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 230 -~~~---~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 -MPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC---CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111 2234567788899999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=376.58 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=198.0
Q ss_pred hccccccCeEEEEEEEEcCC----ceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEec-CceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV~e~ 462 (682)
.++||+|+||+||+|.+.++ ..||||+++.... ..++|.+|++++.++ +||||++++|++.+. ...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999997542 2589999875322 236799999999999 899999999998764 578999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++.... ...++..+++++.|++.||.|+|+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999987533 34788999999999999999999998 999999999999999999999999999875432
Q ss_pred C--------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 005693 543 A--------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 614 (682)
Q Consensus 543 ~--------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 614 (682)
. ...+|+.|+|||.+.+..++.++||||||+++|||+||+.||...... .++..+ +...... .
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~---i~~g~~~-~--- 254 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY---LLQGRRL-L--- 254 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HHTTCCC-C---
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH---HHcCCCC-C---
Confidence 2 234678899999999999999999999999999999988887643211 122211 1111110 0
Q ss_pred hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005693 615 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 663 (682)
Q Consensus 615 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 663 (682)
.. ......+.+++.+||+.||++||+++||+++|+.+.+.-.
T Consensus 255 ----~p---~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 255 ----QP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ----CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----Cc---ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 11 1223456788889999999999999999999999987543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=382.43 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=196.2
Q ss_pred hccccccCeEEEEEEEEcC-Cc----eEEEEEeeccc--cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||+||+|.+.. ++ .||+|+++... ...+++.+|++++.++ +|||||+++|++.+ +..++++||
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~-~~~~~v~e~ 91 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT-STVQLITQL 91 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEEC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCeeEEEEe
Confidence 4789999999999999753 32 58899886543 2456899999999999 99999999999976 467788999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+.+|+|.+++... ...+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 92 MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp CTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred ccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 9999999988753 335899999999999999999999998 999999999999999999999999999765432
Q ss_pred C------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 543 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 543 ~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
. ...+|+.|+|||++.++.++.++|||||||++|||+| |..||.+....+ +. ..+.....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~----~~i~~~~~------ 231 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGER------ 231 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH----HHHHHTCC------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCC------
Confidence 2 2246889999999999999999999999999999999 788987654332 11 11111111
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
....+.....+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 01112233456778889999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-45 Score=376.62 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=200.4
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeeccccC--hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||+||+|+++ +++.||||+++..... .++|.+|+++++++ +||||+++++++...+..++|||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCceEEEEE
Confidence 568999999999999975 3467999999754322 45789999999999 99999999999999999999999
Q ss_pred eccCCchhHhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEe
Q 005693 462 YFASGSLSTLLHGNRG-------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 522 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 522 (682)
|+++|+|.++++.... .....+++..++.++.|++.||+|||+++ |+||||||+|||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEE
Confidence 9999999999964321 12334899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCC------CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCCC
Q 005693 523 NQDLDGCISDFGLTPLMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVD 595 (682)
Q Consensus 523 ~~~~~~kl~DfGla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~-~Pf~~~~~~~~~~ 595 (682)
+.++.+||+|||+|+.... .....+++.|+|||.+.+..++.++|||||||++|||++|. +||.+....
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~---- 249 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 249 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH----
Confidence 9999999999999865432 12345678899999999999999999999999999999986 567654322
Q ss_pred hhHHHHHHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 596 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 596 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
+....+ .+...... . ......+.+++.+||+.+|++||||.||+++|++|.+
T Consensus 250 --e~~~~v-~~~~~~~~-------p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 250 --EVIYYV-RDGNILAC-------P---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp --HHHHHH-HTTCCCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --HHHHHH-HcCCCCCC-------C---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 122222 22211111 1 1223457788889999999999999999999999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=379.31 Aligned_cols=245 Identities=19% Similarity=0.310 Sum_probs=193.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEe----cCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.||||+++. ...+.+|++++.++.+|||||+++++|++ +...|+||||++
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 357999999999999974 578999999864 35678899988877789999999999976 356799999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCCCCCCC
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNV 541 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~ 541 (682)
||+|.+++.... ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+|+....
T Consensus 93 gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 93 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp SEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccC
Confidence 999999997532 235999999999999999999999998 999999999999986 46799999999976543
Q ss_pred C---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhc
Q 005693 542 P---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 618 (682)
Q Consensus 542 ~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 618 (682)
. ....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+....+... ...... .....+..
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i----~~~~~~~~-- 237 (335)
T d2ozaa1 167 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRI----RMGQYEFP-- 237 (335)
T ss_dssp CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC----CSCSSSCC--
T ss_pred CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHH----hcCCCCCC--
Confidence 3 34568999999999999999999999999999999999999997654332211 000000 00000000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 619 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..........+.+++.+||+.||++|||++|++++
T Consensus 238 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 238 -NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00112234567788889999999999999999884
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-44 Score=382.28 Aligned_cols=243 Identities=21% Similarity=0.375 Sum_probs=198.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 467 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 467 (682)
.+.||+|+||+||+|... +++.||||+++.... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|+
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 478999999999999975 588999999876532 345688999999999 99999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEec--CCCCeEEeecCCCCCCCCCC--
Q 005693 468 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 468 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DfGla~~~~~~~-- 543 (682)
|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+......
T Consensus 113 L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 113 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 99887643 234999999999999999999999998 99999999999998 67899999999998776543
Q ss_pred -CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccC
Q 005693 544 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 622 (682)
Q Consensus 544 -~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 622 (682)
...+|+.|+|||++.+..++.++||||+||++|||+||+.||.+.... .....+....... . ......
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~---~--~~~~~~ 254 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWEF---D--EDAFSS 254 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCCC---C--SSTTTT
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC---C--cccccC
Confidence 246889999999999999999999999999999999999999754321 1122222211110 0 001112
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 623 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....+.+++.+||+.||++|||++|++++
T Consensus 255 ---~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 255 ---VSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23345677789999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=373.23 Aligned_cols=238 Identities=22% Similarity=0.293 Sum_probs=197.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||.||+|+.+ +++.||+|++++.. ...+.+.+|+.+++++ +||||+++++++.+++..|+||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccceeccC
Confidence 478999999999999975 57899999997542 2346688999999999 89999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999997533 4899999999999999999999998 999999999999999999999999999875432
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.. .....+..... ...
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~~~---------~~p 225 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEI---------RFP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC---------CCC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcCCC---------CCC
Confidence 2345899999999999999999999999999999999999999865422 11222222111 011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
..++ ..+.+++.+||+.||++||+ ++|++++
T Consensus 226 ~~~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 RTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccCC---HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1222 34566777999999999994 8888874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-44 Score=373.78 Aligned_cols=238 Identities=19% Similarity=0.293 Sum_probs=197.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.+ +++.||||+++... ...+.+.+|+.+++++ +|||||++++++.+++..|+||||++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEeeecC
Confidence 478999999999999975 57899999997542 2346788999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-C
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 543 (682)
+|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 88 gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 88 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred Cccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 999999987533 4788999999999999999999998 999999999999999999999999999876543 3
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
+..||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.+. ......+...... .....
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p~~~ 224 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELR---------FPPFF 224 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCC---------CCTTS
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCCC---------CCCCC
Confidence 45799999999999999999999999999999999999999976432 1222222222110 11112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 654 (682)
+ ..+.+++.+|++.||++|+ |++|++++
T Consensus 225 s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 N---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C---HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 2 3456777799999999996 89999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=372.07 Aligned_cols=244 Identities=26% Similarity=0.364 Sum_probs=188.5
Q ss_pred hccccccCeEEEEEEEEcCC----ceEEEEEeecccc----ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||+||+|++... ..||||+++.... ..++|.+|++++.++ +|||||+++|++.+ ...++|||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cchheeee
Confidence 46799999999999986432 3689999875422 135789999999999 99999999999965 56789999
Q ss_pred eccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC
Q 005693 462 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 541 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 541 (682)
|+++|++.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999998886432 34999999999999999999999988 99999999999999999999999999987644
Q ss_pred CC-------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 542 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 542 ~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+.... .....+..+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~~-- 235 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP-- 235 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCC--
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCCC--
Confidence 32 2235678999999999999999999999999999998 89999754322 22223222221111
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 658 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i 658 (682)
.. +.....+.+++.+||+.||++|||++||.+.|++.
T Consensus 236 -----~~---~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 -----RP---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----Cc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 12234567888899999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=370.71 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=198.6
Q ss_pred hccccccCeEEEEEEEEcC--------CceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 459 (682)
.+.||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++.+|||||+++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 5789999999999998643 24699999976543 2367888999999998899999999999999999999
Q ss_pred EeeccCCchhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCe
Q 005693 460 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 528 (682)
|||+++|+|.+++...... ....+++.++++++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCe
Confidence 9999999999999755321 1345899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005693 529 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 529 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-g~~Pf~~~~~~~~~~l~~~~~ 601 (682)
||+|||+++...... ...+++.|+|||.+.++.|+.++|||||||++|||++ |..||.+....+ +.
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-------~~ 247 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF 247 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HH
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-------HH
Confidence 999999998664322 2346788999999999999999999999999999998 688887543221 11
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
..+....... .... ....+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 248 ~~i~~~~~~~-------~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 248 KLLKEGHRMD-------KPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHTTCCCC-------CCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCC-------CCcc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2222221111 1111 234567788899999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=372.74 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=202.4
Q ss_pred hccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEe
Q 005693 390 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 461 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 461 (682)
.+.||+|+||.||+|++. .++.||||+++.... ...++.+|+.++.++.+|||||++++++.+++..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 578999999999999863 346799999975432 345688999999999789999999999999999999999
Q ss_pred eccCCchhHhhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCe
Q 005693 462 YFASGSLSTLLHGNRG-------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 528 (682)
Q Consensus 462 ~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 528 (682)
|+++|+|.++++.... .....+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcc
Confidence 9999999999975432 12335899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCC------CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHH
Q 005693 529 CISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQ 601 (682)
Q Consensus 529 kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg-~~Pf~~~~~~~~~~l~~~~~ 601 (682)
|++|||+++....... ..+|+.|+|||++.+..++.++|||||||++|||+|+ .+||......+ .+.
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~------~~~ 258 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFY 258 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 9999999987654322 3468889999999999999999999999999999995 55554433221 122
Q ss_pred HHhhhccccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005693 602 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 661 (682)
Q Consensus 602 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~ 661 (682)
..+....... ..+.....+.+++.+||+.||++|||++|++++|+++...
T Consensus 259 ~~i~~~~~~~----------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 2222221111 1112234577888899999999999999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.8e-44 Score=362.73 Aligned_cols=243 Identities=20% Similarity=0.361 Sum_probs=195.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 458 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 458 (682)
.+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|+.+++++..||||+++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 578999999999999974 5789999999754321 13578899999999669999999999999999999
Q ss_pred EEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCC
Q 005693 459 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 538 (682)
Q Consensus 459 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 538 (682)
||||+++|+|.++++.. ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 vmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999743 24999999999999999999999998 99999999999999999999999999977
Q ss_pred CCCC---CCCCCCCcccCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 005693 539 MNVP---ATPSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 609 (682)
Q Consensus 539 ~~~~---~~~~~~~~y~aPE~~~~------~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 609 (682)
.... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... .....+......
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i~~~~~~ 233 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGNYQ 233 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHHHhCCCC
Confidence 6543 33457899999999853 34688999999999999999999999865321 112222222211
Q ss_pred cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.. . .........+.+++.+||+.||++|||++|++++
T Consensus 234 ~~-----~---~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 FG-----S---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CC-----T---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC-----C---cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 0 0111223456677789999999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-44 Score=371.82 Aligned_cols=243 Identities=21% Similarity=0.339 Sum_probs=198.3
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||+||+|... +++.||+|+++........+.+|++++..+ +|||||++++++.+++..|+||||+++|+|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 478999999999999986 467899999987655566788999999999 999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCC--CCeEEeecCCCCCCCCCC---
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMNVPA--- 543 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~--~~~kl~DfGla~~~~~~~--- 543 (682)
.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 89 ~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99997432 24899999999999999999999998 9999999999999854 589999999998765433
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...+++.|+|||.+.+..++.++||||+||++|||++|+.||.+.... .....+...... ++.. ....+
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~---~~~~--~~~~~ 230 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYT---FDEE--AFKEI 230 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC---CCHH--HHTTS
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---CChh--hccCC
Confidence 235789999999999999999999999999999999999999865322 122222222211 0000 01112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
...+.+++.+|+..||++|||++|++++
T Consensus 231 ---s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 231 ---SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2345677789999999999999999984
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-43 Score=361.15 Aligned_cols=247 Identities=22% Similarity=0.335 Sum_probs=194.4
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC----hhhHHHHHHHHHHhcCCCceeceEEEEEecCc----eEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE----KLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----~~lV~ 460 (682)
.+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|+++++.+ +|||||++++++..++. .|+||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceEEEEE
Confidence 478999999999999974 5788999999765332 24688999999998 99999999999987653 78999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++..+++|||.+....
T Consensus 91 E~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred ECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999988643 24899999999999999999999998 9999999999999999999999999886543
Q ss_pred CC-------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~-------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+... .........+.....
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~-- 234 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP-- 234 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCG--
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCC--
Confidence 22 234589999999999999999999999999999999999999975432 122223332221110
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhh
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVR 659 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~i~ 659 (682)
.......+ ..+.+++.+||+.||++|| |++++.+.|.++.
T Consensus 235 ---~~~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 ---SARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GGTSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---chhccCCC---HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00111222 3456677799999999999 8999999988775
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=371.88 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=190.5
Q ss_pred ccccccCeEEEEEEEEc-CCceEEEEEeeccccC------hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeec
Q 005693 391 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 463 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 463 (682)
++||+|+||+||+|+.. +++.||||+++..... .+.+.+|+++++++ +|||||++++++.+++..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhhhh
Confidence 67999999999999975 5788999998654321 24688999999999 9999999999999999999999999
Q ss_pred cCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC
Q 005693 464 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 543 (682)
Q Consensus 464 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 543 (682)
.++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99888777653 234888999999999999999999998 9999999999999999999999999997765432
Q ss_pred ----CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcccccc--
Q 005693 544 ----TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEV-- 612 (682)
Q Consensus 544 ----~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~~~-- 612 (682)
...+|+.|+|||++... .++.++||||+||++|||+||+.||.+....+. ......... +.+....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhcc
Confidence 34588999999998654 579999999999999999999999976542221 111111100 0000000
Q ss_pred -chhhhcccc--C----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 613 -FDVELMRFQ--N----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 613 -~d~~l~~~~--~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
......... . .......+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000 0 01122457788889999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-43 Score=373.44 Aligned_cols=237 Identities=18% Similarity=0.205 Sum_probs=197.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.+ +++.||||++.... ...+.+.+|+++++.+ +|||||++++++.+.+..++||||+.
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccccccccc
Confidence 468999999999999975 58899999987432 2345688999999999 99999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC-C
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 543 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 543 (682)
+|+|.+++.... .+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+..... .
T Consensus 125 ~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred ccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999997432 4899999999999999999999998 999999999999999999999999999876543 3
Q ss_pred CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccccCh
Q 005693 544 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 623 (682)
Q Consensus 544 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 623 (682)
...||+.|||||++.+..++.++|||||||++|||+||+.||.+... ......+...... ....
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p~~- 260 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKVR---------FPSH- 260 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CCTT-
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCCCC---------CCcc-
Confidence 45689999999999999999999999999999999999999975431 1222222222110 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005693 624 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 653 (682)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 653 (682)
....+.+++.+||+.||++|+ |++|+++
T Consensus 261 --~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 223466777799999999994 8999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-43 Score=371.78 Aligned_cols=242 Identities=18% Similarity=0.259 Sum_probs=190.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhc--CCCceeceEEEEEecCceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
.+.||+|+||.||+|+.. +++.||||++.... .....+.+|..++..+. +|||||++++++.+++..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 478999999999999976 47899999986542 22344555655444442 699999999999999999999999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 542 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 542 (682)
+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 89 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred cCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999743 34889999999999999999999998 999999999999999999999999999866543
Q ss_pred --CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhcc
Q 005693 543 --ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 619 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 619 (682)
....||+.|+|||++.. ..|+.++|||||||++|||+||+.||.+....+. ........... ...
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~~~~---------~~~ 228 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMA---------VEL 228 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSSSCC---------CCC
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcccCC---------CCC
Confidence 34568999999999975 5689999999999999999999999986543321 11111111100 001
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005693 620 FQNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 654 (682)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 654 (682)
...++ ..+.+++.+||+.||++||| ++|++++
T Consensus 229 ~~~~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 229 PDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CSSSC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCC---HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11222 34567777999999999999 6888763
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=369.23 Aligned_cols=238 Identities=22% Similarity=0.355 Sum_probs=193.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccc----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeecc
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 464 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 464 (682)
.+.||+|+||+||+|+.. +++.||||+++... ...+.+..|+.++.+..+|||||++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 478999999999999976 47889999997532 2345677788877755599999999999999999999999999
Q ss_pred CCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC--
Q 005693 465 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 542 (682)
Q Consensus 465 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 542 (682)
+|+|.++++... .+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999997433 4899999999999999999999998 999999999999999999999999999765432
Q ss_pred --CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhccc
Q 005693 543 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 620 (682)
Q Consensus 543 --~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 620 (682)
....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+..+ ....+...... ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~~---------~p 223 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNPF---------YP 223 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC---------CC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCC---------CC
Confidence 23468999999999999999999999999999999999999998654221 11121111110 11
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 005693 621 QNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR 653 (682)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 653 (682)
..+ ...+.+++.+||+.||++||+++ |+++
T Consensus 224 ~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccC---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122 23456777799999999999995 7764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=368.22 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=202.8
Q ss_pred hhccccccCeEEEEEEEEc------CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
..+.||+|+||+||+|.+. +++.||||+++.... ....|.+|+++++++ +|||||++++++..++..++||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCceeEEE
Confidence 4678999999999999864 246899999975432 234588999999999 8999999999999999999999
Q ss_pred eeccCCchhHhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCC
Q 005693 461 DYFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 535 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 535 (682)
||+++|+|.+++..... .....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeeccc
Confidence 99999999999864321 12234789999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhcc
Q 005693 536 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQSVVREEW 608 (682)
Q Consensus 536 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~-~Pf~~~~~~~~~~l~~~~~~~~~~~~ 608 (682)
|+...... ...+++.|+|||.+.+..++.++||||||+++|||+||. .||.+.. .......+....
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~~i~~~~- 252 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVMEGG- 252 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHHHHTTC-
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhCC-
Confidence 98664322 234688999999999999999999999999999999985 6776432 223333332221
Q ss_pred ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 609 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 609 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
.... . ......+.+++.+||+.+|++|||++||+++|++..+..
T Consensus 253 ~~~~-------p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 253 LLDK-------P---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp CCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred CCCC-------c---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111 1 122345778888999999999999999999998776543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=358.37 Aligned_cols=233 Identities=21% Similarity=0.377 Sum_probs=188.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc-------ChhhHHHHHHHHHHhc-CCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||+||+|+.. +++.||||+++.... ....+.+|+.+++++. .|||||++++++.+++..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 478999999999999975 578999999975432 1234678999999994 3999999999999999999999
Q ss_pred eeccC-CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-CCCeEEeecCCCCC
Q 005693 461 DYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPL 538 (682)
Q Consensus 461 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~ 538 (682)
||+.+ +++.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 89 e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccccee
Confidence 99976 6788888643 34899999999999999999999998 999999999999985 47999999999976
Q ss_pred CCCC--CCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 005693 539 MNVP--ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 615 (682)
Q Consensus 539 ~~~~--~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 615 (682)
.... .+..||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... .+.....
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~------- 221 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV------- 221 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC-------
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc-------
Confidence 5443 34568999999999987765 567899999999999999999997421 1111110
Q ss_pred hhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 616 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 616 ~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.....++ ..+.+++.+||+.||++|||++|++++
T Consensus 222 --~~~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 --FFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCCCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111222 345667779999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=361.60 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=189.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|+.. +++.||+|+++.... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEeecCC
Confidence 368999999999999974 578999999965432 246788999999998 999999999999999999999999976
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC---
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 542 (682)
+ +.+++.... ...+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.|+.....
T Consensus 86 ~-~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 86 D-LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp E-HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred c-hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 5 444443222 234999999999999999999999998 999999999999999999999999998665432
Q ss_pred -CCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh--hccccccc-----
Q 005693 543 -ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR--EEWTAEVF----- 613 (682)
Q Consensus 543 -~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~--~~~~~~~~----- 613 (682)
....+|+.|+|||.+.... ++.++||||+||++|||++|+.||.+....+. +......... +.......
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhcccccccccc
Confidence 2345889999999987666 47899999999999999999999975432111 1111110000 00000000
Q ss_pred hhhhc--cccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 614 DVELM--RFQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 614 d~~l~--~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
..... ...... .....+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 000001 122456778889999999999999999885
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-42 Score=356.57 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=192.5
Q ss_pred hccccccCeEEEEEEEEcCCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+.++++.||||+++.... ..+.+.+|+.+++++ +|||||++++++..++..++++||+.++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEEeehhh
Confidence 467999999999999999899999999965432 246789999999999 8999999999999999999999999887
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCC----
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 542 (682)
.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+......
T Consensus 86 ~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 86 LKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp HHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 77777653 234999999999999999999999998 999999999999999999999999998665432
Q ss_pred CCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hccc----cccch
Q 005693 543 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEWT----AEVFD 614 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~---~~~~----~~~~d 614 (682)
....+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+. +.+....... ..+. ....+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhhhhcc
Confidence 233578889999998765 468999999999999999999999976432211 1110110000 0000 00000
Q ss_pred hhhc------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 615 VELM------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 615 ~~l~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.... ...........+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000111123456778889999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-42 Score=354.36 Aligned_cols=256 Identities=20% Similarity=0.287 Sum_probs=189.7
Q ss_pred hccccccCeEEEEEEEEc-C-CceEEEEEeecccc---ChhhHHHHHHHHHHhc--CCCceeceEEEEEe-----cCceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-E-STTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYS-----KDEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~ 457 (682)
.+.||+|+||+||+|+.. + ++.||||+++.... ....+.+|+.+++.+. +||||+++++++.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 467999999999999974 3 45689999875432 2345778888887764 79999999999863 24678
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
++|||+++|++....... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 92 ~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 999999988776554432 234899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccccc
Q 005693 538 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAE 611 (682)
Q Consensus 538 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~~~~ 611 (682)
..... ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.+..+.. ........ ...+...
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCGGGSCTT
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH--HHHHHhhCCCchhccccc
Confidence 65432 3556899999999999999999999999999999999999999865422211 01011000 0011000
Q ss_pred cchh--hh------ccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 612 VFDV--EL------MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 612 ~~d~--~l------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.... .. ............+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00 0000011122345677789999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-41 Score=346.48 Aligned_cols=251 Identities=17% Similarity=0.165 Sum_probs=190.8
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||+||+|++. +++.||||++.... ..+++.+|+++++.+.+|++|+.+.+++.+.+..++||||+ +|++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l 89 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 89 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCch
Confidence 478999999999999975 57889999887543 34568899999999955556666777778888889999999 4567
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC---CCCeEEeecCCCCCCCCC---
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~--- 542 (682)
.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+|++|||+|+.....
T Consensus 90 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 90 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 66665332 34899999999999999999999998 999999999999864 557999999999765432
Q ss_pred --------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChh-HHHHHHhhhccccccc
Q 005693 543 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RWVQSVVREEWTAEVF 613 (682)
Q Consensus 543 --------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~-~~~~~~~~~~~~~~~~ 613 (682)
....||+.|+|||++.+..++.++|||||||++|||+||+.||......+..... .+........ .
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~---- 237 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I---- 237 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-H----
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-h----
Confidence 2335899999999999999999999999999999999999999876544332211 1111100000 0
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 660 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~ 660 (682)
.. ... .....+.+++.+||+.+|++||+++++.+.|+.+..
T Consensus 238 -~~--~~~---~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 -EV--LCK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -HH--HTT---TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -hH--hcc---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00 011 122456777789999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-40 Score=341.83 Aligned_cols=254 Identities=17% Similarity=0.195 Sum_probs=200.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCch
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 468 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 468 (682)
.+.||+|+||+||+|+.. +++.||||++... .....+.+|++++..+.+|+|++.+++++..+...++||||+ +|+|
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l 87 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 87 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence 478999999999999976 4788999988653 334568889999999977899999999999999999999998 6899
Q ss_pred hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecC-----CCCeEEeecCCCCCCCCC-
Q 005693 469 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----DLDGCISDFGLTPLMNVP- 542 (682)
Q Consensus 469 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-----~~~~kl~DfGla~~~~~~- 542 (682)
.++++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.....
T Consensus 88 ~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 88 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99987543 24899999999999999999999998 999999999999974 578999999999765321
Q ss_pred ----------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 005693 543 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 612 (682)
Q Consensus 543 ----------~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 612 (682)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.+........ ....+........
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~---~~~~i~~~~~~~~- 236 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---KYERIGEKKQSTP- 236 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH---HHHHHHHHHHHSC-
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH---HHHHHHhccCCCC-
Confidence 23458999999999999999999999999999999999999998654332211 1111111110000
Q ss_pred chhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005693 613 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 662 (682)
Q Consensus 613 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 662 (682)
. ..+ .... ..++.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus 237 ~-~~l--~~~~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 237 L-REL--CAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp H-HHH--TTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred h-HHh--cCCC---CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0 000 0112 235667778999999999999999999999887544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=352.66 Aligned_cols=261 Identities=24% Similarity=0.304 Sum_probs=188.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV~e~ 462 (682)
.++||+|+||+||+|+.. +++.||||+++... ....+|+++++++ +||||+++++++.... ..++||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 368999999999999986 57889999997543 3345799999999 9999999999986432 46899999
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCC
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNV 541 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~ 541 (682)
+++|.+..+.+... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 101 ~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 101 VPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp CSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred cCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 98764444332111 2345999999999999999999999998 99999999999999775 899999999976643
Q ss_pred C---CCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCCh---------hHHHHHHhhhc-
Q 005693 542 P---ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL---------PRWVQSVVREE- 607 (682)
Q Consensus 542 ~---~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l---------~~~~~~~~~~~- 607 (682)
. .+..+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... ..+........
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 3 34467889999998865 5689999999999999999999999976543221100 00000000000
Q ss_pred --cccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 005693 608 --WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ 660 (682)
Q Consensus 608 --~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~~ 660 (682)
............ .........+.+++.+||+.||++|||++|++++ ++++..
T Consensus 256 ~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000000000000 0001123356777889999999999999999974 666654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=347.59 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=186.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc---ChhhHHHHHHHHHHhcCCCceeceEEEEEe--------cCceE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--------KDEKL 457 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~ 457 (682)
.+.||+|+||+||+|+.. +++.||||++..... ..+++.+|+++++++ +||||+++++++.. +...+
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----------CEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccCceEE
Confidence 468999999999999975 688999999865432 245688999999999 89999999999865 34578
Q ss_pred EEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 458 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 458 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
+||||+.++.+...... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 94 iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 99999988777665542 234889999999999999999999998 9999999999999999999999999996
Q ss_pred CCCC--------CCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---
Q 005693 538 LMNV--------PATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR--- 605 (682)
Q Consensus 538 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~--- 605 (682)
.... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA---LISQLCGSIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH---HHHHhcCCCC
Confidence 5432 2234578999999998765 58999999999999999999999997543211110 0111110
Q ss_pred hcccccc--------chhhhccccChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 606 EEWTAEV--------FDVELMRFQNIEEE------MVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 606 ~~~~~~~--------~d~~l~~~~~~~~~------~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....... ............+. ...+++++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 00000001111111 2346678899999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=354.02 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=187.7
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecC------ceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 459 (682)
.+.||+|+||+||+|... +++.||||+++..... .+.+.+|+++++.+ +|||||+++++|...+ +.++|
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEEEE
Confidence 467999999999999975 4788999999765433 34678899999999 9999999999997654 46999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+ +++|..+.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+..
T Consensus 102 ~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred Eecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 9999 56888877532 3999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC-CCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--hhc----c---
Q 005693 540 NVPA-TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV--REE----W--- 608 (682)
Q Consensus 540 ~~~~-~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~--~~~----~--- 608 (682)
.... ...+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+.. ........ ... .
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--KEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHTCSCH
T ss_pred CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH--HHHHhccCCCcHHHHhhhcch
Confidence 6543 35688999999998764 4689999999999999999999999865322111 00000000 000 0
Q ss_pred --------ccccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 005693 609 --------TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ 660 (682)
Q Consensus 609 --------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i~~ 660 (682)
........+. .........+.+++.+||+.||++|||++|++++ ++++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0000000000 0011122345678889999999999999999985 666543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=350.61 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=187.0
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeecccc--ChhhHHHHHHHHHHhcCCCceeceEEEEEecC----ceEEEEee
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----EKLLVYDY 462 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lV~e~ 462 (682)
.+.||+|+||+||+|... +++.||||++..... ..+.+.+|++++.++ +||||+++++++.... ..+++++|
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEEEe
Confidence 478999999999999964 688999999975432 234678999999999 9999999999997653 23556677
Q ss_pred ccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCC-
Q 005693 463 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 541 (682)
Q Consensus 463 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 541 (682)
+.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 92 ~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 92 LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 7899999999743 3899999999999999999999998 99999999999999999999999999975532
Q ss_pred ------CCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc---ccc
Q 005693 542 ------PATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW---TAE 611 (682)
Q Consensus 542 ------~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~---~~~ 611 (682)
.....+++.|+|||++.. ..++.++||||+||++|||++|+.||.+....+... .......... ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH---HHhhhccCCChhhhhh
Confidence 233457889999999854 457899999999999999999999997654321110 0000000000 000
Q ss_pred cc-------hhhhc--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 005693 612 VF-------DVELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEV 658 (682)
Q Consensus 612 ~~-------d~~l~--~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~i 658 (682)
.. ..... ..... ......+.+++.+|++.||++|||++|++++ +++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 00000 00000 0112346788889999999999999999985 5433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-39 Score=340.98 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=189.2
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEec--CceEEEEeeccCC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFASG 466 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~~~g 466 (682)
.+.||+|+||+||+|+.. +++.||||+++.. ..+++.+|++++..+.+||||+++++++... ...++||||+++|
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 578999999999999974 5788999998753 3567899999999997799999999999854 4689999999999
Q ss_pred chhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCC-CeEEeecCCCCCCCCC---
Q 005693 467 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP--- 542 (682)
Q Consensus 467 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~--- 542 (682)
+|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 9987653 3899999999999999999999998 99999999999998765 5899999999766543
Q ss_pred CCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---------h-cc-c-
Q 005693 543 ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---------E-EW-T- 609 (682)
Q Consensus 543 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~---------~-~~-~- 609 (682)
....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||....... +.......... . .. .
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhhhcccccC
Confidence 3345788999999987654 7999999999999999999999997543211 00000000000 0 00 0
Q ss_pred ---cccc-------hhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005693 610 ---AEVF-------DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 653 (682)
Q Consensus 610 ---~~~~-------d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 653 (682)
.... ...............++.+++.+|++.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000011111222345678888999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=343.04 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=192.1
Q ss_pred hccccccCeEEEEEEEEc----CCceEEEEEeeccc-----cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 460 (682)
.+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++.++.+||||+++++++.+....++||
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 478999999999999862 36789999986432 234568899999999966689999999999999999999
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
||+.+|+|.+++.... .+++..+..++.|++.||+|+|+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999997543 3788999999999999999999998 9999999999999999999999999997654
Q ss_pred CC-----CCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 005693 541 VP-----ATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 613 (682)
Q Consensus 541 ~~-----~~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 613 (682)
.. ....+++.|+|||.+.+. .++.++||||+||++|||+||+.||.+....+.. ...........
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~~------ 252 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE------ 252 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccCC------
Confidence 32 234578899999999764 4688999999999999999999999876544321 11111111110
Q ss_pred hhhhccccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005693 614 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 653 (682)
Q Consensus 614 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 653 (682)
..........+.+++.+||++||++|| |++|+++
T Consensus 253 ------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001112334566777899999999999 5888887
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=334.02 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=192.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccC
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 465 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 465 (682)
.+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|+.+++.+ +||||+++++++.+.+..++|+|++.+
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeeccc
Confidence 368999999999999975 5778999999755332 35688999999998 999999999999999999999999999
Q ss_pred CchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCCCCC--
Q 005693 466 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 543 (682)
Q Consensus 466 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 543 (682)
+++..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 86 ~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 86 DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred cccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9998888643 34889999999999999999999998 9999999999999999999999999998765433
Q ss_pred --CCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc-----------
Q 005693 544 --TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT----------- 609 (682)
Q Consensus 544 --~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~----------- 609 (682)
...+++.|+|||++.... ++.++||||+||++|||++|+.||.... +.......+......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-----CHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 233567799999987665 6899999999999999999999975322 111112211110000
Q ss_pred ------cccchhhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 610 ------AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 610 ------~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
....................+.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000011111223456777889999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=342.24 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=182.9
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccCh---hhHHHHHHHHHHhcCCCceeceEEEEEec------CceEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 459 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 459 (682)
.+.||+|+||+||+|.+. +++.||||+++...... .++.+|+.+++++ +|||||++++++... ...|+|
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCceeEEE
Confidence 368999999999999976 58899999998654432 4578999999999 899999999999643 577999
Q ss_pred EeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCC
Q 005693 460 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 539 (682)
Q Consensus 460 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 539 (682)
|||+.++.+ +.+.. .+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+|++|||+++..
T Consensus 101 ~Ey~~~~l~-~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 101 MELMDANLC-QVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EECCSEEHH-HHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EeccchHHH-Hhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 999976544 44431 3899999999999999999999998 999999999999999999999999998766
Q ss_pred CCCC---CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCC----------------hhHHH
Q 005693 540 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD----------------LPRWV 600 (682)
Q Consensus 540 ~~~~---~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~----------------l~~~~ 600 (682)
.... ...+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...... .....
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 5432 3457889999999999999999999999999999999999997653211100 00000
Q ss_pred HHHhhhcccc-c-----cchhhhcc--ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005693 601 QSVVREEWTA-E-----VFDVELMR--FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 654 (682)
Q Consensus 601 ~~~~~~~~~~-~-----~~d~~l~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 654 (682)
.......... . .+...... ..........+.+++.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0011110000 0 00000000 00122345567889999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=345.08 Aligned_cols=254 Identities=20% Similarity=0.284 Sum_probs=188.1
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccC---hhhHHHHHHHHHHhcCCCceeceEEEEEec-----CceEEEE
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 460 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 460 (682)
.+.||+|+||+||+|+.. +++.||||+++....+ .+.+.+|+++++++ +|||||++++++... ...++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCceEEEE
Confidence 468999999999999975 5889999999765433 34678899999999 999999999998643 3456778
Q ss_pred eeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeEEeecCCCCCCC
Q 005693 461 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 540 (682)
Q Consensus 461 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 540 (682)
+|+.+|+|.++++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++....
T Consensus 102 ~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC
Confidence 888999999999632 3999999999999999999999998 9999999999999999999999999987665
Q ss_pred CC-CCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc--ccc----
Q 005693 541 VP-ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT--AEV---- 612 (682)
Q Consensus 541 ~~-~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~--~~~---- 612 (682)
.. ....+++.|+|||...+.. ++.++||||+||++|||++|+.||.+...... ...+...... .+.
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~------~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ------LKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCCCCHHHHTTC
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCCCChHHhhhc
Confidence 43 3445778899999877654 58899999999999999999999986532211 1111100000 000
Q ss_pred c-------hhhhcc--ccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 005693 613 F-------DVELMR--FQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR 659 (682)
Q Consensus 613 ~-------d~~l~~--~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~i~ 659 (682)
. ...... .... ......+.+++.+|++.||++|||++|+++ .+.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0 000000 0000 011234667888999999999999999998 355443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.7e-36 Score=316.18 Aligned_cols=270 Identities=18% Similarity=0.238 Sum_probs=190.6
Q ss_pred hccccccCeEEEEEEEEc-CCceEEEEEeeccccChhhHHHHHHHHHHhc----------CCCceeceEEEEEec--Cce
Q 005693 390 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QHPNVVPLRAYYYSK--DEK 456 (682)
Q Consensus 390 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~--~~~ 456 (682)
.+.||+|+||+||+|+.. +++.||||+++......+.+.+|+++++.+. .|+||+++++++... ...
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 97 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence 578999999999999975 5889999999865444567788888888763 368899999988653 455
Q ss_pred EEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeEecCCCC------eE
Q 005693 457 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLD------GC 529 (682)
Q Consensus 457 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~------~k 529 (682)
+++++++..+.......... ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++. ++
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceee
Confidence 66777665554333222111 23458899999999999999999998 66 999999999999987654 89
Q ss_pred EeecCCCCCCCCC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---
Q 005693 530 ISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR--- 605 (682)
Q Consensus 530 l~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltg~~Pf~~~~~~~~~~l~~~~~~~~~--- 605 (682)
++|||.+...... ....+|+.|+|||++....++.++||||+||+++||++|+.||....................
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 9999998765443 345689999999999999999999999999999999999999986543222221111111100
Q ss_pred h---------ccccccch------------------hhhccccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HH
Q 005693 606 E---------EWTAEVFD------------------VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IE 656 (682)
Q Consensus 606 ~---------~~~~~~~d------------------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~ 656 (682)
. ......++ ...............+.+++.+|++.||++|||++|++++ ++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccC
Confidence 0 00000000 0001222345667788999999999999999999999985 65
Q ss_pred HhhhcCCC
Q 005693 657 EVRQSDSE 664 (682)
Q Consensus 657 ~i~~~~~~ 664 (682)
+.....+.
T Consensus 333 ~~~~~~~~ 340 (362)
T d1q8ya_ 333 DTLGMEEI 340 (362)
T ss_dssp TCTTCTTC
T ss_pred CCCCcccC
Confidence 44444333
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.4e-30 Score=270.30 Aligned_cols=203 Identities=38% Similarity=0.696 Sum_probs=147.7
Q ss_pred cCChhHHHHHHHHHHhCCCCCC-cCCCCCCCCCC-CcceEEecCCC--CeEEEEEeCCCcccc--cCCccccCCCCCCcE
Q 005693 72 ADLNSDRQALLDFADAVPHLRK-LNWSSTNPICQ-SWVGINCTQDR--TRVFGLRLPGIGLVG--PIPNNTLGKLDALEV 145 (682)
Q Consensus 72 ~~~~~~~~al~~~~~~~~~~~~-~~w~~~~~~c~-~w~gv~C~~~~--~~v~~l~l~~~~l~g--~lp~~~~~~l~~L~~ 145 (682)
.|.++|++||++||+++.+... .+|..+.|||. +|.||+|+..+ .||+.|+|++++++| .+|+ .+++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCccccc
Confidence 3678999999999999965543 48988888884 69999998744 489999999999998 5787 7999999999
Q ss_pred EEccC-CCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--------------------------cccceeeccccc
Q 005693 146 LSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--------------------------PQLVVLDLSFNS 198 (682)
Q Consensus 146 L~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--------------------------~~L~~L~ls~N~ 198 (682)
|+|++ |+++|.+|++|++|++|++|+|++|+|.+..|..+. ++|+++++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 999999999999999999999999999876654332 234445554444
Q ss_pred CcccCCcc-----------------------------------------------------------------------h
Q 005693 199 FTGNIPQS-----------------------------------------------------------------------I 207 (682)
Q Consensus 199 l~g~~p~~-----------------------------------------------------------------------~ 207 (682)
++|.+|.. +
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 44433332 2
Q ss_pred hhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCcc--ccCCCCCCCCCCCCCCCCCCCCC
Q 005693 208 QNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKAC 275 (682)
Q Consensus 208 ~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~--~~~l~~l~~~~n~~~~~~~l~~c 275 (682)
+.+++|+.|+|++|+|+|.+|.. .+++|++|+|++|+|+|.+|+. +.++..+.+.+|+.+||.|++.|
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 23445566666666666666653 5666777777777777666642 23344445556777777666655
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3.2e-22 Score=191.23 Aligned_cols=160 Identities=18% Similarity=0.155 Sum_probs=116.9
Q ss_pred hhccccccCeEEEEEEEEcCCceEEEEEeeccccC-------------------hhhHHHHHHHHHHhcCCCceeceEEE
Q 005693 389 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------------------KRDFEQQMEIVGRVGQHPNVVPLRAY 449 (682)
Q Consensus 389 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~~~e~~~l~~l~~h~niv~l~~~ 449 (682)
.++.||+|+||+||+|...+|+.||||+++..... ......|...+.++ .|.+++..+++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEEEe
Confidence 36789999999999999988999999987532110 12234567778888 89999988765
Q ss_pred EEecCceEEEEeeccCCchhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeEecCCCCeE
Q 005693 450 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 529 (682)
Q Consensus 450 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 529 (682)
. ..+++|||+++..+.+ ++......++.|++.+++|||+.+ |+||||||+|||+++++ ++
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EE
Confidence 3 3479999998865533 233445678999999999999998 99999999999999654 89
Q ss_pred EeecCCCCCCCCCCCCCCCCcccCc------cccccCCCCCcchHHHHHHH
Q 005693 530 ISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVL 574 (682)
Q Consensus 530 l~DfGla~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~sDvwS~Gvv 574 (682)
|+|||.|.....+.. ..|... |. ..+.|+.++|+||..--
T Consensus 143 liDFG~a~~~~~~~~----~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 143 IIDFPQSVEVGEEGW----REILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECCCTTCEETTSTTH----HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred EEECCCcccCCCCCc----HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 999999876543221 111111 11 13567889999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=1e-18 Score=166.66 Aligned_cols=123 Identities=28% Similarity=0.332 Sum_probs=88.7
Q ss_pred EEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCC-CCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccc
Q 005693 121 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL-PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 197 (682)
Q Consensus 121 l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N 197 (682)
++.++++|+ ++|.+ +. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..+. ++|++|+|++|
T Consensus 13 v~Cs~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEeCCCcC-ccCCC-CC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 455566676 67763 32 56777888888887644 34567778888888888888776666665 67788888888
Q ss_pred cCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCC
Q 005693 198 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 198 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g 247 (682)
+|++..|..|.++++|+.|+|++|+|++..|.. .+++|++|+|++|.+..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 888777777777888888888888887666653 67778888888777764
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=1.5e-16 Score=151.37 Aligned_cols=165 Identities=24% Similarity=0.259 Sum_probs=138.9
Q ss_pred CcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccc
Q 005693 105 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 175 (682)
Q Consensus 105 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 175 (682)
+|..|.|++.+ ..++.|+|++|.+++.++...|+++++|++|+|++|++.+..+..|..+++|++|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 79999998632 368899999999998888878999999999999999999999999999999999999999
Q ss_pred ccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCcc
Q 005693 176 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSS 252 (682)
Q Consensus 176 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~ 252 (682)
+|++..|..|. ++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.. -...++.+.+..|.++...|..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~ 168 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh
Confidence 99977777776 89999999999999988999999999999999999998654432 2234667778889998888887
Q ss_pred ccCCCCCCCCCCCCCCC
Q 005693 253 LQKFPNSSFVGNSLLCG 269 (682)
Q Consensus 253 ~~~l~~l~~~~n~~~~~ 269 (682)
+.++.-+.+..|..-|.
T Consensus 169 l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 169 VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTSBGGGSCTTTCCCC
T ss_pred hcCCEeeecCHhhCcCC
Confidence 76665445555555553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=3.5e-16 Score=156.83 Aligned_cols=148 Identities=30% Similarity=0.284 Sum_probs=95.4
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccce---
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV--- 191 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~--- 191 (682)
.++.|+|++|.++ .+|++.|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|++++. |..+. ++|++
T Consensus 32 ~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCC-CcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccccc-ccccccccccccccc
Confidence 5778888888887 466657888888888888888887 455 357788888888888888743 33332 44444
Q ss_pred ---------------------eecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCC
Q 005693 192 ---------------------LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGS 248 (682)
Q Consensus 192 ---------------------L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~ 248 (682)
|++++|.+++..+..+..+++|+.|++++|+|++..+.. .+++|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 555555555444455555666666666666666555442 5666666666666666 5
Q ss_pred CCccccCCCCCC---CCCCCCCCC
Q 005693 249 IPSSLQKFPNSS---FVGNSLLCG 269 (682)
Q Consensus 249 ~p~~~~~l~~l~---~~~n~~~~~ 269 (682)
+|+.+..+++|+ ..+|++.|.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cChhHCCCCCCCEEEecCCCCCCC
Confidence 665554444433 345555553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=7.3e-16 Score=154.49 Aligned_cols=145 Identities=23% Similarity=0.235 Sum_probs=109.0
Q ss_pred EecCCCCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCccccc
Q 005693 110 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 189 (682)
Q Consensus 110 ~C~~~~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L 189 (682)
.|+... ....++.++++|+ .+|+ .+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+..-+....++|
T Consensus 5 ~~~~~~-~~~~v~C~~~~L~-~iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L 79 (266)
T d1p9ag_ 5 EVSKVA-SHLEVNCDKRNLT-ALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVL 79 (266)
T ss_dssp EEECST-TCCEEECTTSCCS-SCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTC
T ss_pred EEcccC-CCeEEEccCCCCC-eeCc-CcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccccccccccc
Confidence 555433 3455688999999 6887 343 5799999999999976667899999999999999999954333444899
Q ss_pred ceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCC
Q 005693 190 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 260 (682)
Q Consensus 190 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~ 260 (682)
++|+|++|+|+ .+|..+.++++|+.|++++|.+.+..+.. .+.+++.|++++|.+++..+..+..++++.
T Consensus 80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~ 151 (266)
T d1p9ag_ 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151 (266)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccch
Confidence 99999999999 45778899999999999999888655443 556666666666666644444444444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=3.1e-15 Score=151.33 Aligned_cols=157 Identities=23% Similarity=0.242 Sum_probs=119.4
Q ss_pred cceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCC--------------------
Q 005693 106 WVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGG-------------------- 156 (682)
Q Consensus 106 w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~-------------------- 156 (682)
|.-|.|++.+ ..++.|+|++|+++ ++|+..|.++++|++|++++|++.+.
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCC-CCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 5567787522 24678999999998 78877899999999999999987532
Q ss_pred -----CCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCC
Q 005693 157 -----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 229 (682)
Q Consensus 157 -----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 229 (682)
.|..|.++++|++|+|++|.+.+..+..+. .+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 245667778888888888888765555554 6788888888888876677788888888888888888866665
Q ss_pred C--CCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 230 F--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 230 ~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
. .+++|+.+++++|++++..|..|.+++++..++
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 3 678888888888888877777787777766554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.58 E-value=3.1e-15 Score=152.83 Aligned_cols=157 Identities=25% Similarity=0.335 Sum_probs=124.3
Q ss_pred CCcceEEecCC---------CCeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecc
Q 005693 104 QSWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 174 (682)
Q Consensus 104 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 174 (682)
|.|.+|.|++. ...++.|+|++|+++ .+|+..|.++++|++|++++|.+....|..|.++++|+.|+|++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 37999999863 145889999999998 78876899999999999999999988888999999999999999
Q ss_pred cccCCcCCCCcc--------------------------------------------------------------------
Q 005693 175 NNFSGKIPSSFS-------------------------------------------------------------------- 186 (682)
Q Consensus 175 N~l~g~~p~~~~-------------------------------------------------------------------- 186 (682)
|+++ .+|..+.
T Consensus 89 n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~ 167 (305)
T d1xkua_ 89 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 167 (305)
T ss_dssp SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred CccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence 9987 3333221
Q ss_pred ---cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCC
Q 005693 187 ---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 261 (682)
Q Consensus 187 ---~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~ 261 (682)
++|+.|++++|.+++..+..|.+++.++.|++++|++++..+.. .+++|+.|+|++|+|+ .+|+.|.++++|+.
T Consensus 168 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~ 246 (305)
T d1xkua_ 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246 (305)
T ss_dssp SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCE
T ss_pred ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCE
Confidence 23556666666666677777888888888888888888766654 6788888888888888 66777877777766
Q ss_pred CC
Q 005693 262 VG 263 (682)
Q Consensus 262 ~~ 263 (682)
++
T Consensus 247 L~ 248 (305)
T d1xkua_ 247 VY 248 (305)
T ss_dssp EE
T ss_pred EE
Confidence 54
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=3e-15 Score=151.45 Aligned_cols=153 Identities=24% Similarity=0.294 Sum_probs=130.5
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.+..+....++....+++..|+++++|++|+|++|.+.+..+..+..+++|+.+++++|+|++..+..|. ++|+.|+|
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 4455555544444467676899999999999999999988888899999999999999999976667775 78999999
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCC---CCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCG 269 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~---~n~~~~~ 269 (682)
++|+|++..|..|.++++|+.|++++|++++..|.. .+++|++|++++|++++..|..|+++++|+.+ +|++-|.
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999999988999999999999999999999888865 88999999999999998888888877776654 6766653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.50 E-value=5.3e-15 Score=151.72 Aligned_cols=119 Identities=30% Similarity=0.544 Sum_probs=111.7
Q ss_pred CCCcEEEccCCCCCC--CCCCcCCCCCCCcEEeecc-cccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccc
Q 005693 141 DALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTG 215 (682)
Q Consensus 141 ~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 215 (682)
.+++.|||++|+++| .+|++|++|++|++|+|++ |+++|.+|.+++ ++|++|+|++|+|++..|..+.++.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468999999999998 5899999999999999997 899999999998 79999999999999999999999999999
Q ss_pred eeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCC
Q 005693 216 LSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS 259 (682)
Q Consensus 216 L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l 259 (682)
+++++|++.+.+|.. .+++|+.+++++|.++|.+|..+..+..+
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l 175 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccc
Confidence 999999999999875 89999999999999999999998887765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=5.8e-14 Score=122.95 Aligned_cols=100 Identities=27% Similarity=0.318 Sum_probs=71.0
Q ss_pred EEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccc
Q 005693 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 197 (682)
Q Consensus 120 ~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N 197 (682)
.|+|++|+++ .++. ++.+++|++|+|++|+|+ .+|+.++.+++|+.|++++|+|++ +|. +. ++|++|++++|
T Consensus 2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCc-cccccccCeEECCCC
Confidence 4777888887 5553 777888888888888887 567677788888888888888874 342 33 67777777777
Q ss_pred cCcccC-CcchhhhccccceeccCCcccC
Q 005693 198 SFTGNI-PQSIQNLTQLTGLSLQSNNLSG 225 (682)
Q Consensus 198 ~l~g~~-p~~~~~l~~L~~L~l~~N~l~g 225 (682)
+|+... ...++.+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 777433 2456777777777777777764
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3.1e-14 Score=130.93 Aligned_cols=125 Identities=18% Similarity=0.126 Sum_probs=95.2
Q ss_pred ccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccc
Q 005693 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 213 (682)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L 213 (682)
.+.+...|++|||++|+|+ .+|..+..+++|+.|+|++|+|+ .++. +. ++|++|+|++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-cccCcchhhhhcccccccCCCcccccccccc
Confidence 3677888888999998888 55766678888899999999888 3432 33 788899999999886666667788899
Q ss_pred cceeccCCcccCCCC--C-CCCCCCCeEEecccCCCCCCCc----cccCCCCCCCCCC
Q 005693 214 TGLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPS----SLQKFPNSSFVGN 264 (682)
Q Consensus 214 ~~L~l~~N~l~g~~p--~-~~l~~L~~l~ls~N~l~g~~p~----~~~~l~~l~~~~n 264 (682)
+.|+|++|+|+.... . ..+++|++|++++|.++ ..|. .+..+++|.+++.
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence 999999998874321 2 27888999999999887 3443 4677888887763
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.44 E-value=1.4e-13 Score=132.34 Aligned_cols=137 Identities=33% Similarity=0.411 Sum_probs=106.3
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.+++.|+|++|++++ +++ ++++++|++|+|++|+|++ +| .+.++++|+.|++++|.+.. ++ .+. ++|+.++
T Consensus 68 ~~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLY 140 (210)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CG-GGGGCTTCCEEE
T ss_pred CCCCEEeCCCccccC-ccc--cccCccccccccccccccc-cc-cccccccccccccccccccc-cc-cccccccccccc
Confidence 367888888888885 553 6788888888988888884 55 58888888888888888873 33 232 6788999
Q ss_pred cccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 194 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 194 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+++|.+++ +..+.++++|+.+++++|++++..+-..+++|+.|+|++|+++ .+| .+.++++|++++
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~ 206 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLE 206 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEE
T ss_pred cccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEE
Confidence 99998885 3457788899999999999987555458889999999999988 455 577888877654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=9.2e-14 Score=121.62 Aligned_cols=99 Identities=32% Similarity=0.368 Sum_probs=86.3
Q ss_pred cEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccccceeccCC
Q 005693 144 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 221 (682)
Q Consensus 144 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N 221 (682)
++|||++|+|+ .+| .+..+++|++|+|++|+|+ .+|..+. ++|++|++++|+|++ +| .++++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 58999999999 666 5999999999999999998 6777776 799999999999995 44 5999999999999999
Q ss_pred cccCCCCC---CCCCCCCeEEecccCCCC
Q 005693 222 NLSGSIPN---FDIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 222 ~l~g~~p~---~~l~~L~~l~ls~N~l~g 247 (682)
+|+..... ..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 99964432 278999999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.42 E-value=2.4e-13 Score=129.59 Aligned_cols=135 Identities=24% Similarity=0.332 Sum_probs=71.5
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeeccc
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~ 196 (682)
++..|+|++|.+++ +++ ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+....+-.-.++|+.|++++
T Consensus 63 nL~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~ 137 (199)
T d2omxa2 63 NLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 137 (199)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CcCcCccccccccC-ccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccccccchhhhhHHhhhhh
Confidence 45555666655553 332 555566666666665555 233 2555566666666655555332211125566666666
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 260 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~ 260 (682)
|+++. + +.+..+++|+.|++++|++++..+-..+++|+.|++++|+++. ++ .+.++++|+
T Consensus 138 n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~ 197 (199)
T d2omxa2 138 NTISD-I-SALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-IS-VLAKLTNLE 197 (199)
T ss_dssp SCCCC-C-GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCS
T ss_pred hhhcc-c-ccccccccccccccccccccCCccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCC
Confidence 66652 2 2455666666666666666654333356666666666666653 32 344454443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.39 E-value=4.3e-13 Score=127.78 Aligned_cols=139 Identities=24% Similarity=0.307 Sum_probs=113.1
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.+++.|++++++++ .++ .+..+++|++|+|++|+|++..| ++++++|++|++++|.+....+-.-.++|+.|+++
T Consensus 40 ~~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc--ccCCccccccccccccccccccccccccccccccc
Confidence 36788999999998 565 38899999999999999996543 99999999999999999843322222799999999
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
+|.+... ..+..+++|+.|++++|++....+-..+++|+.|++++|++++. + .++++++|+.++
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ 178 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLD 178 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCC-c-cccCCCCCCEEE
Confidence 9999864 34889999999999999998543334899999999999999964 3 377777776654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=2.1e-13 Score=125.26 Aligned_cols=120 Identities=23% Similarity=0.301 Sum_probs=99.4
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|+++ .++. .+..+++|++|||++|+|+ .++ .|..+++|++|+|++|+++...+..+. ++|+.|+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence 36788999999998 6775 6788999999999999999 554 589999999999999999954443333 7999999
Q ss_pred cccccCcccCC-cchhhhccccceeccCCcccCCCCC------CCCCCCCeEEe
Q 005693 194 LSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPN------FDIPKLRHLNL 240 (682)
Q Consensus 194 ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~------~~l~~L~~l~l 240 (682)
|++|+|+.... ..+..+++|+.|++++|.++.. |. ..+++|+.||-
T Consensus 94 L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~-~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 94 LTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETT
T ss_pred eccccccccccccccccccccchhhcCCCccccc-cchHHHHHHHCCCcCeeCC
Confidence 99999984322 4788999999999999999853 43 27889998873
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.5e-12 Score=127.62 Aligned_cols=160 Identities=18% Similarity=0.119 Sum_probs=99.4
Q ss_pred CCcceEEecCCC---------CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCC-cCC-----------
Q 005693 104 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EIT----------- 162 (682)
Q Consensus 104 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~----------- 162 (682)
|.+..|.|...+ ..++.|+|++|.++ .+|...|.++++|++|+|++|.+...+|. .|.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 367888997522 35889999999987 67777899999999999999987654432 233
Q ss_pred --------------CCCCCcEEeecccccCCcCCCCcc----------------------------cccceeecccccCc
Q 005693 163 --------------SLPSLRYLYLQHNNFSGKIPSSFS----------------------------PQLVVLDLSFNSFT 200 (682)
Q Consensus 163 --------------~l~~L~~L~L~~N~l~g~~p~~~~----------------------------~~L~~L~ls~N~l~ 200 (682)
++++|+.|++++|++....+..+. ..++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 455566666666666532221110 13555666666666
Q ss_pred ccCCcchhhhcccc-ceeccCCcccCCCCCC--CCCCCCeEEecccCCCCCCCccccCCCCCCCCCCC
Q 005693 201 GNIPQSIQNLTQLT-GLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNS 265 (682)
Q Consensus 201 g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~n~ 265 (682)
...+. ..+..+++ .+++++|+|+...+.. .+++|+.|+|++|+|+...+..|.++++|+.+++.
T Consensus 167 ~i~~~-~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 167 EIHNC-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp EECTT-TTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccc-cccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 33333 33333433 3345666666433322 67788888888888874444557777777766643
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.33 E-value=1.5e-12 Score=125.05 Aligned_cols=136 Identities=22% Similarity=0.288 Sum_probs=112.9
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeec
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 194 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~l 194 (682)
.++.|++++++++ .++. +..+++|++|+|++|+|++. + .++++++|++|++++|++++ +|. +. ++|+.|++
T Consensus 47 ~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~~-l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEEC
T ss_pred CccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-ccc-cccccccccccc
Confidence 5788999999988 4553 88999999999999999964 4 37899999999999999995 442 33 89999999
Q ss_pred ccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCCCC
Q 005693 195 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 263 (682)
Q Consensus 195 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~ 263 (682)
++|.++. + ..+.++++|+.+++++|.+++..+...+++|+.+++++|++++ ++ .+.++++|+.++
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~ 184 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLY 184 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEE
T ss_pred ccccccc-c-ccccccccccccccccccccccccccccccccccccccccccc-cc-cccCCCCCCEEE
Confidence 9999984 3 4689999999999999999975555589999999999999996 43 367777766554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.29 E-value=4.1e-12 Score=129.13 Aligned_cols=109 Identities=25% Similarity=0.322 Sum_probs=70.7
Q ss_pred ccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhhhccc
Q 005693 136 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 213 (682)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L 213 (682)
.+..+++|+.+++++|+++ .+|..+ +++|+.|++++|.+++..+..+. +.+++|++++|++++..|..+.++++|
T Consensus 145 ~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 145 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp GGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred ccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccc
Confidence 5666677777777777666 455433 46677777777777666665554 566777777777776666667777777
Q ss_pred cceeccCCcccCCCCCC-CCCCCCeEEecccCCCC
Q 005693 214 TGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 214 ~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g 247 (682)
++|+|++|+|+...+.. .+++|+.|+|++|+|+.
T Consensus 222 ~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred eeeecccccccccccccccccCCCEEECCCCccCc
Confidence 77777777776332222 56677777777777663
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=2.2e-14 Score=136.68 Aligned_cols=127 Identities=24% Similarity=0.326 Sum_probs=103.2
Q ss_pred CCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcccCCcchhh
Q 005693 132 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQN 209 (682)
Q Consensus 132 lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~ 209 (682)
+|. .++.|++|++|+|++|+|+ .++ .+.+|++|+.|+|++|+|+ .+|..+. ++|++|++++|+|+. + +.+.+
T Consensus 40 l~~-sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 40 MDA-TLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CHH-HHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhh-HHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 444 6889999999999999999 565 5999999999999999998 5665443 689999999999995 3 45899
Q ss_pred hccccceeccCCcccCCCC--C-CCCCCCCeEEecccCCCCCCCcc----------ccCCCCCCCCCC
Q 005693 210 LTQLTGLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPSS----------LQKFPNSSFVGN 264 (682)
Q Consensus 210 l~~L~~L~l~~N~l~g~~p--~-~~l~~L~~l~ls~N~l~g~~p~~----------~~~l~~l~~~~n 264 (682)
+++|+.|+|++|+|+.... . ..+++|+.|+|++|.++...+.. +.++++|..+|.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD~ 181 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDG 181 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEESS
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeCC
Confidence 9999999999999985322 2 38999999999999987544332 556788887774
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.27 E-value=4.1e-12 Score=123.41 Aligned_cols=138 Identities=23% Similarity=0.332 Sum_probs=92.8
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc---------
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--------- 186 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--------- 186 (682)
.++..|++++|.+++ +++ +..+++|++|++++|.++ .++ .+.++++|+.|++++|.+.+..+-...
T Consensus 63 ~~L~~L~ls~n~i~~-~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCcEeecCCceeec-ccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 467888888888874 332 788888888888888887 444 578888888888888887754332111
Q ss_pred -------------cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccc
Q 005693 187 -------------PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 253 (682)
Q Consensus 187 -------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~ 253 (682)
++|+.|++++|++++.. .++++++|+.|+|++|++++..+-..+++|++|+|++|++++ ++ .+
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~-i~-~l 213 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISD-VS-PL 213 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCB-CG-GG
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCCC-Cc-cc
Confidence 35777777777766432 366777777777777777653332366777777777777763 33 25
Q ss_pred cCCCCCCCC
Q 005693 254 QKFPNSSFV 262 (682)
Q Consensus 254 ~~l~~l~~~ 262 (682)
.++++|..+
T Consensus 214 ~~l~~L~~L 222 (227)
T d1h6ua2 214 ANTSNLFIV 222 (227)
T ss_dssp TTCTTCCEE
T ss_pred ccCCCCCEE
Confidence 566665544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.24 E-value=5.2e-12 Score=132.29 Aligned_cols=137 Identities=26% Similarity=0.345 Sum_probs=95.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc---------
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--------- 186 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--------- 186 (682)
.++..|++++|.++. ++ .+..+++|+.|++++|.+++..| ++.+++|+.|++++|++++..+-.-.
T Consensus 219 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~ 293 (384)
T d2omza2 219 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293 (384)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccc
Confidence 467788999998874 44 58888999999999999986544 78889999999999988865432111
Q ss_pred -------------cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCCC-CCCCCCeEEecccCCCCCCCcc
Q 005693 187 -------------PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSS 252 (682)
Q Consensus 187 -------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~g~~p~~ 252 (682)
++++.|+|++|+|++.. .+..+++|+.|+|++|+|++ ++.. .+++|++|+|++|++++..|
T Consensus 294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~-- 368 (384)
T d2omza2 294 ENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP-- 368 (384)
T ss_dssp SSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--
T ss_pred ccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--
Confidence 45677777777777543 26677777777777777764 3333 66777777777777775443
Q ss_pred ccCCCCCCCC
Q 005693 253 LQKFPNSSFV 262 (682)
Q Consensus 253 ~~~l~~l~~~ 262 (682)
+.++++|+.+
T Consensus 369 l~~l~~L~~L 378 (384)
T d2omza2 369 LANLTRITQL 378 (384)
T ss_dssp GTTCTTCSEE
T ss_pred hccCCCCCEe
Confidence 5555555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=9.2e-12 Score=113.30 Aligned_cols=96 Identities=24% Similarity=0.281 Sum_probs=59.3
Q ss_pred CCcccccCCccccCCCCCCcEEEccCC-CCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceeecccccCcc
Q 005693 125 GIGLVGPIPNNTLGKLDALEVLSLRSN-VLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG 201 (682)
Q Consensus 125 ~~~l~g~lp~~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g 201 (682)
+++++ .+|. .+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|. ++|++|+|++|+|+
T Consensus 17 ~~~~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~- 93 (156)
T d2ifga3 17 RDGAL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE- 93 (156)
T ss_dssp SSCCC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-
T ss_pred CCCCc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-
Confidence 34444 4555 5777888888888765 47755556688888888888888887755455444 45666666666666
Q ss_pred cCCcchhhhccccceeccCCcc
Q 005693 202 NIPQSIQNLTQLTGLSLQSNNL 223 (682)
Q Consensus 202 ~~p~~~~~l~~L~~L~l~~N~l 223 (682)
.+|.......+|+.|+|++|.+
T Consensus 94 ~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 94 SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CCCSTTTCSCCCCEEECCSSCC
T ss_pred ccChhhhccccccccccCCCcc
Confidence 3333222222455555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=2.8e-11 Score=110.00 Aligned_cols=107 Identities=17% Similarity=0.092 Sum_probs=90.1
Q ss_pred CCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccc-cCCcCCCCcc--cccceeecccccCcccCCcchhhhccccc
Q 005693 139 KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN-FSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTG 215 (682)
Q Consensus 139 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 215 (682)
.....+.++.+++++. ..|..+.++++|+.|+|++|+ |+..-+..|. ++|+.|+|++|+|+...|.+|..+++|+.
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 3444567899999998 678889999999999998764 8855555665 79999999999999888999999999999
Q ss_pred eeccCCcccCCCCCC-CCCCCCeEEecccCCC
Q 005693 216 LSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLK 246 (682)
Q Consensus 216 L~l~~N~l~g~~p~~-~l~~L~~l~ls~N~l~ 246 (682)
|+|++|+|+...+.. ...+|+.|+|++|.+.
T Consensus 85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhccccccccccCCCccc
Confidence 999999999555543 5568999999999985
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=4.6e-11 Score=115.80 Aligned_cols=140 Identities=26% Similarity=0.316 Sum_probs=110.1
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCC-cccccceeec
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FSPQLVVLDL 194 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~~L~~L~l 194 (682)
..++.|++.+++++ .++ .+..+++|++|+|++|++++..| +.++++|++|++++|.++ .++.- -.++|+.|++
T Consensus 41 ~~L~~L~l~~~~i~-~l~--~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCC-cch--hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-cccccccccccccccc
Confidence 35889999999998 575 38999999999999999996554 899999999999999998 44421 1278999999
Q ss_pred ccccCcccCC--------------------cchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCcccc
Q 005693 195 SFNSFTGNIP--------------------QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 254 (682)
Q Consensus 195 s~N~l~g~~p--------------------~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~ 254 (682)
++|...+..+ ..+.++++|+.|++++|++++..+-..+++|+.|+|++|++++ +|. +.
T Consensus 115 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~-l~ 192 (227)
T d1h6ua2 115 TSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISP-LA 192 (227)
T ss_dssp TTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGG-GG
T ss_pred ccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchhhcccccceecccCCCccCC-Chh-hc
Confidence 9988764322 2467778889999999988865554588899999999999985 443 66
Q ss_pred CCCCCCCCC
Q 005693 255 KFPNSSFVG 263 (682)
Q Consensus 255 ~l~~l~~~~ 263 (682)
++++|+.++
T Consensus 193 ~l~~L~~L~ 201 (227)
T d1h6ua2 193 SLPNLIEVH 201 (227)
T ss_dssp GCTTCCEEE
T ss_pred CCCCCCEEE
Confidence 677766554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.14 E-value=2.9e-11 Score=126.41 Aligned_cols=141 Identities=31% Similarity=0.373 Sum_probs=104.7
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 195 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls 195 (682)
.....++++++.+++..| +...++|+.|++++|+++. +| .+..+++|+.|++++|++++..|-...++|++|+++
T Consensus 197 ~~~~~l~l~~n~i~~~~~---~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~ 271 (384)
T d2omza2 197 TNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG 271 (384)
T ss_dssp TTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred cccceeeccCCccCCCCc---ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCCcccccccCCEeecc
Confidence 356788999999986433 5678899999999999984 44 689999999999999999987665555899999999
Q ss_pred cccCcccCC--------------------cchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCCCCCCccccC
Q 005693 196 FNSFTGNIP--------------------QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 255 (682)
Q Consensus 196 ~N~l~g~~p--------------------~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~ 255 (682)
+|++++..+ ..+..+++++.|++++|++++..+-..+++|+.|+|++|++++ ++ .+.+
T Consensus 272 ~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~ 349 (384)
T d2omza2 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLAN 349 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGG
T ss_pred CcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcC
Confidence 999986533 2355566667777777777665443467777777777777763 33 4666
Q ss_pred CCCCCCCC
Q 005693 256 FPNSSFVG 263 (682)
Q Consensus 256 l~~l~~~~ 263 (682)
+++|+.++
T Consensus 350 l~~L~~L~ 357 (384)
T d2omza2 350 LTNINWLS 357 (384)
T ss_dssp CTTCCEEE
T ss_pred CCCCCEEE
Confidence 66665554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.03 E-value=1.3e-12 Score=124.03 Aligned_cols=118 Identities=23% Similarity=0.307 Sum_probs=98.1
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcc--cccceee
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 193 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~L~~L~ 193 (682)
.++..|+|++|+++ .++ .+..|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++. ++. +. ++|++|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSG-IEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHH-HHHHHHSSEEE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhcccccc-cccccccccccccccccccccccc-ccc-ccccccccccc
Confidence 46889999999998 676 4899999999999999998 677666777899999999999995 332 33 7899999
Q ss_pred cccccCcccCC-cchhhhccccceeccCCcccCCCCCC------------CCCCCCeEE
Q 005693 194 LSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF------------DIPKLRHLN 239 (682)
Q Consensus 194 ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~------------~l~~L~~l~ 239 (682)
|++|+|+.... ..+.+|++|+.|+|++|++....+.. .+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999995422 47899999999999999998655542 578899887
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=2.3e-09 Score=104.33 Aligned_cols=133 Identities=16% Similarity=0.123 Sum_probs=102.2
Q ss_pred EEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCC-cc--cccceeecc-
Q 005693 120 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLDLS- 195 (682)
Q Consensus 120 ~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~--~~L~~L~ls- 195 (682)
.++.++.+++ .+|++ + .+++++|+|++|+|+...+..|.++++|++|+|++|.+...+|.. |. +++++|++.
T Consensus 12 ~i~c~~~~l~-~iP~~-l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp EEEEESCSCS-SCCSC-S--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred EEEEeCCCCC-CcCCC-C--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 4777888888 89874 3 257999999999999555567999999999999999998776654 43 688888876
Q ss_pred cccCcccCCcchhhhccccceeccCCcccCCCCCC---CCCCCCeEEecccCCCCCCCccccCC
Q 005693 196 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKF 256 (682)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~l~~L~~l~ls~N~l~g~~p~~~~~l 256 (682)
.|+++...+..|.++++|+.|++++|++....+.. .+..+..+..+++++....+..+..+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~ 151 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 151 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccc
Confidence 57898888899999999999999999998654433 34555556667777764444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.84 E-value=6.6e-09 Score=106.38 Aligned_cols=115 Identities=29% Similarity=0.411 Sum_probs=91.3
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeeccc
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 196 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~ 196 (682)
+++.|+|++++|+ .+|+ . +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++ .+.+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~-~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~-~lp~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE-L---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALS-DLPPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCS-C---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCC-SCCTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCC-C---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhh-hhccccccccccc
Confidence 4678999999998 6886 2 578999999999999 888654 57899999999998 454 3557899999999
Q ss_pred ccCcccCCcchhhhccccceeccCCcccCCCCCCCCCCCCeEEecccCCC
Q 005693 197 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 246 (682)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~l~~L~~l~ls~N~l~ 246 (682)
|.++ .+|. ++.+++|+.|++++|.++..... ...+..+.+.++...
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~~ 153 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQLE 153 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCS
T ss_pred cccc-cccc-hhhhccceeeccccccccccccc--cccccchhhcccccc
Confidence 9999 5664 68999999999999999854432 345566666655554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.78 E-value=1.5e-08 Score=103.67 Aligned_cols=110 Identities=20% Similarity=0.206 Sum_probs=86.7
Q ss_pred CCCcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCcccccceeecccccCcccCCcchhhhccccceeccC
Q 005693 141 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 220 (682)
Q Consensus 141 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~ 220 (682)
.+|+.|||++|+++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .++|++|+|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch-hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 46899999999998 68864 578999999999999 778765 58999999999998 44432 14699999999
Q ss_pred CcccCCCCCCCCCCCCeEEecccCCCCCCCccccCCCCCCC
Q 005693 221 NNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 261 (682)
Q Consensus 221 N~l~g~~p~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~ 261 (682)
|++........+++|+.|++++|.++ ..|.....+..+..
T Consensus 108 n~l~~lp~~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~~ 147 (353)
T d1jl5a_ 108 NQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAA 147 (353)
T ss_dssp SCCSSCCCCTTCTTCCEEECCSSCCS-CCCCCCTTCCEEEC
T ss_pred cccccccchhhhccceeecccccccc-ccccccccccchhh
Confidence 99995443348999999999999998 44544445544443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=1.5e-09 Score=108.79 Aligned_cols=148 Identities=23% Similarity=0.270 Sum_probs=92.3
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCCCCCCcCCCCCCCcEEeeccc-ccCCcCCCCc---ccccce
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN-NFSGKIPSSF---SPQLVV 191 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~---~~~L~~ 191 (682)
.++..|||+++.+.+......+..+++|++|+|+++.+++..+..++.+++|++|+|+++ .++...-..+ .++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 467889999888765433335788899999999999888777778888899999999884 5552110011 167888
Q ss_pred eecccc-cCccc-CCcchhhh-ccccceeccCC--cccCC-CCCC--CCCCCCeEEeccc-CCCCCCCccccCCCCCCCC
Q 005693 192 LDLSFN-SFTGN-IPQSIQNL-TQLTGLSLQSN--NLSGS-IPNF--DIPKLRHLNLSYN-GLKGSIPSSLQKFPNSSFV 262 (682)
Q Consensus 192 L~ls~N-~l~g~-~p~~~~~l-~~L~~L~l~~N--~l~g~-~p~~--~l~~L~~l~ls~N-~l~g~~p~~~~~l~~l~~~ 262 (682)
|+|+++ +++.. +...+..+ ++|+.|++++. .++.. +... .+++|++|++++| .+++.....+.++++|+.+
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 888874 45421 22233333 56777776653 23211 1111 4566777777664 3555555556666666555
Q ss_pred C
Q 005693 263 G 263 (682)
Q Consensus 263 ~ 263 (682)
+
T Consensus 206 ~ 206 (284)
T d2astb2 206 S 206 (284)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1.3e-08 Score=92.50 Aligned_cols=119 Identities=19% Similarity=0.168 Sum_probs=75.2
Q ss_pred CcEEEccCCCCCCCCCCcCCCCCCCcEEeecccccCCcCCCCc--ccccceeecccccCccc--CCcchhhhccccceec
Q 005693 143 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLSFNSFTGN--IPQSIQNLTQLTGLSL 218 (682)
Q Consensus 143 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~L~ls~N~l~g~--~p~~~~~l~~L~~L~l 218 (682)
.+.||++++... +.+..+..+..|++.+|... .++..+ .++|++|+|++|+|+.. ++..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 445566554432 23445555555665555443 222211 15788888888888854 3456778888888888
Q ss_pred cCCcccCCCCC--CCCCCCCeEEecccCCCCCCCcc-------ccCCCCCCCCCCCC
Q 005693 219 QSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSS-------LQKFPNSSFVGNSL 266 (682)
Q Consensus 219 ~~N~l~g~~p~--~~l~~L~~l~ls~N~l~g~~p~~-------~~~l~~l~~~~n~~ 266 (682)
++|+|+...+. ....+|+.|+|++|.++...... +..+++|..+|+..
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LDg~~ 155 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEETTEE
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEECcCC
Confidence 88888843321 14557888999999888655432 56788888887543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=4.8e-08 Score=97.42 Aligned_cols=147 Identities=24% Similarity=0.305 Sum_probs=91.0
Q ss_pred CeEEEEEeCCCcccccCCccccCCCCCCcEEEccCC-CCCCC-CCCcCCCCCCCcEEeeccc-ccCCc-CCCCc---ccc
Q 005693 116 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSN-VLTGG-LPSEITSLPSLRYLYLQHN-NFSGK-IPSSF---SPQ 188 (682)
Q Consensus 116 ~~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L~L~~N-~l~g~-~p~~~---~~~ 188 (682)
.++..|+|+++.+.+..+. .++.+++|++|+|+++ .++.. +..-..++++|++|+|+++ .++.. +...+ .++
T Consensus 71 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCcccccccccCCCcHHHH-HHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 3577788888877766555 5778888888888884 56521 2222356788888888874 44321 11111 256
Q ss_pred cceeecccc--cCccc-CCcchhhhccccceeccCC-cccCCCCC-C-CCCCCCeEEecc-cCCCCCCCccccCCCCCCC
Q 005693 189 LVVLDLSFN--SFTGN-IPQSIQNLTQLTGLSLQSN-NLSGSIPN-F-DIPKLRHLNLSY-NGLKGSIPSSLQKFPNSSF 261 (682)
Q Consensus 189 L~~L~ls~N--~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~~p~-~-~l~~L~~l~ls~-N~l~g~~p~~~~~l~~l~~ 261 (682)
|+.|++++. .++.. +...+.++++|+.|+|++| .+++.... . .+++|++|+|++ +.++......++++++|+.
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~ 229 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence 888888753 34432 3333456778888888775 45543332 2 677888888887 4566555556666677666
Q ss_pred CC
Q 005693 262 VG 263 (682)
Q Consensus 262 ~~ 263 (682)
++
T Consensus 230 L~ 231 (284)
T d2astb2 230 LQ 231 (284)
T ss_dssp EE
T ss_pred Ee
Confidence 54
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=2.2e-06 Score=83.64 Aligned_cols=129 Identities=17% Similarity=0.148 Sum_probs=91.2
Q ss_pred eEEEEEEEEcCCceEEEEEeeccc-cChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEeeccCCchhHhhccCC
Q 005693 398 YGTAYKAVLEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR 476 (682)
Q Consensus 398 fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~ 476 (682)
.+.||+... +++.+++|+..... .....+.+|..++..+..+--+.+++.+...++..++||++++|.++.+.....
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 468998864 46667888876543 234568889999988866656788898888888899999999998886654311
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 005693 477 GAGRTPLDWETRVKILLGTARGVAHIHSMG-------------------------------------------------- 506 (682)
Q Consensus 477 ~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-------------------------------------------------- 506 (682)
.....++.++++.++.||+..
T Consensus 105 ---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 105 ---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp ---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred ---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 112234455555555555320
Q ss_pred ------CCCcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 507 ------GPKFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 507 ------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
.+.++|+|+.+.||++++++.+.|+||+.+.
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127899999999999987767799998754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=3.2e-08 Score=89.85 Aligned_cols=78 Identities=28% Similarity=0.321 Sum_probs=40.3
Q ss_pred CCCCCCcEEeecccccCCcC--CCCcc--cccceeecccccCcccCCcchhhhccccceeccCCcccCCCCC--------
Q 005693 162 TSLPSLRYLYLQHNNFSGKI--PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-------- 229 (682)
Q Consensus 162 ~~l~~L~~L~L~~N~l~g~~--p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-------- 229 (682)
..+++|++|+|++|+|+..- +..+. ++|+.|+|++|+|+...+-.+....+|+.|+|++|.++.....
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 34555555555555555321 11121 4566666666666633222333344566666777766654442
Q ss_pred -CCCCCCCeEE
Q 005693 230 -FDIPKLRHLN 239 (682)
Q Consensus 230 -~~l~~L~~l~ 239 (682)
..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 1466676665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=4.1e-08 Score=104.01 Aligned_cols=108 Identities=22% Similarity=0.262 Sum_probs=65.9
Q ss_pred eEEEEEeCCCcccccCCccccCCCCCCcEEEccCCCCCC----CCCCcCCCCCCCcEEeecccccCC----cCCCCcc--
Q 005693 117 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSG----KIPSSFS-- 186 (682)
Q Consensus 117 ~v~~l~l~~~~l~g~lp~~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~-- 186 (682)
++..||++++++++.-=...+..+++|+.|+|++|+|+- .+...+..+++|+.|||++|+|+. .+...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 577788888877642111135566777788888887762 334445677777888887777752 1112221
Q ss_pred -cccceeecccccCccc----CCcchhhhccccceeccCCccc
Q 005693 187 -PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLS 224 (682)
Q Consensus 187 -~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 224 (682)
.+|++|+|++|+++.. ++..+..+++|+.|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 3577777777777643 3445555666666666666655
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.05 E-value=6.8e-08 Score=99.02 Aligned_cols=38 Identities=34% Similarity=0.419 Sum_probs=17.5
Q ss_pred cccceeecccccCccc----CCcchhhhccccceeccCCccc
Q 005693 187 PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLS 224 (682)
Q Consensus 187 ~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 224 (682)
++|+.|+|++|.|+.. +...+..+++|+.|+|++|+|+
T Consensus 215 ~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 215 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 3455555555554321 2233444445555555555544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=9.4e-06 Score=78.53 Aligned_cols=76 Identities=7% Similarity=0.043 Sum_probs=55.0
Q ss_pred cccccCe-EEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCC-CceeceEEEEEecCceEEEEeeccCCchh
Q 005693 392 VLGKGSY-GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLS 469 (682)
Q Consensus 392 ~lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 469 (682)
.+..|.. +.||+....++..+++|...... ..++..|...++.+..+ -.+.+++++..+++..++||++++|-++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3444543 67999988778788888765432 34678888888877543 23677888888888899999999886553
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=2.1e-07 Score=98.24 Aligned_cols=106 Identities=25% Similarity=0.358 Sum_probs=77.7
Q ss_pred CCcEEEccCCCCCCCC-CCcCCCCCCCcEEeecccccCC----cCCCCcc--cccceeecccccCccc----CCcchh-h
Q 005693 142 ALEVLSLRSNVLTGGL-PSEITSLPSLRYLYLQHNNFSG----KIPSSFS--PQLVVLDLSFNSFTGN----IPQSIQ-N 209 (682)
Q Consensus 142 ~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~--~~L~~L~ls~N~l~g~----~p~~~~-~ 209 (682)
+|+.||++.|++++.. ..-+..+++|+.|+|++|.++. .+...+. ++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998532 2345678999999999999873 2222222 6899999999999732 122222 2
Q ss_pred hccccceeccCCcccCC----CCC--CCCCCCCeEEecccCCCC
Q 005693 210 LTQLTGLSLQSNNLSGS----IPN--FDIPKLRHLNLSYNGLKG 247 (682)
Q Consensus 210 l~~L~~L~l~~N~l~g~----~p~--~~l~~L~~l~ls~N~l~g 247 (682)
..+|+.|+|++|+++.. ++. ..+++|++|+|++|+++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 34799999999999753 222 267899999999999873
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.83 E-value=3.8e-07 Score=93.28 Aligned_cols=110 Identities=19% Similarity=0.238 Sum_probs=62.3
Q ss_pred cCCCCCCcEEEccCCCCCCC----CCCcCCCCCCCcEEeecccccCCcCCCCc---------------ccccceeecccc
Q 005693 137 LGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSF---------------SPQLVVLDLSFN 197 (682)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~---------------~~~L~~L~ls~N 197 (682)
+...++|+.|+|++|.++.. +...+...++|+.|+|++|.++..-...+ .+.|+.|++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 45566777777777777643 22334456677777777776642110001 135667777777
Q ss_pred cCccc----CCcchhhhccccceeccCCcccCC-----CCC--CCCCCCCeEEecccCCC
Q 005693 198 SFTGN----IPQSIQNLTQLTGLSLQSNNLSGS-----IPN--FDIPKLRHLNLSYNGLK 246 (682)
Q Consensus 198 ~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~-----~p~--~~l~~L~~l~ls~N~l~ 246 (682)
+++.. +...+..++.|+.|+|++|+++.. +.. ...++|+.|+|++|.++
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 66522 233445566677777777766521 111 14566777777777664
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.45 E-value=9.5e-06 Score=73.38 Aligned_cols=106 Identities=13% Similarity=0.114 Sum_probs=60.6
Q ss_pred CCCCCCcEEEccCC-CCCCC----CCCcCCCCCCCcEEeecccccCCcCCCCcc------cccceeecccccCccc----
Q 005693 138 GKLDALEVLSLRSN-VLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN---- 202 (682)
Q Consensus 138 ~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~------~~L~~L~ls~N~l~g~---- 202 (682)
.+.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+.......+. +.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34567777777763 45421 222455666777777777777633222332 5677777777777643
Q ss_pred CCcchhhhccccceeccCCcccCCCC-------CC--CCCCCCeEEeccc
Q 005693 203 IPQSIQNLTQLTGLSLQSNNLSGSIP-------NF--DIPKLRHLNLSYN 243 (682)
Q Consensus 203 ~p~~~~~l~~L~~L~l~~N~l~g~~p-------~~--~l~~L~~l~ls~N 243 (682)
+-..+...++|+.|+|++|.+...-. .. ..++|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 22245555667777777776542111 00 3456677776554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.39 E-value=0.00031 Score=72.29 Aligned_cols=75 Identities=12% Similarity=0.149 Sum_probs=48.8
Q ss_pred ccccccCeEEEEEEEEcC-CceEEEEEeeccc--------cChhhHHHHHHHHHHhcCC--CceeceEEEEEecCceEEE
Q 005693 391 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--------VGKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSKDEKLLV 459 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lV 459 (682)
+.||.|....||+....+ ++.+++|.-.... ....+...|.+.+..+..+ ..+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 5678888653211 1223456788888877554 335555543 56677899
Q ss_pred EeeccCCc
Q 005693 460 YDYFASGS 467 (682)
Q Consensus 460 ~e~~~~g~ 467 (682)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.06 E-value=3.1e-05 Score=69.86 Aligned_cols=108 Identities=14% Similarity=0.183 Sum_probs=72.9
Q ss_pred CeEEEEEeCCCc-cccc----CCccccCCCCCCcEEEccCCCCCCC----CCCcCCCCCCCcEEeecccccCCcCCCCcc
Q 005693 116 TRVFGLRLPGIG-LVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS 186 (682)
Q Consensus 116 ~~v~~l~l~~~~-l~g~----lp~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 186 (682)
.+++.|+|++++ +... +-. .+...+.|+.|+|++|.+... +-..+...+.|+.|+|++|.|+..--..+.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~-~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHH-HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 467888888643 3321 111 466778899999999988632 223445568899999999998843222221
Q ss_pred ------cccceeecccccCccc-------CCcchhhhccccceeccCCccc
Q 005693 187 ------PQLVVLDLSFNSFTGN-------IPQSIQNLTQLTGLSLQSNNLS 224 (682)
Q Consensus 187 ------~~L~~L~ls~N~l~g~-------~p~~~~~l~~L~~L~l~~N~l~ 224 (682)
++|++|+|++|++... +...+...++|+.|+++.+...
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCch
Confidence 6799999999876632 3455666788999998877543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.68 E-value=0.0022 Score=65.68 Aligned_cols=73 Identities=12% Similarity=0.076 Sum_probs=50.2
Q ss_pred ccccccCeEEEEEEEEcCC--------ceEEEEEeeccccChhhHHHHHHHHHHhcCCCceeceEEEEEecCceEEEEee
Q 005693 391 EVLGKGSYGTAYKAVLEES--------TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 462 (682)
Q Consensus 391 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 462 (682)
+.|+-|-.-.+|++...++ ..|++++.- ......+..+|..+++.+..+.-..++++++. -.+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 4577788889999987543 345555543 33344566788889988877765667887763 2689999
Q ss_pred ccCCch
Q 005693 463 FASGSL 468 (682)
Q Consensus 463 ~~~g~L 468 (682)
++|-.+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.64 E-value=0.0057 Score=60.65 Aligned_cols=68 Identities=10% Similarity=0.044 Sum_probs=47.0
Q ss_pred EEEEEEEEcCCceEEEEEeeccccChhhHHHHHHHHHHhcCCC-ceeceE-----EEEEecCceEEEEeeccCC
Q 005693 399 GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLR-----AYYYSKDEKLLVYDYFASG 466 (682)
Q Consensus 399 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~-----~~~~~~~~~~lV~e~~~~g 466 (682)
-.||++..++|..+++|+........+++..|...+..+..+. -++..+ .........+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4799999999999999998765556778888998888875331 111111 1123455678899998763
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.30 E-value=0.00014 Score=65.23 Aligned_cols=107 Identities=16% Similarity=0.222 Sum_probs=57.8
Q ss_pred CCCCCCcEEEccC-CCCCCC----CCCcCCCCCCCcEEeecccccCCcCCCCcc------cccceeecccccCccc----
Q 005693 138 GKLDALEVLSLRS-NVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN---- 202 (682)
Q Consensus 138 ~~l~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~------~~L~~L~ls~N~l~g~---- 202 (682)
.+.++|++|+|++ |.++.. +-..+...++|+.|+|++|.++...-..+. ++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4456677777776 445421 122344566777777777776532222221 5677777777776533
Q ss_pred CCcchhhhccccceec--cCCcccCC----CCCC--CCCCCCeEEecccC
Q 005693 203 IPQSIQNLTQLTGLSL--QSNNLSGS----IPNF--DIPKLRHLNLSYNG 244 (682)
Q Consensus 203 ~p~~~~~l~~L~~L~l--~~N~l~g~----~p~~--~l~~L~~l~ls~N~ 244 (682)
+-..+...++|+.++| ++|.+... +... ..++|+.|+++.|.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2244556666765444 45555421 1111 45667777776554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.28 E-value=0.00044 Score=61.76 Aligned_cols=108 Identities=14% Similarity=0.139 Sum_probs=72.4
Q ss_pred CeEEEEEeCCC-cccc----cCCccccCCCCCCcEEEccCCCCCCC----CCCcCCCCCCCcEEeecccccCCcCCC---
Q 005693 116 TRVFGLRLPGI-GLVG----PIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPS--- 183 (682)
Q Consensus 116 ~~v~~l~l~~~-~l~g----~lp~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~--- 183 (682)
..++.|+|+++ +++. .+-. .+...++|+.|+|++|.++.. +-..+...++|+.|++++|.++...-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~-al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHH-HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 46777888763 3431 1111 466788999999999998743 223345678999999999998743211
Q ss_pred -Ccc--cccce--eecccccCcc----cCCcchhhhccccceeccCCccc
Q 005693 184 -SFS--PQLVV--LDLSFNSFTG----NIPQSIQNLTQLTGLSLQSNNLS 224 (682)
Q Consensus 184 -~~~--~~L~~--L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~ 224 (682)
.+. ++|+. |++++|.+.. .+...+...++|+.|+++.|+..
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 122 56776 4556778864 35556778899999999887654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.62 E-value=0.088 Score=51.18 Aligned_cols=29 Identities=21% Similarity=0.204 Sum_probs=25.7
Q ss_pred CcEecCCCCCCeEecCCCCeEEeecCCCC
Q 005693 509 KFTHGNIKASNVLINQDLDGCISDFGLTP 537 (682)
Q Consensus 509 ~ivHrDLk~~NILl~~~~~~kl~DfGla~ 537 (682)
.+||+|+.+.||+++++...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 38999999999999998877899999763
|